Gene,Phecode,RareGPS,Indication,Max phase,Gene expression,HGMD,Locus2gene,Mouse models,OTP clinical genetics,Text mining,Common variants,Rare variants,Rare variants (gene-level),Ultrarare variants (gene-level),Mantis-ML,Sources
MYH7,CV_414.1 [Hypertrophic cardiomyopathy],0.573,1,4.0,0.0,0.9,0.0,0.439,0.944,0.449,,5.924,0.216,0.196,0.996,5
VWF,GE_971.14 [Von Willebrand's disease],0.492,1,4.0,0.0,0.0,0.462,0.663,0.854,0.333,3.211,10.11,2.668,9.914,,4
MYH6,CV_414.1 [Hypertrophic cardiomyopathy],0.427,1,4.0,0.0,0.887,0.0,0.71,0.683,0.372,,2.878,0.326,0.426,0.982,5
HTT,GE_973.5 [Huntington's disease],0.41,1,3.0,0.0,0.0,0.0,0.394,0.701,0.973,,2.812,0.349,0.144,,4
TPM1,CV_414.1 [Hypertrophic cardiomyopathy],0.409,0,0.0,0.0,0.894,0.0,0.39,0.856,0.274,2.932,0.391,0.11,0.177,0.966,5
CACNA1A,GE_972.2 [Hereditary ataxia],0.404,1,4.0,0.0,0.898,0.0,0.517,0.884,0.096,4.164,3.517,0.164,0.125,0.999,5
DYSF,GE_972.9 [Muscular dystrophy],0.396,1,0.5,0.0,0.9,0.0,0.475,0.892,0.137,4.745,3.549,2.683,2.035,0.999,5
RYR1,GE_972.9 [Muscular dystrophy],0.394,1,1.0,0.0,0.892,0.0,0.486,0.883,0.134,,2.692,0.854,0.153,0.997,5
MYL2,CV_414.1 [Hypertrophic cardiomyopathy],0.391,1,4.0,0.0,0.892,0.0,0.646,0.838,0.191,2.897,2.809,0.231,0.169,0.92,5
SCO2,GE_963.1 [Lipid storage disorders],0.386,0,0.0,0.0,0.547,0.0,0.0,0.0,0.0,,0.108,0.221,0.115,0.98,2
DMD,GE_972.9 [Muscular dystrophy],0.381,1,4.0,0.069,0.9,0.0,0.594,0.865,0.108,4.685,3.088,0.229,4.213,0.996,6
HBB,GE_970.2 [Thalassemia],0.381,1,4.0,0.0,0.0,0.0,0.459,0.824,0.115,5.24,67.532,209.346,29.781,,4
RBM20,CV_414.1 [Hypertrophic cardiomyopathy],0.351,0,0.0,0.0,0.867,0.0,0.783,0.184,0.377,3.5,2.809,0.338,0.159,,4
ANKH,MS_703.2 [Chondrocalcinosis],0.34,0,0.0,0.0,0.304,0.0,0.408,0.839,0.259,3.938,2.428,0.242,0.7,,4
FHOD3,CV_414.1 [Hypertrophic cardiomyopathy],0.338,0,0.0,0.0,0.888,0.593,0.463,0.539,0.37,2.251,8.375,8.212,0.511,0.68,5
CAPN3,GE_972.9 [Muscular dystrophy],0.337,0,0.0,0.0,0.9,0.0,0.449,0.877,0.118,,3.576,0.199,0.1,0.994,5
KCNA1,GE_972.2 [Hereditary ataxia],0.336,1,2.0,0.15,0.889,0.0,0.36,0.208,0.175,2.909,1.189,0.084,0.093,0.969,6
SOST,CM_770.5 [Congenital osteodystrophies],0.336,1,3.0,0.0,0.857,0.0,0.4,0.743,0.175,,0.103,0.093,0.065,0.957,4
NDUFS6,CV_414.1 [Hypertrophic cardiomyopathy],0.335,0,0.0,0.0,0.426,0.0,0.292,0.0,0.0,1.35,0.188,0.199,0.136,0.998,4
TMEM67,GE_972.2 [Hereditary ataxia],0.33,0,0.0,0.0,0.426,0.0,0.0,0.29,0.0,2.359,2.655,0.271,0.306,0.996,3
CYP11B2,EM_211.1 [Adrenal hyperfunction],0.325,1,4.0,0.213,0.0,0.0,0.404,0.454,0.134,,1.261,0.419,0.153,,4
FGFR3,GE_978.3 [Osteochondrodysplasias],0.323,1,2.0,0.0,0.0,0.0,0.475,0.822,0.179,,3.679,3.151,3.494,,4
TNFSF11,CM_770.5 [Congenital osteodystrophies],0.322,1,3.0,0.0,0.801,0.0,0.355,0.701,0.136,4.245,2.613,0.146,0.054,0.996,5
NR3C1,EM_211.1 [Adrenal hyperfunction],0.321,1,4.0,0.0,0.0,0.0,0.47,0.0,0.123,3.387,2.714,0.176,0.163,,3
PKHD1,GE_976.5 [Polycystic kidney disease],0.32,0,0.0,0.0,0.0,0.0,0.429,0.822,0.268,4.143,3.411,2.34,0.635,,4
LARGE1,GE_972.9 [Muscular dystrophy],0.32,0,0.0,0.0,0.84,0.0,0.392,0.161,0.098,2.861,2.664,0.179,0.139,,4
TNNI3,CV_414.1 [Hypertrophic cardiomyopathy],0.316,0,0.0,0.0,0.896,0.0,0.561,0.891,0.874,,4.528,0.159,1.567,0.977,5
SCO2,NS_341.1 [Cerebral palsy],0.315,0,0.0,0.0,0.547,0.0,0.0,0.0,0.0,,3.157,0.351,0.139,0.985,3
SMN1,NS_323.3 [Motor neuron disease],0.312,1,4.0,0.0,0.654,0.0,0.435,0.686,0.102,,0.093,0.093,,0.003,4
CP,GE_972.2 [Hereditary ataxia],0.312,0,0.0,0.0,0.0,0.0,0.368,0.623,0.119,,2.23,0.181,0.134,0.729,5
SCN4A,NS_339.2 [Myotonic disorders],0.309,1,4.0,0.0,0.0,0.0,0.434,0.883,0.085,,3.533,0.145,1.109,,4
ACE,GU_580.1 [Acute nephritic syndrome],0.308,1,4.0,0.0,0.532,0.0,0.521,0.0,0.183,3.973,2.575,0.347,0.334,0.913,5
PRKAG2,CV_414.1 [Hypertrophic cardiomyopathy],0.307,0,0.0,0.0,0.89,0.0,0.345,0.795,0.346,2.41,2.745,0.162,0.166,0.994,5
NDUFA10,GE_972.2 [Hereditary ataxia],0.298,1,4.0,0.0,0.426,0.0,0.0,0.0,0.0,3.467,3.121,3.083,1.583,0.99,3
PYGM,GE_964.3 [Glycogen storage disease],0.297,0,0.0,0.0,0.0,0.0,0.418,0.9,0.108,,9.69,9.319,0.639,,4
FYCO1,CM_751.213 [Congenital cataract],0.296,0,0.0,0.0,0.872,0.0,0.381,0.635,0.143,3.417,2.711,0.622,0.411,0.992,5
ENG,GE_975.2 [Hereditary hemorrhagic telangiectasia],0.294,0,0.0,0.0,0.0,0.0,0.363,0.906,0.436,,2.788,0.16,23.274,,4
AVP,EM_209.4 [Diabetes insipidus],0.293,1,0.5,0.0,0.895,0.0,0.388,0.811,0.429,,0.237,0.193,4.213,0.935,5
FKRP,GE_972.9 [Muscular dystrophy],0.291,0,0.0,0.0,0.898,0.0,0.411,0.872,0.083,,2.234,0.173,0.121,1.0,5
COL1A1,CM_770.5 [Congenital osteodystrophies],0.289,0,0.0,0.0,0.304,0.0,0.38,0.788,0.148,2.92,3.313,3.059,33.848,0.958,5
AVPR2,EM_209.4 [Diabetes insipidus],0.287,1,4.0,0.0,0.899,0.0,0.359,0.783,0.128,,2.248,0.055,0.059,0.829,5
PDC,SO_386.6 [Night blindness],0.286,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.189,0.231,0.108,0.991,1
COL6A1,GE_972.9 [Muscular dystrophy],0.285,0,0.0,0.043,0.898,0.0,0.423,0.82,0.099,2.819,2.787,0.313,1.474,0.989,6
CYP11B1,EM_211.1 [Adrenal hyperfunction],0.283,1,4.0,0.0,0.0,0.0,0.404,0.716,0.087,,2.271,0.943,0.176,,4
ALPK3,CV_414.1 [Hypertrophic cardiomyopathy],0.281,0,0.0,0.0,0.89,0.324,0.648,0.834,0.705,2.714,4.129,5.401,5.76,0.85,5
ANK1,GE_970.61 [Hereditary spherocytosis],0.281,0,0.0,0.0,0.0,0.0,0.449,0.771,0.191,2.135,0.869,0.187,20.705,,4
RAF1,CV_414.1 [Hypertrophic cardiomyopathy],0.278,0,0.0,0.0,0.869,0.0,0.431,0.453,0.119,,1.76,0.362,0.168,0.971,5
NEB,GE_972.9 [Muscular dystrophy],0.278,0,0.0,0.0,0.871,0.0,0.396,0.644,0.142,2.106,3.451,0.195,0.921,0.976,5
TTN,CV_414.1 [Hypertrophic cardiomyopathy],0.277,0,0.0,0.0,0.892,0.0,0.619,0.624,0.425,3.086,3.819,0.195,1.06,0.993,5
CACNA1C,CV_414.1 [Hypertrophic cardiomyopathy],0.275,1,4.0,0.0,0.796,0.0,0.604,0.479,0.179,3.553,2.326,0.534,0.404,0.867,5
CACNA1H,NS_341.1 [Cerebral palsy],0.273,0,0.0,0.0,0.426,0.0,0.0,0.0,0.0,2.759,3.63,0.349,1.774,0.968,3
NDUFS6,GE_972.2 [Hereditary ataxia],0.273,1,4.0,0.0,0.0,0.0,0.0,0.0,0.0,1.974,0.116,0.138,0.078,0.986,2
CRYBA1,CM_751.213 [Congenital cataract],0.271,0,0.0,0.0,0.822,0.0,0.603,0.803,0.099,,2.504,0.158,0.121,0.992,5
EXT1,CM_770.5 [Congenital osteodystrophies],0.271,0,0.0,0.0,0.0,0.0,0.424,0.904,0.122,3.103,1.819,0.153,11.369,0.737,5
KIT,GE_977.6 [Congenital cutaneous mastocytosis*],0.27,1,4.0,0.0,0.0,0.0,0.373,0.83,0.253,2.727,0.257,0.08,0.071,,4
G6PC1,GE_964.3 [Glycogen storage disease],0.27,0,0.0,0.0,0.0,0.0,0.473,0.852,0.106,,0.178,0.411,0.125,,3
SCN5A,CV_414.1 [Hypertrophic cardiomyopathy],0.267,1,4.0,0.0,0.877,0.0,0.842,0.189,0.244,2.064,2.861,0.126,0.686,0.967,5
REN,GU_580.1 [Acute nephritic syndrome],0.267,1,4.0,0.0,0.0,0.0,0.393,0.176,0.14,,1.37,0.219,0.121,0.745,5
TNFRSF11A,MS_727.3 [Osteitis deformans [Paget's disease of bone]],0.267,0,0.0,0.0,0.0,0.69,0.392,0.731,0.151,1.877,2.831,0.06,0.094,,4
NDUFAF6,NS_341.1 [Cerebral palsy],0.267,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.365,0.298,0.102,0.984,1
PFKM,GE_964.3 [Glycogen storage disease],0.266,0,0.0,0.0,0.0,0.0,0.362,0.87,0.129,,4.253,2.255,0.194,,4
NDUFA12,GE_972.2 [Hereditary ataxia],0.265,1,4.0,0.0,0.0,0.0,0.0,0.0,0.0,2.704,2.206,0.191,0.106,0.982,2
OR13C9,NS_341.1 [Cerebral palsy],0.264,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.74,0.228,0.075,1.0,2
TNF,MS_705.2 [Juvenile rheumatoid arthritis [JRA/JIA]],0.263,1,4.0,0.0,0.35,0.0,0.4,0.0,0.313,,0.256,0.148,0.032,,3
FUS,NS_323.3 [Motor neuron disease],0.262,1,3.0,0.0,0.896,0.0,0.366,0.759,0.109,,3.062,0.236,1.797,0.999,5
LAMA2,GE_972.9 [Muscular dystrophy],0.262,0,0.0,0.0,0.899,0.0,0.507,0.824,0.114,2.523,3.41,0.35,0.158,0.998,5
SLC24A1,SO_386.6 [Night blindness],0.261,0,0.0,0.0,0.881,0.0,0.373,0.733,0.067,,3.352,0.349,0.168,0.993,5
NDUFA4,CV_414.1 [Hypertrophic cardiomyopathy],0.26,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.446,0.267,0.172,0.133,0.997,2
CACNB4,GE_972.2 [Hereditary ataxia],0.259,1,4.0,0.0,0.654,0.0,0.306,0.246,0.018,1.408,1.912,0.224,0.207,0.961,5
NRL,SO_369.62 [Keratoconus],0.259,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.344,0.161,0.154,0.999,2
GLA,GE_963.1 [Lipid storage disorders],0.259,1,4.0,0.0,0.9,0.0,0.0,0.96,0.119,1.555,8.145,0.012,6.471,0.57,4
FSCN2,SO_386.5 [Color vision deficiencies],0.258,0,0.0,0.0,0.0,0.0,0.413,0.0,0.0,,2.895,0.189,0.108,0.997,3
GDF5,CM_770.5 [Congenital osteodystrophies],0.257,0,0.0,0.0,0.0,0.0,0.478,0.721,0.107,,3.078,0.153,0.118,0.909,5
RCVRN,SO_386.5 [Color vision deficiencies],0.257,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.466,0.209,0.147,0.079,0.996,2
ALS2,NS_323.3 [Motor neuron disease],0.257,0,0.0,0.0,0.894,0.0,0.419,0.609,0.142,,2.669,0.387,0.034,0.998,5
IGHMBP2,NS_323.3 [Motor neuron disease],0.256,0,0.0,0.0,0.532,0.0,0.402,0.893,0.13,,2.703,0.484,2.096,0.257,5
SQSTM1,MS_727.3 [Osteitis deformans [Paget's disease of bone]],0.254,0,0.0,0.0,0.0,0.0,0.356,0.869,0.15,,17.709,2.625,1.939,,4
CEP290,GE_972.2 [Hereditary ataxia],0.254,0,0.0,0.0,0.808,0.0,0.0,0.37,0.0,2.314,3.396,0.583,0.402,0.998,3
NPC1,GE_972.2 [Hereditary ataxia],0.253,0,0.0,0.0,0.864,0.0,0.361,0.462,0.157,1.659,2.725,0.196,0.319,0.91,5
MYL3,CV_414.1 [Hypertrophic cardiomyopathy],0.252,1,4.0,0.0,0.889,0.0,0.0,0.834,0.075,,2.29,0.227,0.159,0.941,4
SLC4A1,GE_970.61 [Hereditary spherocytosis],0.252,0,0.0,0.0,0.0,0.0,0.376,0.717,0.139,,2.887,0.352,46.479,,4
NDUFS4,NS_341.1 [Cerebral palsy],0.25,1,2.0,0.0,0.0,0.0,0.0,0.0,0.0,1.75,0.228,0.182,0.079,0.989,2
FGFR3,CM_770.5 [Congenital osteodystrophies],0.246,1,2.0,0.0,0.0,0.0,0.461,0.822,0.166,2.239,3.726,4.414,3.373,0.946,5
TMEM126B,CV_414.1 [Hypertrophic cardiomyopathy],0.245,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.529,0.839,0.125,0.979,2
C20orf144,SO_369.62 [Keratoconus],0.245,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.825,0.431,0.095,0.996,2
UMOD,GU_580.1 [Acute nephritic syndrome],0.244,0,0.0,0.0,0.837,0.0,0.479,0.618,0.333,,1.802,0.29,0.169,0.629,5
TNFSF11,GE_978.3 [Osteochondrodysplasias],0.243,1,3.0,0.0,0.0,0.0,0.367,0.701,0.141,3.94,2.738,0.145,0.047,,4
VAPB,NS_323.3 [Motor neuron disease],0.242,0,0.0,0.0,0.857,0.0,0.408,0.639,0.095,2.96,2.502,2.34,0.141,0.996,5
TTN,GE_972.9 [Muscular dystrophy],0.242,0,0.0,0.018,0.897,0.102,0.35,0.626,0.129,1.957,5.23,1.973,0.506,0.997,6
OR13F1,GE_972.2 [Hereditary ataxia],0.241,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.953,2.642,0.088,1.0,2
SMN2,NS_323.3 [Motor neuron disease],0.24,1,4.0,0.0,0.0,0.0,0.435,0.29,0.131,,0.049,,0.09,0.977,4
NDUFV2,GE_972.2 [Hereditary ataxia],0.24,1,4.0,0.0,0.654,0.0,0.0,0.0,0.0,1.99,0.171,0.36,0.166,0.994,3
AQP2,EM_209.4 [Diabetes insipidus],0.24,1,0.5,0.0,0.894,0.0,0.353,0.736,0.149,,2.746,0.146,1.982,0.817,5
PANK2,NS_341.1 [Cerebral palsy],0.24,0,0.0,0.0,0.547,0.0,0.0,0.0,0.0,,3.155,0.216,0.153,0.989,3
APP,NS_323.3 [Motor neuron disease],0.239,1,2.0,0.029,0.426,0.0,0.403,0.0,0.132,2.684,2.17,0.165,1.065,0.995,6
EXT1,GE_978.3 [Osteochondrodysplasias],0.238,0,0.0,0.0,0.0,0.0,0.43,0.904,0.113,1.792,1.623,0.144,10.322,,4
NEXN,CV_414.1 [Hypertrophic cardiomyopathy],0.237,0,0.0,0.0,0.844,0.0,0.749,0.64,0.136,,2.84,0.241,0.195,0.848,5
CLCN7,CM_770.5 [Congenital osteodystrophies],0.237,1,0.5,0.0,0.897,0.0,0.404,0.847,0.127,2.344,1.342,0.383,1.189,0.98,5
RP1L1,SO_369.62 [Keratoconus],0.237,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.386,3.642,1.221,0.268,0.992,2
RCVRN,SO_386.6 [Night blindness],0.235,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.888,1.658,0.184,0.113,0.994,2
ATCAY,GE_972.2 [Hereditary ataxia],0.235,0,0.0,0.151,0.801,0.0,0.414,0.547,0.084,2.25,2.696,0.19,0.165,0.808,6
DNAJC19,CV_414.1 [Hypertrophic cardiomyopathy],0.235,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.934,0.166,0.082,0.108,0.988,2
F8,GE_971.11 [Hereditary factor VIII deficiency [Hemophilia A]],0.234,1,4.0,0.0,0.0,0.0,0.0,0.917,0.597,,10.144,0.092,43.243,,3
NDUFB10,GE_963.1 [Lipid storage disorders],0.233,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.13,0.135,0.069,0.977,1
GARS1,GE_972.1 [Hereditary neuropathy],0.232,0,0.0,0.0,0.0,0.0,0.35,0.831,0.231,,0.305,0.455,0.269,,3
SGCD,GE_972.9 [Muscular dystrophy],0.231,0,0.0,0.0,0.876,0.0,0.403,0.67,0.087,2.112,2.467,0.186,0.13,0.994,5
C8orf76,CM_770.5 [Congenital osteodystrophies],0.231,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.547,1.88,0.107,0.998,2
HSF4,CM_751.213 [Congenital cataract],0.23,0,0.0,0.0,0.852,0.0,0.724,0.281,0.281,,0.426,0.227,0.138,0.999,4
NDUFAF6,GE_963.1 [Lipid storage disorders],0.23,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.984,1.933,1.745,0.06,0.998,2
EMX2,NS_347.1 [Cerebral cysts],0.23,0,0.0,0.0,0.0,0.0,0.39,0.744,0.1,2.952,1.074,,0.081,,4
APP,EM_249.1 [Cerebral amyloid angiopathy*],0.229,1,2.0,0.0,0.817,0.0,0.339,0.713,0.181,3.721,0.18,0.34,0.169,,4
TTC7A,BI_179.1 [Hypogammaglobulinemia NOS],0.228,0,0.0,0.0,0.684,0.0,0.0,0.0,0.0,1.358,3.291,0.268,0.234,0.98,3
PKD1,GE_976.5 [Polycystic kidney disease],0.228,0,0.0,0.0,0.0,0.0,0.459,0.739,0.28,1.449,5.034,1.444,118.64,,4
AHI1,SO_386.6 [Night blindness],0.228,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.273,3.565,0.386,0.74,0.979,2
CNR1,MB_305.1 [Tics and tic disorders],0.227,1,2.0,0.0,0.0,0.0,0.378,0.0,0.167,3.047,0.123,0.092,0.105,,3
NDUFS6,NS_341.1 [Cerebral palsy],0.227,1,2.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.083,0.1,0.087,0.996,1
CACNA1G,GE_972.2 [Hereditary ataxia],0.227,1,4.0,0.038,0.856,0.0,0.431,0.261,0.059,,3.214,0.996,0.323,0.953,6
LMNA,GE_972.9 [Muscular dystrophy],0.227,0,0.0,0.0,0.898,0.0,0.387,0.591,0.09,,1.23,0.134,0.107,0.998,4
PRLR,EM_209.13 [Hyperprolactinemia*],0.226,1,2.0,0.0,0.745,0.0,0.392,0.646,0.106,1.9,0.298,0.166,0.129,,4
NRL,SO_380.3 [Optic atrophy],0.225,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.406,0.189,0.123,0.988,1
CRYGB,CM_751.213 [Congenital cataract],0.225,0,0.0,0.0,0.654,0.0,0.878,0.533,0.0,,0.25,0.318,0.104,0.988,3
NDUFB4,NS_341.1 [Cerebral palsy],0.224,1,2.0,0.0,0.0,0.0,0.0,0.0,0.0,2.198,0.123,0.189,0.08,0.983,2
IMPG1,SO_386.5 [Color vision deficiencies],0.223,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.459,1.236,0.24,0.128,0.991,2
LDB3,CV_414.1 [Hypertrophic cardiomyopathy],0.223,0,0.0,0.0,0.844,0.0,0.516,0.797,0.24,1.795,3.408,0.183,0.14,0.99,5
SCN8A,GE_972.2 [Hereditary ataxia],0.223,1,2.0,0.0,0.808,0.0,0.447,0.209,0.169,1.673,2.926,2.01,0.194,0.988,5
RP1L1,SO_386.6 [Night blindness],0.223,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.119,2.968,0.216,0.864,0.997,2
MSTN,NS_323.3 [Motor neuron disease],0.222,1,3.0,0.0,0.0,0.0,0.503,0.0,0.149,,2.875,1.201,0.171,0.087,4
NDUFV3,GE_972.2 [Hereditary ataxia],0.222,1,4.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.388,0.823,0.157,0.991,2
NDUFAF1,GE_972.2 [Hereditary ataxia],0.222,1,4.0,0.0,0.0,0.0,0.0,0.0,0.0,2.414,2.483,0.263,0.168,0.979,2
PLP1,GE_963.1 [Lipid storage disorders],0.221,0,0.0,0.0,0.898,0.0,0.352,0.906,0.225,,0.035,0.02,2.588,0.98,5
PROM1,SO_386.5 [Color vision deficiencies],0.22,0,0.0,0.0,0.547,0.0,0.35,0.0,0.0,2.074,3.239,0.333,0.146,0.996,4
JPH2,CV_414.1 [Hypertrophic cardiomyopathy],0.22,0,0.0,0.0,0.861,0.0,0.629,0.779,0.504,,5.084,2.518,0.261,0.952,5
CLCN7,GE_978.3 [Osteochondrodysplasias],0.22,1,0.5,0.0,0.0,0.0,0.409,0.847,0.127,1.331,1.849,0.329,1.352,,4
PAX2,GU_580.52 [Diffuse membranous glomerulonephritis],0.219,0,0.0,0.0,0.0,0.0,0.506,0.835,0.153,,0.223,0.105,0.1,,3
TPP1,GE_972.2 [Hereditary ataxia],0.218,0,0.0,0.0,0.854,0.0,0.417,0.792,0.149,2.542,2.892,0.571,0.2,0.986,5
PMP22,GE_972.1 [Hereditary neuropathy],0.218,1,0.5,0.0,0.0,0.0,0.444,0.84,0.099,3.592,1.968,0.49,2.032,,4
PEX2,NS_341.1 [Cerebral palsy],0.218,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.201,0.353,0.238,0.118,0.976,2
NDUFB3,GE_972.2 [Hereditary ataxia],0.217,1,4.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.777,0.829,0.069,0.992,1
ANO5,GE_972.9 [Muscular dystrophy],0.217,0,0.0,0.0,0.897,0.392,0.312,0.813,0.154,2.326,2.623,2.421,0.158,0.987,5
GJA3,CM_751.213 [Congenital cataract],0.217,0,0.0,0.0,0.888,0.0,0.749,0.873,0.083,,1.031,0.142,2.097,1.0,5
CSRP3,CV_414.1 [Hypertrophic cardiomyopathy],0.217,0,0.0,0.0,0.884,0.0,0.655,0.69,0.818,2.99,3.455,0.339,1.938,0.815,5
DMD,CV_414.1 [Hypertrophic cardiomyopathy],0.215,0,0.0,0.0,0.728,0.0,0.519,0.16,0.174,3.524,2.882,0.57,0.17,0.927,5
MUSK,NS_338.1 [Myasthenia gravis],0.215,1,0.5,0.0,0.0,0.0,0.459,0.84,0.149,2.069,2.26,1.524,0.288,,4
PTH1R,CM_770.5 [Congenital osteodystrophies],0.215,1,4.0,0.0,0.853,0.0,0.285,0.705,0.084,2.7,2.933,0.105,0.062,0.879,5
COX19,CV_414.1 [Hypertrophic cardiomyopathy],0.214,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.94,1.343,0.195,0.141,0.99,2
CACNA2D2,GE_972.2 [Hereditary ataxia],0.214,1,4.0,0.0,0.547,0.0,0.35,0.402,0.052,,3.328,0.357,0.233,0.936,5
NDUFB4,CV_414.1 [Hypertrophic cardiomyopathy],0.214,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.213,0.349,0.129,0.986,1
GJB1,GE_972.1 [Hereditary neuropathy],0.213,0,0.0,0.0,0.0,0.0,0.367,0.815,0.122,1.85,1.901,,7.457,,4
GUCA1B,SO_386.6 [Night blindness],0.213,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.172,0.203,0.074,0.998,1
NPR2,GE_978.3 [Osteochondrodysplasias],0.212,1,4.0,0.0,0.0,0.0,0.356,0.0,0.098,,1.743,0.145,0.123,,3
ACVRL1,GE_975.2 [Hereditary hemorrhagic telangiectasia],0.212,0,0.0,0.0,0.0,0.0,0.355,0.769,0.175,1.529,0.23,0.166,29.844,,4
SOD1,NS_323.3 [Motor neuron disease],0.212,1,4.0,0.0,0.898,0.0,0.0,0.777,0.141,1.888,5.708,5.352,1.835,1.0,4
DNM2,GE_972.9 [Muscular dystrophy],0.212,1,0.5,0.0,0.813,0.0,0.46,0.888,0.118,,1.433,0.219,0.125,0.96,5
FKRP,SO_380.3 [Optic atrophy],0.212,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.709,1.837,0.25,0.132,0.979,2
OR1M1,BI_179.1 [Hypogammaglobulinemia NOS],0.211,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,1.761,0.175,0.08,0.991,2
NR3C1,DE_663.1 [Pemphigus],0.211,1,4.0,0.0,0.0,0.0,0.305,0.0,0.231,2.306,0.213,0.08,0.089,,3
CRYGA,CM_751.213 [Congenital cataract],0.211,0,0.0,0.0,0.547,0.0,0.814,0.008,0.0,,1.897,0.257,0.102,0.997,4
GAA,GE_964.3 [Glycogen storage disease],0.21,1,4.0,0.0,0.0,0.0,0.395,0.926,0.124,1.857,3.229,1.088,0.293,,4
PTPRO,GU_580.52 [Diffuse membranous glomerulonephritis],0.21,0,0.0,0.0,0.0,0.0,0.467,0.0,0.124,3.393,0.595,0.377,0.174,,3
PTGS2,SO_365.3 [Exophthalmos [Proptosis]],0.21,1,4.0,0.0,0.0,0.0,0.0,0.0,0.076,3.586,2.225,0.18,0.169,0.953,3
NEFH,NS_323.3 [Motor neuron disease],0.21,0,0.0,0.0,0.885,0.0,0.376,0.185,0.099,1.313,3.024,0.199,0.175,0.994,5
FOXRED1,GE_963.1 [Lipid storage disorders],0.21,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.905,0.214,0.355,0.115,0.986,2
ETS1,GI_542.8 [Biliary cirrhosis],0.21,0,0.0,0.0,0.0,0.475,0.0,0.0,0.523,3.588,0.633,0.1,0.136,,2
COX7A1,CV_414.1 [Hypertrophic cardiomyopathy],0.21,0,0.0,0.0,0.0,0.0,0.518,0.0,0.0,,1.679,0.36,0.09,0.988,3
NMNAT1,SO_386.6 [Night blindness],0.21,0,0.0,0.0,0.547,0.0,0.275,0.0,0.0,,0.396,0.153,0.1,0.998,3
PPARGC1A,CV_414.1 [Hypertrophic cardiomyopathy],0.209,0,0.0,0.0,0.0,0.0,0.485,0.0,0.211,3.315,2.593,2.057,0.405,0.974,4
LMNA,CV_414.1 [Hypertrophic cardiomyopathy],0.209,0,0.0,0.0,0.817,0.0,0.703,0.405,0.158,,1.864,0.284,0.206,0.993,5
TRIM32,GE_972.9 [Muscular dystrophy],0.208,0,0.0,0.0,0.881,0.0,0.368,0.54,0.098,2.339,1.7,0.175,0.105,0.92,5
MYO1E,GU_580.52 [Diffuse membranous glomerulonephritis],0.208,0,0.0,0.0,0.0,0.0,0.678,0.783,0.098,2.962,4.046,1.369,1.07,,4
DNM2,GE_972.1 [Hereditary neuropathy],0.208,0,0.0,0.0,0.0,0.0,0.363,0.888,0.129,,2.54,0.39,0.246,,4
CERKL,SO_386.5 [Color vision deficiencies],0.206,0,0.0,0.0,0.0,0.0,0.416,0.0,0.0,2.235,0.439,0.303,0.118,0.997,3
ITPR1,GE_972.2 [Hereditary ataxia],0.206,0,0.0,0.0,0.888,0.0,0.302,0.207,0.104,2.485,3.659,0.11,0.372,0.995,5
ALOX12B,GE_977.1 [Congenital ichthyosis],0.206,0,0.0,0.0,0.883,0.0,0.383,0.742,0.086,2.668,0.296,0.157,0.089,0.999,5
PRKCA,CV_414.1 [Hypertrophic cardiomyopathy],0.206,0,0.0,0.0,0.0,0.695,0.358,0.0,0.27,6.538,1.895,0.902,0.211,0.831,4
GATA4,CM_763.31 [Ventricular septal defect],0.206,0,0.0,0.0,0.883,0.0,0.421,0.434,0.405,,2.505,2.305,0.081,0.914,5
KCNJ10,GE_972.2 [Hereditary ataxia],0.206,0,0.0,0.0,0.882,0.0,0.286,0.362,0.181,,2.724,0.093,0.147,0.921,5
MTOR,CV_414.1 [Hypertrophic cardiomyopathy],0.206,1,3.0,0.0,0.0,0.0,0.0,0.0,0.184,2.312,2.471,0.206,0.752,0.984,3
AHI1,SO_380.3 [Optic atrophy],0.205,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.378,3.525,0.588,0.67,0.978,2
INPP5E,GE_972.2 [Hereditary ataxia],0.204,0,0.0,0.0,0.745,0.0,0.0,0.0,0.0,1.913,1.076,0.355,1.053,0.984,3
EMD,GE_972.9 [Muscular dystrophy],0.204,0,0.0,0.0,0.896,0.0,0.351,0.487,0.172,,0.064,0.078,2.791,0.886,5
NDUFAF6,GE_972.2 [Hereditary ataxia],0.204,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.223,3.337,0.372,0.106,0.98,2
MYBPC3,CV_414.1 [Hypertrophic cardiomyopathy],0.204,1,0.5,0.0,0.9,0.0,0.696,0.928,0.933,2.067,12.056,15.827,33.77,0.973,5
COX20,CV_414.1 [Hypertrophic cardiomyopathy],0.203,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.698,0.518,0.283,0.174,0.997,2
BOLA3,NS_341.1 [Cerebral palsy],0.203,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.276,0.188,0.079,0.985,1
RCVRN,SO_369.62 [Keratoconus],0.203,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.638,2.687,0.32,0.121,0.991,2
CACNA1H,GE_972.2 [Hereditary ataxia],0.202,1,4.0,0.0,0.0,0.0,0.0,0.0,0.0,2.575,3.296,0.37,1.108,0.948,2
DES,GE_972.9 [Muscular dystrophy],0.202,1,0.5,0.0,0.865,0.0,0.449,0.724,0.068,,0.7,0.293,1.694,0.993,5
SLC6A4,MB_305.1 [Tics and tic disorders],0.202,1,4.0,0.0,0.0,0.0,0.459,0.0,0.311,1.639,2.216,0.087,0.09,,3
POMGNT1,GE_972.9 [Muscular dystrophy],0.201,0,0.0,0.0,0.887,0.0,0.276,0.69,0.111,,3.695,0.375,0.163,0.999,5
SOST,MS_727.3 [Osteitis deformans [Paget's disease of bone]],0.201,1,4.0,0.0,0.0,0.0,0.483,0.0,0.205,,2.947,0.15,0.118,,3
BLK,BI_179.1 [Hypogammaglobulinemia NOS],0.201,0,0.0,0.0,0.426,0.0,0.0,0.0,0.0,1.872,1.977,1.771,0.161,0.992,3
NDUFB3,GE_963.1 [Lipid storage disorders],0.2,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.321,0.342,0.029,0.979,1
C20orf144,CM_763.31 [Ventricular septal defect],0.2,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,3.737,0.004,0.033,1.0,2
NDUFAF6,CV_414.1 [Hypertrophic cardiomyopathy],0.2,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.79,0.286,1.606,0.998,2
MKKS,SO_369.62 [Keratoconus],0.2,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.011,2.197,0.197,0.205,0.99,2
RDH12,SO_386.5 [Color vision deficiencies],0.199,0,0.0,0.0,0.547,0.0,0.0,0.0,0.0,,0.105,0.242,0.09,1.0,2
PEX5,CM_763.31 [Ventricular septal defect],0.198,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.446,2.461,0.295,0.171,0.983,2
CASR,EM_208.1 [Hypoparathyroidism],0.198,1,0.5,0.0,0.889,0.0,0.652,0.837,0.194,,2.859,1.444,3.134,0.953,5
SYNE1,GE_972.9 [Muscular dystrophy],0.198,0,0.0,0.0,0.859,0.0,0.316,0.2,0.084,3.734,3.968,0.225,0.344,0.977,5
TMEM126B,GE_963.1 [Lipid storage disorders],0.197,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.25,0.298,0.06,0.977,2
NDUFB6,GE_972.2 [Hereditary ataxia],0.197,1,4.0,0.0,0.0,0.0,0.0,0.0,0.0,1.449,0.352,0.149,0.101,0.979,2
SCN4A,NS_323.3 [Motor neuron disease],0.197,1,4.0,0.0,0.0,0.0,0.455,0.0,0.015,,3.305,1.583,0.576,0.07,4
SYT2,NS_338.1 [Myasthenia gravis],0.197,0,0.0,0.0,0.0,0.0,0.49,0.771,0.118,1.889,3.412,1.858,0.126,,4
NPR2,CM_770.5 [Congenital osteodystrophies],0.197,1,4.0,0.0,0.0,0.0,0.349,0.92,0.082,,1.77,0.167,0.132,0.725,5
ABCA12,GE_977.1 [Congenital ichthyosis],0.197,0,0.0,0.0,0.887,0.0,0.385,0.717,0.112,1.556,1.797,0.293,0.212,0.999,5
SETX,NS_323.3 [Motor neuron disease],0.197,0,0.0,0.0,0.894,0.0,0.251,0.26,0.109,1.679,2.88,0.677,0.435,0.998,5
NLRP3,DE_663.1 [Pemphigus],0.197,1,1.0,0.0,0.0,0.0,0.457,0.0,0.162,1.569,0.202,0.091,0.101,,3
NDUFA8,NS_341.1 [Cerebral palsy],0.196,1,2.0,0.0,0.0,0.0,0.0,0.0,0.0,1.71,0.188,0.224,1.823,0.994,2
COL1A1,GE_978.3 [Osteochondrodysplasias],0.194,0,0.0,0.0,0.0,0.0,0.389,0.642,0.151,2.582,3.633,3.222,35.137,,4
SNX10,CM_770.5 [Congenital osteodystrophies],0.194,0,0.0,0.0,0.867,0.0,0.372,0.834,0.164,2.586,0.13,0.105,0.071,0.91,5
GLA,CV_414.1 [Hypertrophic cardiomyopathy],0.194,0,0.0,0.0,0.891,0.0,0.651,0.446,0.155,1.685,5.583,0.036,3.431,0.982,5
MKKS,SO_386.6 [Night blindness],0.194,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.011,2.077,0.189,0.152,0.996,2
NDUFA12,CV_414.1 [Hypertrophic cardiomyopathy],0.194,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.71,2.543,0.274,0.167,0.972,2
SPTBN2,GE_972.2 [Hereditary ataxia],0.194,0,0.0,0.0,0.889,0.0,0.396,0.761,0.044,,3.229,0.515,1.175,0.99,5
SFRP4,CM_770.5 [Congenital osteodystrophies],0.193,0,0.0,0.0,0.836,0.0,0.435,0.732,0.093,1.86,0.245,0.193,0.129,0.811,5
ERBB2,GE_964.3 [Glycogen storage disease],0.193,0,0.0,0.0,0.0,0.0,0.383,0.0,0.103,,3.515,2.902,0.104,,3
CRB1,SO_380.3 [Optic atrophy],0.192,0,0.0,0.0,0.547,0.0,0.0,0.0,0.0,2.407,3.265,0.267,0.138,0.993,3
PTGS2,GU_580.1 [Acute nephritic syndrome],0.192,1,3.0,0.0,0.0,0.0,0.27,0.0,0.11,2.658,0.113,0.113,0.111,0.992,4
CNGA1,SO_380.3 [Optic atrophy],0.191,0,0.0,0.0,0.0,0.0,0.325,0.0,0.0,,0.138,0.343,0.16,0.992,2
FSCN2,SO_369.62 [Keratoconus],0.191,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.499,0.658,0.249,0.997,2
TNFSF11,MS_727.3 [Osteitis deformans [Paget's disease of bone]],0.191,1,4.0,0.0,0.0,0.23,0.263,0.0,0.219,2.285,0.774,0.244,0.075,,3
ARMC5,EM_211.1 [Adrenal hyperfunction],0.191,0,0.0,0.0,0.801,0.0,0.38,0.0,0.084,,2.438,0.775,0.206,,4
TNNT2,CV_414.1 [Hypertrophic cardiomyopathy],0.191,0,0.0,0.0,0.896,0.0,0.634,0.83,0.611,,2.629,0.549,3.108,0.938,5
PCDH15,SO_386.6 [Night blindness],0.191,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.58,3.224,0.233,0.161,0.996,2
ACTC1,CV_414.1 [Hypertrophic cardiomyopathy],0.189,0,0.0,0.0,0.887,0.0,0.372,0.862,0.167,1.976,3.125,0.084,2.531,0.988,5
COX14,CV_414.1 [Hypertrophic cardiomyopathy],0.189,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.209,0.334,0.073,0.997,1
PLS3,CM_770.5 [Congenital osteodystrophies],0.188,0,0.0,0.0,0.0,0.0,0.374,0.184,0.103,3.518,2.766,0.092,0.074,0.513,5
COL4A4,GU_580.52 [Diffuse membranous glomerulonephritis],0.188,0,0.0,0.0,0.0,0.0,0.669,0.354,0.138,,3.835,1.108,0.13,,4
PTGS2,MS_704.1 [Polyarteritis nodosa and related conditions],0.188,1,4.0,0.0,0.0,0.0,0.0,0.0,0.303,2.854,0.105,0.091,2.083,,2
CACNB2,GE_972.2 [Hereditary ataxia],0.187,1,4.0,0.0,0.0,0.0,0.0,0.0,0.0,4.372,2.905,0.415,1.673,0.982,2
CLRN1,SO_369.62 [Keratoconus],0.187,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.23,3.407,1.779,0.164,0.996,2
POLG,NS_341.1 [Cerebral palsy],0.187,0,0.0,0.0,0.684,0.0,0.0,0.0,0.0,1.742,2.752,0.282,0.28,0.997,3
NDUFAF7,GE_963.1 [Lipid storage disorders],0.186,0,0.0,0.0,0.426,0.0,0.0,0.0,0.0,,3.457,2.97,0.105,0.986,3
PABPN1,GE_972.9 [Muscular dystrophy],0.186,1,0.5,0.0,0.828,0.0,0.373,0.693,0.251,1.98,0.674,0.128,0.061,0.69,5
NR3C1,GU_580.1 [Acute nephritic syndrome],0.186,1,4.0,0.0,0.304,0.0,0.0,0.0,0.063,2.134,2.407,0.185,0.143,0.923,4
LRP5,MS_727.3 [Osteitis deformans [Paget's disease of bone]],0.186,0,0.0,0.0,0.0,0.418,0.397,0.0,0.111,2.507,2.511,0.126,0.127,,3
GJA8,CM_751.213 [Congenital cataract],0.185,0,0.0,0.0,0.891,0.0,0.894,0.547,0.157,,7.372,5.195,11.874,0.996,5
VLDLR,GE_972.2 [Hereditary ataxia],0.185,0,0.0,0.0,0.843,0.0,0.0,0.877,0.131,3.216,2.383,0.236,0.297,0.916,4
PPARG,GE_964.3 [Glycogen storage disease],0.185,0,0.0,0.0,0.0,0.0,0.354,0.0,0.115,1.995,2.023,0.096,0.1,,3
AGTR1,GU_580.52 [Diffuse membranous glomerulonephritis],0.185,1,3.0,0.0,0.0,0.0,0.374,0.0,0.374,3.137,0.315,0.22,1.784,,3
NDUFA11,NS_341.1 [Cerebral palsy],0.185,1,2.0,0.0,0.0,0.0,0.0,0.0,0.0,2.221,2.84,0.046,0.049,0.951,2
KIF1A,GE_972.2 [Hereditary ataxia],0.184,0,0.0,0.125,0.864,0.0,0.268,0.835,0.165,1.947,2.794,0.046,0.063,0.949,6
LMO2,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.184,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.584,2.652,0.322,1.564,0.969,2
CDH2,MB_305.1 [Tics and tic disorders],0.184,0,0.0,0.0,0.0,0.0,0.459,0.0,0.103,3.347,2.684,0.247,0.116,,3
GRID2,GE_972.2 [Hereditary ataxia],0.184,0,0.0,0.0,0.872,0.0,0.531,0.764,0.092,2.781,2.744,0.775,0.532,0.97,5
DCTN1,NS_323.3 [Motor neuron disease],0.184,0,0.0,0.0,0.889,0.0,0.384,0.504,0.037,,2.134,0.466,0.357,0.998,5
CNGA3,SO_386.6 [Night blindness],0.183,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.526,0.225,0.171,0.999,2
CD14,GU_580.1 [Acute nephritic syndrome],0.183,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,1.587,0.142,0.077,0.983,2
PDE6G,SO_369.62 [Keratoconus],0.183,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.183,0.184,0.078,0.981,1
CACNA1E,GE_972.2 [Hereditary ataxia],0.183,1,4.0,0.095,0.547,0.0,0.0,0.0,0.03,3.773,3.96,2.476,0.28,0.898,5
GRN,NS_328.13 [Frontotemporal dementia [FTD]],0.182,1,2.0,0.0,0.0,0.0,0.261,0.78,0.322,,4.354,4.027,3.933,,4
CLCN1,NS_339.2 [Myotonic disorders],0.182,0,0.0,0.0,0.0,0.335,0.393,0.524,0.107,1.6,6.498,6.299,1.724,,4
PITX1,GE_961.1 [Phakomatoses],0.182,0,0.0,0.0,0.0,0.0,0.369,0.0,0.201,3.112,2.466,0.267,0.119,0.335,4
ZNF469,SO_369.62 [Keratoconus],0.182,0,0.0,0.0,0.886,0.273,0.252,0.58,0.361,2.77,3.846,0.138,0.192,,4
RCVRN,SO_380.3 [Optic atrophy],0.181,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.395,2.449,0.279,0.103,0.956,2
COL10A1,GE_978.3 [Osteochondrodysplasias],0.181,0,0.0,0.0,0.0,0.0,0.383,0.896,0.073,,1.338,0.999,1.202,,4
PODXL,GU_580.52 [Diffuse membranous glomerulonephritis],0.181,0,0.0,0.0,0.0,0.0,0.378,0.0,0.114,2.052,2.967,2.738,0.091,,3
APP,NS_340.3 [Inflammatory and immune myopathies],0.18,0,0.0,0.0,0.0,0.0,0.416,0.0,0.115,3.304,0.085,0.183,0.089,,3
CDKN1A,BI_179.1 [Hypogammaglobulinemia NOS],0.18,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.556,0.509,0.073,0.976,1
PEX13,CM_763.31 [Ventricular septal defect],0.18,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.322,0.297,0.131,0.983,1
SACS,GE_972.2 [Hereditary ataxia],0.18,0,0.0,0.0,0.899,0.0,0.339,0.887,0.147,2.66,3.032,0.894,0.104,0.98,5
FSCN2,SO_386.6 [Night blindness],0.18,0,0.0,0.0,0.0,0.0,0.272,0.0,0.0,,2.126,0.517,0.16,0.999,3
NDUFA8,GE_972.2 [Hereditary ataxia],0.18,1,4.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.269,0.318,0.13,0.978,1
CHM,GE_974.3 [Hereditary choroidal dystrophies],0.18,1,2.0,0.0,0.0,0.0,0.474,0.868,0.781,1.982,1.491,0.049,3.591,,4
TRPM1,SO_386.6 [Night blindness],0.18,0,0.0,0.0,0.895,0.0,0.0,0.741,0.091,2.573,3.59,0.216,0.268,0.989,4
NDUFS5,GE_972.2 [Hereditary ataxia],0.179,1,4.0,0.051,0.0,0.0,0.0,0.0,0.0,3.359,2.754,0.098,0.076,0.982,3
NDUFB7,GE_972.2 [Hereditary ataxia],0.179,1,4.0,0.0,0.0,0.0,0.0,0.0,0.0,,3.644,0.372,0.101,0.954,2
C3,GU_580.51 [Focal and segmental glomerular lesions*],0.179,0,0.0,0.0,0.0,0.0,0.425,0.01,0.677,2.551,2.674,0.245,0.171,,4
PTPRC,GI_540.11 [Autoimmune hepatitis],0.179,0,0.0,0.0,0.0,0.0,0.292,0.0,0.122,3.481,2.081,0.091,0.109,,3
RHO,SO_386.6 [Night blindness],0.178,0,0.0,0.0,0.547,0.0,0.385,0.613,0.105,,3.537,1.509,0.132,1.0,5
NDUFA9,GE_972.2 [Hereditary ataxia],0.178,1,4.0,0.0,0.0,0.0,0.0,0.0,0.0,2.382,3.626,2.87,1.298,0.992,2
COL2A1,CM_770.5 [Congenital osteodystrophies],0.178,0,0.0,0.0,0.898,0.0,0.442,0.815,0.089,,2.958,0.532,4.715,0.985,5
PPARGC1A,GE_973.5 [Huntington's disease],0.178,0,0.0,0.0,0.0,0.0,0.306,0.0,0.883,2.403,0.196,0.116,0.086,,3
F8,GE_971.14 [Von Willebrand's disease],0.178,1,4.0,0.0,0.0,0.0,0.536,0.0,0.126,,4.579,2.932,0.097,,3
MYO1E,GU_580.51 [Focal and segmental glomerular lesions*],0.178,0,0.0,0.0,0.0,0.0,0.678,0.783,0.163,1.768,3.802,1.127,0.208,,4
NDUFV1,CV_414.1 [Hypertrophic cardiomyopathy],0.178,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.509,0.29,0.126,0.998,2
VSX2,SO_386.5 [Color vision deficiencies],0.178,0,0.0,0.0,0.0,0.0,0.408,0.0,0.0,1.884,0.584,0.207,0.086,0.984,3
GCM2,EM_208.1 [Hypoparathyroidism],0.178,0,0.0,0.0,0.867,0.0,0.426,0.528,0.218,,3.345,1.167,0.223,0.888,5
CNTNAP2,MB_305.1 [Tics and tic disorders],0.177,0,0.0,0.0,0.0,0.0,0.444,0.0,0.332,3.485,2.538,0.294,0.207,,3
AHI1,SO_369.62 [Keratoconus],0.177,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.777,3.877,1.993,0.269,0.983,2
NDUFB4,GE_972.2 [Hereditary ataxia],0.177,1,4.0,0.0,0.0,0.0,0.0,0.0,0.0,2.233,0.18,0.271,1.954,0.953,2
SGCA,GE_972.9 [Muscular dystrophy],0.177,0,0.0,0.0,0.897,0.0,0.436,0.89,0.082,1.882,0.247,0.338,0.133,0.995,5
RP1L1,SO_386.5 [Color vision deficiencies],0.177,0,0.0,0.0,0.0,0.0,0.295,0.0,0.0,,3.518,0.136,0.127,0.989,3
RYR1,NS_339.2 [Myotonic disorders],0.177,0,0.0,0.0,0.0,0.0,0.292,0.129,0.275,,4.136,0.237,0.132,,4
PLEKHM1,CM_770.5 [Congenital osteodystrophies],0.177,0,0.0,0.0,0.684,0.0,0.285,0.537,0.083,,4.631,0.3,0.197,0.92,5
CAV3,GE_972.9 [Muscular dystrophy],0.177,0,0.0,0.0,0.874,0.0,0.403,0.555,0.102,2.151,0.426,0.093,0.067,0.993,5
P3H1,GE_978.3 [Osteochondrodysplasias],0.177,0,0.0,0.0,0.0,0.0,0.32,0.726,0.469,2.108,3.7,0.191,1.759,,4
TGM1,GE_977.1 [Congenital ichthyosis],0.176,0,0.0,0.0,0.896,0.0,0.321,0.785,0.124,1.905,3.453,3.355,0.143,0.999,5
NR3C1,CM_772.1 [Congenital malformations of endocrine glands],0.176,1,4.0,0.0,0.0,0.0,0.256,0.0,0.112,2.416,0.974,0.147,0.126,,3
REN,EM_211.1 [Adrenal hyperfunction],0.176,0,0.0,0.0,0.0,0.0,0.383,0.0,0.111,,2.28,0.238,0.153,,3
CNGA3,SO_386.5 [Color vision deficiencies],0.176,1,2.0,0.0,0.898,0.0,0.394,0.663,0.104,1.472,2.899,0.383,0.108,0.998,5
TP53,CV_414.1 [Hypertrophic cardiomyopathy],0.176,0,0.0,0.0,0.0,0.0,0.0,0.0,0.617,1.714,2.265,0.21,0.173,0.993,3
FLVCR1,BI_162.1 [Constitutional (hereditary) aplastic anemia],0.175,0,0.0,0.0,0.0,0.0,0.446,0.0,0.158,,2.368,0.113,1.908,,3
ARSA,GE_963.1 [Lipid storage disorders],0.175,1,4.0,0.0,0.899,0.0,0.293,0.917,0.087,,0.195,0.223,0.041,0.362,4
DES,CV_414.1 [Hypertrophic cardiomyopathy],0.175,0,0.0,0.0,0.873,0.0,0.828,0.228,0.217,,2.459,0.559,0.3,0.816,5
NDUFAF5,NS_341.1 [Cerebral palsy],0.175,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.315,0.264,0.148,0.985,1
FBN1,CV_438.41 [Aortic dissection],0.175,0,0.0,0.0,0.893,0.497,0.0,0.404,0.074,8.257,2.745,,11.458,0.971,4
GUCA1B,SO_369.62 [Keratoconus],0.175,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,1.934,0.219,0.093,0.995,2
NDUFB10,NS_341.1 [Cerebral palsy],0.174,1,2.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.721,1.759,0.107,0.973,2
FLG,GE_977.1 [Congenital ichthyosis],0.174,0,0.0,0.0,0.426,0.0,0.483,0.755,0.082,1.358,3.462,5.143,3.024,,4
SPATA7,SO_386.5 [Color vision deficiencies],0.173,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.716,2.645,0.201,0.101,0.994,2
PEX6,NS_341.1 [Cerebral palsy],0.173,0,0.0,0.0,0.426,0.0,0.0,0.0,0.0,3.411,3.455,1.134,0.194,0.992,3
SCN8A,NS_323.3 [Motor neuron disease],0.173,1,4.0,0.0,0.0,0.0,0.355,0.0,0.018,2.361,1.805,0.317,0.289,0.268,4
NDUFB10,GE_972.2 [Hereditary ataxia],0.172,1,4.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.362,0.954,0.17,0.972,2
EARS2,NS_341.1 [Cerebral palsy],0.172,0,0.0,0.0,0.701,0.0,0.0,0.0,0.0,1.35,3.144,0.905,0.166,0.995,3
CHM,SO_373.2 [Choroidal degenerations],0.172,1,2.0,0.0,0.0,0.0,0.516,0.868,0.396,1.611,0.665,0.102,2.803,,4
MYH7B,CV_414.1 [Hypertrophic cardiomyopathy],0.172,1,4.0,0.0,0.877,0.0,0.0,0.54,0.267,2.119,3.381,0.343,0.441,0.682,4
ANKRD53,CM_751.213 [Congenital cataract],0.171,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.274,1.7,0.115,0.989,2
GUCY2D,SO_373.2 [Choroidal degenerations],0.171,0,0.0,0.0,0.0,0.0,0.425,0.71,0.053,,2.739,0.394,0.148,,4
SLC27A4,GE_977.1 [Congenital ichthyosis],0.171,0,0.0,0.0,0.0,0.0,0.412,0.412,0.08,,2.34,2.52,0.133,0.998,5
CEP290,SO_386.6 [Night blindness],0.171,0,0.0,0.0,0.0,0.0,0.256,0.37,0.0,1.798,3.64,0.156,0.393,1.0,4
LMOD3,GE_972.9 [Muscular dystrophy],0.17,0,0.0,0.0,0.0,0.0,0.387,0.834,0.154,1.676,2.591,0.214,1.724,0.343,5
ANKRD53,NS_341.1 [Cerebral palsy],0.17,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.222,0.229,1.782,0.989,2
PLS3,GE_978.3 [Osteochondrodysplasias],0.17,0,0.0,0.0,0.0,0.0,0.367,0.184,0.103,3.881,2.985,0.081,0.073,,4
SIRT6,NS_341.1 [Cerebral palsy],0.17,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.717,0.184,0.159,0.991,2
IRF7,GU_580.1 [Acute nephritic syndrome],0.169,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.342,0.329,0.17,0.956,2
NFU1,CV_414.1 [Hypertrophic cardiomyopathy],0.169,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.662,1.128,0.372,0.238,0.973,2
SCN1A,NS_341.1 [Cerebral palsy],0.169,1,4.0,0.0,0.732,0.0,0.0,0.0,0.0,1.993,2.351,0.285,0.224,0.995,3
POLR3A,GE_963.1 [Lipid storage disorders],0.169,0,0.0,0.0,0.888,0.0,0.0,0.904,0.181,1.754,1.741,0.223,0.178,0.988,4
SCN2A,NS_341.1 [Cerebral palsy],0.169,1,4.0,0.0,0.745,0.0,0.0,0.0,0.0,1.341,3.469,0.408,0.183,0.993,3
GRID2,NS_323.3 [Motor neuron disease],0.169,0,0.0,0.0,0.0,0.0,0.38,0.121,0.012,2.775,2.475,0.907,0.367,0.142,5
ADRA2A,CV_433.3 [Cerebrovascular insufficiency],0.168,1,4.0,0.0,0.0,0.0,0.0,0.0,0.033,2.355,1.007,0.027,0.045,0.296,3
NMNAT1,SO_369.62 [Keratoconus],0.168,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.739,0.187,0.09,0.998,2
DRD2,GE_973.5 [Huntington's disease],0.167,1,3.0,0.0,0.0,0.0,0.357,0.0,0.4,1.708,2.105,0.12,0.047,,3
SELENON,GE_972.9 [Muscular dystrophy],0.167,0,0.0,0.0,0.883,0.0,0.376,0.837,0.064,1.948,2.439,0.321,0.134,,4
NDUFAF5,CV_414.1 [Hypertrophic cardiomyopathy],0.167,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.276,3.12,1.018,0.216,0.991,2
PEX13,NS_341.1 [Cerebral palsy],0.167,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,1.966,0.273,0.143,0.994,2
COL4A1,CM_751.213 [Congenital cataract],0.167,0,0.0,0.0,0.654,0.0,0.422,0.472,0.097,1.852,1.735,0.167,0.246,0.893,5
SNAI2,DE_663.1 [Pemphigus],0.167,0,0.0,0.0,0.0,0.0,0.0,0.0,0.7,2.526,0.074,,3.067,,2
PKD2,GE_976.5 [Polycystic kidney disease],0.167,0,0.0,0.0,0.0,0.0,0.421,0.722,0.197,2.164,3.008,0.303,86.143,,4
PEX13,SO_380.3 [Optic atrophy],0.167,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.97,0.287,0.362,1.091,0.985,2
SCN8A,NS_341.1 [Cerebral palsy],0.167,1,4.0,0.0,0.547,0.0,0.0,0.0,0.0,1.839,3.542,0.157,0.158,0.989,3
SPTA1,GE_970.61 [Hereditary spherocytosis],0.166,0,0.0,0.0,0.0,0.0,0.55,0.627,0.095,2.629,4.032,3.267,4.924,,4
IMPG2,SO_386.5 [Color vision deficiencies],0.166,0,0.0,0.0,0.547,0.0,0.319,0.0,0.0,,3.826,0.287,1.693,0.979,4
UNC13A,NS_323.3 [Motor neuron disease],0.166,0,0.0,0.0,0.623,0.702,0.0,0.449,0.112,4.338,3.147,0.09,0.193,0.919,4
TRIM63,CV_414.1 [Hypertrophic cardiomyopathy],0.166,0,0.0,0.0,0.868,0.0,0.469,0.51,0.509,,3.349,1.795,0.613,0.946,5
RAD51C,CV_441 [Arteriovenous malformation],0.166,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.196,2.71,0.221,1.022,0.963,2
PPIB,GE_978.3 [Osteochondrodysplasias],0.165,0,0.0,0.0,0.0,0.0,0.315,0.682,0.114,,0.092,0.149,0.111,,3
MIP,CM_751.213 [Congenital cataract],0.165,0,0.0,0.0,0.728,0.0,0.756,0.836,0.082,,5.434,4.595,5.349,0.981,5
TONSL,CM_770.5 [Congenital osteodystrophies],0.165,0,0.0,0.0,0.884,0.0,0.0,0.851,0.018,1.392,3.355,0.246,0.633,0.214,4
NPHP4,SO_369.62 [Keratoconus],0.165,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.358,3.316,0.862,0.349,0.992,2
MMP13,RE_484.1 [Spontaneous pneumothorax],0.165,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.306,0.216,0.229,0.978,2
SPTBN4,GE_972.1 [Hereditary neuropathy],0.165,0,0.0,0.0,0.0,0.0,0.452,0.0,0.13,,2.752,0.647,0.294,,3
SCN8A,GE_972.1 [Hereditary neuropathy],0.164,1,4.0,0.0,0.0,0.0,0.38,0.0,0.066,1.722,3.992,3.7,0.549,,3
MOCS3,NS_341.1 [Cerebral palsy],0.164,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,3.6,1.488,1.605,0.989,2
ARL13B,SO_369.62 [Keratoconus],0.164,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.253,2.427,0.258,0.162,0.986,2
ACO2,SO_380.3 [Optic atrophy],0.164,0,0.0,0.0,0.893,0.0,0.0,0.773,0.114,1.396,2.799,0.143,0.167,0.965,4
SCN1A,MB_302.1 [Speech and language developmental delay],0.164,1,4.0,0.0,0.0,0.0,0.438,0.366,0.014,1.937,3.091,0.333,0.237,0.953,5
NPHP4,SO_386.6 [Night blindness],0.163,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.454,2.98,1.988,0.505,0.99,2
GSK3B,CV_414.1 [Hypertrophic cardiomyopathy],0.163,0,0.0,0.0,0.0,0.0,0.481,0.0,0.148,3.05,2.296,,0.157,0.912,4
NR3C1,GE_972.2 [Hereditary ataxia],0.163,1,3.0,0.0,0.0,0.0,0.0,0.0,0.219,2.997,2.072,0.198,1.691,0.936,3
TMEM216,GE_972.2 [Hereditary ataxia],0.163,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,3.246,1.297,0.05,0.98,2
PTH1R,EM_208.1 [Hypoparathyroidism],0.163,1,4.0,0.0,0.426,0.0,0.352,0.0,0.101,,2.656,0.969,0.114,0.531,5
CHAT,NS_338.1 [Myasthenia gravis],0.162,0,0.0,0.0,0.0,0.0,0.453,0.86,0.1,1.741,2.129,0.692,0.489,,4
BBS12,SO_369.62 [Keratoconus],0.161,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.736,1.975,0.638,0.167,0.978,2
GABRA2,"MB_280.4 [Sedative, hypnotic, or anxiolytic related disorders]",0.161,1,4.0,0.0,0.0,0.0,0.0,0.0,0.102,3.08,0.078,,1.817,,2
FLNC,CV_414.1 [Hypertrophic cardiomyopathy],0.161,0,0.0,0.0,0.891,0.201,0.0,0.558,0.361,2.211,4.661,1.293,5.496,0.968,4
OXT,MB_293.2 [Bulimia nervosa],0.161,0,0.0,0.0,0.0,0.0,0.499,0.0,0.286,,2.716,2.64,0.114,,3
VDR,EM_208.1 [Hypoparathyroidism],0.161,1,4.0,0.0,0.0,0.0,0.433,0.0,0.125,2.281,2.063,0.299,0.138,0.963,4
IL23A,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.161,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.066,0.095,0.093,0.978,1
DDHD2,GE_972.2 [Hereditary ataxia],0.161,0,0.0,0.0,0.547,0.0,0.0,0.838,0.227,,3.21,0.371,0.238,0.979,4
CACNA1C,GE_972.2 [Hereditary ataxia],0.161,1,4.0,0.0,0.547,0.0,0.0,0.0,0.152,2.733,3.324,0.674,0.307,0.99,4
NR3C1,MB_296.4 [Borderline personality disorder],0.161,1,4.0,0.0,0.0,0.0,0.0,0.0,0.424,2.612,1.366,0.164,0.137,,2
C17orf107,GE_972.2 [Hereditary ataxia],0.161,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.425,0.508,0.076,1.0,1
RPS19,BI_162.1 [Constitutional (hereditary) aplastic anemia],0.16,0,0.0,0.0,0.898,0.0,0.37,0.891,0.295,,0.167,,,,3
ATP8A2,GE_972.2 [Hereditary ataxia],0.16,0,0.0,0.119,0.867,0.0,0.369,0.84,0.042,1.727,2.876,0.087,0.169,0.725,6
MRPL20,CV_416.8 [Pre-excitation syndrome [Anomalous atrioventricular excitation]],0.16,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.164,0.219,0.113,0.968,1
NDUFAF5,GE_963.1 [Lipid storage disorders],0.16,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.18,1.857,0.155,0.083,0.998,2
PEX5,NS_341.1 [Cerebral palsy],0.16,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.708,2.274,0.282,0.167,0.994,2
NR3C1,SO_365.3 [Exophthalmos [Proptosis]],0.159,1,4.0,0.0,0.0,0.0,0.0,0.0,0.071,2.551,2.867,2.494,0.934,0.871,3
GUCY2D,SO_380.3 [Optic atrophy],0.159,0,0.0,0.0,0.654,0.0,0.0,0.0,0.0,,2.282,0.259,0.251,0.995,3
GABRA2,NS_333.4 [Circadian rhythm sleep disorder],0.159,1,4.0,0.0,0.0,0.0,0.0,0.0,0.017,3.255,0.118,,0.095,0.33,3
ETFDH,CV_414.1 [Hypertrophic cardiomyopathy],0.159,0,0.0,0.0,0.684,0.0,0.0,0.281,0.0,1.742,2.1,0.375,0.388,0.97,3
SETX,NS_341.1 [Cerebral palsy],0.159,0,0.0,0.0,0.809,0.0,0.0,0.209,0.061,1.402,2.808,0.349,0.464,0.998,4
GABRB3,NS_333.4 [Circadian rhythm sleep disorder],0.159,1,4.0,0.0,0.0,0.0,0.0,0.121,0.033,2.337,0.112,0.039,0.06,0.348,4
NPAS3,MB_306 [Conduct disorders],0.159,0,0.0,0.0,0.0,0.0,0.0,0.0,0.239,3.578,2.038,0.174,0.151,,2
PDSS2,GU_580.1 [Acute nephritic syndrome],0.159,0,0.0,0.0,0.779,0.0,0.286,0.176,0.103,2.053,2.781,0.228,0.122,0.422,5
HTR2A,MB_305.1 [Tics and tic disorders],0.159,1,4.0,0.0,0.0,0.0,0.582,0.0,0.117,2.518,0.107,0.092,0.069,,3
P3H1,CM_770.5 [Congenital osteodystrophies],0.158,0,0.0,0.0,0.0,0.0,0.31,0.726,0.469,,3.599,0.397,1.23,,4
APTX,GE_972.2 [Hereditary ataxia],0.158,0,0.0,0.0,0.883,0.0,0.0,0.859,0.081,,0.629,0.204,0.167,0.936,3
NDUFAF7,NS_341.1 [Cerebral palsy],0.158,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.963,0.257,0.195,0.997,1
TCIRG1,GE_978.3 [Osteochondrodysplasias],0.158,0,0.0,0.0,0.0,0.0,0.357,0.798,0.117,,3.438,0.796,0.953,,4
FLNC,GE_972.9 [Muscular dystrophy],0.158,0,0.0,0.0,0.879,0.0,0.367,0.0,0.07,,3.913,0.136,0.301,0.998,5
DARS2,NS_341.1 [Cerebral palsy],0.158,0,0.0,0.0,0.563,0.0,0.0,0.0,0.0,1.853,2.401,0.248,0.194,0.99,3
PEX12,GE_972.2 [Hereditary ataxia],0.157,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,1.639,0.253,0.13,0.976,2
TTC8,SO_380.3 [Optic atrophy],0.157,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.429,2.135,0.449,0.169,0.983,2
CNTNAP1,GE_972.1 [Hereditary neuropathy],0.157,0,0.0,0.0,0.0,0.0,0.449,0.836,0.063,,2.424,0.208,2.021,,4
SFRP4,GE_978.3 [Osteochondrodysplasias],0.157,0,0.0,0.0,0.0,0.0,0.413,0.75,0.093,1.827,0.316,0.199,0.121,,4
HLA-DQB1,EM_209.4 [Diabetes insipidus],0.157,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.221,0.224,0.088,0.954,1
PDE6H,SO_386.6 [Night blindness],0.157,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.777,0.077,0.12,0.073,0.979,2
MYH9,GU_580.51 [Focal and segmental glomerular lesions*],0.157,0,0.0,0.0,0.0,0.0,0.744,0.132,0.255,2.791,1.874,0.348,1.128,,4
HK1,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.157,0,0.0,0.0,0.848,0.0,0.324,0.0,0.219,1.755,1.487,0.254,0.843,0.816,5
UQCRC2,NS_341.1 [Cerebral palsy],0.157,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.796,0.325,0.162,1.715,0.974,2
C3,GU_580.52 [Diffuse membranous glomerulonephritis],0.157,1,2.0,0.0,0.0,0.0,0.425,0.01,0.389,1.821,5.679,0.248,0.191,,4
CACNA1F,SO_386.6 [Night blindness],0.157,0,0.0,0.0,0.898,0.0,0.484,0.757,0.12,1.537,2.881,1.131,0.212,1.0,5
EGR2,GE_972.1 [Hereditary neuropathy],0.157,0,0.0,0.0,0.0,0.0,0.32,0.699,0.088,2.632,2.038,0.101,0.125,,4
B3GAT3,CM_770.5 [Congenital osteodystrophies],0.156,0,0.0,0.0,0.547,0.0,0.403,0.0,0.189,,3.202,2.848,0.099,0.273,5
LRAT,SO_380.3 [Optic atrophy],0.156,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.94,2.768,2.396,0.089,0.983,2
SCN3A,MB_305.1 [Tics and tic disorders],0.156,1,4.0,0.0,0.0,0.0,0.0,0.0,0.091,1.898,3.722,3.17,0.204,,2
CD14,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.156,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.5,1.899,0.141,0.096,0.983,2
TNNC1,CV_414.1 [Hypertrophic cardiomyopathy],0.156,0,0.0,0.0,0.857,0.0,0.67,0.681,0.344,,3.151,3.001,0.131,0.95,5
IFT27,SO_386.6 [Night blindness],0.156,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.424,0.45,0.092,1.855,0.993,2
GTPBP3,GE_963.1 [Lipid storage disorders],0.156,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,1.942,0.186,0.125,0.986,2
PRKCD,GI_540.11 [Autoimmune hepatitis],0.156,0,0.0,0.0,0.0,0.0,0.294,0.0,0.222,,2.198,0.143,0.176,,3
NR3C1,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.155,1,4.0,0.0,0.0,0.0,0.0,0.0,0.024,3.264,2.272,0.17,0.145,0.935,3
TMEM231,GE_972.2 [Hereditary ataxia],0.155,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.327,0.165,1.804,0.987,2
COL6A2,GE_972.9 [Muscular dystrophy],0.155,0,0.0,0.058,0.899,0.0,0.0,0.837,0.09,1.872,3.002,0.085,0.678,0.992,5
SGCB,GE_972.9 [Muscular dystrophy],0.155,0,0.0,0.0,0.894,0.0,0.36,0.865,0.083,1.875,0.196,0.298,0.087,0.995,5
SETX,GE_972.2 [Hereditary ataxia],0.155,0,0.0,0.0,0.898,0.0,0.0,0.801,0.083,2.036,3.688,1.148,0.291,0.988,4
FANCF,BI_162.1 [Constitutional (hereditary) aplastic anemia],0.155,0,0.0,0.0,0.0,0.0,0.279,0.812,0.116,2.79,3.923,0.158,0.047,,4
CAV3,CV_414.1 [Hypertrophic cardiomyopathy],0.155,0,0.0,0.0,0.779,0.0,0.539,0.648,0.116,2.11,0.433,0.188,0.145,0.868,5
GRM1,GE_972.2 [Hereditary ataxia],0.154,0,0.0,0.063,0.862,0.0,0.397,0.725,0.09,2.191,2.501,0.606,0.218,0.968,6
C3,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.154,1,4.0,0.0,0.894,0.0,0.0,0.0,0.183,,3.295,0.675,0.271,0.98,4
CACNA1C,CV_416.8 [Pre-excitation syndrome [Anomalous atrioventricular excitation]],0.154,1,4.0,0.0,0.426,0.0,0.386,0.151,0.0,2.599,3.518,2.583,0.266,0.658,4
KCNMA1,GE_972.2 [Hereditary ataxia],0.154,0,0.0,0.0,0.684,0.0,0.393,0.129,0.082,2.799,2.403,0.561,0.841,0.962,5
TCTN1,GE_972.2 [Hereditary ataxia],0.153,0,0.0,0.0,0.684,0.0,0.0,0.0,0.0,,3.502,0.927,0.135,0.993,3
LRP5,CM_770.5 [Congenital osteodystrophies],0.153,0,0.0,0.0,0.85,0.0,0.38,0.769,0.074,,2.728,2.491,0.088,0.93,5
POLR3A,GE_972.2 [Hereditary ataxia],0.153,0,0.0,0.0,0.89,0.0,0.539,0.804,0.091,1.868,3.294,0.89,0.902,0.919,5
EVPLL,GE_972.2 [Hereditary ataxia],0.153,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,1.79,0.58,0.103,1.0,2
ATL1,GE_972.2 [Hereditary ataxia],0.153,0,0.0,0.119,0.547,0.0,0.0,0.876,0.19,,2.385,0.062,1.687,0.922,5
MTM1,GE_972.9 [Muscular dystrophy],0.153,1,3.0,0.0,0.828,0.0,0.424,0.904,0.143,2.284,0.734,0.064,0.048,0.894,5
SP4,NS_328.13 [Frontotemporal dementia [FTD]],0.153,0,0.0,0.0,0.0,0.0,0.291,0.0,0.103,4.16,2.752,2.481,0.142,,3
EVC,GE_978.3 [Osteochondrodysplasias],0.152,0,0.0,0.0,0.0,0.0,0.319,0.884,0.112,1.87,4.338,1.631,0.181,,4
MPZ,GE_972.1 [Hereditary neuropathy],0.152,0,0.0,0.0,0.0,0.0,0.365,0.837,0.105,1.917,3.237,3.237,1.98,,4
RGR,SO_386.5 [Color vision deficiencies],0.152,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.776,1.941,0.684,0.082,0.99,2
NR3C1,GE_972.9 [Muscular dystrophy],0.151,1,4.0,0.0,0.0,0.0,0.0,0.0,0.088,3.529,3.899,3.516,1.975,0.737,3
RYR1,NS_340.3 [Inflammatory and immune myopathies],0.151,0,0.0,0.0,0.899,0.0,0.628,0.0,0.101,3.005,4.755,0.17,0.082,,4
COL2A1,GE_978.3 [Osteochondrodysplasias],0.151,0,0.0,0.0,0.0,0.0,0.438,0.815,0.098,,2.958,0.476,5.05,,4
DCSTAMP,MS_727.3 [Osteitis deformans [Paget's disease of bone]],0.151,0,0.0,0.0,0.0,0.429,0.277,0.0,0.081,3.343,1.663,0.094,0.197,,3
CLRN1,SO_386.6 [Night blindness],0.151,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.347,1.711,0.936,0.101,0.999,2
NDUFB5,CV_414.1 [Hypertrophic cardiomyopathy],0.151,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.116,1.998,0.16,0.974,2
VCL,CV_414.1 [Hypertrophic cardiomyopathy],0.151,0,0.0,0.0,0.859,0.0,0.627,0.547,0.253,1.567,2.54,0.292,0.585,0.957,5
COL10A1,CM_770.5 [Congenital osteodystrophies],0.151,0,0.0,0.0,0.893,0.0,0.365,0.896,0.072,,1.268,0.797,1.249,0.909,4
NLRP7,SO_373.2 [Choroidal degenerations],0.151,0,0.0,0.0,0.0,0.0,0.437,0.0,0.186,,0.95,0.141,0.088,,2
SAMD9L,BI_162.1 [Constitutional (hereditary) aplastic anemia],0.151,0,0.0,0.0,0.0,0.0,0.471,0.792,0.042,,2.688,1.164,0.123,,4
SHOX,CM_770.5 [Congenital osteodystrophies],0.15,0,0.0,0.0,0.0,0.0,0.0,0.839,0.108,,0.121,,3.067,0.643,4
BBS12,SO_386.6 [Night blindness],0.15,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.645,2.404,0.295,0.12,0.992,2
ESR1,"EM_209.11 [Tall stature, acromegaly and gigantism]",0.149,1,2.0,0.0,0.0,0.0,0.441,0.0,0.205,2.745,2.095,0.72,0.074,,3
DDHD2,NS_341.1 [Cerebral palsy],0.149,0,0.0,0.0,0.886,0.0,0.0,0.0,0.076,,1.865,0.289,0.172,0.999,4
TNFSF11,MS_705.2 [Juvenile rheumatoid arthritis [JRA/JIA]],0.149,0,0.0,0.0,0.0,0.471,0.264,0.0,0.196,3.975,0.347,0.14,0.03,,3
SCN1A,GE_972.2 [Hereditary ataxia],0.149,1,2.0,0.045,0.758,0.0,0.338,0.0,0.193,2.684,2.769,0.902,0.295,0.99,6
NDUFA12,NS_341.1 [Cerebral palsy],0.149,1,2.0,0.0,0.0,0.0,0.0,0.0,0.0,2.991,3.551,3.47,0.107,0.984,2
PEX13,SO_386.6 [Night blindness],0.149,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,1.815,0.299,0.126,0.979,2
PEX12,CM_763.31 [Ventricular septal defect],0.149,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,1.159,0.364,0.122,0.98,1
AGTR1,GU_580.1 [Acute nephritic syndrome],0.149,1,4.0,0.0,0.0,0.0,0.379,0.0,0.12,2.929,1.945,0.488,0.14,0.755,4
STK11,GE_961.1 [Phakomatoses],0.149,0,0.0,0.0,0.0,0.0,0.472,0.912,0.181,,3.104,0.059,0.067,0.973,5
NDUFB3,NS_341.1 [Cerebral palsy],0.148,1,2.0,0.0,0.0,0.0,0.0,0.0,0.0,1.409,0.586,0.621,0.061,0.983,2
GNAT2,SO_386.5 [Color vision deficiencies],0.148,0,0.0,0.0,0.885,0.0,0.293,0.774,0.09,,3.785,3.097,1.94,0.979,5
AHSP,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.148,0,0.0,0.0,0.0,0.0,0.382,0.0,0.0,2.162,0.866,0.834,0.064,0.988,3
ATM,GE_972.2 [Hereditary ataxia],0.148,0,0.0,0.1,0.887,0.0,0.258,0.926,0.096,1.34,2.82,0.522,1.065,0.981,6
SCO2,GE_972.2 [Hereditary ataxia],0.148,0,0.0,0.0,0.547,0.0,0.0,0.0,0.0,,0.286,0.496,0.178,0.967,2
FANCL,CV_441 [Arteriovenous malformation],0.148,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.24,2.412,1.086,0.378,0.99,2
COL6A3,GE_972.9 [Muscular dystrophy],0.148,0,0.0,0.04,0.898,0.0,0.456,0.712,0.057,2.193,2.706,0.425,0.426,0.981,6
NDUFB10,SO_380.3 [Optic atrophy],0.148,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.473,0.249,0.126,0.949,2
KCND3,GE_972.2 [Hereditary ataxia],0.148,1,2.0,0.0,0.882,0.0,0.0,0.0,0.09,2.367,2.342,0.382,1.698,0.979,4
PEX10,CM_763.31 [Ventricular septal defect],0.147,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,1.812,0.289,0.128,0.98,2
NDUFS1,NS_341.1 [Cerebral palsy],0.147,1,2.0,0.0,0.547,0.0,0.0,0.0,0.0,,3.019,1.15,0.196,0.993,3
SCN3A,GE_972.2 [Hereditary ataxia],0.147,1,2.0,0.217,0.0,0.0,0.0,0.0,0.017,2.39,4.813,3.382,0.15,0.935,4
MYB,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.147,0,0.0,0.0,0.0,0.0,0.358,0.0,0.1,,2.075,1.61,0.182,0.978,4
COL4A5,GU_580.51 [Focal and segmental glomerular lesions*],0.147,0,0.0,0.0,0.0,0.0,0.615,0.493,0.155,,2.038,0.228,1.909,,4
VDR,GE_978.3 [Osteochondrodysplasias],0.147,1,4.0,0.0,0.0,0.0,0.353,0.0,0.184,,1.952,0.161,0.073,,3
ESR1,MS_727.3 [Osteitis deformans [Paget's disease of bone]],0.147,1,3.0,0.0,0.0,0.432,0.289,0.0,0.084,4.433,2.953,0.549,0.172,,3
HCN4,CV_414.1 [Hypertrophic cardiomyopathy],0.146,0,0.0,0.0,0.0,0.0,0.656,0.162,0.155,,3.233,0.238,0.146,0.706,5
HBB,GE_970.1 [Sickle-cell disorders],0.146,1,4.0,0.0,0.0,0.0,0.0,0.781,0.183,,54.939,0.532,0.063,,3
ATP2B2,GE_972.2 [Hereditary ataxia],0.146,0,0.0,0.108,0.547,0.0,0.431,0.0,0.03,3.628,2.598,1.314,0.248,0.919,6
SCN2A,MB_302.1 [Speech and language developmental delay],0.146,1,4.0,0.0,0.0,0.0,0.0,0.452,0.012,1.629,2.188,0.139,0.226,0.886,4
MET,GE_961.1 [Phakomatoses],0.146,1,2.0,0.0,0.0,0.0,0.34,0.0,0.086,1.731,2.833,0.133,0.299,0.94,4
PTGS1,CV_414.1 [Hypertrophic cardiomyopathy],0.146,1,3.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.396,0.364,0.245,0.996,2
ENG,CV_441 [Arteriovenous malformation],0.146,0,0.0,0.0,0.0,0.0,0.352,0.495,0.113,,2.374,0.314,7.443,0.973,5
SPG11,GE_972.2 [Hereditary ataxia],0.146,0,0.0,0.053,0.874,0.0,0.279,0.836,0.198,2.445,3.105,0.827,1.367,0.997,6
NEK1,NS_323.3 [Motor neuron disease],0.145,0,0.0,0.0,0.896,0.0,0.0,0.296,0.119,2.366,5.461,2.919,1.629,0.99,4
GRK1,SO_386.5 [Color vision deficiencies],0.145,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.328,0.233,0.071,1.0,1
SQSTM1,NS_323.3 [Motor neuron disease],0.145,0,0.0,0.0,0.892,0.0,0.0,0.737,0.174,,2.228,0.361,0.644,0.998,4
DSG2,CV_414.1 [Hypertrophic cardiomyopathy],0.145,0,0.0,0.0,0.844,0.0,0.807,0.181,0.121,,4.253,0.6,0.37,0.794,5
SPG7,GE_972.2 [Hereditary ataxia],0.145,0,0.0,0.0,0.894,0.0,0.0,0.886,0.106,1.368,10.932,3.192,0.277,0.995,4
PDSS2,GU_580.51 [Focal and segmental glomerular lesions*],0.145,0,0.0,0.0,0.0,0.0,0.494,0.161,0.103,2.332,0.761,0.155,0.093,,4
GNAT1,SO_369.62 [Keratoconus],0.145,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.183,0.32,0.175,0.974,1
FST,NS_323.3 [Motor neuron disease],0.145,0,0.0,0.089,0.0,0.0,0.352,0.0,0.109,2.285,1.633,0.151,0.142,0.073,5
DSP,CV_414.1 [Hypertrophic cardiomyopathy],0.145,0,0.0,0.0,0.867,0.0,0.637,0.194,0.115,1.64,2.725,0.527,1.782,0.957,5
B4GALNT1,GE_972.2 [Hereditary ataxia],0.145,0,0.0,0.138,0.426,0.0,0.0,0.849,0.124,1.393,2.75,0.404,0.215,0.77,5
NPHP4,GE_972.2 [Hereditary ataxia],0.145,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.686,3.062,0.956,0.371,0.984,2
RP9,SO_380.3 [Optic atrophy],0.145,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.125,0.094,3.245,0.983,2
CACNA1B,GE_972.2 [Hereditary ataxia],0.144,1,4.0,0.065,0.0,0.0,0.0,0.0,0.213,1.886,3.469,0.912,0.325,0.925,4
ATM,CM_770.5 [Congenital osteodystrophies],0.144,0,0.0,0.0,0.0,0.0,0.423,0.0,0.104,,3.487,3.197,0.146,0.984,4
TUBA4A,NS_323.3 [Motor neuron disease],0.144,1,2.0,0.0,0.868,0.0,0.0,0.615,0.051,,0.105,0.051,0.149,0.99,3
NDUFAF3,GE_972.2 [Hereditary ataxia],0.144,1,4.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.65,1.323,0.085,0.996,2
SPATA7,NS_341.1 [Cerebral palsy],0.144,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,3.418,0.257,0.149,0.976,2
HDC,MB_305.1 [Tics and tic disorders],0.144,0,0.0,0.0,0.0,0.0,0.435,0.416,0.086,1.727,0.233,0.123,0.105,,4
TCAP,CV_414.1 [Hypertrophic cardiomyopathy],0.144,0,0.0,0.0,0.829,0.0,0.58,0.496,0.333,,0.792,0.111,0.144,0.951,4
PEX19,GI_516.1 [Pyloric stenosis],0.144,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.382,0.142,0.179,0.984,2
MPZ,GE_972.2 [Hereditary ataxia],0.144,0,0.0,0.0,0.0,0.0,0.402,0.776,0.04,,0.083,0.027,2.062,0.738,5
UNC119,SO_386.6 [Night blindness],0.143,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.159,0.104,0.102,0.992,1
CRB1,SO_386.5 [Color vision deficiencies],0.143,0,0.0,0.0,0.547,0.0,0.533,0.0,0.0,,2.781,0.191,0.083,1.0,4
ACP5,CM_770.5 [Congenital osteodystrophies],0.143,0,0.0,0.0,0.886,0.0,0.348,0.0,0.111,1.903,2.646,0.162,0.095,0.916,5
ATP13A2,GE_972.2 [Hereditary ataxia],0.143,0,0.0,0.0,0.846,0.0,0.0,0.0,0.153,,2.974,0.211,0.268,0.986,4
ACVR1,MS_719.2 [Muscle calcification and ossification],0.143,1,3.0,0.0,0.869,0.0,0.283,0.881,0.828,2.015,2.325,0.053,0.086,,4
ZFYVE26,GE_972.2 [Hereditary ataxia],0.143,0,0.0,0.0,0.813,0.0,0.329,0.852,0.087,3.292,3.288,2.067,0.425,0.984,5
MSTN,GE_972.9 [Muscular dystrophy],0.143,1,2.0,0.0,0.0,0.0,0.399,0.0,0.169,2.21,0.288,0.117,0.082,0.946,4
IFT27,SO_369.62 [Keratoconus],0.143,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.987,0.565,0.453,0.093,0.99,2
DNMT3A,CM_763.31 [Ventricular septal defect],0.143,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.2,3.433,0.277,0.265,0.965,2
NDUFS6,SO_380.3 [Optic atrophy],0.143,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.851,0.105,0.136,0.067,0.971,2
CERKL,SO_369.62 [Keratoconus],0.143,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.331,2.679,0.449,0.655,0.998,2
NOS3,CV_433.3 [Cerebrovascular insufficiency],0.143,1,2.0,0.0,0.35,0.0,0.0,0.204,0.202,,4.148,0.272,0.51,0.989,4
DST,DE_663.3 [Dermatitis herpetiformis],0.142,0,0.0,0.0,0.0,0.0,0.0,0.0,0.087,2.159,4.041,3.207,0.148,,2
GTPBP3,GE_972.2 [Hereditary ataxia],0.142,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.376,0.408,0.244,0.977,2
PPIB,CM_770.5 [Congenital osteodystrophies],0.142,0,0.0,0.0,0.0,0.0,0.312,0.682,0.114,,0.1,0.168,0.121,0.559,4
GRK1,SO_386.6 [Night blindness],0.142,0,0.0,0.0,0.886,0.0,0.0,0.607,0.04,,2.843,0.305,1.83,0.998,4
NDUFV1,NS_341.1 [Cerebral palsy],0.142,1,2.0,0.0,0.0,0.0,0.0,0.0,0.0,,3.395,2.248,0.209,0.994,2
TP53,MS_704.1 [Polyarteritis nodosa and related conditions],0.142,0,0.0,0.0,0.0,0.0,0.273,0.0,0.401,,0.129,0.102,0.073,,2
ITGA7,GE_972.9 [Muscular dystrophy],0.142,1,0.5,0.0,0.758,0.0,0.409,0.821,0.072,1.312,3.979,1.179,0.18,0.984,5
TLR7,GI_540.11 [Autoimmune hepatitis],0.142,1,1.0,0.0,0.0,0.0,0.39,0.0,0.302,,0.433,0.143,0.101,,2
SCN4A,NS_338.1 [Myasthenia gravis],0.141,0,0.0,0.0,0.0,0.0,0.553,0.829,0.07,,3.065,0.58,0.424,,4
LRP5,GE_978.3 [Osteochondrodysplasias],0.141,0,0.0,0.0,0.0,0.0,0.372,0.769,0.069,,2.923,2.71,0.074,,4
NFKB1,GI_542.8 [Biliary cirrhosis],0.141,0,0.0,0.0,0.304,0.383,0.0,0.0,0.218,1.751,2.943,1.039,0.159,,3
GNAT2,SO_369.62 [Keratoconus],0.141,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,1.93,0.292,0.185,0.992,2
IL1B,MS_705.2 [Juvenile rheumatoid arthritis [JRA/JIA]],0.141,1,4.0,0.045,0.182,0.0,0.259,0.0,0.528,,3.346,0.084,0.035,,5
PAX8,GE_978.3 [Osteochondrodysplasias],0.141,0,0.0,0.0,0.0,0.0,0.278,0.0,0.177,1.337,2.6,0.169,0.126,,3
TCIRG1,CM_770.5 [Congenital osteodystrophies],0.141,0,0.0,0.0,0.897,0.0,0.341,0.798,0.117,,3.291,1.15,0.849,0.973,5
RYR2,GE_972.9 [Muscular dystrophy],0.141,0,0.0,0.0,0.0,0.0,0.423,0.0,0.176,2.556,3.404,0.455,0.271,0.941,4
CFB,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.141,1,3.0,0.0,0.88,0.0,0.0,0.0,0.073,,3.178,0.187,0.218,0.961,4
GBA2,NS_341.1 [Cerebral palsy],0.14,0,0.0,0.0,0.881,0.0,0.0,0.378,0.045,1.465,2.499,0.341,0.237,0.992,4
ESR1,CM_770.5 [Congenital osteodystrophies],0.14,1,4.0,0.0,0.0,0.0,0.383,0.0,0.042,3.317,2.887,1.186,0.095,0.989,4
POLG,SO_380.3 [Optic atrophy],0.14,0,0.0,0.0,0.801,0.0,0.0,0.0,0.012,,2.914,0.342,0.342,0.992,4
POLR3B,GE_963.1 [Lipid storage disorders],0.14,0,0.0,0.0,0.816,0.0,0.0,0.0,0.215,1.378,2.999,0.188,0.136,0.925,4
ADRB1,GE_972.9 [Muscular dystrophy],0.14,1,4.0,0.0,0.0,0.0,0.0,0.0,0.082,2.199,2.711,0.026,0.059,0.608,3
GSK3B,MS_727.3 [Osteitis deformans [Paget's disease of bone]],0.14,0,0.0,0.0,0.0,0.0,0.454,0.0,0.099,2.957,0.36,,1.043,,3
UQCRQ,GE_972.2 [Hereditary ataxia],0.14,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.219,0.086,1.87,0.993,2
TTC24,CV_414.1 [Hypertrophic cardiomyopathy],0.14,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,1.549,0.297,0.182,0.977,2
KLF1,GE_970.2 [Thalassemia],0.14,0,0.0,0.0,0.0,0.0,0.502,0.576,0.107,,0.511,0.126,0.454,,3
NFKB1,BI_179.1 [Hypogammaglobulinemia NOS],0.14,0,0.0,0.0,0.896,0.0,0.0,0.0,0.13,2.272,3.281,0.353,1.863,0.998,4
SCN5A,CV_416.8 [Pre-excitation syndrome [Anomalous atrioventricular excitation]],0.14,1,4.0,0.0,0.73,0.0,0.759,0.352,0.0,3.457,3.342,0.645,0.449,0.635,4
ANK1,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.14,0,0.0,0.0,0.878,0.0,0.386,0.129,0.06,2.212,1.884,0.555,1.245,0.987,5
NDRG1,GE_972.1 [Hereditary neuropathy],0.14,0,0.0,0.0,0.0,0.0,0.373,0.447,0.151,2.138,1.651,0.822,0.242,,4
MANBA,GI_542.8 [Biliary cirrhosis],0.14,0,0.0,0.0,0.304,0.556,0.0,0.0,0.401,1.398,2.674,0.64,0.315,,3
SQSTM1,GE_972.2 [Hereditary ataxia],0.139,0,0.0,0.017,0.836,0.0,0.0,0.0,0.075,1.708,2.744,0.278,0.178,0.931,5
MAPT,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.139,1,2.0,0.0,0.0,0.617,0.267,0.736,0.082,,3.711,1.669,0.186,0.972,5
COL4A4,GE_976.5 [Polycystic kidney disease],0.139,0,0.0,0.0,0.0,0.0,0.361,0.362,0.128,1.756,2.911,2.835,0.775,,4
SOD1,CV_416.8 [Pre-excitation syndrome [Anomalous atrioventricular excitation]],0.139,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.802,0.286,0.104,0.073,0.995,2
C17orf107,NS_341.1 [Cerebral palsy],0.139,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.288,0.172,0.054,1.0,1
ATF6,SO_386.5 [Color vision deficiencies],0.139,0,0.0,0.0,0.881,0.0,0.263,0.775,0.194,1.5,3.991,0.136,0.104,0.987,5
EPO,GE_970.2 [Thalassemia],0.139,0,0.0,0.0,0.0,0.0,0.55,0.0,0.128,,0.917,0.338,0.156,,2
NDUFA8,GE_963.1 [Lipid storage disorders],0.139,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.819,0.12,0.159,0.071,0.99,2
TTBK2,GE_972.2 [Hereditary ataxia],0.138,0,0.0,0.0,0.844,0.0,0.0,0.07,0.024,3.426,2.709,0.478,0.615,0.992,4
CRYBB2,CM_751.213 [Congenital cataract],0.138,0,0.0,0.0,0.86,0.0,0.797,0.651,0.116,1.885,4.045,1.167,0.115,0.982,5
GALC,GE_963.1 [Lipid storage disorders],0.138,1,2.0,0.0,0.899,0.0,0.297,0.917,0.1,1.986,0.377,0.31,0.127,0.924,5
B9D2,GE_972.2 [Hereditary ataxia],0.138,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.671,1.306,1.589,0.986,2
PLEKHM1,GE_978.3 [Osteochondrodysplasias],0.138,0,0.0,0.0,0.0,0.0,0.292,0.537,0.083,,4.797,0.27,0.183,,4
SIL1,GE_972.2 [Hereditary ataxia],0.138,0,0.0,0.0,0.89,0.0,0.495,0.802,0.11,2.275,0.945,0.395,0.186,0.798,5
MPV17,SO_380.3 [Optic atrophy],0.138,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.612,1.774,0.116,0.975,2
SMAD3,SO_369.62 [Keratoconus],0.138,0,0.0,0.0,0.0,0.478,0.0,0.0,0.144,3.189,0.098,0.055,2.119,0.612,3
FXN,GE_972.2 [Hereditary ataxia],0.138,1,1.0,0.087,0.89,0.0,0.0,0.878,0.149,2.296,2.987,0.165,0.102,0.982,5
NFIB,SO_369.62 [Keratoconus],0.137,0,0.0,0.0,0.623,0.0,0.0,0.0,0.207,3.041,0.639,0.157,0.144,0.353,4
TRPC3,GE_972.2 [Hereditary ataxia],0.137,0,0.0,0.0,0.701,0.0,0.389,0.0,0.097,,3.0,0.131,1.933,0.912,5
VEGFA,NS_323.3 [Motor neuron disease],0.137,1,2.0,0.0,0.654,0.0,0.0,0.0,0.107,1.992,3.583,2.7,0.154,0.965,4
GRK1,SO_369.62 [Keratoconus],0.137,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.602,0.544,0.122,0.995,2
NDUFA7,NS_341.1 [Cerebral palsy],0.137,1,2.0,0.0,0.0,0.0,0.0,0.0,0.0,2.818,1.813,0.121,0.095,0.972,2
TF,GE_970.2 [Thalassemia],0.137,0,0.0,0.0,0.0,0.0,0.51,0.0,0.107,,2.161,0.065,0.391,,3
F9,GE_971.11 [Hereditary factor VIII deficiency [Hemophilia A]],0.137,1,4.0,0.0,0.0,0.0,0.0,0.587,0.184,,0.755,,3.369,,3
IL1B,SO_365.3 [Exophthalmos [Proptosis]],0.136,0,0.0,0.0,0.304,0.0,0.0,0.0,0.187,,2.319,0.192,0.112,0.947,4
MTO1,CV_414.1 [Hypertrophic cardiomyopathy],0.136,0,0.0,0.0,0.801,0.0,0.506,0.0,0.384,1.746,2.958,0.408,0.916,0.934,5
GFM1,CV_414.1 [Hypertrophic cardiomyopathy],0.136,0,0.0,0.0,0.684,0.0,0.0,0.0,0.0,4.072,2.089,0.532,0.396,0.997,3
BBS4,SO_386.6 [Night blindness],0.136,0,0.0,0.0,0.426,0.0,0.0,0.0,0.0,1.528,2.932,0.261,0.163,1.0,3
SACS,NS_341.1 [Cerebral palsy],0.136,0,0.0,0.0,0.888,0.0,0.258,0.608,0.021,2.562,4.114,0.392,0.436,0.964,5
LRAT,SO_386.6 [Night blindness],0.136,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.712,2.476,0.075,1.0,2
MAPT,NS_323.3 [Motor neuron disease],0.136,0,0.0,0.0,0.85,0.0,0.377,0.0,0.132,2.523,2.476,0.053,0.344,0.997,5
ATM,GE_978.3 [Osteochondrodysplasias],0.136,0,0.0,0.0,0.0,0.0,0.398,0.0,0.104,,3.269,2.426,0.35,,3
NDUFAF4,CV_414.1 [Hypertrophic cardiomyopathy],0.136,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.144,0.23,0.136,0.994,1
BBS10,SO_369.62 [Keratoconus],0.136,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.994,2.513,0.514,0.153,0.989,2
DPM1,SO_380.3 [Optic atrophy],0.136,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.171,0.203,0.102,0.984,1
FLCN,RE_484.1 [Spontaneous pneumothorax],0.136,0,0.0,0.0,0.864,0.0,0.0,0.736,0.131,1.799,8.032,7.067,14.848,0.437,4
TP53,GE_961.1 [Phakomatoses],0.136,0,0.0,0.0,0.0,0.0,0.357,0.0,0.116,1.836,2.881,0.117,0.101,0.967,4
KIT,GU_580.1 [Acute nephritic syndrome],0.136,1,2.0,0.0,0.0,0.0,0.0,0.0,0.076,3.438,2.44,0.18,0.149,0.944,3
PTGS2,MS_712.51 [Hypermobility syndrome],0.135,0,0.0,0.0,0.0,0.0,0.0,0.0,0.125,2.622,0.163,0.132,0.138,,2
CACNA1D,GE_972.2 [Hereditary ataxia],0.135,1,4.0,0.0,0.0,0.0,0.0,0.0,0.114,1.713,3.061,0.324,0.251,0.924,3
RPL15,GE_972.9 [Muscular dystrophy],0.135,1,4.0,0.0,0.0,0.0,0.0,0.0,0.0,1.671,0.052,,,0.18,2
CHEK2,CM_763.31 [Ventricular septal defect],0.135,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.04,2.509,0.271,0.968,0.97,2
GAD1,GE_972.2 [Hereditary ataxia],0.135,0,0.0,0.121,0.532,0.0,0.0,0.51,0.256,1.701,2.243,0.088,0.181,0.955,5
OR51F1,SO_386.5 [Color vision deficiencies],0.135,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,1.411,0.053,0.058,0.989,2
PTPN22,GI_540.11 [Autoimmune hepatitis],0.135,0,0.0,0.0,0.0,0.0,0.372,0.0,0.192,,3.406,0.284,0.194,,3
RDH5,SO_386.5 [Color vision deficiencies],0.135,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.971,2.696,2.34,0.089,1.0,2
HBA2,GE_970.2 [Thalassemia],0.135,0,0.0,0.0,0.0,0.0,0.712,0.772,0.157,,0.213,0.034,0.781,,3
DRD2,MB_305.1 [Tics and tic disorders],0.135,1,4.0,0.0,0.0,0.455,0.0,0.0,0.153,1.88,2.846,1.581,0.075,,2
RDH5,SO_369.62 [Keratoconus],0.135,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.693,0.333,0.186,0.996,2
DYNC1H1,GE_972.2 [Hereditary ataxia],0.135,0,0.0,0.089,0.0,0.0,0.362,0.169,0.024,,2.562,0.15,0.38,0.881,6
CDKN1A,SO_365.3 [Exophthalmos [Proptosis]],0.134,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.126,3.257,0.126,0.111,0.971,2
NFKB1,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.134,1,0.5,0.0,0.547,0.0,0.0,0.0,0.114,3.622,3.218,0.412,0.157,0.992,4
PROKR2,SO_386.5 [Color vision deficiencies],0.134,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.294,2.939,0.568,1.931,0.958,2
NEU1,GE_963.1 [Lipid storage disorders],0.134,0,0.0,0.0,0.0,0.0,0.296,0.921,0.21,,0.128,0.132,0.088,0.183,4
NR1H4,GI_542.8 [Biliary cirrhosis],0.134,1,4.0,0.0,0.0,0.0,0.276,0.0,0.289,,2.682,0.174,0.221,,3
SMCHD1,GE_972.9 [Muscular dystrophy],0.134,0,0.0,0.0,0.872,0.0,0.0,0.789,0.234,1.547,4.294,2.688,1.641,0.778,4
CCR5,BI_179.1 [Hypogammaglobulinemia NOS],0.134,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.989,0.317,0.083,0.957,2
NDUFA3,GE_963.1 [Lipid storage disorders],0.134,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.882,0.096,0.031,0.98,2
KIF7,CM_770.5 [Congenital osteodystrophies],0.134,0,0.0,0.0,0.547,0.0,0.293,0.721,0.015,1.39,2.615,0.174,0.218,0.43,5
ATXN3,GE_973.5 [Huntington's disease],0.134,0,0.0,0.0,0.0,0.0,0.286,0.0,0.491,,2.105,0.091,0.036,,3
ADRA2A,NS_333.4 [Circadian rhythm sleep disorder],0.134,1,4.0,0.0,0.0,0.0,0.0,0.0,0.04,2.52,2.274,0.021,0.049,0.586,3
UBR4,GE_972.2 [Hereditary ataxia],0.134,0,0.0,0.0,0.635,0.0,0.0,0.0,0.065,1.879,2.523,0.323,0.25,0.923,4
PKLR,GE_970.1 [Sickle-cell disorders],0.134,1,3.0,0.0,0.0,0.0,0.493,0.0,0.1,,1.716,0.806,0.209,,3
APOE,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.133,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.305,0.157,0.08,0.983,1
IL23A,GU_580.1 [Acute nephritic syndrome],0.133,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.062,0.112,0.075,0.986,1
C1S,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.133,1,4.0,0.0,0.547,0.0,0.0,0.0,0.081,1.428,2.825,0.198,1.353,0.818,4
HSP90B1,NS_338.1 [Myasthenia gravis],0.133,0,0.0,0.0,0.0,0.0,0.0,0.0,0.067,2.317,4.175,3.825,1.01,,2
GRIN2B,NS_341.1 [Cerebral palsy],0.133,1,4.0,0.0,0.0,0.0,0.0,0.29,0.0,2.146,1.692,,,0.984,3
ESRRG,CV_414.1 [Hypertrophic cardiomyopathy],0.133,0,0.0,0.0,0.0,0.0,0.555,0.0,0.165,3.229,2.614,2.464,0.167,0.567,4
NDUFA10,GE_963.1 [Lipid storage disorders],0.133,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.84,3.596,0.322,0.103,0.996,2
BRIP1,BI_162.1 [Constitutional (hereditary) aplastic anemia],0.133,0,0.0,0.0,0.0,0.0,0.359,0.546,0.11,1.571,3.761,1.082,0.139,,4
F2,CV_433.3 [Cerebrovascular insufficiency],0.133,1,4.0,0.0,0.304,0.0,0.0,0.203,0.1,,1.914,0.091,0.114,0.863,4
C9orf72,NS_323.3 [Motor neuron disease],0.133,1,2.0,0.0,0.774,0.361,0.0,0.547,0.183,5.427,1.797,0.337,0.235,0.217,4
FSCN2,SO_380.3 [Optic atrophy],0.133,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.723,2.21,0.329,0.206,0.964,2
ABCA4,SO_369.62 [Keratoconus],0.133,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.78,3.43,1.533,0.161,1.0,2
C8orf76,NS_341.1 [Cerebral palsy],0.133,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.435,0.264,0.208,0.11,0.959,2
PLN,CV_414.1 [Hypertrophic cardiomyopathy],0.132,0,0.0,0.0,0.861,0.161,0.647,0.78,0.393,5.904,2.329,2.223,0.065,0.978,5
NDUFS5,CV_414.1 [Hypertrophic cardiomyopathy],0.132,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.02,1.79,1.617,0.105,0.976,2
SLC4A1,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.132,0,0.0,0.0,0.828,0.0,0.355,0.21,0.088,1.944,2.832,0.398,1.894,0.988,5
PTPN11,CV_414.1 [Hypertrophic cardiomyopathy],0.132,0,0.0,0.0,0.847,0.0,0.432,0.462,0.559,,3.374,0.064,1.718,0.941,5
UNC119,SO_369.62 [Keratoconus],0.132,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.168,0.768,0.109,0.978,2
RD3,SO_369.62 [Keratoconus],0.132,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.031,0.776,0.093,0.998,2
SLC18A3,NS_338.1 [Myasthenia gravis],0.132,0,0.0,0.0,0.0,0.0,0.453,0.669,0.16,,2.932,0.055,0.099,,4
OPA1,GE_972.2 [Hereditary ataxia],0.132,0,0.0,0.0,0.866,0.0,0.28,0.37,0.017,1.917,2.951,0.242,0.244,0.99,5
OR13C9,CV_433.3 [Cerebrovascular insufficiency],0.132,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,1.71,0.081,0.072,0.986,2
CHKB,GE_972.9 [Muscular dystrophy],0.132,0,0.0,0.0,0.88,0.0,0.324,0.778,0.283,,2.986,3.163,0.119,0.178,5
MLH1,BI_179.7 [Common variable immunodeficiency [CVID]],0.132,0,0.0,0.0,0.0,0.0,0.313,0.0,0.316,,2.559,0.135,0.072,,3
B4GALNT1,NS_341.1 [Cerebral palsy],0.132,0,0.0,0.0,0.858,0.0,0.0,0.591,0.074,,0.769,0.313,0.159,0.987,3
FGF19,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.132,0,0.0,0.0,0.0,0.0,0.0,0.0,0.091,2.779,2.762,0.022,0.056,0.104,3
VWF,GE_971.11 [Hereditary factor VIII deficiency [Hemophilia A]],0.132,1,4.0,0.0,0.0,0.0,0.3,0.129,0.288,2.346,3.625,1.378,1.166,,4
NRXN3,MB_296.2 [Schizoid personality disorder],0.131,0,0.0,0.0,0.0,0.0,0.0,0.0,0.212,2.594,0.453,0.12,2.042,,2
ADAR,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.131,0,0.0,0.0,0.0,0.0,0.0,0.843,0.16,1.898,3.055,0.167,0.163,0.972,4
PEX11A,NS_341.1 [Cerebral palsy],0.131,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.499,0.36,0.256,0.122,0.968,2
PTGS2,GE_976.5 [Polycystic kidney disease],0.131,0,0.0,0.0,0.0,0.0,0.353,0.0,0.118,1.596,2.849,0.154,1.119,,3
SCUBE3,MS_727.3 [Osteitis deformans [Paget's disease of bone]],0.131,0,0.0,0.0,0.0,0.0,0.277,0.0,0.133,,4.013,3.374,1.595,,3
SLC6A4,MB_293.1 [Anorexia nervosa],0.131,1,4.0,0.0,0.0,0.0,0.0,0.0,0.104,1.393,2.663,0.122,0.696,,2
PTGS2,GE_972.9 [Muscular dystrophy],0.131,1,3.0,0.0,0.0,0.0,0.0,0.0,0.097,3.484,0.09,0.087,0.082,0.888,3
DYNC2H1,SO_386.6 [Night blindness],0.131,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.926,2.353,0.266,0.16,0.992,2
PTGS2,MS_700.3 [Systemic sclerosis],0.131,1,4.0,0.0,0.0,0.0,0.0,0.0,0.374,2.475,1.675,0.131,0.127,,2
FLNA,CM_770.5 [Congenital osteodystrophies],0.131,0,0.0,0.0,0.0,0.0,0.0,0.894,0.111,,3.518,0.102,0.209,0.704,4
RGR,SO_369.62 [Keratoconus],0.13,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,1.901,0.859,0.158,0.998,2
CABP4,SO_369.62 [Keratoconus],0.13,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.231,0.483,0.147,0.997,2
NDUFA3,CV_414.1 [Hypertrophic cardiomyopathy],0.13,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.621,1.726,0.296,0.105,0.974,2
PEX10,NS_341.1 [Cerebral palsy],0.13,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,3.817,0.308,0.112,0.989,2
SLC12A6,GE_972.1 [Hereditary neuropathy],0.13,0,0.0,0.0,0.0,0.0,0.352,0.718,0.093,2.585,1.813,0.433,0.31,,4
MTOR,GU_580.1 [Acute nephritic syndrome],0.13,0,0.0,0.0,0.0,0.0,0.0,0.0,0.146,1.889,2.372,0.347,0.247,0.963,3
SPATA7,SO_380.3 [Optic atrophy],0.13,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.207,5.266,4.976,0.153,0.979,2
NDUFAF3,CV_414.1 [Hypertrophic cardiomyopathy],0.13,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.042,0.344,1.681,0.99,2
TNIP1,MS_700.3 [Systemic sclerosis],0.13,0,0.0,0.0,0.0,0.529,0.0,0.0,0.17,,1.247,0.439,0.208,,2
SOS1,CV_414.1 [Hypertrophic cardiomyopathy],0.13,0,0.0,0.0,0.801,0.0,0.427,0.01,0.182,1.763,2.371,1.371,0.313,0.707,5
SEMA4A,SO_386.6 [Night blindness],0.13,0,0.0,0.0,0.0,0.0,0.325,0.0,0.0,2.379,1.725,0.24,0.18,0.999,3
ACE,GE_976.5 [Polycystic kidney disease],0.13,1,3.0,0.0,0.0,0.0,0.449,0.0,0.271,2.146,2.663,0.523,0.455,,3
CDH2,CV_441 [Arteriovenous malformation],0.13,0,0.0,0.0,0.0,0.0,0.0,0.29,0.03,2.097,2.26,0.128,0.245,0.907,4
CHEK2,NS_344.2 [Benign intracranial hypertension],0.129,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.312,0.201,0.185,0.974,2
C6orf226,CM_751.213 [Congenital cataract],0.129,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.77,0.064,0.049,0.972,2
ATM,NS_344.2 [Benign intracranial hypertension],0.129,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.815,3.406,0.154,1.049,0.991,2
SPATA7,SO_369.62 [Keratoconus],0.129,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,1.965,0.301,0.936,1.0,2
NF1,CV_413.41 [Pulmonary valve stenosis],0.129,0,0.0,0.0,0.0,0.0,0.0,0.0,0.086,1.356,2.808,0.215,0.176,0.973,3
IKZF1,BI_179.1 [Hypogammaglobulinemia NOS],0.129,0,0.0,0.0,0.877,0.0,0.0,0.0,0.048,2.448,0.101,0.146,1.723,0.994,4
GNAS,CM_770.5 [Congenital osteodystrophies],0.129,0,0.0,0.0,0.779,0.0,0.0,0.861,0.074,2.291,0.238,0.089,0.075,0.884,4
HIF1A,CV_433.3 [Cerebrovascular insufficiency],0.129,0,0.0,0.0,0.0,0.0,0.0,0.0,0.176,3.175,2.973,0.239,0.141,0.982,3
EXT1,MS_704.1 [Polyarteritis nodosa and related conditions],0.129,0,0.0,0.0,0.0,0.0,0.0,0.0,0.279,3.097,0.192,0.148,0.119,,2
CACNA1D,EM_211.1 [Adrenal hyperfunction],0.129,1,2.0,0.0,0.801,0.0,0.264,0.0,0.042,1.814,4.665,0.334,0.333,,4
COL4A3,GU_580.1 [Acute nephritic syndrome],0.129,0,0.0,0.0,0.895,0.0,0.37,0.353,0.232,1.488,3.299,0.441,0.293,0.598,5
IFT57,SO_386.6 [Night blindness],0.129,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,3.281,1.297,0.126,0.99,2
EVC,CM_770.5 [Congenital osteodystrophies],0.129,0,0.0,0.0,0.0,0.0,0.317,0.884,0.112,1.878,4.177,1.442,0.186,0.43,5
COQ4,GE_972.2 [Hereditary ataxia],0.129,0,0.0,0.0,0.816,0.0,0.0,0.527,0.182,,2.557,0.181,0.166,0.887,4
ALS2,NS_341.1 [Cerebral palsy],0.129,0,0.0,0.0,0.892,0.0,0.0,0.743,0.062,1.782,3.252,0.329,0.277,0.994,4
NDUFS8,GE_972.2 [Hereditary ataxia],0.129,1,4.0,0.0,0.0,0.0,0.0,0.0,0.0,3.957,3.165,0.32,0.159,0.975,2
CNGA3,SO_369.62 [Keratoconus],0.129,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.669,2.366,0.742,0.22,0.99,2
MORC2,GE_972.1 [Hereditary neuropathy],0.129,0,0.0,0.0,0.0,0.0,0.312,0.186,0.26,,2.193,0.27,0.229,,4
XRCC2,CV_414.1 [Hypertrophic cardiomyopathy],0.129,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.248,2.511,0.344,0.17,0.948,2
FNDC3B,CV_414.1 [Hypertrophic cardiomyopathy],0.128,0,0.0,0.0,0.0,0.594,0.0,0.0,0.03,2.635,3.114,0.324,0.511,0.205,3
TUBB2B,CV_433.3 [Cerebrovascular insufficiency],0.128,1,4.0,0.0,0.0,0.0,0.0,0.0,0.0,1.705,0.088,,,0.224,2
UQCRQ,NS_341.1 [Cerebral palsy],0.128,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.177,0.064,0.074,0.972,1
TRAPPC11,GE_972.9 [Muscular dystrophy],0.128,0,0.0,0.0,0.872,0.0,0.0,0.725,0.148,1.923,1.554,0.16,0.202,0.936,4
BAX,BI_179.1 [Hypogammaglobulinemia NOS],0.128,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.909,0.83,0.15,0.084,0.975,2
LAMP2,CV_414.1 [Hypertrophic cardiomyopathy],0.128,0,0.0,0.0,0.885,0.0,0.659,0.451,0.188,1.857,2.501,0.375,0.091,0.965,5
NYX,SO_386.6 [Night blindness],0.128,0,0.0,0.0,0.894,0.0,0.278,0.721,0.11,1.698,1.711,0.111,0.081,0.991,5
MKS1,GE_972.2 [Hereditary ataxia],0.128,0,0.0,0.0,0.426,0.0,0.0,0.29,0.0,,3.518,2.665,0.905,0.995,3
CYP4F22,GE_977.1 [Congenital ichthyosis],0.128,0,0.0,0.0,0.869,0.0,0.341,0.762,0.133,1.459,3.786,2.49,0.117,0.998,5
TEAD1,MS_712.51 [Hypermobility syndrome],0.128,0,0.0,0.0,0.0,0.0,0.0,0.0,0.146,2.601,1.646,0.139,0.159,,2
PSEN1,NS_323.3 [Motor neuron disease],0.128,0,0.0,0.0,0.654,0.0,0.0,0.0,0.127,1.515,0.958,0.172,0.181,0.978,4
PNPLA1,GE_977.1 [Congenital ichthyosis],0.128,0,0.0,0.0,0.684,0.0,0.349,0.637,0.152,1.394,2.782,0.113,0.071,0.998,5
NFKB1,BI_179.7 [Common variable immunodeficiency [CVID]],0.128,0,0.0,0.0,0.0,0.0,0.652,0.821,0.604,1.976,1.893,0.148,2.677,,4
COX18,CV_414.1 [Hypertrophic cardiomyopathy],0.128,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.621,2.183,0.273,0.19,0.971,2
POLR3B,GE_972.2 [Hereditary ataxia],0.127,0,0.0,0.0,0.843,0.0,0.0,0.831,0.077,1.878,2.586,0.353,0.281,0.808,4
CHD7,CM_763.31 [Ventricular septal defect],0.127,0,0.0,0.0,0.841,0.0,0.0,0.129,0.021,3.102,3.956,0.318,0.25,0.923,4
ADRB1,NS_333.4 [Circadian rhythm sleep disorder],0.127,1,4.0,0.0,0.0,0.0,0.0,0.0,0.018,3.056,1.698,0.042,0.049,0.295,3
MTOR,BI_179.7 [Common variable immunodeficiency [CVID]],0.127,0,0.0,0.0,0.0,0.0,0.549,0.0,0.384,1.372,2.741,0.109,0.087,,3
NDUFAF5,GE_972.2 [Hereditary ataxia],0.127,0,0.0,0.017,0.0,0.0,0.0,0.0,0.0,3.648,2.278,0.864,0.147,0.975,3
KAT6B,MB_302.1 [Speech and language developmental delay],0.127,0,0.0,0.0,0.0,0.0,0.0,0.129,0.018,2.324,2.92,0.262,0.339,0.212,4
GRIN2B,NS_323.3 [Motor neuron disease],0.127,1,3.0,0.0,0.0,0.0,0.0,0.0,0.072,3.588,2.377,,,0.769,3
EYS,SO_386.5 [Color vision deficiencies],0.127,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.036,3.105,0.303,1.04,0.999,2
GTPBP3,NS_341.1 [Cerebral palsy],0.127,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.4,1.126,0.19,0.987,2
RD3,SO_386.6 [Night blindness],0.127,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.423,0.36,0.325,0.076,0.996,2
MYO9A,GU_580.52 [Diffuse membranous glomerulonephritis],0.127,0,0.0,0.0,0.0,0.0,0.688,0.172,0.09,,2.521,0.307,0.122,,4
GRIA2,GE_972.2 [Hereditary ataxia],0.127,0,0.0,0.152,0.0,0.0,0.283,0.0,0.11,1.858,2.824,0.186,1.437,0.96,5
TNF,GI_540.11 [Autoimmune hepatitis],0.127,1,2.0,0.0,0.0,0.0,0.321,0.0,0.447,,0.268,0.268,0.044,,2
PEX13,GI_516.1 [Pyloric stenosis],0.127,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.379,0.625,0.21,0.986,2
EP300,CM_763.31 [Ventricular septal defect],0.127,0,0.0,0.0,0.547,0.0,0.266,0.0,0.015,,2.659,0.306,0.244,0.976,5
MTOR,GE_970.1 [Sickle-cell disorders],0.127,0,0.0,0.0,0.0,0.0,0.0,0.0,0.097,1.976,0.978,0.102,0.163,,2
UNC119,SO_386.5 [Color vision deficiencies],0.126,0,0.0,0.0,0.0,0.0,0.348,0.0,0.0,,0.254,0.366,0.063,0.993,2
SLC6A3,GE_972.2 [Hereditary ataxia],0.126,1,4.0,0.0,0.0,0.0,0.0,0.0,0.036,1.721,2.85,0.251,0.182,0.902,3
PDZD7,SO_386.6 [Night blindness],0.126,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,3.248,1.495,0.183,0.991,2
FBN1,GE_978.21 [Marfan syndrome],0.126,0,0.0,0.0,0.0,0.0,0.272,0.963,0.27,2.374,3.969,,22.56,,4
GATA3,EM_208.1 [Hypoparathyroidism],0.126,0,0.0,0.0,0.894,0.0,0.0,0.0,0.151,4.186,1.719,0.11,1.887,0.991,4
EPHA2,CM_751.213 [Congenital cataract],0.126,0,0.0,0.0,0.745,0.0,0.611,0.762,0.064,,3.167,0.666,0.223,0.985,5
DNAJC7,NS_323.3 [Motor neuron disease],0.126,0,0.0,0.0,0.881,0.0,0.0,0.435,0.087,,0.939,0.159,0.157,0.092,3
KIRREL1,GU_580.52 [Diffuse membranous glomerulonephritis],0.126,0,0.0,0.0,0.0,0.0,0.612,0.0,0.125,2.538,0.4,0.114,0.109,,3
TEK,CV_433.3 [Cerebrovascular insufficiency],0.126,0,0.0,0.0,0.0,0.0,0.0,0.0,0.237,2.0,4.235,0.21,0.181,0.959,3
OPN1SW,SO_386.5 [Color vision deficiencies],0.126,0,0.0,0.0,0.828,0.0,0.0,0.766,0.0,,2.699,0.18,0.097,0.98,3
KIT,GE_961.1 [Phakomatoses],0.126,1,2.0,0.0,0.0,0.0,0.418,0.0,0.059,2.888,3.858,2.466,0.149,0.976,4
KIF5A,NS_341.1 [Cerebral palsy],0.126,0,0.0,0.0,0.891,0.0,0.0,0.6,0.072,2.042,0.862,0.451,0.16,0.999,4
DPP6,NS_323.3 [Motor neuron disease],0.125,0,0.0,0.0,0.426,0.418,0.0,0.0,0.114,2.665,2.184,0.279,0.167,0.362,4
EPO,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.125,0,0.0,0.0,0.0,0.0,0.547,0.0,0.238,,1.333,0.115,0.111,0.994,4
ARID3A,GI_542.8 [Biliary cirrhosis],0.125,0,0.0,0.0,0.0,0.39,0.0,0.0,0.431,1.691,2.083,0.999,1.696,,2
ITPR1,NS_341.1 [Cerebral palsy],0.125,0,0.0,0.0,0.801,0.0,0.0,0.0,0.049,1.883,2.801,0.444,0.285,0.99,4
DGUOK,CV_414.1 [Hypertrophic cardiomyopathy],0.125,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.862,1.021,0.482,0.2,0.976,2
NPHP4,SO_380.3 [Optic atrophy],0.125,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.34,3.961,0.723,0.323,0.975,2
SCN2A,NS_323.3 [Motor neuron disease],0.125,1,4.0,0.0,0.0,0.0,0.0,0.0,0.018,2.383,2.121,0.274,0.292,0.209,3
MAPT,NS_328.13 [Frontotemporal dementia [FTD]],0.125,1,3.0,0.0,0.0,0.0,0.319,0.829,0.425,,2.88,0.842,0.867,,4
ACHE,NS_338.1 [Myasthenia gravis],0.125,1,4.0,0.0,0.0,0.0,0.354,0.0,0.094,,2.893,0.064,0.184,,3
PRKCB,GI_542.8 [Biliary cirrhosis],0.125,0,0.0,0.0,0.0,0.446,0.0,0.0,0.1,2.867,2.909,0.17,0.152,,2
FLT1,MS_700.3 [Systemic sclerosis],0.125,1,4.0,0.0,0.0,0.0,0.0,0.0,0.211,3.932,3.352,2.51,0.323,,2
TEAD1,SO_369.62 [Keratoconus],0.125,0,0.0,0.0,0.0,0.0,0.47,0.0,0.102,1.913,1.783,0.116,0.122,0.407,4
NF1,GE_961.1 [Phakomatoses],0.124,0,0.0,0.0,0.0,0.0,0.33,0.92,0.094,,2.609,0.412,128.512,0.992,5
NR3C1,BI_162.1 [Constitutional (hereditary) aplastic anemia],0.124,1,4.0,0.0,0.304,0.0,0.0,0.0,0.083,2.536,0.241,0.114,0.084,,3
GUCA1A,SO_369.62 [Keratoconus],0.124,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.549,2.016,0.31,0.078,0.999,2
FGFR2,CM_763.31 [Ventricular septal defect],0.124,0,0.0,0.0,0.684,0.0,0.0,0.0,0.036,1.935,2.472,0.202,0.906,0.951,4
RICTOR,CM_763.31 [Ventricular septal defect],0.124,0,0.0,0.0,0.426,0.0,0.0,0.0,0.103,1.902,3.089,0.256,0.23,0.863,4
CD36,EM_208.1 [Hypoparathyroidism],0.124,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.043,2.117,0.701,0.531,0.97,2
NMNAT1,NS_341.1 [Cerebral palsy],0.124,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.188,0.163,0.079,0.974,1
ATXN2,NS_323.3 [Motor neuron disease],0.124,1,2.0,0.0,0.815,0.0,0.0,0.274,0.152,,3.168,0.304,0.44,0.998,4
KRT1,GE_977.1 [Congenital ichthyosis],0.124,0,0.0,0.0,0.891,0.0,0.339,0.699,0.101,1.338,3.622,0.023,0.056,0.977,5
COL4A1,GE_976.5 [Polycystic kidney disease],0.124,0,0.0,0.0,0.0,0.0,0.44,0.0,0.163,2.25,3.278,0.962,0.784,,3
IGF1R,SO_365.3 [Exophthalmos [Proptosis]],0.124,1,4.0,0.0,0.0,0.0,0.0,0.0,0.121,2.858,2.348,0.607,0.141,0.966,3
MYCN,CV_414.1 [Hypertrophic cardiomyopathy],0.124,0,0.0,0.0,0.0,0.0,0.407,0.0,0.163,2.448,2.625,2.1,0.111,0.913,4
MYH9,GU_580.52 [Diffuse membranous glomerulonephritis],0.124,0,0.0,0.0,0.0,0.0,0.744,0.132,0.136,,2.438,0.113,0.217,,4
PIK3CB,CV_414.1 [Hypertrophic cardiomyopathy],0.124,0,0.0,0.0,0.0,0.0,0.496,0.0,0.152,,2.281,0.484,0.404,0.49,4
PEX12,SO_380.3 [Optic atrophy],0.124,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,1.163,0.424,0.109,0.98,1
MTOR,CM_763.31 [Ventricular septal defect],0.124,0,0.0,0.0,0.547,0.0,0.0,0.0,0.0,1.859,2.845,0.874,0.221,0.989,3
BMP4,MS_719.2 [Muscle calcification and ossification],0.124,0,0.0,0.0,0.0,0.0,0.0,0.0,0.593,2.786,0.169,0.134,0.066,,2
GZMB,GU_580.1 [Acute nephritic syndrome],0.124,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.943,2.758,0.125,0.077,0.972,2
PAPSS2,GE_978.3 [Osteochondrodysplasias],0.124,0,0.0,0.0,0.0,0.0,0.368,0.786,0.032,2.012,4.034,1.834,0.189,,4
PSAP,NS_328.13 [Frontotemporal dementia [FTD]],0.124,0,0.0,0.0,0.0,0.0,0.377,0.0,0.321,2.122,3.111,0.395,0.164,,3
LRPPRC,CV_414.1 [Hypertrophic cardiomyopathy],0.124,0,0.0,0.0,0.684,0.0,0.0,0.0,0.0,2.177,2.546,0.673,0.086,1.0,3
PRKAG2,CV_416.8 [Pre-excitation syndrome [Anomalous atrioventricular excitation]],0.124,0,0.0,0.0,0.834,0.0,0.0,0.827,0.192,2.932,2.199,0.12,0.12,0.871,4
MPV17,NS_341.1 [Cerebral palsy],0.124,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.106,0.179,0.123,0.949,1
TRIM24,MS_700.43 [Polymyositis],0.124,0,0.0,0.0,0.0,0.0,0.0,0.0,0.37,2.133,0.205,0.11,0.09,,2
KDR,CV_441 [Arteriovenous malformation],0.124,0,0.0,0.0,0.0,0.0,0.0,0.0,0.101,2.182,3.078,0.301,0.348,0.993,3
NDUFS4,GE_972.2 [Hereditary ataxia],0.124,1,4.0,0.0,0.547,0.0,0.262,0.0,0.041,1.976,0.462,0.249,0.106,0.99,5
RYR2,CV_414.1 [Hypertrophic cardiomyopathy],0.124,0,0.0,0.0,0.864,0.0,0.846,0.178,0.164,2.147,3.282,1.256,0.112,0.973,5
EARS2,CV_414.1 [Hypertrophic cardiomyopathy],0.124,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.198,0.533,0.309,0.988,2
FOXE3,CM_751.213 [Congenital cataract],0.124,0,0.0,0.0,0.813,0.0,0.725,0.773,0.073,2.233,2.914,0.074,0.09,,4
LPAR1,MS_700.3 [Systemic sclerosis],0.123,1,2.0,0.0,0.0,0.0,0.0,0.0,0.101,3.305,1.788,0.089,0.163,,2
NDUFB5,NS_341.1 [Cerebral palsy],0.123,1,2.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.359,0.063,0.106,0.96,1
EZH2,GI_542.8 [Biliary cirrhosis],0.123,0,0.0,0.0,0.0,0.0,0.0,0.0,0.578,1.968,0.952,0.09,1.76,,2
FASLG,GI_542.8 [Biliary cirrhosis],0.123,0,0.0,0.0,0.0,0.0,0.267,0.0,0.191,2.167,2.614,0.107,0.085,,3
IL12A,GU_580.1 [Acute nephritic syndrome],0.123,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.071,2.134,,0.079,0.984,2
FOXRED1,CV_414.1 [Hypertrophic cardiomyopathy],0.123,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.684,2.297,0.667,0.284,0.991,2
MBNL1,NS_339.2 [Myotonic disorders],0.123,0,0.0,0.0,0.0,0.0,0.0,0.251,0.563,1.883,3.196,3.029,0.064,,3
RHAG,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.123,0,0.0,0.0,0.547,0.0,0.0,0.0,0.012,1.326,2.518,0.217,0.14,0.961,4
AP4B1,NS_341.1 [Cerebral palsy],0.123,0,0.0,0.0,0.886,0.0,0.0,0.772,0.034,1.516,4.418,0.733,0.208,0.988,4
PEX5,SO_386.6 [Night blindness],0.123,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,1.699,0.329,0.161,0.983,2
IGF1,NS_323.3 [Motor neuron disease],0.123,1,2.0,0.0,0.0,0.0,0.443,0.0,0.118,2.203,0.225,0.193,0.138,0.906,4
RP1,SO_386.6 [Night blindness],0.123,0,0.0,0.0,0.684,0.0,0.0,0.0,0.0,1.601,3.634,1.593,0.212,0.976,3
SGCG,GE_972.9 [Muscular dystrophy],0.123,0,0.0,0.0,0.893,0.0,0.419,0.727,0.063,2.022,1.746,0.27,0.09,0.995,5
NDUFB6,GE_963.1 [Lipid storage disorders],0.123,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,1.288,0.189,0.063,0.973,1
ACE,GU_580.52 [Diffuse membranous glomerulonephritis],0.123,1,2.0,0.0,0.0,0.0,0.608,0.0,0.17,,2.738,0.391,0.6,,3
COL9A2,GE_978.3 [Osteochondrodysplasias],0.123,0,0.0,0.0,0.0,0.0,0.353,0.745,0.044,1.903,2.034,0.13,0.177,,4
RDH12,SO_369.62 [Keratoconus],0.123,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.365,0.143,0.398,0.158,1.0,2
COX11,CV_414.1 [Hypertrophic cardiomyopathy],0.123,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.313,0.146,0.223,0.997,2
GRIN2A,MB_302.1 [Speech and language developmental delay],0.123,0,0.0,0.0,0.0,0.0,0.304,0.91,0.089,2.284,2.029,0.307,0.21,0.982,5
CD34,CV_441 [Arteriovenous malformation],0.123,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.672,1.723,0.367,0.135,0.981,2
ERLIN2,NS_341.1 [Cerebral palsy],0.122,0,0.0,0.0,0.874,0.0,0.0,0.582,0.091,,0.124,0.112,0.114,0.989,3
CDKN1A,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.122,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.441,1.304,0.314,0.093,0.949,2
HIF1A,GU_580.1 [Acute nephritic syndrome],0.122,0,0.0,0.0,0.0,0.0,0.0,0.0,0.186,1.527,2.59,0.273,0.162,0.967,3
GAD2,GE_964.3 [Glycogen storage disease],0.122,0,0.0,0.0,0.0,0.0,0.375,0.0,0.152,1.45,0.776,0.291,0.093,,3
LAMA5,GU_580.51 [Focal and segmental glomerular lesions*],0.122,0,0.0,0.0,0.0,0.0,0.603,0.0,0.188,,4.208,0.14,0.312,,3
CUL7,CM_770.5 [Congenital osteodystrophies],0.122,0,0.0,0.0,0.0,0.0,0.0,0.865,0.208,1.593,3.875,0.631,0.261,0.512,4
PPARGC1A,GE_972.9 [Muscular dystrophy],0.122,0,0.0,0.0,0.0,0.0,0.272,0.0,0.174,2.533,2.759,0.217,0.158,0.884,4
COL9A1,CM_770.5 [Congenital osteodystrophies],0.122,0,0.0,0.0,0.789,0.0,0.303,0.446,0.085,3.568,2.769,0.143,0.235,0.857,5
PEX12,NS_341.1 [Cerebral palsy],0.122,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,1.629,0.636,0.108,0.993,2
COL13A1,NS_338.1 [Myasthenia gravis],0.122,0,0.0,0.0,0.0,0.0,0.545,0.811,0.091,2.433,3.072,3.545,0.291,,4
TMEM106B,NS_328.13 [Frontotemporal dementia [FTD]],0.122,0,0.0,0.05,0.0,0.605,0.261,0.402,0.392,2.489,2.569,0.06,0.126,,5
PDE6C,SO_386.5 [Color vision deficiencies],0.122,0,0.0,0.0,0.895,0.0,0.0,0.843,0.121,,1.931,0.114,0.138,0.998,4
LGI1,GE_972.2 [Hereditary ataxia],0.122,0,0.0,0.108,0.0,0.0,0.0,0.0,0.032,2.299,0.212,0.151,1.877,0.925,4
COL4A1,GU_580.1 [Acute nephritic syndrome],0.122,0,0.0,0.0,0.532,0.0,0.369,0.0,0.342,2.134,4.379,1.722,0.264,0.775,5
GJC2,GE_963.1 [Lipid storage disorders],0.122,0,0.0,0.0,0.813,0.0,0.0,0.852,0.091,,3.752,0.104,1.877,0.91,4
GPI,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.121,0,0.0,0.0,0.853,0.0,0.0,0.281,0.11,,2.581,0.26,0.82,0.904,4
SPART,NS_323.3 [Motor neuron disease],0.121,0,0.0,0.0,0.426,0.0,0.0,0.845,0.34,,2.993,2.918,0.387,,3
NIPAL4,GE_977.1 [Congenital ichthyosis],0.121,0,0.0,0.0,0.796,0.0,0.32,0.78,0.106,1.442,3.508,0.234,0.074,0.997,5
AIRE,GI_540.11 [Autoimmune hepatitis],0.121,0,0.0,0.0,0.0,0.0,0.428,0.0,0.131,,2.418,0.714,0.149,,3
DAG1,GE_972.9 [Muscular dystrophy],0.121,1,0.5,0.0,0.779,0.0,0.282,0.696,0.081,,2.602,0.333,1.576,1.0,5
ATP2A2,CV_414.1 [Hypertrophic cardiomyopathy],0.121,0,0.0,0.0,0.0,0.0,0.409,0.0,0.424,,1.852,1.341,0.185,0.844,4
F7,GE_971.11 [Hereditary factor VIII deficiency [Hemophilia A]],0.121,1,4.0,0.0,0.0,0.0,0.0,0.129,0.172,1.904,2.522,0.171,1.785,,3
WNT1,CM_770.5 [Congenital osteodystrophies],0.121,0,0.0,0.0,0.0,0.0,0.0,0.73,0.19,,2.282,0.187,1.745,0.909,4
TNFSF15,GI_542.8 [Biliary cirrhosis],0.121,0,0.0,0.0,0.304,0.604,0.0,0.0,0.371,,1.683,0.173,0.116,,3
TNNT1,GE_972.9 [Muscular dystrophy],0.121,0,0.0,0.0,0.547,0.0,0.417,0.503,0.093,1.934,0.123,0.136,0.089,0.856,5
SLC6A4,MB_293.2 [Bulimia nervosa],0.121,1,4.0,0.0,0.0,0.0,0.0,0.0,0.098,1.329,2.366,0.14,0.895,,2
POMT2,GE_972.9 [Muscular dystrophy],0.121,0,0.0,0.0,0.894,0.0,0.0,0.509,0.091,,3.631,0.325,0.162,0.999,4
IL21R,GI_542.8 [Biliary cirrhosis],0.121,0,0.0,0.0,0.0,0.553,0.0,0.0,0.48,2.916,2.904,0.35,0.119,,2
KIT,NS_323.3 [Motor neuron disease],0.121,1,4.0,0.035,0.0,0.0,0.0,0.0,0.065,2.693,2.033,0.28,0.597,0.301,4
TBX5,CM_763.31 [Ventricular septal defect],0.12,0,0.0,0.0,0.779,0.0,0.356,0.37,0.186,2.519,1.702,0.984,0.097,0.746,5
HNRNPC,SO_386.6 [Night blindness],0.12,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.625,0.073,,,0.204,2
AARS2,NS_341.1 [Cerebral palsy],0.12,0,0.0,0.0,0.654,0.0,0.0,0.0,0.0,2.532,3.156,0.212,0.744,0.964,3
FA2H,NS_341.1 [Cerebral palsy],0.12,0,0.0,0.0,0.892,0.0,0.0,0.599,0.066,,0.964,0.144,0.113,0.995,3
GDAP1,GE_972.1 [Hereditary neuropathy],0.12,0,0.0,0.0,0.0,0.0,0.274,0.861,0.103,2.123,0.243,0.2,0.224,,4
SQSTM1,MB_302.1 [Speech and language developmental delay],0.12,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.053,3.331,1.94,1.138,0.952,2
TCERG1,GE_973.5 [Huntington's disease],0.12,0,0.0,0.0,0.0,0.0,0.0,0.0,0.466,2.075,0.228,0.111,0.082,,2
TNFSF11,GI_542.8 [Biliary cirrhosis],0.12,0,0.0,0.0,0.0,0.618,0.0,0.0,0.659,2.813,2.408,0.262,0.072,,2
F11,GE_971.13 [Factor XI deficiency [Hemophilia C]],0.12,1,4.0,0.0,0.0,0.0,0.0,0.913,0.072,2.214,10.748,21.467,11.261,,3
KCNMA1,NS_339.2 [Myotonic disorders],0.12,0,0.0,0.0,0.0,0.0,0.0,0.0,0.612,2.705,1.719,0.137,1.716,,2
C20orf144,SO_386.6 [Night blindness],0.12,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.494,0.5,0.046,0.998,1
TARDBP,NS_323.3 [Motor neuron disease],0.119,1,0.5,0.0,0.894,0.0,0.381,0.691,0.139,,2.855,0.045,0.048,1.0,5
NDUFB3,CV_414.1 [Hypertrophic cardiomyopathy],0.119,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.259,0.261,0.09,0.098,0.96,2
NLRP3,GU_580.1 [Acute nephritic syndrome],0.119,0,0.0,0.0,0.0,0.0,0.0,0.162,0.182,4.602,2.794,0.129,0.153,0.989,4
KIF7,GE_978.3 [Osteochondrodysplasias],0.119,0,0.0,0.0,0.0,0.0,0.293,0.721,0.015,,2.795,0.382,0.21,,4
UQCRQ,CV_414.1 [Hypertrophic cardiomyopathy],0.119,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.296,0.135,1.651,0.987,2
RAB3GAP1,SO_369.62 [Keratoconus],0.119,0,0.0,0.0,0.623,0.202,0.0,0.0,0.106,1.555,2.438,0.389,0.308,0.16,4
FST,GE_972.9 [Muscular dystrophy],0.119,0,0.0,0.034,0.0,0.0,0.301,0.0,0.075,2.694,4.205,3.473,2.351,0.266,5
PMPCA,GE_972.2 [Hereditary ataxia],0.119,0,0.0,0.0,0.832,0.0,0.0,0.787,0.031,1.53,3.087,0.38,0.739,0.933,4
TTC8,SO_369.62 [Keratoconus],0.119,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.826,3.262,0.511,0.196,0.997,2
ANK2,CV_416.8 [Pre-excitation syndrome [Anomalous atrioventricular excitation]],0.119,0,0.0,0.0,0.58,0.0,0.431,0.164,0.0,3.437,3.839,1.032,0.441,0.304,4
KCNV2,SO_386.5 [Color vision deficiencies],0.119,0,0.0,0.0,0.0,0.0,0.0,0.362,0.015,1.775,3.757,1.109,0.169,0.994,4
ANO10,GE_972.2 [Hereditary ataxia],0.119,0,0.0,0.01,0.878,0.0,0.0,0.756,0.072,2.467,1.768,0.221,0.486,0.941,5
BVES,GE_972.9 [Muscular dystrophy],0.119,0,0.0,0.0,0.836,0.0,0.312,0.543,0.082,,0.195,0.136,0.091,0.803,4
BEST1,SO_369.62 [Keratoconus],0.119,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.15,2.939,1.115,0.223,0.998,2
SLC6A3,NS_333.4 [Circadian rhythm sleep disorder],0.118,1,4.0,0.0,0.0,0.488,0.0,0.0,0.012,,1.896,0.19,0.131,0.961,3
TCTN2,GE_972.2 [Hereditary ataxia],0.118,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.435,0.37,0.269,0.179,0.992,2
MATN3,CM_770.5 [Congenital osteodystrophies],0.118,0,0.0,0.0,0.881,0.0,0.334,0.865,0.069,,3.117,0.32,1.624,0.705,5
CCND1,SO_365.3 [Exophthalmos [Proptosis]],0.118,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.222,0.174,0.045,1.731,0.986,2
FN1,GU_580.1 [Acute nephritic syndrome],0.118,0,0.0,0.0,0.815,0.0,0.0,0.0,0.101,2.699,2.627,0.099,0.573,0.906,4
NDUFV2,GE_963.1 [Lipid storage disorders],0.118,0,0.0,0.0,0.758,0.0,0.0,0.0,0.0,1.688,0.08,0.16,0.082,0.997,3
SCN4A,GE_972.9 [Muscular dystrophy],0.118,0,0.0,0.0,0.828,0.0,0.482,0.575,0.059,,3.234,0.562,0.233,0.764,5
COL4A4,GU_580.1 [Acute nephritic syndrome],0.118,0,0.0,0.0,0.896,0.0,0.254,0.354,0.183,3.195,3.087,3.543,0.142,0.687,5
EVC2,GE_978.3 [Osteochondrodysplasias],0.118,0,0.0,0.0,0.0,0.0,0.329,0.877,0.084,2.193,3.122,0.094,0.152,,4
CD2AP,GU_580.51 [Focal and segmental glomerular lesions*],0.118,0,0.0,0.0,0.0,0.0,0.66,0.711,0.207,1.638,2.943,2.223,0.096,,4
ADCY2,GE_978.21 [Marfan syndrome],0.118,0,0.0,0.0,0.0,0.0,0.0,0.0,0.091,1.968,3.879,2.445,2.061,,2
GJC2,GE_972.2 [Hereditary ataxia],0.118,0,0.0,0.0,0.816,0.0,0.0,0.785,0.056,,2.622,0.225,0.169,0.796,4
FOXP3,GI_540.11 [Autoimmune hepatitis],0.118,0,0.0,0.0,0.0,0.0,0.415,0.0,0.422,,0.295,0.112,0.071,,2
STAT3,MS_700.3 [Systemic sclerosis],0.118,0,0.0,0.0,0.0,0.344,0.0,0.0,0.743,1.724,4.654,3.583,0.117,,2
MPV17,CV_414.1 [Hypertrophic cardiomyopathy],0.118,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.663,0.802,0.195,0.991,2
EFNB2,MS_700.3 [Systemic sclerosis],0.117,0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,2.63,0.226,0.093,0.071,,2
NLGN4X,GE_977.1 [Congenital ichthyosis],0.117,0,0.0,0.0,0.0,0.0,0.0,0.0,0.04,3.344,2.643,,0.023,0.219,3
NOTCH1,CM_763.31 [Ventricular septal defect],0.117,0,0.0,0.0,0.89,0.0,0.0,0.0,0.079,1.459,3.614,2.95,0.292,0.977,4
SYNE1,GE_972.2 [Hereditary ataxia],0.117,0,0.0,0.0,0.897,0.0,0.272,0.367,0.091,2.383,3.39,0.86,0.604,0.992,5
FN1,RE_464.2 [Chronic nasopharyngitis],0.117,0,0.0,0.0,0.0,0.0,0.0,0.0,0.164,1.767,3.845,1.058,0.295,,2
CA2,GE_978.3 [Osteochondrodysplasias],0.117,0,0.0,0.0,0.0,0.0,0.283,0.832,0.117,2.064,0.1,0.095,0.097,,4
CALR3,CV_414.1 [Hypertrophic cardiomyopathy],0.117,0,0.0,0.0,0.547,0.0,0.0,0.447,0.082,,2.635,0.183,0.538,0.91,4
CANT1,CM_770.5 [Congenital osteodystrophies],0.117,0,0.0,0.0,0.684,0.0,0.317,0.875,0.128,1.572,2.54,0.205,1.878,0.294,5
SOX9,MS_727.5 [Cyst of bone],0.117,0,0.0,0.0,0.0,0.0,0.337,0.926,0.171,2.574,2.667,0.134,0.096,,4
PEX10,SO_380.3 [Optic atrophy],0.117,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,3.119,0.336,0.142,0.98,2
NR3C1,MB_296.1 [Paranoid personality disorder],0.117,1,4.0,0.0,0.0,0.0,0.0,0.0,0.42,3.369,0.189,0.077,0.052,,2
FANCD2,CV_414.1 [Hypertrophic cardiomyopathy],0.117,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.45,2.472,0.93,0.546,0.977,2
AKAP9,CV_414.1 [Hypertrophic cardiomyopathy],0.117,0,0.0,0.0,0.58,0.0,0.0,0.132,0.082,,2.776,0.223,0.5,0.78,4
GRIN2B,GE_972.2 [Hereditary ataxia],0.117,0,0.0,0.144,0.0,0.0,0.0,0.352,0.039,2.362,3.426,,,0.971,5
PTGS2,NS_343.3 [Complex regional pain syndrome],0.117,1,3.0,0.0,0.0,0.0,0.0,0.0,0.078,2.629,1.914,0.136,0.141,,2
TUBB2A,GE_961.1 [Phakomatoses],0.117,1,2.0,0.0,0.0,0.0,0.0,0.0,0.0,1.671,0.043,,,0.186,2
VDR,CM_772.1 [Congenital malformations of endocrine glands],0.117,0,0.0,0.0,0.0,0.0,0.376,0.0,0.121,1.999,2.711,0.164,0.089,,3
COL4A1,CV_433.3 [Cerebrovascular insufficiency],0.117,0,0.0,0.0,0.532,0.617,0.0,0.0,0.036,2.658,2.176,1.414,0.219,0.932,4
SPTA1,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.116,0,0.0,0.0,0.892,0.0,0.447,0.401,0.073,2.423,3.859,0.099,2.289,0.968,5
C8orf76,CV_433.3 [Cerebrovascular insufficiency],0.116,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.709,0.237,0.128,0.952,2
SLC40A1,GE_964.3 [Glycogen storage disease],0.116,0,0.0,0.0,0.0,0.0,0.379,0.0,0.076,2.551,1.721,0.083,0.121,,3
SLC1A2,GE_972.2 [Hereditary ataxia],0.116,0,0.0,0.235,0.0,0.0,0.0,0.0,0.107,3.56,3.082,0.202,0.145,0.939,4
CERS3,GE_977.1 [Congenital ichthyosis],0.116,0,0.0,0.0,0.0,0.0,0.325,0.602,0.105,2.196,2.77,2.756,0.078,0.999,5
AP4M1,GE_972.2 [Hereditary ataxia],0.116,0,0.0,0.0,0.547,0.0,0.0,0.447,0.119,,3.607,0.237,0.243,0.805,4
CACNA2D1,GE_972.2 [Hereditary ataxia],0.116,1,4.0,0.0,0.0,0.0,0.0,0.0,0.024,2.26,2.147,0.133,0.165,0.907,3
S100B,MB_302.1 [Speech and language developmental delay],0.116,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.189,0.071,0.09,0.064,0.963,2
PEX2,SO_380.3 [Optic atrophy],0.116,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.476,2.413,0.271,0.114,0.967,2
NPHS1,GU_580.51 [Focal and segmental glomerular lesions*],0.116,0,0.0,0.0,0.0,0.0,0.588,0.505,0.355,,2.886,1.296,0.191,,4
PLEC,GE_972.9 [Muscular dystrophy],0.116,1,0.5,0.0,0.893,0.0,0.357,0.233,0.081,2.184,3.582,0.044,0.127,0.997,5
PTGS2,CM_770.5 [Congenital osteodystrophies],0.116,0,0.0,0.0,0.0,0.0,0.0,0.0,0.046,1.999,0.107,0.091,0.095,0.99,3
MDM2,DE_663.1 [Pemphigus],0.116,0,0.0,0.0,0.0,0.0,0.29,0.0,0.485,,0.124,0.123,0.042,,2
SNX10,GE_978.3 [Osteochondrodysplasias],0.116,0,0.0,0.0,0.0,0.0,0.385,0.834,0.164,1.958,0.36,0.091,0.063,,4
ACADVL,CV_414.1 [Hypertrophic cardiomyopathy],0.116,0,0.0,0.0,0.547,0.0,0.458,0.432,0.071,,3.802,0.441,0.44,0.721,5
TNFAIP3,MS_700.3 [Systemic sclerosis],0.116,0,0.0,0.0,0.0,0.418,0.0,0.0,0.749,3.518,2.334,1.527,0.181,,2
FECH,GE_966.2 [Disorders of porphyrin metabolism],0.116,0,0.0,0.0,0.0,0.0,0.34,0.816,0.119,1.564,6.681,5.58,2.734,,4
UQCRC2,CV_414.1 [Hypertrophic cardiomyopathy],0.116,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.681,3.216,0.254,0.992,2
LZTR1,EM_208.1 [Hypoparathyroidism],0.116,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.291,0.453,1.021,0.959,2
IGF2R,MS_700.3 [Systemic sclerosis],0.116,0,0.0,0.0,0.0,0.0,0.0,0.0,0.377,1.612,3.668,0.503,0.452,,2
PAX2,GU_580.51 [Focal and segmental glomerular lesions*],0.116,0,0.0,0.0,0.0,0.0,0.506,0.835,0.237,1.808,3.196,0.117,0.088,,4
CD2AP,GU_580.52 [Diffuse membranous glomerulonephritis],0.116,0,0.0,0.0,0.0,0.0,0.66,0.711,0.127,1.943,0.359,0.201,0.093,,4
NAT16,GE_972.2 [Hereditary ataxia],0.116,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,3.565,0.132,0.099,0.959,2
CYFIP2,MS_704.1 [Polyarteritis nodosa and related conditions],0.116,0,0.0,0.0,0.0,0.0,0.0,0.0,0.144,2.901,0.214,0.113,1.595,,2
CHMP2B,NS_341.1 [Cerebral palsy],0.116,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.594,0.939,0.171,0.106,0.96,2
NAMPT,MS_712.51 [Hypermobility syndrome],0.116,0,0.0,0.0,0.0,0.0,0.0,0.0,0.187,2.889,0.707,0.099,0.103,,2
ZNF423,GE_972.2 [Hereditary ataxia],0.116,0,0.0,0.0,0.0,0.0,0.404,0.0,0.018,2.808,2.588,0.606,0.312,0.314,4
MYH9,CM_751.213 [Congenital cataract],0.116,0,0.0,0.0,0.547,0.0,0.0,0.0,0.018,1.655,2.068,0.461,0.258,0.906,4
GLI3,GE_978.3 [Osteochondrodysplasias],0.116,0,0.0,0.0,0.0,0.0,0.36,0.0,0.073,2.76,2.398,0.128,0.179,,3
NTRK3,NS_323.3 [Motor neuron disease],0.116,0,0.0,0.0,0.0,0.0,0.0,0.0,0.072,4.219,3.607,3.076,0.358,0.385,3
UBE2D3,GE_961.1 [Phakomatoses],0.115,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.714,0.054,,,0.251,2
ZEB1,SO_369.62 [Keratoconus],0.115,0,0.0,0.0,0.732,0.0,0.512,0.0,0.205,1.749,3.04,0.771,0.135,0.72,5
CSF1R,GE_963.1 [Lipid storage disorders],0.115,0,0.0,0.0,0.861,0.0,0.298,0.899,0.2,1.924,2.404,0.169,0.089,0.578,5
PINK1,NS_333.4 [Circadian rhythm sleep disorder],0.115,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,3.5,0.849,1.432,0.979,2
SMAD6,CV_438.41 [Aortic dissection],0.115,0,0.0,0.0,0.58,0.0,0.0,0.0,0.0,1.988,2.695,0.377,0.423,0.937,3
TYK2,MS_705.2 [Juvenile rheumatoid arthritis [JRA/JIA]],0.115,1,3.0,0.0,0.0,0.0,0.267,0.0,0.402,,2.617,0.582,0.11,,3
ADRB1,GE_978.21 [Marfan syndrome],0.115,1,4.0,0.0,0.0,0.0,0.0,0.0,0.103,1.329,3.675,0.029,0.029,,2
DRD4,"MB_280.4 [Sedative, hypnotic, or anxiolytic related disorders]",0.115,1,4.0,0.0,0.0,0.0,0.0,0.0,0.182,1.887,4.12,0.248,0.093,,2
GABRG2,NS_333.4 [Circadian rhythm sleep disorder],0.115,1,4.0,0.0,0.0,0.0,0.0,0.0,0.103,2.1,0.092,0.028,0.072,0.241,3
GABRA1,GE_961.1 [Phakomatoses],0.115,1,3.0,0.0,0.0,0.0,0.0,0.0,0.03,2.13,0.08,,0.064,0.131,3
IGFBP3,CV_414.1 [Hypertrophic cardiomyopathy],0.115,0,0.0,0.0,0.0,0.0,0.492,0.0,0.529,3.503,1.806,0.361,0.132,0.346,4
PTPRO,GU_580.51 [Focal and segmental glomerular lesions*],0.115,0,0.0,0.0,0.0,0.0,0.467,0.0,0.124,1.637,1.814,0.339,1.518,,3
VEGFA,CM_763.31 [Ventricular septal defect],0.115,0,0.0,0.0,0.654,0.0,0.292,0.0,0.127,3.734,0.214,0.157,0.089,0.91,5
PDSS2,GU_580.52 [Diffuse membranous glomerulonephritis],0.115,0,0.0,0.0,0.0,0.0,0.494,0.161,0.103,1.71,2.194,0.164,0.088,,4
LRAT,SO_369.62 [Keratoconus],0.115,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.52,1.801,0.152,0.09,1.0,2
C17orf107,SO_386.5 [Color vision deficiencies],0.115,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,1.664,1.461,0.033,1.0,2
OSTM1,CM_770.5 [Congenital osteodystrophies],0.115,0,0.0,0.0,0.84,0.0,0.292,0.577,0.103,2.532,0.297,0.091,0.077,0.958,5
NFE2L2,GE_972.2 [Hereditary ataxia],0.115,1,4.0,0.0,0.0,0.0,0.0,0.0,0.229,2.007,2.184,0.142,0.11,0.962,3
CYLD,MS_727.5 [Cyst of bone],0.115,0,0.0,0.0,0.0,0.0,0.0,0.0,0.248,3.005,2.734,0.142,0.867,,2
MYB,GE_970.1 [Sickle-cell disorders],0.115,0,0.0,0.0,0.0,0.0,0.417,0.0,0.138,,1.267,0.403,0.078,,2
GLI3,GE_961.1 [Phakomatoses],0.115,0,0.0,0.0,0.0,0.0,0.341,0.175,0.122,2.903,3.013,0.497,0.746,0.928,5
DDHD1,NS_341.1 [Cerebral palsy],0.115,0,0.0,0.0,0.869,0.0,0.0,0.121,0.023,2.211,3.515,0.204,1.253,0.996,4
PIK3CD,BI_179.1 [Hypogammaglobulinemia NOS],0.114,0,0.0,0.0,0.547,0.0,0.0,0.0,0.035,2.94,2.635,0.172,0.155,0.982,4
PNPLA6,GE_972.2 [Hereditary ataxia],0.114,0,0.0,0.0,0.874,0.0,0.0,0.833,0.088,1.342,3.287,2.816,3.785,0.99,4
INVS,GU_580.1 [Acute nephritic syndrome],0.114,0,0.0,0.0,0.765,0.0,0.264,0.176,0.012,2.312,1.966,0.252,0.284,0.122,5
CALM1,SO_386.6 [Night blindness],0.114,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.696,0.062,,,0.257,2
ABCD1,GE_972.2 [Hereditary ataxia],0.114,0,0.0,0.0,0.779,0.0,0.302,0.572,0.067,,2.252,0.284,1.764,0.951,5
GRIN1,CV_433.3 [Cerebrovascular insufficiency],0.114,1,3.0,0.0,0.0,0.0,0.0,0.0,0.032,1.873,0.114,0.045,0.108,0.208,3
LCK,MS_700.3 [Systemic sclerosis],0.114,1,1.0,0.0,0.0,0.0,0.0,0.0,0.529,1.678,1.625,0.193,0.16,,2
SOD1,GE_977.1 [Congenital ichthyosis],0.114,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.155,0.052,0.039,0.97,1
SLC6A3,MB_302.1 [Speech and language developmental delay],0.114,1,2.0,0.0,0.0,0.0,0.0,0.121,0.015,2.504,1.743,0.199,1.179,0.77,4
UQCRC1,GE_972.2 [Hereditary ataxia],0.114,0,0.0,0.039,0.0,0.0,0.0,0.0,0.0,,0.442,0.166,0.226,0.986,2
CTSK,CM_770.5 [Congenital osteodystrophies],0.114,0,0.0,0.0,0.894,0.0,0.324,0.392,0.069,,0.11,0.107,0.096,0.98,4
B3GALT6,MS_712.51 [Hypermobility syndrome],0.114,0,0.0,0.0,0.0,0.0,0.0,0.81,0.239,,2.7,0.147,0.083,,3
NDUFB8,GE_972.2 [Hereditary ataxia],0.114,1,4.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.201,0.211,0.097,0.985,1
C20orf144,SO_380.3 [Optic atrophy],0.114,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.567,0.56,0.031,1.0,1
MYOZ2,CV_414.1 [Hypertrophic cardiomyopathy],0.114,0,0.0,0.0,0.808,0.0,0.618,0.645,0.213,,1.687,1.546,0.186,0.874,5
SNAP25,NS_338.1 [Myasthenia gravis],0.114,0,0.0,0.0,0.0,0.0,0.286,0.658,0.07,2.049,0.136,0.077,0.09,,4
DRD2,MB_306 [Conduct disorders],0.114,1,4.0,0.0,0.0,0.369,0.0,0.0,0.148,1.705,1.289,1.221,0.077,,2
ABCA4,SO_386.6 [Night blindness],0.114,0,0.0,0.0,0.684,0.0,0.0,0.432,0.028,1.971,2.189,0.322,0.292,1.0,4
SCN5A,GE_972.9 [Muscular dystrophy],0.114,0,0.0,0.0,0.0,0.0,0.378,0.0,0.069,1.358,3.551,0.845,0.276,0.947,4
CRTAP,CM_770.5 [Congenital osteodystrophies],0.114,0,0.0,0.0,0.0,0.0,0.303,0.721,0.109,,2.451,0.349,0.169,0.789,5
KDR,CV_433.3 [Cerebrovascular insufficiency],0.114,0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,2.515,2.447,0.567,0.223,0.986,3
PEX2,GE_972.2 [Hereditary ataxia],0.114,0,0.0,0.02,0.547,0.0,0.277,0.0,0.0,2.951,2.634,0.861,0.128,0.95,5
ELOVL4,GE_977.1 [Congenital ichthyosis],0.114,0,0.0,0.0,0.0,0.0,0.354,0.811,0.033,1.933,2.421,2.398,0.072,0.99,5
RPS26,SO_380.3 [Optic atrophy],0.113,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.364,0.079,0.029,,0.234,2
STAT4,MS_700.3 [Systemic sclerosis],0.113,0,0.0,0.0,0.0,0.711,0.0,0.0,0.452,3.427,2.226,0.371,0.16,,2
JAK2,GE_970.2 [Thalassemia],0.113,1,4.0,0.0,0.0,0.0,0.468,0.0,0.034,3.041,1.614,0.922,0.452,,3
COX4I2,CV_414.1 [Hypertrophic cardiomyopathy],0.113,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.378,0.561,2.406,0.999,2
SQSTM1,NS_341.1 [Cerebral palsy],0.113,0,0.0,0.0,0.547,0.0,0.0,0.0,0.012,1.904,2.581,0.207,0.146,0.975,4
REEP1,GE_972.2 [Hereditary ataxia],0.113,0,0.0,0.185,0.0,0.0,0.258,0.853,0.179,2.822,2.913,0.034,1.853,0.839,6
SCN2A,GE_972.2 [Hereditary ataxia],0.113,1,2.0,0.092,0.87,0.0,0.0,0.33,0.081,2.427,1.483,0.11,0.236,0.992,5
VDR,CM_770.5 [Congenital osteodystrophies],0.113,1,4.0,0.0,0.0,0.0,0.335,0.0,0.184,1.855,1.82,0.164,0.089,0.956,4
BRCA2,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.113,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.108,2.188,0.385,0.261,0.984,2
NDUFS4,CM_763.31 [Ventricular septal defect],0.113,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.908,2.092,0.183,0.098,0.953,2
ANXA11,NS_323.3 [Motor neuron disease],0.113,0,0.0,0.0,0.888,0.0,0.0,0.679,0.129,2.703,1.81,0.056,0.311,0.945,4
VCAN,NS_323.3 [Motor neuron disease],0.113,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,2.456,2.599,0.527,0.437,0.138,3
BECN1,GE_972.2 [Hereditary ataxia],0.113,0,0.0,0.0,0.182,0.0,0.0,0.0,0.065,,2.511,0.314,0.156,0.964,4
PDYN,GE_972.2 [Hereditary ataxia],0.113,0,0.0,0.0,0.856,0.0,0.0,0.192,0.069,2.094,2.34,0.327,1.677,0.945,4
RPS26,CM_750.16 [Arnold-Chiari syndrome*],0.113,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.729,0.047,0.019,,0.189,2
MAP3K1,CV_414.1 [Hypertrophic cardiomyopathy],0.113,0,0.0,0.0,0.0,0.0,0.49,0.0,0.19,3.058,3.193,0.708,0.402,0.682,4
ITPKC,MS_704.1 [Polyarteritis nodosa and related conditions],0.113,0,0.0,0.0,0.0,0.246,0.0,0.402,0.686,,2.548,0.199,0.106,,3
UQCRFS1,CV_414.1 [Hypertrophic cardiomyopathy],0.113,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.074,1.028,0.161,0.145,0.984,2
SDHA,CV_414.1 [Hypertrophic cardiomyopathy],0.113,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.743,0.147,0.156,0.998,2
FBN2,CV_438.41 [Aortic dissection],0.113,0,0.0,0.0,0.58,0.0,0.0,0.0,0.085,5.026,3.757,0.455,0.346,0.886,4
MTFMT,CV_414.1 [Hypertrophic cardiomyopathy],0.113,0,0.0,0.0,0.654,0.0,0.0,0.0,0.0,,3.462,0.059,0.484,0.975,3
NR3C1,MB_296.2 [Schizoid personality disorder],0.112,1,4.0,0.0,0.0,0.0,0.0,0.0,0.42,2.066,0.172,0.073,0.063,,2
PROM1,SO_369.62 [Keratoconus],0.112,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.784,2.763,1.178,0.264,0.996,2
GRIN2A,NS_341.1 [Cerebral palsy],0.112,1,4.0,0.0,0.0,0.0,0.0,0.0,0.0,2.171,2.302,2.235,0.173,0.988,2
SRC,GE_976.5 [Polycystic kidney disease],0.112,1,2.0,0.0,0.0,0.0,0.0,0.0,0.12,1.865,0.166,0.106,0.207,,2
MOBP,NS_323.3 [Motor neuron disease],0.112,0,0.0,0.0,0.0,0.467,0.0,0.129,0.093,2.502,1.499,0.161,0.098,0.449,4
HSPB7,CV_414.1 [Hypertrophic cardiomyopathy],0.112,0,0.0,0.0,0.0,0.43,0.548,0.0,0.017,7.619,0.212,0.112,0.195,0.242,4
GAA,CV_414.1 [Hypertrophic cardiomyopathy],0.112,0,0.0,0.0,0.874,0.0,0.703,0.01,0.08,1.63,2.792,0.239,0.548,0.946,5
KLHL7,SO_369.62 [Keratoconus],0.112,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.157,0.126,0.157,0.982,1
THBD,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.112,0,0.0,0.0,0.865,0.0,0.0,0.0,0.129,2.096,3.584,0.1,0.076,0.954,4
RUBCN,GE_972.2 [Hereditary ataxia],0.112,0,0.0,0.0,0.547,0.0,0.0,0.0,0.085,,2.766,0.247,1.158,,3
IMPDH1,NS_341.1 [Cerebral palsy],0.112,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,1.253,0.228,1.144,0.977,1
ANK2,NS_339.2 [Myotonic disorders],0.112,0,0.0,0.0,0.0,0.0,0.0,0.0,0.07,2.142,3.191,2.565,1.038,,2
ISCA1,GE_963.1 [Lipid storage disorders],0.112,0,0.0,0.0,0.547,0.0,0.0,0.0,0.0,1.637,0.104,0.023,0.034,0.958,3
REN,GE_976.5 [Polycystic kidney disease],0.112,0,0.0,0.0,0.0,0.0,0.359,0.0,0.169,,0.714,0.329,0.82,,2
SLC6A3,MB_296.4 [Borderline personality disorder],0.112,1,4.0,0.0,0.0,0.0,0.0,0.0,0.598,,1.704,0.186,0.143,,2
TNF,BI_162.1 [Constitutional (hereditary) aplastic anemia],0.112,1,0.5,0.0,0.0,0.0,0.369,0.0,0.095,,0.946,0.135,0.043,,2
CACNA1A,NS_341.1 [Cerebral palsy],0.112,1,0.5,0.0,0.732,0.0,0.0,0.233,0.02,3.254,2.918,0.094,0.098,0.988,4
ACE,GU_580.51 [Focal and segmental glomerular lesions*],0.112,1,2.0,0.0,0.0,0.0,0.608,0.0,0.216,,3.477,0.345,1.751,,3
NOTCH1,GU_580.51 [Focal and segmental glomerular lesions*],0.112,0,0.0,0.0,0.0,0.0,0.0,0.0,0.109,1.638,3.98,3.33,0.243,,2
GFM1,GE_963.1 [Lipid storage disorders],0.112,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.689,0.366,0.154,0.983,2
CD3D,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.112,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.156,0.148,0.088,0.958,1
ACTN4,GU_580.52 [Diffuse membranous glomerulonephritis],0.112,0,0.0,0.0,0.0,0.0,0.564,0.621,0.359,,2.876,0.864,0.108,,4
NDUFC2,GE_972.2 [Hereditary ataxia],0.112,1,4.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.176,0.109,2.56,0.99,2
GATA5,CM_763.31 [Ventricular septal defect],0.112,0,0.0,0.0,0.848,0.0,0.318,0.402,0.169,1.932,3.861,0.172,1.581,0.654,5
DPYSL3,NS_323.3 [Motor neuron disease],0.112,0,0.0,0.0,0.304,0.0,0.0,0.0,0.067,1.732,2.704,0.168,0.184,0.236,4
TBX3,CV_416.8 [Pre-excitation syndrome [Anomalous atrioventricular excitation]],0.111,0,0.0,0.0,0.0,0.0,0.636,0.0,0.316,3.159,1.939,0.215,0.145,0.249,4
COL8A1,SO_369.62 [Keratoconus],0.111,0,0.0,0.0,0.0,0.0,0.432,0.0,0.128,2.199,2.446,0.19,0.187,0.277,4
PEX11A,GI_516.1 [Pyloric stenosis],0.111,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,1.578,0.42,1.588,0.974,2
HIF1A,GE_961.1 [Phakomatoses],0.111,0,0.0,0.0,0.0,0.0,0.0,0.0,0.07,1.728,1.679,0.278,0.16,0.985,3
KCNQ2,CV_433.3 [Cerebrovascular insufficiency],0.111,1,3.0,0.0,0.0,0.0,0.0,0.0,0.223,3.555,3.118,2.796,0.125,0.268,3
SLC26A2,GE_978.3 [Osteochondrodysplasias],0.111,0,0.0,0.0,0.0,0.0,0.333,0.833,0.118,,3.02,0.976,0.152,,4
PIGB,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.111,0,0.0,0.0,0.547,0.0,0.0,0.0,0.024,1.391,2.829,0.336,0.997,0.141,4
NDUFA13,GE_963.1 [Lipid storage disorders],0.111,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,4.078,2.359,0.082,0.983,2
GABRA1,NS_333.4 [Circadian rhythm sleep disorder],0.111,1,4.0,0.0,0.0,0.0,0.0,0.0,0.122,2.084,0.08,,0.048,0.227,3
HIF1A,CV_438.41 [Aortic dissection],0.111,0,0.0,0.0,0.0,0.0,0.0,0.0,0.298,1.878,2.622,0.738,0.215,0.966,3
MYH6,CM_763.31 [Ventricular septal defect],0.111,0,0.0,0.0,0.85,0.0,0.332,0.0,0.158,,3.773,0.165,0.136,0.832,5
DMD,NS_340.3 [Inflammatory and immune myopathies],0.111,0,0.0,0.0,0.862,0.0,0.624,0.0,0.176,2.657,4.731,0.122,0.034,,4
HTR2C,MB_306 [Conduct disorders],0.111,1,4.0,0.0,0.0,0.0,0.0,0.0,0.054,2.008,3.807,,0.024,,2
STAU1,NS_339.2 [Myotonic disorders],0.111,0,0.0,0.0,0.0,0.0,0.0,0.0,0.704,1.736,0.093,0.124,0.077,,2
TOPORS,SO_386.6 [Night blindness],0.111,0,0.0,0.0,0.0,0.0,0.0,0.129,0.018,,0.908,0.153,0.143,0.993,3
NR3C1,CV_433.3 [Cerebrovascular insufficiency],0.111,1,3.0,0.0,0.0,0.0,0.0,0.0,0.032,2.005,2.585,0.155,0.116,0.922,3
NLGN1,GE_972.2 [Hereditary ataxia],0.111,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,2.589,2.231,0.206,0.163,0.888,3
TRIM24,MS_700.42 [Dermatomyositis],0.111,0,0.0,0.0,0.0,0.0,0.0,0.0,0.421,3.565,1.658,0.133,0.103,,2
GNPTAB,GE_963.1 [Lipid storage disorders],0.111,0,0.0,0.0,0.0,0.0,0.267,0.892,0.117,,3.021,0.311,1.386,0.239,5
CFAP276,GE_972.1 [Hereditary neuropathy],0.111,0,0.0,0.0,0.0,0.0,0.435,0.0,0.094,,2.667,1.637,0.136,,3
LRP4,CM_770.5 [Congenital osteodystrophies],0.111,0,0.0,0.0,0.764,0.0,0.322,0.84,0.109,1.441,1.781,0.186,0.279,0.798,5
NDUFV3,NS_341.1 [Cerebral palsy],0.111,1,2.0,0.0,0.0,0.0,0.0,0.0,0.0,3.799,3.14,0.277,0.12,0.952,2
PSEN1,GE_972.2 [Hereditary ataxia],0.111,0,0.0,0.0,0.772,0.0,0.0,0.0,0.081,4.759,2.478,0.128,1.575,0.931,4
SORBS2,CV_414.1 [Hypertrophic cardiomyopathy],0.111,0,0.0,0.0,0.0,0.0,0.491,0.0,0.123,2.314,3.35,1.553,0.514,0.228,4
PAX8,NS_333.4 [Circadian rhythm sleep disorder],0.111,0,0.0,0.0,0.0,0.455,0.0,0.0,0.144,1.822,2.935,0.168,0.146,0.334,3
CEP290,NS_341.1 [Cerebral palsy],0.111,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.419,3.222,1.209,0.41,0.987,2
CLSTN1,NS_328.13 [Frontotemporal dementia [FTD]],0.111,0,0.0,0.0,0.0,0.0,0.0,0.0,0.094,1.68,3.433,3.301,0.283,,2
CYP7B1,NS_341.1 [Cerebral palsy],0.111,0,0.0,0.0,0.891,0.0,0.0,0.604,0.057,3.148,2.906,0.109,0.133,0.979,4
WDR35,SO_386.6 [Night blindness],0.111,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.769,0.265,0.24,0.978,2
TUBB2A,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.111,1,2.0,0.0,0.0,0.0,0.0,0.0,0.0,1.676,0.038,,,0.179,2
RAD50,BI_162.1 [Constitutional (hereditary) aplastic anemia],0.11,0,0.0,0.0,0.0,0.0,0.456,0.0,0.107,,3.318,1.713,0.132,,3
SRC,MS_700.3 [Systemic sclerosis],0.11,1,1.0,0.0,0.0,0.0,0.0,0.0,0.266,,0.127,0.084,0.162,,1
RNF216,GE_972.2 [Hereditary ataxia],0.11,0,0.0,0.0,0.853,0.0,0.0,0.809,0.142,,3.438,1.357,0.326,0.868,4
BAG3,GE_972.9 [Muscular dystrophy],0.11,0,0.0,0.0,0.547,0.0,0.282,0.0,0.111,2.192,2.445,0.324,0.088,0.931,5
COL9A1,GE_978.3 [Osteochondrodysplasias],0.11,0,0.0,0.0,0.0,0.0,0.318,0.446,0.085,2.988,2.851,0.159,0.207,,4
CACNA1C,GE_961.1 [Phakomatoses],0.11,0,0.0,0.0,0.0,0.0,0.0,0.0,0.128,2.168,3.048,2.561,0.268,0.338,3
CFAP43,NS_344.11 [Communicating hydrocephalus],0.11,0,0.0,0.0,0.547,0.0,0.0,0.0,0.156,1.352,2.885,0.285,0.122,,3
PODXL,GU_580.51 [Focal and segmental glomerular lesions*],0.11,0,0.0,0.0,0.0,0.0,0.378,0.0,0.16,2.454,3.128,0.173,2.45,,3
IGF2BP2,GE_961.1 [Phakomatoses],0.11,0,0.0,0.0,0.0,0.0,0.0,0.0,0.015,2.516,0.152,0.127,0.183,0.312,3
TNF,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.11,0,0.0,0.0,0.0,0.0,0.386,0.0,0.146,,1.927,0.246,0.043,0.999,4
SP4,GI_542.8 [Biliary cirrhosis],0.11,0,0.0,0.0,0.0,0.0,0.0,0.0,0.066,2.78,1.813,0.14,0.171,,2
MTOR,GE_961.1 [Phakomatoses],0.11,1,4.0,0.0,0.0,0.0,0.0,0.0,0.193,,3.025,0.377,0.273,0.993,3
PDE6G,SO_386.6 [Night blindness],0.11,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.094,0.128,0.066,0.994,1
RAN,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.11,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.741,0.066,,,0.268,2
DRD1,GE_972.2 [Hereditary ataxia],0.11,0,0.0,0.0,0.0,0.0,0.0,0.0,0.061,2.571,2.689,0.17,0.141,0.946,3
PEX6,GI_516.1 [Pyloric stenosis],0.11,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.914,2.367,0.773,0.317,0.989,2
RPL27A,BI_179.1 [Hypogammaglobulinemia NOS],0.109,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.383,0.074,,,0.224,2
TBK1,NS_323.3 [Motor neuron disease],0.109,1,0.5,0.0,0.897,0.465,0.0,0.564,0.073,1.946,3.165,0.662,1.869,0.998,4
SCN1A,NS_323.3 [Motor neuron disease],0.109,1,4.0,0.0,0.772,0.0,0.322,0.0,0.03,,1.871,0.5,0.152,0.298,5
KCNV2,SO_369.62 [Keratoconus],0.109,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,1.153,0.63,0.345,0.966,1
RPL26,CV_433.3 [Cerebrovascular insufficiency],0.109,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.392,0.062,,,0.204,2
KCNH2,CV_414.1 [Hypertrophic cardiomyopathy],0.109,0,0.0,0.0,0.0,0.0,0.645,0.233,0.078,,2.788,0.322,0.251,0.975,5
PTGS2,RE_484.1 [Spontaneous pneumothorax],0.109,0,0.0,0.0,0.0,0.0,0.0,0.0,0.024,1.975,0.181,0.154,0.173,0.937,3
C5,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.109,1,4.0,0.0,0.654,0.0,0.0,0.0,0.129,1.751,3.193,0.922,0.491,0.941,4
NRG1,GE_963.1 [Lipid storage disorders],0.109,0,0.0,0.0,0.426,0.0,0.361,0.0,0.134,3.036,0.229,0.438,0.101,0.196,5
HTRA2,NS_323.3 [Motor neuron disease],0.109,0,0.0,0.0,0.0,0.0,0.386,0.0,0.1,,1.67,0.687,0.205,0.371,4
DCC,GE_972.2 [Hereditary ataxia],0.109,0,0.0,0.228,0.426,0.0,0.374,0.0,0.012,3.398,3.317,0.632,0.385,0.891,6
IKZF1,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.109,0,0.0,0.0,0.701,0.0,0.404,0.0,0.061,1.921,2.581,0.164,0.155,0.944,5
TNFRSF11A,CM_770.5 [Congenital osteodystrophies],0.109,0,0.0,0.0,0.875,0.0,0.428,0.735,0.071,,3.334,0.043,0.052,0.978,5
FANCA,SO_365.3 [Exophthalmos [Proptosis]],0.109,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.406,3.163,0.228,1.262,0.947,2
SNRPD2,SO_386.6 [Night blindness],0.109,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.733,0.053,,,0.262,2
CRYAB,CM_751.213 [Congenital cataract],0.109,0,0.0,0.0,0.547,0.0,0.587,0.71,0.041,,0.486,0.185,0.105,0.997,4
ATXN7,GE_972.2 [Hereditary ataxia],0.109,0,0.0,0.0,0.426,0.0,0.386,0.0,0.077,1.604,1.878,0.653,1.133,0.985,5
KCNQ2,GE_972.2 [Hereditary ataxia],0.109,1,2.0,0.162,0.0,0.0,0.0,0.0,0.031,3.153,0.386,0.165,1.72,0.992,4
KLHL1,MB_302.1 [Speech and language developmental delay],0.109,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.387,2.536,0.507,0.185,0.98,2
SP7,GE_978.3 [Osteochondrodysplasias],0.109,0,0.0,0.0,0.0,0.0,0.275,0.613,0.112,,0.164,0.247,0.096,,3
RASA1,CV_441 [Arteriovenous malformation],0.109,0,0.0,0.0,0.828,0.0,0.0,0.851,0.03,2.048,2.211,0.568,0.208,0.889,4
PTK2,GE_973.5 [Huntington's disease],0.109,0,0.0,0.0,0.0,0.0,0.0,0.0,0.431,1.918,0.096,0.124,0.087,,2
CD28,GI_542.8 [Biliary cirrhosis],0.109,0,0.0,0.0,0.0,0.523,0.0,0.0,0.151,,0.322,0.131,0.092,,2
NFE2L2,GI_540.11 [Autoimmune hepatitis],0.109,0,0.0,0.0,0.0,0.0,0.349,0.0,0.252,2.287,2.792,1.189,0.108,,3
TACO1,CV_414.1 [Hypertrophic cardiomyopathy],0.109,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,1.77,0.335,0.224,0.997,2
PEX10,GI_516.1 [Pyloric stenosis],0.109,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,1.864,0.183,2.194,0.98,2
CD19,BI_179.7 [Common variable immunodeficiency [CVID]],0.108,0,0.0,0.0,0.0,0.0,0.692,0.762,0.372,,2.297,0.061,0.038,,4
TMEM63C,GE_972.2 [Hereditary ataxia],0.108,0,0.0,0.0,0.0,0.0,0.0,0.553,0.199,1.712,2.985,0.179,1.079,0.624,4
EYA1,CM_751.213 [Congenital cataract],0.108,0,0.0,0.0,0.0,0.0,0.0,0.0,0.072,2.239,0.706,0.218,0.173,0.966,3
NR3C1,GE_961.1 [Phakomatoses],0.108,0,0.0,0.0,0.0,0.0,0.0,0.0,0.147,3.477,2.058,0.204,0.139,0.85,3
SPAST,GE_972.2 [Hereditary ataxia],0.108,0,0.0,0.0,0.684,0.0,0.274,0.906,0.168,1.405,3.403,3.036,21.116,0.909,5
HTR2C,MB_287.2 [Schizoaffective disorder],0.108,1,4.0,0.0,0.0,0.0,0.0,0.0,0.078,2.562,1.906,,0.034,,2
TRIP11,GE_978.3 [Osteochondrodysplasias],0.108,0,0.0,0.0,0.0,0.0,0.281,0.71,0.081,1.876,3.633,0.798,0.613,,4
KDR,CV_438.41 [Aortic dissection],0.108,0,0.0,0.0,0.0,0.0,0.0,0.0,0.066,2.173,1.998,0.132,0.313,0.952,3
MTOR,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.108,0,0.0,0.0,0.0,0.0,0.0,0.0,0.162,1.434,2.719,0.323,0.221,0.992,3
ATXN1,GE_972.2 [Hereditary ataxia],0.108,0,0.0,0.0,0.0,0.0,0.302,0.0,0.105,2.866,3.383,1.984,0.185,0.983,4
RS1,SO_374.2 [Retinoschisis and retinal cysts],0.108,1,2.0,0.0,0.899,0.0,0.0,0.676,0.136,1.664,0.24,0.2,4.61,,3
ANTXR1,GE_970.1 [Sickle-cell disorders],0.108,0,0.0,0.0,0.0,0.0,0.0,0.0,0.084,1.949,0.526,0.097,0.147,,2
FN1,GU_580.52 [Diffuse membranous glomerulonephritis],0.108,0,0.0,0.0,0.0,0.0,0.0,0.0,0.173,1.836,3.881,0.725,0.271,,2
COL4A5,GU_580.1 [Acute nephritic syndrome],0.108,0,0.0,0.0,0.897,0.0,0.0,0.39,0.119,1.98,2.389,0.349,1.68,0.765,4
ACTN1,GE_972.9 [Muscular dystrophy],0.108,0,0.0,0.0,0.0,0.0,0.0,0.0,0.079,2.72,0.201,0.213,0.14,0.935,3
ITGB1,GE_961.1 [Phakomatoses],0.108,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,1.669,2.038,0.144,0.158,0.968,3
GRIN2B,GE_978.22 [Ehler's Danlos syndrome],0.108,0,0.0,0.0,0.0,0.0,0.0,0.0,0.085,3.24,3.525,,,,2
NUP98,NS_323.3 [Motor neuron disease],0.108,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,2.717,2.461,0.58,0.441,0.169,3
ANGPT1,MS_700.3 [Systemic sclerosis],0.108,0,0.0,0.0,0.0,0.0,0.0,0.0,0.386,2.38,1.943,0.175,0.169,,2
IKZF1,BI_179.7 [Common variable immunodeficiency [CVID]],0.108,0,0.0,0.0,0.0,0.0,0.687,0.581,0.129,2.74,0.062,0.061,0.049,,4
NDUFS6,GE_963.1 [Lipid storage disorders],0.108,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.423,1.443,0.062,0.045,0.996,2
MTOR,RE_484.1 [Spontaneous pneumothorax],0.108,0,0.0,0.0,0.0,0.0,0.0,0.0,0.015,1.616,2.634,0.291,0.18,0.913,3
WDR81,GE_972.2 [Hereditary ataxia],0.108,0,0.0,0.0,0.822,0.0,0.337,0.839,0.061,4.392,3.162,0.16,0.167,0.751,5
FNIP1,CV_414.1 [Hypertrophic cardiomyopathy],0.108,0,0.0,0.0,0.745,0.0,0.427,0.452,0.055,,1.884,,1.759,0.146,5
RDH12,SO_380.3 [Optic atrophy],0.108,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.745,2.356,0.37,0.16,0.994,2
IL16,GI_542.8 [Biliary cirrhosis],0.108,0,0.0,0.0,0.0,0.413,0.0,0.0,0.199,2.894,2.448,0.079,0.336,,2
COX7A2,CV_414.1 [Hypertrophic cardiomyopathy],0.108,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.779,1.76,,0.082,0.991,2
KLF1,GE_970.1 [Sickle-cell disorders],0.108,0,0.0,0.0,0.0,0.0,0.365,0.0,0.206,,2.044,0.085,0.126,,3
CALM1,CV_433.3 [Cerebrovascular insufficiency],0.107,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.735,0.065,,,0.156,2
CPT2,CV_414.1 [Hypertrophic cardiomyopathy],0.107,1,3.0,0.0,0.547,0.0,0.0,0.0,0.038,1.464,2.709,0.296,1.745,0.953,4
PDGFRA,GE_961.1 [Phakomatoses],0.107,1,2.0,0.0,0.0,0.0,0.25,0.0,0.087,3.004,2.341,0.133,0.08,0.99,4
PCDH15,SO_369.62 [Keratoconus],0.107,0,0.0,0.0,0.0,0.24,0.0,0.0,0.0,3.201,2.459,2.117,0.223,0.971,2
HK1,NS_323.3 [Motor neuron disease],0.107,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,1.435,2.496,0.371,0.276,0.188,3
PPARG,GE_972.2 [Hereditary ataxia],0.107,1,4.0,0.0,0.0,0.0,0.0,0.0,0.118,2.001,2.829,0.137,1.593,0.972,3
GRM5,MB_293.2 [Bulimia nervosa],0.107,0,0.0,0.0,0.0,0.0,0.475,0.0,0.09,2.299,0.906,0.456,0.25,,3
SENP1,CV_433.3 [Cerebrovascular insufficiency],0.107,0,0.0,0.0,0.0,0.0,0.0,0.0,0.193,,1.409,0.16,0.148,0.227,3
INSR,CV_433.3 [Cerebrovascular insufficiency],0.107,1,4.0,0.0,0.0,0.0,0.0,0.0,0.097,3.065,2.73,0.191,0.127,0.937,3
MORC2,NS_323.3 [Motor neuron disease],0.107,0,0.0,0.0,0.426,0.0,0.28,0.0,0.1,,1.083,0.325,0.726,0.026,4
CHMP2B,NS_323.3 [Motor neuron disease],0.107,0,0.0,0.0,0.872,0.0,0.0,0.753,0.062,2.996,0.999,0.282,0.16,0.998,4
HLA-DQA1,MS_700.3 [Systemic sclerosis],0.107,0,0.0,0.0,0.0,0.351,0.0,0.0,0.182,,3.586,0.151,0.052,,2
RNASEH2C,NS_341.1 [Cerebral palsy],0.107,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.256,0.08,0.072,0.968,1
NDUFB6,NS_341.1 [Cerebral palsy],0.107,1,2.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.269,0.305,0.07,0.95,1
PDK1,CV_414.1 [Hypertrophic cardiomyopathy],0.107,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.459,2.76,0.334,0.422,0.962,2
MTHFD2,NS_341.1 [Cerebral palsy],0.107,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.216,0.289,0.114,0.977,1
PEX6,SO_380.3 [Optic atrophy],0.107,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.925,1.954,0.181,0.77,0.979,2
NF2,GE_961.1 [Phakomatoses],0.107,1,0.5,0.0,0.0,0.0,0.328,0.871,0.098,2.344,2.238,0.18,0.16,0.56,5
PAX2,GU_580.1 [Acute nephritic syndrome],0.107,0,0.0,0.0,0.884,0.0,0.519,0.0,0.231,2.126,0.261,0.166,0.127,0.815,5
GNB3,SO_386.6 [Night blindness],0.107,0,0.0,0.0,0.839,0.0,0.0,0.402,0.039,,0.183,0.288,0.145,0.987,3
HIF1A,CV_414.1 [Hypertrophic cardiomyopathy],0.107,0,0.0,0.0,0.304,0.0,0.0,0.0,0.13,2.037,2.273,0.854,0.235,0.984,4
ABCB4,GI_542.8 [Biliary cirrhosis],0.107,0,0.0,0.0,0.701,0.0,0.351,0.0,0.329,1.638,3.131,0.691,1.326,,4
MYLK,CV_438.41 [Aortic dissection],0.106,0,0.0,0.0,0.861,0.0,0.0,0.129,0.036,,2.82,0.144,0.916,0.964,4
AGTR1,GU_580.51 [Focal and segmental glomerular lesions*],0.106,1,3.0,0.0,0.0,0.0,0.374,0.0,0.398,1.808,0.525,0.571,0.099,,3
AIPL1,SO_386.5 [Color vision deficiencies],0.106,0,0.0,0.0,0.0,0.0,0.287,0.0,0.0,2.696,0.35,0.249,0.1,1.0,3
ERBB2,CV_414.1 [Hypertrophic cardiomyopathy],0.106,0,0.0,0.0,0.0,0.0,0.616,0.0,0.21,,2.654,0.121,0.19,0.886,4
PDE6B,SO_369.62 [Keratoconus],0.106,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,1.758,0.563,0.285,0.999,2
SLC6A4,GE_972.2 [Hereditary ataxia],0.106,1,4.0,0.0,0.0,0.0,0.0,0.0,0.036,1.652,2.274,0.166,0.188,0.873,3
TP53,BI_162.1 [Constitutional (hereditary) aplastic anemia],0.106,0,0.0,0.0,0.547,0.0,0.334,0.452,0.181,,0.103,0.067,0.061,,3
PRKAG2,GE_964.3 [Glycogen storage disease],0.106,0,0.0,0.0,0.0,0.0,0.261,0.838,0.05,3.492,0.297,0.088,0.1,,4
UBE2E3,BI_179.1 [Hypogammaglobulinemia NOS],0.106,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.584,0.074,,,0.198,2
FARS2,GE_972.2 [Hereditary ataxia],0.106,0,0.0,0.0,0.547,0.0,0.0,0.569,0.071,3.057,2.094,0.283,2.081,0.929,4
ATXN2,GE_972.2 [Hereditary ataxia],0.106,0,0.0,0.0,0.426,0.0,0.0,0.0,0.082,,3.145,0.746,0.316,0.993,4
EPAS1,GE_961.1 [Phakomatoses],0.106,1,4.0,0.0,0.0,0.0,0.0,0.0,0.049,3.255,2.65,0.296,0.171,0.991,3
CLN5,GE_972.2 [Hereditary ataxia],0.106,0,0.0,0.0,0.745,0.0,0.0,0.0,0.015,,2.694,0.234,0.112,0.923,4
CHEK2,SO_365.3 [Exophthalmos [Proptosis]],0.106,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.635,1.716,0.382,0.369,0.967,2
LOX,SO_369.62 [Keratoconus],0.106,0,0.0,0.0,0.502,0.441,0.0,0.0,0.649,1.443,0.284,0.101,0.094,0.472,4
POMGNT1,NS_341.1 [Cerebral palsy],0.106,0,0.0,0.0,0.684,0.0,0.0,0.0,0.0,,3.305,0.341,0.194,0.949,3
ADRB1,NS_343.1 [Peripheral autonomic neuropathy],0.106,1,4.0,0.0,0.0,0.0,0.0,0.0,0.012,1.876,2.725,0.037,0.05,,2
GATA3,BI_179.7 [Common variable immunodeficiency [CVID]],0.106,0,0.0,0.0,0.0,0.0,0.338,0.0,0.236,2.49,0.079,0.091,0.04,,3
PIAS2,GI_540.11 [Autoimmune hepatitis],0.106,0,0.0,0.0,0.0,0.0,0.0,0.0,0.091,2.067,1.868,0.106,0.152,,2
ACE2,CV_414.1 [Hypertrophic cardiomyopathy],0.106,0,0.0,0.0,0.0,0.0,0.645,0.0,0.633,,2.685,1.732,0.173,0.163,4
GPR179,SO_386.6 [Night blindness],0.106,0,0.0,0.0,0.89,0.0,0.0,0.729,0.075,2.028,3.35,0.382,0.178,0.984,4
REN,CM_772.1 [Congenital malformations of endocrine glands],0.106,0,0.0,0.0,0.0,0.0,0.37,0.0,0.114,,2.999,0.173,0.125,,3
GRIN2B,CV_433.3 [Cerebrovascular insufficiency],0.106,1,3.0,0.0,0.0,0.0,0.0,0.0,0.076,2.011,3.034,,,0.448,3
PDE4D,CM_770.5 [Congenital osteodystrophies],0.106,0,0.0,0.0,0.779,0.0,0.0,0.73,0.135,3.412,2.358,0.203,0.134,0.551,4
SP7,CM_770.5 [Congenital osteodystrophies],0.106,0,0.0,0.0,0.0,0.0,0.276,0.657,0.112,,0.176,0.26,0.107,0.954,4
PEX2,GI_516.1 [Pyloric stenosis],0.106,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.179,3.126,0.435,0.141,0.971,2
NR3C1,CM_770.5 [Congenital osteodystrophies],0.106,0,0.0,0.0,0.0,0.0,0.0,0.0,0.152,2.639,2.906,0.144,1.816,0.913,3
MRE11,GE_972.2 [Hereditary ataxia],0.106,0,0.0,0.0,0.816,0.0,0.0,0.824,0.088,3.015,2.654,0.399,0.894,,3
VEGFA,GE_975.2 [Hereditary hemorrhagic telangiectasia],0.106,1,3.0,0.0,0.0,0.0,0.0,0.0,0.242,2.893,0.176,0.144,0.088,,2
KCNC3,NS_341.1 [Cerebral palsy],0.106,1,3.0,0.0,0.654,0.0,0.0,0.0,0.012,1.649,2.653,0.194,0.093,0.914,4
NAMPT,MS_727.3 [Osteitis deformans [Paget's disease of bone]],0.105,0,0.0,0.0,0.0,0.0,0.0,0.0,0.103,3.36,0.259,0.072,0.121,,2
GABRG2,MB_302.1 [Speech and language developmental delay],0.105,1,2.0,0.0,0.0,0.0,0.451,0.593,0.015,2.516,1.803,0.036,0.077,0.845,5
UQCRH,CV_414.1 [Hypertrophic cardiomyopathy],0.105,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.902,1.07,0.088,0.115,0.981,2
HBG1,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.105,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.288,0.103,0.02,0.95,1
FOXE1,CM_772.2 [Congenital hypothyroidism],0.105,0,0.0,0.0,0.0,0.243,0.0,0.402,0.183,1.642,1.289,0.057,0.046,,3
ATM,SO_365.3 [Exophthalmos [Proptosis]],0.105,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.413,0.982,0.979,0.988,2
MTOR,GE_973.5 [Huntington's disease],0.105,0,0.0,0.0,0.0,0.0,0.0,0.0,0.232,2.193,1.777,0.14,0.104,,2
HNRNPC,CM_751.213 [Congenital cataract],0.105,0,0.0,0.0,0.0,0.0,0.258,0.0,0.0,1.461,0.069,,,0.207,3
SMAD3,CM_763.31 [Ventricular septal defect],0.105,0,0.0,0.0,0.0,0.0,0.0,0.0,0.371,1.998,0.067,0.044,0.07,0.967,3
PEX5,GI_516.1 [Pyloric stenosis],0.105,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.133,0.888,0.496,0.536,0.995,2
GNAS,GE_978.3 [Osteochondrodysplasias],0.105,0,0.0,0.0,0.0,0.0,0.0,0.861,0.074,2.142,0.194,0.072,0.076,,3
EXT1,GU_580.52 [Diffuse membranous glomerulonephritis],0.105,0,0.0,0.0,0.0,0.0,0.0,0.0,0.164,1.886,0.164,0.128,0.116,,2
PPARGC1A,NS_333.4 [Circadian rhythm sleep disorder],0.105,0,0.0,0.0,0.0,0.0,0.0,0.0,0.225,2.858,2.656,0.257,0.188,0.944,3
COX17,CV_414.1 [Hypertrophic cardiomyopathy],0.105,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.225,0.094,0.072,0.999,1
FGFR2,CM_770.5 [Congenital osteodystrophies],0.105,1,2.0,0.0,0.0,0.0,0.324,0.0,0.068,2.764,3.245,0.185,0.148,0.981,4
TPP1,GE_963.1 [Lipid storage disorders],0.105,1,4.0,0.0,0.0,0.0,0.327,0.919,0.095,,3.231,0.486,0.137,0.726,5
SRC,GI_540.11 [Autoimmune hepatitis],0.105,0,0.0,0.0,0.0,0.0,0.0,0.0,0.17,1.414,0.114,0.083,0.159,,2
OLIG1,CV_433.3 [Cerebrovascular insufficiency],0.105,0,0.0,0.0,0.0,0.0,0.0,0.0,0.077,2.421,1.409,0.023,0.04,0.19,3
NFAT5,CV_414.1 [Hypertrophic cardiomyopathy],0.105,0,0.0,0.0,0.0,0.0,0.329,0.0,0.236,2.557,2.76,0.248,0.45,0.134,4
SMARCA4,CM_763.31 [Ventricular septal defect],0.105,0,0.0,0.0,0.547,0.0,0.0,0.283,0.017,2.193,3.513,0.168,0.178,0.968,4
CACNB2,NS_341.1 [Cerebral palsy],0.105,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.708,3.141,1.019,0.238,0.993,2
NR3C1,MS_704.1 [Polyarteritis nodosa and related conditions],0.105,1,4.0,0.0,0.0,0.0,0.0,0.0,0.17,1.923,0.278,0.133,0.094,,2
GAA,GE_972.9 [Muscular dystrophy],0.105,0,0.0,0.0,0.879,0.0,0.461,0.121,0.022,3.116,3.016,1.131,0.196,0.942,5
COMP,CM_770.5 [Congenital osteodystrophies],0.105,0,0.0,0.0,0.898,0.0,0.398,0.837,0.063,,3.571,0.153,0.084,0.715,5
GNAS,EM_208.1 [Hypoparathyroidism],0.105,0,0.0,0.0,0.899,0.0,0.365,0.0,0.024,2.057,1.799,0.153,0.118,0.922,5
MTOR,MB_306 [Conduct disorders],0.105,0,0.0,0.0,0.0,0.0,0.0,0.0,0.173,1.919,2.614,2.835,1.605,,2
HMGCR,GU_580.1 [Acute nephritic syndrome],0.105,1,4.0,0.0,0.0,0.0,0.0,0.0,0.03,,2.518,0.375,0.902,0.916,3
TMEM67,SO_369.62 [Keratoconus],0.105,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.269,0.103,0.288,0.984,2
MYH11,CV_438.41 [Aortic dissection],0.105,0,0.0,0.0,0.858,0.0,0.0,0.0,0.083,2.139,3.116,0.428,0.455,0.972,4
C6orf226,NS_341.1 [Cerebral palsy],0.105,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,1.893,0.058,0.062,0.954,2
CHEK2,CV_441 [Arteriovenous malformation],0.104,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,3.018,0.402,0.204,0.976,2
RUNX2,CM_770.5 [Congenital osteodystrophies],0.104,0,0.0,0.0,0.0,0.0,0.326,0.72,0.059,2.681,0.283,0.183,0.149,0.969,5
DRD3,MB_298 [Impulse disorders],0.104,1,4.0,0.0,0.0,0.0,0.0,0.0,0.084,,0.083,0.089,2.403,,2
USP48,GE_972.2 [Hereditary ataxia],0.104,0,0.0,0.0,0.0,0.0,0.0,0.0,0.286,2.769,0.659,0.204,0.159,0.299,3
MYH6,CV_416.8 [Pre-excitation syndrome [Anomalous atrioventricular excitation]],0.104,0,0.0,0.0,0.654,0.0,0.427,0.121,0.0,,2.697,0.199,0.171,0.902,4
RP1,SO_369.62 [Keratoconus],0.104,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.441,3.837,0.398,0.291,0.972,2
TNF,DE_663.1 [Pemphigus],0.104,1,2.0,0.0,0.0,0.0,0.514,0.0,0.296,,0.658,0.117,0.036,,2
HBD,GE_970.2 [Thalassemia],0.104,0,0.0,0.0,0.0,0.0,0.459,0.538,0.054,5.254,0.74,0.225,0.305,,4
ANK2,GE_972.9 [Muscular dystrophy],0.104,0,0.0,0.0,0.0,0.0,0.369,0.0,0.024,2.885,2.742,0.432,0.255,0.896,4
MEN1,GE_961.1 [Phakomatoses],0.104,0,0.0,0.0,0.0,0.0,0.383,0.0,0.07,2.336,2.611,0.165,0.16,0.975,4
PAX8,CM_770.5 [Congenital osteodystrophies],0.104,0,0.0,0.0,0.0,0.0,0.289,0.0,0.095,,2.429,0.184,0.145,0.628,4
GATA4,CV_414.1 [Hypertrophic cardiomyopathy],0.104,0,0.0,0.0,0.426,0.0,0.512,0.0,0.134,1.62,2.472,0.261,0.241,0.76,5
RALGAPA1,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.104,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,2.488,2.457,0.595,0.332,0.214,3
NPHS2,GU_580.52 [Diffuse membranous glomerulonephritis],0.104,0,0.0,0.0,0.0,0.0,0.599,0.509,0.321,,2.891,0.886,0.11,,4
EYS,SO_380.3 [Optic atrophy],0.104,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.232,3.041,0.184,0.281,0.991,2
TEAD1,MS_700.3 [Systemic sclerosis],0.104,0,0.0,0.0,0.0,0.0,0.0,0.0,0.068,2.595,3.278,2.994,0.135,,2
NF1,CV_441 [Arteriovenous malformation],0.104,0,0.0,0.0,0.0,0.0,0.262,0.0,0.015,1.845,2.456,0.148,0.516,0.976,4
GALC,GE_972.2 [Hereditary ataxia],0.104,0,0.0,0.0,0.772,0.0,0.431,0.442,0.048,2.634,1.958,0.298,0.274,0.935,5
FOXP2,NS_323.3 [Motor neuron disease],0.104,0,0.0,0.0,0.0,0.0,0.0,0.0,0.023,2.592,0.505,0.773,0.53,0.11,3
VEGFA,GU_580.1 [Acute nephritic syndrome],0.104,0,0.0,0.0,0.0,0.0,0.0,0.0,0.198,2.459,2.489,0.177,0.097,0.963,3
KIF5A,GE_972.2 [Hereditary ataxia],0.104,0,0.0,0.223,0.732,0.0,0.0,0.84,0.114,,2.746,0.069,3.404,0.864,5
FERMT3,GE_978.3 [Osteochondrodysplasias],0.104,0,0.0,0.0,0.0,0.0,0.327,0.0,0.152,,2.021,0.305,0.143,,3
SIAH1,CV_413.41 [Pulmonary valve stenosis],0.104,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.747,0.026,,,0.203,2
SYT1,CV_433.3 [Cerebrovascular insufficiency],0.104,0,0.0,0.0,0.0,0.0,0.0,0.0,0.517,2.247,0.084,0.048,0.087,0.244,3
CNGB1,SO_386.6 [Night blindness],0.104,0,0.0,0.0,0.684,0.0,0.0,0.0,0.039,1.343,3.655,0.223,0.208,1.0,4
HDAC9,CV_433.3 [Cerebrovascular insufficiency],0.104,0,0.0,0.0,0.0,0.32,0.0,0.0,0.156,3.249,0.648,0.259,0.187,0.822,3
BANF1,BI_179.1 [Hypogammaglobulinemia NOS],0.104,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.452,0.078,,,0.226,2
ALOXE3,GE_977.1 [Congenital ichthyosis],0.104,0,0.0,0.0,0.868,0.0,0.344,0.704,0.072,3.203,2.447,0.97,3.071,0.998,5
SCFD1,NS_323.3 [Motor neuron disease],0.104,0,0.0,0.0,0.182,0.529,0.0,0.161,0.189,1.966,2.883,0.74,0.262,0.664,4
GRIN2B,MS_712.51 [Hypermobility syndrome],0.104,0,0.0,0.0,0.0,0.0,0.0,0.0,0.085,3.337,3.266,,,,2
TNFRSF11B,MS_727.3 [Osteitis deformans [Paget's disease of bone]],0.103,0,0.0,0.0,0.0,0.049,0.328,0.0,0.181,3.279,2.635,0.147,1.51,,3
PSEN1,NS_341.1 [Cerebral palsy],0.103,0,0.0,0.0,0.853,0.0,0.0,0.362,0.12,,0.72,0.087,1.638,0.929,4
SSB,GI_542.8 [Biliary cirrhosis],0.103,0,0.0,0.0,0.0,0.0,0.0,0.0,0.388,,0.674,0.142,0.123,,1
RGR,SO_380.3 [Optic atrophy],0.103,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.217,0.123,0.129,0.976,2
KLHL7,SO_386.6 [Night blindness],0.103,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.319,0.071,0.104,0.141,0.992,2
PLCG2,DE_666.3 [Urticaria due to cold and heat],0.103,0,0.0,0.0,0.0,0.0,0.297,0.566,0.275,3.89,2.854,0.32,0.175,,4
CFAP410,NS_323.3 [Motor neuron disease],0.103,0,0.0,0.0,0.758,0.491,0.0,0.434,0.091,2.095,2.115,0.188,0.232,,3
SRC,MS_727.3 [Osteitis deformans [Paget's disease of bone]],0.103,0,0.0,0.0,0.0,0.0,0.0,0.0,0.09,1.401,1.802,0.085,0.201,,2
IL12A,GI_542.8 [Biliary cirrhosis],0.103,1,2.0,0.0,0.0,0.684,0.0,0.0,0.435,6.404,0.476,,0.099,,2
RPS26,CM_751.213 [Congenital cataract],0.103,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.76,0.083,0.022,,0.191,2
SOD3,DE_663.1 [Pemphigus],0.103,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.664,2.663,0.027,0.059,,2
RB1CC1,DE_663.2 [Pemphigoid],0.103,0,0.0,0.0,0.0,0.0,0.0,0.0,0.28,1.753,2.486,0.154,0.217,,2
S1PR1,CV_414.1 [Hypertrophic cardiomyopathy],0.103,0,0.0,0.0,0.0,0.0,0.0,0.0,0.097,3.272,1.863,0.085,0.149,0.111,3
TP63,MS_712.51 [Hypermobility syndrome],0.103,0,0.0,0.0,0.0,0.0,0.0,0.0,0.085,2.82,1.726,0.196,0.769,,2
ATP2A1,GE_972.9 [Muscular dystrophy],0.103,0,0.0,0.0,0.779,0.0,0.281,0.0,0.059,,2.819,0.309,0.2,0.94,5
CLDN5,CV_433.3 [Cerebrovascular insufficiency],0.103,0,0.0,0.0,0.0,0.0,0.0,0.0,0.094,1.319,3.33,0.043,0.063,0.743,3
CMAS,GE_972.9 [Muscular dystrophy],0.103,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,1.886,0.078,0.054,2.017,0.122,3
GAD1,DE_663.2 [Pemphigoid],0.103,0,0.0,0.0,0.0,0.0,0.0,0.0,0.106,2.799,2.774,0.083,0.164,,2
KIFAP3,NS_323.3 [Motor neuron disease],0.103,0,0.0,0.0,0.599,0.299,0.0,0.0,0.057,,2.924,0.354,0.325,0.773,4
AR,MS_700.3 [Systemic sclerosis],0.103,0,0.0,0.0,0.0,0.0,0.0,0.0,0.041,2.757,4.408,,0.02,,2
ACTN2,GE_972.9 [Muscular dystrophy],0.103,0,0.0,0.0,0.816,0.0,0.0,0.411,0.051,,3.713,0.312,0.167,0.968,4
MYH11,CM_763.13 [Patent ductus arteriosus],0.103,0,0.0,0.0,0.834,0.0,0.0,0.0,0.199,1.306,2.283,0.654,0.139,0.904,4
CYP11A1,EM_211.1 [Adrenal hyperfunction],0.103,1,4.0,0.0,0.0,0.0,0.484,0.0,0.018,,1.752,0.593,0.182,,3
MTOR,GE_972.2 [Hereditary ataxia],0.103,0,0.0,0.0,0.0,0.0,0.257,0.0,0.05,1.658,2.284,0.252,0.299,0.993,4
HADHB,NS_341.1 [Cerebral palsy],0.103,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.209,0.279,1.565,0.952,2
MECP2,GE_973.5 [Huntington's disease],0.103,0,0.0,0.0,0.0,0.0,0.435,0.0,0.192,,4.258,3.193,0.051,,3
MEFV,MS_705.2 [Juvenile rheumatoid arthritis [JRA/JIA]],0.103,0,0.0,0.0,0.837,0.0,0.352,0.0,0.259,,3.671,0.096,0.088,,4
SYK,BI_179.1 [Hypogammaglobulinemia NOS],0.103,0,0.0,0.0,0.0,0.0,0.0,0.402,0.012,2.575,0.212,0.214,1.66,0.989,4
NDUFA8,CV_414.1 [Hypertrophic cardiomyopathy],0.103,0,0.0,0.0,0.0,0.0,0.289,0.0,0.0,1.654,2.515,1.409,0.913,0.991,3
PLA2G6,GE_972.2 [Hereditary ataxia],0.103,0,0.0,0.0,0.861,0.0,0.321,0.366,0.111,2.725,2.797,0.443,1.565,0.983,5
OPTN,NS_323.3 [Motor neuron disease],0.103,0,0.0,0.0,0.893,0.0,0.0,0.694,0.101,2.451,2.739,1.792,0.483,0.999,4
LEMD3,CM_770.5 [Congenital osteodystrophies],0.103,0,0.0,0.0,0.884,0.0,0.0,0.553,0.11,2.101,2.508,0.167,4.988,0.404,4
OPA1,SO_380.3 [Optic atrophy],0.102,0,0.0,0.0,0.9,0.0,0.343,0.897,0.076,1.653,3.482,1.074,9.734,0.991,5
MMP13,CM_770.5 [Congenital osteodystrophies],0.102,0,0.0,0.0,0.848,0.0,0.327,0.0,0.037,,2.603,0.266,0.123,0.968,5
PHKB,GE_964.3 [Glycogen storage disease],0.102,0,0.0,0.0,0.0,0.0,0.343,0.685,0.054,1.961,3.953,0.259,0.26,,4
PPARG,CV_433.3 [Cerebrovascular insufficiency],0.102,0,0.0,0.0,0.0,0.0,0.0,0.0,0.206,1.548,0.094,0.111,0.106,0.962,3
NDUFA10,NS_341.1 [Cerebral palsy],0.102,1,2.0,0.0,0.0,0.0,0.0,0.0,0.0,1.845,2.178,0.124,0.138,0.991,2
SLC5A3,CV_433.3 [Cerebrovascular insufficiency],0.102,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,1.885,0.947,,2.309,0.126,3
KIF5A,NS_323.3 [Motor neuron disease],0.102,0,0.0,0.0,0.887,0.0,0.0,0.175,0.046,,2.973,0.745,0.265,0.991,4
CYP1A1,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.102,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.767,0.18,0.176,0.948,1
SLC26A2,CM_770.5 [Congenital osteodystrophies],0.102,0,0.0,0.0,0.865,0.0,0.316,0.833,0.118,1.724,3.02,1.818,0.176,0.568,5
CYP7B1,GE_972.2 [Hereditary ataxia],0.102,0,0.0,0.036,0.813,0.0,0.289,0.883,0.085,2.973,3.417,0.588,2.237,0.765,6
SPIN1,CM_750.16 [Arnold-Chiari syndrome*],0.102,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.668,0.049,0.034,,0.174,2
SLC18A2,GE_973.5 [Huntington's disease],0.102,1,4.0,0.0,0.0,0.0,0.295,0.0,0.111,1.882,2.828,0.086,0.071,,3
CRTAP,GE_978.3 [Osteochondrodysplasias],0.102,0,0.0,0.0,0.0,0.0,0.307,0.721,0.109,,2.711,0.503,0.154,,4
ESR1,GE_978.3 [Osteochondrodysplasias],0.102,1,4.0,0.0,0.0,0.0,0.369,0.0,0.041,3.566,2.947,0.998,0.094,,3
MAP2K2,GE_961.1 [Phakomatoses],0.102,1,4.0,0.0,0.0,0.0,0.0,0.402,0.015,,0.163,0.256,0.171,0.84,3
ACTN4,GU_580.51 [Focal and segmental glomerular lesions*],0.102,0,0.0,0.0,0.0,0.0,0.564,0.621,0.359,,3.568,1.175,0.109,,4
VAV1,NS_338.1 [Myasthenia gravis],0.102,0,0.0,0.0,0.0,0.0,0.0,0.0,0.119,2.29,1.819,0.145,0.139,,2
TOMM40,EM_249.1 [Cerebral amyloid angiopathy*],0.102,0,0.0,0.0,0.0,0.099,0.0,0.0,0.079,14.212,2.679,2.667,0.067,,2
ALK,GE_973.5 [Huntington's disease],0.102,0,0.0,0.0,0.0,0.0,0.0,0.0,0.103,2.641,0.151,0.099,0.069,,2
FOXO1,SO_369.62 [Keratoconus],0.102,0,0.0,0.0,0.606,0.385,0.0,0.0,0.082,2.982,1.91,0.043,0.114,0.381,4
IGF1R,CM_763.31 [Ventricular septal defect],0.102,0,0.0,0.0,0.0,0.0,0.0,0.0,0.217,2.396,1.945,0.296,0.775,0.917,3
NR2F1,SO_380.3 [Optic atrophy],0.102,0,0.0,0.0,0.801,0.0,0.0,0.856,0.164,3.42,0.142,,2.177,0.386,4
RUNX1,MS_705.2 [Juvenile rheumatoid arthritis [JRA/JIA]],0.102,0,0.0,0.0,0.0,0.0,0.338,0.0,0.158,2.864,0.181,0.219,0.079,,3
TEAD1,CV_414.1 [Hypertrophic cardiomyopathy],0.102,0,0.0,0.0,0.0,0.0,0.513,0.0,0.119,2.347,2.497,2.015,1.171,0.159,4
RP9,SO_386.5 [Color vision deficiencies],0.102,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.263,0.051,0.076,0.988,1
SH3TC2,NS_323.3 [Motor neuron disease],0.102,0,0.0,0.0,0.547,0.0,0.0,0.281,0.018,2.04,2.537,0.414,0.349,0.123,4
NFU1,NS_341.1 [Cerebral palsy],0.102,0,0.0,0.0,0.86,0.0,0.0,0.0,0.046,2.758,2.692,0.212,0.135,0.947,4
MTOR,GE_972.9 [Muscular dystrophy],0.102,0,0.0,0.0,0.0,0.0,0.0,0.0,0.069,1.927,2.894,0.242,0.166,0.899,3
SLC6A3,"MB_280.4 [Sedative, hypnotic, or anxiolytic related disorders]",0.102,1,4.0,0.0,0.0,0.0,0.0,0.0,0.182,,2.546,0.196,0.155,,2
NR3C1,MS_705.2 [Juvenile rheumatoid arthritis [JRA/JIA]],0.101,1,4.0,0.0,0.0,0.0,0.0,0.0,0.135,2.283,3.177,2.97,0.087,,2
IL23A,BI_179.1 [Hypogammaglobulinemia NOS],0.101,1,1.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.057,0.102,0.074,0.973,1
KRT10,GE_977.1 [Congenital ichthyosis],0.101,0,0.0,0.0,0.888,0.0,0.394,0.731,0.108,1.976,2.706,0.986,0.051,0.979,5
IGF1R,GE_972.2 [Hereditary ataxia],0.101,0,0.0,0.0,0.0,0.0,0.342,0.0,0.041,2.939,4.17,4.048,0.392,0.94,4
FOXP2,MB_302.1 [Speech and language developmental delay],0.101,0,0.0,0.0,0.0,0.0,0.0,0.825,0.1,2.608,3.507,0.654,0.186,0.988,4
OBSCN,GE_972.9 [Muscular dystrophy],0.101,0,0.0,0.0,0.426,0.0,0.367,0.0,0.082,2.842,4.53,0.205,1.118,0.917,5
PLCB1,CV_438.43 [Coronary artery dissection],0.101,0,0.0,0.0,0.0,0.0,0.0,0.0,0.071,3.019,4.02,2.485,0.165,,2
TNPO3,GE_972.9 [Muscular dystrophy],0.101,0,0.0,0.0,0.801,0.0,0.0,0.201,0.1,,2.83,0.118,0.154,0.835,4
CTLA4,GI_542.8 [Biliary cirrhosis],0.101,0,0.0,0.0,0.0,0.53,0.0,0.0,0.575,2.723,0.941,0.079,0.049,,2
CA4,SO_369.62 [Keratoconus],0.101,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.493,0.251,0.127,0.994,2
GUCA1B,SO_386.5 [Color vision deficiencies],0.101,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.671,2.804,0.159,0.064,0.998,2
CNGB3,SO_386.5 [Color vision deficiencies],0.101,1,2.0,0.0,0.897,0.0,0.0,0.826,0.114,,2.173,0.478,0.141,1.0,4
GPC6,GE_978.3 [Osteochondrodysplasias],0.101,0,0.0,0.0,0.0,0.0,0.305,0.0,0.089,2.302,2.741,0.17,0.117,,3
TMEM163,GI_542.8 [Biliary cirrhosis],0.101,0,0.0,0.0,0.0,0.684,0.0,0.0,0.147,2.515,2.809,0.136,0.112,,2
PTPRC,GE_976.5 [Polycystic kidney disease],0.101,0,0.0,0.0,0.0,0.0,0.0,0.0,0.096,2.377,2.076,0.091,0.129,,2
KIT,CV_441 [Arteriovenous malformation],0.101,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.975,2.32,0.259,0.238,0.976,2
NR3C1,NS_338.1 [Myasthenia gravis],0.101,1,4.0,0.0,0.0,0.0,0.0,0.0,0.137,3.626,0.992,0.21,1.38,,2
GRIN2A,GE_973.5 [Huntington's disease],0.101,1,4.0,0.0,0.0,0.0,0.0,0.0,0.205,3.166,0.529,0.123,0.077,,2
PTGS2,GE_961.1 [Phakomatoses],0.101,1,2.0,0.0,0.0,0.0,0.275,0.0,0.131,1.924,3.297,0.111,0.129,0.958,4
GNAS,MS_727.5 [Cyst of bone],0.101,0,0.0,0.0,0.0,0.0,0.0,0.0,0.088,2.751,0.31,0.154,0.12,,2
SULF2,CV_414.1 [Hypertrophic cardiomyopathy],0.101,0,0.0,0.0,0.0,0.0,0.0,0.0,0.24,3.566,4.951,2.78,0.448,0.307,3
TUBA1B,SO_386.5 [Color vision deficiencies],0.101,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.378,0.098,,,0.248,2
PLCG2,BI_179.7 [Common variable immunodeficiency [CVID]],0.101,0,0.0,0.0,0.0,0.0,0.646,0.0,0.171,2.387,2.48,2.042,0.098,,3
TP53,GE_972.2 [Hereditary ataxia],0.101,0,0.0,0.0,0.0,0.0,0.0,0.0,0.134,,2.702,0.143,1.697,0.998,3
IMPG2,SO_386.6 [Night blindness],0.101,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.95,3.922,0.398,0.194,0.996,2
SAR1B,GE_963.1 [Lipid storage disorders],0.101,0,0.0,0.0,0.0,0.0,0.574,0.833,0.23,,0.12,0.106,0.041,0.217,4
KARS1,GE_972.2 [Hereditary ataxia],0.101,0,0.0,0.0,0.843,0.0,0.406,0.0,0.014,,2.264,0.573,0.284,,4
REEP1,NS_323.3 [Motor neuron disease],0.101,0,0.0,0.0,0.0,0.0,0.395,0.674,0.012,,2.575,0.052,0.141,0.794,5
RNF31,MS_727.5 [Cyst of bone],0.101,0,0.0,0.0,0.0,0.0,0.0,0.0,0.213,,2.877,0.199,0.384,,2
SCN3A,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.101,1,3.0,0.0,0.0,0.0,0.0,0.0,0.024,1.731,2.092,0.712,0.306,0.112,3
XRCC1,GE_972.2 [Hereditary ataxia],0.101,0,0.0,0.0,0.684,0.0,0.0,0.716,0.062,,3.564,0.224,0.209,0.736,4
FASLG,GI_540.11 [Autoimmune hepatitis],0.101,0,0.0,0.0,0.0,0.0,0.48,0.0,0.193,1.54,2.617,0.138,0.07,,3
WNT5A,GE_976.5 [Polycystic kidney disease],0.101,0,0.0,0.0,0.0,0.0,0.0,0.0,0.094,3.034,0.142,0.17,0.158,,2
CACNA1A,SO_380.3 [Optic atrophy],0.101,0,0.0,0.0,0.684,0.0,0.0,0.0,0.09,2.408,2.158,0.107,0.102,0.946,4
PTPRC,GI_542.8 [Biliary cirrhosis],0.101,0,0.0,0.0,0.0,0.0,0.0,0.0,0.143,3.217,1.779,0.098,1.526,,2
GLS,NS_341.1 [Cerebral palsy],0.101,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.999,0.263,0.15,0.117,0.967,2
FGFR2,NS_344.11 [Communicating hydrocephalus],0.101,0,0.0,0.0,0.0,0.0,0.0,0.29,0.08,2.287,0.101,0.11,0.077,,3
COL4A5,GU_580.52 [Diffuse membranous glomerulonephritis],0.101,0,0.0,0.0,0.0,0.0,0.615,0.493,0.155,2.566,1.818,0.252,0.129,,4
TWNK,GE_972.2 [Hereditary ataxia],0.1,0,0.0,0.0,0.877,0.0,0.0,0.204,0.063,,1.81,0.169,0.908,,3
KCNC3,GE_972.2 [Hereditary ataxia],0.1,1,2.0,0.126,0.853,0.0,0.0,0.0,0.051,2.796,3.413,0.252,0.121,0.971,5
NAMPT,DE_663.2 [Pemphigoid],0.1,0,0.0,0.0,0.0,0.0,0.0,0.0,0.286,2.258,1.276,0.087,0.079,,2
STUB1,GE_972.2 [Hereditary ataxia],0.1,0,0.0,0.0,0.895,0.0,0.344,0.0,0.122,,2.416,0.12,1.398,0.953,5
BANP,SO_369.62 [Keratoconus],0.1,0,0.0,0.0,0.532,0.0,0.0,0.0,0.035,2.733,3.024,2.811,0.247,0.178,4
IQCB1,SO_380.3 [Optic atrophy],0.1,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.64,3.354,1.796,0.169,0.982,2
CD9,GU_580.51 [Focal and segmental glomerular lesions*],0.1,0,0.0,0.0,0.0,0.0,0.0,0.0,0.38,2.794,0.236,0.098,0.081,,2
BMP4,GE_961.1 [Phakomatoses],0.1,0,0.0,0.0,0.0,0.0,0.259,0.0,0.116,2.119,0.411,0.313,0.118,0.972,4
OLIG1,GE_972.2 [Hereditary ataxia],0.1,0,0.0,0.0,0.0,0.0,0.0,0.0,0.061,1.951,2.618,0.04,0.055,0.572,3
TLR3,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.1,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.863,2.748,0.65,0.219,0.978,2
RARS2,NS_341.1 [Cerebral palsy],0.1,0,0.0,0.0,0.813,0.0,0.0,0.0,0.0,,2.783,0.649,0.178,0.999,3
MRPL44,CV_414.1 [Hypertrophic cardiomyopathy],0.1,0,0.0,0.0,0.547,0.0,0.0,0.0,0.08,,2.736,0.228,0.61,0.944,4
NKX6-2,GE_972.2 [Hereditary ataxia],0.1,0,0.0,0.0,0.684,0.0,0.291,0.503,0.085,2.96,1.848,0.249,0.165,0.765,5
RBP3,SO_386.6 [Night blindness],0.1,0,0.0,0.0,0.547,0.0,0.0,0.281,0.0,,2.156,0.073,0.102,0.999,3
NDUFB9,CV_414.1 [Hypertrophic cardiomyopathy],0.1,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.749,0.35,0.13,0.971,1
RPS26,CV_433.3 [Cerebrovascular insufficiency],0.1,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.053,0.031,,0.226,1
GARS1,NS_323.3 [Motor neuron disease],0.1,0,0.0,0.0,0.857,0.0,0.34,0.752,0.082,1.54,0.543,0.542,0.478,,4
PRCD,SO_369.62 [Keratoconus],0.1,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.846,,0.054,0.996,2
TUBB2A,CV_414.1 [Hypertrophic cardiomyopathy],0.1,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.552,0.059,,,0.218,2
WFS1,GE_972.2 [Hereditary ataxia],0.1,0,0.0,0.0,0.868,0.0,0.388,0.407,0.037,2.158,3.611,0.25,0.305,0.869,5
UBE2D3,GE_972.9 [Muscular dystrophy],0.1,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.76,0.052,,,0.177,2
NBN,CV_441 [Arteriovenous malformation],0.1,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.867,1.657,0.271,0.283,0.968,2
ATP13A2,NS_341.1 [Cerebral palsy],0.1,0,0.0,0.0,0.88,0.0,0.0,0.0,0.03,,2.7,0.549,0.214,0.995,4
IL6ST,MS_727.5 [Cyst of bone],0.1,0,0.0,0.0,0.0,0.0,0.323,0.0,0.116,1.877,2.621,0.99,0.744,,3
HMGB1,NS_328.13 [Frontotemporal dementia [FTD]],0.1,0,0.0,0.0,0.0,0.0,0.0,0.0,0.233,2.783,2.886,2.732,,,2
WNT1,GE_978.3 [Osteochondrodysplasias],0.1,0,0.0,0.0,0.0,0.0,0.0,0.73,0.261,,2.387,0.174,1.767,,3
KCNA4,NS_323.3 [Motor neuron disease],0.1,1,2.0,0.0,0.0,0.0,0.0,0.0,0.012,1.909,0.311,,1.886,0.148,3
MGAT5,GE_972.2 [Hereditary ataxia],0.1,0,0.0,0.037,0.0,0.0,0.0,0.0,0.055,2.824,1.914,0.157,0.165,0.301,4
CAPN1,GE_972.2 [Hereditary ataxia],0.1,0,0.0,0.0,0.88,0.0,0.0,0.0,0.143,,2.429,0.089,0.624,0.866,4
NDUFA11,GE_972.2 [Hereditary ataxia],0.1,1,4.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.152,0.056,0.06,0.953,1
ERCC1,CV_441 [Arteriovenous malformation],0.1,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.453,1.9,0.097,0.164,0.955,2
WNT5A,SO_373.2 [Choroidal degenerations],0.1,0,0.0,0.0,0.0,0.0,0.0,0.0,0.14,2.608,0.057,0.085,0.076,,2
ABCA1,GU_580.1 [Acute nephritic syndrome],0.1,1,4.0,0.0,0.0,0.0,0.0,0.0,0.145,2.163,3.645,0.384,1.268,0.882,3
PDGFRA,GE_977.6 [Congenital cutaneous mastocytosis*],0.1,1,4.0,0.0,0.0,0.0,0.0,0.0,0.081,2.158,3.205,3.043,0.031,,2
CERKL,SO_380.3 [Optic atrophy],0.1,0,0.0,0.0,0.0,0.0,0.38,0.0,0.0,2.754,2.978,0.493,0.157,0.969,3
MTOR,CV_433.3 [Cerebrovascular insufficiency],0.1,0,0.0,0.0,0.0,0.0,0.0,0.0,0.243,1.56,3.143,0.312,0.235,0.987,3
GRID1,NS_341.1 [Cerebral palsy],0.1,0,0.0,0.0,0.0,0.0,0.0,0.0,0.099,2.678,0.519,0.273,0.161,0.974,3
RPS29,RE_484.1 [Spontaneous pneumothorax],0.099,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.852,0.057,,,0.239,2
SYT14,GE_972.2 [Hereditary ataxia],0.099,0,0.0,0.15,0.654,0.0,0.406,0.503,0.0,2.478,3.31,0.227,0.18,0.573,5
FUZ,GE_977.1 [Congenital ichthyosis],0.099,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,3.405,2.291,1.701,0.97,2
ATP2C1,CV_433.3 [Cerebrovascular insufficiency],0.099,0,0.0,0.0,0.0,0.0,0.0,0.0,0.118,1.875,1.897,0.179,0.199,0.25,3
CTSD,GE_963.1 [Lipid storage disorders],0.099,0,0.0,0.0,0.0,0.0,0.308,0.892,0.082,1.876,1.362,0.099,0.109,0.564,5
BDNF,NS_328.13 [Frontotemporal dementia [FTD]],0.099,0,0.0,0.0,0.0,0.0,0.314,0.0,0.113,3.554,1.013,0.164,0.114,,3
VEGFA,CV_441 [Arteriovenous malformation],0.099,0,0.0,0.0,0.0,0.0,0.314,0.0,0.239,2.145,0.294,0.245,1.711,0.999,4
PRPF6,SO_369.62 [Keratoconus],0.099,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.814,3.504,1.135,0.177,0.984,2
PRKCG,GE_972.2 [Hereditary ataxia],0.099,0,0.0,0.0,0.894,0.0,0.458,0.244,0.073,2.822,1.882,,1.871,0.982,5
LSS,CM_751.213 [Congenital cataract],0.099,0,0.0,0.0,0.0,0.0,0.521,0.539,0.075,,2.544,0.661,0.242,0.914,5
PAK3,GI_516.1 [Pyloric stenosis],0.099,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.718,4.426,0.421,1.115,0.98,2
CXCR4,MS_705.2 [Juvenile rheumatoid arthritis [JRA/JIA]],0.099,0,0.0,0.023,0.606,0.439,0.0,0.0,0.263,2.391,0.101,0.052,0.072,,4
RPS23,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.099,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.771,0.071,,,0.178,2
RELN,GE_972.2 [Hereditary ataxia],0.099,0,0.0,0.054,0.0,0.0,0.464,0.0,0.048,4.006,3.369,0.423,0.536,0.981,5
CASP3,MB_302.1 [Speech and language developmental delay],0.099,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.788,0.201,0.229,1.908,0.99,2
DRD2,GE_978.3 [Osteochondrodysplasias],0.099,0,0.0,0.0,0.0,0.0,0.28,0.0,0.213,2.019,3.573,0.226,0.098,,3
MIPEP,CV_414.1 [Hypertrophic cardiomyopathy],0.099,0,0.0,0.0,0.547,0.0,0.0,0.0,0.0,1.965,2.127,0.211,0.412,0.906,3
PLIN2,SO_369.62 [Keratoconus],0.099,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.629,2.205,0.069,0.155,0.995,2
BMP4,CM_763.31 [Ventricular septal defect],0.099,0,0.0,0.0,0.0,0.0,0.0,0.0,0.121,3.062,2.346,0.258,0.101,0.96,3
C17orf75,NS_341.1 [Cerebral palsy],0.099,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.962,0.093,0.14,0.129,0.983,2
PTGS2,CV_433.3 [Cerebrovascular insufficiency],0.099,1,4.0,0.0,0.0,0.0,0.0,0.0,0.105,,2.247,0.098,0.098,0.987,3
GBA1,GE_963.1 [Lipid storage disorders],0.099,1,2.0,0.0,0.0,0.0,0.297,0.855,0.09,,,,,,3
SCN2A,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.099,1,3.0,0.0,0.0,0.0,0.0,0.0,0.012,2.287,2.114,0.486,0.638,0.333,3
SDHA,NS_341.1 [Cerebral palsy],0.099,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.299,2.726,0.343,0.085,0.987,2
CRB1,SO_386.6 [Night blindness],0.099,0,0.0,0.0,0.684,0.0,0.25,0.0,0.036,2.122,4.123,0.242,0.143,1.0,5
NF1,CM_763.31 [Ventricular septal defect],0.099,0,0.0,0.0,0.745,0.0,0.0,0.0,0.012,2.232,2.279,0.321,1.464,0.94,4
SRC,GI_542.8 [Biliary cirrhosis],0.099,0,0.0,0.0,0.0,0.0,0.0,0.0,0.386,,1.306,0.093,0.201,,2
USH1G,SO_386.6 [Night blindness],0.099,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,1.614,0.041,0.087,0.987,2
IL23A,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.099,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.067,0.103,0.073,0.971,1
MT-ND1,SO_380.3 [Optic atrophy],0.099,1,0.5,0.0,0.0,0.0,0.0,0.848,0.111,,,,,,2
SYK,DE_663.2 [Pemphigoid],0.098,0,0.0,0.0,0.0,0.0,0.0,0.0,0.105,3.825,0.783,0.186,0.124,,2
PYCARD,GU_580.1 [Acute nephritic syndrome],0.098,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.792,0.185,0.065,0.07,0.963,2
TPM2,GE_972.9 [Muscular dystrophy],0.098,0,0.0,0.0,0.684,0.0,0.0,0.695,0.107,4.922,2.245,0.136,0.062,0.97,4
KITLG,GU_603.4 [Atrophy of testis],0.098,0,0.0,0.0,0.0,0.0,0.0,0.0,0.201,1.887,0.071,0.097,0.055,,2
ANGPT1,GE_976.5 [Polycystic kidney disease],0.098,0,0.0,0.0,0.0,0.0,0.0,0.0,0.11,2.758,1.937,0.186,0.185,,2
SUN1,GE_972.9 [Muscular dystrophy],0.098,0,0.0,0.0,0.623,0.0,0.0,0.211,0.166,2.572,3.273,2.694,0.137,0.921,4
SRSF1,SO_386.5 [Color vision deficiencies],0.098,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.711,0.04,,,0.259,2
COX6A1,CV_414.1 [Hypertrophic cardiomyopathy],0.098,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.487,1.909,1.0,0.078,0.99,2
CDKN1A,CV_433.3 [Cerebrovascular insufficiency],0.098,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.775,1.546,0.075,0.965,2
ANGPT1,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.098,0,0.0,0.0,0.0,0.0,0.0,0.0,0.266,2.616,3.581,3.234,0.128,0.509,3
FGFR2,SO_386.5 [Color vision deficiencies],0.098,0,0.0,0.0,0.0,0.0,0.0,0.0,0.055,1.999,2.588,0.162,0.113,0.944,3
CTSK,GE_978.3 [Osteochondrodysplasias],0.098,0,0.0,0.0,0.0,0.0,0.358,0.392,0.07,1.907,0.104,0.1,0.096,,4
BANF1,CV_413.41 [Pulmonary valve stenosis],0.098,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.403,0.056,,,0.243,2
SRC,GE_961.1 [Phakomatoses],0.098,0,0.0,0.0,0.0,0.0,0.0,0.0,0.082,1.746,0.123,0.079,0.147,0.926,3
GUCA1A,SO_373.2 [Choroidal degenerations],0.098,0,0.0,0.0,0.0,0.0,0.421,0.402,0.094,,0.347,0.136,0.074,,3
THBS1,CV_438.41 [Aortic dissection],0.098,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,1.994,2.624,,0.088,0.979,3
PINK1,NS_341.1 [Cerebral palsy],0.098,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.511,2.843,0.392,0.151,0.983,2
ZC3H14,SO_386.5 [Color vision deficiencies],0.098,0,0.0,0.0,0.0,0.0,0.0,0.0,0.213,1.543,4.049,0.412,1.608,0.15,3
LIMK1,GE_973.5 [Huntington's disease],0.098,0,0.0,0.0,0.0,0.0,0.0,0.0,0.123,2.576,0.084,0.083,0.054,,2
HIF1A,DE_663.1 [Pemphigus],0.098,0,0.0,0.0,0.0,0.0,0.0,0.0,0.216,1.884,0.395,0.128,0.088,,2
COL5A1,MS_712.51 [Hypermobility syndrome],0.098,0,0.0,0.0,0.0,0.0,0.0,0.865,0.076,3.023,2.935,,15.693,,3
FIG4,NS_323.3 [Motor neuron disease],0.098,0,0.0,0.0,0.888,0.0,0.0,0.697,0.046,1.374,3.19,1.095,0.329,0.996,4
EDNRA,MS_700.3 [Systemic sclerosis],0.098,1,4.0,0.0,0.0,0.0,0.0,0.0,0.215,1.45,0.892,0.082,0.132,,2
RPL27A,NS_333.4 [Circadian rhythm sleep disorder],0.098,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.825,0.073,,,0.227,2
CA2,CM_770.5 [Congenital osteodystrophies],0.098,0,0.0,0.0,0.745,0.0,0.283,0.832,0.099,1.773,0.118,0.106,0.098,0.912,5
RLBP1,SO_369.62 [Keratoconus],0.098,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.564,2.8,0.389,0.13,0.997,2
SIM1,GE_978.22 [Ehler's Danlos syndrome],0.098,0,0.0,0.0,0.0,0.0,0.0,0.0,0.083,3.021,1.835,0.142,0.118,,2
LEMD3,GE_978.3 [Osteochondrodysplasias],0.098,0,0.0,0.0,0.0,0.0,0.0,0.553,0.11,2.513,2.795,0.139,0.099,,3
SORD,GE_972.1 [Hereditary neuropathy],0.098,0,0.0,0.0,0.0,0.0,0.0,0.402,0.143,1.88,4.019,3.956,1.2,,3
JPH1,CV_414.1 [Hypertrophic cardiomyopathy],0.098,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,1.756,2.568,0.431,0.67,0.254,3
IMPDH1,SO_386.6 [Night blindness],0.098,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.636,1.647,0.188,0.183,1.0,2
AARS2,GE_963.1 [Lipid storage disorders],0.098,0,0.0,0.0,0.871,0.0,0.0,0.402,0.09,,3.678,0.278,0.154,0.81,4
MOBP,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.098,0,0.0,0.015,0.0,0.596,0.0,0.0,0.323,1.565,1.774,0.099,0.076,0.327,4
TFAP2B,GE_976.5 [Polycystic kidney disease],0.098,0,0.0,0.0,0.0,0.0,0.267,0.0,0.146,2.34,0.712,0.239,0.175,,3
FGF8,EM_208.1 [Hypoparathyroidism],0.098,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.034,1.681,0.174,0.978,2
IFNAR1,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.098,0,0.0,0.0,0.426,0.0,0.0,0.0,0.0,3.663,2.981,0.219,0.109,0.908,3
PHACTR1,CV_433.3 [Cerebrovascular insufficiency],0.098,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.425,1.711,0.097,0.148,0.288,3
OPRK1,MB_296.2 [Schizoid personality disorder],0.098,1,3.0,0.0,0.0,0.0,0.0,0.0,0.122,2.88,0.097,0.136,2.043,,2
FANCD2,CV_441 [Arteriovenous malformation],0.098,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,3.249,1.284,0.447,0.986,2
SLC2A3,GE_973.5 [Huntington's disease],0.098,0,0.0,0.0,0.0,0.0,0.0,0.402,0.632,1.92,0.187,0.095,0.06,,3
CD46,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.098,0,0.0,0.0,0.894,0.0,0.0,0.0,0.143,3.073,2.949,2.113,2.047,0.984,4
CD40LG,BI_162.1 [Constitutional (hereditary) aplastic anemia],0.098,0,0.0,0.0,0.0,0.0,0.37,0.0,0.119,2.238,2.747,,0.03,,3
PEX13,GE_972.2 [Hereditary ataxia],0.098,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.939,0.896,0.193,0.976,2
DRD2,MB_293.1 [Anorexia nervosa],0.098,1,4.0,0.0,0.0,0.455,0.0,0.0,0.151,,0.606,0.316,0.099,,2
CR2,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.098,0,0.0,0.0,0.547,0.0,0.0,0.0,0.17,1.421,2.689,0.103,0.163,0.977,4
MSH6,BI_179.1 [Hypogammaglobulinemia NOS],0.098,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,3.07,0.287,0.405,0.976,2
DRD2,NS_333.4 [Circadian rhythm sleep disorder],0.097,1,2.0,0.0,0.0,0.0,0.0,0.0,0.292,1.951,2.229,0.283,0.089,0.976,3
CFH,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.097,1,0.5,0.0,0.898,0.0,0.0,0.0,0.254,1.936,2.414,0.051,0.081,0.96,4
TCF4,MB_287.2 [Schizoaffective disorder],0.097,0,0.0,0.0,0.0,0.0,0.0,0.0,0.109,2.113,3.398,2.508,0.166,,2
SYK,GE_963.1 [Lipid storage disorders],0.097,0,0.0,0.0,0.0,0.0,0.265,0.0,0.123,3.163,0.38,0.116,0.078,0.341,4
PEX12,SO_386.6 [Night blindness],0.097,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.642,0.375,0.103,0.974,1
NFATC2,MS_704.1 [Polyarteritis nodosa and related conditions],0.097,0,0.0,0.0,0.0,0.0,0.0,0.0,0.657,2.784,1.767,0.209,0.134,,2
CACNA1C,CV_433.3 [Cerebrovascular insufficiency],0.097,1,4.0,0.0,0.0,0.0,0.0,0.0,0.106,2.042,3.772,0.283,0.238,0.778,3
SIAH1,GE_961.1 [Phakomatoses],0.097,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.815,0.054,,,0.288,2
BRIP1,CV_441 [Arteriovenous malformation],0.097,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.961,3.179,2.996,1.799,0.981,2
FGFR2,SO_365.3 [Exophthalmos [Proptosis]],0.097,0,0.0,0.0,0.547,0.0,0.0,0.0,0.024,2.467,2.084,0.361,0.219,0.968,4
NFE2L2,GE_972.1 [Hereditary neuropathy],0.097,0,0.0,0.0,0.0,0.0,0.0,0.0,0.111,3.178,0.214,0.117,0.13,,2
TP53,NS_323.3 [Motor neuron disease],0.097,0,0.0,0.0,0.0,0.0,0.0,0.0,0.064,,1.926,0.196,0.17,0.972,3
SLC6A4,MB_296.4 [Borderline personality disorder],0.097,1,4.0,0.0,0.0,0.0,0.0,0.0,0.068,1.801,3.097,2.735,0.173,,2
CFH,GU_580.1 [Acute nephritic syndrome],0.097,0,0.0,0.0,0.886,0.244,0.0,0.176,0.079,2.373,4.276,0.038,0.087,0.835,4
EPCAM,NS_344.2 [Benign intracranial hypertension],0.097,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.848,0.117,0.094,0.983,2
TXNRD2,EM_208.1 [Hypoparathyroidism],0.097,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.533,2.22,0.5,0.324,0.986,2
STAT1,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.097,0,0.0,0.011,0.0,0.0,0.353,0.0,0.07,2.737,1.953,0.194,0.098,0.957,5
GBA2,GE_972.2 [Hereditary ataxia],0.097,0,0.0,0.0,0.825,0.0,0.0,0.843,0.081,,2.981,1.041,0.319,0.891,4
RPL7,BI_179.1 [Hypogammaglobulinemia NOS],0.097,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.644,2.186,,,0.253,2
ALB,GE_973.5 [Huntington's disease],0.097,0,0.0,0.0,0.0,0.0,0.0,0.0,0.508,,0.138,0.149,0.046,,1
DUOX2,GE_978.3 [Osteochondrodysplasias],0.097,0,0.0,0.0,0.0,0.0,0.417,0.0,0.145,,2.671,0.722,0.271,,3
PDGFRA,GE_978.3 [Osteochondrodysplasias],0.097,0,0.0,0.0,0.0,0.0,0.298,0.0,0.091,2.99,2.908,2.542,0.056,,3
ARID1B,MB_302.1 [Speech and language developmental delay],0.097,0,0.0,0.0,0.0,0.0,0.0,0.29,0.027,2.725,3.454,0.409,0.296,0.923,4
GRN,NS_323.3 [Motor neuron disease],0.097,0,0.0,0.0,0.871,0.0,0.0,0.402,0.117,,2.694,1.243,0.228,0.997,4
DPYSL2,CV_433.3 [Cerebrovascular insufficiency],0.097,1,2.0,0.0,0.0,0.0,0.0,0.0,0.106,1.987,1.337,0.09,0.122,0.401,3
FOSL2,MS_700.3 [Systemic sclerosis],0.097,0,0.0,0.0,0.0,0.0,0.0,0.0,0.42,1.731,0.236,0.084,0.075,,2
MYO7A,SO_369.62 [Keratoconus],0.097,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.662,3.33,0.924,0.543,0.994,2
ALPL,CM_770.5 [Congenital osteodystrophies],0.097,0,0.0,0.0,0.0,0.0,0.313,0.645,0.051,3.259,2.524,0.416,0.162,0.956,5
CTF1,CV_414.1 [Hypertrophic cardiomyopathy],0.097,0,0.0,0.0,0.426,0.0,0.0,0.13,0.426,,1.127,0.158,1.743,0.06,4
IL1B,MS_704.1 [Polyarteritis nodosa and related conditions],0.097,1,2.0,0.0,0.0,0.0,0.0,0.0,0.295,2.976,0.107,0.094,0.048,,2
CHP1,GE_972.2 [Hereditary ataxia],0.097,0,0.0,0.0,0.684,0.0,0.375,0.0,0.158,2.457,0.137,0.032,0.1,0.459,5
PSMC4,EM_209.4 [Diabetes insipidus],0.097,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.093,0.075,,0.094,0.216,2
FLNA,CM_763.31 [Ventricular septal defect],0.097,0,0.0,0.0,0.772,0.0,0.275,0.121,0.079,1.441,3.763,0.097,0.204,0.874,5
DES,NS_340.3 [Inflammatory and immune myopathies],0.097,0,0.0,0.0,0.893,0.0,0.496,0.0,0.091,2.602,2.046,0.176,0.065,,4
PDE6B,SO_386.6 [Night blindness],0.097,0,0.0,0.0,0.745,0.0,0.573,0.72,0.044,,1.989,0.828,0.192,1.0,5
PEX5,SO_380.3 [Optic atrophy],0.096,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.376,3.504,0.323,0.186,0.987,2
CACNA1D,NS_323.3 [Motor neuron disease],0.096,0,0.0,0.0,0.745,0.0,0.0,0.0,0.061,1.812,2.927,0.201,0.481,0.24,4
NFASC,NS_323.3 [Motor neuron disease],0.096,0,0.0,0.0,0.0,0.0,0.271,0.0,0.051,1.675,3.547,0.348,0.837,0.1,4
BBS5,SO_369.62 [Keratoconus],0.096,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,1.742,0.215,0.159,0.994,2
PPOX,GE_966.2 [Disorders of porphyrin metabolism],0.096,0,0.0,0.0,0.0,0.0,0.0,0.863,0.072,,6.033,4.721,14.131,,3
LAMA5,GU_580.1 [Acute nephritic syndrome],0.096,0,0.0,0.0,0.868,0.0,0.445,0.0,0.071,1.867,3.625,0.379,0.422,0.435,5
MYH7,GE_972.9 [Muscular dystrophy],0.096,0,0.0,0.0,0.891,0.0,0.0,0.833,0.063,,4.077,0.105,0.102,0.981,4
AR,GE_964.3 [Glycogen storage disease],0.096,0,0.0,0.0,0.0,0.0,0.0,0.0,0.08,2.103,3.318,,0.031,,2
RPS29,GE_972.9 [Muscular dystrophy],0.096,1,4.0,0.0,0.0,0.0,0.0,0.0,0.0,1.723,0.033,,,0.148,2
NOS2,DE_663.1 [Pemphigus],0.096,0,0.0,0.0,0.0,0.0,0.457,0.0,0.126,1.838,3.794,0.194,0.155,,3
DCLK1,NS_339.2 [Myotonic disorders],0.096,0,0.0,0.0,0.0,0.0,0.0,0.0,0.088,2.503,0.134,0.092,0.073,,2
WNT5A,GE_972.2 [Hereditary ataxia],0.096,0,0.0,0.023,0.0,0.0,0.281,0.0,0.081,2.75,0.128,0.143,0.141,0.762,5
CYP2U1,NS_341.1 [Cerebral palsy],0.096,0,0.0,0.0,0.886,0.0,0.0,0.477,0.092,,1.172,0.258,0.116,0.978,3
SLC6A4,MB_296.1 [Paranoid personality disorder],0.096,1,4.0,0.0,0.304,0.0,0.0,0.0,0.073,3.689,0.145,0.048,0.064,,3
NLRP3,GE_970.1 [Sickle-cell disorders],0.096,0,0.0,0.0,0.0,0.0,0.28,0.0,0.111,2.585,3.808,0.727,0.138,,3
PLCE1,GU_580.51 [Focal and segmental glomerular lesions*],0.096,0,0.0,0.0,0.0,0.0,0.0,0.423,0.291,2.59,4.587,0.381,0.257,,3
WNK1,SO_369.62 [Keratoconus],0.096,0,0.0,0.0,0.0,0.0,0.0,0.0,0.024,2.29,2.539,1.639,0.327,0.208,3
ECHS1,NS_341.1 [Cerebral palsy],0.096,0,0.0,0.0,0.426,0.0,0.0,0.0,0.0,2.332,0.175,0.232,0.125,0.959,3
GNE,NS_340.3 [Inflammatory and immune myopathies],0.096,0,0.0,0.0,0.859,0.0,0.0,0.7,0.08,,0.165,0.148,0.079,,2
TGM6,GE_972.2 [Hereditary ataxia],0.096,0,0.0,0.0,0.882,0.0,0.0,0.008,0.079,2.754,2.681,0.535,0.253,0.959,4
PPP2R2C,NS_323.3 [Motor neuron disease],0.096,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,1.813,0.189,,0.12,0.117,3
PDE6B,SO_380.3 [Optic atrophy],0.096,0,0.0,0.0,0.0,0.0,0.57,0.0,0.0,,2.983,2.355,0.228,0.991,3
HNRNPC,GE_961.1 [Phakomatoses],0.096,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.725,0.089,,,0.151,2
ATXN2,NS_341.1 [Cerebral palsy],0.096,0,0.0,0.0,0.0,0.0,0.0,0.0,0.048,1.746,3.748,0.924,0.24,0.985,3
PPARGC1A,GE_972.2 [Hereditary ataxia],0.096,0,0.0,0.086,0.0,0.0,0.3,0.0,0.183,2.932,2.76,1.268,0.257,0.975,5
RHO,SO_380.3 [Optic atrophy],0.096,0,0.0,0.0,0.0,0.0,0.447,0.0,0.0,2.325,0.621,0.528,0.157,0.991,3
ANGPT1,MS_704.1 [Polyarteritis nodosa and related conditions],0.096,0,0.0,0.0,0.0,0.0,0.0,0.0,0.097,3.193,0.192,0.089,0.097,,2
CACNG2,GE_972.2 [Hereditary ataxia],0.096,1,4.0,0.019,0.0,0.0,0.309,0.0,0.034,1.955,0.892,0.077,0.094,0.79,5
ADCY1,CV_414.1 [Hypertrophic cardiomyopathy],0.096,0,0.0,0.0,0.0,0.0,0.0,0.0,0.106,2.458,2.504,0.082,0.757,0.101,3
JAK2,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.096,0,0.0,0.0,0.426,0.0,0.282,0.0,0.074,1.474,3.917,0.372,0.29,0.984,5
NDUFA4,GE_963.1 [Lipid storage disorders],0.096,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.995,0.102,0.042,0.042,0.975,2
C4orf3,GE_972.2 [Hereditary ataxia],0.096,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.7,1.99,0.101,,0.953,2
HSPG2,GE_978.3 [Osteochondrodysplasias],0.096,0,0.0,0.0,0.0,0.0,0.343,0.816,0.071,,3.073,0.585,0.752,,4
GJB1,NS_323.3 [Motor neuron disease],0.096,0,0.0,0.0,0.547,0.0,0.0,0.0,0.021,,4.177,,2.422,0.268,4
AGK,CM_751.213 [Congenital cataract],0.096,0,0.0,0.0,0.877,0.0,0.0,0.504,0.048,1.725,1.949,0.288,0.156,0.855,4
MTMR2,GE_972.1 [Hereditary neuropathy],0.096,0,0.0,0.0,0.0,0.0,0.309,0.206,0.085,2.687,0.355,0.215,0.714,,4
PAPSS2,CM_770.5 [Congenital osteodystrophies],0.096,0,0.0,0.0,0.684,0.0,0.346,0.786,0.03,2.76,4.105,1.91,0.215,0.383,5
SEC23B,GE_961.1 [Phakomatoses],0.096,0,0.0,0.0,0.0,0.0,0.283,0.721,0.09,1.872,3.487,2.123,0.664,0.27,5
RORA,GE_972.2 [Hereditary ataxia],0.096,0,0.0,0.0,0.0,0.0,0.455,0.0,0.077,4.248,0.328,,,0.982,4
CACNB2,SO_380.3 [Optic atrophy],0.096,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.762,1.652,0.105,0.219,0.986,2
DSCAM,GE_961.1 [Phakomatoses],0.096,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,4.334,3.865,2.481,0.411,0.323,3
KIRREL1,GU_580.51 [Focal and segmental glomerular lesions*],0.096,0,0.0,0.0,0.0,0.0,0.612,0.0,0.232,2.545,3.789,0.115,0.094,,3
SETDB1,GE_972.9 [Muscular dystrophy],0.096,0,0.0,0.0,0.0,0.0,0.0,0.0,0.258,1.34,2.498,0.179,0.167,0.299,3
AGT,GU_580.52 [Diffuse membranous glomerulonephritis],0.096,0,0.0,0.0,0.0,0.0,0.467,0.0,0.349,,2.929,0.403,0.1,,3
COL1A2,CM_770.5 [Congenital osteodystrophies],0.096,0,0.0,0.0,0.0,0.0,0.359,0.673,0.083,1.971,3.001,0.952,6.969,0.97,5
SNAI2,NS_323.3 [Motor neuron disease],0.096,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,1.965,1.72,,0.102,0.102,3
JAK2,MS_705.2 [Juvenile rheumatoid arthritis [JRA/JIA]],0.096,1,3.0,0.0,0.0,0.0,0.477,0.0,0.017,1.995,2.1,1.435,0.176,,3
COX5B,CV_414.1 [Hypertrophic cardiomyopathy],0.096,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,3.058,0.914,0.182,0.997,2
GSK3B,CM_770.5 [Congenital osteodystrophies],0.096,0,0.0,0.0,0.0,0.0,0.32,0.0,0.113,3.249,2.235,,0.091,0.939,4
BANF1,MB_302.1 [Speech and language developmental delay],0.096,0,0.0,0.0,0.0,0.0,0.0,0.0,0.033,2.384,0.091,,,0.248,3
INPP5A,GE_972.2 [Hereditary ataxia],0.096,0,0.0,0.0,0.0,0.0,0.284,0.0,0.108,1.654,0.234,0.17,1.79,0.812,4
MPV17,GE_963.1 [Lipid storage disorders],0.096,0,0.0,0.0,0.547,0.0,0.0,0.0,0.0,,0.067,0.11,0.064,0.964,2
IKZF1,SO_386.5 [Color vision deficiencies],0.095,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,2.384,0.094,0.095,0.089,0.368,3
PIK3CB,BI_179.7 [Common variable immunodeficiency [CVID]],0.095,0,0.0,0.0,0.0,0.0,0.0,0.0,0.499,1.685,0.125,0.094,0.066,,2
TGFB3,MS_700.3 [Systemic sclerosis],0.095,1,1.0,0.0,0.0,0.0,0.259,0.0,0.181,2.9,2.854,0.244,0.159,,3
FHL1,GE_972.9 [Muscular dystrophy],0.095,0,0.0,0.0,0.86,0.0,0.299,0.593,0.108,1.967,0.121,0.069,0.047,0.969,5
GNMT,GE_964.3 [Glycogen storage disease],0.095,0,0.0,0.0,0.0,0.0,0.414,0.0,0.131,,0.442,0.115,0.113,,2
SIK2,CV_433.3 [Cerebrovascular insufficiency],0.095,0,0.0,0.0,0.0,0.0,0.0,0.0,0.176,2.441,2.016,0.167,0.133,0.264,3
POMK,GE_972.9 [Muscular dystrophy],0.095,0,0.0,0.0,0.836,0.0,0.0,0.596,0.082,,0.205,0.268,0.095,0.986,3
LPAR1,DE_663.2 [Pemphigoid],0.095,0,0.0,0.0,0.0,0.0,0.0,0.0,0.158,3.616,2.201,0.094,0.138,,2
ADRA2C,CV_413.41 [Pulmonary valve stenosis],0.095,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.514,2.985,,0.022,0.143,2
RPS29,BI_179.1 [Hypogammaglobulinemia NOS],0.095,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.648,0.056,,,0.288,2
ANGPT1,GE_972.2 [Hereditary ataxia],0.095,0,0.0,0.0,0.0,0.0,0.0,0.0,0.608,2.493,2.997,2.557,0.15,0.543,3
HCRTR2,NS_333.4 [Circadian rhythm sleep disorder],0.095,1,4.0,0.0,0.0,0.0,0.0,0.0,0.17,1.403,3.775,3.52,0.118,0.422,3
PDGFRA,MS_700.3 [Systemic sclerosis],0.095,1,4.0,0.0,0.0,0.0,0.0,0.0,0.728,1.761,2.346,0.144,0.095,,2
FOXO3,GE_976.5 [Polycystic kidney disease],0.095,0,0.0,0.0,0.0,0.0,0.0,0.0,0.562,2.302,0.787,0.403,0.148,,2
MMP16,GE_972.2 [Hereditary ataxia],0.095,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,2.989,0.945,0.104,0.129,0.214,3
SNRPD2,NS_344.2 [Benign intracranial hypertension],0.095,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.869,0.059,,,0.239,2
MT-CO3,SO_380.3 [Optic atrophy],0.095,0,0.0,0.0,0.0,0.0,0.0,0.709,0.077,,,,,,2
FERMT3,CM_770.5 [Congenital osteodystrophies],0.095,0,0.0,0.0,0.547,0.0,0.327,0.0,0.152,,1.889,0.4,0.161,0.334,5
SPIN1,CM_763.31 [Ventricular septal defect],0.095,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.972,0.072,0.047,,0.259,2
SMAD3,GE_978.3 [Osteochondrodysplasias],0.095,0,0.0,0.0,0.0,0.0,0.306,0.0,0.091,2.076,0.055,0.031,2.291,,3
RORB,MB_302.1 [Speech and language developmental delay],0.095,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,2.228,0.12,0.058,0.061,0.299,3
SERAC1,NS_341.1 [Cerebral palsy],0.095,0,0.0,0.0,0.745,0.0,0.0,0.0,0.017,1.59,0.281,0.227,0.151,0.91,4
PEX19,NS_341.1 [Cerebral palsy],0.095,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.979,0.113,0.117,0.994,1
TET2,BI_162.1 [Constitutional (hereditary) aplastic anemia],0.095,0,0.0,0.0,0.0,0.0,0.41,0.0,0.091,2.899,2.44,0.075,0.149,,3
CAV3,CV_416.8 [Pre-excitation syndrome [Anomalous atrioventricular excitation]],0.095,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.74,0.374,0.138,0.094,0.975,2
DSTYK,NS_341.1 [Cerebral palsy],0.095,0,0.0,0.0,0.684,0.0,0.0,0.0,0.024,1.44,2.42,0.245,0.166,0.234,4
PRKDC,BI_179.1 [Hypogammaglobulinemia NOS],0.095,0,0.0,0.0,0.635,0.0,0.0,0.0,0.0,2.752,3.485,0.843,0.231,0.995,3
SIAH1,SO_386.6 [Night blindness],0.095,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.361,0.06,,,0.17,2
ITPR1,GE_973.5 [Huntington's disease],0.095,0,0.0,0.0,0.0,0.0,0.0,0.0,0.368,1.898,2.43,0.177,1.593,,2
SLC6A4,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.095,1,2.0,0.0,0.0,0.0,0.0,0.0,0.095,,0.982,0.144,0.125,0.285,2
INSR,MB_287.2 [Schizoaffective disorder],0.095,1,4.0,0.0,0.0,0.0,0.0,0.0,0.158,2.181,3.416,2.474,0.171,,2
TP53,GI_516.1 [Pyloric stenosis],0.095,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.143,2.529,2.169,1.529,0.996,2
SRC,CV_433.3 [Cerebrovascular insufficiency],0.095,1,0.5,0.0,0.0,0.0,0.0,0.0,0.183,1.422,0.108,0.063,0.15,0.973,3
RASA3,GE_970.1 [Sickle-cell disorders],0.095,0,0.0,0.0,0.0,0.0,0.428,0.0,0.1,1.532,1.378,0.995,0.182,,3
PTH1R,GE_978.3 [Osteochondrodysplasias],0.095,1,4.0,0.0,0.0,0.0,0.287,0.402,0.08,2.503,3.208,0.105,0.068,,4
PEX6,SO_386.6 [Night blindness],0.095,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.183,4.027,0.415,0.192,0.976,2
BRCA2,CV_441 [Arteriovenous malformation],0.095,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.94,0.632,0.428,0.992,2
IFT140,SO_369.62 [Keratoconus],0.095,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,3.279,0.273,0.356,0.997,2
SMAD3,CM_770.5 [Congenital osteodystrophies],0.095,0,0.0,0.0,0.0,0.0,0.301,0.0,0.084,2.123,0.062,0.035,2.324,0.982,4
ATXN7,SO_369.62 [Keratoconus],0.095,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.805,2.269,0.65,1.043,0.911,3
SETX,GE_963.1 [Lipid storage disorders],0.095,0,0.0,0.0,0.0,0.0,0.0,0.129,0.012,,2.663,0.307,1.487,0.302,4
HRAS,CV_414.1 [Hypertrophic cardiomyopathy],0.095,0,0.0,0.0,0.779,0.0,0.0,0.0,0.122,,2.286,0.237,1.878,0.894,4
HMBS,GE_966.2 [Disorders of porphyrin metabolism],0.095,1,2.0,0.0,0.0,0.0,0.0,0.93,0.089,,3.943,3.291,2.55,,3
PPARD,GI_542.8 [Biliary cirrhosis],0.095,1,3.0,0.0,0.0,0.0,0.0,0.0,0.074,2.472,2.205,0.163,0.17,,2
PITX1,GE_973.5 [Huntington's disease],0.095,0,0.0,0.0,0.0,0.0,0.0,0.0,0.108,4.306,0.062,0.093,0.048,,2
SCN3A,NS_323.3 [Motor neuron disease],0.095,1,4.0,0.0,0.0,0.0,0.0,0.0,0.018,1.821,3.026,0.744,0.541,0.098,3
SYK,GE_973.5 [Huntington's disease],0.095,0,0.0,0.0,0.0,0.0,0.0,0.0,0.103,2.502,0.087,0.089,0.054,,2
IKZF1,BI_162.1 [Constitutional (hereditary) aplastic anemia],0.095,0,0.0,0.0,0.426,0.0,0.568,0.362,0.036,2.294,0.072,0.096,0.07,,4
SNRPD2,BI_179.1 [Hypogammaglobulinemia NOS],0.094,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.968,0.056,,,0.216,2
RTN4R,NS_323.3 [Motor neuron disease],0.094,0,0.0,0.0,0.0,0.0,0.0,0.0,0.21,2.163,2.108,,3.163,0.109,3
UNC13D,MS_705.2 [Juvenile rheumatoid arthritis [JRA/JIA]],0.094,0,0.0,0.0,0.817,0.0,0.0,0.0,0.104,,2.066,0.105,0.166,,3
CHRNA1,NS_338.1 [Myasthenia gravis],0.094,0,0.0,0.0,0.0,0.495,0.0,0.862,0.071,1.562,3.223,0.943,0.234,,3
FOS,EM_208.1 [Hypoparathyroidism],0.094,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.953,1.853,0.166,0.183,0.976,2
DPYSL5,GE_972.2 [Hereditary ataxia],0.094,0,0.0,0.115,0.0,0.0,0.0,0.0,0.017,1.965,1.861,0.198,0.151,0.813,4
FAM161A,SO_386.6 [Night blindness],0.094,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.608,0.92,0.353,0.145,0.999,2
MTOR,GE_963.1 [Lipid storage disorders],0.094,0,0.0,0.0,0.0,0.0,0.0,0.0,0.079,1.709,3.674,0.197,0.165,0.908,3
TNIP1,GI_540.11 [Autoimmune hepatitis],0.094,0,0.0,0.0,0.0,0.0,0.443,0.0,0.043,,1.917,0.326,0.206,,3
EGFR,CV_414.1 [Hypertrophic cardiomyopathy],0.094,0,0.0,0.0,0.0,0.0,0.637,0.0,0.582,3.029,3.012,1.103,0.539,0.952,4
EZH2,GI_540.11 [Autoimmune hepatitis],0.094,0,0.0,0.0,0.0,0.0,0.0,0.0,0.175,2.343,0.688,0.079,0.106,,2
CRYBA4,CM_751.213 [Congenital cataract],0.094,0,0.0,0.0,0.532,0.0,0.0,0.711,0.026,1.92,0.172,0.224,2.0,0.971,4
THBD,GE_973.5 [Huntington's disease],0.094,0,0.0,0.0,0.0,0.0,0.0,0.0,0.158,2.049,4.035,0.034,0.033,,2
COL1A2,SO_386.5 [Color vision deficiencies],0.094,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,2.454,1.009,0.425,0.154,0.328,3
UBQLN2,NS_323.3 [Motor neuron disease],0.094,0,0.0,0.029,0.883,0.0,0.0,0.648,0.088,2.424,0.281,0.211,0.113,0.999,5
IKZF1,DE_663.2 [Pemphigoid],0.094,0,0.0,0.0,0.0,0.0,0.0,0.0,0.095,2.239,1.746,0.151,0.113,,2
SOX3,EM_208.1 [Hypoparathyroidism],0.094,0,0.0,0.0,0.0,0.0,0.0,0.201,0.103,1.993,2.869,0.093,0.025,,3
CHMP4B,CM_751.213 [Congenital cataract],0.094,0,0.0,0.0,0.654,0.0,0.0,0.698,0.012,2.382,0.107,0.065,3.417,0.923,4
GBE1,GE_964.3 [Glycogen storage disease],0.094,0,0.0,0.0,0.0,0.0,0.28,0.905,0.088,2.845,1.92,0.243,0.223,,4
MT-CO1,SO_380.3 [Optic atrophy],0.094,0,0.0,0.0,0.0,0.0,0.0,0.729,0.07,,,,,,2
NDUFA10,SO_380.3 [Optic atrophy],0.094,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.375,2.3,0.731,0.16,0.96,2
IGF1R,GE_961.1 [Phakomatoses],0.094,0,0.0,0.0,0.0,0.0,0.0,0.0,0.091,4.354,2.401,0.343,0.632,0.906,3
TPK1,GE_972.2 [Hereditary ataxia],0.094,1,4.0,0.0,0.547,0.0,0.0,0.0,0.071,3.178,2.866,0.21,0.144,0.719,4
NOTCH1,GE_977.1 [Congenital ichthyosis],0.094,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.98,4.081,0.29,0.201,0.993,2
WNT5A,GE_961.1 [Phakomatoses],0.094,0,0.0,0.0,0.0,0.0,0.298,0.0,0.093,3.654,2.948,0.124,0.122,0.894,4
XYLT1,CM_770.5 [Congenital osteodystrophies],0.094,0,0.0,0.0,0.0,0.0,0.36,0.805,0.109,1.986,2.398,1.143,0.178,0.549,5
THBD,GU_580.1 [Acute nephritic syndrome],0.094,0,0.0,0.0,0.701,0.0,0.0,0.132,0.09,1.903,2.418,0.066,0.079,0.825,4
GRM6,SO_386.6 [Night blindness],0.094,0,0.0,0.0,0.892,0.0,0.0,0.741,0.075,,2.784,2.605,0.106,0.993,4
IL12RB2,DE_669.2 [Behcet's syndrome],0.094,0,0.0,0.0,0.0,0.59,0.0,0.0,0.302,3.105,0.621,0.167,0.098,,2
HMGCL,NS_341.1 [Cerebral palsy],0.094,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.193,0.208,0.127,0.994,2
PPARG,GI_542.8 [Biliary cirrhosis],0.094,1,3.0,0.0,0.0,0.0,0.0,0.0,0.249,2.584,1.583,0.154,0.153,,2
AICDA,BI_179.1 [Hypogammaglobulinemia NOS],0.094,0,0.0,0.0,0.532,0.0,0.0,0.0,0.03,2.275,0.066,0.055,2.103,0.973,4
POMGNT2,SO_380.3 [Optic atrophy],0.094,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.574,2.809,0.224,0.176,0.969,2
TUBB2B,GE_961.1 [Phakomatoses],0.094,1,2.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.074,,,0.292,1
NFKB1,GI_540.11 [Autoimmune hepatitis],0.094,0,0.0,0.0,0.0,0.0,0.273,0.0,0.417,3.971,1.825,0.467,0.155,,3
SYK,GI_542.8 [Biliary cirrhosis],0.094,0,0.0,0.0,0.0,0.0,0.0,0.0,0.096,2.618,1.777,0.3,0.164,,2
FA2H,GE_963.1 [Lipid storage disorders],0.094,0,0.0,0.0,0.745,0.0,0.292,0.0,0.091,,1.22,0.088,0.092,0.97,4
TNXB,GE_978.22 [Ehler's Danlos syndrome],0.094,0,0.0,0.0,0.0,0.0,0.0,0.621,0.227,,4.077,4.721,1.439,,3
MYL12B,CV_414.1 [Hypertrophic cardiomyopathy],0.094,0,0.0,0.0,0.0,0.0,0.0,0.0,0.035,2.138,0.087,0.062,0.08,0.268,3
MTOR,GE_977.6 [Congenital cutaneous mastocytosis*],0.094,0,0.0,0.0,0.0,0.0,0.0,0.0,0.119,2.551,1.668,0.154,0.101,,2
BMPR2,CV_433.3 [Cerebrovascular insufficiency],0.094,0,0.0,0.0,0.0,0.0,0.0,0.0,0.061,,2.37,0.193,0.147,0.961,3
NR3C1,GE_963.1 [Lipid storage disorders],0.093,1,4.0,0.0,0.0,0.0,0.0,0.0,0.027,2.429,2.951,0.099,0.125,0.221,3
C3orf38,CV_414.1 [Hypertrophic cardiomyopathy],0.093,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.412,0.399,0.178,0.998,2
CDKN1A,CM_750.16 [Arnold-Chiari syndrome*],0.093,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.5,0.022,0.049,0.981,1
UROS,GE_966.2 [Disorders of porphyrin metabolism],0.093,0,0.0,0.0,0.0,0.0,0.277,0.903,0.075,2.005,2.271,0.11,0.051,,4
HLA-DQB1,GU_580.1 [Acute nephritic syndrome],0.093,0,0.0,0.0,0.0,0.256,0.0,0.0,0.0,,0.261,0.26,0.079,0.939,2
LHX2,NS_347.1 [Cerebral cysts],0.093,0,0.0,0.0,0.0,0.0,0.0,0.0,0.103,2.098,0.426,0.084,0.097,,2
SMAD3,DE_663.2 [Pemphigoid],0.093,0,0.0,0.0,0.0,0.0,0.0,0.0,0.119,3.658,0.069,0.047,2.188,,2
MC1R,MS_700.3 [Systemic sclerosis],0.093,1,2.0,0.0,0.0,0.0,0.0,0.0,0.172,,3.947,0.176,0.106,,2
RPS10,SO_365.3 [Exophthalmos [Proptosis]],0.093,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.406,0.043,,,0.218,2
SSB,MS_700.3 [Systemic sclerosis],0.093,0,0.0,0.0,0.0,0.0,0.0,0.0,0.106,,2.651,0.124,0.155,,2
CANT1,GE_978.3 [Osteochondrodysplasias],0.093,0,0.0,0.0,0.0,0.0,0.33,0.633,0.128,,2.619,0.191,1.651,,4
NDUFA2,GE_972.2 [Hereditary ataxia],0.093,1,4.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.347,0.047,0.059,0.973,2
PEX19,SO_380.3 [Optic atrophy],0.093,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.681,0.118,0.132,0.986,1
FN1,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.093,0,0.0,0.0,0.0,0.0,0.0,0.0,0.118,2.269,3.084,0.286,1.178,0.964,3
UQCRC1,GE_963.1 [Lipid storage disorders],0.093,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.604,0.276,0.113,0.99,1
DPYSL5,NS_338.1 [Myasthenia gravis],0.093,0,0.0,0.0,0.0,0.0,0.0,0.0,0.087,2.652,2.82,0.191,0.182,,2
FGFR1,CM_770.5 [Congenital osteodystrophies],0.093,1,2.0,0.0,0.0,0.0,0.354,0.0,0.041,2.192,3.529,2.037,1.556,0.956,4
GSK3B,NS_339.2 [Myotonic disorders],0.093,1,3.0,0.0,0.0,0.046,0.0,0.0,0.182,2.072,0.098,,0.068,,2
NF1,GE_973.5 [Huntington's disease],0.093,0,0.0,0.0,0.0,0.0,0.0,0.0,0.108,1.429,3.464,3.111,1.822,,2
NAMPT,MS_700.3 [Systemic sclerosis],0.093,0,0.0,0.0,0.0,0.0,0.0,0.0,0.357,1.738,0.214,0.091,0.104,,2
GABBR1,NS_341.1 [Cerebral palsy],0.093,1,4.0,0.0,0.0,0.0,0.0,0.0,0.015,,0.12,0.163,0.149,0.866,2
PLP1,GE_972.2 [Hereditary ataxia],0.093,0,0.0,0.0,0.0,0.0,0.374,0.874,0.07,,0.082,0.033,0.048,0.934,4
ELMO1,GI_542.8 [Biliary cirrhosis],0.093,0,0.0,0.0,0.0,0.58,0.0,0.0,0.015,2.542,2.988,0.191,0.216,,2
ZEB2,MS_712.51 [Hypermobility syndrome],0.093,0,0.0,0.0,0.0,0.0,0.0,0.0,0.131,2.142,2.698,2.553,0.973,,2
RPSA,CV_441 [Arteriovenous malformation],0.093,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.782,0.144,,,0.24,2
SLC12A3,GU_580.1 [Acute nephritic syndrome],0.093,1,4.0,0.0,0.758,0.0,0.0,0.0,0.044,,2.698,0.188,0.316,0.197,4
UBE2N,NS_333.4 [Circadian rhythm sleep disorder],0.093,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.055,,,0.293,1
KDR,CM_763.31 [Ventricular septal defect],0.093,0,0.0,0.0,0.875,0.0,0.0,0.0,0.027,2.431,3.277,0.755,0.201,0.922,4
DRD1,MS_728.2 [Osteochondritis dissecans],0.093,0,0.0,0.0,0.0,0.0,0.0,0.0,0.188,2.413,0.298,0.118,0.084,,2
GNAS,GE_963.1 [Lipid storage disorders],0.093,0,0.0,0.0,0.0,0.0,0.0,0.0,0.679,1.495,0.08,0.08,0.064,0.31,3
ACSS2,NS_341.1 [Cerebral palsy],0.093,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.75,3.124,0.537,0.181,0.982,2
KCNB1,NS_323.3 [Motor neuron disease],0.093,1,2.0,0.0,0.0,0.0,0.0,0.0,0.061,2.501,0.301,0.32,0.143,0.229,3
TNXB,MS_712.51 [Hypermobility syndrome],0.093,0,0.0,0.0,0.0,0.0,0.0,0.544,0.264,,4.095,3.437,1.523,,3
DGKE,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.093,0,0.0,0.0,0.888,0.0,0.0,0.362,0.088,1.997,1.401,0.232,0.168,0.627,4
TPI1,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.093,0,0.0,0.0,0.547,0.0,0.336,0.0,0.125,,0.219,0.06,0.055,0.942,4
CD34,BI_179.1 [Hypogammaglobulinemia NOS],0.093,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.311,2.863,0.253,0.08,0.968,2
HNRNPC,BI_179.1 [Hypogammaglobulinemia NOS],0.093,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.585,0.079,,,0.255,2
DNMT3B,NS_339.2 [Myotonic disorders],0.093,0,0.0,0.0,0.0,0.0,0.0,0.0,0.16,2.252,3.756,3.543,0.104,,2
PTPRC,MS_700.3 [Systemic sclerosis],0.093,0,0.0,0.0,0.0,0.0,0.0,0.0,0.19,4.672,2.283,0.086,1.609,,2
BTK,BI_179.1 [Hypogammaglobulinemia NOS],0.093,1,0.5,0.0,0.9,0.0,0.0,0.503,0.081,,2.056,0.037,0.051,0.995,4
RGR,SO_386.6 [Night blindness],0.093,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.503,3.422,1.606,0.12,0.999,2
SOX5,NS_323.3 [Motor neuron disease],0.093,0,0.0,0.0,0.0,0.0,0.0,0.0,0.015,2.556,3.024,0.392,0.633,0.079,3
KDR,GU_580.1 [Acute nephritic syndrome],0.093,1,2.0,0.0,0.0,0.0,0.0,0.0,0.075,4.682,3.657,1.242,0.784,0.889,3
VPS13D,GE_972.2 [Hereditary ataxia],0.093,0,0.0,0.0,0.879,0.0,0.0,0.869,0.037,,3.384,0.048,0.247,0.793,4
F5,CV_433.3 [Cerebrovascular insufficiency],0.093,1,3.0,0.0,0.304,0.0,0.0,0.235,0.087,1.357,2.521,0.574,0.269,0.335,4
STAC3,GE_972.9 [Muscular dystrophy],0.093,0,0.0,0.0,0.0,0.0,0.306,0.786,0.091,,0.379,0.27,0.102,0.529,4
UBA5,GE_972.2 [Hereditary ataxia],0.093,0,0.0,0.0,0.801,0.0,0.0,0.688,0.015,,0.156,0.006,0.138,0.372,3
UBE2L3,CV_433.3 [Cerebrovascular insufficiency],0.093,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.988,0.078,,,0.21,2
TP53,EM_211.1 [Adrenal hyperfunction],0.092,0,0.0,0.0,0.0,0.0,0.0,0.0,0.082,,0.185,0.134,0.143,,1
RPS26,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.092,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.08,0.042,,0.197,1
NDUFB9,NS_341.1 [Cerebral palsy],0.092,1,2.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.209,0.137,0.073,0.974,1
HLA-DRA,MS_700.3 [Systemic sclerosis],0.092,0,0.0,0.0,0.0,0.461,0.0,0.0,0.108,1.673,0.93,0.062,0.064,,2
KIT,CV_433.3 [Cerebrovascular insufficiency],0.092,0,0.0,0.0,0.0,0.0,0.0,0.0,0.106,2.256,2.142,0.158,0.145,0.947,3
ANO5,GE_978.3 [Osteochondrodysplasias],0.092,0,0.0,0.0,0.0,0.0,0.381,0.402,0.049,2.725,0.375,0.19,0.191,,4
TP53BP1,CM_770.5 [Congenital osteodystrophies],0.092,0,0.0,0.0,0.0,0.0,0.0,0.0,0.122,1.625,1.183,0.428,0.261,0.756,3
CHRM3,GI_542.8 [Biliary cirrhosis],0.092,0,0.0,0.0,0.0,0.0,0.0,0.0,0.149,3.743,1.665,0.135,0.167,,2
TP53,RE_477.2 [Hypersensitivity pneumonitis],0.092,0,0.0,0.0,0.0,0.0,0.0,0.0,0.181,1.869,1.09,0.135,0.111,,2
NDUFB7,GE_963.1 [Lipid storage disorders],0.092,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.089,0.177,0.05,0.958,1
GRIN2B,MB_298 [Impulse disorders],0.092,1,4.0,0.0,0.0,0.0,0.0,0.0,0.073,1.757,2.837,,,,2
MATN3,GE_978.3 [Osteochondrodysplasias],0.092,0,0.0,0.0,0.0,0.0,0.362,0.865,0.069,,0.457,0.278,1.716,,4
PEX12,GI_516.1 [Pyloric stenosis],0.092,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.319,0.723,0.151,0.974,2
TNF,DE_669.2 [Behcet's syndrome],0.092,1,4.0,0.0,0.0,0.0,0.0,0.0,0.93,,2.615,0.141,0.028,,2
FGFR1,EM_208.1 [Hypoparathyroidism],0.092,1,4.0,0.0,0.0,0.0,0.0,0.0,0.012,3.192,2.481,0.481,0.258,0.915,3
ANGPT1,CV_433.3 [Cerebrovascular insufficiency],0.092,0,0.0,0.0,0.0,0.0,0.0,0.0,0.271,2.139,1.852,0.107,0.106,0.922,3
MT-CYB,SO_380.3 [Optic atrophy],0.092,0,0.0,0.0,0.0,0.0,0.0,0.783,0.084,,,,,,2
SLC40A1,GE_972.2 [Hereditary ataxia],0.092,0,0.0,0.0,0.0,0.0,0.0,0.0,0.086,1.403,1.011,0.127,0.162,0.589,3
VAMP1,NS_341.1 [Cerebral palsy],0.092,0,0.0,0.0,0.654,0.0,0.0,0.572,0.018,,0.058,0.042,0.062,0.976,3
HEXB,NS_341.1 [Cerebral palsy],0.092,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.564,2.789,0.126,2.188,0.964,2
BRCA2,NS_344.2 [Benign intracranial hypertension],0.092,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.378,3.547,0.894,0.228,0.988,2
HGF,GE_972.2 [Hereditary ataxia],0.092,0,0.0,0.0,0.0,0.0,0.537,0.0,0.103,3.479,3.023,0.357,0.676,0.832,4
FZR1,GE_972.2 [Hereditary ataxia],0.092,0,0.0,0.0,0.0,0.0,0.0,0.129,0.042,1.693,2.824,2.529,0.15,0.291,4
MMP9,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.092,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,3.744,0.957,0.215,0.973,2
CHST3,CM_770.5 [Congenital osteodystrophies],0.092,0,0.0,0.0,0.852,0.0,0.267,0.21,0.081,1.86,1.207,0.167,0.139,0.526,5
VEGFA,NS_344.11 [Communicating hydrocephalus],0.092,0,0.0,0.0,0.0,0.0,0.0,0.0,0.349,2.434,0.098,0.082,0.05,,2
NPHP4,GU_580.1 [Acute nephritic syndrome],0.092,0,0.0,0.0,0.832,0.0,0.0,0.482,0.018,2.494,3.275,0.427,0.303,0.157,4
PPARGC1A,DE_663.1 [Pemphigus],0.092,0,0.0,0.0,0.0,0.0,0.0,0.0,0.125,3.116,2.174,0.168,0.138,,2
SCN10A,CV_414.1 [Hypertrophic cardiomyopathy],0.092,0,0.0,0.0,0.0,0.0,0.377,0.0,0.137,1.858,2.57,0.625,1.624,0.295,4
NTRK3,GE_973.5 [Huntington's disease],0.092,0,0.0,0.0,0.0,0.0,0.0,0.0,0.159,3.133,0.115,0.158,0.083,,2
DRD1,GE_978.3 [Osteochondrodysplasias],0.092,0,0.0,0.0,0.0,0.0,0.0,0.0,0.146,2.771,2.858,0.088,0.099,,2
RD3,NS_341.1 [Cerebral palsy],0.092,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.585,0.314,0.376,0.065,0.978,2
NAMPT,CV_438.41 [Aortic dissection],0.092,0,0.0,0.0,0.0,0.0,0.0,0.0,0.036,2.57,0.21,0.07,0.103,0.304,3
FANCE,CV_441 [Arteriovenous malformation],0.092,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.575,0.305,1.0,0.987,2
RIN3,MS_727.3 [Osteitis deformans [Paget's disease of bone]],0.092,0,0.0,0.0,0.0,0.553,0.0,0.0,0.074,4.563,2.612,0.212,0.491,,2
IGF1R,CV_433.3 [Cerebrovascular insufficiency],0.092,1,2.0,0.0,0.061,0.0,0.0,0.0,0.173,3.196,2.918,0.688,0.21,0.958,4
FGFR1,GE_961.1 [Phakomatoses],0.092,1,2.0,0.0,0.0,0.0,0.0,0.0,0.068,1.996,2.751,1.084,0.173,0.972,3
ARPC4,GI_516.1 [Pyloric stenosis],0.092,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.901,0.069,,,0.193,2
KITLG,MS_700.3 [Systemic sclerosis],0.092,0,0.0,0.0,0.0,0.0,0.0,0.0,0.245,2.947,0.168,0.121,0.091,,2
WDR35,GE_978.3 [Osteochondrodysplasias],0.092,0,0.0,0.0,0.0,0.0,0.312,0.864,0.065,1.707,2.215,0.347,0.227,,4
NPHS2,GE_976.5 [Polycystic kidney disease],0.092,0,0.0,0.0,0.0,0.0,0.378,0.0,0.149,,1.079,0.876,0.255,,2
CHRND,NS_338.1 [Myasthenia gravis],0.092,0,0.0,0.0,0.0,0.0,0.0,0.795,0.088,,2.928,0.2,0.797,,3
IL6R,MS_705.2 [Juvenile rheumatoid arthritis [JRA/JIA]],0.092,1,4.0,0.015,0.0,0.069,0.0,0.0,0.168,2.777,2.454,0.04,0.068,,3
TLR8,MS_700.3 [Systemic sclerosis],0.092,0,0.0,0.0,0.0,0.0,0.0,0.0,0.302,3.439,2.835,,0.128,,2
SRC,DE_663.1 [Pemphigus],0.092,0,0.0,0.0,0.0,0.0,0.0,0.0,0.096,2.734,0.06,0.036,0.074,,2
UGT8,GE_972.2 [Hereditary ataxia],0.092,0,0.0,0.0,0.0,0.0,0.332,0.0,0.116,1.886,2.487,0.115,0.123,0.75,4
ADRA2C,NS_333.4 [Circadian rhythm sleep disorder],0.092,1,4.0,0.0,0.0,0.0,0.0,0.0,0.0,2.927,0.452,,0.03,0.163,2
BANF1,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.092,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.104,,,0.294,1
PTEN,GE_961.1 [Phakomatoses],0.092,0,0.0,0.0,0.0,0.0,0.335,0.926,0.213,,0.272,,7.288,0.991,5
WEE1,GE_976.5 [Polycystic kidney disease],0.092,0,0.0,0.0,0.0,0.0,0.0,0.0,0.099,1.78,1.799,0.099,0.13,,2
TFAP2B,MS_712.51 [Hypermobility syndrome],0.091,0,0.0,0.0,0.0,0.0,0.0,0.0,0.112,2.469,0.217,0.203,0.161,,2
VAV1,BI_179.1 [Hypogammaglobulinemia NOS],0.091,0,0.0,0.0,0.547,0.0,0.0,0.0,0.0,1.989,2.54,0.13,0.112,0.99,3
KDR,GE_961.1 [Phakomatoses],0.091,1,2.0,0.0,0.0,0.0,0.0,0.0,0.025,1.966,2.953,0.652,0.249,0.902,3
BMP4,GE_973.5 [Huntington's disease],0.091,0,0.0,0.0,0.0,0.0,0.0,0.0,0.274,2.684,0.146,0.107,0.042,,2
GNE,GE_972.9 [Muscular dystrophy],0.091,0,0.0,0.0,0.871,0.0,0.0,0.504,0.053,2.144,0.367,0.288,0.139,0.955,4
RPS23,GU_580.1 [Acute nephritic syndrome],0.091,1,1.0,0.0,0.0,0.0,0.0,0.0,0.0,2.846,0.062,,,0.302,2
FN1,GE_961.1 [Phakomatoses],0.091,0,0.0,0.0,0.0,0.0,0.0,0.0,0.108,1.916,3.13,0.643,0.51,0.914,3
SNAP25,CV_433.3 [Cerebrovascular insufficiency],0.091,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,1.986,0.116,0.051,0.086,0.224,3
YPEL5,CV_416.8 [Pre-excitation syndrome [Anomalous atrioventricular excitation]],0.091,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.775,0.058,,,0.269,2
NOS1,DE_663.2 [Pemphigoid],0.091,0,0.0,0.0,0.0,0.0,0.0,0.0,0.68,1.872,3.388,0.546,0.55,,2
NRXN3,CV_414.1 [Hypertrophic cardiomyopathy],0.091,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,4.332,2.483,0.387,0.403,0.207,3
TLR8,MS_705.2 [Juvenile rheumatoid arthritis [JRA/JIA]],0.091,0,0.0,0.043,0.0,0.0,0.0,0.0,0.313,2.741,4.088,,0.062,,3
PIK3R1,BI_179.1 [Hypogammaglobulinemia NOS],0.091,0,0.0,0.0,0.837,0.0,0.0,0.503,0.024,3.61,1.793,0.09,1.569,0.993,4
FNDC3B,SO_369.62 [Keratoconus],0.091,0,0.0,0.0,0.644,0.396,0.0,0.0,0.051,2.458,3.475,0.188,0.155,0.284,4
WNT5A,DE_663.2 [Pemphigoid],0.091,0,0.0,0.0,0.0,0.0,0.0,0.0,0.114,2.738,0.109,0.153,0.113,,2
RPS26,BI_179.1 [Hypogammaglobulinemia NOS],0.091,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.556,0.068,0.027,,0.298,2
SCN3A,NS_343.6 [Multi-system degeneration of the autonomic nervous system*],0.091,1,3.0,0.0,0.0,0.0,0.0,0.0,0.024,1.985,4.727,2.403,0.147,,2
POLR1C,GE_963.1 [Lipid storage disorders],0.091,0,0.0,0.0,0.884,0.0,0.0,0.402,0.072,,2.861,0.196,0.102,0.926,4
HMGA1,CV_438.41 [Aortic dissection],0.091,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.054,,,0.295,1
VWF,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.091,0,0.0,0.0,0.866,0.0,0.0,0.0,0.141,2.651,3.191,1.275,0.363,0.966,4
ECEL1,GE_972.2 [Hereditary ataxia],0.091,0,0.0,0.112,0.547,0.0,0.0,0.0,0.03,1.335,4.719,0.451,0.31,0.359,5
DNAJC13,GE_972.2 [Hereditary ataxia],0.091,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,1.848,2.705,0.262,0.353,0.942,3
SYK,MS_727.5 [Cyst of bone],0.091,0,0.0,0.0,0.0,0.0,0.0,0.0,0.216,2.591,2.144,0.241,0.225,,2
ROCK2,DE_669.2 [Behcet's syndrome],0.091,0,0.0,0.0,0.0,0.0,0.0,0.0,0.109,1.884,0.175,0.18,0.098,,2
HTR2C,NS_333.4 [Circadian rhythm sleep disorder],0.091,1,4.0,0.0,0.0,0.0,0.0,0.0,0.021,2.573,1.252,,0.035,0.429,3
ZC3H12A,MS_727.5 [Cyst of bone],0.091,0,0.0,0.0,0.0,0.0,0.0,0.0,0.14,1.656,2.656,0.169,0.197,,2
PTPRC,CV_433.3 [Cerebrovascular insufficiency],0.091,0,0.0,0.0,0.0,0.0,0.0,0.0,0.131,2.225,2.74,0.069,0.089,0.983,3
GRIN2B,CM_770.5 [Congenital osteodystrophies],0.091,0,0.0,0.0,0.0,0.0,0.0,0.0,0.036,3.252,2.715,,,0.431,3
KCNQ2,NS_341.1 [Cerebral palsy],0.091,1,3.0,0.0,0.0,0.0,0.0,0.0,0.012,2.198,1.781,0.112,0.11,0.988,3
RPL9,GE_972.9 [Muscular dystrophy],0.091,1,4.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.101,0.017,,0.217,1
TIA1,NS_323.3 [Motor neuron disease],0.091,0,0.0,0.0,0.864,0.0,0.0,0.0,0.098,,1.909,0.439,0.177,0.988,4
FLT1,NS_323.3 [Motor neuron disease],0.091,1,1.0,0.0,0.0,0.0,0.34,0.0,0.076,3.365,2.444,0.216,0.362,0.277,4
SPTB,CM_770.5 [Congenital osteodystrophies],0.091,0,0.0,0.0,0.0,0.0,0.418,0.0,0.018,,3.346,1.283,0.307,0.217,4
FGFR3,MS_700.3 [Systemic sclerosis],0.091,1,4.0,0.0,0.0,0.0,0.0,0.0,0.134,1.758,3.792,3.221,0.494,,2
EPB42,GE_970.61 [Hereditary spherocytosis],0.091,0,0.0,0.0,0.0,0.0,0.285,0.76,0.16,1.402,3.184,2.861,2.064,,4
PLXNA4,SO_386.5 [Color vision deficiencies],0.091,0,0.0,0.0,0.0,0.0,0.0,0.0,0.106,2.676,1.75,0.366,0.143,0.383,3
PAX8,CM_772.2 [Congenital hypothyroidism],0.091,0,0.0,0.0,0.0,0.0,0.0,0.699,0.252,2.366,2.753,3.118,0.107,,3
GNAS,MS_727.3 [Osteitis deformans [Paget's disease of bone]],0.091,0,0.0,0.0,0.0,0.0,0.0,0.0,0.086,2.709,0.386,0.139,0.09,,2
UBA52,BI_179.1 [Hypogammaglobulinemia NOS],0.091,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.09,,,0.299,1
CD44,GU_580.1 [Acute nephritic syndrome],0.091,0,0.0,0.0,0.426,0.0,0.0,0.0,0.086,1.927,2.967,0.203,1.29,0.988,4
RPS29,EM_208.1 [Hypoparathyroidism],0.091,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.136,0.069,,,0.206,2
RPL18A,GE_972.9 [Muscular dystrophy],0.091,1,4.0,0.0,0.0,0.0,0.0,0.0,0.0,,3.36,,,0.288,2
DYNC1H1,NS_341.1 [Cerebral palsy],0.091,0,0.0,0.0,0.547,0.0,0.264,0.0,0.021,,3.929,0.387,0.343,0.975,5
HTR2C,"MB_280.4 [Sedative, hypnotic, or anxiolytic related disorders]",0.091,1,4.0,0.0,0.0,0.0,0.0,0.0,0.064,2.276,2.961,,0.03,,2
MAP3K4,NS_339.2 [Myotonic disorders],0.091,0,0.0,0.0,0.0,0.0,0.0,0.0,0.334,1.886,1.869,0.198,0.122,,2
NARS2,NS_341.1 [Cerebral palsy],0.091,0,0.0,0.0,0.547,0.0,0.0,0.0,0.015,3.581,2.076,0.078,0.154,0.974,4
F8,GI_540.11 [Autoimmune hepatitis],0.091,0,0.0,0.0,0.0,0.0,0.0,0.0,0.178,,4.983,4.482,0.165,,2
THBD,NS_340.3 [Inflammatory and immune myopathies],0.091,0,0.0,0.021,0.0,0.0,0.0,0.0,0.018,2.361,2.822,0.029,0.026,,3
TFG,NS_323.3 [Motor neuron disease],0.091,0,0.0,0.0,0.732,0.0,0.0,0.0,0.123,,1.899,0.219,0.206,0.942,4
LONP1,NS_323.3 [Motor neuron disease],0.091,0,0.0,0.0,0.0,0.0,0.0,0.0,0.017,,2.669,0.554,0.417,0.293,3
TMEM67,SO_380.3 [Optic atrophy],0.091,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.981,0.115,0.265,0.982,1
SRC,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.091,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,1.857,0.121,0.068,0.169,0.992,3
HTT,NS_341.1 [Cerebral palsy],0.091,0,0.0,0.0,0.0,0.0,0.0,0.129,0.03,,2.861,0.501,0.176,0.98,4
PPARG,CV_414.1 [Hypertrophic cardiomyopathy],0.091,0,0.0,0.0,0.0,0.0,0.0,0.0,0.351,3.035,0.251,0.179,0.165,0.977,3
COL9A2,CM_770.5 [Congenital osteodystrophies],0.091,0,0.0,0.0,0.841,0.0,0.334,0.745,0.044,1.828,2.003,0.109,0.194,0.844,5
EXT1,GU_580.1 [Acute nephritic syndrome],0.091,0,0.0,0.0,0.0,0.0,0.0,0.0,0.043,2.726,2.716,0.205,0.145,0.263,3
KCNA4,NS_338.1 [Myasthenia gravis],0.091,1,4.0,0.0,0.0,0.0,0.0,0.0,0.101,3.123,3.467,,0.097,,2
TNFRSF13B,BI_179.1 [Hypogammaglobulinemia NOS],0.091,0,0.0,0.0,0.887,0.0,0.0,0.0,0.068,,2.502,2.512,2.342,0.989,4
MARS2,NS_341.1 [Cerebral palsy],0.091,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.348,0.232,0.176,0.99,1
DRD1,GE_978.22 [Ehler's Danlos syndrome],0.091,0,0.0,0.0,0.0,0.0,0.0,0.0,0.152,2.758,0.261,0.073,0.069,,2
FKBP5,GE_973.5 [Huntington's disease],0.091,0,0.0,0.0,0.0,0.0,0.0,0.0,0.612,,0.176,0.065,0.052,,1
GUCY2D,SO_386.5 [Color vision deficiencies],0.091,0,0.0,0.0,0.0,0.0,0.269,0.151,0.0,,2.891,1.749,0.178,1.0,4
ROCK2,GU_580.51 [Focal and segmental glomerular lesions*],0.091,0,0.0,0.0,0.0,0.0,0.0,0.0,0.426,1.729,1.998,0.197,1.971,,2
CEP290,GE_976.5 [Polycystic kidney disease],0.091,0,0.0,0.0,0.0,0.0,0.318,0.527,0.146,,2.768,0.404,0.107,,4
TRIO,CV_433.3 [Cerebrovascular insufficiency],0.09,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,1.896,2.864,0.581,0.405,0.253,3
NDUFA5,GE_963.1 [Lipid storage disorders],0.09,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.627,0.121,0.051,0.029,0.992,2
ANK2,MB_302.1 [Speech and language developmental delay],0.09,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.341,2.889,0.458,0.17,0.916,3
MT-ND6,GE_972.2 [Hereditary ataxia],0.09,1,4.0,0.0,0.0,0.0,0.0,0.37,0.015,,,,,,2
HIF1A,MB_302.1 [Speech and language developmental delay],0.09,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.993,3.629,0.715,1.369,0.99,2
DMD,NS_339.2 [Myotonic disorders],0.09,0,0.0,0.0,0.0,0.0,0.355,0.0,0.198,2.719,2.146,0.177,0.048,,3
SEC61A1,BI_179.1 [Hypogammaglobulinemia NOS],0.09,0,0.0,0.0,0.547,0.0,0.0,0.0,0.042,2.259,0.102,0.046,0.072,0.247,4
SUB1,CM_750.16 [Arnold-Chiari syndrome*],0.09,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.068,0.018,0.014,0.254,1
CLCN2,EM_211.1 [Adrenal hyperfunction],0.09,0,0.0,0.0,0.825,0.0,0.345,0.0,0.071,,3.13,0.419,0.297,,4
IMPDH1,SO_380.3 [Optic atrophy],0.09,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.097,1.102,0.186,0.995,2
HDAC9,GE_973.5 [Huntington's disease],0.09,1,2.0,0.0,0.0,0.0,0.0,0.0,0.482,2.728,2.904,0.103,0.089,,2
ATP13A3,GE_963.1 [Lipid storage disorders],0.09,0,0.0,0.0,0.0,0.0,0.262,0.0,0.091,2.74,3.447,3.216,0.132,0.037,4
GSK3B,NS_333.4 [Circadian rhythm sleep disorder],0.09,1,4.0,0.0,0.0,0.0,0.0,0.0,0.152,1.869,0.142,,0.082,0.982,3
SSBP3,CV_413.41 [Pulmonary valve stenosis],0.09,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.679,0.153,,,0.18,2
RPL17,GE_972.9 [Muscular dystrophy],0.09,1,4.0,0.0,0.0,0.0,0.0,0.0,0.0,1.975,0.077,,,0.178,2
IMPDH1,SO_369.62 [Keratoconus],0.09,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.736,3.531,2.695,0.207,1.0,2
GRIN2A,CV_433.3 [Cerebrovascular insufficiency],0.09,1,3.0,0.0,0.0,0.0,0.0,0.0,0.094,2.562,0.385,0.28,0.184,0.229,3
RPS26,BI_162.1 [Constitutional (hereditary) aplastic anemia],0.09,0,0.0,0.0,0.886,0.0,0.0,0.838,0.187,,0.054,0.017,,,2
VEGFA,RE_477.2 [Hypersensitivity pneumonitis],0.09,0,0.0,0.0,0.0,0.0,0.0,0.0,0.169,2.294,3.391,2.599,0.101,,2
ALDH7A1,GE_963.1 [Lipid storage disorders],0.09,0,0.0,0.0,0.0,0.0,0.0,0.37,0.015,,0.156,0.132,0.145,0.76,3
PDGFC,DE_663.2 [Pemphigoid],0.09,0,0.0,0.0,0.0,0.0,0.0,0.0,0.097,2.088,0.238,0.115,0.084,,2
SPTAN1,NS_341.1 [Cerebral palsy],0.09,0,0.0,0.0,0.825,0.0,0.0,0.0,0.072,1.344,2.739,0.111,0.327,0.917,4
PRDM1,MS_700.3 [Systemic sclerosis],0.09,0,0.0,0.0,0.0,0.259,0.0,0.0,0.083,2.653,2.405,1.21,0.227,,2
DRD4,MB_305.1 [Tics and tic disorders],0.09,1,4.0,0.0,0.0,0.0,0.0,0.0,0.163,1.353,3.841,0.164,0.064,,2
DDRGK1,CM_770.5 [Congenital osteodystrophies],0.09,0,0.0,0.0,0.684,0.0,0.0,0.0,0.046,1.343,0.128,0.254,0.108,0.583,4
RPL31,BI_179.1 [Hypogammaglobulinemia NOS],0.09,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.994,0.064,,,0.181,2
COL3A1,RE_484.1 [Spontaneous pneumothorax],0.09,0,0.0,0.0,0.0,0.0,0.0,0.0,0.046,2.545,2.712,0.311,0.68,0.996,3
NR3C1,GE_972.1 [Hereditary neuropathy],0.09,1,3.0,0.0,0.0,0.0,0.0,0.0,0.067,2.303,2.963,3.748,1.418,,2
MSH6,NS_344.2 [Benign intracranial hypertension],0.09,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.542,2.873,0.677,0.267,0.988,2
DNM1,GE_972.2 [Hereditary ataxia],0.09,0,0.0,0.0,0.0,0.0,0.33,0.29,0.026,,3.112,0.652,0.163,0.905,5
NKX2-5,CM_763.31 [Ventricular septal defect],0.09,0,0.0,0.0,0.875,0.0,0.421,0.402,0.21,,1.127,0.032,0.043,0.889,4
CSRP3,CV_416.8 [Pre-excitation syndrome [Anomalous atrioventricular excitation]],0.09,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.59,0.223,0.116,0.962,1
HTR2C,GE_961.1 [Phakomatoses],0.09,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,2.635,2.367,,0.04,0.281,3
ABCA4,SO_386.5 [Color vision deficiencies],0.09,0,0.0,0.0,0.0,0.0,0.276,0.452,0.029,2.254,2.655,0.115,0.204,1.0,5
VAV1,GI_540.11 [Autoimmune hepatitis],0.09,0,0.0,0.0,0.0,0.0,0.0,0.0,0.14,2.589,1.887,0.128,0.166,,2
KLF15,CV_414.1 [Hypertrophic cardiomyopathy],0.09,0,0.0,0.0,0.0,0.0,0.0,0.0,0.111,1.828,2.661,0.184,0.216,0.172,3
GAS1,SO_369.62 [Keratoconus],0.09,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.417,3.085,0.025,0.04,0.173,3
SPIN1,EM_209.4 [Diabetes insipidus],0.09,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.585,0.051,0.023,,0.213,2
RPA1,BI_162.1 [Constitutional (hereditary) aplastic anemia],0.09,0,0.0,0.0,0.0,0.0,0.452,0.0,0.082,,0.208,0.218,0.1,,2
EGR2,MS_700.3 [Systemic sclerosis],0.09,0,0.0,0.0,0.0,0.0,0.0,0.0,0.226,,0.346,0.081,0.139,,1
UFM1,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.09,0,0.0,0.0,0.0,0.0,0.0,0.814,0.036,2.642,0.085,0.085,0.038,0.304,4
INPP5E,SO_369.62 [Keratoconus],0.09,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.471,0.356,0.228,0.959,2
COL3A1,CM_770.5 [Congenital osteodystrophies],0.09,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,3.021,2.304,0.092,0.144,0.889,3
TBP,GE_972.2 [Hereditary ataxia],0.09,0,0.0,0.0,0.0,0.0,0.354,0.0,0.068,1.939,2.495,0.161,0.116,0.986,4
BCL11A,GE_970.2 [Thalassemia],0.09,1,2.0,0.0,0.0,0.0,0.464,0.281,0.051,2.82,0.791,0.147,0.242,,4
MMP14,GE_961.1 [Phakomatoses],0.09,0,0.0,0.0,0.0,0.0,0.0,0.0,0.079,1.962,2.085,0.329,0.152,0.867,3
EIF2AK3,GI_540.11 [Autoimmune hepatitis],0.09,0,0.0,0.0,0.0,0.0,0.0,0.0,0.128,,4.14,2.714,0.251,,2
NOTCH1,BI_179.1 [Hypogammaglobulinemia NOS],0.09,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.78,3.582,0.346,0.399,0.982,2
CDK5,GE_972.1 [Hereditary neuropathy],0.09,0,0.0,0.0,0.0,0.0,0.0,0.0,0.097,,0.112,0.099,0.129,,1
JMJD1C,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.09,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,1.995,2.931,0.838,0.285,0.177,3
SOST,GE_978.3 [Osteochondrodysplasias],0.09,1,3.0,0.0,0.0,0.0,0.417,0.0,0.146,1.355,0.103,0.085,0.062,,3
MT-ATP6,CV_414.1 [Hypertrophic cardiomyopathy],0.09,0,0.0,0.0,0.0,0.0,0.0,0.407,0.015,,,,,,2
TP53BP1,GE_972.2 [Hereditary ataxia],0.09,0,0.0,0.0,0.0,0.0,0.0,0.0,0.106,1.525,3.668,1.127,0.355,0.675,3
TSC1,GE_972.2 [Hereditary ataxia],0.09,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.94,2.849,0.261,0.238,0.902,3
SEMA7A,MS_700.3 [Systemic sclerosis],0.09,0,0.0,0.0,0.0,0.0,0.0,0.0,0.244,1.332,2.552,0.215,0.182,,2
ZBTB16,MS_727.5 [Cyst of bone],0.09,0,0.0,0.0,0.0,0.0,0.459,0.0,0.03,3.57,1.952,0.373,0.178,,3
ATXN1,NS_343.6 [Multi-system degeneration of the autonomic nervous system*],0.09,0,0.0,0.0,0.0,0.0,0.0,0.0,0.205,2.605,0.312,0.14,0.064,,2
UBE2E3,CM_763.31 [Ventricular septal defect],0.09,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.6,0.064,,,0.223,2
CDH2,GE_977.6 [Congenital cutaneous mastocytosis*],0.09,0,0.0,0.0,0.0,0.0,0.0,0.0,0.192,2.783,0.142,0.17,0.076,,2
WNT5A,MS_700.3 [Systemic sclerosis],0.09,0,0.0,0.0,0.0,0.0,0.0,0.0,0.231,2.241,2.677,0.142,0.127,,2
KIF5B,MS_727.5 [Cyst of bone],0.09,0,0.0,0.0,0.0,0.0,0.0,0.201,0.088,1.623,2.434,0.238,0.276,,3
HNRNPA1,NS_323.3 [Motor neuron disease],0.089,0,0.0,0.0,0.861,0.0,0.0,0.554,0.079,,0.189,0.168,0.112,0.993,3
IRF4,MS_727.5 [Cyst of bone],0.089,0,0.0,0.0,0.0,0.0,0.0,0.0,0.777,2.731,2.574,0.101,0.133,,2
ERBB4,NS_323.3 [Motor neuron disease],0.089,0,0.0,0.0,0.885,0.0,0.0,0.703,0.088,3.812,2.183,1.219,0.818,0.933,4
DRD3,MB_305.1 [Tics and tic disorders],0.089,1,4.0,0.0,0.0,0.0,0.0,0.0,0.102,,0.111,0.116,0.09,,1
JAG1,CM_770.5 [Congenital osteodystrophies],0.089,0,0.0,0.0,0.0,0.0,0.0,0.0,0.099,3.092,1.95,0.205,1.41,0.876,3
AQP2,GU_580.1 [Acute nephritic syndrome],0.089,0,0.0,0.0,0.0,0.0,0.414,0.0,0.082,,0.114,0.173,0.115,0.263,3
TSC2,GE_978.3 [Osteochondrodysplasias],0.089,0,0.0,0.0,0.0,0.0,0.393,0.0,0.03,,5.81,2.938,0.321,,3
FAS,GI_542.8 [Biliary cirrhosis],0.089,0,0.0,0.0,0.0,0.0,0.354,0.0,0.125,2.776,0.272,,0.073,,3
PNPLA6,NS_323.3 [Motor neuron disease],0.089,0,0.0,0.0,0.532,0.0,0.0,0.161,0.055,,2.487,0.244,0.949,0.179,4
ITSN1,CV_414.1 [Hypertrophic cardiomyopathy],0.089,0,0.0,0.0,0.0,0.0,0.0,0.0,0.043,2.287,2.525,0.203,0.161,0.216,3
PRKCB,MS_712.51 [Hypermobility syndrome],0.089,1,3.0,0.0,0.0,0.0,0.0,0.0,0.612,3.444,1.893,0.127,0.135,,2
RPSA,NS_333.4 [Circadian rhythm sleep disorder],0.089,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.311,0.099,,,0.314,2
OGDH,GE_972.2 [Hereditary ataxia],0.089,0,0.0,0.0,0.547,0.0,0.0,0.0,0.102,1.937,2.783,1.425,0.539,0.934,4
DST,NS_323.3 [Motor neuron disease],0.089,0,0.0,0.0,0.0,0.0,0.295,0.0,0.012,1.99,4.292,0.203,0.23,0.162,4
VEGFA,MS_700.42 [Dermatomyositis],0.089,0,0.0,0.0,0.0,0.0,0.0,0.0,0.716,2.299,0.132,0.109,0.071,,2
ATXN3,GE_972.2 [Hereditary ataxia],0.089,0,0.0,0.0,0.0,0.0,0.0,0.554,0.17,2.137,2.163,0.252,2.106,0.99,4
TNIK,CV_414.1 [Hypertrophic cardiomyopathy],0.089,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,1.973,4.012,1.879,0.464,0.068,3
PTGS2,NS_340.3 [Inflammatory and immune myopathies],0.089,1,4.0,0.0,0.0,0.0,0.0,0.0,0.043,1.983,0.057,0.039,0.054,,2
OTUD4,NS_328.13 [Frontotemporal dementia [FTD]],0.089,0,0.0,0.0,0.0,0.0,0.0,0.0,0.249,3.773,1.126,0.093,0.074,,2
PJA1,GE_972.2 [Hereditary ataxia],0.089,0,0.0,0.0,0.0,0.0,0.0,0.0,0.09,2.405,1.861,,0.032,0.362,3
MAF,CM_751.213 [Congenital cataract],0.089,0,0.0,0.0,0.825,0.0,0.805,0.496,0.025,3.094,0.427,0.091,2.283,0.973,5
LGI1,NS_338.1 [Myasthenia gravis],0.089,0,0.0,0.0,0.0,0.0,0.0,0.0,0.072,2.422,0.229,0.186,0.134,,2
SLC40A1,CV_433.3 [Cerebrovascular insufficiency],0.089,0,0.0,0.0,0.0,0.0,0.0,0.0,0.198,2.189,0.17,0.104,0.122,0.645,3
COL3A1,CV_438.41 [Aortic dissection],0.089,0,0.0,0.0,0.635,0.0,0.0,0.281,0.072,1.99,3.028,0.183,4.203,0.977,4
TBX2,CM_763.31 [Ventricular septal defect],0.089,0,0.0,0.0,0.801,0.0,0.0,0.0,0.081,2.342,2.761,0.239,0.119,0.712,4
MTOR,NS_341.1 [Cerebral palsy],0.089,0,0.0,0.0,0.0,0.0,0.0,0.0,0.077,2.329,3.482,1.424,0.216,0.992,3
FGF7,GE_976.5 [Polycystic kidney disease],0.089,0,0.0,0.0,0.0,0.0,0.0,0.0,0.162,3.19,0.116,0.065,0.102,,2
FOXP3,DE_663.2 [Pemphigoid],0.089,0,0.0,0.0,0.0,0.0,0.4,0.0,0.179,,2.299,0.076,0.06,,3
KDR,MS_704.1 [Polyarteritis nodosa and related conditions],0.089,0,0.0,0.0,0.0,0.0,0.0,0.0,0.285,3.109,1.666,0.601,0.167,,2
VEGFA,CV_433.3 [Cerebrovascular insufficiency],0.089,1,0.5,0.0,0.0,0.0,0.0,0.0,0.12,3.564,0.226,0.164,0.1,0.992,3
RPSA,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.089,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.913,0.119,,,0.286,2
OR2W3,SO_386.6 [Night blindness],0.089,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.854,0.248,0.075,0.113,0.957,2
COX4I1,CV_414.1 [Hypertrophic cardiomyopathy],0.089,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.043,0.114,1.574,0.995,2
AGFG1,GU_580.1 [Acute nephritic syndrome],0.089,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.45,1.755,0.166,0.138,0.105,3
VEGFA,GU_580.51 [Focal and segmental glomerular lesions*],0.089,0,0.0,0.0,0.0,0.0,0.0,0.0,0.169,2.759,0.14,0.122,0.094,,2
AR,BI_162.1 [Constitutional (hereditary) aplastic anemia],0.089,1,4.0,0.0,0.0,0.0,0.0,0.0,0.176,2.76,2.032,,0.009,,2
MYH10,GE_963.1 [Lipid storage disorders],0.089,0,0.0,0.0,0.0,0.0,0.302,0.0,0.012,2.315,1.876,0.191,1.177,0.038,4
GNA11,EM_208.1 [Hypoparathyroidism],0.089,0,0.0,0.0,0.745,0.0,0.0,0.803,0.08,,2.618,0.055,0.107,0.976,4
GUCA1A,SO_386.5 [Color vision deficiencies],0.089,0,0.0,0.0,0.0,0.0,0.0,0.806,0.0,,0.269,0.122,0.054,0.999,2
PIK3CG,BI_179.7 [Common variable immunodeficiency [CVID]],0.089,0,0.0,0.0,0.0,0.0,0.558,0.0,0.499,2.913,0.089,0.129,0.066,,3
EPHB1,NS_323.3 [Motor neuron disease],0.089,0,0.0,0.0,0.0,0.0,0.0,0.0,0.024,1.649,4.916,1.072,0.365,0.316,3
SCN5A,GE_972.2 [Hereditary ataxia],0.089,1,2.0,0.0,0.0,0.0,0.284,0.0,0.012,1.88,3.279,1.189,0.448,0.991,4
TDP2,GE_972.2 [Hereditary ataxia],0.089,0,0.0,0.0,0.832,0.0,0.0,0.626,0.065,,0.764,0.264,0.162,0.504,3
CREB3L1,GE_978.3 [Osteochondrodysplasias],0.089,0,0.0,0.0,0.0,0.0,0.291,0.557,0.443,1.706,3.816,0.101,0.075,,4
RPS6KB1,CV_414.1 [Hypertrophic cardiomyopathy],0.089,0,0.0,0.0,0.772,0.0,0.0,0.202,0.396,1.777,0.399,0.05,0.137,0.458,4
JAG1,GE_972.2 [Hereditary ataxia],0.089,0,0.0,0.0,0.0,0.0,0.433,0.0,0.033,3.657,2.75,1.143,0.226,0.864,4
SRC,GU_580.1 [Acute nephritic syndrome],0.089,0,0.0,0.0,0.0,0.0,0.0,0.0,0.025,1.71,0.108,0.065,0.154,0.992,3
PRPF8,SO_386.5 [Color vision deficiencies],0.089,0,0.0,0.0,0.0,0.0,0.394,0.0,0.0,1.888,1.53,0.096,0.167,0.984,3
VEGFA,DE_669.2 [Behcet's syndrome],0.089,0,0.0,0.0,0.0,0.0,0.0,0.0,0.597,2.268,0.119,0.102,0.058,,2
FOXO1,CV_433.3 [Cerebrovascular insufficiency],0.089,0,0.0,0.0,0.0,0.0,0.0,0.0,0.166,3.518,2.302,0.039,0.113,0.96,3
GRIN2B,GE_972.1 [Hereditary neuropathy],0.089,0,0.0,0.0,0.0,0.0,0.0,0.0,0.085,2.142,3.046,,,,2
TNIP1,NS_323.3 [Motor neuron disease],0.089,0,0.0,0.0,0.0,0.206,0.0,0.129,0.064,1.572,2.352,0.29,0.281,0.609,4
SOD1,CM_751.213 [Congenital cataract],0.089,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.581,0.066,0.059,0.957,1
TTC21B,SO_386.6 [Night blindness],0.089,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.327,2.89,0.903,0.247,0.984,2
PKP2,CV_414.1 [Hypertrophic cardiomyopathy],0.089,0,0.0,0.0,0.864,0.0,0.329,0.087,0.094,2.935,2.013,0.498,0.285,0.961,5
STAT1,GI_542.8 [Biliary cirrhosis],0.089,0,0.0,0.0,0.0,0.223,0.0,0.0,0.247,2.995,1.665,1.197,0.124,,2
EPAS1,CV_414.1 [Hypertrophic cardiomyopathy],0.089,0,0.0,0.0,0.0,0.0,0.504,0.0,0.1,4.157,3.077,0.485,0.272,0.714,4
EPHA4,GE_973.5 [Huntington's disease],0.089,0,0.0,0.0,0.0,0.0,0.0,0.0,0.061,2.63,0.068,0.108,0.09,,2
NR3C1,GI_540.11 [Autoimmune hepatitis],0.089,1,4.0,0.0,0.0,0.0,0.0,0.0,0.062,2.953,1.912,0.212,0.164,,2
ANKHD1-EIF4EBP3,CM_750.16 [Arnold-Chiari syndrome*],0.089,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.755,0.048,0.031,,0.286,2
HRAS,GE_961.1 [Phakomatoses],0.089,0,0.0,0.0,0.0,0.0,0.0,0.725,0.13,,0.124,0.148,0.104,0.986,3
YPEL5,SO_365.3 [Exophthalmos [Proptosis]],0.089,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.069,0.067,,,0.179,2
WFS1,SO_380.3 [Optic atrophy],0.089,0,0.0,0.0,0.899,0.0,0.0,0.0,0.09,1.777,5.722,0.155,0.601,0.892,4
PPARD,MS_700.3 [Systemic sclerosis],0.089,1,2.0,0.0,0.0,0.0,0.0,0.0,0.339,,2.038,0.133,0.161,,2
PRNP,EM_249.1 [Cerebral amyloid angiopathy*],0.089,0,0.0,0.0,0.0,0.0,0.272,0.729,0.127,1.892,0.135,0.157,0.067,,4
IREB2,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.089,0,0.0,0.0,0.0,0.0,0.331,0.0,0.024,1.963,1.051,0.1,0.21,0.127,4
HSPG2,MB_296.2 [Schizoid personality disorder],0.088,0,0.0,0.0,0.0,0.0,0.0,0.0,0.182,1.335,4.252,0.326,0.116,,2
CPEB4,CV_433.3 [Cerebrovascular insufficiency],0.088,0,0.0,0.0,0.0,0.0,0.0,0.0,0.041,2.011,1.71,0.144,0.131,0.18,3
CLCN1,GE_972.2 [Hereditary ataxia],0.088,0,0.0,0.0,0.684,0.0,0.354,0.0,0.036,3.553,2.757,0.184,0.323,0.851,5
LCA5,NS_341.1 [Cerebral palsy],0.088,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.965,2.797,0.287,1.516,0.98,2
PTGS2,GE_964.3 [Glycogen storage disease],0.088,1,2.0,0.0,0.0,0.0,0.329,0.0,0.037,3.213,0.126,0.091,0.101,,3
VPS35,GE_972.2 [Hereditary ataxia],0.088,0,0.0,0.0,0.0,0.0,0.286,0.0,0.012,2.408,1.309,0.116,0.152,0.956,4
NPHS1,GU_580.52 [Diffuse membranous glomerulonephritis],0.088,0,0.0,0.0,0.0,0.0,0.588,0.505,0.272,1.608,3.273,0.489,1.476,,4
NFKB1,CV_438.41 [Aortic dissection],0.088,0,0.0,0.0,0.0,0.0,0.0,0.0,0.116,2.193,2.543,0.595,0.165,0.895,3
STS,GE_977.1 [Congenital ichthyosis],0.088,0,0.0,0.0,0.0,0.0,0.0,0.852,0.071,2.9,1.823,0.133,2.998,0.988,4
CD5,BI_179.1 [Hypogammaglobulinemia NOS],0.088,0,0.0,0.0,0.426,0.0,0.0,0.0,0.091,1.313,2.514,0.077,0.117,0.959,4
GCNT2,CM_751.213 [Congenital cataract],0.088,0,0.0,0.0,0.779,0.0,0.0,0.655,0.025,1.979,1.987,0.247,0.142,0.944,4
GRIA3,CM_770.5 [Congenital osteodystrophies],0.088,0,0.0,0.0,0.0,0.0,0.0,0.0,0.061,2.777,2.215,0.037,0.029,0.297,3
SCN11A,NS_323.3 [Motor neuron disease],0.088,1,4.0,0.0,0.0,0.0,0.0,0.121,0.012,1.595,2.28,0.656,0.593,0.073,4
MMEL1,GI_542.8 [Biliary cirrhosis],0.088,0,0.0,0.0,0.182,0.478,0.0,0.0,0.079,1.311,3.123,0.438,0.151,,3
BBS10,SO_386.6 [Night blindness],0.088,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.51,4.139,0.471,0.102,0.989,2
ACTN2,CV_414.1 [Hypertrophic cardiomyopathy],0.088,0,0.0,0.0,0.877,0.0,0.0,0.593,0.528,1.486,3.088,0.817,0.117,0.959,4
NRG1,GE_972.2 [Hereditary ataxia],0.088,0,0.0,0.0,0.0,0.0,0.0,0.201,0.012,3.683,2.146,0.025,0.991,0.921,4
BRCA2,CM_763.13 [Patent ductus arteriosus],0.088,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,3.565,0.435,1.625,0.979,2
IFT81,SO_386.6 [Night blindness],0.088,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.174,3.414,1.611,0.173,0.966,2
RPSA,SO_386.6 [Night blindness],0.088,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.098,3.78,,,0.181,2
ETS1,MS_727.5 [Cyst of bone],0.088,0,0.0,0.0,0.0,0.0,0.0,0.0,0.346,2.397,2.302,0.125,0.164,,2
RPS26,EM_209.4 [Diabetes insipidus],0.088,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.528,0.055,0.031,,0.148,2
OLFM1,MB_305.1 [Tics and tic disorders],0.088,0,0.0,0.0,0.0,0.0,0.0,0.0,0.079,5.455,2.958,2.858,0.077,,2
UROD,GE_966.2 [Disorders of porphyrin metabolism],0.088,0,0.0,0.0,0.0,0.0,0.0,0.892,0.103,,3.27,3.736,4.234,,3
VEGFA,MS_704.2 [Wegener's granulomatosis],0.088,0,0.0,0.0,0.0,0.0,0.0,0.0,0.163,2.572,0.173,0.134,0.088,,2
FOXRED1,NS_341.1 [Cerebral palsy],0.088,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,3.507,0.219,1.46,0.95,2
GRM5,GE_961.1 [Phakomatoses],0.088,1,2.0,0.0,0.0,0.0,0.0,0.0,0.231,1.464,2.743,0.339,0.227,0.138,3
SLC6A3,MB_287.2 [Schizoaffective disorder],0.088,1,4.0,0.0,0.0,0.0,0.0,0.0,0.087,,1.169,0.212,0.149,,1
CADM1,MB_293.1 [Anorexia nervosa],0.088,0,0.0,0.0,0.0,0.691,0.0,0.0,0.061,2.996,2.852,0.104,0.094,,2
APP,CV_433.3 [Cerebrovascular insufficiency],0.088,1,2.0,0.0,0.0,0.0,0.0,0.402,0.174,3.228,2.84,0.445,0.228,0.924,4
RPL27A,MB_302.1 [Speech and language developmental delay],0.088,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.325,0.097,,,0.24,2
GLRX5,GE_963.1 [Lipid storage disorders],0.088,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.421,0.51,0.11,0.042,0.997,2
HTT,NS_323.3 [Motor neuron disease],0.088,0,0.0,0.0,0.0,0.0,0.0,0.0,0.088,1.783,2.683,1.618,1.157,0.989,3
ANKS1B,GE_963.1 [Lipid storage disorders],0.088,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,3.382,0.193,0.2,0.14,0.134,3
DNMT3A,GI_516.1 [Pyloric stenosis],0.088,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.957,2.655,0.546,0.479,0.963,2
ERCC2,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.088,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.769,0.266,0.477,0.954,2
CYP4V2,SO_369.62 [Keratoconus],0.088,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.839,3.304,1.72,2.284,0.968,2
GATA2,GE_961.1 [Phakomatoses],0.088,0,0.0,0.0,0.0,0.0,0.0,0.0,0.024,1.723,2.631,0.237,0.136,0.915,3
NR1H4,GE_966.2 [Disorders of porphyrin metabolism],0.088,0,0.0,0.0,0.0,0.0,0.292,0.0,0.097,1.962,0.132,0.045,0.073,,3
HNRNPC,NS_333.4 [Circadian rhythm sleep disorder],0.088,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.946,0.076,,,0.177,2
DDAH1,CV_414.1 [Hypertrophic cardiomyopathy],0.088,0,0.0,0.0,0.0,0.0,0.476,0.0,0.128,2.79,3.035,2.321,0.198,0.087,4
IL1B,SO_369.62 [Keratoconus],0.088,0,0.0,0.0,0.536,0.0,0.0,0.0,0.685,,0.134,0.119,0.071,0.645,3
GRN,CM_770.5 [Congenital osteodystrophies],0.088,0,0.0,0.0,0.0,0.0,0.0,0.0,0.109,,2.59,0.187,0.125,0.878,3
PRNP,GE_972.2 [Hereditary ataxia],0.088,0,0.0,0.093,0.684,0.0,0.464,0.0,0.054,1.836,0.221,0.247,0.106,0.952,6
MMP13,CV_438.41 [Aortic dissection],0.088,0,0.0,0.0,0.532,0.0,0.0,0.0,0.0,3.255,2.491,0.481,0.196,0.911,3
CEP120,GE_972.2 [Hereditary ataxia],0.088,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.862,2.328,1.573,0.515,0.99,2
CFI,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.088,0,0.0,0.0,0.895,0.0,0.0,0.0,0.11,2.555,2.27,0.887,0.902,0.902,4
HK1,GE_972.9 [Muscular dystrophy],0.088,0,0.0,0.0,0.0,0.0,0.0,0.0,0.034,2.222,0.14,0.152,0.134,0.338,3
MYH2,NS_340.3 [Inflammatory and immune myopathies],0.088,0,0.0,0.0,0.882,0.0,0.0,0.623,0.045,,3.873,0.081,2.736,,3
SMAD7,MS_700.3 [Systemic sclerosis],0.088,0,0.0,0.0,0.0,0.0,0.0,0.0,0.246,3.392,1.049,0.231,0.181,,2
HMGCR,GE_972.2 [Hereditary ataxia],0.088,1,0.5,0.0,0.0,0.0,0.0,0.0,0.012,1.563,2.567,0.455,0.229,0.948,3
PLCE1,GU_580.1 [Acute nephritic syndrome],0.088,0,0.0,0.0,0.894,0.0,0.0,0.197,0.012,2.601,3.436,0.367,0.346,0.644,4
NFE2L2,GE_976.5 [Polycystic kidney disease],0.088,1,3.0,0.0,0.0,0.0,0.0,0.0,0.238,1.366,4.246,0.82,0.152,,2
REEP1,NS_341.1 [Cerebral palsy],0.088,0,0.0,0.0,0.883,0.0,0.0,0.29,0.05,1.943,0.217,0.04,0.088,1.0,4
F9,GE_972.9 [Muscular dystrophy],0.088,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.905,1.955,,0.045,0.323,3
SPIN1,CM_751.213 [Congenital cataract],0.088,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.076,0.044,,0.178,1
RPL32,GE_972.9 [Muscular dystrophy],0.088,1,4.0,0.0,0.0,0.0,0.0,0.0,0.0,2.516,0.101,,,0.303,2
IL12RB2,GU_580.1 [Acute nephritic syndrome],0.088,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.526,2.744,1.33,0.175,0.988,2
RAP1B,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.088,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.659,0.057,,3.309,0.224,2
KITLG,NS_339.2 [Myotonic disorders],0.088,0,0.0,0.0,0.0,0.0,0.0,0.0,0.474,1.806,0.066,0.079,0.048,,2
LCK,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.088,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,2.06,1.216,0.166,0.136,0.977,3
ADAMTS13,GE_971.14 [Von Willebrand's disease],0.088,0,0.0,0.0,0.0,0.0,0.62,0.0,0.141,1.992,1.425,0.099,0.115,,3
IBA57,NS_341.1 [Cerebral palsy],0.088,0,0.0,0.0,0.745,0.0,0.0,0.0,0.012,,3.539,3.385,0.125,0.989,4
REN,GU_580.51 [Focal and segmental glomerular lesions*],0.088,0,0.0,0.0,0.0,0.0,0.529,0.0,0.132,,3.329,0.147,0.111,,3
LRIT3,SO_386.6 [Night blindness],0.088,0,0.0,0.0,0.861,0.0,0.0,0.704,0.089,,3.118,0.092,0.082,0.972,4
NFE2L2,GE_966.2 [Disorders of porphyrin metabolism],0.088,0,0.0,0.0,0.0,0.0,0.259,0.0,0.464,1.741,0.437,0.158,0.04,,3
AGT,CM_772.1 [Congenital malformations of endocrine glands],0.088,0,0.0,0.0,0.0,0.0,0.358,0.0,0.114,,2.744,0.537,0.111,,3
POGLUT1,GI_542.8 [Biliary cirrhosis],0.088,0,0.0,0.0,0.0,0.236,0.0,0.0,0.284,2.094,2.097,0.288,0.873,,2
SYNGAP1,MB_302.1 [Speech and language developmental delay],0.088,0,0.0,0.0,0.0,0.0,0.0,0.393,0.015,,0.156,0.23,0.159,0.874,3
GFRA1,GE_963.1 [Lipid storage disorders],0.087,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,2.423,0.173,0.103,0.1,0.257,3
SCN5A,MB_306 [Conduct disorders],0.087,1,4.0,0.0,0.0,0.0,0.0,0.0,0.085,1.434,3.617,0.738,0.244,,2
EBF3,GE_972.2 [Hereditary ataxia],0.087,0,0.0,0.241,0.886,0.0,0.0,0.462,0.073,3.906,2.318,0.074,1.586,0.423,5
EYA1,GU_580.51 [Focal and segmental glomerular lesions*],0.087,0,0.0,0.0,0.0,0.0,0.0,0.281,0.03,2.394,0.28,0.134,0.139,,3
NDUFS7,GE_972.2 [Hereditary ataxia],0.087,1,4.0,0.0,0.547,0.0,0.0,0.0,0.0,,2.614,0.054,0.085,0.992,3
TMEM67,GU_580.1 [Acute nephritic syndrome],0.087,0,0.0,0.0,0.635,0.0,0.265,0.176,0.012,1.613,1.95,0.531,0.243,0.149,5
CAPN3,NS_340.3 [Inflammatory and immune myopathies],0.087,0,0.0,0.0,0.865,0.0,0.621,0.245,0.133,,4.064,0.104,0.057,,4
PRKCA,GI_540.11 [Autoimmune hepatitis],0.087,0,0.0,0.0,0.0,0.0,0.0,0.0,0.103,1.943,2.806,0.143,0.119,,2
CBL,GE_977.6 [Congenital cutaneous mastocytosis*],0.087,0,0.0,0.0,0.0,0.0,0.0,0.0,0.09,2.859,0.169,0.102,0.094,,2
UBE2M,CM_770.5 [Congenital osteodystrophies],0.087,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.121,0.038,,0.262,1
SLC6A4,MS_712.51 [Hypermobility syndrome],0.087,0,0.0,0.0,0.0,0.0,0.0,0.0,0.167,1.38,3.095,0.193,0.638,,2
PDGFRB,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.087,1,2.0,0.0,0.0,0.0,0.0,0.76,0.299,2.982,3.599,1.05,0.159,0.95,4
CALM2,BI_179.1 [Hypogammaglobulinemia NOS],0.087,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.871,0.051,,,0.29,2
PMS1,NS_344.2 [Benign intracranial hypertension],0.087,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,3.234,0.215,0.203,0.957,2
PTPRD,NS_333.7 [Narcolepsy],0.087,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,3.192,4.561,3.706,0.518,,2
MARCKS,NS_323.3 [Motor neuron disease],0.087,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,2.824,2.271,0.041,0.036,0.418,3
MT-ND5,SO_380.3 [Optic atrophy],0.087,0,0.0,0.0,0.0,0.0,0.0,0.844,0.218,,,,,,2
IVD,NS_341.1 [Cerebral palsy],0.087,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.03,0.138,1.558,0.978,2
SRSF1,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.087,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.053,,,0.223,1
NLRP3,DE_666.3 [Urticaria due to cold and heat],0.087,0,0.0,0.0,0.0,0.0,0.0,0.792,0.109,1.814,1.863,0.092,0.102,,3
ARNT,GE_961.1 [Phakomatoses],0.087,0,0.0,0.0,0.0,0.0,0.0,0.0,0.122,1.324,4.497,0.174,1.119,0.633,3
KCNA2,GE_972.2 [Hereditary ataxia],0.087,1,2.0,0.083,0.801,0.0,0.283,0.0,0.204,2.153,0.131,0.062,1.927,0.986,6
GANAB,GU_580.1 [Acute nephritic syndrome],0.087,0,0.0,0.0,0.0,0.0,0.0,0.58,0.091,,2.521,0.364,0.67,0.258,4
VWF,GE_972.2 [Hereditary ataxia],0.087,0,0.0,0.09,0.0,0.0,0.0,0.0,0.104,2.814,2.722,0.18,0.121,0.861,4
CDH11,MS_727.5 [Cyst of bone],0.087,0,0.0,0.0,0.0,0.0,0.0,0.0,0.119,2.288,1.28,0.134,0.293,,2
P4HA1,GU_580.1 [Acute nephritic syndrome],0.087,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,2.381,0.528,0.084,0.135,0.206,3
HNRNPC,EM_208.1 [Hypoparathyroidism],0.087,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.116,,,0.29,1
AFG3L2,GE_972.2 [Hereditary ataxia],0.087,0,0.0,0.056,0.888,0.0,0.329,0.86,0.068,2.567,2.807,0.672,1.965,0.985,6
FKBP10,GE_978.3 [Osteochondrodysplasias],0.087,0,0.0,0.0,0.0,0.0,0.0,0.718,0.227,,2.631,0.366,0.163,,3
THBS1,MS_712.51 [Hypermobility syndrome],0.087,0,0.0,0.0,0.0,0.0,0.0,0.0,0.185,2.742,2.683,,0.098,,2
NF1,NS_344.2 [Benign intracranial hypertension],0.087,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.794,3.675,1.368,0.283,0.988,2
NR3C1,MB_293.2 [Bulimia nervosa],0.087,0,0.0,0.0,0.0,0.0,0.0,0.0,0.093,2.06,3.917,0.182,0.17,,2
RPL23,GE_972.9 [Muscular dystrophy],0.087,1,4.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.16,,0.022,0.299,1
CACNA1C,NS_333.4 [Circadian rhythm sleep disorder],0.087,1,4.0,0.0,0.0,0.0,0.0,0.0,0.015,5.422,4.019,0.243,0.213,0.72,3
THBD,MS_700.42 [Dermatomyositis],0.087,0,0.0,0.021,0.0,0.0,0.0,0.0,0.059,3.228,1.781,0.041,0.054,,3
RPSA,GE_977.1 [Congenital ichthyosis],0.087,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.068,,,0.245,1
PSEN1,MB_302.1 [Speech and language developmental delay],0.087,0,0.0,0.0,0.0,0.0,0.0,0.0,0.08,2.34,1.797,0.091,0.127,0.979,3
TEK,GE_972.2 [Hereditary ataxia],0.087,0,0.0,0.0,0.0,0.0,0.0,0.0,0.292,2.694,3.049,0.245,0.234,0.955,3
GATA1,BI_162.1 [Constitutional (hereditary) aplastic anemia],0.087,0,0.0,0.0,0.841,0.0,0.557,0.771,0.253,,0.063,0.023,0.024,,3
KLF10,CV_414.1 [Hypertrophic cardiomyopathy],0.087,0,0.0,0.0,0.832,0.0,0.0,0.004,0.183,1.975,2.654,2.623,0.16,0.307,4
DAO,NS_323.3 [Motor neuron disease],0.087,0,0.0,0.0,0.869,0.0,0.0,0.489,0.094,,1.959,0.351,0.231,0.991,4
EDNRA,CV_414.1 [Hypertrophic cardiomyopathy],0.087,0,0.0,0.0,0.0,0.0,0.0,0.0,0.128,2.32,0.713,0.118,0.924,0.211,3
MEIS2,CM_763.31 [Ventricular septal defect],0.087,0,0.0,0.0,0.0,0.0,0.0,0.0,0.066,2.578,0.089,0.097,0.115,0.747,3
NTN1,CV_433.3 [Cerebrovascular insufficiency],0.087,0,0.0,0.0,0.0,0.0,0.0,0.0,0.099,4.235,1.449,0.161,0.14,0.62,3
BRD1,MB_306 [Conduct disorders],0.087,0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,3.164,1.744,0.395,0.144,,2
FOXO6,CM_770.5 [Congenital osteodystrophies],0.087,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.57,2.048,,0.027,0.288,2
UBASH3B,MS_705.2 [Juvenile rheumatoid arthritis [JRA/JIA]],0.087,0,0.0,0.0,0.0,0.0,0.0,0.0,0.109,3.246,0.558,0.101,0.111,,2
MATR3,NS_323.3 [Motor neuron disease],0.087,0,0.0,0.0,0.875,0.0,0.0,0.642,0.064,,2.332,0.252,2.119,0.998,4
NDUFS4,SO_380.3 [Optic atrophy],0.087,0,0.0,0.0,0.547,0.0,0.298,0.0,0.144,,0.237,0.211,0.094,0.969,4
PAX5,GE_977.6 [Congenital cutaneous mastocytosis*],0.087,0,0.0,0.0,0.0,0.0,0.0,0.0,0.382,1.984,0.181,0.108,0.048,,2
TP53,MS_712.51 [Hypermobility syndrome],0.087,0,0.0,0.0,0.0,0.0,0.0,0.0,0.156,1.618,2.475,0.136,0.143,,2
CDKN2B,CV_433.3 [Cerebrovascular insufficiency],0.087,0,0.0,0.0,0.0,0.604,0.0,0.0,0.0,1.809,0.165,0.083,0.09,0.914,2
FANCI,BI_162.1 [Constitutional (hereditary) aplastic anemia],0.087,0,0.0,0.0,0.0,0.0,0.0,0.855,0.15,,2.847,0.077,0.16,,3
TFAP2B,GE_961.1 [Phakomatoses],0.087,0,0.0,0.0,0.0,0.0,0.0,0.0,0.207,2.46,2.751,0.172,0.131,0.304,3
SRSF4,CV_414.1 [Hypertrophic cardiomyopathy],0.087,0,0.0,0.0,0.0,0.0,0.0,0.0,0.015,2.0,2.49,0.196,0.181,0.038,3
CCNF,NS_323.3 [Motor neuron disease],0.087,0,0.0,0.0,0.888,0.0,0.0,0.442,0.052,,2.667,0.456,0.413,0.984,4
NR3C1,MS_712.51 [Hypermobility syndrome],0.087,0,0.0,0.0,0.0,0.0,0.0,0.0,0.118,2.384,2.302,0.211,0.188,,2
PHKA1,GE_972.9 [Muscular dystrophy],0.087,0,0.0,0.035,0.684,0.0,0.0,0.0,0.015,,1.589,0.312,1.801,0.108,5
SRC,GE_972.2 [Hereditary ataxia],0.087,0,0.0,0.0,0.0,0.0,0.25,0.0,0.037,1.37,0.118,0.087,0.178,0.983,4
SYK,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.087,1,3.0,0.0,0.0,0.0,0.0,0.0,0.03,2.378,3.552,0.789,0.157,0.993,3
ANK2,CV_414.1 [Hypertrophic cardiomyopathy],0.087,0,0.0,0.0,0.0,0.0,0.709,0.192,0.117,2.338,3.4,0.835,0.652,0.622,5
SPTLC1,NS_323.3 [Motor neuron disease],0.087,0,0.0,0.0,0.877,0.0,0.0,0.322,0.141,2.231,1.58,0.267,0.231,0.04,4
GRIA2,NS_341.1 [Cerebral palsy],0.087,1,4.0,0.0,0.0,0.0,0.0,0.0,0.0,2.122,2.664,0.142,0.127,0.984,2
TYK2,MS_700.3 [Systemic sclerosis],0.087,1,2.0,0.0,0.0,0.248,0.0,0.0,0.317,,2.913,1.179,0.237,,2
AGFG1,GE_974.3 [Hereditary choroidal dystrophies],0.087,0,0.0,0.0,0.0,0.0,0.0,0.0,0.307,2.502,4.243,3.401,0.042,,2
MTOR,GE_966.2 [Disorders of porphyrin metabolism],0.087,0,0.0,0.0,0.0,0.0,0.0,0.0,0.188,1.676,1.939,0.147,0.108,,2
NAMPT,GE_972.1 [Hereditary neuropathy],0.087,0,0.0,0.0,0.0,0.0,0.0,0.0,0.052,2.787,0.24,0.094,0.124,,2
IRF8,MS_700.3 [Systemic sclerosis],0.087,0,0.0,0.0,0.0,0.585,0.0,0.0,0.402,2.891,2.263,2.166,0.13,,2
COL3A1,CV_433.3 [Cerebrovascular insufficiency],0.087,0,0.0,0.0,0.0,0.0,0.0,0.402,0.018,1.998,3.04,1.748,0.172,0.973,4
RPS23,MB_302.1 [Speech and language developmental delay],0.086,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.022,0.078,,,0.248,2
TULP1,SO_369.62 [Keratoconus],0.086,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.366,1.856,0.176,1.0,2
IL2,GE_978.3 [Osteochondrodysplasias],0.086,0,0.0,0.0,0.0,0.0,0.268,0.0,0.07,1.926,0.078,,4.183,,3
TSPAN5,MS_704.1 [Polyarteritis nodosa and related conditions],0.086,0,0.0,0.0,0.0,0.0,0.0,0.0,0.438,2.404,0.04,0.04,0.08,,2
NDUFA4,NS_341.1 [Cerebral palsy],0.086,1,2.0,0.0,0.0,0.0,0.0,0.0,0.0,1.873,0.157,0.066,0.061,0.956,2
HSPH1,MS_727.5 [Cyst of bone],0.086,0,0.0,0.0,0.0,0.0,0.0,0.0,0.115,1.925,2.233,0.178,0.281,,2
COL11A1,GE_978.3 [Osteochondrodysplasias],0.086,0,0.0,0.0,0.0,0.0,0.301,0.0,0.087,2.311,3.842,0.119,0.298,,3
BCL2L2-PABPN1,GE_972.9 [Muscular dystrophy],0.086,0,0.0,0.0,0.0,0.0,0.0,0.475,0.0,,0.044,,0.018,0.305,2
SPINT4,NS_341.1 [Cerebral palsy],0.086,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.753,0.17,0.154,0.066,0.96,2
CLCN2,GE_963.1 [Lipid storage disorders],0.086,0,0.0,0.0,0.779,0.0,0.269,0.0,0.22,1.317,3.723,0.618,0.13,0.153,5
SOX2,CV_414.1 [Hypertrophic cardiomyopathy],0.086,0,0.0,0.0,0.0,0.0,0.0,0.0,0.388,2.36,0.193,,0.098,0.804,3
RPS23,CV_433.3 [Cerebrovascular insufficiency],0.086,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.282,0.064,,,0.18,2
SLC6A3,NS_328.13 [Frontotemporal dementia [FTD]],0.086,0,0.0,0.0,0.0,0.0,0.303,0.0,0.13,2.637,2.584,0.236,0.176,,3
MTOR,MS_704.1 [Polyarteritis nodosa and related conditions],0.086,0,0.0,0.0,0.0,0.0,0.0,0.0,0.247,1.723,2.075,0.258,0.194,,2
SLC6A3,MB_293.2 [Bulimia nervosa],0.086,1,4.0,0.0,0.0,0.0,0.0,0.0,0.093,1.804,1.246,0.24,0.146,,2
TRIP11,CM_770.5 [Congenital osteodystrophies],0.086,0,0.0,0.0,0.865,0.0,0.271,0.71,0.081,2.802,3.882,0.874,0.482,0.614,5
SLITRK1,MB_298 [Impulse disorders],0.086,0,0.0,0.0,0.684,0.0,0.0,0.647,0.044,3.291,0.185,0.052,0.06,,3
RAB7A,GE_972.1 [Hereditary neuropathy],0.086,0,0.0,0.0,0.0,0.0,0.0,0.756,0.07,1.919,3.108,,,,3
IRF4,MS_700.3 [Systemic sclerosis],0.086,0,0.0,0.0,0.0,0.0,0.0,0.0,0.103,1.895,2.553,0.082,0.103,,2
COL5A1,GE_978.22 [Ehler's Danlos syndrome],0.086,0,0.0,0.0,0.0,0.0,0.0,0.865,0.079,2.336,2.969,,16.157,,3
SDHD,GE_961.1 [Phakomatoses],0.086,0,0.0,0.0,0.0,0.0,0.0,0.706,0.107,,0.703,0.042,0.065,0.99,3
CDC73,GE_963.1 [Lipid storage disorders],0.086,0,0.0,0.0,0.0,0.0,0.0,0.0,0.041,1.967,0.095,0.019,0.058,0.273,3
DUOX2,CM_770.5 [Congenital osteodystrophies],0.086,0,0.0,0.0,0.0,0.0,0.398,0.0,0.145,,2.434,0.514,0.29,0.556,4
LMNA,GE_973.5 [Huntington's disease],0.086,0,0.0,0.0,0.0,0.0,0.0,0.0,0.539,1.766,0.27,0.079,0.059,,2
COL4A3,GU_580.51 [Focal and segmental glomerular lesions*],0.086,0,0.0,0.0,0.0,0.0,0.641,0.012,0.196,2.694,2.604,0.51,1.632,,4
FURIN,CV_433.3 [Cerebrovascular insufficiency],0.086,0,0.0,0.0,0.0,0.174,0.0,0.0,0.137,,2.713,0.152,0.132,0.879,3
RPL15,CM_751.213 [Congenital cataract],0.086,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.076,,,0.241,1
IL1B,GE_970.1 [Sickle-cell disorders],0.086,1,2.0,0.0,0.0,0.0,0.0,0.0,0.143,2.403,0.062,0.039,0.169,,2
MTOR,SO_380.3 [Optic atrophy],0.086,0,0.0,0.0,0.0,0.0,0.0,0.0,0.061,3.271,1.74,0.36,0.591,0.994,3
PRKCD,MS_700.3 [Systemic sclerosis],0.086,0,0.0,0.0,0.0,0.0,0.0,0.0,0.639,1.774,2.798,2.388,0.197,,2
MED13L,MB_302.1 [Speech and language developmental delay],0.086,0,0.0,0.0,0.0,0.0,0.0,0.37,0.016,3.318,2.11,0.328,0.219,0.8,4
ADRA2C,CV_433.3 [Cerebrovascular insufficiency],0.086,1,4.0,0.0,0.0,0.0,0.0,0.0,0.0,2.035,3.358,,0.033,0.204,2
SMAD3,CV_433.3 [Cerebrovascular insufficiency],0.086,0,0.0,0.0,0.0,0.0,0.0,0.0,0.224,2.092,0.092,0.031,0.072,0.993,3
SEMA7A,MS_704.1 [Polyarteritis nodosa and related conditions],0.086,0,0.0,0.0,0.0,0.0,0.0,0.0,0.571,2.578,2.833,0.149,0.116,,2
LGI1,EM_249.1 [Cerebral amyloid angiopathy*],0.086,0,0.0,0.0,0.0,0.0,0.0,0.0,0.12,1.455,0.135,0.145,1.809,,2
PTBP2,MB_293.1 [Anorexia nervosa],0.086,0,0.0,0.0,0.0,0.485,0.0,0.0,0.061,6.004,0.143,0.058,0.055,,2
RPL15,BI_179.1 [Hypogammaglobulinemia NOS],0.086,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.078,,,0.285,1
PTGS1,GE_972.2 [Hereditary ataxia],0.086,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.093,2.31,0.358,0.234,0.952,2
CD19,GE_977.6 [Congenital cutaneous mastocytosis*],0.086,0,0.0,0.0,0.0,0.0,0.0,0.0,0.678,,0.232,0.071,0.05,,1
GRIN2B,MB_302.1 [Speech and language developmental delay],0.086,0,0.0,0.0,0.0,0.0,0.0,0.245,0.036,3.046,0.311,,,0.989,4
HMGB2,GI_540.11 [Autoimmune hepatitis],0.086,0,0.0,0.0,0.0,0.0,0.0,0.0,0.14,1.688,0.148,,2.929,,2
HIF1A,CV_413.41 [Pulmonary valve stenosis],0.086,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.995,2.494,0.154,1.941,0.977,2
MTHFR,NS_341.1 [Cerebral palsy],0.086,0,0.0,0.0,0.843,0.0,0.0,0.362,0.08,1.475,2.41,0.307,0.15,0.899,4
EYS,SO_369.62 [Keratoconus],0.086,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.842,2.476,0.987,0.351,0.999,2
HIF1A,GE_975.2 [Hereditary hemorrhagic telangiectasia],0.086,0,0.0,0.0,0.0,0.0,0.0,0.0,0.222,1.85,0.564,0.185,0.118,,2
EZH2,MS_727.5 [Cyst of bone],0.086,0,0.0,0.0,0.0,0.0,0.0,0.0,0.276,1.594,1.971,0.119,0.158,,2
ABCD1,GE_963.1 [Lipid storage disorders],0.086,1,3.0,0.0,0.9,0.0,0.0,0.0,0.033,,1.613,0.311,2.688,0.784,4
UBE2D3,SO_380.3 [Optic atrophy],0.086,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.707,0.058,,,0.332,2
MAPT,GE_972.2 [Hereditary ataxia],0.086,0,0.0,0.0,0.426,0.0,0.311,0.0,0.074,,2.432,0.39,0.236,0.997,5
DHX9,GE_972.1 [Hereditary neuropathy],0.086,0,0.0,0.0,0.0,0.0,0.0,0.475,0.122,1.716,2.575,2.545,0.168,,3
RPS10-NUDT3,SO_386.5 [Color vision deficiencies],0.086,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.103,0.021,0.014,0.262,1
UBE2E3,MB_302.1 [Speech and language developmental delay],0.086,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.253,0.084,,,0.304,2
B9D1,GE_972.2 [Hereditary ataxia],0.086,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.142,1.418,0.219,0.096,0.99,2
RNF220,NS_323.3 [Motor neuron disease],0.086,0,0.0,0.0,0.0,0.0,0.489,0.0,0.024,1.895,0.888,0.201,0.217,0.022,4
AMPD2,NS_341.1 [Cerebral palsy],0.086,0,0.0,0.0,0.684,0.0,0.0,0.0,0.017,,2.038,0.231,0.186,0.774,4
TMEM237,GE_972.2 [Hereditary ataxia],0.086,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.424,3.016,1.109,0.099,0.979,2
NDUFAF3,GE_963.1 [Lipid storage disorders],0.086,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.222,0.12,0.058,0.994,1
ENTPD1,NS_341.1 [Cerebral palsy],0.086,0,0.0,0.0,0.732,0.0,0.0,0.0,0.071,3.476,2.407,0.116,0.125,0.91,4
APOL1,GU_580.52 [Diffuse membranous glomerulonephritis],0.086,1,3.0,0.0,0.0,0.458,0.0,0.726,0.354,2.542,1.93,0.094,0.073,,3
KIF5B,GE_972.2 [Hereditary ataxia],0.086,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,1.809,0.973,0.167,0.195,0.884,3
LYST,GE_972.2 [Hereditary ataxia],0.086,0,0.0,0.0,0.623,0.0,0.316,0.336,0.151,4.874,3.191,0.201,0.519,0.85,5
PTH,EM_208.1 [Hypoparathyroidism],0.086,1,2.0,0.0,0.856,0.0,0.275,0.779,0.646,,0.189,0.077,0.082,0.807,4
IL18,RE_477.2 [Hypersensitivity pneumonitis],0.086,0,0.0,0.0,0.0,0.0,0.0,0.0,0.137,2.296,2.832,0.027,0.029,,2
COX7A1,NS_341.1 [Cerebral palsy],0.086,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,1.947,1.65,0.041,0.962,2
MMP9,NS_344.2 [Benign intracranial hypertension],0.086,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,3.472,0.364,0.167,0.96,2
MED13,MB_302.1 [Speech and language developmental delay],0.086,0,0.0,0.0,0.0,0.0,0.0,0.402,0.012,1.814,2.326,0.532,1.608,0.173,4
RPL17,NS_344.2 [Benign intracranial hypertension],0.086,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.542,0.108,,,0.224,2
AGFG1,SO_365.3 [Exophthalmos [Proptosis]],0.086,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,1.782,1.619,0.248,0.996,0.222,3
ISY1-RAB43,SO_386.6 [Night blindness],0.086,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.483,0.036,,,0.208,2
EDNRB,MS_700.3 [Systemic sclerosis],0.086,1,4.0,0.0,0.0,0.0,0.0,0.0,0.202,2.393,2.798,0.142,0.157,,2
CD55,GU_580.51 [Focal and segmental glomerular lesions*],0.086,0,0.0,0.0,0.0,0.0,0.437,0.0,0.433,,1.425,0.076,2.475,,3
ARPC4,CM_750.16 [Arnold-Chiari syndrome*],0.086,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.591,0.025,,,0.18,2
EVC2,CM_770.5 [Congenital osteodystrophies],0.086,0,0.0,0.0,0.0,0.0,0.337,0.877,0.084,2.641,3.22,0.628,0.178,0.419,5
AFDN,NS_344.11 [Communicating hydrocephalus],0.086,0,0.0,0.0,0.0,0.0,0.0,0.0,0.333,3.597,0.233,0.368,0.146,,2
S1PR1,NS_323.3 [Motor neuron disease],0.086,1,2.0,0.0,0.0,0.0,0.0,0.0,0.018,2.361,1.022,0.09,0.123,0.017,3
HMGB1,MS_700.3 [Systemic sclerosis],0.086,0,0.0,0.0,0.0,0.0,0.259,0.0,0.821,3.299,0.288,0.117,,,3
TP63,GE_961.1 [Phakomatoses],0.086,0,0.0,0.0,0.0,0.0,0.277,0.0,0.03,3.713,0.481,0.436,0.163,0.922,4
ESRP1,"EM_209.11 [Tall stature, acromegaly and gigantism]",0.086,0,0.0,0.0,0.0,0.0,0.0,0.0,0.106,1.382,0.415,0.116,0.104,,2
COL1A2,CV_433.3 [Cerebrovascular insufficiency],0.086,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,1.335,3.783,0.489,0.225,0.958,3
NDUFA5,CV_414.1 [Hypertrophic cardiomyopathy],0.085,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.302,0.305,0.111,0.084,0.994,2
KLC4,NS_341.1 [Cerebral palsy],0.085,0,0.0,0.0,0.547,0.0,0.0,0.0,0.079,,2.154,0.238,0.178,0.596,4
ADCY1,CV_433.3 [Cerebrovascular insufficiency],0.085,0,0.0,0.0,0.0,0.0,0.0,0.0,0.082,1.803,0.276,0.047,0.16,0.204,3
RPS10,GE_963.1 [Lipid storage disorders],0.085,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.411,0.022,,,0.212,2
CASP3,MS_704.1 [Polyarteritis nodosa and related conditions],0.085,0,0.0,0.0,0.0,0.497,0.0,0.402,0.459,,2.957,0.165,0.084,,3
ANKHD1-EIF4EBP3,CM_763.31 [Ventricular septal defect],0.085,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.086,0.048,,0.216,1
ABCB1,NS_339.2 [Myotonic disorders],0.085,0,0.0,0.0,0.0,0.0,0.0,0.0,0.123,2.72,2.443,0.092,0.17,,2
UMOD,GU_580.51 [Focal and segmental glomerular lesions*],0.085,0,0.0,0.0,0.0,0.0,0.636,0.0,0.162,,1.993,0.209,0.119,,3
C20orf141,CM_763.31 [Ventricular septal defect],0.085,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.304,0.079,0.023,1.0,1
ANGPT1,CV_413.13 [Mitral valve stenosis],0.085,0,0.0,0.0,0.0,0.0,0.0,0.0,0.079,2.467,1.549,0.151,0.142,,2
SLC25A46,SO_380.3 [Optic atrophy],0.085,0,0.0,0.0,0.869,0.0,0.0,0.402,0.012,,2.668,0.198,0.117,0.819,4
CRMP1,NS_323.3 [Motor neuron disease],0.085,0,0.0,0.0,0.0,0.0,0.0,0.0,0.082,2.002,2.131,0.185,0.862,0.193,3
POU2AF1,GI_542.8 [Biliary cirrhosis],0.085,0,0.0,0.0,0.0,0.537,0.0,0.0,0.075,3.677,1.75,0.077,0.12,,2
PPARG,MS_704.1 [Polyarteritis nodosa and related conditions],0.085,0,0.0,0.0,0.0,0.0,0.0,0.0,0.281,,0.078,0.105,0.086,,1
PRKCQ,DE_669.2 [Behcet's syndrome],0.085,0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,2.532,2.413,0.144,0.122,,2
HTR2A,MB_296.2 [Schizoid personality disorder],0.085,1,4.0,0.0,0.0,0.0,0.0,0.0,0.116,2.782,0.249,0.052,0.054,,2
ADAR,GI_540.11 [Autoimmune hepatitis],0.085,0,0.0,0.0,0.0,0.0,0.0,0.0,0.107,,0.798,0.217,0.225,,1
SURF1,GE_963.1 [Lipid storage disorders],0.085,0,0.0,0.0,0.684,0.0,0.0,0.0,0.125,,0.176,0.275,0.11,0.984,3
GRM5,GE_973.5 [Huntington's disease],0.085,1,2.0,0.0,0.0,0.0,0.0,0.0,0.715,2.733,1.689,0.127,0.073,,2
FGF14,GE_972.2 [Hereditary ataxia],0.085,0,0.0,0.181,0.825,0.0,0.319,0.277,0.172,2.05,0.246,0.029,2.746,0.978,6
FGFR1,NS_339.2 [Myotonic disorders],0.085,0,0.0,0.0,0.0,0.0,0.0,0.0,0.122,1.986,1.675,0.167,0.102,,2
ADCY1,EM_208.1 [Hypoparathyroidism],0.085,0,0.0,0.0,0.0,0.0,0.0,0.0,0.015,3.091,2.579,0.094,0.214,0.33,3
NF1,CV_414.1 [Hypertrophic cardiomyopathy],0.085,0,0.0,0.0,0.684,0.0,0.289,0.0,0.079,1.6,2.658,0.651,1.594,0.905,5
ELN,CV_438.41 [Aortic dissection],0.085,0,0.0,0.0,0.789,0.0,0.0,0.0,0.072,,2.92,0.26,0.109,0.94,4
HMGCR,MS_700.43 [Polymyositis],0.085,0,0.0,0.0,0.0,0.0,0.0,0.0,0.191,2.113,0.359,0.193,0.123,,2
NDUFB9,GE_972.2 [Hereditary ataxia],0.085,1,4.0,0.0,0.0,0.0,0.0,0.0,0.0,1.423,2.394,0.212,0.091,0.958,2
PEX19,CM_763.31 [Ventricular septal defect],0.085,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,1.286,0.099,0.108,0.975,1
NFIB,GE_972.9 [Muscular dystrophy],0.085,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,2.675,0.571,0.097,0.083,0.338,3
IL1B,NS_333.4 [Circadian rhythm sleep disorder],0.085,0,0.0,0.0,0.0,0.0,0.0,0.0,0.26,,0.102,0.092,0.055,0.973,2
RPL26,SO_386.6 [Night blindness],0.085,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.065,,,0.208,1
PRKAA1,GE_973.5 [Huntington's disease],0.085,0,0.0,0.0,0.0,0.0,0.0,0.0,0.822,,0.078,0.051,0.049,,1
KBTBD13,GE_972.9 [Muscular dystrophy],0.085,0,0.0,0.0,0.654,0.0,0.305,0.0,0.11,,1.809,0.126,0.094,0.788,5
NR3C2,CM_772.1 [Congenital malformations of endocrine glands],0.085,1,4.0,0.0,0.0,0.0,0.311,0.0,0.061,4.243,2.47,,0.023,,3
HTR2A,MB_301.2 [Asperger's syndrome*],0.085,1,4.0,0.0,0.0,0.0,0.0,0.0,0.015,3.654,0.127,0.083,0.09,,2
SPG21,NS_341.1 [Cerebral palsy],0.085,0,0.0,0.0,0.848,0.0,0.0,0.0,0.029,,0.623,0.195,0.114,0.997,3
RPGRIP1,GE_972.2 [Hereditary ataxia],0.085,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.868,2.453,0.457,0.338,0.98,2
KCNMA1,GE_963.1 [Lipid storage disorders],0.085,0,0.0,0.0,0.0,0.0,0.299,0.0,0.047,4.306,0.395,0.152,0.104,0.273,4
HTR2A,MB_296.4 [Borderline personality disorder],0.085,1,4.0,0.0,0.0,0.0,0.0,0.0,0.148,1.9,2.658,2.42,0.136,,2
NDUFB9,GE_963.1 [Lipid storage disorders],0.085,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.047,0.128,0.081,0.055,0.986,2
KITLG,GE_978.3 [Osteochondrodysplasias],0.085,0,0.0,0.0,0.0,0.0,0.0,0.0,0.097,2.348,0.082,0.087,0.07,,2
SPIN1,NS_344.2 [Benign intracranial hypertension],0.085,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.606,0.044,0.042,,0.244,2
ARPC4,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.085,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.055,,,0.221,1
GSK3B,GE_978.3 [Osteochondrodysplasias],0.085,0,0.0,0.0,0.0,0.0,0.334,0.0,0.135,2.831,2.337,,0.086,,3
WEE1,NS_323.3 [Motor neuron disease],0.085,0,0.0,0.0,0.0,0.0,0.0,0.0,0.102,2.255,2.949,2.485,0.109,0.045,3
COL6A3,NS_340.3 [Inflammatory and immune myopathies],0.085,0,0.0,0.091,0.862,0.0,0.582,0.0,0.061,2.118,4.555,0.348,0.16,,5
HTR2A,NS_333.4 [Circadian rhythm sleep disorder],0.085,1,4.0,0.0,0.0,0.0,0.0,0.0,0.216,1.847,0.172,0.101,0.104,0.756,3
PTK2,GE_961.1 [Phakomatoses],0.085,0,0.0,0.0,0.0,0.0,0.0,0.0,0.049,2.994,4.874,4.753,0.235,0.752,3
POMGNT1,SO_380.3 [Optic atrophy],0.085,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,5.509,0.56,0.245,0.987,2
EDNRA,GI_542.8 [Biliary cirrhosis],0.085,0,0.0,0.0,0.0,0.0,0.0,0.0,0.091,2.718,2.542,0.105,0.144,,2
COL4A3,GU_580.52 [Diffuse membranous glomerulonephritis],0.085,0,0.0,0.0,0.0,0.0,0.641,0.012,0.132,1.418,3.654,1.182,0.761,,4
PDE4D,CV_433.3 [Cerebrovascular insufficiency],0.085,1,4.0,0.0,0.0,0.0,0.0,0.0,0.175,2.9,2.849,0.237,0.148,0.576,3
DAB1,GE_972.2 [Hereditary ataxia],0.085,0,0.0,0.0,0.532,0.0,0.435,0.29,0.038,2.266,2.877,1.356,0.144,0.863,5
IL1B,DE_669.2 [Behcet's syndrome],0.085,1,3.0,0.0,0.0,0.0,0.0,0.0,0.529,,0.087,0.071,0.046,,1
MT-ATP6,SO_380.3 [Optic atrophy],0.085,0,0.0,0.0,0.0,0.0,0.0,0.797,0.054,,,,,,2
LAMA5,GU_580.52 [Diffuse membranous glomerulonephritis],0.085,0,0.0,0.0,0.0,0.0,0.603,0.0,0.188,2.478,4.053,1.97,0.313,,3
MEIS2,CM_751.213 [Congenital cataract],0.085,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,2.405,0.465,0.118,0.111,0.169,3
HDAC9,GE_972.9 [Muscular dystrophy],0.085,0,0.0,0.0,0.0,0.0,0.0,0.0,0.109,3.445,2.513,0.187,0.134,0.312,3
AFG3L2,SO_380.3 [Optic atrophy],0.085,0,0.0,0.0,0.874,0.0,0.0,0.557,0.07,,1.648,0.15,2.231,0.948,4
NLRP3,MS_705.2 [Juvenile rheumatoid arthritis [JRA/JIA]],0.085,0,0.0,0.0,0.0,0.0,0.0,0.0,0.253,2.508,3.466,3.106,0.096,,2
BANF1,NS_344.2 [Benign intracranial hypertension],0.085,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.066,,,0.211,1
PLCG2,BI_179.1 [Hypogammaglobulinemia NOS],0.085,0,0.0,0.0,0.644,0.0,0.0,0.0,0.111,1.877,3.213,0.151,0.226,0.982,4
CR1,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.085,0,0.0,0.0,0.654,0.0,0.0,0.0,0.209,,3.142,0.475,0.164,0.975,4
ACVRL1,CV_441 [Arteriovenous malformation],0.085,0,0.0,0.0,0.182,0.0,0.0,0.402,0.106,,1.614,0.279,0.141,0.979,4
NLRP3,GU_580.51 [Focal and segmental glomerular lesions*],0.085,0,0.0,0.0,0.0,0.0,0.0,0.01,0.168,3.236,1.672,0.12,0.135,,3
SPIN1,CV_433.3 [Cerebrovascular insufficiency],0.085,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.107,0.056,0.037,,0.146,2
IMPG2,SO_369.62 [Keratoconus],0.085,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.868,2.738,0.623,0.265,0.993,2
TLR8,GI_540.11 [Autoimmune hepatitis],0.085,0,0.0,0.0,0.0,0.0,0.306,0.0,0.378,,2.567,,0.096,,3
TP53,CV_433.3 [Cerebrovascular insufficiency],0.085,1,0.5,0.0,0.0,0.0,0.0,0.0,0.119,,1.858,0.127,0.113,0.988,3
RBFOX2,CM_770.5 [Congenital osteodystrophies],0.085,0,0.0,0.0,0.0,0.0,0.0,0.0,0.055,2.077,0.177,0.19,0.109,0.301,3
C17orf107,SO_380.3 [Optic atrophy],0.085,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,1.041,0.175,0.064,0.957,1
MDH2,NS_341.1 [Cerebral palsy],0.085,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.782,0.279,0.135,0.992,1
RBM45,NS_323.3 [Motor neuron disease],0.085,0,0.0,0.0,0.532,0.0,0.0,0.0,0.086,2.754,2.745,0.248,0.162,0.262,4
DRD3,MB_293.1 [Anorexia nervosa],0.085,1,4.0,0.0,0.0,0.0,0.0,0.0,0.17,1.883,1.613,0.172,0.114,,2
CLCNKB,EM_211.1 [Adrenal hyperfunction],0.085,0,0.0,0.0,0.893,0.0,0.313,0.0,0.012,2.608,2.254,0.109,0.279,,4
BMPR2,GE_975.2 [Hereditary hemorrhagic telangiectasia],0.085,0,0.0,0.0,0.0,0.0,0.0,0.0,0.19,,2.297,0.173,0.133,,2
YPEL5,BI_179.1 [Hypogammaglobulinemia NOS],0.085,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.803,0.045,,,0.194,2
MFSD8,GE_963.1 [Lipid storage disorders],0.085,1,0.5,0.0,0.547,0.0,0.0,0.91,0.109,1.629,0.23,0.126,0.111,0.112,4
UBAP1,GE_972.2 [Hereditary ataxia],0.085,0,0.0,0.0,0.0,0.0,0.314,0.648,0.445,,2.087,1.854,0.104,0.306,5
FAM161A,SO_369.62 [Keratoconus],0.085,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.799,2.054,0.245,0.184,0.998,2
AR,DE_669.2 [Behcet's syndrome],0.085,0,0.0,0.0,0.0,0.0,0.0,0.0,0.208,2.739,2.11,,0.013,,2
GRIN2B,DE_663.2 [Pemphigoid],0.085,0,0.0,0.0,0.0,0.0,0.0,0.0,0.173,2.224,2.257,,,,2
TUBB2A,NS_323.3 [Motor neuron disease],0.085,1,2.0,0.025,0.0,0.0,0.0,0.0,0.0,,0.065,,,0.2,2
PRKCD,CM_770.5 [Congenital osteodystrophies],0.085,1,4.0,0.0,0.0,0.0,0.0,0.0,0.117,,1.849,0.104,0.123,0.876,3
DISC1,MB_301.2 [Asperger's syndrome*],0.085,0,0.0,0.0,0.0,0.0,0.469,0.0,0.116,1.942,3.276,0.91,0.127,,3
SARM1,NS_323.3 [Motor neuron disease],0.085,1,0.5,0.0,0.848,0.166,0.0,0.129,0.061,,2.965,0.255,0.135,0.434,4
NLRP3,MS_700.42 [Dermatomyositis],0.085,0,0.0,0.0,0.0,0.0,0.0,0.0,0.352,2.498,2.851,2.705,0.093,,2
IL1B,GI_540.11 [Autoimmune hepatitis],0.084,0,0.0,0.0,0.0,0.0,0.0,0.0,0.36,,0.138,0.127,0.086,,1
INPPL1,CM_770.5 [Congenital osteodystrophies],0.084,0,0.0,0.0,0.884,0.0,0.0,0.0,0.082,,3.928,4.195,0.234,0.676,4
HIF1A,GE_978.22 [Ehler's Danlos syndrome],0.084,0,0.0,0.0,0.0,0.0,0.0,0.0,0.109,2.077,0.425,0.19,0.124,,2
NR3C1,GE_978.22 [Ehler's Danlos syndrome],0.084,0,0.0,0.0,0.0,0.0,0.0,0.0,0.118,3.663,0.414,0.139,0.082,,2
PCSK9,GE_963.1 [Lipid storage disorders],0.084,0,0.0,0.0,0.0,0.0,0.395,0.0,0.122,2.266,2.481,0.236,0.111,0.109,4
SLC8A1,MS_704.1 [Polyarteritis nodosa and related conditions],0.084,0,0.0,0.0,0.0,0.0,0.0,0.0,0.116,2.765,0.742,0.231,0.146,,2
ADRB1,CV_433.3 [Cerebrovascular insufficiency],0.084,1,4.0,0.0,0.0,0.0,0.0,0.0,0.03,2.313,2.995,0.057,0.042,0.486,3
IDS,GE_963.3 [Mucopolysaccharidoses],0.084,1,4.0,0.0,0.0,0.0,0.272,0.924,0.089,1.69,0.235,0.123,0.032,,4
TFAP2B,CM_763.13 [Patent ductus arteriosus],0.084,0,0.0,0.0,0.745,0.0,0.0,0.0,0.379,2.779,0.181,0.068,2.51,0.594,4
GRIN2B,MB_306 [Conduct disorders],0.084,1,4.0,0.0,0.0,0.0,0.0,0.0,0.032,2.727,2.292,,,,2
BCL2,BI_179.1 [Hypogammaglobulinemia NOS],0.084,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.102,0.102,0.036,0.074,0.993,2
WNT5A,CV_433.3 [Cerebrovascular insufficiency],0.084,0,0.0,0.0,0.0,0.0,0.0,0.0,0.093,3.513,1.963,0.106,0.102,0.94,3
CREBBP,CV_433.3 [Cerebrovascular insufficiency],0.084,0,0.0,0.0,0.0,0.0,0.0,0.0,0.14,1.633,4.041,0.412,0.599,0.91,3
TRPV4,NS_323.3 [Motor neuron disease],0.084,0,0.0,0.0,0.701,0.0,0.0,0.694,0.083,,2.319,0.431,0.418,0.436,4
MT-ND2,SO_380.3 [Optic atrophy],0.084,0,0.0,0.0,0.0,0.0,0.0,0.792,0.043,,,,,,2
SIPA1L3,CM_751.213 [Congenital cataract],0.084,0,0.0,0.0,0.0,0.0,0.528,0.493,0.012,2.288,3.007,0.268,0.239,0.905,5
AGTR1,CV_414.1 [Hypertrophic cardiomyopathy],0.084,1,2.0,0.0,0.304,0.0,0.555,0.0,0.334,1.795,2.517,0.913,0.217,0.415,5
ARSB,GE_963.3 [Mucopolysaccharidoses],0.084,1,0.5,0.0,0.0,0.0,0.254,0.936,0.134,2.176,0.111,0.112,0.089,,4
SEMA4A,SO_386.5 [Color vision deficiencies],0.084,0,0.0,0.0,0.0,0.0,0.4,0.0,0.0,1.998,0.685,0.15,0.128,0.997,3
AR,NS_344.13 [(Idiopathic) normal pressure hydrocephalus],0.084,0,0.0,0.0,0.0,0.0,0.0,0.0,0.085,2.863,2.787,,0.021,,2
SLC40A1,GE_973.5 [Huntington's disease],0.084,0,0.0,0.0,0.0,0.0,0.0,0.0,0.096,4.238,0.053,0.039,0.067,,2
BANF1,CM_750.16 [Arnold-Chiari syndrome*],0.084,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.056,,,0.188,1
CDH2,GE_972.9 [Muscular dystrophy],0.084,0,0.0,0.0,0.0,0.0,0.0,0.0,0.17,3.197,2.704,1.259,0.13,0.878,3
AP4M1,NS_341.1 [Cerebral palsy],0.084,0,0.0,0.0,0.885,0.0,0.0,0.767,0.057,1.401,2.564,1.719,0.18,0.975,4
TREM2,NS_323.3 [Motor neuron disease],0.084,0,0.0,0.0,0.688,0.0,0.0,0.0,0.076,,2.291,0.088,0.155,0.977,4
RBMS3,MS_700.3 [Systemic sclerosis],0.084,0,0.0,0.0,0.0,0.0,0.0,0.0,0.298,3.093,0.409,0.141,0.129,,2
RPS10,GE_972.2 [Hereditary ataxia],0.084,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.58,0.04,,,0.299,2
RAB7A,NS_341.1 [Cerebral palsy],0.084,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.741,0.096,,,0.977,2
PRKCA,GE_963.1 [Lipid storage disorders],0.084,0,0.0,0.0,0.0,0.0,0.0,0.0,0.086,3.18,0.295,0.088,0.077,0.228,3
FLNC,MS_704.1 [Polyarteritis nodosa and related conditions],0.084,0,0.0,0.0,0.0,0.0,0.0,0.0,0.353,1.996,4.016,0.452,0.335,,2
PEX19,GE_972.2 [Hereditary ataxia],0.084,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.928,0.124,0.135,0.982,2
VEGFA,DE_663.2 [Pemphigoid],0.084,0,0.0,0.0,0.0,0.0,0.0,0.0,0.247,2.185,3.121,2.589,0.117,,2
RPL26,SO_386.5 [Color vision deficiencies],0.084,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.05,,,0.295,1
RPL9,CM_750.16 [Arnold-Chiari syndrome*],0.084,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.567,0.079,0.018,,0.293,2
HOPX,CV_414.1 [Hypertrophic cardiomyopathy],0.084,0,0.0,0.0,0.0,0.0,0.508,0.0,0.214,2.528,2.254,0.136,0.109,0.087,4
GUCY2D,NS_341.1 [Cerebral palsy],0.084,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.1,2.32,1.893,0.228,0.98,2
PPARA,CV_414.1 [Hypertrophic cardiomyopathy],0.084,0,0.0,0.0,0.0,0.0,0.49,0.0,0.163,1.4,2.287,0.955,0.236,0.976,4
RAN,CM_770.5 [Congenital osteodystrophies],0.084,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.052,,,0.299,1
GUSB,GE_963.3 [Mucopolysaccharidoses],0.084,1,4.0,0.0,0.0,0.0,0.0,0.931,0.107,1.893,2.216,0.085,0.09,,3
COQ2,GU_580.1 [Acute nephritic syndrome],0.084,0,0.0,0.0,0.86,0.0,0.0,0.161,0.035,2.056,0.385,0.19,0.139,0.481,4
NOS1,GE_973.5 [Huntington's disease],0.084,0,0.0,0.0,0.0,0.0,0.0,0.0,0.317,2.643,1.199,0.21,1.767,,2
GMPPA,GE_972.9 [Muscular dystrophy],0.084,0,0.0,0.0,0.0,0.0,0.318,0.0,0.0,,3.082,0.317,1.93,0.97,3
LRRK2,NS_323.3 [Motor neuron disease],0.084,1,0.5,0.0,0.58,0.0,0.0,0.0,0.087,2.967,2.809,0.476,0.269,0.983,4
PYGL,GE_964.3 [Glycogen storage disease],0.084,0,0.0,0.0,0.0,0.0,0.353,0.863,0.052,1.617,3.221,0.486,0.457,,4
TSC2,GU_580.51 [Focal and segmental glomerular lesions*],0.084,0,0.0,0.0,0.0,0.0,0.0,0.0,0.024,1.801,5.717,3.072,0.393,,2
PPP1R1B,NS_343.6 [Multi-system degeneration of the autonomic nervous system*],0.084,0,0.0,0.0,0.0,0.0,0.0,0.0,0.303,,0.093,0.105,0.05,,1
MT-ND4L,SO_380.3 [Optic atrophy],0.084,0,0.0,0.0,0.0,0.0,0.0,0.742,0.194,,,,,,2
UBE2L3,CM_751.213 [Congenital cataract],0.084,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.069,,,0.204,1
VEGFA,MS_700.43 [Polymyositis],0.084,0,0.0,0.0,0.0,0.0,0.0,0.0,0.479,1.87,0.11,0.117,0.064,,2
HIF1A,GE_970.1 [Sickle-cell disorders],0.084,0,0.0,0.0,0.0,0.0,0.0,0.0,0.073,1.991,0.988,0.109,0.148,,2
DEGS1,GE_963.1 [Lipid storage disorders],0.084,0,0.0,0.0,0.547,0.0,0.0,0.785,0.227,2.018,2.997,0.111,0.103,0.182,4
VAPA,NS_323.3 [Motor neuron disease],0.084,0,0.0,0.0,0.0,0.0,0.0,0.0,0.042,2.314,2.643,2.489,0.094,0.253,3
CD9,GU_580.52 [Diffuse membranous glomerulonephritis],0.084,0,0.0,0.0,0.0,0.0,0.0,0.0,0.38,1.954,0.196,0.099,0.083,,2
SCN9A,GE_972.1 [Hereditary neuropathy],0.084,1,4.0,0.0,0.0,0.0,0.0,0.741,0.091,1.962,2.763,0.28,0.325,,3
RNF220,GE_972.2 [Hereditary ataxia],0.084,0,0.0,0.0,0.684,0.0,0.0,0.402,0.12,1.753,2.649,0.186,0.183,0.322,4
TNF,CV_433.3 [Cerebrovascular insufficiency],0.084,1,0.5,0.0,0.304,0.0,0.0,0.0,0.153,,3.196,0.208,0.031,0.987,4
COL4A1,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.084,0,0.0,0.0,0.801,0.0,0.0,0.0,0.081,3.488,2.46,0.718,0.276,0.265,4
ANK3,GE_972.2 [Hereditary ataxia],0.084,0,0.0,0.0,0.0,0.0,0.389,0.0,0.07,2.664,3.234,1.528,0.443,0.935,4
IGF1,EM_211.1 [Adrenal hyperfunction],0.084,0,0.0,0.0,0.0,0.0,0.289,0.0,0.367,2.713,0.26,0.139,0.074,,3
ARHGEF28,NS_323.3 [Motor neuron disease],0.084,0,0.0,0.0,0.859,0.0,0.0,0.201,0.074,2.631,3.243,2.8,0.235,0.934,4
LRAT,SO_386.5 [Color vision deficiencies],0.084,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.248,0.097,0.047,0.998,1
IQCB1,SO_386.6 [Night blindness],0.084,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.552,0.202,0.251,0.149,0.999,2
PIK3R1,CV_433.3 [Cerebrovascular insufficiency],0.084,0,0.0,0.0,0.0,0.0,0.0,0.0,0.103,3.309,2.545,0.097,0.12,0.825,3
FLT1,GE_972.9 [Muscular dystrophy],0.084,0,0.0,0.0,0.0,0.0,0.0,0.0,0.302,1.869,3.951,0.271,0.179,0.65,3
DRAM2,SO_386.6 [Night blindness],0.084,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.096,0.285,0.454,0.096,0.964,2
UBE2N,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.084,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.048,,,0.296,1
KCNN2,CV_438.43 [Coronary artery dissection],0.084,0,0.0,0.0,0.0,0.354,0.0,0.0,0.083,2.388,0.257,0.121,2.02,,2
ATM,CM_763.13 [Patent ductus arteriosus],0.084,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.687,2.855,0.994,0.175,0.983,2
UQCRH,NS_341.1 [Cerebral palsy],0.084,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.152,0.054,0.057,0.97,1
RPL15,MB_302.1 [Speech and language developmental delay],0.084,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.382,0.099,,,0.163,2
TGFBI,SO_369.62 [Keratoconus],0.083,0,0.0,0.0,0.846,0.0,0.392,0.0,0.288,2.416,2.517,0.748,0.248,0.346,5
CFI,GU_580.52 [Diffuse membranous glomerulonephritis],0.083,0,0.0,0.0,0.0,0.0,0.494,0.008,0.079,,0.397,0.263,0.138,,3
GRIN2B,CV_441 [Arteriovenous malformation],0.083,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.943,2.843,,,0.199,2
GTPBP3,CV_414.1 [Hypertrophic cardiomyopathy],0.083,0,0.0,0.0,0.862,0.0,0.0,0.161,0.308,,2.457,1.443,0.34,0.995,4
SRC,MS_727.5 [Cyst of bone],0.083,0,0.0,0.0,0.0,0.0,0.0,0.0,0.113,1.485,2.568,0.121,0.24,,2
RB1CC1,CV_433.3 [Cerebrovascular insufficiency],0.083,0,0.0,0.0,0.0,0.0,0.0,0.0,0.061,2.292,2.257,0.172,0.208,0.31,3
CLN6,GE_963.1 [Lipid storage disorders],0.083,1,2.0,0.0,0.426,0.0,0.0,0.916,0.089,2.455,1.717,0.167,0.079,0.303,4
TUBA1A,BI_179.1 [Hypogammaglobulinemia NOS],0.083,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.111,,0.021,0.299,1
PAX5,MS_727.5 [Cyst of bone],0.083,0,0.0,0.0,0.0,0.0,0.0,0.0,0.196,1.562,0.313,0.436,0.222,,2
PLOD1,GE_978.22 [Ehler's Danlos syndrome],0.083,0,0.0,0.0,0.0,0.0,0.0,0.85,0.1,2.593,2.956,0.424,0.132,,3
MAP3K5,GU_580.1 [Acute nephritic syndrome],0.083,0,0.0,0.0,0.0,0.0,0.0,0.0,0.115,1.584,1.767,0.229,1.012,0.679,3
RBPJ,CV_441 [Arteriovenous malformation],0.083,0,0.0,0.0,0.0,0.0,0.0,0.0,0.076,2.221,1.902,,0.093,0.962,3
KDM5C,GI_516.1 [Pyloric stenosis],0.083,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.212,0.043,0.162,0.988,2
RBBP4,BI_179.1 [Hypogammaglobulinemia NOS],0.083,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.802,,0.021,0.302,2
STAT4,MS_705.2 [Juvenile rheumatoid arthritis [JRA/JIA]],0.083,0,0.0,0.0,0.0,0.518,0.0,0.0,0.247,1.495,2.167,0.196,0.094,,2
NDUFA9,GE_963.1 [Lipid storage disorders],0.083,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,1.374,0.224,0.09,0.996,2
RDH5,SO_386.6 [Night blindness],0.083,0,0.0,0.0,0.893,0.0,0.0,0.543,0.093,2.014,1.204,0.326,0.131,1.0,4
COL2A1,GE_961.1 [Phakomatoses],0.083,0,0.0,0.0,0.0,0.0,0.29,0.0,0.038,1.657,2.653,0.246,0.262,0.939,4
CD247,MS_700.3 [Systemic sclerosis],0.083,0,0.0,0.0,0.0,0.625,0.0,0.0,0.229,1.901,3.357,0.825,0.055,,2
MT-ND6,SO_380.3 [Optic atrophy],0.083,0,0.0,0.0,0.0,0.0,0.0,0.838,0.125,,,,,,2
NDUFAF3,NS_341.1 [Cerebral palsy],0.083,1,2.0,0.0,0.0,0.0,0.0,0.0,0.0,,3.795,0.178,0.063,0.975,2
LMNA,NS_323.3 [Motor neuron disease],0.083,0,0.0,0.0,0.654,0.0,0.0,0.0,0.029,1.645,1.968,0.281,0.221,0.726,4
FANCG,BI_162.1 [Constitutional (hereditary) aplastic anemia],0.083,0,0.0,0.0,0.0,0.0,0.0,0.823,0.099,,3.051,0.111,2.57,,3
UFSP2,CM_770.5 [Congenital osteodystrophies],0.083,0,0.0,0.0,0.796,0.0,0.0,0.0,0.111,,0.142,0.278,0.128,0.666,3
MAOA,"MB_280.4 [Sedative, hypnotic, or anxiolytic related disorders]",0.083,1,4.0,0.0,0.0,0.0,0.0,0.0,0.146,2.704,3.866,0.087,0.072,,2
PANK2,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.083,0,0.0,0.0,0.0,0.0,0.0,0.889,0.097,1.977,0.198,0.269,0.147,0.144,4
RRM1,NS_323.3 [Motor neuron disease],0.083,1,2.0,0.0,0.0,0.0,0.0,0.0,0.018,2.934,2.385,0.1,0.166,0.25,3
POP1,CM_770.5 [Congenital osteodystrophies],0.083,0,0.0,0.0,0.745,0.0,0.0,0.0,0.024,1.905,2.227,0.306,0.167,0.156,4
FHL1,CV_414.1 [Hypertrophic cardiomyopathy],0.083,0,0.0,0.0,0.88,0.0,0.0,0.459,0.072,2.696,0.92,0.135,0.135,0.918,4
HMGCR,MS_712.51 [Hypermobility syndrome],0.083,0,0.0,0.0,0.0,0.0,0.0,0.0,0.094,1.725,1.124,0.056,0.255,,2
PPARG,MS_700.3 [Systemic sclerosis],0.083,1,2.0,0.0,0.0,0.0,0.0,0.0,0.87,1.907,0.138,0.151,0.146,,2
HNRNPC,SO_369.62 [Keratoconus],0.083,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.108,0.078,,,0.252,2
MTOR,SO_386.5 [Color vision deficiencies],0.083,0,0.0,0.0,0.0,0.0,0.0,0.0,0.045,1.353,2.482,0.219,0.166,0.979,3
MFN2,CV_414.1 [Hypertrophic cardiomyopathy],0.083,0,0.0,0.0,0.0,0.0,0.0,0.0,0.299,2.876,2.869,0.55,0.274,0.989,3
FN1,BI_168.12 [Hemorrhagic disorder due to intrinsic circulating anticoagulants],0.083,0,0.0,0.0,0.0,0.0,0.0,0.0,0.103,2.34,4.796,2.342,0.418,,2
ACLY,GI_540.11 [Autoimmune hepatitis],0.083,0,0.0,0.0,0.0,0.0,0.0,0.0,0.094,,1.89,0.102,0.237,,2
GNAT1,SO_380.3 [Optic atrophy],0.083,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.773,0.316,1.55,0.954,2
BMP4,NS_323.3 [Motor neuron disease],0.083,0,0.0,0.0,0.0,0.0,0.0,0.0,0.04,2.285,1.156,0.447,0.177,0.188,3
MTOR,MB_302.1 [Speech and language developmental delay],0.083,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.696,2.749,1.922,0.254,0.992,3
FGFR3,GE_972.1 [Hereditary neuropathy],0.083,0,0.0,0.0,0.0,0.0,0.334,0.0,0.202,,2.783,0.361,0.318,,3
KITLG,DE_663.2 [Pemphigoid],0.083,0,0.0,0.0,0.0,0.0,0.354,0.0,0.077,2.267,0.156,0.126,2.217,,3
AGPS,GE_963.1 [Lipid storage disorders],0.083,0,0.0,0.0,0.0,0.0,0.0,0.0,0.191,1.468,0.191,0.047,2.106,0.367,3
CACNA1C,GE_978.21 [Marfan syndrome],0.083,1,4.0,0.0,0.0,0.0,0.0,0.0,0.271,2.627,2.936,1.877,0.156,,2
NRXN1,MB_302.1 [Speech and language developmental delay],0.083,0,0.0,0.0,0.0,0.0,0.0,0.0,0.049,3.371,2.945,0.409,0.202,0.977,3
GABRA2,GE_961.1 [Phakomatoses],0.083,1,3.0,0.0,0.0,0.0,0.0,0.0,0.012,2.474,1.905,,0.119,0.045,3
TERF2,CM_751.213 [Congenital cataract],0.083,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,3.451,,0.022,0.291,2
RPS23,GE_972.9 [Muscular dystrophy],0.083,1,4.0,0.0,0.0,0.0,0.0,0.0,0.0,3.59,0.047,,,0.275,2
JPH3,GE_972.2 [Hereditary ataxia],0.083,0,0.0,0.022,0.0,0.0,0.0,0.0,0.031,1.961,1.636,0.202,0.21,0.946,4
CYS1,GE_976.5 [Polycystic kidney disease],0.083,0,0.0,0.0,0.0,0.0,0.415,0.42,0.276,2.092,2.068,1.843,0.073,,4
RPL7,GE_972.9 [Muscular dystrophy],0.083,1,4.0,0.0,0.0,0.0,0.0,0.0,0.0,2.238,0.171,,,0.246,2
HIVEP3,GE_978.3 [Osteochondrodysplasias],0.083,0,0.0,0.0,0.0,0.0,0.389,0.0,0.087,2.819,3.44,1.154,0.723,,3
MTOR,CV_416.8 [Pre-excitation syndrome [Anomalous atrioventricular excitation]],0.083,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,2.358,3.268,0.418,0.285,0.991,3
YPEL5,CV_413.41 [Pulmonary valve stenosis],0.083,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.474,0.022,,,0.218,2
RPS26,GE_977.1 [Congenital ichthyosis],0.083,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.044,0.028,,0.253,1
DSC2,CV_414.1 [Hypertrophic cardiomyopathy],0.083,0,0.0,0.0,0.802,0.0,0.554,0.147,0.012,,1.74,0.138,0.159,0.724,5
CPT1C,NS_341.1 [Cerebral palsy],0.083,0,0.0,0.0,0.801,0.0,0.0,0.161,0.029,,1.875,0.586,0.172,0.913,4
PEX19,SO_386.6 [Night blindness],0.083,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.857,1.724,0.119,1.704,0.974,2
SYK,CM_770.5 [Congenital osteodystrophies],0.083,0,0.0,0.0,0.0,0.0,0.0,0.0,0.017,2.038,2.051,0.166,0.11,0.886,3
MKS1,SO_380.3 [Optic atrophy],0.083,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,1.108,0.347,0.17,0.978,1
SENP6,CV_433.3 [Cerebrovascular insufficiency],0.083,0,0.0,0.0,0.0,0.0,0.0,0.0,0.261,1.749,3.534,1.608,0.196,0.124,3
RPS29,NS_333.4 [Circadian rhythm sleep disorder],0.083,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.9,0.052,,,0.178,2
SDCCAG8,SO_369.62 [Keratoconus],0.083,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.636,1.801,0.307,0.214,0.974,2
KCNQ1,CV_414.1 [Hypertrophic cardiomyopathy],0.083,0,0.0,0.0,0.547,0.0,0.509,0.009,0.306,2.162,2.608,0.746,0.238,0.738,5
SCN2A,GE_972.9 [Muscular dystrophy],0.083,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,2.486,1.971,0.17,1.435,0.162,3
PRKCD,GE_978.3 [Osteochondrodysplasias],0.083,1,4.0,0.0,0.0,0.0,0.0,0.0,0.117,1.371,1.943,0.097,0.107,,2
THBS1,MS_700.3 [Systemic sclerosis],0.083,0,0.0,0.0,0.0,0.0,0.0,0.0,0.82,2.948,3.488,,0.098,,2
DDR2,MS_700.3 [Systemic sclerosis],0.083,0,0.0,0.0,0.0,0.0,0.0,0.0,0.092,,2.463,0.143,0.622,,2
USP11,SO_386.6 [Night blindness],0.083,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,,4.66,,0.088,0.083,3
NAMPT,GE_972.2 [Hereditary ataxia],0.083,0,0.0,0.0,0.0,0.0,0.0,0.0,0.495,2.508,1.003,0.075,0.102,0.429,3
NFASC,GE_972.2 [Hereditary ataxia],0.083,0,0.0,0.169,0.684,0.0,0.0,0.0,0.054,2.135,3.363,0.314,1.272,0.876,5
RBFOX2,NS_339.2 [Myotonic disorders],0.083,0,0.0,0.0,0.0,0.0,0.0,0.0,0.078,1.884,3.075,2.89,0.076,,2
COL4A1,GE_972.9 [Muscular dystrophy],0.083,0,0.0,0.028,0.547,0.0,0.328,0.0,0.023,2.259,3.407,0.212,0.197,0.938,6
TCAP,GE_972.9 [Muscular dystrophy],0.083,0,0.0,0.0,0.871,0.0,0.332,0.712,0.068,,2.592,0.052,0.045,0.988,5
TNFAIP8L2,GI_540.11 [Autoimmune hepatitis],0.083,0,0.0,0.0,0.0,0.0,0.3,0.0,0.316,,0.694,0.142,2.093,,3
SRSF1,EM_209.4 [Diabetes insipidus],0.083,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.372,0.045,,,0.28,2
SIAH1,CM_751.213 [Congenital cataract],0.083,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.078,,,0.206,1
SMARCA2,CV_414.1 [Hypertrophic cardiomyopathy],0.083,0,0.0,0.0,0.0,0.0,0.0,0.0,0.021,4.46,3.935,1.665,0.394,0.208,3
GUCA1A,SO_386.6 [Night blindness],0.083,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.919,4.223,0.154,0.056,0.999,2
RAN,GE_961.1 [Phakomatoses],0.083,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.071,,,0.214,1
VPS29,CM_763.13 [Patent ductus arteriosus],0.083,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.052,0.019,0.02,0.317,1
LPAR1,GI_542.8 [Biliary cirrhosis],0.083,0,0.0,0.0,0.0,0.0,0.0,0.0,0.219,3.03,2.457,2.387,0.194,,2
GNB3,SO_386.5 [Color vision deficiencies],0.083,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,,0.109,0.207,0.111,0.991,2
APC,GE_970.2 [Thalassemia],0.083,0,0.0,0.0,0.0,0.0,0.396,0.0,0.046,1.782,3.924,0.918,0.258,,3
LPAR1,GE_961.1 [Phakomatoses],0.083,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,2.603,0.11,0.064,0.144,0.324,3
RPL26,GU_580.1 [Acute nephritic syndrome],0.083,1,1.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.058,,,0.308,1
GRIN2B,MB_303.1 [Dyslexia and alexia],0.083,0,0.0,0.0,0.0,0.0,0.0,0.0,0.127,2.6,2.702,,,,2
SIAH1,CV_433.3 [Cerebrovascular insufficiency],0.083,0,0.0,0.0,0.0,0.0,0.0,0.0,0.047,2.633,0.064,,,0.183,3
ADCY1,SO_365.3 [Exophthalmos [Proptosis]],0.083,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,3.072,1.872,0.09,0.69,0.345,3
MYH9,GU_580.1 [Acute nephritic syndrome],0.083,0,0.0,0.0,0.88,0.0,0.0,0.163,0.212,,2.176,0.132,0.539,0.784,4
TRIM24,MS_719.2 [Muscle calcification and ossification],0.083,0,0.0,0.0,0.0,0.0,0.0,0.0,0.071,3.013,0.638,0.082,2.127,,2
CA8,GE_972.2 [Hereditary ataxia],0.083,0,0.0,0.059,0.828,0.0,0.357,0.818,0.055,2.201,3.092,0.101,0.089,0.851,6
GRIN2B,SO_386.5 [Color vision deficiencies],0.083,0,0.0,0.0,0.0,0.0,0.0,0.0,0.073,3.667,0.199,,,0.707,3
MLH1,NS_344.2 [Benign intracranial hypertension],0.083,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.054,3.329,0.311,0.15,0.991,2
MARS2,GE_972.2 [Hereditary ataxia],0.083,0,0.0,0.0,0.772,0.0,0.0,0.802,0.096,,0.646,0.299,1.904,0.674,4
TNFRSF1A,SO_386.5 [Color vision deficiencies],0.082,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.155,0.04,0.013,0.286,1
TNF,GE_978.3 [Osteochondrodysplasias],0.082,0,0.0,0.0,0.0,0.0,0.306,0.0,0.115,,0.306,0.177,0.027,,2
UBE2M,NS_344.2 [Benign intracranial hypertension],0.082,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.168,0.024,,0.234,1
SUN2,GE_972.9 [Muscular dystrophy],0.082,0,0.0,0.0,0.772,0.0,0.0,0.211,0.095,1.703,1.662,0.298,0.112,0.913,4
ROCK2,MS_712.51 [Hypermobility syndrome],0.082,0,0.0,0.0,0.0,0.0,0.0,0.0,0.171,1.725,3.368,0.42,0.189,,2
SORCS1,EM_249.1 [Cerebral amyloid angiopathy*],0.082,0,0.0,0.0,0.0,0.0,0.278,0.0,0.103,3.481,0.66,0.19,0.155,,3
TEAD1,CV_433.3 [Cerebrovascular insufficiency],0.082,0,0.0,0.0,0.0,0.0,0.0,0.0,0.079,2.959,1.655,0.09,0.129,0.464,3
TULP1,NS_341.1 [Cerebral palsy],0.082,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.803,0.204,0.137,0.98,2
RAN,CV_433.3 [Cerebrovascular insufficiency],0.082,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.05,,,0.287,1
NAA30,CM_763.13 [Patent ductus arteriosus],0.082,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.076,0.019,0.021,0.251,1
OGA,MS_712.51 [Hypermobility syndrome],0.082,0,0.0,0.0,0.0,0.0,0.0,0.0,0.146,1.736,1.622,0.106,0.128,,2
PAX3,NS_344.11 [Communicating hydrocephalus],0.082,0,0.0,0.0,0.0,0.0,0.0,0.0,0.526,2.535,0.096,0.162,0.064,,2
WTAP,CV_414.1 [Hypertrophic cardiomyopathy],0.082,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,2.657,0.453,,0.092,0.042,3
CD163,MS_700.43 [Polymyositis],0.082,0,0.0,0.018,0.0,0.0,0.0,0.0,0.447,1.333,4.524,0.096,0.092,,3
PRMT5,MS_700.3 [Systemic sclerosis],0.082,0,0.0,0.0,0.0,0.0,0.0,0.0,0.404,,2.33,0.191,0.161,,2
FOXO6,NS_333.4 [Circadian rhythm sleep disorder],0.082,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.562,2.966,,0.028,0.109,2
RPS29,EM_209.4 [Diabetes insipidus],0.082,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.558,0.034,,,0.178,2
EDNRA,GE_976.5 [Polycystic kidney disease],0.082,0,0.0,0.0,0.0,0.0,0.0,0.0,0.073,2.317,0.453,0.103,0.168,,2
NLRP3,CV_433.3 [Cerebrovascular insufficiency],0.082,0,0.0,0.0,0.304,0.0,0.0,0.0,0.717,1.992,3.038,2.774,1.562,0.861,4
HIF1A,MS_700.3 [Systemic sclerosis],0.082,0,0.0,0.0,0.0,0.0,0.0,0.0,0.637,1.771,1.692,0.337,0.202,,2
BRCA1,BI_179.1 [Hypogammaglobulinemia NOS],0.082,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.883,2.343,0.305,0.213,0.981,2
COL1A2,GE_978.3 [Osteochondrodysplasias],0.082,0,0.0,0.0,0.0,0.0,0.372,0.673,0.092,1.913,2.704,1.011,5.63,,4
BSCL2,NS_323.3 [Motor neuron disease],0.082,0,0.0,0.0,0.644,0.0,0.0,0.725,0.063,3.639,2.155,0.167,0.141,0.758,4
CTSK,MS_727.3 [Osteitis deformans [Paget's disease of bone]],0.082,0,0.0,0.0,0.0,0.0,0.457,0.0,0.059,,2.442,0.177,0.184,,3
PKLR,GE_970.2 [Thalassemia],0.082,1,3.0,0.0,0.0,0.0,0.469,0.0,0.03,,1.56,0.38,0.45,,3
NRXN3,GE_973.5 [Huntington's disease],0.082,0,0.0,0.0,0.0,0.0,0.0,0.0,0.169,3.054,2.713,0.117,0.089,,2
MRTFA,CV_438.41 [Aortic dissection],0.082,0,0.0,0.0,0.0,0.0,0.0,0.0,0.126,1.595,2.742,0.202,0.273,,2
IGF1R,MS_704.1 [Polyarteritis nodosa and related conditions],0.082,0,0.0,0.0,0.0,0.0,0.0,0.0,0.102,2.331,1.61,0.239,0.182,,2
VEGFA,GE_964.3 [Glycogen storage disease],0.082,0,0.0,0.0,0.0,0.0,0.25,0.0,0.108,3.173,2.814,0.174,0.098,,3
RPS27A,CV_433.3 [Cerebrovascular insufficiency],0.082,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.078,0.013,0.021,0.312,1
BANF1,CM_751.213 [Congenital cataract],0.082,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.164,0.075,,,0.262,2
DRD2,MB_296.1 [Paranoid personality disorder],0.082,1,4.0,0.0,0.0,0.0,0.0,0.0,0.189,1.898,0.219,0.112,0.054,,2
SLC6A4,MS_700.3 [Systemic sclerosis],0.082,0,0.0,0.0,0.0,0.0,0.0,0.0,0.116,,3.135,2.622,1.062,,2
CALR,CV_414.1 [Hypertrophic cardiomyopathy],0.082,0,0.0,0.0,0.0,0.0,0.34,0.0,0.204,,2.903,1.601,0.139,0.755,4
SIAH1,RE_484.1 [Spontaneous pneumothorax],0.082,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.013,0.07,,,0.164,2
NR3C1,GE_970.1 [Sickle-cell disorders],0.082,1,3.0,0.0,0.0,0.0,0.0,0.0,0.103,3.017,2.606,0.049,0.092,,2
WDR27,NS_333.4 [Circadian rhythm sleep disorder],0.082,0,0.0,0.0,0.0,0.518,0.0,0.0,0.039,2.902,2.437,0.615,0.142,0.024,3
IGF2BP2,CV_414.1 [Hypertrophic cardiomyopathy],0.082,0,0.0,0.0,0.0,0.0,0.0,0.0,0.128,1.607,1.887,0.192,0.257,0.222,3
STAT5A,GU_580.1 [Acute nephritic syndrome],0.082,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,1.843,2.502,0.394,0.148,0.95,3
FN1,CM_770.5 [Congenital osteodystrophies],0.082,0,0.0,0.0,0.836,0.0,0.0,0.0,0.053,1.778,3.473,0.392,0.145,0.965,4
CYLD,NS_328.13 [Frontotemporal dementia [FTD]],0.082,0,0.0,0.039,0.0,0.0,0.0,0.0,0.149,,0.135,0.115,0.151,,2
POLG2,GE_972.2 [Hereditary ataxia],0.082,0,0.0,0.0,0.547,0.0,0.0,0.197,0.092,,2.254,0.158,1.363,0.952,4
KL,CV_414.1 [Hypertrophic cardiomyopathy],0.082,0,0.0,0.0,0.0,0.0,0.427,0.0,0.102,2.587,2.932,1.582,0.422,0.134,4
HAS2,CV_414.1 [Hypertrophic cardiomyopathy],0.082,0,0.0,0.0,0.0,0.0,0.332,0.0,0.03,4.086,1.582,,0.114,0.273,4
NEFL,GE_972.1 [Hereditary neuropathy],0.082,0,0.0,0.0,0.0,0.0,0.0,0.869,0.155,2.176,4.038,,0.109,,3
NCOA3,CV_433.3 [Cerebrovascular insufficiency],0.082,0,0.0,0.0,0.0,0.0,0.0,0.0,0.17,1.637,3.289,1.052,0.526,0.63,3
SLITRK1,MB_305.1 [Tics and tic disorders],0.082,0,0.0,0.0,0.0,0.0,0.0,0.502,0.12,2.161,0.24,0.079,0.062,,3
SH2B3,BI_162.1 [Constitutional (hereditary) aplastic anemia],0.082,0,0.0,0.0,0.0,0.0,0.434,0.0,0.155,2.943,3.368,0.46,0.111,,3
NAB1,MS_700.3 [Systemic sclerosis],0.082,0,0.0,0.0,0.0,0.611,0.0,0.0,0.141,,2.673,0.22,0.132,,2
CD34,NS_344.2 [Benign intracranial hypertension],0.082,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.206,0.198,0.07,0.958,2
TUBB2B,CV_413.41 [Pulmonary valve stenosis],0.082,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.334,0.046,,,0.312,2
RAPGEF2,NS_323.3 [Motor neuron disease],0.082,0,0.0,0.0,0.547,0.0,0.0,0.0,0.061,1.821,2.981,0.51,0.308,0.137,4
UBE2E3,SO_380.3 [Optic atrophy],0.082,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.47,0.078,,,0.242,2
COL4A1,GE_964.3 [Glycogen storage disease],0.082,0,0.0,0.0,0.0,0.0,0.367,0.0,0.061,2.954,1.942,0.393,0.255,,3
RPS23,RE_484.1 [Spontaneous pneumothorax],0.082,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.385,0.107,,,0.23,2
TMEM186,CV_414.1 [Hypertrophic cardiomyopathy],0.082,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.548,1.932,0.52,1.145,0.962,2
GRIN2B,NS_339.2 [Myotonic disorders],0.082,0,0.0,0.0,0.0,0.0,0.0,0.0,0.103,2.927,0.16,,,,2
TGFBR1,RE_484.1 [Spontaneous pneumothorax],0.082,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.86,2.84,2.554,0.16,0.987,2
DCLK1,NS_323.3 [Motor neuron disease],0.082,0,0.0,0.166,0.0,0.0,0.0,0.0,0.03,3.442,2.851,0.272,0.224,0.327,4
CLU,GU_580.52 [Diffuse membranous glomerulonephritis],0.082,0,0.0,0.0,0.0,0.0,0.622,0.0,0.117,,0.704,0.113,0.099,,2
ADRA2C,CM_770.5 [Congenital osteodystrophies],0.082,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.916,0.91,,0.026,0.197,2
LPAR1,GE_978.3 [Osteochondrodysplasias],0.082,0,0.0,0.0,0.0,0.0,0.0,0.0,0.108,2.672,0.098,0.054,0.085,,2
CNTNAP1,GE_972.2 [Hereditary ataxia],0.082,0,0.0,0.064,0.0,0.0,0.463,0.0,0.042,,3.626,0.689,0.262,0.888,5
FBN2,CV_433.3 [Cerebrovascular insufficiency],0.082,0,0.0,0.0,0.547,0.0,0.0,0.281,0.0,2.195,3.401,0.182,0.414,0.926,3
LMX1B,GU_580.1 [Acute nephritic syndrome],0.082,0,0.0,0.0,0.859,0.0,0.0,0.161,0.067,2.896,0.394,0.113,0.119,0.615,4
GRIN2B,"MB_280.4 [Sedative, hypnotic, or anxiolytic related disorders]",0.082,1,4.0,0.0,0.0,0.0,0.0,0.0,0.038,2.982,3.531,,,,2
TBX1,EM_208.1 [Hypoparathyroidism],0.082,0,0.0,0.0,0.779,0.0,0.0,0.0,0.175,2.659,3.105,0.094,0.128,0.997,4
ZFYVE27,NS_341.1 [Cerebral palsy],0.082,0,0.0,0.0,0.789,0.0,0.0,0.21,0.05,,1.108,0.362,0.162,0.995,3
NRP1,CV_433.3 [Cerebrovascular insufficiency],0.082,0,0.0,0.0,0.0,0.0,0.0,0.0,0.226,2.552,2.676,0.761,0.243,0.959,3
SLC39A8,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.082,0,0.0,0.0,0.0,0.0,0.0,0.0,0.122,2.344,3.217,3.012,0.129,0.234,3
FGFR1,MS_727.3 [Osteitis deformans [Paget's disease of bone]],0.082,0,0.0,0.0,0.0,0.0,0.0,0.0,0.015,1.737,4.775,0.426,0.205,,2
HRH2,GI_516.1 [Pyloric stenosis],0.082,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,1.975,1.836,,0.108,0.171,3
C3orf38,NS_341.1 [Cerebral palsy],0.082,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.295,0.329,0.089,0.999,2
RPL26,BI_179.1 [Hypogammaglobulinemia NOS],0.082,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.053,,,0.24,1
SEC61A1,NS_323.3 [Motor neuron disease],0.082,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.575,0.183,0.045,0.142,0.093,3
GRIN2A,NS_323.3 [Motor neuron disease],0.082,1,3.0,0.0,0.0,0.0,0.0,0.0,0.092,3.416,1.901,0.581,0.345,0.818,3
PEX3,NS_341.1 [Cerebral palsy],0.082,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.384,0.228,0.103,0.985,1
KDR,GE_978.22 [Ehler's Danlos syndrome],0.082,0,0.0,0.0,0.0,0.0,0.0,0.0,0.104,3.29,2.596,0.335,0.139,,2
ANO1,GE_976.5 [Polycystic kidney disease],0.082,0,0.0,0.0,0.0,0.0,0.0,0.0,0.169,2.621,2.427,2.654,0.375,,2
FNIP1,BI_179.1 [Hypogammaglobulinemia NOS],0.082,0,0.0,0.0,0.745,0.0,0.0,0.452,0.109,1.822,1.894,,2.624,0.428,4
NPAS3,NS_323.3 [Motor neuron disease],0.082,0,0.0,0.0,0.0,0.0,0.263,0.0,0.012,3.422,4.702,1.872,0.315,0.084,4
NDUFB6,CV_414.1 [Hypertrophic cardiomyopathy],0.082,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.084,1.339,0.141,0.953,2
NFE2L1,GU_580.1 [Acute nephritic syndrome],0.082,0,0.0,0.0,0.0,0.0,0.0,0.0,0.176,,2.404,0.333,0.173,0.297,3
MYOM1,CV_414.1 [Hypertrophic cardiomyopathy],0.082,0,0.0,0.0,0.86,0.0,0.0,0.208,0.139,2.104,3.07,0.538,0.321,0.902,4
SMAD3,MS_700.3 [Systemic sclerosis],0.082,0,0.0,0.0,0.0,0.0,0.0,0.0,0.434,2.381,0.138,0.067,0.113,,2
FGFR1,GE_978.22 [Ehler's Danlos syndrome],0.082,0,0.0,0.0,0.0,0.0,0.0,0.0,0.094,1.944,1.017,0.203,0.114,,2
TP53,MS_705.2 [Juvenile rheumatoid arthritis [JRA/JIA]],0.082,0,0.0,0.0,0.0,0.0,0.0,0.0,0.087,1.846,0.128,0.077,2.3,,2
CNGA3,SO_380.3 [Optic atrophy],0.082,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.211,0.16,0.174,0.961,2
ENG,MS_712.51 [Hypermobility syndrome],0.082,0,0.0,0.0,0.0,0.0,0.0,0.0,0.231,1.705,2.723,0.951,0.146,,2
GFAP,GE_972.2 [Hereditary ataxia],0.082,0,0.0,0.0,0.547,0.0,0.0,0.0,0.141,,3.302,0.153,0.164,0.987,4
NF1,CM_770.5 [Congenital osteodystrophies],0.082,0,0.0,0.0,0.0,0.0,0.396,0.0,0.058,1.956,2.564,0.306,0.315,0.904,4
HIKESHI,GE_963.1 [Lipid storage disorders],0.081,0,0.0,0.0,0.547,0.0,0.0,0.0,0.088,2.557,0.271,0.047,0.062,,3
FH,CV_414.1 [Hypertrophic cardiomyopathy],0.081,0,0.0,0.0,0.0,0.0,0.0,0.0,0.112,1.386,2.437,0.321,0.269,0.942,3
ITGAM,MS_700.3 [Systemic sclerosis],0.081,0,0.0,0.0,0.0,0.371,0.0,0.0,0.204,,2.36,0.276,0.147,,2
B3GAT3,GE_978.3 [Osteochondrodysplasias],0.081,0,0.0,0.0,0.0,0.0,0.425,0.0,0.189,,3.71,3.422,0.082,,3
COL12A1,GE_978.22 [Ehler's Danlos syndrome],0.081,0,0.0,0.0,0.0,0.0,0.0,0.0,0.084,1.845,3.912,0.402,0.579,,2
WASL,NS_344.11 [Communicating hydrocephalus],0.081,0,0.0,0.0,0.0,0.0,0.0,0.0,0.116,2.651,0.101,0.052,0.052,,2
PEX10,SO_386.6 [Night blindness],0.081,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,4.162,0.288,0.12,0.971,2
HMGA1,SO_386.5 [Color vision deficiencies],0.081,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.52,0.037,,,0.193,2
NEK8,GE_976.5 [Polycystic kidney disease],0.081,0,0.0,0.0,0.0,0.0,0.341,0.503,0.03,,2.133,0.245,0.458,,4
MARCKS,MB_287.2 [Schizoaffective disorder],0.081,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,1.985,2.565,0.038,0.047,,2
SLC7A1,GE_961.1 [Phakomatoses],0.081,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,2.516,1.663,0.153,0.151,0.175,3
DEPDC5,MB_302.1 [Speech and language developmental delay],0.081,0,0.0,0.0,0.0,0.0,0.0,0.564,0.024,,2.491,0.399,0.201,0.376,4
PDE6B,SO_386.5 [Color vision deficiencies],0.081,0,0.0,0.0,0.0,0.0,0.632,0.281,0.035,,2.852,0.68,0.139,0.995,5
POLR3A,NS_341.1 [Cerebral palsy],0.081,0,0.0,0.0,0.859,0.0,0.0,0.0,0.027,2.263,2.907,0.549,0.363,0.961,4
ACTN1,NS_323.3 [Motor neuron disease],0.081,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.439,0.2,0.544,0.339,0.342,3
NAMPT,NS_328.13 [Frontotemporal dementia [FTD]],0.081,0,0.0,0.024,0.0,0.0,0.0,0.0,0.134,2.551,2.35,0.083,2.124,,3
SLC39A13,GE_978.22 [Ehler's Danlos syndrome],0.081,0,0.0,0.0,0.0,0.0,0.271,0.2,0.189,,0.113,0.057,0.101,,3
KCNJ5,EM_211.1 [Adrenal hyperfunction],0.081,0,0.0,0.0,0.84,0.0,0.0,0.209,0.09,2.164,1.238,0.351,0.172,,3
SRC,GE_973.5 [Huntington's disease],0.081,0,0.0,0.0,0.0,0.0,0.0,0.0,0.508,2.615,0.046,0.033,0.058,,2
SPG11,NS_341.1 [Cerebral palsy],0.081,0,0.0,0.0,0.899,0.0,0.0,0.402,0.078,2.112,2.761,0.485,0.362,0.999,4
ETFA,CV_414.1 [Hypertrophic cardiomyopathy],0.081,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.354,1.946,0.424,0.294,0.952,2
NDUFA12,GE_963.1 [Lipid storage disorders],0.081,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.977,0.29,0.097,0.054,0.984,2
PRKCA,CV_433.3 [Cerebrovascular insufficiency],0.081,0,0.0,0.0,0.0,0.0,0.0,0.0,0.208,2.919,0.549,0.115,0.105,0.915,3
FBL,GE_972.1 [Hereditary neuropathy],0.081,0,0.0,0.0,0.0,0.0,0.0,0.0,0.091,1.725,2.858,0.259,0.137,,2
SLC6A3,MB_303.1 [Dyslexia and alexia],0.081,0,0.0,0.0,0.0,0.0,0.0,0.0,0.172,3.086,1.511,0.131,0.093,,2
MITF,GE_978.3 [Osteochondrodysplasias],0.081,0,0.0,0.0,0.0,0.0,0.324,0.0,0.111,1.863,2.963,0.457,0.141,,3
BANK1,BI_179.1 [Hypogammaglobulinemia NOS],0.081,0,0.0,0.0,0.426,0.0,0.0,0.0,0.0,3.235,2.935,0.575,0.173,0.922,3
NDUFA9,NS_341.1 [Cerebral palsy],0.081,1,2.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.614,0.423,0.126,0.989,1
CLN8,GE_963.1 [Lipid storage disorders],0.081,1,0.5,0.0,0.0,0.0,0.287,0.891,0.071,2.491,2.364,0.058,0.027,0.505,5
IDH3B,SO_386.6 [Night blindness],0.081,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.146,0.229,0.149,0.976,2
IRF1,MS_700.3 [Systemic sclerosis],0.081,0,0.0,0.0,0.0,0.472,0.0,0.0,0.246,,0.999,0.094,0.073,,2
SALL4,CM_763.31 [Ventricular septal defect],0.081,0,0.0,0.0,0.684,0.0,0.0,0.0,0.102,2.658,2.424,0.183,1.633,0.851,4
RPS23,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.081,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.8,0.069,,,0.166,2
TAF12,NS_333.4 [Circadian rhythm sleep disorder],0.081,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.139,0.026,0.019,0.306,1
ROCK2,NS_323.3 [Motor neuron disease],0.081,1,2.0,0.0,0.0,0.0,0.0,0.0,0.012,2.227,2.887,0.775,0.687,0.262,3
SPG11,NS_323.3 [Motor neuron disease],0.081,0,0.0,0.0,0.892,0.0,0.302,0.199,0.043,,3.026,0.361,0.099,0.995,5
DNASE1L3,MS_700.3 [Systemic sclerosis],0.081,0,0.0,0.0,0.0,0.524,0.0,0.0,0.146,2.977,1.918,0.451,0.106,,2
COX4I1,NS_341.1 [Cerebral palsy],0.081,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.463,0.079,0.067,0.99,1
UBA52,NS_333.4 [Circadian rhythm sleep disorder],0.081,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.068,,,0.316,1
RAN,GI_516.1 [Pyloric stenosis],0.081,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.1,,,0.234,1
SLC6A3,NS_343.6 [Multi-system degeneration of the autonomic nervous system*],0.081,0,0.0,0.0,0.0,0.0,0.0,0.0,0.397,1.958,1.999,0.093,0.063,,2
DICER1,GE_972.9 [Muscular dystrophy],0.081,0,0.0,0.0,0.0,0.0,0.0,0.0,0.064,1.985,1.256,0.128,0.148,0.797,3
ETS1,GE_972.2 [Hereditary ataxia],0.081,0,0.0,0.0,0.0,0.0,0.0,0.0,0.015,3.975,0.33,0.098,0.145,0.981,3
TEAD1,GE_964.3 [Glycogen storage disease],0.081,0,0.0,0.0,0.0,0.0,0.287,0.0,0.036,2.325,1.72,0.111,0.115,,3
PEX7,GI_516.1 [Pyloric stenosis],0.081,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.903,0.515,0.315,1.075,0.983,2
NAMPT,MB_293.1 [Anorexia nervosa],0.081,0,0.0,0.0,0.0,0.0,0.0,0.0,0.131,2.887,0.316,0.074,0.079,,2
FAM161A,SO_386.5 [Color vision deficiencies],0.081,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.56,0.274,0.103,0.989,1
CNGA1,SO_369.62 [Keratoconus],0.081,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,3.032,2.094,0.136,0.999,2
CXCR3,GE_972.2 [Hereditary ataxia],0.081,0,0.0,0.0,0.0,0.0,0.0,0.0,0.055,2.201,1.661,,0.082,0.222,3
SGCD,CV_414.1 [Hypertrophic cardiomyopathy],0.081,0,0.0,0.0,0.304,0.0,0.623,0.008,0.149,3.238,3.05,1.378,0.253,0.832,5
DES,NS_338.1 [Myasthenia gravis],0.081,0,0.0,0.0,0.0,0.0,0.475,0.0,0.048,,2.489,0.578,0.21,,3
ATXN1,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.081,0,0.0,0.0,0.0,0.0,0.306,0.0,0.109,2.761,3.686,1.873,0.143,0.3,4
FOXO1,MS_727.5 [Cyst of bone],0.081,0,0.0,0.0,0.0,0.0,0.0,0.0,0.096,3.112,2.856,0.061,0.158,,2
ACBD5,GE_963.1 [Lipid storage disorders],0.081,0,0.0,0.0,0.684,0.0,0.266,0.0,0.082,,0.306,0.204,0.096,0.232,4
TFAP2B,MB_293.1 [Anorexia nervosa],0.081,0,0.0,0.0,0.0,0.494,0.0,0.0,0.036,2.152,0.158,0.153,0.104,,2
BANF1,SO_380.3 [Optic atrophy],0.081,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.018,0.101,,,0.199,2
ACAN,MS_728.2 [Osteochondritis dissecans],0.081,0,0.0,0.0,0.813,0.0,0.0,0.786,0.051,,4.1,0.049,2.823,,3
NDUFA11,GE_963.1 [Lipid storage disorders],0.081,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.478,0.031,0.031,0.953,1
CD163,MS_705.2 [Juvenile rheumatoid arthritis [JRA/JIA]],0.081,0,0.0,0.0,0.0,0.0,0.0,0.0,0.214,1.886,2.648,0.086,0.104,,2
BMP4,GE_972.9 [Muscular dystrophy],0.081,0,0.0,0.0,0.0,0.0,0.0,0.0,0.289,3.196,0.264,0.197,0.089,0.736,3
TNFRSF13B,BI_179.4 [Selective deficiency of immunoglobulin A [IgA]],0.081,0,0.0,0.0,0.0,0.0,0.444,0.503,0.227,4.482,2.474,2.114,0.051,,4
GLB1,GE_972.2 [Hereditary ataxia],0.081,0,0.0,0.0,0.547,0.0,0.358,0.37,0.09,2.196,2.976,1.059,0.175,0.937,5
UBE3C,NS_323.3 [Motor neuron disease],0.081,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,1.682,2.028,0.121,0.423,0.041,3
SPAST,NS_341.1 [Cerebral palsy],0.081,0,0.0,0.0,0.9,0.0,0.0,0.453,0.072,2.048,1.53,0.042,6.462,0.999,4
ADRA1B,SO_386.6 [Night blindness],0.081,1,4.0,0.0,0.0,0.0,0.0,0.0,0.0,2.503,2.18,0.205,0.158,0.912,2
NRP1,GU_580.1 [Acute nephritic syndrome],0.081,0,0.0,0.0,0.0,0.0,0.0,0.0,0.097,3.302,3.153,0.264,0.254,0.92,3
HMGA1,CV_416.8 [Pre-excitation syndrome [Anomalous atrioventricular excitation]],0.081,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.045,,,0.294,1
IL15,BI_179.1 [Hypogammaglobulinemia NOS],0.081,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.045,0.155,0.152,0.056,0.95,2
EGFR,GI_542.8 [Biliary cirrhosis],0.081,0,0.0,0.0,0.0,0.0,0.0,0.0,0.13,1.873,2.845,2.779,0.104,,2
NPC1,GE_963.1 [Lipid storage disorders],0.081,1,0.5,0.0,0.547,0.0,0.3,0.837,0.055,,3.037,1.435,0.157,0.292,5
DES,NS_323.3 [Motor neuron disease],0.081,0,0.0,0.0,0.0,0.0,0.412,0.0,0.019,,0.356,0.689,0.629,0.267,3
RPL15,GU_580.1 [Acute nephritic syndrome],0.081,1,1.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.082,,,0.306,1
RAN,CV_414.1 [Hypertrophic cardiomyopathy],0.081,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.573,0.117,,,0.21,2
RPS12,GE_972.9 [Muscular dystrophy],0.081,1,4.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.124,,0.014,0.325,1
COX6A2,CV_414.1 [Hypertrophic cardiomyopathy],0.081,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.471,0.387,0.133,0.947,1
SGPL1,GU_580.1 [Acute nephritic syndrome],0.081,0,0.0,0.0,0.88,0.0,0.0,0.0,0.012,,2.783,0.204,0.144,0.192,4
PEX2,CM_763.31 [Ventricular septal defect],0.081,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.025,0.304,0.228,0.086,0.961,2
ATXN1,GE_973.5 [Huntington's disease],0.081,0,0.0,0.0,0.0,0.0,0.0,0.0,0.19,2.77,0.547,0.14,0.062,,2
SCO1,SO_380.3 [Optic atrophy],0.081,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.67,1.428,0.233,0.123,0.955,2
DRD1,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.081,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,3.13,0.185,0.129,0.118,0.285,3
ALS2,GE_972.2 [Hereditary ataxia],0.081,0,0.0,0.062,0.0,0.0,0.0,0.208,0.164,2.663,2.683,0.468,1.034,0.96,5
VEGFA,GE_972.2 [Hereditary ataxia],0.08,0,0.0,0.0,0.0,0.0,0.0,0.0,0.154,2.197,2.894,0.201,0.134,0.896,3
AHR,DE_669.2 [Behcet's syndrome],0.08,0,0.0,0.0,0.0,0.0,0.0,0.0,0.576,2.692,1.321,0.091,0.098,,2
HIBADH,NS_341.1 [Cerebral palsy],0.08,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.521,0.436,0.223,0.093,0.969,2
ARPC4,CM_763.31 [Ventricular septal defect],0.08,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.058,,,0.308,1
L1CAM,GE_972.2 [Hereditary ataxia],0.08,0,0.0,0.15,0.0,0.0,0.0,0.304,0.073,,2.664,0.146,2.13,0.887,5
RPL15,CM_750.16 [Arnold-Chiari syndrome*],0.08,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.056,,,0.323,1
YPEL5,SO_380.3 [Optic atrophy],0.08,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.341,0.054,,,0.156,2
RPS29,CV_433.3 [Cerebrovascular insufficiency],0.08,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.295,0.05,,,0.225,2
CD163,MS_704.2 [Wegener's granulomatosis],0.08,0,0.0,0.0,0.0,0.0,0.0,0.0,0.108,2.251,2.583,0.139,0.145,,2
COL1A2,MS_712.51 [Hypermobility syndrome],0.08,0,0.0,0.0,0.0,0.0,0.306,0.786,0.087,1.527,2.829,1.421,0.397,,4
MTOR,CM_770.5 [Congenital osteodystrophies],0.08,0,0.0,0.0,0.0,0.0,0.0,0.0,0.057,3.31,3.297,0.279,0.894,0.985,3
SLC4A3,CV_414.1 [Hypertrophic cardiomyopathy],0.08,0,0.0,0.0,0.0,0.0,0.0,0.0,0.369,2.608,2.676,2.548,1.282,0.07,3
RELN,MB_302.1 [Speech and language developmental delay],0.08,0,0.0,0.0,0.0,0.0,0.0,0.553,0.0,2.159,2.632,1.238,0.467,0.984,3
PGK1,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.08,0,0.0,0.0,0.885,0.0,0.0,0.0,0.166,,2.088,0.059,0.128,0.915,4
LAMB2,GU_580.52 [Diffuse membranous glomerulonephritis],0.08,0,0.0,0.0,0.0,0.0,0.5,0.193,0.063,,3.008,1.995,0.252,,4
BMP4,CV_441 [Arteriovenous malformation],0.08,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,2.885,2.688,2.319,0.171,0.927,3
ACTA1,GE_972.9 [Muscular dystrophy],0.08,0,0.0,0.0,0.852,0.0,0.316,0.401,0.115,1.435,0.25,0.05,0.069,0.973,5
SOX2,MB_293.1 [Anorexia nervosa],0.08,0,0.0,0.0,0.0,0.33,0.0,0.0,0.046,4.329,0.137,,0.049,,2
LRP12,GE_972.9 [Muscular dystrophy],0.08,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,2.133,0.64,0.407,0.144,0.152,3
SMAD3,GI_542.8 [Biliary cirrhosis],0.08,0,0.0,0.0,0.0,0.0,0.0,0.0,0.19,3.207,0.101,0.05,0.115,,2
TDRD7,CM_751.213 [Congenital cataract],0.08,0,0.0,0.0,0.426,0.0,0.57,0.49,0.029,1.503,3.508,0.233,1.267,0.956,5
TP53BP1,GE_978.3 [Osteochondrodysplasias],0.08,0,0.0,0.0,0.0,0.0,0.0,0.0,0.152,1.335,0.717,0.385,0.242,,2
UBE2E3,CV_413.41 [Pulmonary valve stenosis],0.08,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.985,0.047,,,0.211,2
PMP22,GE_972.2 [Hereditary ataxia],0.08,0,0.0,0.0,0.0,0.0,0.413,0.621,0.031,2.859,1.952,0.403,0.088,0.845,5
DCLK1,CV_414.1 [Hypertrophic cardiomyopathy],0.08,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,2.212,1.297,1.19,0.851,0.066,3
ITM2B,EM_249.1 [Cerebral amyloid angiopathy*],0.08,0,0.0,0.0,0.0,0.0,0.0,0.777,0.16,1.931,2.693,2.622,0.067,,3
MAP3K7,CV_433.3 [Cerebrovascular insufficiency],0.08,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.089,1.356,0.153,0.147,0.906,3
PALB2,CV_441 [Arteriovenous malformation],0.08,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.409,0.172,0.315,0.979,2
TRIM8,GU_580.52 [Diffuse membranous glomerulonephritis],0.08,0,0.0,0.0,0.0,0.0,0.0,0.43,0.217,2.78,0.904,0.176,0.035,,3
CHD4,CM_763.31 [Ventricular septal defect],0.08,0,0.0,0.0,0.58,0.0,0.265,0.0,0.047,,2.258,0.188,0.21,0.882,5
CYLD,CV_433.3 [Cerebrovascular insufficiency],0.08,0,0.0,0.0,0.0,0.0,0.0,0.0,0.112,,3.686,3.293,0.14,0.584,3
TUBA1B,BI_179.1 [Hypogammaglobulinemia NOS],0.08,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.189,,,0.294,1
TUBB2B,EM_209.4 [Diabetes insipidus],0.08,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.082,,,0.224,1
GRHL3,NS_323.3 [Motor neuron disease],0.08,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,1.521,2.92,0.506,0.653,0.003,3
FGA,CV_433.3 [Cerebrovascular insufficiency],0.08,1,3.0,0.0,0.182,0.612,0.0,0.0,0.012,,2.645,1.513,0.107,0.435,4
WNK1,NS_323.3 [Motor neuron disease],0.08,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,2.76,2.384,0.363,1.712,0.22,3
AHR,MS_700.3 [Systemic sclerosis],0.08,0,0.0,0.0,0.0,0.0,0.0,0.0,0.183,2.339,4.308,0.183,1.187,,2
MYO9A,GU_580.51 [Focal and segmental glomerular lesions*],0.08,0,0.0,0.0,0.0,0.0,0.688,0.172,0.09,1.791,2.019,0.667,0.106,,4
SLC4A1,GU_580.1 [Acute nephritic syndrome],0.08,0,0.0,0.0,0.0,0.0,0.0,0.0,0.065,1.689,3.659,0.78,1.29,0.173,3
CLCN3,CV_414.1 [Hypertrophic cardiomyopathy],0.08,0,0.0,0.0,0.0,0.0,0.0,0.0,0.021,2.153,2.105,0.322,0.176,0.099,3
RICTOR,GE_973.5 [Huntington's disease],0.08,0,0.0,0.0,0.0,0.0,0.0,0.0,0.111,1.974,0.315,0.195,0.092,,2
KIF5A,CV_433.3 [Cerebrovascular insufficiency],0.08,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,1.749,2.186,0.466,0.184,0.16,3
NDUFV1,CM_763.31 [Ventricular septal defect],0.08,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,3.33,1.782,0.198,0.957,2
CYLD,NS_323.3 [Motor neuron disease],0.08,0,0.0,0.062,0.656,0.0,0.0,0.0,0.127,2.523,0.143,0.164,0.22,0.489,5
PRDM16,CV_414.1 [Hypertrophic cardiomyopathy],0.08,0,0.0,0.0,0.772,0.0,0.0,0.129,0.091,2.159,4.992,1.625,0.294,0.607,4
APOB,GE_972.2 [Hereditary ataxia],0.08,0,0.0,0.0,0.654,0.0,0.0,0.129,0.147,2.581,3.728,0.427,0.232,0.923,4
VEGFA,GE_972.9 [Muscular dystrophy],0.08,1,0.5,0.0,0.0,0.0,0.0,0.0,0.103,2.277,0.137,0.138,0.088,0.748,3
CPEB4,GE_963.1 [Lipid storage disorders],0.08,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,2.659,0.19,0.096,0.082,0.051,3
MYB,MS_700.3 [Systemic sclerosis],0.08,0,0.0,0.0,0.0,0.0,0.0,0.0,0.126,1.713,1.965,0.556,0.844,,2
LGI1,DE_669.2 [Behcet's syndrome],0.08,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,2.151,0.117,0.105,0.091,,2
IDH2,GE_978.3 [Osteochondrodysplasias],0.08,0,0.0,0.0,0.0,0.0,0.27,0.442,0.099,,0.122,0.091,0.146,,3
SPIN1,CM_770.5 [Congenital osteodystrophies],0.08,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.875,0.043,0.037,,0.27,2
COX4I1,GE_963.1 [Lipid storage disorders],0.08,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.425,0.144,0.043,0.051,0.984,2
TNFAIP3,DE_669.2 [Behcet's syndrome],0.08,0,0.0,0.0,0.0,0.0,0.0,0.0,0.269,4.613,2.31,0.174,1.951,,2
SETBP1,GU_580.1 [Acute nephritic syndrome],0.08,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,2.839,2.739,0.481,0.242,0.169,3
KDR,MS_700.3 [Systemic sclerosis],0.08,1,4.0,0.0,0.0,0.0,0.0,0.0,0.383,2.781,2.936,0.99,0.258,,2
SAMHD1,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.08,0,0.0,0.0,0.0,0.0,0.0,0.898,0.174,,2.243,0.261,0.198,0.838,4
G6PD,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.08,0,0.0,0.0,0.898,0.0,0.0,0.129,0.0,,2.089,0.473,3.773,0.98,3
NDUFA3,GE_972.2 [Hereditary ataxia],0.08,1,4.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.145,0.175,0.067,0.927,1
KCNQ5,GE_972.9 [Muscular dystrophy],0.08,0,0.0,0.0,0.0,0.0,0.0,0.0,0.091,1.991,3.557,3.937,0.084,0.155,3
CD2AP,GU_580.1 [Acute nephritic syndrome],0.08,0,0.0,0.0,0.87,0.0,0.0,0.01,0.046,1.937,1.415,0.283,1.677,0.846,4
CRMP1,GE_973.5 [Huntington's disease],0.08,0,0.0,0.0,0.0,0.0,0.0,0.0,0.623,2.217,0.196,0.053,0.061,,2
FLNC,GE_961.1 [Phakomatoses],0.08,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,1.623,3.282,0.536,0.515,0.288,3
TTN,NS_338.1 [Myasthenia gravis],0.08,0,0.0,0.0,0.0,0.0,0.263,0.0,0.219,1.407,3.857,1.132,0.173,,3
COLQ,NS_338.1 [Myasthenia gravis],0.08,0,0.0,0.0,0.0,0.0,0.0,0.829,0.104,,3.248,1.664,0.639,,3
ZC3H12A,GI_542.8 [Biliary cirrhosis],0.08,0,0.0,0.0,0.0,0.0,0.0,0.0,0.44,1.383,2.536,0.514,0.182,,2
CSF1R,NS_323.3 [Motor neuron disease],0.08,1,4.0,0.0,0.654,0.0,0.0,0.0,0.078,1.839,4.029,0.398,0.257,0.931,4
TRIM24,NS_340.3 [Inflammatory and immune myopathies],0.08,0,0.0,0.0,0.0,0.0,0.0,0.0,0.102,2.448,0.406,0.094,0.058,,2
FIG4,GE_972.1 [Hereditary neuropathy],0.08,0,0.0,0.0,0.0,0.0,0.286,0.637,0.095,,2.415,1.034,0.291,,4
UQCRC2,GE_963.1 [Lipid storage disorders],0.08,0,0.0,0.0,0.426,0.0,0.0,0.0,0.0,1.358,0.558,0.09,0.086,0.965,3
AGL,GE_972.9 [Muscular dystrophy],0.08,0,0.0,0.0,0.684,0.0,0.309,0.0,0.036,3.452,2.696,0.177,0.247,0.283,5
KITLG,CV_433.3 [Cerebrovascular insufficiency],0.08,0,0.0,0.0,0.0,0.0,0.0,0.0,0.142,2.827,1.927,0.094,0.091,0.927,3
SPART,GE_972.2 [Hereditary ataxia],0.08,0,0.0,0.0,0.654,0.0,0.0,0.242,0.07,1.437,1.735,0.382,0.231,,3
EFNB2,CV_433.3 [Cerebrovascular insufficiency],0.08,0,0.0,0.0,0.0,0.0,0.0,0.0,0.104,3.556,2.084,0.088,0.065,0.799,3
HLA-A,GE_973.5 [Huntington's disease],0.08,0,0.0,0.0,0.0,0.0,0.0,0.0,0.169,1.68,2.826,0.041,0.044,,2
RPL27A,CM_751.213 [Congenital cataract],0.08,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.094,,,0.198,1
BACE1,NS_340.3 [Inflammatory and immune myopathies],0.08,0,0.0,0.0,0.0,0.0,0.0,0.0,0.252,3.301,0.134,0.079,0.057,,2
SMAD3,GE_972.2 [Hereditary ataxia],0.08,0,0.0,0.0,0.0,0.0,0.0,0.0,0.206,2.363,2.176,0.077,0.086,0.92,3
TSN,GI_516.1 [Pyloric stenosis],0.08,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.802,0.073,,1.96,0.094,2
FLG,DE_663.1 [Pemphigus],0.08,0,0.0,0.0,0.0,0.0,0.413,0.0,0.018,,4.156,1.152,0.246,,3
MYB,GE_970.2 [Thalassemia],0.08,0,0.0,0.0,0.0,0.0,0.479,0.0,0.051,,0.929,0.134,0.135,,2
YPEL5,CM_751.213 [Congenital cataract],0.08,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.682,0.043,,,0.17,2
AIRE,EM_208.1 [Hypoparathyroidism],0.08,0,0.0,0.0,0.897,0.0,0.0,0.0,0.152,,4.166,2.787,0.215,0.91,4
RPL15,SO_380.3 [Optic atrophy],0.08,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.076,,,0.319,1
ANKHD1-EIF4EBP3,CV_413.41 [Pulmonary valve stenosis],0.08,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.06,0.048,,0.177,1
NAMPT,"EM_209.11 [Tall stature, acromegaly and gigantism]",0.08,0,0.0,0.0,0.0,0.0,0.0,0.0,0.337,3.194,3.113,2.99,0.042,,2
ADARB1,GE_972.2 [Hereditary ataxia],0.08,0,0.0,0.053,0.0,0.0,0.0,0.0,0.012,1.987,0.16,0.148,0.155,0.341,4
GATA6,CM_763.13 [Patent ductus arteriosus],0.08,0,0.0,0.0,0.0,0.0,0.0,0.0,0.015,2.062,0.134,,3.238,0.913,3
SLC6A3,GE_961.1 [Phakomatoses],0.08,1,4.0,0.0,0.0,0.0,0.0,0.0,0.018,,0.884,0.211,1.508,0.187,3
EZH2,GE_976.5 [Polycystic kidney disease],0.08,0,0.0,0.0,0.0,0.0,0.0,0.0,0.055,2.561,0.414,0.082,0.142,,2
SMAD3,GE_978.22 [Ehler's Danlos syndrome],0.08,0,0.0,0.0,0.0,0.0,0.0,0.484,0.118,3.355,0.061,0.025,0.06,,3
ISL1,CV_414.1 [Hypertrophic cardiomyopathy],0.08,0,0.0,0.0,0.0,0.0,0.0,0.0,0.048,3.658,1.887,0.16,1.547,0.325,3
PTPRD,DE_663.1 [Pemphigus],0.08,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,3.008,4.535,2.796,0.868,,2
HTR2C,CV_433.3 [Cerebrovascular insufficiency],0.08,1,4.0,0.0,0.0,0.0,0.0,0.0,0.0,2.963,3.693,,0.024,0.181,2
FOXP1,NS_323.3 [Motor neuron disease],0.08,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.847,0.063,,,0.262,2
OTX2,NS_323.3 [Motor neuron disease],0.08,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.906,1.242,,0.077,0.212,3
RPS29,GE_972.2 [Hereditary ataxia],0.08,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.953,0.056,,,0.307,2
SHANK2,GE_961.1 [Phakomatoses],0.08,0,0.0,0.0,0.0,0.0,0.0,0.0,0.036,1.874,3.687,1.37,0.241,0.294,3
GP1BA,GE_971.14 [Von Willebrand's disease],0.08,0,0.0,0.0,0.0,0.0,0.46,0.827,0.075,,3.514,1.938,0.075,,4
RPL15,CM_770.5 [Congenital osteodystrophies],0.08,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.058,,,0.316,1
TNFRSF11B,GE_972.1 [Hereditary neuropathy],0.08,0,0.0,0.0,0.0,0.0,0.33,0.0,0.122,3.098,2.698,0.159,0.139,,3
UBE2E3,CM_770.5 [Congenital osteodystrophies],0.08,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.075,0.076,,,0.281,2
CHEK1,CV_441 [Arteriovenous malformation],0.08,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,3.08,0.495,0.155,0.988,2
PDE6C,SO_369.62 [Keratoconus],0.08,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,3.676,0.404,0.272,0.996,2
VEGFA,GE_976.5 [Polycystic kidney disease],0.08,1,2.0,0.0,0.0,0.0,0.0,0.0,0.133,2.305,2.654,3.12,0.151,,2
AGRN,NS_338.1 [Myasthenia gravis],0.08,0,0.0,0.0,0.0,0.0,0.262,0.475,0.113,,2.984,0.134,0.186,,4
RPL32,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.08,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.692,0.2,,,0.242,2
TP53,GE_972.9 [Muscular dystrophy],0.079,0,0.0,0.0,0.304,0.0,0.0,0.0,0.153,1.944,3.35,0.079,0.075,0.986,4
PCSK9,CV_433.3 [Cerebrovascular insufficiency],0.079,1,4.0,0.0,0.304,0.0,0.0,0.0,0.1,1.511,2.745,0.353,0.198,0.516,4
PEX6,CM_763.31 [Ventricular septal defect],0.079,0,0.0,0.0,0.532,0.0,0.0,0.0,0.0,1.691,2.978,0.965,0.191,0.972,3
BCL2,CV_433.3 [Cerebrovascular insufficiency],0.079,0,0.0,0.0,0.0,0.0,0.0,0.0,0.16,1.893,0.117,0.034,0.071,0.985,3
GRIN2B,CV_438.41 [Aortic dissection],0.079,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.85,1.911,,,0.213,2
NLRP3,NS_340.3 [Inflammatory and immune myopathies],0.079,0,0.0,0.0,0.0,0.0,0.0,0.0,0.295,2.946,4.339,3.119,0.066,,2
MYLK2,CV_414.1 [Hypertrophic cardiomyopathy],0.079,0,0.0,0.0,0.817,0.0,0.0,0.638,0.08,,2.965,0.053,0.118,0.842,4
HSD11B1,EM_211.1 [Adrenal hyperfunction],0.079,1,2.0,0.0,0.0,0.0,0.407,0.0,0.073,1.962,1.0,0.061,0.147,,3
SPIN1,SO_386.5 [Color vision deficiencies],0.079,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.179,0.036,0.026,,0.166,2
RPS11,CM_751.213 [Congenital cataract],0.079,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.573,,0.021,0.305,1
BDNF,NS_323.3 [Motor neuron disease],0.079,0,0.0,0.0,0.0,0.0,0.0,0.0,0.125,2.523,1.331,0.226,1.343,0.967,3
APP,SO_380.3 [Optic atrophy],0.079,0,0.0,0.0,0.0,0.0,0.0,0.0,0.036,1.749,3.359,1.113,0.223,0.989,3
WNK2,CV_441 [Arteriovenous malformation],0.079,0,0.0,0.0,0.0,0.0,0.0,0.0,0.017,2.054,3.214,3.317,0.631,0.088,3
BGN,MS_712.51 [Hypermobility syndrome],0.079,0,0.0,0.0,0.0,0.0,0.278,0.0,0.101,,2.722,0.376,0.135,,3
HNRNPC,GU_580.1 [Acute nephritic syndrome],0.079,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.816,0.069,,,0.149,2
UBA52,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.079,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.076,,,0.322,1
KDR,CM_770.5 [Congenital osteodystrophies],0.079,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,2.626,3.718,0.143,0.201,0.921,3
STAU1,NS_323.3 [Motor neuron disease],0.079,0,0.0,0.0,0.0,0.0,0.0,0.0,0.024,1.676,1.96,0.375,0.185,0.312,3
CDKN2B,NS_333.4 [Circadian rhythm sleep disorder],0.079,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.892,2.934,0.04,0.067,0.448,3
SYNE1,CV_414.1 [Hypertrophic cardiomyopathy],0.079,0,0.0,0.0,0.0,0.0,0.275,0.0,0.017,2.049,4.525,0.73,0.478,0.907,4
GABRQ,NS_328.13 [Frontotemporal dementia [FTD]],0.079,0,0.0,0.0,0.0,0.0,0.0,0.0,0.258,1.877,2.314,,0.091,,2
POMK,SO_380.3 [Optic atrophy],0.079,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.917,3.158,0.14,0.128,0.952,2
EDNRA,GU_580.1 [Acute nephritic syndrome],0.079,1,1.0,0.0,0.0,0.0,0.0,0.0,0.08,1.976,0.103,0.087,0.113,0.58,3
TTPA,GE_972.2 [Hereditary ataxia],0.079,0,0.0,0.0,0.848,0.0,0.287,0.884,0.076,1.605,1.858,0.245,0.108,0.649,5
APC,GE_977.1 [Congenital ichthyosis],0.079,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,1.955,3.772,1.82,0.242,0.08,3
C6orf118,CV_414.1 [Hypertrophic cardiomyopathy],0.079,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.147,2.862,0.205,0.177,0.946,2
TTC21B,GU_580.52 [Diffuse membranous glomerulonephritis],0.079,0,0.0,0.0,0.0,0.0,0.0,0.402,0.102,2.973,2.779,0.21,0.211,,3
PKD2,GU_580.1 [Acute nephritic syndrome],0.079,0,0.0,0.0,0.532,0.0,0.602,0.29,0.049,1.874,2.693,0.221,0.16,0.525,5
RPL9,MB_302.1 [Speech and language developmental delay],0.079,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.139,0.029,,0.223,1
MTOR,MS_719.2 [Muscle calcification and ossification],0.079,0,0.0,0.0,0.0,0.0,0.0,0.0,0.103,1.79,2.686,0.165,0.116,,2
RPL27A,GU_580.1 [Acute nephritic syndrome],0.079,1,1.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.098,,,0.241,1
COL4A1,NS_347.1 [Cerebral cysts],0.079,0,0.0,0.0,0.0,0.0,0.0,0.719,0.112,2.906,3.198,0.522,0.346,,3
FOXO3,CV_433.3 [Cerebrovascular insufficiency],0.079,0,0.0,0.0,0.0,0.0,0.0,0.0,0.108,3.06,2.677,0.244,0.093,0.868,3
PRX,GE_972.1 [Hereditary neuropathy],0.079,0,0.0,0.0,0.0,0.0,0.285,0.778,0.115,,2.873,1.493,0.31,,4
UBE2L3,GE_972.9 [Muscular dystrophy],0.079,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.053,,,0.283,1
GNAT1,SO_386.6 [Night blindness],0.079,0,0.0,0.0,0.864,0.0,0.0,0.7,0.085,,2.626,1.42,1.879,0.998,4
BCL2,NS_344.2 [Benign intracranial hypertension],0.079,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.988,0.093,0.024,0.083,0.992,2
GRIA1,"MB_280.4 [Sedative, hypnotic, or anxiolytic related disorders]",0.079,0,0.0,0.0,0.0,0.0,0.0,0.0,0.068,2.221,0.796,0.171,0.156,,2
PCYT1A,CM_770.5 [Congenital osteodystrophies],0.079,0,0.0,0.0,0.0,0.0,0.0,0.858,0.012,,0.192,0.278,0.126,0.777,3
ERLIN2,GE_972.2 [Hereditary ataxia],0.079,0,0.0,0.0,0.0,0.0,0.0,0.774,0.243,,0.202,0.133,1.74,0.814,4
AR,CM_772.1 [Congenital malformations of endocrine glands],0.079,0,0.0,0.0,0.0,0.0,0.0,0.0,0.044,2.317,3.143,,0.021,,2
QKI,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.079,0,0.0,0.0,0.0,0.0,0.31,0.0,0.049,3.217,0.248,0.042,0.061,0.229,4
COL1A2,GE_978.21 [Marfan syndrome],0.079,0,0.0,0.0,0.0,0.0,0.0,0.121,0.072,2.117,2.9,0.105,0.127,,3
KIT,GI_516.1 [Pyloric stenosis],0.079,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,2.474,1.745,0.256,0.236,0.926,3
GJC2,NS_341.1 [Cerebral palsy],0.079,0,0.0,0.0,0.816,0.0,0.0,0.587,0.052,,0.676,0.161,0.118,0.98,3
UBE2D3,CV_441 [Arteriovenous malformation],0.079,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.076,,,0.261,1
GRIN2B,GE_961.1 [Phakomatoses],0.079,0,0.0,0.0,0.0,0.0,0.0,0.0,0.359,2.441,2.88,,,0.378,3
ARHGEF12,GE_972.9 [Muscular dystrophy],0.079,0,0.0,0.0,0.0,0.0,0.0,0.0,0.097,,2.753,0.135,0.147,0.128,3
BMP4,GU_580.1 [Acute nephritic syndrome],0.079,0,0.0,0.0,0.547,0.0,0.306,0.0,0.033,2.126,3.681,1.055,1.718,0.971,5
RORB,MS_727.3 [Osteitis deformans [Paget's disease of bone]],0.079,0,0.0,0.0,0.0,0.0,0.0,0.0,0.073,2.155,0.177,0.095,0.071,,2
UBE2E3,CM_750.16 [Arnold-Chiari syndrome*],0.079,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.223,0.045,,,0.217,2
NFKB1,CV_433.3 [Cerebrovascular insufficiency],0.079,0,0.0,0.0,0.0,0.0,0.0,0.0,0.164,2.177,1.833,0.376,0.144,0.984,3
NUMA1,DE_669.2 [Behcet's syndrome],0.079,0,0.0,0.0,0.0,0.0,0.0,0.0,0.304,1.381,3.987,2.274,0.193,,2
RPS29,BI_162.1 [Constitutional (hereditary) aplastic anemia],0.079,0,0.0,0.0,0.813,0.0,0.0,0.715,0.119,3.382,0.026,,,,3
RLBP1,SO_386.6 [Night blindness],0.079,0,0.0,0.0,0.745,0.0,0.0,0.129,0.036,,2.027,0.273,0.11,1.0,4
SRSF1,RE_484.1 [Spontaneous pneumothorax],0.079,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.076,,,0.269,1
TRIP4,GE_972.9 [Muscular dystrophy],0.079,0,0.0,0.0,0.547,0.0,0.0,0.0,0.046,,2.208,0.223,0.123,0.12,4
PLA2R1,GU_580.1 [Acute nephritic syndrome],0.079,0,0.0,0.0,0.248,0.0,0.0,0.184,0.105,1.711,3.319,1.08,0.297,0.338,4
ACLY,GE_976.5 [Polycystic kidney disease],0.079,0,0.0,0.0,0.0,0.0,0.0,0.0,0.307,,2.263,0.282,0.319,,2
SYK,MS_704.1 [Polyarteritis nodosa and related conditions],0.079,0,0.0,0.0,0.0,0.0,0.0,0.0,0.084,2.485,0.166,0.157,0.094,,2
TEK,GE_972.9 [Muscular dystrophy],0.079,0,0.0,0.0,0.0,0.0,0.0,0.0,0.117,2.354,2.31,0.174,0.141,0.659,3
DRD2,EM_209.13 [Hyperprolactinemia*],0.079,1,4.0,0.0,0.0,0.0,0.319,0.0,0.069,1.573,1.757,0.306,0.135,,3
UBE2L3,CM_770.5 [Congenital osteodystrophies],0.079,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.074,,,0.258,1
HMGCR,MS_700.3 [Systemic sclerosis],0.079,1,3.0,0.0,0.0,0.0,0.0,0.0,0.271,,0.383,0.426,0.236,,1
LPAR1,CV_414.1 [Hypertrophic cardiomyopathy],0.079,0,0.0,0.0,0.0,0.0,0.0,0.0,0.612,2.686,2.198,0.098,0.186,0.124,3
PTK2,MS_700.3 [Systemic sclerosis],0.079,0,0.0,0.0,0.0,0.0,0.0,0.0,0.101,1.733,3.052,1.571,0.249,,2
MPL,BI_162.1 [Constitutional (hereditary) aplastic anemia],0.079,1,2.0,0.0,0.532,0.0,0.438,0.0,0.035,,0.187,0.138,0.085,,3
RBM24,GI_540.11 [Autoimmune hepatitis],0.079,0,0.0,0.0,0.0,0.0,0.0,0.0,0.182,2.863,0.186,0.047,0.063,,2
TNRC6A,SO_369.62 [Keratoconus],0.079,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.965,2.326,0.446,0.304,0.185,3
PARP14,MS_700.3 [Systemic sclerosis],0.079,0,0.0,0.0,0.0,0.0,0.0,0.0,0.318,,2.526,0.217,0.239,,2
TSC1,GE_961.1 [Phakomatoses],0.079,0,0.0,0.0,0.0,0.0,0.254,0.724,0.123,1.686,3.018,2.001,9.716,0.966,5
CHRM3,MS_700.3 [Systemic sclerosis],0.079,0,0.0,0.0,0.0,0.0,0.0,0.0,0.092,2.281,2.136,0.119,0.139,,2
RUNX1,GE_977.6 [Congenital cutaneous mastocytosis*],0.079,0,0.0,0.0,0.0,0.0,0.0,0.0,0.13,2.958,0.11,0.135,0.07,,2
IRF4,GU_580.1 [Acute nephritic syndrome],0.079,0,0.0,0.0,0.0,0.0,0.0,0.0,0.091,1.918,0.347,0.081,2.187,0.944,3
CALM1,CM_751.213 [Congenital cataract],0.079,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.457,0.061,,,0.156,2
CARD11,MS_727.5 [Cyst of bone],0.079,0,0.0,0.0,0.0,0.0,0.0,0.0,0.491,2.194,2.32,0.129,0.214,,2
CRYBB1,CM_751.213 [Congenital cataract],0.079,0,0.0,0.0,0.817,0.0,0.0,0.438,0.071,2.99,4.364,3.983,0.139,0.99,4
VSX2,SO_386.6 [Night blindness],0.079,0,0.0,0.0,0.654,0.0,0.0,0.0,0.03,1.457,0.216,0.308,0.138,0.971,4
HDGF,GE_972.2 [Hereditary ataxia],0.079,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,3.279,,0.021,0.29,2
FBXL4,CV_414.1 [Hypertrophic cardiomyopathy],0.079,0,0.0,0.0,0.547,0.0,0.0,0.0,0.012,2.312,2.756,0.59,0.473,0.937,4
YY1,GE_961.1 [Phakomatoses],0.079,0,0.0,0.0,0.0,0.0,0.0,0.0,0.096,3.252,2.506,,,0.766,3
MEGF10,GE_972.9 [Muscular dystrophy],0.079,0,0.0,0.037,0.732,0.0,0.0,0.0,0.061,1.325,2.424,0.173,0.224,0.333,5
PXK,MS_700.3 [Systemic sclerosis],0.079,0,0.0,0.0,0.0,0.262,0.0,0.0,0.1,4.201,2.774,0.402,0.19,,2
SIAH1,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.079,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.427,0.047,,,0.244,2
PCDH10,GE_972.9 [Muscular dystrophy],0.079,0,0.0,0.0,0.0,0.0,0.0,0.0,0.061,3.032,0.543,0.121,0.118,0.251,3
NFKB1,SO_365.3 [Exophthalmos [Proptosis]],0.079,0,0.0,0.0,0.304,0.0,0.0,0.0,0.054,3.634,2.049,0.619,0.197,0.959,4
DNAJC6,CV_414.1 [Hypertrophic cardiomyopathy],0.079,0,0.0,0.0,0.0,0.0,0.0,0.0,0.024,2.005,3.26,1.918,0.354,0.112,3
CCN2,GE_972.2 [Hereditary ataxia],0.079,0,0.0,0.0,0.0,0.0,0.269,0.0,0.106,2.572,0.753,0.127,0.139,,3
ASTN1,GE_972.9 [Muscular dystrophy],0.079,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,1.787,2.637,0.412,0.207,0.17,3
ATP2B4,GE_972.2 [Hereditary ataxia],0.079,0,0.0,0.0,0.0,0.0,0.0,0.0,0.243,1.652,3.224,1.904,0.188,0.87,3
SEPTIN9,GE_972.1 [Hereditary neuropathy],0.079,0,0.0,0.0,0.0,0.0,0.0,0.192,0.097,2.532,1.879,0.467,0.153,,3
KIAA0319L,MB_303.1 [Dyslexia and alexia],0.079,0,0.0,0.0,0.0,0.0,0.0,0.0,0.111,,3.619,3.079,0.113,,2
ZIC1,GE_972.2 [Hereditary ataxia],0.079,0,0.0,0.126,0.0,0.0,0.45,0.0,0.024,1.985,0.47,0.074,1.792,0.472,5
FXN,CV_414.1 [Hypertrophic cardiomyopathy],0.079,0,0.0,0.0,0.547,0.0,0.0,0.129,0.094,4.12,0.366,0.256,1.467,0.797,4
UFM1,GE_963.1 [Lipid storage disorders],0.079,0,0.0,0.0,0.0,0.0,0.0,0.814,0.06,2.965,0.052,0.05,0.022,0.078,4
PRDM1,BI_179.7 [Common variable immunodeficiency [CVID]],0.079,0,0.0,0.0,0.0,0.0,0.256,0.0,0.355,1.936,2.893,0.133,0.055,,3
ADA,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.079,0,0.0,0.0,0.547,0.0,0.0,0.0,0.079,2.663,2.683,0.439,0.163,0.98,4
ARID3A,MS_700.3 [Systemic sclerosis],0.079,0,0.0,0.0,0.0,0.0,0.0,0.0,0.255,2.692,2.307,0.241,0.139,,2
IL18,GE_961.1 [Phakomatoses],0.079,0,0.0,0.0,0.0,0.0,0.0,0.0,0.13,2.84,3.869,0.036,0.026,0.614,3
MAPK8,CV_433.3 [Cerebrovascular insufficiency],0.079,0,0.0,0.0,0.0,0.0,0.0,0.0,0.262,1.954,2.595,2.583,0.08,0.976,3
RPL14,GE_972.9 [Muscular dystrophy],0.079,1,4.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.165,,0.014,0.294,2
UBA52,GI_516.1 [Pyloric stenosis],0.079,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.132,,,0.231,1
PJA1,NS_323.3 [Motor neuron disease],0.079,0,0.0,0.0,0.0,0.0,0.0,0.0,0.033,2.645,1.717,,0.043,0.025,3
KLF1,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.079,0,0.0,0.0,0.855,0.0,0.359,0.0,0.111,,1.331,1.201,0.086,0.978,5
BAG3,CV_414.1 [Hypertrophic cardiomyopathy],0.079,0,0.0,0.0,0.809,0.633,0.0,0.152,0.069,1.638,1.784,0.13,0.206,0.893,4
BCL2L11,MS_704.1 [Polyarteritis nodosa and related conditions],0.079,0,0.0,0.0,0.0,0.465,0.297,0.0,0.068,1.919,0.176,0.171,0.103,,3
RAE1,NS_323.3 [Motor neuron disease],0.078,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,1.637,1.69,0.557,0.167,0.145,3
CERKL,SO_386.6 [Night blindness],0.078,0,0.0,0.0,0.547,0.0,0.338,0.29,0.078,1.977,3.344,0.077,0.151,1.0,5
KIAA0586,GE_972.2 [Hereditary ataxia],0.078,0,0.0,0.0,0.547,0.0,0.0,0.0,0.053,1.493,2.705,0.443,0.282,0.988,4
RPL17,CV_413.41 [Pulmonary valve stenosis],0.078,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.549,0.084,,,0.256,2
MMP3,RE_484.1 [Spontaneous pneumothorax],0.078,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.708,2.699,0.288,0.127,0.962,2
COL3A1,CV_414.1 [Hypertrophic cardiomyopathy],0.078,0,0.0,0.0,0.0,0.0,0.0,0.0,0.065,2.381,1.884,0.212,0.321,0.362,3
UBE2L3,NS_344.2 [Benign intracranial hypertension],0.078,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.802,0.053,,,0.324,2
OBSCN,CV_414.1 [Hypertrophic cardiomyopathy],0.078,0,0.0,0.0,0.884,0.0,0.734,0.004,0.185,3.788,3.467,2.53,0.029,0.84,5
MYH7,CV_416.8 [Pre-excitation syndrome [Anomalous atrioventricular excitation]],0.078,0,0.0,0.0,0.684,0.0,0.0,0.391,0.116,,3.231,2.443,0.132,0.972,4
CACNA1F,SO_369.62 [Keratoconus],0.078,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.901,0.264,0.248,0.994,2
RPL26,GI_516.1 [Pyloric stenosis],0.078,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.102,,,0.208,1
CALM2,CV_441 [Arteriovenous malformation],0.078,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.186,0.049,,,0.288,2
UCK2,CM_763.13 [Patent ductus arteriosus],0.078,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.045,0.012,0.022,0.229,1
PLCB1,MS_704.1 [Polyarteritis nodosa and related conditions],0.078,0,0.0,0.0,0.0,0.0,0.0,0.0,0.12,2.931,2.952,0.155,0.129,,2
ADRA2C,GU_580.1 [Acute nephritic syndrome],0.078,1,4.0,0.0,0.0,0.0,0.0,0.0,0.0,2.587,1.6,,0.028,0.213,2
USP15,MS_700.3 [Systemic sclerosis],0.078,1,0.5,0.0,0.0,0.0,0.0,0.0,0.315,1.688,2.133,0.17,0.173,,2
SV2A,NS_323.3 [Motor neuron disease],0.078,0,0.0,0.0,0.426,0.0,0.0,0.0,0.012,,2.865,0.234,0.226,0.242,4
MFSD8,GE_972.2 [Hereditary ataxia],0.078,0,0.0,0.0,0.684,0.0,0.0,0.0,0.032,,1.209,0.293,0.21,0.942,3
ROCK1,MS_700.3 [Systemic sclerosis],0.078,1,2.0,0.0,0.0,0.0,0.0,0.0,0.12,1.746,3.594,1.948,0.185,,2
PEX3,SO_380.3 [Optic atrophy],0.078,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.585,0.184,0.247,0.124,0.973,2
OLFM1,NS_323.3 [Motor neuron disease],0.078,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.751,2.02,0.2,0.189,0.086,3
PKN2,CM_770.5 [Congenital osteodystrophies],0.078,0,0.0,0.0,0.0,0.0,0.0,0.0,0.043,2.837,0.136,0.022,0.056,0.302,3
FGFR2,GE_961.1 [Phakomatoses],0.078,0,0.0,0.0,0.0,0.0,0.263,0.0,0.082,2.522,2.143,1.466,0.177,0.953,4
CR2,BI_179.7 [Common variable immunodeficiency [CVID]],0.078,0,0.0,0.0,0.0,0.0,0.741,0.402,0.573,,1.573,0.165,0.058,,4
FOS,GE_976.5 [Polycystic kidney disease],0.078,0,0.0,0.0,0.0,0.0,0.0,0.0,0.264,2.931,1.014,0.123,0.172,,2
HNRNPC,CV_433.3 [Cerebrovascular insufficiency],0.078,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.078,,,0.267,1
HIF1A,SO_380.3 [Optic atrophy],0.078,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,1.767,1.785,0.559,0.173,0.982,3
PDGFRB,EM_249.1 [Cerebral amyloid angiopathy*],0.078,0,0.0,0.0,0.0,0.0,0.305,0.0,0.518,1.914,3.856,1.06,0.129,,3
DGKE,GU_580.1 [Acute nephritic syndrome],0.078,0,0.0,0.0,0.844,0.0,0.0,0.162,0.055,1.309,3.076,0.21,0.149,0.139,4
DLGAP4,CV_433.3 [Cerebrovascular insufficiency],0.078,0,0.0,0.0,0.0,0.0,0.0,0.0,0.015,1.934,2.938,0.401,0.179,0.126,3
FKBP5,MB_306 [Conduct disorders],0.078,0,0.0,0.0,0.0,0.0,0.0,0.0,0.402,2.516,0.396,0.093,0.094,,2
TSN,SO_386.5 [Color vision deficiencies],0.078,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.868,0.041,,0.084,0.21,2
CORO2B,GU_580.52 [Diffuse membranous glomerulonephritis],0.078,0,0.0,0.0,0.0,0.0,0.51,0.0,0.091,2.802,3.238,1.965,0.094,,3
EPHA6,GE_972.1 [Hereditary neuropathy],0.078,0,0.0,0.0,0.0,0.0,0.0,0.0,0.103,2.828,3.08,0.087,0.153,,2
CRB1,NS_341.1 [Cerebral palsy],0.078,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.668,1.439,0.14,0.978,2
ITGAL,DE_663.2 [Pemphigoid],0.078,0,0.0,0.0,0.0,0.0,0.0,0.0,0.101,1.35,2.781,0.193,0.181,,2
KLF15,NS_333.4 [Circadian rhythm sleep disorder],0.078,0,0.0,0.0,0.0,0.488,0.0,0.0,0.018,1.419,1.155,0.119,0.113,0.15,3
PEX1,CM_763.31 [Ventricular septal defect],0.078,0,0.0,0.0,0.684,0.0,0.0,0.0,0.0,,3.502,0.726,0.259,0.987,3
ADAM10,MS_700.3 [Systemic sclerosis],0.078,0,0.0,0.0,0.0,0.0,0.0,0.0,0.076,2.404,2.5,0.157,0.133,,2
MMP14,CV_414.1 [Hypertrophic cardiomyopathy],0.078,0,0.0,0.0,0.0,0.0,0.0,0.0,0.097,1.754,2.971,0.277,0.707,0.144,3
TMEM63C,GU_580.51 [Focal and segmental glomerular lesions*],0.078,0,0.0,0.0,0.0,0.0,0.0,0.0,0.202,2.376,1.784,0.109,0.098,,2
COMP,GE_978.3 [Osteochondrodysplasias],0.078,0,0.0,0.0,0.0,0.0,0.412,0.837,0.063,,3.836,0.145,0.081,,4
SDCCAG8,SO_386.6 [Night blindness],0.078,0,0.0,0.0,0.0,0.0,0.254,0.0,0.0,1.826,2.417,0.249,0.18,0.972,3
IDUA,GE_963.3 [Mucopolysaccharidoses],0.078,1,2.0,0.0,0.0,0.0,0.279,0.921,0.095,2.233,2.704,0.356,0.103,,4
LIG3,GE_972.2 [Hereditary ataxia],0.078,0,0.0,0.0,0.0,0.0,0.0,0.614,0.015,2.465,2.924,0.559,0.299,0.84,4
ARID2,GU_580.1 [Acute nephritic syndrome],0.078,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,3.209,2.584,0.097,0.26,0.332,3
ALKBH5,CM_763.13 [Patent ductus arteriosus],0.078,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.443,0.085,,,0.31,2
GRIN2B,MS_700.42 [Dermatomyositis],0.078,0,0.0,0.0,0.0,0.0,0.0,0.0,0.036,2.91,2.06,,,,2
DARS2,GE_972.2 [Hereditary ataxia],0.078,0,0.0,0.0,0.814,0.0,0.0,0.452,0.038,,0.245,0.321,0.244,0.867,3
PPARG,MS_700.42 [Dermatomyositis],0.078,0,0.0,0.0,0.0,0.0,0.0,0.0,0.082,2.275,0.097,0.079,0.078,,2
KCNB2,GE_972.2 [Hereditary ataxia],0.078,1,2.0,0.156,0.532,0.0,0.0,0.0,0.0,2.344,1.934,0.047,0.095,0.907,4
BCL2L1,MS_727.5 [Cyst of bone],0.078,0,0.0,0.0,0.0,0.0,0.0,0.0,0.057,1.998,0.229,0.078,0.088,,2
TGFB1,GE_978.3 [Osteochondrodysplasias],0.078,1,1.0,0.0,0.0,0.0,0.276,0.813,0.18,2.265,0.21,0.036,0.032,,4
IMPDH1,SO_386.5 [Color vision deficiencies],0.078,0,0.0,0.0,0.0,0.0,0.348,0.0,0.0,1.716,1.825,0.144,0.13,0.999,3
MORF4L1,GE_972.2 [Hereditary ataxia],0.078,0,0.0,0.0,0.0,0.0,0.0,0.0,0.213,2.256,0.136,0.051,0.076,0.425,3
IP6K2,NS_323.3 [Motor neuron disease],0.078,0,0.0,0.0,0.0,0.0,0.0,0.0,0.077,1.39,0.313,0.118,0.192,0.038,3
SYNPO,GU_580.51 [Focal and segmental glomerular lesions*],0.078,0,0.0,0.0,0.0,0.0,0.0,0.129,0.269,,3.828,1.205,0.108,,3
CITED2,CM_763.31 [Ventricular septal defect],0.078,0,0.0,0.0,0.0,0.0,0.256,0.402,0.326,3.21,0.263,0.071,0.067,0.732,5
TNF,CV_414.1 [Hypertrophic cardiomyopathy],0.078,0,0.0,0.0,0.0,0.0,0.298,0.0,0.23,,1.941,0.385,0.062,0.975,4
UBE2N,CV_433.3 [Cerebrovascular insufficiency],0.078,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.062,,,0.265,1
TUBA1B,NS_344.2 [Benign intracranial hypertension],0.078,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.142,,,0.244,1
BRD1,MB_302.1 [Speech and language developmental delay],0.078,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.182,2.535,0.194,0.213,0.106,3
CFL1,EM_208.1 [Hypoparathyroidism],0.078,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.102,,,0.239,1
TFG,NS_341.1 [Cerebral palsy],0.078,0,0.0,0.0,0.816,0.0,0.0,0.0,0.073,1.954,2.327,0.109,0.117,0.921,4
REEP2,GE_972.2 [Hereditary ataxia],0.078,0,0.0,0.119,0.0,0.0,0.0,0.725,0.147,,0.205,0.092,0.095,0.874,4
SCN5A,CM_763.31 [Ventricular septal defect],0.078,0,0.0,0.0,0.0,0.0,0.305,0.0,0.097,1.548,4.218,1.689,0.331,0.724,4
ZNF804A,MB_303.1 [Dyslexia and alexia],0.078,0,0.0,0.0,0.0,0.0,0.0,0.0,0.182,2.454,0.98,0.103,0.08,,2
MAK,SO_386.6 [Night blindness],0.078,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,1.182,0.489,0.17,0.994,1
NOTCH1,GI_516.1 [Pyloric stenosis],0.078,0,0.0,0.0,0.0,0.0,0.0,0.121,0.0,2.468,3.254,0.276,1.389,0.988,3
NOS1,GE_972.1 [Hereditary neuropathy],0.078,0,0.0,0.0,0.0,0.0,0.0,0.0,0.133,1.635,2.818,0.438,0.376,,2
ATP7A,NS_323.3 [Motor neuron disease],0.078,0,0.0,0.0,0.532,0.0,0.0,0.0,0.053,2.059,4.006,0.249,0.225,0.335,4
TNF,GE_976.5 [Polycystic kidney disease],0.078,0,0.0,0.0,0.0,0.0,0.279,0.0,0.265,,0.366,0.366,0.049,,2
EZH2,CM_770.5 [Congenital osteodystrophies],0.078,0,0.0,0.0,0.0,0.0,0.31,0.0,0.03,1.98,2.569,0.058,0.087,0.951,4
AFF2,GI_516.1 [Pyloric stenosis],0.078,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.907,2.868,0.294,0.237,0.992,2
SYK,CV_433.3 [Cerebrovascular insufficiency],0.078,1,0.5,0.0,0.0,0.0,0.0,0.0,0.073,2.687,0.213,0.18,1.644,0.809,3
TNFSF11,GE_970.1 [Sickle-cell disorders],0.078,0,0.0,0.0,0.0,0.0,0.262,0.0,0.1,2.45,0.482,0.104,0.032,,3
DST,DE_663.2 [Pemphigoid],0.078,0,0.0,0.0,0.0,0.0,0.0,0.0,0.094,2.689,3.799,0.143,0.21,,2
EFEMP1,RE_477.2 [Hypersensitivity pneumonitis],0.078,0,0.0,0.0,0.0,0.0,0.0,0.0,0.091,2.209,1.935,0.166,0.129,,2
GRK2,GI_540.11 [Autoimmune hepatitis],0.078,0,0.0,0.0,0.0,0.0,0.0,0.0,0.119,,0.203,0.16,0.146,,1
BBS9,SO_380.3 [Optic atrophy],0.078,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.403,3.363,1.302,0.214,0.977,2
JAK2,CV_433.3 [Cerebrovascular insufficiency],0.078,0,0.0,0.0,0.547,0.0,0.0,0.0,0.25,1.979,3.536,1.285,0.285,0.969,4
NDUFV2,CV_414.1 [Hypertrophic cardiomyopathy],0.078,0,0.0,0.0,0.684,0.0,0.0,0.0,0.226,2.835,1.99,0.455,0.22,0.998,4
CYP2U1,GE_972.2 [Hereditary ataxia],0.078,0,0.0,0.0,0.0,0.0,0.0,0.814,0.076,1.439,2.479,0.359,0.16,0.913,4
PTPRE,GE_977.6 [Congenital cutaneous mastocytosis*],0.078,0,0.0,0.0,0.0,0.0,0.0,0.0,0.109,2.586,1.719,0.108,0.074,,2
ABL1,SO_365.3 [Exophthalmos [Proptosis]],0.078,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,1.965,2.666,2.328,0.287,0.96,3
WNT5A,GE_978.3 [Osteochondrodysplasias],0.078,0,0.0,0.0,0.0,0.0,0.304,0.0,0.061,1.933,0.068,0.101,0.091,,3
COL4A2,CV_433.3 [Cerebrovascular insufficiency],0.078,0,0.0,0.0,0.426,0.373,0.0,0.0,0.0,2.816,2.836,0.564,0.403,0.898,3
DPM3,SO_380.3 [Optic atrophy],0.078,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.099,0.134,0.066,0.954,1
UBA52,GE_972.9 [Muscular dystrophy],0.078,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.045,,,0.195,1
RPL27A,CM_750.16 [Arnold-Chiari syndrome*],0.078,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.049,,,0.306,1
SCN5A,NS_339.2 [Myotonic disorders],0.078,1,4.0,0.0,0.0,0.0,0.0,0.0,0.28,1.558,2.965,0.592,0.191,,2
LGI1,NS_333.4 [Circadian rhythm sleep disorder],0.078,0,0.0,0.0,0.0,0.0,0.0,0.0,0.134,1.886,0.132,0.122,0.105,0.4,3
TLR8,GE_961.1 [Phakomatoses],0.078,0,0.0,0.0,0.0,0.0,0.0,0.0,0.055,2.507,0.215,,0.081,0.234,3
CD163,DE_663.2 [Pemphigoid],0.078,0,0.0,0.0,0.0,0.0,0.0,0.0,0.168,3.454,2.459,0.162,1.099,,2
ACAD9,NS_341.1 [Cerebral palsy],0.078,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.027,1.844,0.393,0.17,0.978,2
COL1A2,MS_725.1 [Spinal osteochondrosis],0.078,0,0.0,0.0,0.547,0.0,0.0,0.0,0.09,3.224,2.869,1.073,0.169,,3
FGFR3,MS_712.51 [Hypermobility syndrome],0.078,0,0.0,0.0,0.0,0.0,0.416,0.0,0.018,,2.24,1.005,0.313,,3
TNF,MS_700.43 [Polymyositis],0.078,1,2.0,0.0,0.0,0.0,0.0,0.0,0.543,,0.255,0.126,0.035,,1
PPARGC1A,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.078,0,0.0,0.0,0.0,0.0,0.0,0.0,0.107,2.374,1.532,0.349,0.792,0.805,3
SLC6A1,GE_972.2 [Hereditary ataxia],0.078,0,0.0,0.142,0.0,0.0,0.321,0.0,0.068,3.493,2.816,0.084,1.913,0.89,5
UBA52,GE_963.1 [Lipid storage disorders],0.078,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.05,,,0.186,1
NDUFB10,CV_414.1 [Hypertrophic cardiomyopathy],0.078,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.353,0.444,0.22,0.947,2
TYK2,MS_700.42 [Dermatomyositis],0.078,1,3.0,0.0,0.0,0.0,0.0,0.0,0.185,1.563,4.003,0.382,0.116,,2
CPT1A,CV_414.1 [Hypertrophic cardiomyopathy],0.078,1,3.0,0.0,0.426,0.0,0.0,0.0,0.0,1.862,2.326,0.365,0.314,0.923,3
CHCHD10,NS_323.3 [Motor neuron disease],0.078,0,0.0,0.0,0.874,0.0,0.0,0.434,0.097,,0.855,0.285,1.606,0.986,4
GLI2,CM_770.5 [Congenital osteodystrophies],0.078,0,0.0,0.0,0.0,0.0,0.323,0.0,0.021,2.788,2.744,0.176,0.242,0.938,4
WNT5A,EM_209.4 [Diabetes insipidus],0.078,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.527,0.092,0.088,0.135,0.942,3
VEGFA,GU_580.52 [Diffuse membranous glomerulonephritis],0.078,1,2.0,0.0,0.0,0.0,0.0,0.0,0.137,3.061,0.148,0.118,0.101,,2
OPA1,SO_386.5 [Color vision deficiencies],0.078,0,0.0,0.0,0.684,0.0,0.0,0.0,0.0,1.725,3.355,1.392,0.137,0.994,3
SORT1,GE_973.5 [Huntington's disease],0.078,0,0.0,0.0,0.0,0.0,0.0,0.0,0.557,2.494,1.472,0.09,0.078,,2
SNRNP70,GU_580.1 [Acute nephritic syndrome],0.078,0,0.0,0.0,0.0,0.0,0.0,0.0,0.024,2.733,0.569,0.073,0.096,0.252,3
SLC9A1,GE_972.2 [Hereditary ataxia],0.078,0,0.0,0.0,0.684,0.0,0.322,0.0,0.089,,1.816,0.292,0.168,0.811,5
RPL26,MB_302.1 [Speech and language developmental delay],0.078,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.058,,,0.259,1
CHCHD2,NS_333.4 [Circadian rhythm sleep disorder],0.078,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.285,1.643,0.166,0.069,0.935,2
GMPPB,SO_380.3 [Optic atrophy],0.078,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,1.837,0.201,0.122,0.967,2
FANCC,BI_162.1 [Constitutional (hereditary) aplastic anemia],0.078,1,0.5,0.0,0.0,0.0,0.0,0.824,0.113,1.879,2.58,0.597,0.094,,3
LTBP4,GE_972.9 [Muscular dystrophy],0.078,1,0.5,0.0,0.182,0.055,0.0,0.452,0.151,1.66,3.194,0.249,0.121,0.501,4
TP53,GI_542.8 [Biliary cirrhosis],0.078,0,0.0,0.0,0.0,0.0,0.0,0.0,0.268,,2.951,2.472,0.145,,2
TUBB2B,NS_344.2 [Benign intracranial hypertension],0.078,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.085,,,0.309,1
SV2A,GE_961.1 [Phakomatoses],0.078,0,0.0,0.0,0.0,0.0,0.0,0.0,0.049,1.664,1.971,0.179,0.159,0.068,3
ADAM10,GI_540.11 [Autoimmune hepatitis],0.078,0,0.0,0.0,0.0,0.0,0.0,0.0,0.608,2.938,3.485,0.18,1.696,,2
ZIC1,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.078,0,0.0,0.0,0.0,0.0,0.332,0.0,0.059,3.486,0.112,0.072,0.093,0.106,4
KCND3,NS_341.1 [Cerebral palsy],0.077,1,3.0,0.0,0.0,0.0,0.0,0.0,0.03,2.345,1.699,0.443,1.987,0.897,3
SNRPD2,GU_580.1 [Acute nephritic syndrome],0.077,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.056,,,0.247,1
NRXN3,MB_296.1 [Paranoid personality disorder],0.077,0,0.0,0.0,0.0,0.0,0.0,0.0,0.212,2.968,2.806,0.121,0.083,,2
KLF2,GE_977.1 [Congenital ichthyosis],0.077,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.767,1.944,,0.021,0.093,2
SLC6A3,MB_305.1 [Tics and tic disorders],0.077,1,0.5,0.0,0.0,0.0,0.574,0.0,0.095,1.711,2.365,2.125,0.093,,3
KMT2C,GE_961.1 [Phakomatoses],0.077,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,2.941,3.266,0.355,0.336,0.897,3
KCNA6,GE_972.2 [Hereditary ataxia],0.077,1,2.0,0.0,0.0,0.0,0.0,0.29,0.012,1.456,0.221,0.031,0.139,0.86,4
UBE2E3,CV_416.8 [Pre-excitation syndrome [Anomalous atrioventricular excitation]],0.077,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.68,0.08,,,0.128,2
CD40LG,BI_179.1 [Hypogammaglobulinemia NOS],0.077,0,0.0,0.0,0.813,0.0,0.0,0.0,0.104,1.973,2.42,,0.036,0.992,4
HDAC4,CM_770.5 [Congenital osteodystrophies],0.077,0,0.0,0.0,0.0,0.0,0.288,0.0,0.086,2.81,2.717,1.113,0.168,0.951,4
HTR2A,GE_973.5 [Huntington's disease],0.077,1,3.0,0.0,0.0,0.0,0.0,0.0,0.11,2.684,0.251,0.044,0.044,,2
GRIN2B,GE_978.3 [Osteochondrodysplasias],0.077,0,0.0,0.0,0.0,0.0,0.0,0.0,0.036,2.836,2.872,,,,2
CD163,MS_704.1 [Polyarteritis nodosa and related conditions],0.077,0,0.0,0.0,0.0,0.0,0.0,0.0,0.107,,2.623,0.118,0.14,,2
CACNA1A,GU_580.1 [Acute nephritic syndrome],0.077,1,1.0,0.0,0.0,0.0,0.0,0.0,0.03,3.087,1.996,0.112,0.092,0.275,3
RPS10,MB_302.1 [Speech and language developmental delay],0.077,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.047,,,0.188,1
BMPR2,DE_663.2 [Pemphigoid],0.077,0,0.0,0.0,0.0,0.0,0.0,0.0,0.472,1.31,2.99,2.401,0.144,,2
DNM1L,SO_380.3 [Optic atrophy],0.077,0,0.0,0.0,0.779,0.0,0.267,0.776,0.035,,1.225,0.767,0.167,0.971,4
MALT1,MS_727.5 [Cyst of bone],0.077,0,0.0,0.0,0.0,0.0,0.0,0.0,0.676,2.882,0.431,0.124,0.898,,2
TNF,MS_704.1 [Polyarteritis nodosa and related conditions],0.077,1,3.0,0.0,0.0,0.04,0.0,0.0,0.207,,3.123,0.179,0.028,,2
SLC6A3,NS_333.7 [Narcolepsy],0.077,1,4.0,0.0,0.0,0.0,0.0,0.0,0.094,1.85,1.577,0.142,0.099,,2
IFITM5,CM_770.5 [Congenital osteodystrophies],0.077,0,0.0,0.0,0.0,0.0,0.343,0.531,0.16,,2.439,0.156,0.06,0.603,5
ADA2,BI_179.1 [Hypogammaglobulinemia NOS],0.077,0,0.0,0.0,0.828,0.0,0.0,0.0,0.104,,1.831,0.278,0.101,,3
RPGRIP1L,GU_580.1 [Acute nephritic syndrome],0.077,0,0.0,0.0,0.532,0.0,0.0,0.177,0.021,1.942,4.039,2.895,0.277,0.216,4
CPEB4,DE_663.1 [Pemphigus],0.077,0,0.0,0.0,0.0,0.0,0.0,0.0,0.085,2.519,2.624,2.556,0.074,,2
AHR,"EM_209.11 [Tall stature, acromegaly and gigantism]",0.077,0,0.0,0.0,0.0,0.0,0.0,0.0,0.15,2.67,1.643,0.096,0.112,,2
VEGFA,GE_972.1 [Hereditary neuropathy],0.077,0,0.0,0.0,0.0,0.0,0.301,0.0,0.132,2.442,3.398,0.243,0.142,,3
PANK1,NS_341.1 [Cerebral palsy],0.077,0,0.0,0.0,0.0,0.0,0.0,0.0,0.033,2.246,0.116,0.211,0.146,0.972,3
HTR2A,CV_433.3 [Cerebrovascular insufficiency],0.077,1,4.0,0.0,0.0,0.0,0.0,0.0,0.04,2.603,0.196,0.11,0.094,0.319,3
PRDM1,GE_973.5 [Huntington's disease],0.077,0,0.0,0.0,0.0,0.0,0.0,0.0,0.136,3.116,0.208,0.13,0.053,,2
MAGOH,SO_380.3 [Optic atrophy],0.077,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.109,,0.023,0.296,1
PTPN22,NS_338.1 [Myasthenia gravis],0.077,0,0.0,0.0,0.0,0.29,0.0,0.0,0.108,,3.607,0.694,0.713,,2
HAAO,NS_341.1 [Cerebral palsy],0.077,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.689,1.948,0.224,0.17,0.908,2
CALM1,SO_386.5 [Color vision deficiencies],0.077,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.371,0.04,,,0.197,2
B3GALT6,GE_978.22 [Ehler's Danlos syndrome],0.077,0,0.0,0.0,0.0,0.0,0.0,0.81,0.239,,1.965,0.081,0.049,,3
SLC4A2,GI_542.8 [Biliary cirrhosis],0.077,0,0.0,0.0,0.0,0.0,0.0,0.0,0.395,,2.283,0.417,0.299,,2
SPIB,GI_542.8 [Biliary cirrhosis],0.077,0,0.0,0.0,0.0,0.507,0.0,0.0,0.049,3.894,0.328,0.06,0.098,,2
FARS2,NS_341.1 [Cerebral palsy],0.077,0,0.0,0.0,0.863,0.0,0.0,0.0,0.095,2.729,2.323,0.848,1.824,0.982,4
EDNRA,CM_763.31 [Ventricular septal defect],0.077,1,4.0,0.0,0.0,0.0,0.0,0.0,0.067,1.951,0.09,0.073,1.789,0.509,3
EGR2,CV_414.1 [Hypertrophic cardiomyopathy],0.077,0,0.0,0.0,0.0,0.0,0.322,0.0,0.012,2.134,1.649,0.113,0.16,0.181,4
KCNC1,GE_972.2 [Hereditary ataxia],0.077,1,2.0,0.053,0.547,0.0,0.0,0.0,0.093,1.373,2.963,0.033,0.087,0.966,5
DNMT3B,DE_663.2 [Pemphigoid],0.077,0,0.0,0.0,0.0,0.0,0.0,0.0,0.07,1.431,1.718,0.153,0.158,,2
ADAMTS2,MS_712.51 [Hypermobility syndrome],0.077,0,0.0,0.0,0.0,0.0,0.0,0.209,0.015,2.712,4.047,0.106,0.273,,3
RPL26,SO_369.62 [Keratoconus],0.077,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.046,,,0.211,1
CHAT,NS_323.3 [Motor neuron disease],0.077,0,0.0,0.0,0.0,0.0,0.399,0.0,0.113,,3.107,2.562,0.244,0.592,4
COL12A1,SO_369.62 [Keratoconus],0.077,0,0.0,0.0,0.0,0.548,0.0,0.0,0.03,3.393,3.616,0.357,0.564,0.422,3
SIM1,MS_712.51 [Hypermobility syndrome],0.077,0,0.0,0.0,0.0,0.0,0.0,0.0,0.083,2.612,1.658,0.273,0.734,,2
AHR,CM_770.5 [Congenital osteodystrophies],0.077,0,0.0,0.0,0.0,0.0,0.0,0.0,0.172,2.374,2.407,0.133,0.137,0.888,3
NLRP3,RE_464.2 [Chronic nasopharyngitis],0.077,0,0.0,0.0,0.0,0.0,0.0,0.0,0.135,3.474,2.692,0.081,0.11,,2
EPAS1,MS_704.1 [Polyarteritis nodosa and related conditions],0.077,0,0.0,0.0,0.0,0.0,0.0,0.0,0.122,2.315,2.726,0.195,0.126,,2
OPTN,NS_341.1 [Cerebral palsy],0.077,0,0.0,0.0,0.547,0.0,0.0,0.0,0.061,2.259,0.266,0.206,1.302,0.952,4
EXT1,MS_719.2 [Muscle calcification and ossification],0.077,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,3.279,0.122,0.094,0.091,,2
HMGCR,CM_770.5 [Congenital osteodystrophies],0.077,0,0.0,0.0,0.0,0.0,0.0,0.0,0.02,2.444,2.215,0.308,0.166,0.89,3
AHI1,GU_580.1 [Acute nephritic syndrome],0.077,0,0.0,0.0,0.632,0.0,0.0,0.0,0.04,2.234,3.112,0.28,0.218,0.231,4
PKNOX2,GE_972.2 [Hereditary ataxia],0.077,0,0.0,0.096,0.0,0.0,0.0,0.0,0.055,2.785,2.98,2.44,0.131,0.248,4
XYLT1,GE_978.3 [Osteochondrodysplasias],0.077,0,0.0,0.0,0.0,0.0,0.35,0.0,0.109,2.159,2.694,1.459,0.166,,3
CLCN2,NS_341.1 [Cerebral palsy],0.077,0,0.0,0.0,0.0,0.0,0.0,0.29,0.015,,2.561,0.46,0.215,0.818,4
VAMP2,CM_750.16 [Arnold-Chiari syndrome*],0.077,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.112,,0.021,0.296,1
SLC6A3,NS_341.1 [Cerebral palsy],0.077,0,0.0,0.0,0.0,0.0,0.0,0.0,0.021,1.979,1.643,0.164,0.141,0.894,3
PITX3,CM_751.213 [Congenital cataract],0.077,0,0.0,0.0,0.855,0.0,0.0,0.766,0.053,,0.356,0.085,0.091,0.978,3
ZFYVE26,NS_341.1 [Cerebral palsy],0.077,0,0.0,0.0,0.894,0.0,0.0,0.607,0.082,1.729,3.0,0.83,1.994,0.998,4
SNRPD2,CV_414.1 [Hypertrophic cardiomyopathy],0.077,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.085,,,0.286,1
PEX6,GE_972.2 [Hereditary ataxia],0.077,0,0.0,0.0,0.789,0.0,0.0,0.553,0.018,1.919,2.659,1.512,0.247,0.967,4
RPL17,CM_750.16 [Arnold-Chiari syndrome*],0.077,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.082,,,0.2,1
GRIA2,CV_433.3 [Cerebrovascular insufficiency],0.077,1,2.0,0.0,0.0,0.0,0.0,0.0,0.031,3.12,0.213,0.151,0.14,0.316,3
SCN2A,GE_961.1 [Phakomatoses],0.077,1,2.0,0.0,0.0,0.0,0.0,0.0,0.038,1.631,2.669,0.577,0.239,0.216,3
ZBTB46,MS_700.3 [Systemic sclerosis],0.077,0,0.0,0.0,0.0,0.0,0.0,0.0,0.091,,2.286,0.218,0.155,,2
STAT1,MS_700.3 [Systemic sclerosis],0.077,0,0.0,0.0,0.0,0.237,0.0,0.0,0.119,,1.186,0.197,0.1,,2
SERPINC1,BI_168.12 [Hemorrhagic disorder due to intrinsic circulating anticoagulants],0.077,1,4.0,0.0,0.0,0.0,0.0,0.0,0.173,1.567,1.48,1.41,2.832,,2
ARL6IP1,GE_972.2 [Hereditary ataxia],0.077,0,0.0,0.0,0.532,0.0,0.0,0.753,0.324,,3.028,2.884,0.079,0.468,4
DAPK1,NS_339.2 [Myotonic disorders],0.077,0,0.0,0.0,0.0,0.0,0.0,0.0,0.413,3.304,2.446,0.216,0.125,,2
FLI1,MS_700.3 [Systemic sclerosis],0.077,0,0.0,0.0,0.0,0.0,0.0,0.0,0.71,3.216,2.118,0.119,0.1,,2
DRD2,MS_712.51 [Hypermobility syndrome],0.077,0,0.0,0.0,0.0,0.0,0.0,0.0,0.231,1.826,3.162,0.147,0.189,,2
CALM1,CM_770.5 [Congenital osteodystrophies],0.077,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.903,0.05,,,0.204,2
EGR3,SO_386.6 [Night blindness],0.077,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.639,0.125,,0.155,0.152,2
MTOR,MS_700.3 [Systemic sclerosis],0.077,0,0.0,0.0,0.0,0.0,0.0,0.0,0.378,3.144,2.229,0.415,0.309,,2
RBMS1,CV_433.3 [Cerebrovascular insufficiency],0.077,0,0.0,0.0,0.0,0.0,0.0,0.0,0.038,2.185,0.148,0.126,1.892,0.194,3
FGF7,CV_414.1 [Hypertrophic cardiomyopathy],0.077,0,0.0,0.0,0.0,0.0,0.0,0.0,0.055,2.853,0.121,0.068,0.116,0.102,3
THBD,GE_970.1 [Sickle-cell disorders],0.077,0,0.0,0.0,0.0,0.0,0.0,0.0,0.029,2.266,1.728,0.025,0.032,,2
GUCY2D,GE_974.3 [Hereditary choroidal dystrophies],0.077,0,0.0,0.0,0.0,0.0,0.384,0.665,0.053,,0.506,0.179,0.075,,3
RPS29,SO_386.5 [Color vision deficiencies],0.077,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.105,0.033,,,0.188,2
PRICKLE3,SO_380.3 [Optic atrophy],0.077,0,0.0,0.0,0.0,0.0,0.0,0.201,0.026,,3.203,0.038,3.354,0.173,4
RBFOX1,GE_972.2 [Hereditary ataxia],0.077,0,0.0,0.0,0.0,0.0,0.0,0.0,0.027,3.39,1.846,0.075,0.257,0.97,3
UBE2L3,CV_413.41 [Pulmonary valve stenosis],0.077,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.59,0.04,,,0.307,2
FGF10,CV_414.1 [Hypertrophic cardiomyopathy],0.077,0,0.0,0.0,0.0,0.0,0.0,0.0,0.099,3.225,2.039,,0.073,0.147,3
TUBA1B,EM_209.4 [Diabetes insipidus],0.077,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.17,,,0.27,1
USH2A,SO_369.62 [Keratoconus],0.077,0,0.0,0.0,0.547,0.0,0.0,0.0,0.085,3.227,3.966,0.779,0.583,1.0,4
HMGA1,GE_977.1 [Congenital ichthyosis],0.077,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.46,0.032,,,0.171,2
UBA52,SO_365.3 [Exophthalmos [Proptosis]],0.077,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.102,,,0.272,1
EXT2,CM_770.5 [Congenital osteodystrophies],0.077,0,0.0,0.0,0.0,0.0,0.251,0.699,0.131,1.88,1.817,0.182,7.939,0.678,5
MAPK1,MB_302.1 [Speech and language developmental delay],0.077,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.761,0.201,,2.223,0.991,2
NDUFB4,GE_963.1 [Lipid storage disorders],0.077,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.077,0.12,0.053,0.979,1
KMT2A,GE_978.3 [Osteochondrodysplasias],0.077,0,0.0,0.0,0.0,0.0,0.332,0.0,0.608,,2.957,0.244,0.238,,3
UBE2E3,CM_751.213 [Congenital cataract],0.077,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.729,3.156,,,0.185,2
SPP1,RE_484.1 [Spontaneous pneumothorax],0.077,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.425,1.889,0.827,0.115,0.959,2
MBNL1,GE_973.5 [Huntington's disease],0.077,0,0.0,0.0,0.0,0.0,0.0,0.0,0.088,2.833,0.07,0.027,0.054,,2
JAZF1,GE_970.2 [Thalassemia],0.077,0,0.0,0.0,0.0,0.0,0.0,0.0,0.103,2.655,0.38,0.043,0.116,,2
CSNK1A1,CV_438.41 [Aortic dissection],0.077,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.145,,,0.229,1
RPL17,NS_333.4 [Circadian rhythm sleep disorder],0.077,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.101,,,0.196,1
RPL11,GE_972.9 [Muscular dystrophy],0.077,1,4.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.169,,,0.311,1
CPOX,GE_966.2 [Disorders of porphyrin metabolism],0.077,0,0.0,0.0,0.0,0.0,0.292,0.88,0.057,1.766,1.902,0.079,2.705,,4
TRPC1,GE_973.5 [Huntington's disease],0.077,0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,2.035,0.096,0.138,0.067,,2
CYFIP1,MB_302.1 [Speech and language developmental delay],0.077,0,0.0,0.0,0.0,0.0,0.0,0.161,0.012,,1.986,0.03,1.795,0.93,4
P2RY12,CV_433.3 [Cerebrovascular insufficiency],0.077,1,4.0,0.0,0.532,0.0,0.0,0.0,0.2,,0.126,0.145,0.081,0.426,3
MAP3K5,RE_464.2 [Chronic nasopharyngitis],0.077,0,0.0,0.0,0.0,0.0,0.0,0.0,0.071,2.042,0.155,0.157,0.144,,2
PTCH1,GE_963.1 [Lipid storage disorders],0.077,0,0.0,0.0,0.0,0.0,0.0,0.0,0.061,2.417,3.34,2.817,0.186,0.176,3
XPR1,GU_580.1 [Acute nephritic syndrome],0.076,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,1.843,1.851,0.193,0.174,0.182,3
HDGF,NS_333.4 [Circadian rhythm sleep disorder],0.076,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.165,,0.025,0.293,1
ADAR,NS_341.1 [Cerebral palsy],0.076,0,0.0,0.0,0.801,0.0,0.0,0.0,0.084,,3.389,1.931,0.194,0.934,4
MTOR,GU_580.51 [Focal and segmental glomerular lesions*],0.076,0,0.0,0.0,0.0,0.0,0.0,0.0,0.17,1.903,2.555,0.222,0.163,,2
NEU1,GE_972.2 [Hereditary ataxia],0.076,0,0.0,0.0,0.684,0.0,0.251,0.0,0.012,,2.276,0.33,0.179,0.923,5
NOTCH1,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.076,0,0.0,0.0,0.0,0.0,0.0,0.0,0.024,1.793,2.851,0.374,0.317,0.889,3
RPSA,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.076,0,0.0,0.0,0.0,0.032,0.0,0.0,0.0,,0.107,,,0.205,2
RET,GE_961.1 [Phakomatoses],0.076,1,2.0,0.0,0.0,0.0,0.0,0.0,0.068,1.931,3.258,0.548,0.253,0.992,3
GAD1,NS_341.1 [Cerebral palsy],0.076,0,0.0,0.0,0.547,0.0,0.0,0.639,0.036,2.552,1.98,0.067,0.137,0.957,4
KCND3,NS_323.3 [Motor neuron disease],0.076,1,2.0,0.0,0.0,0.0,0.0,0.0,0.012,2.357,2.426,0.064,0.152,0.221,3
SMURF2,DE_663.1 [Pemphigus],0.076,0,0.0,0.0,0.0,0.0,0.343,0.0,0.14,1.307,1.807,0.103,0.101,,3
TUBB4A,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.076,1,2.0,0.0,0.0,0.0,0.341,0.827,0.054,1.597,2.552,,0.067,0.302,5
GABRA4,MB_293.2 [Bulimia nervosa],0.076,1,4.0,0.0,0.0,0.0,0.0,0.0,0.0,2.625,0.132,,0.129,,1
TRIM24,SO_380.3 [Optic atrophy],0.076,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.472,2.548,0.208,0.17,0.254,3
GABRA1,CV_433.3 [Cerebrovascular insufficiency],0.076,1,4.0,0.0,0.0,0.0,0.0,0.0,0.018,1.955,2.704,,0.06,0.174,3
PDGFA,MS_700.3 [Systemic sclerosis],0.076,0,0.0,0.0,0.0,0.0,0.0,0.0,0.117,1.686,2.924,0.39,0.095,,2
SIRPA,GI_540.11 [Autoimmune hepatitis],0.076,0,0.0,0.0,0.0,0.0,0.0,0.0,0.103,2.014,2.317,0.275,0.096,,2
MYO7A,SO_386.6 [Night blindness],0.076,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.014,3.178,1.216,0.423,0.999,2
FOXP1,MB_302.1 [Speech and language developmental delay],0.076,0,0.0,0.0,0.0,0.0,0.0,0.29,0.067,4.137,0.043,,,0.918,4
MTOR,CV_441 [Arteriovenous malformation],0.076,0,0.0,0.0,0.0,0.0,0.0,0.0,0.06,1.706,3.474,0.49,0.351,0.955,3
MYH11,GE_961.1 [Phakomatoses],0.076,0,0.0,0.0,0.0,0.0,0.0,0.0,0.045,1.588,5.207,2.627,0.192,0.757,3
PNPLA6,NS_341.1 [Cerebral palsy],0.076,0,0.0,0.0,0.877,0.0,0.0,0.0,0.063,,2.204,0.831,0.696,0.998,4
ROCK2,MS_727.5 [Cyst of bone],0.076,0,0.0,0.0,0.0,0.0,0.0,0.0,0.608,1.854,2.262,0.077,0.266,,2
THBS1,CV_414.1 [Hypertrophic cardiomyopathy],0.076,0,0.0,0.0,0.0,0.0,0.0,0.0,0.075,1.938,2.928,,0.11,0.329,3
DNAJB6,GE_972.9 [Muscular dystrophy],0.076,0,0.0,0.0,0.881,0.0,0.0,0.747,0.095,2.308,3.626,0.081,0.044,0.964,4
UBE2D3,CM_770.5 [Congenital osteodystrophies],0.076,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.052,,,0.311,1
TIMP2,SO_369.62 [Keratoconus],0.076,0,0.0,0.0,0.0,0.0,0.0,0.0,0.174,2.745,0.258,0.115,0.047,0.316,3
UBAP1,NS_341.1 [Cerebral palsy],0.076,0,0.0,0.0,0.875,0.0,0.0,0.0,0.092,,0.26,0.091,0.088,0.516,3
RYR2,GE_973.5 [Huntington's disease],0.076,0,0.0,0.0,0.0,0.0,0.0,0.0,0.518,2.345,2.841,0.234,0.146,,2
VEGFA,CV_438.41 [Aortic dissection],0.076,0,0.0,0.0,0.0,0.0,0.0,0.0,0.375,1.889,1.372,0.227,0.144,0.967,3
SLITRK1,GE_978.3 [Osteochondrodysplasias],0.076,0,0.0,0.0,0.0,0.0,0.0,0.0,0.164,2.549,0.308,0.097,0.063,,2
PPARG,GI_516.1 [Pyloric stenosis],0.076,1,4.0,0.0,0.0,0.0,0.0,0.0,0.0,1.917,2.426,1.926,0.144,0.977,2
MT-ND4,SO_380.3 [Optic atrophy],0.076,1,4.0,0.0,0.0,0.0,0.0,0.77,0.132,,,,,,2
HBA1,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.076,0,0.0,0.0,0.848,0.0,0.484,0.0,0.0,,0.048,,,0.97,3
NRP1,GE_975.2 [Hereditary hemorrhagic telangiectasia],0.076,0,0.0,0.0,0.0,0.0,0.0,0.0,0.061,2.314,3.89,2.959,0.198,,2
LDHA,GI_542.8 [Biliary cirrhosis],0.076,0,0.0,0.0,0.0,0.0,0.0,0.0,0.191,,2.777,0.181,0.123,,2
TP53BP1,GE_973.5 [Huntington's disease],0.076,0,0.0,0.0,0.0,0.0,0.0,0.0,0.549,,1.954,0.186,0.113,,2
ELAVL3,CM_763.13 [Patent ductus arteriosus],0.076,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.052,0.028,0.024,0.301,1
IL1B,CV_441 [Arteriovenous malformation],0.076,0,0.0,0.0,0.38,0.0,0.0,0.0,0.145,1.803,1.924,0.158,0.087,0.916,4
ADRA2C,GE_972.9 [Muscular dystrophy],0.076,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.307,3.061,,0.018,0.11,2
ROCK2,DE_663.1 [Pemphigus],0.076,0,0.0,0.0,0.0,0.0,0.0,0.0,0.134,1.888,1.94,0.151,0.092,,2
MBP,GE_972.2 [Hereditary ataxia],0.076,0,0.0,0.0,0.0,0.0,0.394,0.0,0.092,2.501,3.054,0.384,0.166,0.98,4
MORC3,MS_700.43 [Polymyositis],0.076,0,0.0,0.0,0.0,0.0,0.0,0.0,0.269,1.879,0.358,0.074,0.074,,2
PROM1,GE_976.5 [Polycystic kidney disease],0.076,0,0.0,0.0,0.0,0.0,0.0,0.0,0.099,1.968,4.378,2.587,0.346,,2
COL1A2,RE_484.1 [Spontaneous pneumothorax],0.076,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.851,2.725,0.714,0.348,0.998,2
RPL26,CM_750.16 [Arnold-Chiari syndrome*],0.076,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.034,,,0.224,1
VWF,CV_433.3 [Cerebrovascular insufficiency],0.076,1,1.0,0.0,0.0,0.0,0.0,0.0,0.228,2.382,3.343,0.305,0.412,0.948,3
CDH2,GE_973.5 [Huntington's disease],0.076,0,0.0,0.0,0.0,0.0,0.0,0.0,0.149,2.726,0.131,0.174,0.072,,2
ZFPM2,CM_763.31 [Ventricular septal defect],0.076,0,0.0,0.0,0.849,0.0,0.379,0.0,0.044,2.1,2.683,0.643,0.182,0.872,5
PTGS2,MS_700.43 [Polymyositis],0.076,0,0.0,0.0,0.0,0.0,0.0,0.0,0.158,1.928,0.07,0.063,0.074,,2
UNC5A,GE_972.2 [Hereditary ataxia],0.076,0,0.0,0.163,0.0,0.0,0.315,0.0,0.085,,3.189,0.358,0.987,0.252,5
WARS2,CV_414.1 [Hypertrophic cardiomyopathy],0.076,0,0.0,0.0,0.0,0.0,0.521,0.0,0.112,2.743,0.869,0.361,0.237,0.443,4
WNT5A,CM_763.31 [Ventricular septal defect],0.076,0,0.0,0.0,0.547,0.0,0.0,0.0,0.061,2.874,0.076,0.089,0.106,0.89,4
HOXC8,GE_978.3 [Osteochondrodysplasias],0.076,0,0.0,0.0,0.0,0.0,0.319,0.0,0.103,1.991,0.086,0.101,0.082,,3
VEGFA,SO_365.3 [Exophthalmos [Proptosis]],0.076,1,2.0,0.0,0.0,0.0,0.0,0.0,0.161,2.551,2.97,0.27,0.176,0.966,3
ETS1,MS_700.3 [Systemic sclerosis],0.076,0,0.0,0.0,0.0,0.0,0.0,0.0,0.125,2.451,1.705,0.097,0.106,,2
HTRA2,GE_972.2 [Hereditary ataxia],0.076,0,0.0,0.0,0.654,0.0,0.293,0.0,0.049,,2.031,0.491,0.165,0.92,5
UBQLN2,NS_328.13 [Frontotemporal dementia [FTD]],0.076,0,0.0,0.0,0.0,0.0,0.0,0.0,0.176,,4.042,0.154,0.105,,2
LYN,MS_700.3 [Systemic sclerosis],0.076,1,1.0,0.0,0.0,0.0,0.0,0.0,0.216,1.967,0.22,0.04,0.111,,2
WNT3,GE_963.1 [Lipid storage disorders],0.076,0,0.0,0.0,0.0,0.0,0.0,0.0,0.036,2.208,0.041,0.044,0.302,0.045,3
RPL11,CM_750.16 [Arnold-Chiari syndrome*],0.076,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.15,,,0.219,1
DSCAM,NS_323.3 [Motor neuron disease],0.076,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,2.935,2.602,1.742,0.455,0.106,3
COL11A1,CM_770.5 [Congenital osteodystrophies],0.076,0,0.0,0.0,0.0,0.0,0.295,0.0,0.092,2.52,3.682,0.246,0.311,0.854,4
ARID1B,CM_770.5 [Congenital osteodystrophies],0.076,0,0.0,0.0,0.0,0.0,0.0,0.0,0.195,3.358,3.602,0.337,0.477,0.604,3
HGF,NS_323.3 [Motor neuron disease],0.076,1,2.0,0.0,0.0,0.0,0.0,0.0,0.157,2.105,2.88,3.048,0.313,0.301,3
BANF1,GE_963.1 [Lipid storage disorders],0.076,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.499,0.051,,,0.254,2
CAMTA1,NS_338.1 [Myasthenia gravis],0.076,0,0.0,0.0,0.0,0.0,0.0,0.0,0.152,1.998,3.762,2.067,0.317,,2
LYST,GE_974.3 [Hereditary choroidal dystrophies],0.076,0,0.0,0.0,0.0,0.0,0.414,0.0,0.091,1.672,2.896,0.397,1.503,,3
NTRK3,GU_580.51 [Focal and segmental glomerular lesions*],0.076,0,0.0,0.0,0.0,0.0,0.0,0.0,0.164,2.441,0.175,0.269,0.132,,2
HIF1A,MS_728.2 [Osteochondritis dissecans],0.076,0,0.0,0.0,0.0,0.0,0.0,0.0,0.318,2.97,2.412,0.203,0.123,,2
MARCKS,CV_433.3 [Cerebrovascular insufficiency],0.076,0,0.0,0.0,0.0,0.0,0.0,0.0,0.076,1.953,1.656,0.017,0.038,0.606,3
LIPN,GE_977.1 [Congenital ichthyosis],0.076,0,0.0,0.0,0.0,0.0,0.0,0.607,0.047,2.997,2.411,1.997,0.087,0.996,4
MAOA,MB_296.4 [Borderline personality disorder],0.076,1,4.0,0.0,0.0,0.0,0.0,0.0,0.526,1.882,2.378,0.104,0.068,,2
RPS23,CM_750.16 [Arnold-Chiari syndrome*],0.076,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.155,0.04,,,0.189,2
PRPH2,SO_373.2 [Choroidal degenerations],0.076,0,0.0,0.0,0.0,0.0,0.684,0.574,0.111,3.273,0.261,0.036,0.043,,4
LIPT1,GE_963.1 [Lipid storage disorders],0.076,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,4.277,0.371,2.242,0.948,2
TFAP2A,CV_433.3 [Cerebrovascular insufficiency],0.076,0,0.0,0.0,0.0,0.0,0.0,0.0,0.043,2.397,0.092,0.081,0.09,0.839,3
TBX22,DE_663.2 [Pemphigoid],0.076,0,0.0,0.0,0.0,0.0,0.0,0.0,0.142,2.179,3.479,3.403,0.109,,2
SLC25A4,CV_414.1 [Hypertrophic cardiomyopathy],0.076,0,0.0,0.0,0.745,0.0,0.0,0.495,0.045,,1.509,0.049,0.153,0.963,4
WASHC5,GE_972.2 [Hereditary ataxia],0.076,0,0.0,0.0,0.426,0.0,0.0,0.824,0.124,1.77,1.896,0.501,0.291,,3
NDUFA7,GE_972.2 [Hereditary ataxia],0.076,1,4.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.213,0.165,0.133,0.935,1
MERTK,GI_540.11 [Autoimmune hepatitis],0.076,0,0.0,0.0,0.0,0.439,0.0,0.0,0.069,2.598,3.304,0.21,0.134,,2
ROM1,SO_386.5 [Color vision deficiencies],0.076,0,0.0,0.0,0.0,0.0,0.347,0.0,0.0,,0.343,0.354,0.101,0.997,2
SIM1,GE_973.5 [Huntington's disease],0.076,0,0.0,0.0,0.0,0.0,0.0,0.0,0.067,1.991,0.176,0.085,0.069,,2
SPARC,RE_484.1 [Spontaneous pneumothorax],0.076,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.214,2.421,0.171,0.142,0.97,2
VEGFA,GE_973.5 [Huntington's disease],0.076,1,0.5,0.0,0.0,0.0,0.0,0.0,0.434,2.103,0.099,0.078,0.043,,2
NDUFV2,GE_973.5 [Huntington's disease],0.076,1,3.0,0.0,0.0,0.0,0.0,0.0,0.088,2.424,0.052,0.106,0.057,,2
RPS29,SO_380.3 [Optic atrophy],0.076,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.897,0.048,,,0.28,2
APC,CV_433.3 [Cerebrovascular insufficiency],0.076,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,3.66,2.905,0.674,0.381,0.295,3
TNF,GE_963.3 [Mucopolysaccharidoses],0.076,1,1.0,0.0,0.0,0.0,0.389,0.0,0.092,,0.204,0.106,0.017,,2
PSEN1,NS_328.13 [Frontotemporal dementia [FTD]],0.076,0,0.0,0.0,0.0,0.0,0.0,0.817,0.136,,2.736,0.112,1.619,,3
AR,GE_972.1 [Hereditary neuropathy],0.076,0,0.0,0.0,0.0,0.0,0.0,0.0,0.036,3.7,3.74,,0.027,,2
CRYGC,CM_751.213 [Congenital cataract],0.076,0,0.0,0.0,0.841,0.0,0.82,0.693,0.076,1.942,1.651,0.141,0.077,0.994,5
BSN,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.076,0,0.0,0.0,0.0,0.0,0.0,0.0,0.15,1.892,3.265,1.47,0.436,0.106,3
NUP62,SO_365.3 [Exophthalmos [Proptosis]],0.076,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.559,,0.021,0.296,2
PPARG,GE_972.9 [Muscular dystrophy],0.076,0,0.0,0.0,0.0,0.0,0.0,0.0,0.034,3.401,0.065,0.091,0.073,0.919,3
GRIN2B,CV_414.1 [Hypertrophic cardiomyopathy],0.076,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.188,3.056,,,0.199,2
NLGN4X,NS_323.3 [Motor neuron disease],0.076,0,0.0,0.0,0.0,0.0,0.0,0.0,0.024,1.954,2.241,,0.077,0.166,3
MXRA5,GU_580.1 [Acute nephritic syndrome],0.076,0,0.0,0.0,0.426,0.0,0.0,0.0,0.109,3.561,3.132,0.048,0.091,0.08,4
NEB,DE_663.2 [Pemphigoid],0.076,0,0.0,0.0,0.0,0.0,0.0,0.0,0.105,1.368,3.814,0.259,0.123,,2
HSP90B1,CV_414.1 [Hypertrophic cardiomyopathy],0.076,0,0.0,0.0,0.0,0.0,0.0,0.0,0.593,1.613,1.998,0.338,0.302,0.432,3
ACAD9,CV_414.1 [Hypertrophic cardiomyopathy],0.076,0,0.0,0.0,0.825,0.0,0.0,0.0,0.082,1.399,2.87,0.776,0.318,0.999,4
F9,NS_323.3 [Motor neuron disease],0.076,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,2.554,1.486,,0.103,0.016,3
SIAH1,GU_580.1 [Acute nephritic syndrome],0.076,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,2.121,0.037,,,0.158,3
TP63,GE_978.22 [Ehler's Danlos syndrome],0.076,0,0.0,0.0,0.0,0.0,0.0,0.0,0.085,2.412,0.105,0.044,0.107,,2
DOCK3,GE_972.9 [Muscular dystrophy],0.076,0,0.0,0.0,0.0,0.0,0.0,0.0,0.102,1.582,2.939,0.429,1.037,0.212,3
THBS1,GU_580.1 [Acute nephritic syndrome],0.076,0,0.0,0.0,0.0,0.0,0.0,0.0,0.096,2.211,2.869,,0.084,0.967,3
CREBBP,GI_516.1 [Pyloric stenosis],0.076,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.769,2.957,0.387,0.165,0.978,2
RPL27A,SO_386.5 [Color vision deficiencies],0.076,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.542,0.067,,,0.159,2
CR2,BI_179.1 [Hypogammaglobulinemia NOS],0.076,0,0.0,0.0,0.849,0.0,0.0,0.0,0.017,,1.943,0.509,0.137,0.987,4
COL1A1,MS_712.51 [Hypermobility syndrome],0.076,0,0.0,0.0,0.0,0.0,0.353,0.705,0.089,1.422,2.751,0.098,0.072,,4
UBE2D3,CV_433.3 [Cerebrovascular insufficiency],0.076,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.036,,,0.208,1
ADIPOR1,CV_414.1 [Hypertrophic cardiomyopathy],0.076,0,0.0,0.0,0.745,0.0,0.0,0.0,0.291,,0.199,0.038,0.136,0.315,3
IFT74,SO_386.6 [Night blindness],0.076,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.657,1.843,0.518,0.177,0.965,2
SMARCB1,CV_414.1 [Hypertrophic cardiomyopathy],0.076,0,0.0,0.0,0.0,0.19,0.0,0.0,0.035,5.015,1.634,0.141,0.136,0.324,3
RNASE7,GE_977.1 [Congenital ichthyosis],0.076,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.767,1.317,0.034,0.033,0.178,3
ALAS2,GE_966.2 [Disorders of porphyrin metabolism],0.076,0,0.0,0.0,0.0,0.0,0.0,0.824,0.135,,2.455,0.18,0.031,,3
ALB,MB_293.1 [Anorexia nervosa],0.076,0,0.0,0.0,0.0,0.0,0.0,0.0,0.215,1.372,2.668,0.207,0.118,,2
MAPK14,NS_323.3 [Motor neuron disease],0.076,0,0.0,0.0,0.0,0.0,0.278,0.0,0.078,,2.477,0.092,0.12,0.934,4
CDH2,CM_770.5 [Congenital osteodystrophies],0.076,0,0.0,0.0,0.0,0.0,0.0,0.0,0.046,3.636,2.573,0.357,2.619,0.942,3
IFT88,SO_369.62 [Keratoconus],0.076,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.797,2.515,0.332,0.264,0.988,2
BMP4,MS_727.5 [Cyst of bone],0.075,0,0.0,0.0,0.0,0.0,0.372,0.0,0.015,3.725,2.356,0.759,1.379,,3
AGT,GE_976.5 [Polycystic kidney disease],0.075,0,0.0,0.0,0.0,0.0,0.387,0.0,0.297,2.863,2.898,0.527,1.101,,3
ARPC4,SO_365.3 [Exophthalmos [Proptosis]],0.075,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.063,,,0.254,1
CCNA1,GE_972.9 [Muscular dystrophy],0.075,0,0.0,0.017,0.0,0.0,0.0,0.0,0.4,1.885,2.796,0.083,0.064,0.427,4
NTN1,NS_323.3 [Motor neuron disease],0.075,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,2.565,2.445,0.276,0.262,0.276,3
PCDH12,NS_341.1 [Cerebral palsy],0.075,0,0.0,0.0,0.745,0.0,0.0,0.0,0.015,1.55,2.917,0.466,0.203,0.289,4
SLC7A1,SO_369.62 [Keratoconus],0.075,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,1.763,1.68,0.147,0.143,0.093,3
SLC6A4,"MB_280.4 [Sedative, hypnotic, or anxiolytic related disorders]",0.075,1,4.0,0.0,0.0,0.0,0.0,0.0,0.112,,3.008,0.135,0.138,,2
COQ8B,GU_580.1 [Acute nephritic syndrome],0.075,0,0.0,0.0,0.887,0.0,0.0,0.012,0.043,,3.163,0.183,0.199,,3
SYT1,GE_963.1 [Lipid storage disorders],0.075,0,0.0,0.0,0.0,0.0,0.0,0.0,0.046,2.056,0.062,0.033,0.025,0.202,3
PDLIM3,CV_414.1 [Hypertrophic cardiomyopathy],0.075,0,0.0,0.0,0.701,0.0,0.59,0.167,0.023,2.435,2.58,0.608,0.253,0.867,5
RB1,GE_961.1 [Phakomatoses],0.075,0,0.0,0.0,0.0,0.0,0.336,0.0,0.032,2.278,5.229,0.497,0.175,0.939,4
CLRN1,SO_380.3 [Optic atrophy],0.075,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.17,2.02,0.861,0.109,0.963,2
DARS2,GE_963.1 [Lipid storage disorders],0.075,0,0.0,0.0,0.684,0.0,0.0,0.85,0.083,1.437,2.002,0.16,0.125,0.817,4
RAN,SO_386.5 [Color vision deficiencies],0.075,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.236,0.037,,,0.193,2
PPARG,EM_211.1 [Adrenal hyperfunction],0.075,1,2.0,0.0,0.0,0.0,0.271,0.0,0.073,1.743,0.19,0.134,0.118,,3
CSF1,MS_727.5 [Cyst of bone],0.075,0,0.0,0.0,0.0,0.0,0.258,0.0,0.067,2.798,2.78,2.78,0.069,,3
COL4A4,SO_369.62 [Keratoconus],0.075,0,0.0,0.0,0.839,0.0,0.0,0.0,0.261,,3.393,0.291,0.179,0.329,4
AP4S1,NS_341.1 [Cerebral palsy],0.075,0,0.0,0.0,0.857,0.0,0.0,0.589,0.041,,0.335,0.145,0.119,0.955,3
UBE2N,EM_209.4 [Diabetes insipidus],0.075,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.041,,,0.212,1
ABHD12,GE_972.2 [Hereditary ataxia],0.075,0,0.0,0.0,0.884,0.0,0.287,0.503,0.094,2.298,0.293,0.4,0.973,0.832,5
GABRE,NS_333.4 [Circadian rhythm sleep disorder],0.075,1,4.0,0.0,0.0,0.0,0.0,0.0,0.03,1.874,2.815,2.693,0.078,0.297,3
KPNB1,SO_369.62 [Keratoconus],0.075,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,3.844,,,0.228,2
GHRL,NS_333.7 [Narcolepsy],0.075,0,0.0,0.0,0.0,0.0,0.0,0.0,0.12,2.682,1.958,0.017,0.057,,2
TUBB2A,SO_386.6 [Night blindness],0.075,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.415,0.043,,,0.272,2
L1CAM,NS_341.1 [Cerebral palsy],0.075,0,0.0,0.0,0.854,0.0,0.0,0.603,0.026,,2.251,0.387,0.105,0.988,4
GABRA4,NS_323.3 [Motor neuron disease],0.075,1,1.0,0.0,0.0,0.0,0.0,0.0,0.03,2.103,3.243,,0.165,0.04,3
IL12RB2,GI_542.8 [Biliary cirrhosis],0.075,0,0.0,0.0,0.0,0.704,0.0,0.0,0.363,7.163,2.964,0.448,0.231,,2
GRIK2,GE_972.2 [Hereditary ataxia],0.075,0,0.0,0.0,0.547,0.0,0.0,0.362,0.012,4.651,2.809,0.32,0.234,0.957,4
PPARG,GU_580.1 [Acute nephritic syndrome],0.075,1,1.0,0.0,0.0,0.0,0.0,0.0,0.138,1.358,2.51,0.117,0.101,0.99,3
ITK,BI_179.1 [Hypogammaglobulinemia NOS],0.075,0,0.0,0.0,0.684,0.0,0.0,0.0,0.036,,1.952,0.2,0.151,0.975,4
AKT1,NS_341.1 [Cerebral palsy],0.075,0,0.0,0.0,0.0,0.0,0.0,0.0,0.414,,3.335,3.132,0.091,0.988,3
KPNB1,SO_386.5 [Color vision deficiencies],0.075,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.123,,,0.213,1
GH1,EM_209.13 [Hyperprolactinemia*],0.075,0,0.0,0.0,0.0,0.0,0.362,0.0,0.108,,2.901,0.158,0.058,,3
BCL2,NS_338.1 [Myasthenia gravis],0.075,0,0.0,0.0,0.0,0.0,0.0,0.0,0.159,1.874,0.213,0.04,0.093,,2
CD36,GU_580.1 [Acute nephritic syndrome],0.075,0,0.0,0.0,0.0,0.0,0.0,0.0,0.099,3.172,4.489,3.621,2.351,0.961,3
RIGI,MS_727.5 [Cyst of bone],0.075,0,0.0,0.0,0.0,0.0,0.0,0.609,0.152,3.056,,,,,3
RPL18A,CM_750.16 [Arnold-Chiari syndrome*],0.075,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.131,,,0.326,1
CALM2,CV_438.41 [Aortic dissection],0.075,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.146,0.051,,,0.239,2
PEX7,NS_341.1 [Cerebral palsy],0.075,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.61,1.962,0.433,0.129,0.988,2
BMPER,GE_978.3 [Osteochondrodysplasias],0.075,0,0.0,0.0,0.0,0.0,0.349,0.0,0.07,2.891,1.74,0.1,0.148,,3
ARPC4,GU_580.1 [Acute nephritic syndrome],0.075,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.052,,,0.225,1
ASXL2,GE_972.2 [Hereditary ataxia],0.075,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,1.66,2.84,0.142,0.669,0.299,3
FOXO1,GI_542.8 [Biliary cirrhosis],0.075,0,0.0,0.0,0.0,0.0,0.0,0.0,0.313,2.224,2.389,0.077,0.131,,2
GRIN1,GE_973.5 [Huntington's disease],0.075,1,4.0,0.0,0.0,0.0,0.0,0.0,0.364,,0.053,0.023,0.046,,1
SAG,SO_386.6 [Night blindness],0.075,0,0.0,0.0,0.881,0.0,0.0,0.782,0.03,,3.087,0.899,0.138,0.918,4
ITGB1,GU_580.1 [Acute nephritic syndrome],0.075,0,0.0,0.0,0.0,0.0,0.0,0.0,0.064,2.088,0.177,0.076,0.155,0.925,3
HSPB8,GE_972.1 [Hereditary neuropathy],0.075,0,0.0,0.0,0.0,0.0,0.35,0.716,0.075,1.519,0.337,0.159,0.095,,4
LRIF1,GE_972.9 [Muscular dystrophy],0.075,0,0.0,0.0,0.547,0.0,0.0,0.251,0.073,,0.684,0.261,1.856,0.218,4
RBMS1,CV_414.1 [Hypertrophic cardiomyopathy],0.075,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,2.241,2.386,0.217,1.18,0.153,3
HSD11B2,EM_211.1 [Adrenal hyperfunction],0.075,0,0.0,0.0,0.0,0.0,0.287,0.855,0.024,,1.954,0.142,0.18,,4
MSTN,GE_964.3 [Glycogen storage disease],0.075,0,0.0,0.0,0.0,0.0,0.293,0.0,0.104,1.79,2.615,0.35,0.08,,3
IL18,GE_964.3 [Glycogen storage disease],0.075,0,0.0,0.0,0.0,0.0,0.0,0.0,0.074,1.996,1.6,0.028,0.032,,2
DSTYK,GE_972.2 [Hereditary ataxia],0.075,0,0.0,0.0,0.547,0.0,0.0,0.671,0.038,2.49,3.009,1.066,0.79,0.249,4
ADRA2A,NS_341.1 [Cerebral palsy],0.075,1,4.0,0.0,0.0,0.0,0.0,0.0,0.0,1.764,1.74,0.045,0.044,0.9,2
CCL20,GI_540.4 [Alcoholic hepatitis],0.075,0,0.0,0.0,0.0,0.0,0.0,0.0,0.081,2.242,2.165,0.016,0.062,,2
TUBB4A,GE_972.2 [Hereditary ataxia],0.075,0,0.0,0.065,0.779,0.0,0.423,0.547,0.037,,0.108,,0.08,0.934,5
RPL11,BI_162.1 [Constitutional (hereditary) aplastic anemia],0.075,0,0.0,0.0,0.892,0.0,0.0,0.845,0.24,,0.097,,,,2
TCTN3,GE_972.2 [Hereditary ataxia],0.075,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,3.621,0.39,0.197,0.992,2
CNGB3,SO_369.62 [Keratoconus],0.075,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.917,3.017,0.55,1.847,0.999,2
RPS10,CM_751.213 [Congenital cataract],0.075,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.016,,,0.221,1
CP,CV_433.3 [Cerebrovascular insufficiency],0.075,0,0.0,0.0,0.0,0.0,0.0,0.0,0.183,1.986,1.661,0.162,0.123,0.267,3
CD36,CM_770.5 [Congenital osteodystrophies],0.075,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.945,1.893,0.374,0.268,0.947,2
SPIN1,SO_380.3 [Optic atrophy],0.075,0,0.0,0.0,0.0,0.0,0.268,0.0,0.0,2.646,0.068,0.05,,0.174,3
SLC6A3,GE_973.5 [Huntington's disease],0.075,1,2.0,0.0,0.0,0.0,0.0,0.0,0.212,2.107,2.581,2.504,0.053,,2
EYA1,NS_323.3 [Motor neuron disease],0.075,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,4.616,0.579,0.424,0.265,0.081,3
BIN1,GE_972.9 [Muscular dystrophy],0.075,0,0.0,0.0,0.0,0.0,0.31,0.503,0.137,1.753,1.904,0.331,0.137,0.888,5
BLM,GE_977.6 [Congenital cutaneous mastocytosis*],0.075,0,0.0,0.0,0.0,0.0,0.0,0.925,0.525,1.836,2.757,0.222,0.084,,3
MTOR,MS_704.2 [Wegener's granulomatosis],0.075,0,0.0,0.0,0.0,0.0,0.0,0.0,0.122,1.741,3.556,0.287,1.008,,2
VEGFA,"EM_209.11 [Tall stature, acromegaly and gigantism]",0.075,0,0.0,0.0,0.0,0.0,0.0,0.0,0.166,3.528,0.15,0.127,0.068,,2
SRSF1,GE_977.1 [Congenital ichthyosis],0.075,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.034,,,0.204,1
HNRNPC,SO_386.5 [Color vision deficiencies],0.075,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.354,0.072,,,0.139,2
SMARCAD1,CM_770.5 [Congenital osteodystrophies],0.075,0,0.0,0.0,0.0,0.0,0.0,0.0,0.015,2.847,2.431,0.039,0.107,0.295,3
ANGPT1,DE_669.2 [Behcet's syndrome],0.075,0,0.0,0.0,0.0,0.0,0.0,0.0,0.181,4.413,0.151,0.081,0.071,,2
PTGER4,CM_763.13 [Patent ductus arteriosus],0.075,1,4.0,0.0,0.0,0.0,0.0,0.0,0.058,2.642,0.057,0.037,0.036,0.319,3
DTNA,CV_414.1 [Hypertrophic cardiomyopathy],0.075,0,0.0,0.0,0.58,0.0,0.486,0.148,0.012,1.966,2.57,0.463,0.449,0.781,5
ADAR,MS_700.3 [Systemic sclerosis],0.075,0,0.0,0.0,0.0,0.0,0.0,0.0,0.654,2.58,2.054,0.231,0.235,,2
RPL26,GE_972.9 [Muscular dystrophy],0.075,1,4.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.032,,,0.197,1
IL23R,MS_705.2 [Juvenile rheumatoid arthritis [JRA/JIA]],0.075,0,0.0,0.104,0.0,0.374,0.0,0.0,0.124,2.406,0.644,0.651,0.094,,3
PSMC4,GU_603.4 [Atrophy of testis],0.075,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.543,0.072,,0.117,,1
SLC9A1,MB_302.1 [Speech and language developmental delay],0.075,0,0.0,0.0,0.0,0.0,0.387,0.0,0.024,,2.347,0.48,0.171,0.333,4
PRPF8,SO_380.3 [Optic atrophy],0.075,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.344,1.455,0.146,1.742,0.976,2
ADCY5,NS_323.3 [Motor neuron disease],0.075,0,0.0,0.0,0.0,0.0,0.0,0.0,0.024,1.353,2.221,0.19,0.35,0.047,3
IGF1R,GE_973.5 [Huntington's disease],0.075,1,0.5,0.0,0.0,0.0,0.0,0.0,0.642,3.694,2.187,0.123,0.094,,2
CFL1,CV_441 [Arteriovenous malformation],0.075,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.089,,,0.259,1
ARHGAP35,SO_369.62 [Keratoconus],0.075,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.694,2.732,,0.023,0.259,2
PTGS2,GE_963.1 [Lipid storage disorders],0.075,1,4.0,0.0,0.0,0.0,0.0,0.0,0.03,1.891,2.238,0.066,0.084,0.9,3
COL4A4,GU_580.51 [Focal and segmental glomerular lesions*],0.075,0,0.0,0.0,0.0,0.0,0.669,0.354,0.25,1.614,3.233,0.993,0.084,,4
SRSF1,GE_963.1 [Lipid storage disorders],0.075,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.711,0.031,,,0.33,2
BRD2,MS_712.51 [Hypermobility syndrome],0.075,0,0.0,0.0,0.0,0.0,0.0,0.0,0.187,,2.192,0.179,0.236,,2
APP,GE_972.2 [Hereditary ataxia],0.075,0,0.0,0.0,0.0,0.0,0.0,0.0,0.054,2.352,2.574,0.326,0.572,0.995,3
RPS29,GI_540.11 [Autoimmune hepatitis],0.075,0,0.0,0.0,0.0,0.0,0.0,0.0,0.091,2.873,3.541,,,,2
HNRNPC,GE_963.1 [Lipid storage disorders],0.075,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.984,0.052,,,0.164,2
TNF,GU_580.51 [Focal and segmental glomerular lesions*],0.075,1,2.0,0.0,0.0,0.0,0.0,0.0,0.777,,0.254,0.151,0.039,,1
PSAP,GE_963.1 [Lipid storage disorders],0.075,0,0.0,0.0,0.86,0.0,0.325,0.685,0.084,1.359,0.325,0.213,0.086,0.604,5
GLB1,CM_770.5 [Congenital osteodystrophies],0.075,0,0.0,0.0,0.0,0.0,0.0,0.37,0.014,2.549,3.31,3.988,1.907,0.957,4
NDUFS6,CM_763.31 [Ventricular septal defect],0.075,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.787,0.09,0.121,0.079,0.931,2
DGKI,NS_343.6 [Multi-system degeneration of the autonomic nervous system*],0.075,0,0.0,0.0,0.0,0.0,0.0,0.0,0.091,2.589,2.827,0.09,0.086,,2
DNM2,NS_338.1 [Myasthenia gravis],0.075,0,0.0,0.0,0.0,0.0,0.469,0.0,0.018,,2.464,0.414,0.261,,3
FOXO3,NS_344.11 [Communicating hydrocephalus],0.075,0,0.0,0.0,0.0,0.0,0.0,0.0,0.128,3.694,0.161,0.118,0.057,,2
TUBB2B,SO_369.62 [Keratoconus],0.075,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.079,0.128,,,0.295,2
SNRPD2,CM_751.213 [Congenital cataract],0.075,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.066,,,0.175,1
CACNA1B,NS_333.4 [Circadian rhythm sleep disorder],0.075,1,3.0,0.0,0.0,0.0,0.0,0.0,0.03,1.818,2.757,0.35,0.236,0.333,3
PIK3AP1,GE_961.1 [Phakomatoses],0.075,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,3.349,2.324,0.129,0.188,0.262,3
DMWD,NS_339.2 [Myotonic disorders],0.075,0,0.0,0.0,0.0,0.0,0.0,0.0,0.491,,2.814,0.092,0.086,,2
HADHB,CV_414.1 [Hypertrophic cardiomyopathy],0.075,0,0.0,0.0,0.0,0.0,0.574,0.402,0.018,1.491,1.639,0.295,0.347,0.998,5
SSBP3,GE_961.1 [Phakomatoses],0.075,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,3.029,2.369,,,0.215,3
RNF40,EM_209.4 [Diabetes insipidus],0.075,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,1.399,3.39,0.443,0.189,0.199,3
ADGRL2,BI_179.7 [Common variable immunodeficiency [CVID]],0.075,0,0.0,0.0,0.0,0.468,0.0,0.0,0.012,3.293,0.454,0.179,0.102,,2
AGL,GE_964.3 [Glycogen storage disease],0.075,0,0.0,0.0,0.0,0.0,0.336,0.867,0.093,1.646,3.008,1.435,0.26,,4
SIAH1,CV_441 [Arteriovenous malformation],0.075,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.858,0.076,,,0.144,2
CALU,MS_700.3 [Systemic sclerosis],0.075,0,0.0,0.0,0.0,0.0,0.0,0.0,0.22,,2.605,0.19,0.116,,2
DNMT1,GE_972.2 [Hereditary ataxia],0.075,0,0.0,0.066,0.855,0.0,0.0,0.245,0.06,1.38,3.003,0.231,0.197,0.882,5
MECR,SO_380.3 [Optic atrophy],0.075,0,0.0,0.0,0.836,0.0,0.0,0.42,0.079,2.2,0.809,0.234,0.116,0.504,4
IFT172,SO_386.6 [Night blindness],0.075,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.262,2.215,0.228,0.356,0.978,2
SYNE1,NS_323.3 [Motor neuron disease],0.075,0,0.0,0.0,0.779,0.0,0.396,0.0,0.082,2.993,3.16,0.784,0.686,0.709,5
UBE2N,EM_208.1 [Hypoparathyroidism],0.075,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.086,,,0.246,1
ROBO2,GU_580.1 [Acute nephritic syndrome],0.075,0,0.0,0.0,0.426,0.0,0.411,0.0,0.03,3.238,2.414,,0.08,0.313,5
FOS,CM_770.5 [Congenital osteodystrophies],0.075,0,0.0,0.0,0.0,0.0,0.317,0.0,0.05,2.486,3.989,4.214,0.093,0.987,4
TNFAIP3,GE_972.2 [Hereditary ataxia],0.075,0,0.0,0.0,0.0,0.0,0.0,0.0,0.261,2.828,1.601,0.322,0.167,0.521,3
LYRM7,NS_341.1 [Cerebral palsy],0.075,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,1.712,0.072,0.062,0.966,2
HLA-B,DE_669.2 [Behcet's syndrome],0.075,0,0.0,0.0,0.0,0.303,0.0,0.0,0.914,,2.649,0.126,0.069,,2
RPS29,CM_750.16 [Arnold-Chiari syndrome*],0.075,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.064,0.032,,,0.195,2
CNTF,NS_323.3 [Motor neuron disease],0.075,0,0.0,0.0,0.304,0.0,0.497,0.0,0.178,,1.956,0.104,0.055,0.278,5
MYBPC1,GE_972.9 [Muscular dystrophy],0.075,0,0.0,0.0,0.0,0.0,0.252,0.666,0.019,,3.916,3.285,0.162,0.575,5
SNRPD2,SO_365.3 [Exophthalmos [Proptosis]],0.075,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.057,0.084,,,0.206,2
BANF1,SO_386.5 [Color vision deficiencies],0.074,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.072,,,0.167,1
RPL7,GE_961.1 [Phakomatoses],0.074,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.763,2.788,,,0.155,2
IL12B,GI_542.8 [Biliary cirrhosis],0.074,1,2.0,0.0,0.0,0.42,0.0,0.0,0.048,2.033,2.584,0.099,0.124,,2
ALKBH5,GE_972.9 [Muscular dystrophy],0.074,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.148,,,0.226,1
PLP1,NS_341.1 [Cerebral palsy],0.074,0,0.0,0.0,0.886,0.0,0.0,0.281,0.048,,0.049,0.022,0.052,0.986,3
ETFB,NS_341.1 [Cerebral palsy],0.074,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.927,2.579,0.26,0.121,0.95,2
RPL35,CM_750.16 [Arnold-Chiari syndrome*],0.074,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.226,0.034,0.022,0.272,1
SUMO2,GE_961.1 [Phakomatoses],0.074,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.083,,,0.318,1
PDE10A,GE_973.5 [Huntington's disease],0.074,1,2.0,0.0,0.0,0.0,0.295,0.0,0.81,2.173,0.512,0.051,0.036,,3
SLC6A3,MB_306 [Conduct disorders],0.074,1,4.0,0.0,0.0,0.0,0.0,0.0,0.069,2.193,1.14,0.138,2.144,,2
COL5A2,RE_484.1 [Spontaneous pneumothorax],0.074,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.158,2.376,0.946,0.162,0.989,2
SOX2,MB_296.4 [Borderline personality disorder],0.074,0,0.0,0.0,0.0,0.0,0.0,0.0,0.109,2.759,3.063,,2.755,,2
CLCN6,MB_302.1 [Speech and language developmental delay],0.074,0,0.0,0.0,0.0,0.0,0.0,0.37,0.012,1.637,3.456,0.306,0.892,0.128,4
PUM1,CV_433.3 [Cerebrovascular insufficiency],0.074,0,0.0,0.0,0.0,0.0,0.0,0.0,0.061,2.356,0.554,0.4,0.193,0.303,3
ALG13,CM_763.13 [Patent ductus arteriosus],0.074,0,0.0,0.0,0.0,0.0,0.0,0.0,0.036,2.48,4.237,0.049,0.035,0.323,3
C2CD3,GE_978.3 [Osteochondrodysplasias],0.074,0,0.0,0.0,0.0,0.0,0.0,0.547,0.015,,3.051,0.909,0.253,,3
HDAC9,CV_414.1 [Hypertrophic cardiomyopathy],0.074,0,0.0,0.0,0.0,0.0,0.469,0.0,0.04,2.214,2.578,0.775,0.305,0.045,4
BMP4,MS_705.2 [Juvenile rheumatoid arthritis [JRA/JIA]],0.074,0,0.0,0.0,0.0,0.0,0.0,0.0,0.313,1.925,0.225,0.171,0.06,,2
PTGS2,GE_972.2 [Hereditary ataxia],0.074,0,0.0,0.047,0.0,0.0,0.0,0.0,0.047,1.305,1.894,0.135,0.156,0.956,4
REN,GU_580.52 [Diffuse membranous glomerulonephritis],0.074,0,0.0,0.0,0.0,0.0,0.529,0.0,0.112,,4.187,0.147,0.099,,3
KEAP1,GI_542.8 [Biliary cirrhosis],0.074,0,0.0,0.0,0.0,0.0,0.0,0.0,0.459,,2.28,0.141,0.722,,2
CYP27A1,CV_414.1 [Hypertrophic cardiomyopathy],0.074,0,0.0,0.0,0.0,0.0,0.437,0.0,0.236,1.868,3.112,1.078,0.342,0.358,4
SLC20A2,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.074,0,0.0,0.0,0.0,0.0,0.0,0.699,0.156,2.006,1.865,0.157,2.216,0.756,4
MT-ND4,GE_972.2 [Hereditary ataxia],0.074,1,4.0,0.0,0.0,0.0,0.0,0.121,0.028,,,,,,2
UBE2D3,GU_580.1 [Acute nephritic syndrome],0.074,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.049,,,0.243,1
AP4E1,NS_341.1 [Cerebral palsy],0.074,0,0.0,0.0,0.867,0.0,0.0,0.582,0.023,1.982,3.306,1.275,0.188,0.982,4
AKAP6,MB_293.1 [Anorexia nervosa],0.074,0,0.0,0.0,0.0,0.306,0.0,0.0,0.065,2.487,2.642,0.238,0.344,,2
ICOS,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.074,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.718,0.234,0.14,0.05,0.958,2
HPDL,NS_341.1 [Cerebral palsy],0.074,0,0.0,0.0,0.886,0.0,0.0,0.519,0.03,,0.147,0.177,0.121,0.636,3
SPTB,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.074,0,0.0,0.0,0.89,0.0,0.336,0.37,0.062,,3.324,0.159,0.163,0.966,5
HMGCR,MS_704.1 [Polyarteritis nodosa and related conditions],0.074,1,2.0,0.0,0.0,0.0,0.0,0.0,0.085,1.457,2.151,0.276,0.163,,2
CD28,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.074,0,0.0,0.0,0.0,0.0,0.0,0.0,0.109,1.975,2.863,0.135,0.072,0.992,3
VWF,MS_700.3 [Systemic sclerosis],0.074,1,2.0,0.0,0.0,0.0,0.0,0.0,0.436,2.156,3.983,0.694,0.425,,2
AKT2,GE_972.2 [Hereditary ataxia],0.074,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,1.992,1.443,0.098,0.132,0.906,3
KIT,GI_540.11 [Autoimmune hepatitis],0.074,0,0.0,0.0,0.0,0.0,0.0,0.0,0.157,2.751,1.986,0.22,0.162,,2
TCF12,GE_973.5 [Huntington's disease],0.074,0,0.0,0.0,0.0,0.0,0.0,0.0,0.033,2.123,0.079,0.142,0.096,,2
ARPC4,MB_302.1 [Speech and language developmental delay],0.074,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.416,0.034,,,0.263,2
IMMP2L,MB_305.1 [Tics and tic disorders],0.074,0,0.0,0.0,0.0,0.553,0.0,0.402,0.405,2.495,0.102,0.115,0.067,,3
OXTR,MB_301.2 [Asperger's syndrome*],0.074,0,0.0,0.0,0.0,0.0,0.534,0.0,0.146,2.51,0.348,0.256,0.119,,3
PRKDC,GE_964.3 [Glycogen storage disease],0.074,0,0.0,0.0,0.0,0.0,0.312,0.0,0.015,1.977,2.718,0.518,0.221,,3
RPS23,GE_961.1 [Phakomatoses],0.074,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.147,0.087,,,0.308,2
IBA57,GE_963.1 [Lipid storage disorders],0.074,0,0.0,0.0,0.857,0.0,0.0,0.0,0.033,,2.531,2.359,0.092,0.998,4
SUMO2,NS_323.3 [Motor neuron disease],0.074,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.108,,,0.251,1
LYN,NS_339.2 [Myotonic disorders],0.074,0,0.0,0.0,0.0,0.0,0.0,0.0,0.476,2.224,0.095,0.013,0.06,,2
HIF1A,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.074,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,2.064,2.047,0.282,0.152,0.976,3
RORA,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.074,0,0.0,0.0,0.0,0.0,0.295,0.0,0.0,3.353,2.781,,,0.272,3
MARS1,GE_972.1 [Hereditary neuropathy],0.074,0,0.0,0.0,0.0,0.0,0.0,0.626,0.102,,2.87,0.807,0.342,,3
SUMO2,GE_963.1 [Lipid storage disorders],0.074,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.081,,,0.322,1
INSR,GE_964.3 [Glycogen storage disease],0.074,0,0.0,0.0,0.0,0.0,0.456,0.0,0.041,3.231,2.872,0.18,1.788,,3
SHANK2,NS_323.3 [Motor neuron disease],0.074,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.331,2.491,0.308,1.107,0.272,3
MEIS1,NS_333.4 [Circadian rhythm sleep disorder],0.074,0,0.0,0.0,0.0,0.789,0.0,0.0,0.387,2.309,3.283,0.08,0.109,0.226,3
SPPL3,CV_413.41 [Pulmonary valve stenosis],0.074,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.339,0.163,0.017,,0.194,2
BANF1,CV_414.1 [Hypertrophic cardiomyopathy],0.074,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.563,0.137,,,0.263,2
FOXP1,CV_414.1 [Hypertrophic cardiomyopathy],0.074,0,0.0,0.0,0.0,0.0,0.579,0.0,0.0,2.482,0.066,,,0.216,3
CNGB3,SO_386.6 [Night blindness],0.074,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.984,2.116,0.374,0.188,1.0,2
DIAPH1,MS_700.3 [Systemic sclerosis],0.074,0,0.0,0.0,0.0,0.0,0.0,0.0,0.067,1.901,1.531,0.132,0.56,,2
ANKHD1-EIF4EBP3,SO_369.62 [Keratoconus],0.074,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.088,0.047,,0.327,1
XPO5,GU_580.52 [Diffuse membranous glomerulonephritis],0.074,0,0.0,0.0,0.0,0.0,0.0,0.0,0.097,1.63,2.942,0.11,0.119,,2
SHANK3,CM_770.5 [Congenital osteodystrophies],0.074,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.945,,0.023,0.287,2
TFAP2B,MB_293.2 [Bulimia nervosa],0.074,0,0.0,0.0,0.0,0.0,0.0,0.0,0.128,1.627,0.189,0.18,0.127,,2
CNTN1,CM_770.5 [Congenital osteodystrophies],0.074,0,0.0,0.0,0.0,0.0,0.0,0.0,0.593,1.921,2.575,0.189,0.96,0.356,3
EZH2,"MB_280.4 [Sedative, hypnotic, or anxiolytic related disorders]",0.074,0,0.0,0.0,0.0,0.0,0.0,0.0,0.108,2.474,0.349,0.057,0.081,,2
SRC,BI_179.1 [Hypogammaglobulinemia NOS],0.074,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.33,0.128,0.072,0.14,0.98,3
SLC6A3,SO_386.5 [Color vision deficiencies],0.074,0,0.0,0.0,0.0,0.0,0.0,0.0,0.195,2.726,1.015,0.136,0.088,0.642,3
INPP5K,GE_972.9 [Muscular dystrophy],0.074,0,0.0,0.0,0.853,0.0,0.0,0.0,0.068,1.894,2.134,0.136,1.674,0.18,4
GRIA1,GE_972.2 [Hereditary ataxia],0.074,0,0.0,0.0,0.0,0.0,0.0,0.0,0.165,3.006,3.008,0.482,0.204,0.943,3
EPAS1,GE_970.1 [Sickle-cell disorders],0.074,0,0.0,0.0,0.0,0.0,0.272,0.0,0.086,2.975,2.315,0.275,0.121,,3
GGNBP2,CM_763.13 [Patent ductus arteriosus],0.074,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.106,0.03,0.013,0.258,1
NPLOC4,SO_381.5 [Vertical strabismus],0.074,0,0.0,0.0,0.0,0.256,0.0,0.0,0.1,2.253,3.758,0.112,0.072,,2
RPS10,GU_580.1 [Acute nephritic syndrome],0.074,1,1.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.019,,,0.208,1
APP,CV_414.1 [Hypertrophic cardiomyopathy],0.074,0,0.0,0.0,0.0,0.0,0.0,0.0,0.079,2.543,2.91,0.606,0.853,0.962,3
NDUFA9,CV_414.1 [Hypertrophic cardiomyopathy],0.074,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,1.709,0.129,0.262,0.996,2
SERPINF1,GE_978.3 [Osteochondrodysplasias],0.074,0,0.0,0.0,0.0,0.0,0.0,0.733,0.603,,2.528,0.266,0.115,,3
HTR2C,CM_770.5 [Congenital osteodystrophies],0.074,0,0.0,0.0,0.0,0.0,0.0,0.0,0.078,1.998,0.282,,0.036,0.295,3
PRMT5,GE_973.5 [Huntington's disease],0.074,0,0.0,0.0,0.0,0.0,0.0,0.0,0.264,2.149,0.184,0.06,0.051,,2
CD28,EM_249.1 [Cerebral amyloid angiopathy*],0.074,0,0.0,0.0,0.0,0.0,0.0,0.0,0.392,1.865,2.816,2.715,0.064,,2
SCN5A,NS_323.3 [Motor neuron disease],0.074,1,4.0,0.0,0.0,0.0,0.0,0.0,0.038,2.401,2.82,0.339,0.126,0.2,3
AICDA,BI_179.7 [Common variable immunodeficiency [CVID]],0.074,0,0.0,0.0,0.0,0.0,0.769,0.0,0.483,,0.028,0.016,2.725,,3
RARG,MS_719.2 [Muscle calcification and ossification],0.074,1,4.0,0.0,0.0,0.0,0.0,0.0,0.098,,0.196,0.082,0.048,,1
POLG,GE_972.2 [Hereditary ataxia],0.074,0,0.0,0.0,0.87,0.0,0.0,0.572,0.048,2.084,2.782,1.894,0.134,0.998,4
GAS1,GE_972.9 [Muscular dystrophy],0.074,0,0.0,0.044,0.0,0.0,0.0,0.0,0.061,3.528,2.165,0.024,0.029,0.216,4
MAPK1,NS_323.3 [Motor neuron disease],0.074,1,0.5,0.03,0.0,0.0,0.0,0.0,0.068,1.684,2.398,,0.102,0.968,4
ISY1-RAB43,CM_763.31 [Ventricular septal defect],0.074,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.042,,,0.21,1
DNMT1,NS_323.3 [Motor neuron disease],0.074,0,0.0,0.0,0.0,0.0,0.0,0.0,0.027,,2.691,0.366,0.315,0.176,3
PIGT,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.074,0,0.0,0.0,0.547,0.0,0.0,0.0,0.044,,3.021,0.27,0.299,0.25,4
PRPH,NS_323.3 [Motor neuron disease],0.074,0,0.0,0.0,0.86,0.0,0.0,0.338,0.112,,1.83,0.048,0.149,0.977,4
RPL9,SO_386.6 [Night blindness],0.074,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.128,0.033,,0.178,1
PTGS2,RE_464.2 [Chronic nasopharyngitis],0.074,1,4.0,0.0,0.0,0.0,0.0,0.0,0.02,3.772,0.093,0.091,0.076,,2
IKBKG,CM_770.5 [Congenital osteodystrophies],0.074,0,0.0,0.0,0.547,0.0,0.0,0.732,0.062,,2.765,0.349,0.076,0.87,4
MT-ATP6,GE_972.1 [Hereditary neuropathy],0.074,0,0.0,0.0,0.0,0.0,0.0,0.362,0.075,,,,,,2
RPL26,RE_484.1 [Spontaneous pneumothorax],0.074,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.084,,,0.281,1
RUNX2,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.074,0,0.0,0.0,0.0,0.502,0.0,0.0,0.012,3.043,0.292,0.218,0.151,0.819,3
PTPRC,NS_338.1 [Myasthenia gravis],0.074,0,0.0,0.0,0.0,0.0,0.0,0.0,0.119,2.055,2.805,0.102,1.629,,2
TFAP2A,DE_663.2 [Pemphigoid],0.074,0,0.0,0.0,0.0,0.0,0.0,0.0,0.091,2.869,2.273,0.071,0.127,,2
DNM1,GE_972.1 [Hereditary neuropathy],0.074,0,0.0,0.0,0.0,0.0,0.0,0.0,0.068,1.462,1.68,0.129,0.193,,2
PIK3CD,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.074,1,3.0,0.0,0.0,0.0,0.0,0.0,0.0,1.701,1.721,0.23,0.182,0.959,2
SHANK1,CV_413.41 [Pulmonary valve stenosis],0.074,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.687,2.599,,0.018,0.299,2
CXCR3,NS_323.3 [Motor neuron disease],0.074,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,1.956,0.202,,0.09,0.109,3
MDM2,NS_339.2 [Myotonic disorders],0.074,0,0.0,0.0,0.0,0.0,0.0,0.0,0.122,1.887,0.154,0.139,0.055,,2
IREB2,GE_972.2 [Hereditary ataxia],0.074,0,0.0,0.0,0.0,0.0,0.307,0.0,0.091,2.42,1.62,0.155,0.224,0.634,4
MAPRE2,GI_516.1 [Pyloric stenosis],0.074,0,0.0,0.0,0.547,0.0,0.0,0.0,0.061,2.943,1.131,,0.1,0.304,4
MTOR,DE_663.1 [Pemphigus],0.074,0,0.0,0.0,0.0,0.0,0.0,0.0,0.07,1.767,3.548,3.332,0.131,,2
RAB24,SO_386.6 [Night blindness],0.074,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.664,0.07,,0.035,0.327,2
DNA2,GE_972.2 [Hereditary ataxia],0.074,0,0.0,0.0,0.426,0.0,0.0,0.0,0.018,1.717,3.297,0.193,0.373,0.876,4
ALDH18A1,NS_341.1 [Cerebral palsy],0.074,0,0.0,0.0,0.88,0.0,0.0,0.0,0.075,,2.83,1.32,0.206,0.938,4
CALB1,GE_972.2 [Hereditary ataxia],0.074,0,0.0,0.0,0.0,0.0,0.403,0.0,0.036,2.047,0.137,0.059,1.908,0.971,4
HMGA1,NS_333.4 [Circadian rhythm sleep disorder],0.074,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.77,0.048,,,0.2,2
CRP,CV_433.3 [Cerebrovascular insufficiency],0.074,0,0.0,0.0,0.304,0.0,0.0,0.0,0.122,,2.568,0.233,0.081,0.947,4
SDCCAG8,GU_580.1 [Acute nephritic syndrome],0.074,0,0.0,0.0,0.0,0.0,0.27,0.184,0.122,1.76,3.386,0.271,0.162,0.149,5
DRD2,MB_293.2 [Bulimia nervosa],0.074,0,0.0,0.0,0.0,0.0,0.0,0.0,0.117,,1.721,0.365,0.137,,2
LIMCH1,NS_339.2 [Myotonic disorders],0.074,0,0.0,0.0,0.0,0.0,0.36,0.0,0.193,1.587,3.477,1.336,0.179,,3
VEGFA,NS_341.1 [Cerebral palsy],0.074,0,0.0,0.0,0.0,0.0,0.0,0.0,0.639,3.176,3.271,0.157,0.103,0.989,3
C2CD3,CM_770.5 [Congenital osteodystrophies],0.074,0,0.0,0.0,0.0,0.0,0.0,0.547,0.015,2.02,2.838,1.459,0.445,0.384,4
POMT1,GE_972.9 [Muscular dystrophy],0.074,0,0.0,0.0,0.894,0.0,0.0,0.49,0.067,1.823,2.548,0.42,0.196,0.999,4
MECP2,GI_516.1 [Pyloric stenosis],0.074,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,3.109,2.525,0.17,0.995,2
ITGB1,GE_972.2 [Hereditary ataxia],0.074,0,0.0,0.0,0.0,0.0,0.0,0.0,0.043,2.287,1.782,0.096,0.184,0.982,3
S100A9,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.074,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.182,0.017,0.055,0.963,1
AIP,"EM_209.11 [Tall stature, acromegaly and gigantism]",0.073,0,0.0,0.0,0.0,0.0,0.0,0.842,0.205,,3.789,0.023,3.049,,3
FOXO6,EM_209.4 [Diabetes insipidus],0.073,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.088,3.282,,0.026,0.249,2
CLDN5,MS_704.1 [Polyarteritis nodosa and related conditions],0.073,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,3.084,2.489,0.042,0.054,,2
ATXN2,MS_705.2 [Juvenile rheumatoid arthritis [JRA/JIA]],0.073,0,0.0,0.0,0.0,0.132,0.0,0.0,0.109,,2.653,0.603,0.148,,2
PHF12,GE_972.2 [Hereditary ataxia],0.073,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,,2.47,0.387,1.023,0.192,3
IL21,GE_964.3 [Glycogen storage disease],0.073,0,0.0,0.0,0.0,0.0,0.0,0.0,0.064,2.264,0.08,,0.077,,2
AIMP1,GE_963.1 [Lipid storage disorders],0.073,0,0.0,0.0,0.547,0.0,0.0,0.787,0.083,,0.128,0.12,0.063,0.916,3
ROCK1,GE_978.22 [Ehler's Danlos syndrome],0.073,0,0.0,0.0,0.0,0.0,0.0,0.0,0.108,1.821,0.188,0.142,0.096,,2
MEFV,DE_669.4 [Febrile neutrophilic dermatosis [Sweet's syndrome]*],0.073,0,0.0,0.0,0.0,0.0,0.453,0.83,0.018,,1.551,0.052,0.07,,4
ADAR,GE_972.9 [Muscular dystrophy],0.073,0,0.0,0.0,0.0,0.0,0.0,0.0,0.015,,1.159,0.154,0.145,0.222,2
NRL,SO_386.6 [Night blindness],0.073,0,0.0,0.0,0.547,0.0,0.0,0.0,0.036,,0.222,0.175,0.117,1.0,3
PSMC4,CM_750.16 [Arnold-Chiari syndrome*],0.073,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.662,0.059,,0.072,0.274,2
SORL1,EM_249.1 [Cerebral amyloid angiopathy*],0.073,0,0.0,0.0,0.426,0.0,0.301,0.0,0.134,1.995,3.864,1.464,1.867,,4
TP73,NS_323.3 [Motor neuron disease],0.073,0,0.0,0.0,0.683,0.0,0.0,0.0,0.115,1.98,2.409,0.352,0.3,0.113,4
COQ4,CV_414.1 [Hypertrophic cardiomyopathy],0.073,0,0.0,0.0,0.684,0.0,0.0,0.0,0.012,,1.823,0.25,1.698,0.908,4
NCOA6,CM_751.213 [Congenital cataract],0.073,0,0.0,0.0,0.0,0.0,0.597,0.0,0.043,,3.64,1.91,0.57,0.183,4
ESR1,GU_580.1 [Acute nephritic syndrome],0.073,0,0.0,0.0,0.0,0.0,0.0,0.0,0.248,3.962,2.249,0.384,0.111,0.967,3
NAMPT,MB_293.2 [Bulimia nervosa],0.073,0,0.0,0.0,0.0,0.0,0.0,0.0,0.085,4.1,0.202,0.069,0.094,,2
FANCM,BI_162.1 [Constitutional (hereditary) aplastic anemia],0.073,0,0.0,0.0,0.0,0.0,0.0,0.775,0.164,,2.572,0.519,0.158,,3
MAP4K4,NS_323.3 [Motor neuron disease],0.073,0,0.0,0.0,0.0,0.0,0.0,0.0,0.085,3.47,1.761,0.508,0.937,0.304,3
PSMA1,CV_433.3 [Cerebrovascular insufficiency],0.073,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,1.974,0.12,0.129,0.08,0.159,3
ROCK2,GE_978.22 [Ehler's Danlos syndrome],0.073,0,0.0,0.0,0.0,0.0,0.0,0.0,0.171,1.353,2.643,0.171,0.116,,2
BMP4,GE_977.6 [Congenital cutaneous mastocytosis*],0.073,0,0.0,0.0,0.0,0.0,0.0,0.0,0.195,3.066,0.14,0.122,0.045,,2
UBE2D3,CM_751.213 [Congenital cataract],0.073,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.045,,,0.307,1
PDE4A,CV_433.3 [Cerebrovascular insufficiency],0.073,1,4.0,0.0,0.0,0.0,0.0,0.0,0.07,,1.849,0.292,0.163,0.36,3
RARS1,GE_963.1 [Lipid storage disorders],0.073,0,0.0,0.0,0.745,0.0,0.0,0.0,0.135,,1.27,0.16,1.698,,3
FOXP2,MS_727.5 [Cyst of bone],0.073,0,0.0,0.0,0.0,0.0,0.0,0.0,0.492,2.985,2.327,0.279,0.564,,2
GSK3B,SO_386.5 [Color vision deficiencies],0.073,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,3.48,0.094,,2.243,0.922,3
COL5A1,SO_369.62 [Keratoconus],0.073,0,0.0,0.0,0.84,0.402,0.0,0.0,0.379,6.986,3.478,,0.018,0.466,4
PCBP1,RE_484.1 [Spontaneous pneumothorax],0.073,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.163,,,0.283,1
ALPL,GE_978.3 [Osteochondrodysplasias],0.073,0,0.0,0.0,0.0,0.0,0.313,0.645,0.051,2.917,2.565,0.377,0.143,,4
UBE2N,GI_516.1 [Pyloric stenosis],0.073,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.081,,,0.256,1
EXT2,GE_978.3 [Osteochondrodysplasias],0.073,0,0.0,0.0,0.0,0.0,0.0,0.699,0.12,,1.873,0.188,8.133,,3
CUX2,GE_961.1 [Phakomatoses],0.073,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,1.517,3.732,1.435,0.662,0.196,3
CALM1,NS_323.3 [Motor neuron disease],0.073,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.58,0.142,,,0.307,2
AR,SO_386.5 [Color vision deficiencies],0.073,0,0.0,0.0,0.0,0.0,0.0,0.0,0.188,2.022,3.756,,0.005,0.834,3
CXCR4,MS_700.3 [Systemic sclerosis],0.073,1,2.0,0.0,0.0,0.0,0.0,0.0,0.82,3.494,2.777,2.603,0.161,,2
NDUFS3,NS_341.1 [Cerebral palsy],0.073,1,2.0,0.0,0.0,0.0,0.0,0.0,0.0,,1.726,0.216,0.111,0.988,2
FASLG,MS_700.3 [Systemic sclerosis],0.073,0,0.0,0.0,0.0,0.0,0.0,0.0,0.267,3.21,1.768,0.119,0.089,,2
ISY1-RAB43,CM_763.13 [Patent ductus arteriosus],0.073,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.926,0.019,,,0.196,2
UBE2E3,CV_433.3 [Cerebrovascular insufficiency],0.073,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.534,0.087,,,0.176,2
RPS10,GE_977.1 [Congenital ichthyosis],0.073,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.019,,,0.305,1
WASHC5,NS_341.1 [Cerebral palsy],0.073,0,0.0,0.0,0.883,0.0,0.0,0.188,0.054,1.939,2.494,0.509,0.677,,3
HDAC4,CV_433.3 [Cerebrovascular insufficiency],0.073,0,0.0,0.0,0.0,0.0,0.0,0.0,0.198,2.981,2.302,0.407,0.184,0.817,3
TSC2,CM_770.5 [Congenital osteodystrophies],0.073,0,0.0,0.0,0.0,0.0,0.412,0.0,0.021,2.211,5.792,2.324,0.347,0.689,4
UGCG,GE_976.5 [Polycystic kidney disease],0.073,1,3.0,0.0,0.0,0.0,0.0,0.0,0.082,1.905,1.24,0.048,2.123,,2
FOXP1,SO_386.6 [Night blindness],0.073,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.112,0.038,,,0.232,2
SYK,GE_977.6 [Congenital cutaneous mastocytosis*],0.073,0,0.0,0.0,0.0,0.0,0.0,0.0,0.045,2.517,0.103,0.089,0.062,,2
ARID3A,CV_414.1 [Hypertrophic cardiomyopathy],0.073,0,0.0,0.0,0.0,0.0,0.0,0.0,0.122,,4.252,0.374,0.166,0.093,3
PFN1,NS_323.3 [Motor neuron disease],0.073,0,0.0,0.0,0.858,0.0,0.0,0.442,0.086,,0.646,0.069,,0.996,3
ADRA2A,GE_963.1 [Lipid storage disorders],0.073,1,0.5,0.0,0.0,0.0,0.0,0.0,0.036,1.995,0.908,0.023,0.06,0.079,3
UBE2E3,CM_763.13 [Patent ductus arteriosus],0.073,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.726,0.036,,,0.332,2
PROM1,SO_380.3 [Optic atrophy],0.073,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.607,4.543,3.444,0.213,0.947,2
DNAJC14,CM_763.13 [Patent ductus arteriosus],0.073,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.118,0.02,0.021,0.244,1
RAD51C,BI_162.1 [Constitutional (hereditary) aplastic anemia],0.073,0,0.0,0.0,0.0,0.0,0.0,0.76,0.117,2.634,0.633,0.085,0.076,,3
KCND3,GE_972.1 [Hereditary neuropathy],0.073,0,0.0,0.0,0.0,0.0,0.0,0.0,0.039,2.642,0.606,0.11,0.14,,2
NLGN4X,MB_301.2 [Asperger's syndrome*],0.073,0,0.0,0.0,0.0,0.0,0.0,0.176,0.042,2.401,0.11,,0.052,,3
DSCAM,CV_433.3 [Cerebrovascular insufficiency],0.073,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,3.977,2.227,0.86,0.492,0.143,3
RAB3GAP2,GE_972.9 [Muscular dystrophy],0.073,0,0.0,0.0,0.547,0.0,0.0,0.0,0.079,1.805,3.544,3.031,0.176,0.157,4
PON3,NS_323.3 [Motor neuron disease],0.073,0,0.0,0.0,0.728,0.0,0.0,0.404,0.0,2.082,2.425,0.253,0.175,0.867,3
SLC1A3,GE_972.2 [Hereditary ataxia],0.073,0,0.0,0.0,0.847,0.0,0.313,0.096,0.082,2.83,3.351,1.35,0.178,0.955,5
TTN,NS_341.1 [Cerebral palsy],0.073,0,0.0,0.0,0.0,0.0,0.0,0.29,0.018,1.8,3.698,0.77,0.646,0.972,4
RPGRIP1L,SO_380.3 [Optic atrophy],0.073,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.78,0.395,0.297,0.988,2
LMTK2,CV_433.3 [Cerebrovascular insufficiency],0.073,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,1.902,2.768,0.86,0.229,0.111,3
GRK2,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.073,0,0.0,0.0,0.0,0.0,0.0,0.0,0.097,,2.396,0.146,0.143,,2
GRIA4,GE_972.2 [Hereditary ataxia],0.073,0,0.0,0.0,0.0,0.0,0.0,0.0,0.034,1.411,2.974,0.234,0.237,0.953,3
LZTR1,CV_414.1 [Hypertrophic cardiomyopathy],0.073,0,0.0,0.0,0.832,0.0,0.0,0.29,0.121,,2.82,0.877,0.578,0.437,4
USH1C,SO_386.6 [Night blindness],0.073,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.252,3.359,0.56,0.207,0.998,2
HDAC4,GE_978.3 [Osteochondrodysplasias],0.073,0,0.0,0.0,0.0,0.0,0.295,0.0,0.098,2.774,2.523,0.829,0.139,,3
FOXP1,GE_972.9 [Muscular dystrophy],0.073,0,0.0,0.0,0.0,0.0,0.281,0.0,0.0,2.048,0.046,,,0.269,3
KCNC4,GE_972.2 [Hereditary ataxia],0.073,1,2.0,0.0,0.426,0.0,0.0,0.0,0.012,1.626,2.56,0.089,0.172,0.878,4
KIT,GI_542.8 [Biliary cirrhosis],0.073,0,0.0,0.0,0.0,0.0,0.0,0.0,0.109,2.758,2.873,0.26,0.625,,2
DNASE1L3,GU_580.1 [Acute nephritic syndrome],0.073,0,0.0,0.0,0.547,0.0,0.0,0.0,0.167,,0.272,0.342,0.106,0.436,3
CD28,NS_338.1 [Myasthenia gravis],0.073,0,0.0,0.0,0.0,0.0,0.0,0.0,0.11,2.466,2.089,0.137,0.095,,2
LRRC3B,GE_983.2 [Hemoglobin C trait [Sickle-cell trait]],0.073,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.149,0.072,,0.179,,1
CCND1,EM_208.1 [Hypoparathyroidism],0.073,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.81,1.603,0.047,0.104,0.996,2
CYP26B1,GE_972.9 [Muscular dystrophy],0.073,0,0.0,0.0,0.0,0.0,0.0,0.0,0.118,2.603,0.413,0.142,0.087,0.171,3
SNRPD2,EM_208.1 [Hypoparathyroidism],0.073,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.084,,,0.255,1
UCHL1,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.073,0,0.0,0.0,0.0,0.0,0.293,0.0,0.27,3.656,0.431,0.038,0.065,0.914,4
HCN1,GE_972.2 [Hereditary ataxia],0.073,0,0.0,0.0,0.0,0.0,0.278,0.0,0.012,3.454,2.395,0.05,0.109,0.914,4
PPARGC1A,GU_580.1 [Acute nephritic syndrome],0.073,0,0.0,0.0,0.0,0.0,0.0,0.0,0.183,2.735,2.926,1.35,0.206,0.9,3
BAX,CV_441 [Arteriovenous malformation],0.073,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.234,0.226,0.094,0.948,2
IRF5,MS_700.3 [Systemic sclerosis],0.073,0,0.0,0.0,0.0,0.357,0.0,0.0,0.353,2.045,0.306,0.133,0.174,,2
PGM3,GE_978.3 [Osteochondrodysplasias],0.073,0,0.0,0.0,0.0,0.0,0.344,0.0,0.127,,2.453,0.24,0.129,,3
PTGS2,GI_540.11 [Autoimmune hepatitis],0.073,0,0.0,0.0,0.0,0.0,0.0,0.0,0.394,,1.918,0.12,0.128,,2
GABRA2,SO_386.6 [Night blindness],0.073,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.045,0.093,,0.092,0.081,2
FLT1,CV_414.1 [Hypertrophic cardiomyopathy],0.073,0,0.0,0.0,0.0,0.0,0.0,0.0,0.179,2.337,2.604,0.274,0.428,0.315,3
CRYM,NS_323.3 [Motor neuron disease],0.073,0,0.0,0.0,0.426,0.0,0.0,0.0,0.097,1.305,1.22,0.236,0.168,0.031,4
SCP2,GE_963.1 [Lipid storage disorders],0.073,0,0.0,0.0,0.0,0.0,0.0,0.684,0.122,2.946,0.705,0.163,0.095,0.301,4
RPL26,SO_365.3 [Exophthalmos [Proptosis]],0.073,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.082,,,0.264,1
FAT1,GU_580.1 [Acute nephritic syndrome],0.073,0,0.0,0.0,0.873,0.0,0.0,0.0,0.121,3.671,3.004,0.286,0.654,0.47,4
EGFR,GU_580.1 [Acute nephritic syndrome],0.073,1,1.0,0.0,0.0,0.0,0.0,0.0,0.177,4.125,4.154,0.493,0.26,0.966,3
NR1H4,GE_964.3 [Glycogen storage disease],0.073,0,0.0,0.0,0.0,0.0,0.397,0.0,0.064,,0.268,0.333,0.175,,2
NF1,SO_381.5 [Vertical strabismus],0.073,0,0.0,0.0,0.0,0.0,0.0,0.121,0.021,1.905,1.201,0.256,0.529,,3
CD40LG,CV_414.1 [Hypertrophic cardiomyopathy],0.073,0,0.0,0.0,0.0,0.0,0.0,0.0,0.044,2.228,2.064,,0.123,0.091,3
GNS,GE_963.3 [Mucopolysaccharidoses],0.073,0,0.0,0.0,0.0,0.0,0.0,0.876,0.075,,0.108,0.124,0.081,,2
STAT5A,CV_433.3 [Cerebrovascular insufficiency],0.073,0,0.0,0.0,0.0,0.0,0.0,0.0,0.017,,2.566,0.326,0.125,0.937,3
BDNF,GE_972.2 [Hereditary ataxia],0.073,0,0.0,0.0,0.0,0.0,0.281,0.0,0.092,2.45,0.204,0.095,0.111,0.976,4
TTC8,SO_386.6 [Night blindness],0.073,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.819,3.361,1.267,0.154,0.999,2
KNG1,GE_978.22 [Ehler's Danlos syndrome],0.073,0,0.0,0.0,0.0,0.0,0.0,0.0,0.084,,0.152,0.099,0.123,,1
RPS23,GE_963.1 [Lipid storage disorders],0.073,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.986,0.039,,,0.174,2
ARPC4,SO_380.3 [Optic atrophy],0.073,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.037,,,0.195,1
TP63,MS_727.5 [Cyst of bone],0.073,0,0.0,0.0,0.0,0.0,0.0,0.0,0.359,2.404,1.724,0.819,0.266,,2
CC2D2A,SO_386.6 [Night blindness],0.073,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.238,3.104,1.724,0.279,0.999,2
DGKI,MB_303.1 [Dyslexia and alexia],0.073,0,0.0,0.0,0.0,0.0,0.0,0.0,0.105,2.431,2.662,0.139,1.609,,2
PTPN1,CV_414.1 [Hypertrophic cardiomyopathy],0.073,0,0.0,0.0,0.0,0.0,0.0,0.0,0.015,4.762,2.267,0.097,0.153,0.634,3
S1PR1,CV_433.3 [Cerebrovascular insufficiency],0.073,1,2.0,0.0,0.0,0.0,0.0,0.0,0.099,2.26,0.223,0.042,0.093,0.776,3
ANGPT1,GE_964.3 [Glycogen storage disease],0.073,0,0.0,0.0,0.0,0.0,0.0,0.0,0.107,2.348,0.535,0.175,0.105,,2
ADD1,GE_973.5 [Huntington's disease],0.073,0,0.0,0.0,0.0,0.0,0.0,0.0,0.149,3.086,0.242,0.15,0.089,,2
AHR,GU_580.1 [Acute nephritic syndrome],0.073,0,0.0,0.0,0.0,0.0,0.0,0.0,0.165,3.392,1.169,0.146,1.399,0.892,3
FGB,CV_433.3 [Cerebrovascular insufficiency],0.073,1,3.0,0.0,0.304,0.082,0.0,0.0,0.018,1.489,1.31,0.198,0.16,0.771,4
NPHS1,GU_580.1 [Acute nephritic syndrome],0.073,0,0.0,0.0,0.899,0.0,0.341,0.398,0.085,2.533,2.969,0.438,0.765,0.806,5
LMX1B,GU_580.51 [Focal and segmental glomerular lesions*],0.073,0,0.0,0.0,0.0,0.0,0.0,0.657,0.116,2.179,0.384,0.066,0.065,,3
NDUFAF7,CV_414.1 [Hypertrophic cardiomyopathy],0.073,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,1.601,0.526,0.336,0.973,2
STAT1,CV_433.3 [Cerebrovascular insufficiency],0.073,0,0.0,0.0,0.0,0.0,0.0,0.0,0.114,,2.438,0.139,0.092,0.968,3
CRMP1,GE_972.2 [Hereditary ataxia],0.073,0,0.0,0.152,0.0,0.0,0.0,0.0,0.03,2.812,2.927,2.55,0.16,0.794,4
TNF,GE_978.22 [Ehler's Danlos syndrome],0.073,0,0.0,0.0,0.0,0.0,0.25,0.0,0.594,,1.573,0.155,0.029,,3
RPS26,EM_208.1 [Hypoparathyroidism],0.073,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.31,0.118,0.044,,0.166,2
RPE65,SO_386.5 [Color vision deficiencies],0.073,0,0.0,0.0,0.0,0.0,0.377,0.0,0.033,,1.918,1.254,1.783,0.999,4
CDH2,GE_961.1 [Phakomatoses],0.073,0,0.0,0.0,0.0,0.0,0.0,0.0,0.089,3.189,2.109,0.486,0.966,0.856,3
CAPN1,NS_341.1 [Cerebral palsy],0.073,0,0.0,0.0,0.881,0.0,0.0,0.0,0.051,2.58,2.588,0.687,0.178,0.991,4
TUBB3,GE_972.2 [Hereditary ataxia],0.073,0,0.0,0.0,0.426,0.0,0.0,0.29,0.018,,0.195,0.032,0.114,0.965,3
IL1B,MS_700.42 [Dermatomyositis],0.073,1,3.0,0.0,0.0,0.0,0.0,0.0,0.195,2.479,0.086,0.076,0.061,,2
RAPSN,NS_338.1 [Myasthenia gravis],0.073,0,0.0,0.0,0.0,0.0,0.0,0.843,0.111,1.6,1.842,0.229,1.042,,3
MOBP,NS_343.6 [Multi-system degeneration of the autonomic nervous system*],0.073,0,0.0,0.0,0.0,0.0,0.0,0.0,0.634,1.626,0.058,0.046,0.044,,2
AMFR,GE_972.2 [Hereditary ataxia],0.073,0,0.0,0.0,0.0,0.0,0.0,0.0,0.207,1.935,4.727,0.375,0.156,0.665,3
RPL27A,SO_365.3 [Exophthalmos [Proptosis]],0.073,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.138,,,0.27,1
GNE,NS_323.3 [Motor neuron disease],0.073,0,0.0,0.0,0.547,0.0,0.0,0.0,0.036,,2.248,0.111,0.321,0.148,4
LPAR1,CV_433.3 [Cerebrovascular insufficiency],0.073,0,0.0,0.0,0.0,0.0,0.0,0.0,0.504,1.871,0.105,0.067,0.108,0.399,3
SF3B2,NS_323.3 [Motor neuron disease],0.073,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.359,2.733,0.184,0.222,0.063,3
ITK,RE_477.2 [Hypersensitivity pneumonitis],0.073,0,0.0,0.0,0.0,0.0,0.0,0.0,0.213,,2.507,0.19,0.167,,2
CXCR4,GE_972.2 [Hereditary ataxia],0.073,0,0.0,0.0,0.0,0.0,0.0,0.0,0.119,1.331,2.518,0.092,0.135,0.977,3
RPL26,EM_208.1 [Hypoparathyroidism],0.073,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.115,,,0.271,1
HTR2C,GE_963.1 [Lipid storage disorders],0.073,0,0.0,0.0,0.0,0.0,0.0,0.0,0.024,2.768,0.582,,0.022,0.177,3
PCNA,CV_433.3 [Cerebrovascular insufficiency],0.073,0,0.0,0.0,0.0,0.0,0.0,0.0,0.061,,0.079,,2.47,0.961,3
VEGFA,DE_663.1 [Pemphigus],0.073,0,0.0,0.0,0.0,0.0,0.0,0.0,0.106,1.915,0.139,0.089,0.064,,2
EP300,CM_770.5 [Congenital osteodystrophies],0.072,0,0.0,0.0,0.0,0.0,0.333,0.0,0.015,1.402,1.728,0.292,0.241,0.97,4
BDNF,GE_972.1 [Hereditary neuropathy],0.072,0,0.0,0.0,0.0,0.0,0.319,0.0,0.107,2.453,2.401,0.835,0.128,,3
MAG,GE_972.2 [Hereditary ataxia],0.072,0,0.0,0.0,0.816,0.0,0.295,0.175,0.083,,2.266,0.546,0.176,0.762,5
RAPH1,GE_961.1 [Phakomatoses],0.072,0,0.0,0.0,0.0,0.0,0.266,0.0,0.018,1.981,3.228,0.508,0.216,0.096,4
SUMO2,EM_209.4 [Diabetes insipidus],0.072,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.128,,,0.266,1
RCAN1,CV_414.1 [Hypertrophic cardiomyopathy],0.072,0,0.0,0.0,0.0,0.0,0.388,0.0,0.1,1.604,2.803,0.194,0.157,0.403,4
SLC4A1,GE_976.5 [Polycystic kidney disease],0.072,0,0.0,0.0,0.0,0.0,0.0,0.0,0.088,1.935,2.871,0.169,0.281,,2
EBF1,GE_978.3 [Osteochondrodysplasias],0.072,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.099,0.121,0.091,0.087,,2
KDR,GE_972.2 [Hereditary ataxia],0.072,0,0.0,0.04,0.0,0.0,0.0,0.0,0.163,1.868,3.417,0.332,0.266,0.708,4
NLGN1,GE_961.1 [Phakomatoses],0.072,0,0.0,0.0,0.0,0.0,0.0,0.0,0.09,2.634,3.323,0.187,0.169,0.161,3
LMOD1,CM_763.13 [Patent ductus arteriosus],0.072,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.167,0.027,0.023,0.284,1
MMP14,RE_477.2 [Hypersensitivity pneumonitis],0.072,0,0.0,0.0,0.0,0.0,0.0,0.0,0.097,2.41,1.854,0.743,0.15,,2
PPARGC1A,CV_433.3 [Cerebrovascular insufficiency],0.072,0,0.0,0.0,0.0,0.0,0.0,0.0,0.16,2.891,3.373,0.294,0.211,0.9,3
RTN4IP1,SO_380.3 [Optic atrophy],0.072,0,0.0,0.0,0.865,0.0,0.0,0.491,0.061,,0.292,0.246,0.137,0.522,3
DICER1,CM_770.5 [Congenital osteodystrophies],0.072,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,1.735,3.701,3.59,0.192,0.863,3
HIF1A,RE_484.1 [Spontaneous pneumothorax],0.072,0,0.0,0.0,0.0,0.0,0.0,0.0,0.088,1.986,3.121,0.385,0.237,0.904,3
DNAJC5,GE_963.1 [Lipid storage disorders],0.072,0,0.0,0.0,0.0,0.0,0.284,0.841,0.086,,0.103,0.131,0.04,0.05,4
CFTR,GE_972.9 [Muscular dystrophy],0.072,1,1.0,0.0,0.0,0.0,0.375,0.0,0.094,,3.288,1.104,0.28,0.912,4
GRIN2B,GE_977.1 [Congenital ichthyosis],0.072,0,0.0,0.0,0.0,0.0,0.0,0.0,0.061,2.452,3.013,,,0.034,3
YPEL5,EM_208.1 [Hypoparathyroidism],0.072,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.599,0.056,,,0.131,2
ALG9,GE_976.5 [Polycystic kidney disease],0.072,0,0.0,0.0,0.0,0.0,0.0,0.452,0.105,,4.293,3.306,1.804,,3
FLNC,NS_338.1 [Myasthenia gravis],0.072,0,0.0,0.0,0.0,0.0,0.497,0.0,0.033,1.639,3.57,0.994,0.579,,3
CALM1,GU_580.1 [Acute nephritic syndrome],0.072,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.456,0.082,,,0.176,2
TBX1,GE_972.1 [Hereditary neuropathy],0.072,0,0.0,0.0,0.0,0.0,0.461,0.0,0.033,,2.484,2.374,0.131,,3
MUC5B,MS_727.5 [Cyst of bone],0.072,0,0.0,0.0,0.0,0.0,0.0,0.0,0.188,1.35,5.388,0.035,0.173,,2
PLCE1,GU_580.52 [Diffuse membranous glomerulonephritis],0.072,0,0.0,0.0,0.0,0.0,0.0,0.423,0.291,2.546,3.364,0.467,0.666,,3
DLG2,CV_433.3 [Cerebrovascular insufficiency],0.072,0,0.0,0.0,0.0,0.0,0.0,0.0,0.036,4.288,1.886,0.178,0.219,0.176,3
ERCC6,GE_972.2 [Hereditary ataxia],0.072,0,0.0,0.0,0.779,0.0,0.338,0.0,0.061,,2.805,0.106,0.175,0.785,5
LPAR1,DE_663.1 [Pemphigus],0.072,0,0.0,0.0,0.0,0.0,0.0,0.0,0.169,2.89,0.069,0.044,0.053,,2
CDH11,SO_369.62 [Keratoconus],0.072,0,0.0,0.0,0.0,0.0,0.0,0.0,0.015,3.911,2.972,0.318,0.227,0.164,3
SLC25A46,GE_972.2 [Hereditary ataxia],0.072,0,0.0,0.017,0.779,0.0,0.0,0.575,0.021,2.953,1.255,0.227,0.146,0.693,5
RET,GU_580.1 [Acute nephritic syndrome],0.072,1,2.0,0.0,0.426,0.0,0.471,0.0,0.0,1.524,2.748,0.851,0.232,0.836,4
KDR,NS_344.11 [Communicating hydrocephalus],0.072,0,0.0,0.0,0.0,0.0,0.0,0.0,0.183,2.267,0.342,0.256,0.091,,2
EPB41,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.072,0,0.0,0.0,0.872,0.0,0.283,0.0,0.025,,1.998,0.809,0.4,0.949,5
PRKCA,NS_328.13 [Frontotemporal dementia [FTD]],0.072,0,0.0,0.0,0.0,0.0,0.0,0.0,0.076,2.191,0.207,0.119,0.128,,2
SLC9A6,GE_963.1 [Lipid storage disorders],0.072,0,0.0,0.0,0.0,0.0,0.272,0.129,0.012,,4.294,0.054,0.063,0.066,5
KIF1B,NS_341.1 [Cerebral palsy],0.072,0,0.0,0.0,0.532,0.0,0.0,0.0,0.0,1.879,3.756,0.715,0.272,0.932,3
CA5B,EM_249.1 [Cerebral amyloid angiopathy*],0.072,0,0.0,0.0,0.0,0.0,0.0,0.0,0.085,2.149,3.865,3.277,0.07,,2
IDH3A,NS_341.1 [Cerebral palsy],0.072,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.301,0.136,0.11,0.973,1
SCN4A,GE_973.5 [Huntington's disease],0.072,1,3.0,0.0,0.0,0.0,0.0,0.0,0.628,,4.158,0.256,0.126,,2
SMAD3,MS_704.1 [Polyarteritis nodosa and related conditions],0.072,0,0.0,0.0,0.0,0.0,0.0,0.0,0.09,3.059,0.066,0.034,0.049,,2
USP24,MS_700.3 [Systemic sclerosis],0.072,0,0.0,0.0,0.0,0.0,0.0,0.0,0.158,2.797,2.295,,0.094,,2
SLC6A4,NS_333.4 [Circadian rhythm sleep disorder],0.072,1,4.0,0.0,0.0,0.0,0.0,0.0,0.054,1.391,0.526,0.13,0.143,0.755,3
ELP1,GE_963.1 [Lipid storage disorders],0.072,0,0.0,0.0,0.0,0.0,0.0,0.121,0.885,1.403,0.553,0.065,0.357,,3
VEGFA,SO_386.6 [Night blindness],0.072,0,0.0,0.0,0.0,0.0,0.0,0.0,0.182,1.935,3.145,2.729,0.101,0.45,3
RPS10,CM_750.16 [Arnold-Chiari syndrome*],0.072,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.921,0.022,,,0.173,2
GLB1,GE_963.1 [Lipid storage disorders],0.072,1,2.0,0.0,0.0,0.0,0.253,0.929,0.099,,0.196,0.16,0.109,0.826,4
AARS1,GE_963.1 [Lipid storage disorders],0.072,0,0.0,0.0,0.0,0.0,0.273,0.281,0.024,,2.865,0.413,0.16,,4
PLXND1,GE_972.9 [Muscular dystrophy],0.072,0,0.0,0.0,0.0,0.0,0.0,0.0,0.024,2.316,2.848,0.552,0.173,0.149,3
INF2,GU_580.51 [Focal and segmental glomerular lesions*],0.072,0,0.0,0.0,0.0,0.0,0.0,0.877,0.361,1.933,3.657,0.29,0.071,,3
CADM1,GE_970.2 [Thalassemia],0.072,0,0.0,0.0,0.0,0.0,0.0,0.0,0.456,2.83,3.653,0.103,0.2,,2
ITGB1,CV_433.3 [Cerebrovascular insufficiency],0.072,0,0.0,0.0,0.0,0.0,0.0,0.0,0.024,2.358,0.335,0.074,0.152,0.984,3
EDNRA,GU_580.52 [Diffuse membranous glomerulonephritis],0.072,1,3.0,0.0,0.0,0.0,0.0,0.0,0.418,1.795,0.418,0.05,0.074,,2
SPIN1,CV_413.41 [Pulmonary valve stenosis],0.072,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.04,0.042,0.032,,0.14,2
OPN1SW,SO_386.6 [Night blindness],0.072,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.929,1.511,0.255,0.112,0.985,2
AR,GU_603.4 [Atrophy of testis],0.072,0,0.0,0.0,0.0,0.0,0.0,0.0,0.043,3.598,2.707,,0.007,,2
MYH3,DE_663.2 [Pemphigoid],0.072,0,0.0,0.0,0.0,0.0,0.0,0.0,0.105,2.487,3.349,0.095,0.153,,2
NIPA1,GE_972.2 [Hereditary ataxia],0.072,0,0.0,0.053,0.684,0.0,0.0,0.797,0.277,2.482,2.554,0.035,0.036,0.886,5
RPL15,GI_516.1 [Pyloric stenosis],0.072,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.1,,,0.175,1
CALM1,GE_972.9 [Muscular dystrophy],0.072,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.662,0.054,,,0.089,2
MAP1B,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.072,0,0.0,0.0,0.0,0.0,0.278,0.0,0.064,2.13,1.905,0.38,1.369,0.309,4
NRP1,CV_414.1 [Hypertrophic cardiomyopathy],0.072,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,4.403,2.409,0.259,0.477,0.118,3
KIT,SO_365.3 [Exophthalmos [Proptosis]],0.072,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.997,2.504,1.04,0.241,0.966,3
GAD2,GE_972.2 [Hereditary ataxia],0.072,0,0.0,0.071,0.0,0.0,0.326,0.0,0.145,,3.073,1.218,1.553,0.927,5
SPG7,NS_341.1 [Cerebral palsy],0.072,0,0.0,0.0,0.897,0.0,0.0,0.459,0.061,,2.769,0.9,0.206,0.998,4
MECP2,GE_972.2 [Hereditary ataxia],0.072,0,0.0,0.0,0.779,0.0,0.341,0.0,0.059,,3.406,0.188,0.125,0.981,5
TNIP1,GU_580.1 [Acute nephritic syndrome],0.072,0,0.0,0.0,0.0,0.0,0.0,0.0,0.071,1.434,3.365,0.529,0.166,0.916,3
NFKB1,CV_441 [Arteriovenous malformation],0.072,0,0.0,0.0,0.0,0.0,0.0,0.0,0.079,1.778,2.724,0.564,1.053,0.94,3
KIT,GE_972.2 [Hereditary ataxia],0.072,0,0.0,0.0,0.0,0.0,0.436,0.0,0.043,2.387,2.011,0.217,0.181,0.939,4
BCL2,GE_972.2 [Hereditary ataxia],0.072,0,0.0,0.0,0.0,0.0,0.0,0.0,0.097,2.278,0.128,0.046,0.066,0.989,3
RORA,DE_663.2 [Pemphigoid],0.072,0,0.0,0.0,0.0,0.0,0.0,0.0,0.065,3.16,1.977,,,,2
CDH1,CM_770.5 [Congenital osteodystrophies],0.072,0,0.0,0.0,0.0,0.0,0.383,0.0,0.012,1.721,4.242,1.073,0.178,0.97,4
FLNB,GE_978.3 [Osteochondrodysplasias],0.072,0,0.0,0.0,0.0,0.0,0.359,0.0,0.077,,4.006,1.885,0.324,,3
ATXN7,GE_963.1 [Lipid storage disorders],0.072,0,0.0,0.0,0.0,0.0,0.354,0.0,0.018,1.882,2.702,1.404,0.096,0.157,4
PIK3R1,DE_669.4 [Febrile neutrophilic dermatosis [Sweet's syndrome]*],0.072,0,0.0,0.0,0.0,0.0,0.0,0.0,0.073,2.788,0.08,0.032,0.059,,2
EFNB2,CM_763.31 [Ventricular septal defect],0.072,0,0.0,0.0,0.0,0.0,0.0,0.0,0.055,2.367,0.17,0.085,0.085,0.547,3
ATM,BI_179.7 [Common variable immunodeficiency [CVID]],0.072,0,0.0,0.0,0.0,0.0,0.635,0.0,0.132,1.357,2.542,1.817,0.15,,3
YPEL5,GU_580.1 [Acute nephritic syndrome],0.072,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.688,0.039,,,0.122,2
TP63,CM_763.31 [Ventricular septal defect],0.072,0,0.0,0.0,0.547,0.0,0.0,0.0,0.0,2.346,4.02,2.191,1.581,0.918,3
ADD1,GU_580.1 [Acute nephritic syndrome],0.072,0,0.0,0.0,0.0,0.0,0.0,0.0,0.078,1.846,2.892,0.39,1.023,0.259,3
TNF,DE_669.1 [Pyoderma gangrenosum],0.072,0,0.0,0.0,0.0,0.0,0.346,0.0,0.103,,0.19,0.116,0.019,,2
UBA52,GE_961.1 [Phakomatoses],0.072,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.089,,,0.177,1
HLA-DRA,GI_542.8 [Biliary cirrhosis],0.072,0,0.0,0.0,0.0,0.553,0.0,0.0,0.052,,2.536,0.06,0.12,,2
NFE2L2,GE_970.1 [Sickle-cell disorders],0.072,1,0.5,0.0,0.0,0.0,0.384,0.0,0.113,1.593,0.64,0.343,0.069,,3
ACACB,CV_414.1 [Hypertrophic cardiomyopathy],0.072,0,0.0,0.0,0.532,0.0,0.0,0.0,0.076,4.28,2.924,0.172,1.24,0.729,4
CD28,MS_704.2 [Wegener's granulomatosis],0.072,0,0.0,0.0,0.0,0.0,0.0,0.0,0.428,2.949,2.442,0.106,0.048,,2
ERCC4,CV_441 [Arteriovenous malformation],0.072,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.171,2.719,1.101,0.344,0.98,2
COL1A2,GE_972.9 [Muscular dystrophy],0.072,0,0.0,0.039,0.0,0.0,0.0,0.0,0.056,1.509,2.762,0.519,0.155,0.987,4
NTN1,GE_973.5 [Huntington's disease],0.072,0,0.0,0.0,0.0,0.0,0.0,0.0,0.114,2.332,0.222,0.066,0.061,,2
NDUFA3,NS_341.1 [Cerebral palsy],0.072,1,2.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.13,0.094,2.986,0.937,2
STAT4,GI_542.8 [Biliary cirrhosis],0.072,0,0.0,0.0,0.0,0.742,0.0,0.0,0.565,2.475,1.906,0.263,0.737,,2
BRCA1,NS_344.2 [Benign intracranial hypertension],0.072,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.791,2.454,0.367,0.197,0.982,2
ABL1,GE_961.1 [Phakomatoses],0.072,1,2.0,0.0,0.0,0.0,0.0,0.0,0.061,1.844,2.333,0.628,0.174,0.914,3
DEPDC5,GE_963.1 [Lipid storage disorders],0.072,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,1.386,4.084,2.424,1.66,0.136,3
GRIN2B,GE_972.9 [Muscular dystrophy],0.072,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.199,0.189,,,0.186,2
UBE2E3,NS_341.1 [Cerebral palsy],0.072,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.391,0.065,,,0.318,2
CCND1,MS_727.3 [Osteitis deformans [Paget's disease of bone]],0.072,0,0.0,0.0,0.0,0.0,0.0,0.0,0.084,2.775,0.149,0.063,0.103,,2
CSDE1,BI_162.1 [Constitutional (hereditary) aplastic anemia],0.072,0,0.0,0.0,0.0,0.0,0.0,0.0,0.073,2.827,2.46,0.077,0.067,,2
PIK3R4,GE_972.2 [Hereditary ataxia],0.072,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,1.694,2.618,0.336,0.273,0.362,3
SPIN1,CM_763.13 [Patent ductus arteriosus],0.072,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.928,0.026,0.015,,0.296,2
HNRNPC,GE_977.1 [Congenital ichthyosis],0.072,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.052,,,0.324,1
DIAPH1,GU_580.1 [Acute nephritic syndrome],0.072,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,2.609,2.432,0.142,0.207,0.266,3
UCHL1,CM_770.5 [Congenital osteodystrophies],0.072,0,0.0,0.0,0.0,0.0,0.0,0.0,0.622,2.906,0.412,0.053,0.054,0.611,3
RPL18,CM_750.16 [Arnold-Chiari syndrome*],0.072,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.227,0.038,0.022,0.246,1
GANAB,GE_976.5 [Polycystic kidney disease],0.072,0,0.0,0.0,0.0,0.0,0.0,0.744,0.088,,2.662,0.041,1.356,,3
CNGB1,SO_369.62 [Keratoconus],0.072,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.705,2.87,0.153,0.344,0.999,2
DDX17,GE_963.1 [Lipid storage disorders],0.072,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,3.149,,0.021,0.292,2
DNMT3A,NS_344.2 [Benign intracranial hypertension],0.072,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.344,3.35,0.244,0.228,0.906,2
MIA3,MS_700.3 [Systemic sclerosis],0.072,0,0.0,0.0,0.0,0.0,0.0,0.0,0.205,,5.542,1.061,0.183,,2
GPR52,GE_973.5 [Huntington's disease],0.072,0,0.0,0.0,0.0,0.0,0.0,0.0,0.764,1.618,0.092,0.052,0.045,,2
MT-ATP6,GE_972.2 [Hereditary ataxia],0.072,0,0.0,0.0,0.0,0.0,0.0,0.474,0.066,,,,,,2
SLC6A3,MB_298 [Impulse disorders],0.072,0,0.0,0.0,0.0,0.0,0.0,0.0,0.209,1.823,1.053,0.096,0.085,,2
USH1C,SO_369.62 [Keratoconus],0.072,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.952,0.321,0.424,0.982,2
EIF5A,CM_750.16 [Arnold-Chiari syndrome*],0.072,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.042,,0.01,0.297,1
PLIN2,SO_386.5 [Color vision deficiencies],0.072,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.498,1.959,1.609,0.075,0.959,2
NR3C1,MB_306 [Conduct disorders],0.072,1,3.0,0.0,0.0,0.0,0.0,0.0,0.05,1.884,0.284,0.109,0.14,,2
RPL35,GE_972.9 [Muscular dystrophy],0.072,1,4.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.415,0.03,0.021,0.22,1
CC2D2A,SO_380.3 [Optic atrophy],0.072,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,3.793,0.713,0.344,0.993,2
LIN28B,GE_964.3 [Glycogen storage disease],0.072,0,0.0,0.0,0.0,0.0,0.0,0.0,0.122,1.324,0.069,0.083,0.059,,2
LAMP2,GU_580.1 [Acute nephritic syndrome],0.072,0,0.0,0.0,0.0,0.0,0.0,0.0,0.122,,4.857,0.059,2.225,0.769,3
SMAD3,GU_580.1 [Acute nephritic syndrome],0.072,0,0.0,0.0,0.0,0.0,0.0,0.0,0.087,2.232,0.096,0.04,0.08,0.944,3
NR3C1,EM_208.1 [Hypoparathyroidism],0.072,1,4.0,0.0,0.0,0.0,0.0,0.0,0.0,1.657,1.937,0.259,0.214,0.96,2
VEGFA,GE_971.11 [Hereditary factor VIII deficiency [Hemophilia A]],0.072,0,0.0,0.0,0.0,0.0,0.0,0.0,0.106,1.896,1.716,0.1,0.08,,2
ADAM10,GE_972.9 [Muscular dystrophy],0.072,0,0.0,0.045,0.0,0.0,0.0,0.0,0.024,2.182,0.268,0.102,0.077,0.374,4
RYR1,GE_973.5 [Huntington's disease],0.072,1,0.5,0.0,0.0,0.0,0.0,0.0,0.182,,2.669,0.167,0.094,,2
IL1R1,GU_580.1 [Acute nephritic syndrome],0.072,0,0.0,0.0,0.0,0.0,0.391,0.0,0.015,,1.057,0.193,0.108,0.947,3
TH,CV_414.1 [Hypertrophic cardiomyopathy],0.072,0,0.0,0.0,0.0,0.0,0.375,0.0,0.097,,2.48,0.151,0.31,0.448,4
IGF2R,CM_770.5 [Congenital osteodystrophies],0.072,0,0.0,0.0,0.0,0.0,0.0,0.0,0.061,1.747,3.057,0.177,0.297,0.885,3
RPL13A,GE_972.9 [Muscular dystrophy],0.072,1,4.0,0.0,0.0,0.0,0.0,0.0,0.0,1.901,2.01,,0.015,0.268,2
PKLR,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.072,0,0.0,0.0,0.899,0.0,0.266,0.281,0.091,,3.39,0.988,0.203,0.707,5
DHX36,NS_323.3 [Motor neuron disease],0.072,0,0.0,0.0,0.0,0.0,0.0,0.0,0.023,2.376,3.74,0.181,0.552,0.214,3
RPL7,CM_750.16 [Arnold-Chiari syndrome*],0.072,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.786,1.731,,,0.214,2
KLF1,BI_162.1 [Constitutional (hereditary) aplastic anemia],0.072,0,0.0,0.0,0.732,0.0,0.436,0.0,0.106,,3.6,3.306,0.049,,4
DNMT3A,MS_705.2 [Juvenile rheumatoid arthritis [JRA/JIA]],0.072,0,0.0,0.0,0.0,0.0,0.0,0.0,0.094,1.876,4.138,0.192,0.173,,2
ADRB1,NS_343.6 [Multi-system degeneration of the autonomic nervous system*],0.072,1,4.0,0.0,0.0,0.0,0.0,0.0,0.015,1.985,2.054,0.023,0.021,,2
GBA,GE_972.2 [Hereditary ataxia],0.072,0,0.0,0.0,0.58,0.0,0.0,0.0,0.0,,2.942,1.603,0.194,0.982,3
AGT,GU_580.1 [Acute nephritic syndrome],0.072,0,0.0,0.0,0.426,0.0,0.431,0.0,0.09,1.959,1.635,0.316,1.819,0.799,5
PANK3,NS_341.1 [Cerebral palsy],0.072,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.486,0.295,0.111,0.098,0.994,2
RPL7,CM_751.213 [Congenital cataract],0.072,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.912,0.227,,,0.256,2
TEAD1,DE_663.2 [Pemphigoid],0.072,0,0.0,0.0,0.0,0.0,0.0,0.0,0.039,3.145,0.314,0.106,0.12,,2
LPAR1,MB_306 [Conduct disorders],0.072,0,0.0,0.0,0.0,0.0,0.0,0.0,0.033,2.713,0.086,0.046,0.088,,2
TP53,DE_663.2 [Pemphigoid],0.072,0,0.0,0.0,0.0,0.0,0.0,0.0,0.381,,1.459,0.118,0.114,,2
NDUFV1,GE_972.2 [Hereditary ataxia],0.072,1,4.0,0.0,0.0,0.0,0.0,0.0,0.015,,2.698,1.969,0.643,0.995,3
DDI2,CV_413.41 [Pulmonary valve stenosis],0.072,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.156,,,0.245,1
GLRX5,CV_414.1 [Hypertrophic cardiomyopathy],0.072,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.066,2.324,0.286,0.129,0.942,2
NPHP1,SO_386.6 [Night blindness],0.072,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.862,0.633,0.799,0.171,0.994,2
HAMP,GE_970.2 [Thalassemia],0.072,1,2.0,0.0,0.0,0.0,0.377,0.0,0.144,2.309,2.289,0.041,0.153,,3
DSP,CV_416.8 [Pre-excitation syndrome [Anomalous atrioventricular excitation]],0.072,0,0.0,0.0,0.0,0.0,0.437,0.151,0.0,2.167,3.764,1.229,0.81,0.696,4
BTG3,MS_700.3 [Systemic sclerosis],0.072,0,0.0,0.0,0.0,0.0,0.0,0.0,0.205,2.867,0.868,0.055,0.078,,2
SSBP3,CM_763.13 [Patent ductus arteriosus],0.072,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.049,0.125,,,0.306,2
CCDC141,GE_972.9 [Muscular dystrophy],0.071,0,0.0,0.0,0.0,0.383,0.0,0.0,0.061,2.505,5.736,0.342,0.111,0.275,3
ZC3H12A,GE_978.21 [Marfan syndrome],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.201,2.062,0.391,0.206,0.095,,2
UBE2I,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.366,0.069,,3.572,0.242,2
BFSP1,CM_751.213 [Congenital cataract],0.071,0,0.0,0.0,0.728,0.0,0.661,0.424,0.03,3.15,2.648,0.621,2.752,0.985,5
RPL7,GE_963.1 [Lipid storage disorders],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.782,1.818,,,0.2,2
GLIS2,GE_976.5 [Polycystic kidney disease],0.071,0,0.0,0.0,0.0,0.0,0.296,0.0,0.194,1.918,2.562,0.938,0.192,,3
ERCC2,CM_751.213 [Congenital cataract],0.071,0,0.0,0.0,0.654,0.0,0.418,0.0,0.0,,3.441,0.279,0.252,0.809,4
GRIN2B,GE_973.5 [Huntington's disease],0.071,1,4.0,0.0,0.0,0.0,0.0,0.0,0.289,2.192,0.116,,,,2
TUBB2A,EM_209.4 [Diabetes insipidus],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.521,0.031,,,0.203,2
GSK3B,GE_976.5 [Polycystic kidney disease],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.086,3.193,1.786,,0.153,,2
DDX4,GE_970.2 [Thalassemia],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.134,2.671,2.134,0.284,0.382,,2
TBX20,CM_763.31 [Ventricular septal defect],0.071,0,0.0,0.0,0.772,0.0,0.0,0.0,0.178,2.009,3.311,2.216,1.583,0.727,4
SNAP25,GE_972.1 [Hereditary neuropathy],0.071,1,3.0,0.0,0.0,0.0,0.0,0.0,0.072,2.133,0.164,0.046,0.09,,2
FKTN,SO_380.3 [Optic atrophy],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.501,1.025,0.229,0.157,0.981,2
CD40LG,GU_580.51 [Focal and segmental glomerular lesions*],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.793,,0.178,,2.689,,2
KCNQ5,NS_323.3 [Motor neuron disease],0.071,1,2.0,0.063,0.0,0.0,0.0,0.0,0.061,2.747,1.709,0.375,0.893,0.092,4
SNAI2,MS_712.51 [Hypermobility syndrome],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.061,2.05,0.127,,0.104,,2
STK40,GE_972.2 [Hereditary ataxia],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.035,2.487,2.636,0.24,0.168,0.199,3
CALM1,NS_341.1 [Cerebral palsy],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.231,0.078,,,0.323,2
MLXIPL,GE_964.3 [Glycogen storage disease],0.071,0,0.0,0.0,0.0,0.0,0.308,0.0,0.103,,1.964,0.221,0.225,,3
UNC13A,NS_328.13 [Frontotemporal dementia [FTD]],0.071,0,0.0,0.026,0.0,0.0,0.0,0.0,0.123,2.253,3.003,0.09,0.136,,3
ETS2,GE_973.5 [Huntington's disease],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.371,1.996,0.225,0.101,0.034,,2
GALNS,CM_770.5 [Congenital osteodystrophies],0.071,0,0.0,0.0,0.426,0.0,0.287,0.442,0.04,1.396,1.989,0.306,0.17,0.85,5
NOTCH1,CV_413.41 [Pulmonary valve stenosis],0.071,0,0.0,0.0,0.547,0.0,0.0,0.0,0.027,2.191,3.044,0.268,0.177,0.971,4
TTN,NS_340.3 [Inflammatory and immune myopathies],0.071,0,0.0,0.0,0.895,0.0,0.325,0.0,0.017,3.015,3.992,1.031,0.493,,4
G2E3,NS_323.3 [Motor neuron disease],0.071,0,0.0,0.0,0.0,0.412,0.0,0.0,0.061,1.691,4.371,0.15,0.235,0.008,3
KARS1,GE_963.1 [Lipid storage disorders],0.071,0,0.0,0.0,0.825,0.0,0.0,0.402,0.094,,3.115,0.169,0.122,,3
MTOR,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,1.594,2.926,0.667,0.537,0.99,3
TBPL1,CV_413.41 [Pulmonary valve stenosis],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.4,,0.023,0.29,1
AP5Z1,GE_972.2 [Hereditary ataxia],0.071,0,0.0,0.0,0.684,0.0,0.0,0.81,0.191,1.918,2.302,0.38,1.785,,3
SEMA4C,CV_433.3 [Cerebrovascular insufficiency],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.105,,2.489,0.248,0.163,0.336,3
COL11A1,EM_209.4 [Diabetes insipidus],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.024,2.469,3.313,2.865,0.337,0.516,3
STK11,CV_414.1 [Hypertrophic cardiomyopathy],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.146,1.36,2.661,0.1,0.111,0.84,3
SMARCB1,GE_961.1 [Phakomatoses],0.071,0,0.0,0.0,0.0,0.0,0.368,0.0,0.034,1.881,2.198,2.191,1.868,0.923,4
UBC,CV_414.1 [Hypertrophic cardiomyopathy],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.823,0.17,0.382,0.087,0.982,2
KEAP1,DE_663.2 [Pemphigoid],0.071,1,0.5,0.0,0.0,0.0,0.0,0.0,0.099,,0.233,0.106,0.182,,1
THBS1,GE_972.1 [Hereditary neuropathy],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.065,3.313,2.112,,0.106,,2
SENP1,DE_663.1 [Pemphigus],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.152,,0.417,0.121,2.303,,2
HSPG2,GE_978.21 [Marfan syndrome],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.177,1.866,3.694,0.27,1.218,,2
F2,GE_971.11 [Hereditary factor VIII deficiency [Hemophilia A]],0.071,1,4.0,0.0,0.0,0.0,0.284,0.0,0.138,,0.248,0.072,0.075,,2
NRXN1,CM_770.5 [Congenital osteodystrophies],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.125,3.413,1.922,1.827,0.179,0.282,3
IL6ST,GU_580.1 [Acute nephritic syndrome],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.024,2.43,2.6,0.256,0.141,0.915,3
PEX1,SO_380.3 [Optic atrophy],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.525,2.247,0.329,0.299,0.995,2
NDUFAB1,GE_972.2 [Hereditary ataxia],0.071,1,4.0,0.0,0.0,0.0,0.0,0.0,0.024,,0.164,0.079,2.25,0.93,3
MYBPC1,MB_302.1 [Speech and language developmental delay],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.021,,2.702,0.09,0.623,0.119,3
TMEM43,CV_414.1 [Hypertrophic cardiomyopathy],0.071,0,0.0,0.0,0.775,0.041,0.0,0.394,0.102,1.851,2.911,1.1,0.282,0.802,4
UGGT1,GI_540.11 [Autoimmune hepatitis],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.292,1.378,3.013,0.18,0.425,,2
MTRFR,NS_341.1 [Cerebral palsy],0.071,0,0.0,0.0,0.816,0.0,0.0,0.578,0.07,,0.156,0.234,0.093,,2
NRXN3,MB_296.4 [Borderline personality disorder],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.212,3.121,2.452,0.3,0.236,,2
NR3C2,EM_211.1 [Adrenal hyperfunction],0.071,1,4.0,0.0,0.0,0.0,0.306,0.0,0.077,2.079,1.871,,0.024,,3
NLRP3,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.146,1.682,3.038,0.183,0.147,0.979,3
UBA52,EM_208.1 [Hypoparathyroidism],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.117,,,0.191,1
SUCLG1,GE_972.2 [Hereditary ataxia],0.071,0,0.0,0.042,0.0,0.0,0.0,0.0,0.0,1.639,2.402,0.173,0.216,0.983,3
RPS26,RE_484.1 [Spontaneous pneumothorax],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.107,0.041,,0.153,1
CAPRIN1,GE_972.2 [Hereditary ataxia],0.071,0,0.0,0.0,0.547,0.0,0.0,0.129,0.045,1.911,2.298,0.216,1.368,0.737,4
JAG1,GI_540.11 [Autoimmune hepatitis],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.184,2.297,2.435,0.273,0.22,,2
VWF,EM_249.1 [Cerebral amyloid angiopathy*],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.07,2.392,5.02,2.782,0.266,,2
P2RX7,CV_414.1 [Hypertrophic cardiomyopathy],0.071,0,0.0,0.0,0.426,0.0,0.0,0.0,0.12,1.448,3.679,0.498,0.229,0.088,4
SLC16A2,GE_972.9 [Muscular dystrophy],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,1.986,1.95,,0.044,0.16,3
TUBB2A,NS_344.2 [Benign intracranial hypertension],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.032,,,0.222,1
LMNA,GE_964.3 [Glycogen storage disease],0.071,0,0.0,0.0,0.0,0.0,0.355,0.0,0.049,,2.131,0.194,0.116,,3
CALM1,GE_977.1 [Congenital ichthyosis],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.929,0.032,,,0.244,2
RPLP0,GE_972.9 [Muscular dystrophy],0.071,1,4.0,0.0,0.0,0.0,0.0,0.0,0.0,2.842,2.252,,0.02,0.267,2
ANGPT1,GE_972.9 [Muscular dystrophy],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.12,3.92,0.161,0.1,0.095,0.358,3
PKD1,NS_344.11 [Communicating hydrocephalus],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.112,,3.697,0.159,0.205,,2
NUTF2,CM_763.13 [Patent ductus arteriosus],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.062,,0.015,0.311,1
TUBB2B,SO_386.5 [Color vision deficiencies],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.05,,,0.169,1
VEGFA,MS_704.3 [Thrombotic microangiopathy],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.193,3.693,0.069,0.054,0.045,,2
SCN9A,NS_341.1 [Cerebral palsy],0.071,1,4.0,0.0,0.0,0.0,0.0,0.0,0.0,3.426,2.519,0.364,0.226,0.958,2
JMJD1C,CV_414.1 [Hypertrophic cardiomyopathy],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.061,2.69,3.518,0.694,0.46,0.302,3
MEN1,"EM_209.11 [Tall stature, acromegaly and gigantism]",0.071,0,0.0,0.0,0.0,0.0,0.347,0.575,0.143,,2.88,0.1,0.085,,4
MAFB,CV_414.1 [Hypertrophic cardiomyopathy],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.225,2.564,2.537,2.538,0.074,0.222,3
LRAT,NS_341.1 [Cerebral palsy],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.974,0.327,0.135,0.077,0.972,2
DNM1L,GE_972.2 [Hereditary ataxia],0.071,0,0.0,0.0,0.547,0.0,0.0,0.129,0.084,1.343,1.477,0.358,0.962,0.94,4
BLM,CV_441 [Arteriovenous malformation],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.018,2.866,0.716,0.334,0.978,2
SNRPE,GE_961.1 [Phakomatoses],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.359,0.076,,,0.21,2
ADRA2C,CM_763.13 [Patent ductus arteriosus],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.637,0.217,,0.014,0.173,2
SNAP25,NS_341.1 [Cerebral palsy],0.071,1,4.0,0.0,0.0,0.0,0.0,0.0,0.012,2.004,0.122,0.023,0.061,0.976,3
TNFRSF11B,GE_978.3 [Osteochondrodysplasias],0.071,0,0.0,0.0,0.0,0.0,0.306,0.0,0.178,1.953,0.39,0.09,2.14,,3
SIAH1,SO_369.62 [Keratoconus],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.044,,,0.263,1
SMAD2,GE_976.5 [Polycystic kidney disease],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.169,2.701,0.222,0.082,1.577,,2
YPEL5,CM_763.31 [Ventricular septal defect],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.658,0.037,,,0.219,2
RPS29,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.025,0.048,,,0.263,2
FST,CV_433.3 [Cerebrovascular insufficiency],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.055,1.964,3.51,3.12,0.077,0.744,3
ATXN2,GE_963.1 [Lipid storage disorders],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.024,1.691,2.848,0.846,0.159,0.231,3
KIT,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.071,0,0.0,0.0,0.0,0.0,0.525,0.0,0.05,3.158,0.731,0.205,0.162,0.976,4
PNPLA8,GE_972.2 [Hereditary ataxia],0.071,0,0.0,0.0,0.684,0.0,0.0,0.0,0.067,1.483,2.794,0.364,0.224,0.638,4
BCKDHB,NS_341.1 [Cerebral palsy],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.329,0.167,0.3,0.144,0.942,2
MYBL1,MS_727.5 [Cyst of bone],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.259,1.416,1.91,0.271,0.199,,2
UBE2L3,GE_961.1 [Phakomatoses],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.088,,,0.176,1
FGF9,GE_972.2 [Hereditary ataxia],0.071,0,0.0,0.032,0.0,0.0,0.344,0.0,0.146,3.245,0.142,0.038,0.048,0.537,5
MT-ATP8,CV_414.1 [Hypertrophic cardiomyopathy],0.071,0,0.0,0.0,0.0,0.0,0.0,0.674,0.033,,,,,,2
PSEN1,EM_249.1 [Cerebral amyloid angiopathy*],0.071,0,0.0,0.0,0.684,0.0,0.0,0.0,0.084,,0.176,0.103,0.074,,2
DLG3,GI_516.1 [Pyloric stenosis],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.412,3.489,0.252,0.135,0.987,2
TIA1,GE_972.9 [Muscular dystrophy],0.071,0,0.0,0.0,0.547,0.0,0.0,0.701,0.126,,0.647,0.378,0.077,0.906,3
ROCK1,GE_972.2 [Hereditary ataxia],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,1.556,2.671,0.25,0.18,0.949,3
TRPC6,GU_580.1 [Acute nephritic syndrome],0.071,0,0.0,0.0,0.893,0.0,0.0,0.176,0.112,2.981,0.963,0.449,0.239,0.771,4
CD40LG,CV_438.41 [Aortic dissection],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.147,1.382,0.185,,2.173,0.488,3
ROCK2,CV_433.3 [Cerebrovascular insufficiency],0.071,1,0.5,0.0,0.0,0.0,0.0,0.0,0.102,2.764,3.114,0.298,0.154,0.79,3
MARK4,GE_961.1 [Phakomatoses],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.036,,1.7,0.22,0.161,0.291,3
MPIG6B,GE_978.3 [Osteochondrodysplasias],0.071,0,0.0,0.0,0.0,0.0,0.413,0.0,0.082,,2.127,0.092,0.106,,3
JAG1,NS_323.3 [Motor neuron disease],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.061,1.978,2.239,1.414,0.292,0.29,3
NEDD9,GE_976.5 [Polycystic kidney disease],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.109,1.982,2.803,0.226,0.336,,2
RUNX1,GI_516.1 [Pyloric stenosis],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.672,0.159,0.078,0.208,0.978,2
NFKBIZ,MS_727.5 [Cyst of bone],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.212,2.08,1.891,0.329,0.283,,2
HARS1,GE_972.1 [Hereditary neuropathy],0.071,0,0.0,0.0,0.0,0.0,0.471,0.547,0.044,1.344,2.934,1.214,0.473,,4
AGTR1,GE_978.3 [Osteochondrodysplasias],0.071,0,0.0,0.0,0.0,0.0,0.353,0.0,0.089,2.445,1.947,0.729,0.119,,3
RXRA,SO_369.62 [Keratoconus],0.071,0,0.0,0.0,0.426,0.126,0.0,0.0,0.064,2.026,2.455,0.097,0.104,0.556,4
GABBR2,GE_963.1 [Lipid storage disorders],0.071,0,0.0,0.0,0.0,0.0,0.294,0.0,0.146,3.092,0.11,0.069,0.092,0.078,4
LYST,SO_373.2 [Choroidal degenerations],0.071,0,0.0,0.0,0.0,0.0,0.444,0.0,0.091,2.097,2.958,0.161,0.548,,3
MBNL2,NS_339.2 [Myotonic disorders],0.071,0,0.0,0.0,0.0,0.0,0.377,0.0,0.23,1.655,0.051,,0.065,,3
AHI1,MS_705.2 [Juvenile rheumatoid arthritis [JRA/JIA]],0.071,0,0.0,0.0,0.0,0.515,0.0,0.0,0.044,1.888,3.408,0.335,0.145,,2
NAMPT,GI_542.8 [Biliary cirrhosis],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.198,2.93,3.271,0.085,0.098,,2
NF1,CV_433.3 [Cerebrovascular insufficiency],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.278,,3.152,0.36,0.254,0.834,3
LONP1,CV_433.3 [Cerebrovascular insufficiency],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.061,1.515,3.474,0.392,0.233,0.144,3
GATA2,DE_663.2 [Pemphigoid],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.04,3.339,0.313,0.191,0.144,,2
RHOQ,EM_209.4 [Diabetes insipidus],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.413,0.073,,0.088,0.133,2
ACE,CV_414.1 [Hypertrophic cardiomyopathy],0.071,0,0.0,0.0,0.0,0.0,0.69,0.0,0.75,,3.217,0.84,0.549,0.513,4
MYB,GI_542.8 [Biliary cirrhosis],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.103,,2.772,0.469,0.253,,2
RARS2,SO_380.3 [Optic atrophy],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.907,0.277,0.193,0.976,2
ASS1,NS_341.1 [Cerebral palsy],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.29,3.542,0.104,0.099,0.96,2
FOXP1,GE_973.5 [Huntington's disease],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.226,3.474,0.018,,,,2
TP53,MS_704.2 [Wegener's granulomatosis],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.155,1.409,0.154,0.103,0.091,,2
KPNB1,CV_433.3 [Cerebrovascular insufficiency],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.173,,,0.32,1
RARA,GE_972.2 [Hereditary ataxia],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.035,1.801,4.228,0.352,0.156,0.869,3
KDELR2,CM_770.5 [Congenital osteodystrophies],0.071,0,0.0,0.0,0.0,0.0,0.0,0.402,0.074,1.851,0.119,0.171,1.876,0.286,4
AR,CV_414.1 [Hypertrophic cardiomyopathy],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.286,2.372,2.744,,0.025,0.714,3
ADAM10,MS_700.43 [Polymyositis],0.071,0,0.0,0.022,0.0,0.0,0.0,0.0,0.063,2.902,0.916,0.075,0.058,,3
ADRA2C,CM_751.213 [Congenital cataract],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.222,3.245,,0.034,0.135,2
OFD1,GE_972.2 [Hereditary ataxia],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.643,0.302,0.14,0.992,2
RECQL4,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.849,3.976,2.261,0.137,0.951,2
DSP,CV_441 [Arteriovenous malformation],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.061,1.534,2.863,0.223,0.392,0.228,3
ADAM10,MS_700.42 [Dermatomyositis],0.071,0,0.0,0.056,0.0,0.0,0.0,0.0,0.09,2.394,1.618,0.084,0.057,,3
EZH2,SO_365.3 [Exophthalmos [Proptosis]],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.061,3.273,1.601,0.08,1.608,0.963,3
SEMA4D,GI_540.11 [Autoimmune hepatitis],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.329,1.982,3.424,3.292,0.181,,2
MARCKS,NS_328.13 [Frontotemporal dementia [FTD]],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.213,3.029,2.548,0.031,0.026,,2
FASLG,SO_373.2 [Choroidal degenerations],0.071,0,0.0,0.0,0.0,0.0,0.615,0.0,0.114,2.0,0.801,0.105,0.05,,3
BCL2,CV_414.1 [Hypertrophic cardiomyopathy],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.189,3.024,0.17,0.056,0.113,0.886,3
RUNX1T1,CV_414.1 [Hypertrophic cardiomyopathy],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,3.184,0.288,0.305,0.217,0.141,3
GRIN2B,SO_386.6 [Night blindness],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.442,0.999,,,0.264,2
PCYT2,NS_341.1 [Cerebral palsy],0.071,0,0.0,0.0,0.836,0.0,0.0,0.503,0.037,,0.598,0.259,0.112,0.915,3
HBEGF,GE_976.5 [Polycystic kidney disease],0.071,0,0.0,0.0,0.0,0.0,0.271,0.0,0.114,,0.613,0.088,0.11,,2
HMGCR,NS_333.4 [Circadian rhythm sleep disorder],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.128,1.444,0.357,0.308,0.168,0.613,3
FOXO1,GU_580.1 [Acute nephritic syndrome],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.031,2.853,2.56,0.042,0.089,0.952,3
HDAC9,MS_700.3 [Systemic sclerosis],0.071,1,1.0,0.0,0.0,0.0,0.0,0.0,0.117,2.021,2.082,0.334,0.659,,2
UBE2M,GE_972.9 [Muscular dystrophy],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.114,0.032,,0.334,1
FLNB,BI_162.1 [Constitutional (hereditary) aplastic anemia],0.071,0,0.0,0.0,0.0,0.0,0.288,0.0,0.182,2.425,0.673,0.135,0.213,,3
BCOR,EM_211.1 [Adrenal hyperfunction],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.119,2.298,4.392,0.054,0.067,,2
SLC5A3,MB_302.1 [Speech and language developmental delay],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.872,0.204,,0.102,0.171,2
PRKD2,CV_414.1 [Hypertrophic cardiomyopathy],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,1.461,2.624,0.488,0.253,0.1,3
DRD3,GE_973.5 [Huntington's disease],0.071,1,3.0,0.0,0.0,0.0,0.0,0.0,0.07,1.968,0.064,0.077,0.054,,2
MYO1E,GU_580.1 [Acute nephritic syndrome],0.071,0,0.0,0.0,0.877,0.0,0.341,0.012,0.061,2.166,2.335,0.265,0.483,0.516,5
BMP2,GE_961.1 [Phakomatoses],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.177,2.771,0.173,0.217,0.135,0.953,3
CXCL12,EM_209.4 [Diabetes insipidus],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.69,2.397,0.053,0.055,0.962,2
ISY1-RAB43,GE_972.2 [Hereditary ataxia],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.047,,,0.237,1
RPL7,SO_365.3 [Exophthalmos [Proptosis]],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.718,1.763,,,0.149,2
BBS4,EM_209.4 [Diabetes insipidus],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.434,2.223,0.203,0.167,0.965,2
ADCY5,GE_976.5 [Polycystic kidney disease],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.015,1.72,3.659,2.448,0.345,,2
TBX21,GI_540.11 [Autoimmune hepatitis],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.116,1.324,1.869,,2.132,,2
CHD6,GE_972.2 [Hereditary ataxia],0.071,0,0.0,0.0,0.0,0.0,0.0,0.0,0.182,2.578,3.265,1.217,0.333,0.335,3
TFRC,GE_970.1 [Sickle-cell disorders],0.07,0,0.0,0.0,0.0,0.0,0.339,0.0,0.113,2.563,1.07,0.081,0.257,,3
PIM1,CV_414.1 [Hypertrophic cardiomyopathy],0.07,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.717,2.718,,,0.279,2
FAM111A,EM_208.1 [Hypoparathyroidism],0.07,0,0.0,0.0,0.701,0.0,0.0,0.0,0.077,1.898,2.399,0.148,0.163,0.788,4
CDH2,CM_751.213 [Congenital cataract],0.07,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.464,1.881,0.218,0.181,0.865,3
TECPR2,NS_341.1 [Cerebral palsy],0.07,0,0.0,0.0,0.745,0.0,0.0,0.755,0.024,1.34,1.307,0.362,0.198,0.967,4
EZH2,MS_700.3 [Systemic sclerosis],0.07,0,0.0,0.0,0.0,0.0,0.0,0.0,0.673,,1.768,0.089,0.11,,2
ABL1,MS_700.3 [Systemic sclerosis],0.07,1,2.0,0.0,0.0,0.0,0.0,0.0,0.115,3.192,0.884,0.844,0.209,,2
BCL2,GU_580.1 [Acute nephritic syndrome],0.07,1,1.0,0.0,0.0,0.0,0.38,0.0,0.084,2.398,1.648,0.048,0.062,0.989,4
DHX36,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.07,0,0.0,0.0,0.0,0.0,0.0,0.0,0.015,2.133,2.796,0.3,0.186,0.098,3
LRP2,GU_580.52 [Diffuse membranous glomerulonephritis],0.07,0,0.0,0.0,0.0,0.0,0.0,0.0,0.129,2.479,4.104,2.064,1.045,,2
RNASEH1,NS_341.1 [Cerebral palsy],0.07,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.407,0.097,0.112,0.969,1
EP300,MS_700.3 [Systemic sclerosis],0.07,0,0.0,0.0,0.0,0.0,0.0,0.0,0.413,1.754,2.586,0.433,0.4,,2
HSF2,GE_973.5 [Huntington's disease],0.07,0,0.0,0.0,0.0,0.0,0.0,0.0,0.13,2.362,0.075,0.035,0.054,,2
MTOR,GE_978.21 [Marfan syndrome],0.07,0,0.0,0.0,0.0,0.0,0.0,0.0,0.071,2.26,2.154,0.215,0.139,,2
ITGAL,BI_162.1 [Constitutional (hereditary) aplastic anemia],0.07,0,0.0,0.0,0.0,0.0,0.32,0.0,0.088,,3.367,0.105,0.104,,3
UBE2L3,NS_333.4 [Circadian rhythm sleep disorder],0.07,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.076,,,0.334,1
HRH2,CV_433.3 [Cerebrovascular insufficiency],0.07,0,0.0,0.0,0.0,0.0,0.0,0.0,0.024,2.129,2.977,,0.089,0.209,3
TEK,CM_770.5 [Congenital osteodystrophies],0.07,0,0.0,0.0,0.0,0.0,0.0,0.0,0.015,2.384,3.16,0.189,0.179,0.918,3
HCRT,NS_333.7 [Narcolepsy],0.07,0,0.0,0.0,0.547,0.0,0.69,0.362,0.43,,0.168,0.059,0.048,,3
TLR7,MS_700.3 [Systemic sclerosis],0.07,1,3.0,0.0,0.0,0.0,0.0,0.0,0.231,3.361,2.227,0.136,0.136,,2
LRP2,GU_580.1 [Acute nephritic syndrome],0.07,0,0.0,0.0,0.0,0.0,0.0,0.0,0.082,1.857,4.168,1.042,0.563,0.414,3
ABL1,CM_763.31 [Ventricular septal defect],0.07,0,0.0,0.0,0.547,0.0,0.257,0.0,0.079,1.527,2.609,0.609,0.16,0.902,5
BRD2,GE_961.1 [Phakomatoses],0.07,0,0.0,0.0,0.0,0.0,0.0,0.0,0.029,1.951,2.986,0.615,1.034,0.33,3
HMGCR,SO_386.5 [Color vision deficiencies],0.07,0,0.0,0.0,0.0,0.0,0.0,0.0,0.109,,0.535,0.252,0.124,0.547,2
GRIN2D,MB_306 [Conduct disorders],0.07,1,4.0,0.0,0.0,0.0,0.0,0.0,0.149,,1.905,0.101,0.106,,2
IL1B,MS_700.3 [Systemic sclerosis],0.07,1,1.0,0.0,0.0,0.0,0.0,0.0,0.788,1.858,1.79,0.14,0.094,,2
PDE4D,MB_306 [Conduct disorders],0.07,0,0.0,0.0,0.0,0.0,0.0,0.0,0.122,2.691,0.757,0.163,0.101,,2
CWH43,NS_344.13 [(Idiopathic) normal pressure hydrocephalus],0.07,0,0.0,0.0,0.0,0.0,0.385,0.0,0.117,1.416,1.716,0.342,0.17,,3
HDAC9,EM_249.1 [Cerebral amyloid angiopathy*],0.07,0,0.0,0.0,0.0,0.44,0.0,0.0,0.024,2.237,0.383,0.207,1.832,,2
COL3A1,GE_978.22 [Ehler's Danlos syndrome],0.07,0,0.0,0.0,0.0,0.0,0.0,0.927,0.203,2.16,2.85,0.767,2.701,,3
FGF23,MS_727.3 [Osteitis deformans [Paget's disease of bone]],0.07,1,4.0,0.0,0.0,0.0,0.283,0.0,0.154,,2.641,0.129,0.113,,3
DDR2,DE_663.2 [Pemphigoid],0.07,0,0.0,0.0,0.0,0.0,0.0,0.0,0.359,1.58,2.96,0.786,0.192,,2
MBTPS2,GE_978.3 [Osteochondrodysplasias],0.07,0,0.0,0.0,0.0,0.0,0.0,0.546,0.731,2.054,2.774,0.025,0.062,,3
VEGFA,GE_970.1 [Sickle-cell disorders],0.07,0,0.0,0.0,0.0,0.0,0.0,0.0,0.248,2.33,1.737,0.079,0.166,,2
NUBPL,CV_414.1 [Hypertrophic cardiomyopathy],0.07,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.707,2.738,0.86,0.228,0.982,2
WDR35,CM_770.5 [Congenital osteodystrophies],0.07,0,0.0,0.0,0.0,0.0,0.312,0.864,0.065,1.578,2.03,0.283,0.246,0.448,5
RAG1,BI_179.1 [Hypogammaglobulinemia NOS],0.07,0,0.0,0.0,0.816,0.0,0.0,0.0,0.065,,3.673,0.718,0.272,0.993,4
NLRP3,GU_580.52 [Diffuse membranous glomerulonephritis],0.07,0,0.0,0.0,0.0,0.0,0.0,0.01,0.168,1.384,2.796,0.077,0.114,,3
BANF1,EM_209.4 [Diabetes insipidus],0.07,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.443,0.083,,,0.156,2
FXR1,NS_333.4 [Circadian rhythm sleep disorder],0.07,0,0.0,0.0,0.0,0.0,0.0,0.0,0.052,1.412,0.242,0.399,4.467,0.221,3
LPL,GE_964.3 [Glycogen storage disease],0.07,0,0.0,0.0,0.0,0.0,0.432,0.0,0.045,3.557,0.356,0.194,0.147,,3
OPN1LW,GU_580.1 [Acute nephritic syndrome],0.07,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,,2.589,,3.327,0.098,3
PPARG,DE_663.2 [Pemphigoid],0.07,0,0.0,0.0,0.0,0.0,0.0,0.0,0.662,2.52,2.001,0.131,0.107,,2
EPAS1,GE_970.2 [Thalassemia],0.07,0,0.0,0.0,0.0,0.0,0.451,0.0,0.015,3.091,3.535,1.223,0.223,,3
HIPK2,CV_414.1 [Hypertrophic cardiomyopathy],0.07,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.723,3.744,,0.084,0.11,2
HIF1A,GE_972.2 [Hereditary ataxia],0.07,0,0.0,0.0,0.0,0.0,0.0,0.0,0.039,2.015,2.787,0.336,1.116,0.957,3
GRB10,MS_700.3 [Systemic sclerosis],0.07,0,0.0,0.0,0.0,0.0,0.0,0.0,0.085,2.272,0.34,0.322,0.144,,2
DNM2,GE_972.2 [Hereditary ataxia],0.07,0,0.0,0.0,0.426,0.0,0.349,0.0,0.083,1.621,2.515,0.73,0.901,0.866,5
GRIN2B,BI_179.1 [Hypogammaglobulinemia NOS],0.07,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.826,3.706,,,0.331,2
ACVR1B,MS_700.3 [Systemic sclerosis],0.07,0,0.0,0.0,0.0,0.0,0.0,0.0,0.079,,0.13,0.094,0.139,,1
ACAD9,GE_972.2 [Hereditary ataxia],0.07,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.471,0.994,0.234,0.996,2
TMEM126A,SO_380.3 [Optic atrophy],0.07,0,0.0,0.0,0.796,0.0,0.0,0.543,0.021,,0.232,0.136,0.103,0.751,3
RPS14,CM_750.16 [Arnold-Chiari syndrome*],0.07,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.053,0.01,0.02,0.209,1
DNMT3A,CM_750.16 [Arnold-Chiari syndrome*],0.07,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.255,0.347,0.181,0.163,0.942,2
SLC6A4,GE_978.22 [Ehler's Danlos syndrome],0.07,0,0.0,0.0,0.0,0.0,0.0,0.0,0.167,,0.198,0.098,0.106,,1
GSK3B,NS_323.3 [Motor neuron disease],0.07,1,2.0,0.0,0.0,0.0,0.0,0.0,0.087,1.962,0.27,,0.152,0.993,3
SPTBN1,GE_972.2 [Hereditary ataxia],0.07,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,1.645,2.616,0.759,0.421,0.898,3
HCN1,GE_972.1 [Hereditary neuropathy],0.07,0,0.0,0.0,0.0,0.0,0.255,0.0,0.175,2.603,2.464,0.044,0.139,,3
F8,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.07,0,0.0,0.0,0.0,0.0,0.0,0.0,0.19,,2.056,0.157,1.382,0.951,3
NFE2L2,GU_580.1 [Acute nephritic syndrome],0.07,0,0.0,0.0,0.0,0.0,0.0,0.0,0.167,2.526,2.956,0.177,0.085,0.924,3
MECP2,MB_302.1 [Speech and language developmental delay],0.07,0,0.0,0.0,0.0,0.0,0.372,0.462,0.022,,1.916,1.115,0.106,0.929,5
SCO1,GE_972.2 [Hereditary ataxia],0.07,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.837,2.837,0.263,0.129,0.963,2
UBE2D3,CV_413.41 [Pulmonary valve stenosis],0.07,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.53,0.033,,,0.277,2
DST,CV_414.1 [Hypertrophic cardiomyopathy],0.07,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.374,3.377,1.783,1.334,0.152,3
GRIA4,NS_323.3 [Motor neuron disease],0.07,1,2.0,0.0,0.0,0.0,0.0,0.0,0.018,1.545,1.608,0.308,0.313,0.361,3
ARHGEF10,GE_972.1 [Hereditary neuropathy],0.07,0,0.0,0.0,0.0,0.0,0.0,0.333,0.12,3.046,3.361,0.2,0.529,,3
CFAP43,NS_344.13 [(Idiopathic) normal pressure hydrocephalus],0.07,0,0.0,0.0,0.547,0.0,0.0,0.594,0.151,,1.972,0.525,0.216,,3
NOS1,GE_978.22 [Ehler's Danlos syndrome],0.07,0,0.0,0.0,0.0,0.0,0.0,0.0,0.401,2.292,2.861,0.368,0.167,,2
ABCB4,GE_976.5 [Polycystic kidney disease],0.07,0,0.0,0.0,0.0,0.0,0.354,0.0,0.027,,2.746,0.692,0.347,,3
LRSAM1,GE_972.1 [Hereditary neuropathy],0.07,0,0.0,0.0,0.0,0.0,0.288,0.401,0.088,,2.407,0.489,0.314,,4
PTGER3,CM_763.13 [Patent ductus arteriosus],0.07,1,4.0,0.0,0.0,0.0,0.0,0.0,0.036,1.906,0.074,0.032,0.053,0.313,3
AMD1,GI_516.1 [Pyloric stenosis],0.07,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.84,0.19,,0.092,0.156,2
CTSB,DE_663.1 [Pemphigus],0.07,0,0.0,0.0,0.0,0.0,0.37,0.0,0.1,,0.324,0.597,0.114,,2
TP53BP1,BI_162.1 [Constitutional (hereditary) aplastic anemia],0.07,0,0.0,0.0,0.0,0.0,0.0,0.0,0.08,1.654,2.73,0.289,0.166,,2
BMPR1B,GE_970.1 [Sickle-cell disorders],0.07,0,0.0,0.0,0.0,0.0,0.0,0.0,0.097,2.504,1.625,0.117,0.069,,2
TNF,DE_669.4 [Febrile neutrophilic dermatosis [Sweet's syndrome]*],0.07,0,0.0,0.0,0.0,0.0,0.352,0.0,0.11,,0.105,0.079,0.024,,2
FGFR1,SO_386.5 [Color vision deficiencies],0.07,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.845,0.198,0.203,0.096,0.991,2
GYS2,GE_964.3 [Glycogen storage disease],0.07,0,0.0,0.0,0.0,0.0,0.426,0.821,0.04,1.608,2.741,0.524,0.237,,4
CHRM2,CV_414.1 [Hypertrophic cardiomyopathy],0.07,0,0.0,0.0,0.0,0.0,0.0,0.0,0.015,2.726,1.955,0.093,0.141,0.109,3
APP,NS_343.6 [Multi-system degeneration of the autonomic nervous system*],0.07,0,0.0,0.0,0.0,0.0,0.0,0.0,0.148,2.662,0.095,0.207,0.1,,2
MTOR,MS_727.5 [Cyst of bone],0.07,0,0.0,0.0,0.0,0.0,0.0,0.0,0.082,1.681,2.847,0.583,0.46,,2
DCTN1,GE_972.2 [Hereditary ataxia],0.07,0,0.0,0.0,0.0,0.0,0.0,0.0,0.028,,3.084,0.35,0.248,0.925,3
SYNGAP1,GE_972.2 [Hereditary ataxia],0.07,0,0.0,0.0,0.654,0.0,0.0,0.281,0.052,,0.167,0.255,0.193,0.922,3
SLC40A1,GE_972.9 [Muscular dystrophy],0.07,0,0.0,0.037,0.0,0.0,0.0,0.0,0.061,1.992,0.144,0.071,0.098,0.131,4
VEGFA,MS_728.2 [Osteochondritis dissecans],0.07,0,0.0,0.0,0.0,0.0,0.0,0.0,0.082,2.571,0.18,0.136,0.097,,2
RORA,CV_441 [Arteriovenous malformation],0.07,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.121,0.167,,,0.198,2
ZAP70,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.07,0,0.0,0.0,0.0,0.0,0.0,0.0,0.065,,2.761,0.246,0.171,0.991,3
HMGA1,GE_963.1 [Lipid storage disorders],0.07,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.029,,,0.206,1
FOXP1,MB_293.1 [Anorexia nervosa],0.07,0,0.0,0.0,0.0,0.585,0.0,0.0,0.018,3.698,0.045,,,,2
USH2A,SO_386.5 [Color vision deficiencies],0.07,0,0.0,0.0,0.0,0.0,0.0,0.121,0.126,2.277,3.939,2.081,0.319,0.999,4
MTOR,GI_540.11 [Autoimmune hepatitis],0.07,0,0.0,0.0,0.0,0.0,0.0,0.0,0.141,1.913,2.326,0.382,0.455,,2
RPL7,EM_209.4 [Diabetes insipidus],0.07,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.411,3.68,,,0.162,2
PHLDB1,CM_770.5 [Congenital osteodystrophies],0.07,0,0.0,0.0,0.0,0.0,0.274,0.0,0.097,,2.769,0.277,0.528,0.484,4
LTBP2,CM_751.213 [Congenital cataract],0.07,0,0.0,0.0,0.426,0.0,0.446,0.0,0.0,1.671,3.159,0.461,0.248,0.642,4
RAB7A,CV_441 [Arteriovenous malformation],0.07,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.111,,,0.188,1
CD163,MS_719.2 [Muscle calcification and ossification],0.07,0,0.0,0.0,0.0,0.0,0.0,0.0,0.405,1.893,0.228,0.074,0.09,,2
RAB35,CM_750.16 [Arnold-Chiari syndrome*],0.07,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.709,0.056,,0.039,0.211,2
RPL7,CV_433.3 [Cerebrovascular insufficiency],0.07,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.31,0.717,,,0.256,2
ATP2B1,CV_433.3 [Cerebrovascular insufficiency],0.07,0,0.0,0.0,0.0,0.44,0.0,0.0,0.073,2.175,2.593,0.067,0.114,0.204,3
APP,NS_333.4 [Circadian rhythm sleep disorder],0.07,0,0.0,0.0,0.0,0.0,0.0,0.0,0.047,2.762,2.938,0.402,0.188,0.991,3
THBD,MS_700.43 [Polymyositis],0.07,0,0.0,0.0,0.0,0.0,0.0,0.0,0.099,1.882,2.581,0.043,0.039,,2
SOS1,CV_413.41 [Pulmonary valve stenosis],0.07,0,0.0,0.0,0.0,0.0,0.0,0.37,0.065,2.176,3.874,0.132,0.114,0.919,4
KPNB1,CV_416.8 [Pre-excitation syndrome [Anomalous atrioventricular excitation]],0.07,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,4.363,,,0.181,2
NFKB1,MS_700.3 [Systemic sclerosis],0.07,0,0.0,0.0,0.0,0.428,0.0,0.0,0.552,1.598,3.285,0.657,0.145,,2
NOX1,MS_712.51 [Hypermobility syndrome],0.07,0,0.0,0.0,0.0,0.0,0.0,0.0,0.081,1.569,4.973,2.885,0.749,,2
RPS11,GE_972.9 [Muscular dystrophy],0.07,1,4.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.401,,0.023,0.241,1
LMX1B,GU_580.52 [Diffuse membranous glomerulonephritis],0.07,0,0.0,0.0,0.0,0.0,0.0,0.657,0.116,1.903,1.903,0.062,0.087,,3
IFT140,GE_976.5 [Polycystic kidney disease],0.07,0,0.0,0.0,0.0,0.0,0.25,0.503,0.305,,18.083,16.898,3.703,,4
CD34,CV_438.41 [Aortic dissection],0.07,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.947,0.317,1.9,0.963,2
FOXP1,MS_727.5 [Cyst of bone],0.07,0,0.0,0.0,0.0,0.0,0.0,0.0,0.795,2.659,2.243,,,,2
NPC2,GE_963.1 [Lipid storage disorders],0.07,0,0.0,0.0,0.0,0.0,0.291,0.842,0.044,,0.44,0.041,0.032,0.28,4
DRD2,NS_323.3 [Motor neuron disease],0.07,1,3.0,0.0,0.0,0.0,0.0,0.0,0.082,1.854,0.478,0.544,0.15,0.547,3
NLRP3,MS_704.1 [Polyarteritis nodosa and related conditions],0.07,0,0.0,0.0,0.0,0.0,0.0,0.0,0.171,1.316,2.264,0.084,0.118,,2
TRAPPC2,CM_770.5 [Congenital osteodystrophies],0.07,0,0.0,0.0,0.891,0.0,0.0,0.189,0.045,,0.091,,0.048,0.398,3
PRKCA,NS_339.2 [Myotonic disorders],0.07,0,0.0,0.0,0.0,0.0,0.0,0.0,0.109,2.439,0.3,0.073,0.074,,2
USP8,GE_961.1 [Phakomatoses],0.07,0,0.0,0.0,0.0,0.0,0.0,0.0,0.023,2.077,4.653,0.362,0.156,0.319,3
ANG,NS_323.3 [Motor neuron disease],0.07,0,0.0,0.0,0.885,0.0,0.0,0.731,0.084,,2.453,0.195,0.053,0.985,4
LACC1,MS_705.2 [Juvenile rheumatoid arthritis [JRA/JIA]],0.07,0,0.0,0.0,0.86,0.0,0.0,0.738,0.373,,3.39,0.084,0.082,,3
GRM5,CV_433.3 [Cerebrovascular insufficiency],0.07,1,0.5,0.0,0.0,0.0,0.0,0.0,0.023,1.588,2.482,0.293,0.185,0.182,3
MCOLN1,GE_972.2 [Hereditary ataxia],0.07,0,0.0,0.0,0.775,0.0,0.27,0.129,0.03,,2.147,0.346,0.171,0.73,5
PTPN1,MS_700.3 [Systemic sclerosis],0.07,0,0.0,0.0,0.0,0.0,0.0,0.0,0.187,3.104,0.59,0.058,0.096,,2
AMH,GU_580.1 [Acute nephritic syndrome],0.07,0,0.0,0.0,0.0,0.0,0.0,0.0,0.116,,3.943,0.195,0.109,0.253,3
POU2F1,GI_542.8 [Biliary cirrhosis],0.07,0,0.0,0.0,0.0,0.0,0.0,0.0,0.12,2.042,2.077,0.467,0.129,,2
RAB35,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.07,0,0.0,0.0,0.0,0.0,0.0,0.0,0.237,,0.199,,2.739,0.177,3
FANCD2,BI_162.1 [Constitutional (hereditary) aplastic anemia],0.07,0,0.0,0.0,0.0,0.0,0.0,0.823,0.102,,2.29,0.881,0.176,,3
PEX3,GI_516.1 [Pyloric stenosis],0.07,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,3.055,1.139,1.283,0.977,2
GNAS,DE_663.2 [Pemphigoid],0.07,0,0.0,0.0,0.0,0.0,0.0,0.0,0.062,2.379,0.273,0.109,0.079,,2
DCTN1,GE_972.1 [Hereditary neuropathy],0.07,0,0.0,0.0,0.0,0.0,0.0,0.231,0.025,,2.396,0.422,0.403,,3
F2,BI_168.12 [Hemorrhagic disorder due to intrinsic circulating anticoagulants],0.07,1,3.0,0.0,0.0,0.0,0.0,0.0,0.105,2.257,1.586,0.068,0.08,,2
KCNN3,DE_663.2 [Pemphigoid],0.07,0,0.0,0.0,0.0,0.0,0.0,0.0,0.093,2.889,1.772,0.069,0.068,,2
ERH,GE_977.1 [Congenital ichthyosis],0.07,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.062,,0.014,0.321,1
ELAVL2,GE_972.9 [Muscular dystrophy],0.07,0,0.0,0.0,0.0,0.0,0.0,0.0,0.036,3.114,0.062,0.037,2.155,0.129,3
GRIN2B,MB_293.1 [Anorexia nervosa],0.07,1,1.0,0.0,0.0,0.0,0.0,0.0,0.061,2.087,3.059,,,,2
NOS1,MS_700.3 [Systemic sclerosis],0.07,0,0.0,0.0,0.0,0.0,0.0,0.0,0.058,1.742,3.846,0.402,0.291,,2
ARIH1,GE_972.2 [Hereditary ataxia],0.07,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,2.304,1.76,,0.074,0.159,3
BCL2,DE_663.2 [Pemphigoid],0.07,0,0.0,0.0,0.0,0.0,0.0,0.0,0.238,2.674,0.142,0.037,0.065,,2
SATB1,CV_414.1 [Hypertrophic cardiomyopathy],0.07,0,0.0,0.0,0.0,0.0,0.0,0.0,0.158,2.791,1.929,0.127,0.157,0.344,3
GNB4,GE_972.1 [Hereditary neuropathy],0.07,0,0.0,0.0,0.0,0.0,0.0,0.691,0.09,,0.601,0.145,0.219,,2
MYOG,NS_323.3 [Motor neuron disease],0.07,0,0.0,0.0,0.0,0.0,0.435,0.0,0.065,,0.664,0.124,0.146,0.271,3
EDNRA,GU_580.51 [Focal and segmental glomerular lesions*],0.07,1,3.0,0.0,0.0,0.0,0.0,0.0,0.418,1.815,0.767,0.045,0.082,,2
CCND1,GE_961.1 [Phakomatoses],0.07,0,0.0,0.0,0.0,0.0,0.0,0.402,0.058,2.516,0.142,0.04,0.1,0.966,4
ADCY2,CV_414.1 [Hypertrophic cardiomyopathy],0.07,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,3.961,2.473,0.448,0.504,0.143,3
EGR3,CV_441 [Arteriovenous malformation],0.07,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.592,0.148,,0.093,0.243,2
BCL6,MS_727.5 [Cyst of bone],0.07,0,0.0,0.0,0.0,0.0,0.0,0.0,0.373,2.524,2.721,1.983,0.207,,2
TUBB2B,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.07,1,2.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.132,,,0.183,1
RBFOX2,CV_414.1 [Hypertrophic cardiomyopathy],0.07,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,,1.007,0.352,0.28,0.141,2
EPB42,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.07,0,0.0,0.0,0.547,0.0,0.265,0.0,0.047,,4.417,3.962,0.187,0.944,5
FURIN,NS_323.3 [Motor neuron disease],0.07,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,1.909,2.6,0.272,0.238,0.123,3
GABRQ,GE_961.1 [Phakomatoses],0.07,1,3.0,0.0,0.0,0.0,0.0,0.0,0.018,,3.396,,0.109,0.031,3
AVPR2,EM_209.12 [Syndrome of inappropriate secretion of antidiuretic hormone],0.07,1,4.0,0.0,0.0,0.0,0.0,0.0,0.102,,3.055,0.105,0.119,,2
CCND2,MS_727.5 [Cyst of bone],0.07,0,0.0,0.0,0.0,0.0,0.0,0.0,0.432,2.708,2.054,0.052,0.084,,2
KCNN4,GE_970.1 [Sickle-cell disorders],0.07,1,3.0,0.0,0.0,0.0,0.381,0.0,0.077,1.712,0.568,0.152,0.134,,3
GFAP,NS_341.1 [Cerebral palsy],0.07,0,0.0,0.0,0.426,0.0,0.0,0.0,0.034,1.886,0.386,0.147,0.12,0.99,4
TJP1,DE_663.2 [Pemphigoid],0.07,0,0.0,0.0,0.0,0.0,0.0,0.0,0.162,2.444,3.337,0.17,0.28,,2
AHR,GI_540.11 [Autoimmune hepatitis],0.07,0,0.0,0.0,0.0,0.0,0.0,0.0,0.209,2.366,0.476,0.168,0.178,,2
COL1A2,CV_438.41 [Aortic dissection],0.07,0,0.0,0.0,0.606,0.0,0.0,0.0,0.061,2.354,2.763,0.569,1.682,0.95,4
DMPK,GE_972.9 [Muscular dystrophy],0.07,0,0.0,0.0,0.426,0.0,0.385,0.0,0.03,,1.958,0.305,0.13,0.849,5
TP53,MS_727.3 [Osteitis deformans [Paget's disease of bone]],0.07,0,0.0,0.0,0.0,0.0,0.423,0.0,0.075,1.497,2.94,0.151,0.15,,3
DYNC2I2,GE_978.3 [Osteochondrodysplasias],0.07,0,0.0,0.0,0.0,0.0,0.0,0.84,0.064,,2.882,0.258,0.166,,3
LRP1B,MS_704.1 [Polyarteritis nodosa and related conditions],0.069,0,0.0,0.0,0.0,0.0,0.0,0.0,0.31,2.781,2.717,0.307,0.755,,2
MBTPS2,CM_770.5 [Congenital osteodystrophies],0.069,0,0.0,0.0,0.0,0.0,0.0,0.546,0.731,1.986,2.493,0.024,0.069,0.622,4
RPL7,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.069,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.68,2.229,,,0.155,2
PLIN2,SO_380.3 [Optic atrophy],0.069,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.034,3.366,0.303,0.117,0.967,2
ANGPT1,MS_712.51 [Hypermobility syndrome],0.069,0,0.0,0.0,0.0,0.0,0.0,0.0,0.116,1.783,3.242,0.203,0.191,,2
RUNX1,DE_663.1 [Pemphigus],0.069,0,0.0,0.0,0.0,0.0,0.0,0.0,0.07,2.652,0.122,0.16,0.131,,2
JAG1,EM_208.1 [Hypoparathyroidism],0.069,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,3.678,3.208,0.383,0.27,0.903,3
GSK3B,NS_344.2 [Benign intracranial hypertension],0.069,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.507,0.134,,0.089,0.982,2
TGFB1,CV_438.41 [Aortic dissection],0.069,0,0.0,0.0,0.58,0.0,0.0,0.0,0.128,,1.927,0.054,2.909,0.997,4
ELMO1,GU_580.1 [Acute nephritic syndrome],0.069,0,0.0,0.0,0.0,0.0,0.0,0.0,0.049,3.418,2.782,0.155,0.157,0.347,3
KIF5B,CV_433.3 [Cerebrovascular insufficiency],0.069,0,0.0,0.0,0.0,0.0,0.0,0.0,0.073,2.145,2.042,0.144,0.135,0.344,3
PPP2R2C,SO_369.62 [Keratoconus],0.069,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.932,0.17,,0.099,0.139,2
CUX1,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.069,0,0.0,0.0,0.0,0.0,0.0,0.0,0.134,2.808,2.121,0.385,0.392,0.517,3
GRIN2A,GE_972.2 [Hereditary ataxia],0.069,0,0.0,0.0,0.0,0.0,0.0,0.0,0.044,2.53,2.901,0.736,0.243,0.989,3
IL1B,GE_976.5 [Polycystic kidney disease],0.069,0,0.0,0.0,0.0,0.0,0.0,0.0,0.218,2.584,1.863,0.18,0.083,,2
CSF2,MS_700.3 [Systemic sclerosis],0.069,0,0.0,0.0,0.0,0.0,0.0,0.0,0.373,,2.63,0.088,0.04,,2
ARPC4,BI_179.1 [Hypogammaglobulinemia NOS],0.069,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.033,,,0.232,1
CD44,NS_344.2 [Benign intracranial hypertension],0.069,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.581,2.571,0.193,0.149,0.981,2
IGF1R,DE_663.2 [Pemphigoid],0.069,0,0.0,0.0,0.0,0.0,0.0,0.0,0.495,4.959,1.844,0.346,0.647,,2
ADCY1,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.069,0,0.0,0.0,0.0,0.0,0.0,0.0,0.079,2.193,2.858,0.065,0.136,0.149,3
HTT,GU_580.1 [Acute nephritic syndrome],0.069,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.458,4.56,2.46,0.397,0.595,3
CDK5,NS_340.3 [Inflammatory and immune myopathies],0.069,0,0.0,0.0,0.0,0.0,0.0,0.0,0.196,,0.064,0.032,2.988,,2
SCUBE1,"EM_209.11 [Tall stature, acromegaly and gigantism]",0.069,0,0.0,0.0,0.0,0.0,0.0,0.0,0.103,1.392,2.728,0.259,0.161,,2
IGF1R,DE_663.1 [Pemphigus],0.069,0,0.0,0.0,0.0,0.0,0.0,0.0,0.175,2.797,1.789,1.332,0.15,,2
ARHGEF12,CM_770.5 [Congenital osteodystrophies],0.069,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.199,2.653,0.16,0.169,0.286,3
GAD2,NS_339.2 [Myotonic disorders],0.069,0,0.0,0.0,0.0,0.0,0.0,0.0,0.391,1.312,0.776,0.166,0.065,,2
GRIN2A,MB_306 [Conduct disorders],0.069,1,4.0,0.0,0.0,0.0,0.0,0.0,0.049,3.405,3.951,0.184,0.138,,2
KCNQ3,NS_341.1 [Cerebral palsy],0.069,1,3.0,0.0,0.0,0.0,0.0,0.0,0.0,1.864,3.229,1.084,1.503,0.98,2
ITGAL,GE_978.3 [Osteochondrodysplasias],0.069,0,0.0,0.0,0.0,0.0,0.0,0.0,0.158,,2.247,0.14,0.153,,2
IGF1R,CM_770.5 [Congenital osteodystrophies],0.069,0,0.0,0.0,0.0,0.0,0.0,0.0,0.048,2.332,2.124,0.284,0.219,0.912,3
PITX2,CV_433.3 [Cerebrovascular insufficiency],0.069,0,0.0,0.0,0.0,0.609,0.0,0.0,0.028,3.377,2.072,0.12,0.097,0.824,3
RPL26,GE_972.2 [Hereditary ataxia],0.069,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.059,,,0.333,1
COL1A2,MS_700.3 [Systemic sclerosis],0.069,0,0.0,0.0,0.0,0.0,0.0,0.0,0.19,1.546,2.943,0.386,0.286,,2
PPARGC1A,GU_580.52 [Diffuse membranous glomerulonephritis],0.069,0,0.0,0.0,0.0,0.0,0.0,0.0,0.172,3.567,1.147,0.214,2.608,,2
GSK3B,MS_700.3 [Systemic sclerosis],0.069,0,0.0,0.0,0.0,0.0,0.0,0.0,0.151,2.729,2.046,,0.117,,2
FAM111A,CM_770.5 [Congenital osteodystrophies],0.069,0,0.0,0.0,0.0,0.0,0.0,0.772,0.067,,2.437,0.448,0.107,0.273,4
RPL30,GE_972.9 [Muscular dystrophy],0.069,1,4.0,0.0,0.0,0.0,0.0,0.0,0.03,,0.061,0.025,0.031,0.288,2
AR,DE_663.1 [Pemphigus],0.069,0,0.0,0.0,0.0,0.0,0.0,0.0,0.132,2.616,1.878,,0.011,,2
SLC44A1,GI_540.11 [Autoimmune hepatitis],0.069,0,0.0,0.0,0.0,0.0,0.0,0.0,0.15,1.702,3.211,0.25,0.198,,2
CTDSPL,CM_763.13 [Patent ductus arteriosus],0.069,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.101,0.041,0.024,0.313,1
XPO5,GU_580.1 [Acute nephritic syndrome],0.069,0,0.0,0.0,0.701,0.0,0.0,0.0,0.043,,2.506,0.174,0.152,0.165,4
COL5A2,MS_712.51 [Hypermobility syndrome],0.069,0,0.0,0.0,0.0,0.0,0.0,0.783,0.232,3.081,3.308,0.822,0.173,,3
RPSA,CV_438.41 [Aortic dissection],0.069,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.879,0.17,,,0.172,2
DMP1,CM_770.5 [Congenital osteodystrophies],0.069,0,0.0,0.0,0.0,0.0,0.385,0.402,0.03,,1.985,0.2,0.102,0.923,5
BRCA2,BI_162.1 [Constitutional (hereditary) aplastic anemia],0.069,0,0.0,0.0,0.0,0.0,0.0,0.631,0.293,1.469,3.027,0.147,0.154,,3
ABCA1,GI_542.8 [Biliary cirrhosis],0.069,0,0.0,0.0,0.0,0.0,0.0,0.0,0.106,1.986,2.922,0.145,0.505,,2
KDELR2,GE_978.3 [Osteochondrodysplasias],0.069,0,0.0,0.0,0.0,0.0,0.0,0.402,0.074,1.39,0.111,0.158,2.005,,3
CNGA1,SO_386.6 [Night blindness],0.069,0,0.0,0.0,0.0,0.0,0.348,0.0,0.035,2.669,2.809,3.361,0.129,1.0,4
IL6ST,GE_972.9 [Muscular dystrophy],0.069,0,0.0,0.033,0.0,0.0,0.0,0.0,0.024,1.869,0.451,0.153,0.095,0.298,4
ATM,GI_516.1 [Pyloric stenosis],0.069,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.884,2.675,0.6,1.193,0.975,2
TUBB2A,CM_750.16 [Arnold-Chiari syndrome*],0.069,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.025,,,0.215,1
FBP1,GE_964.3 [Glycogen storage disease],0.069,0,0.0,0.0,0.0,0.0,0.408,0.547,0.024,2.67,3.409,1.295,0.14,,4
OGDH,GE_972.9 [Muscular dystrophy],0.069,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,1.846,2.197,0.158,0.161,0.26,3
FMR1,GI_516.1 [Pyloric stenosis],0.069,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.939,3.555,0.372,0.183,0.986,2
IL2RA,MS_705.2 [Juvenile rheumatoid arthritis [JRA/JIA]],0.069,0,0.0,0.0,0.182,0.598,0.0,0.0,0.202,3.494,1.558,0.025,0.032,,3
HMGCR,GE_973.5 [Huntington's disease],0.069,0,0.0,0.0,0.0,0.0,0.0,0.0,0.183,1.757,1.916,0.14,0.084,,2
RUNX2,GE_978.3 [Osteochondrodysplasias],0.069,0,0.0,0.0,0.0,0.0,0.329,0.0,0.06,2.142,0.388,0.162,0.143,,3
NAMPT,SO_365.3 [Exophthalmos [Proptosis]],0.069,0,0.0,0.0,0.0,0.0,0.0,0.0,0.135,1.945,1.987,0.098,0.119,0.573,3
PEX2,SO_386.6 [Night blindness],0.069,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.65,3.413,1.973,0.092,0.948,2
HK1,GE_963.1 [Lipid storage disorders],0.069,0,0.0,0.0,0.0,0.0,0.293,0.0,0.068,3.198,1.593,0.143,0.134,0.584,4
PTGER1,CM_763.13 [Patent ductus arteriosus],0.069,1,4.0,0.0,0.0,0.0,0.0,0.0,0.036,1.479,1.315,0.043,3.032,0.108,3
CISD2,GE_972.9 [Muscular dystrophy],0.069,0,0.0,0.0,0.0,0.0,0.27,0.0,0.0,,0.055,0.036,0.026,0.209,2
UBA52,RE_484.1 [Spontaneous pneumothorax],0.069,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.098,,,0.333,1
RPS10,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.069,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.037,,,0.252,1
ACER3,GE_963.1 [Lipid storage disorders],0.069,0,0.0,0.0,0.684,0.0,0.0,0.402,0.063,2.836,0.181,0.05,0.053,0.034,4
SLC39A7,BI_179.1 [Hypogammaglobulinemia NOS],0.069,0,0.0,0.0,0.828,0.0,0.0,0.553,0.012,,2.859,0.176,1.67,0.399,4
CAMK2D,MS_704.1 [Polyarteritis nodosa and related conditions],0.069,0,0.0,0.0,0.0,0.0,0.0,0.0,0.071,2.837,1.683,0.113,0.12,,2
PAK1,GE_972.2 [Hereditary ataxia],0.069,0,0.0,0.076,0.684,0.0,0.0,0.0,0.109,3.694,0.569,0.054,0.135,0.889,5
NOTCH4,MS_700.3 [Systemic sclerosis],0.069,0,0.0,0.0,0.0,0.405,0.0,0.0,0.362,5.36,2.843,0.651,0.119,,2
GATA3,DE_663.1 [Pemphigus],0.069,0,0.0,0.0,0.0,0.0,0.0,0.0,0.103,2.649,0.136,0.131,0.062,,2
ALAD,GE_966.2 [Disorders of porphyrin metabolism],0.069,1,4.0,0.0,0.0,0.0,0.0,0.004,0.049,,0.095,0.097,0.044,,2
FOXO1,CV_414.1 [Hypertrophic cardiomyopathy],0.069,0,0.0,0.0,0.0,0.0,0.0,0.0,0.036,2.101,2.622,2.578,0.168,0.713,3
ALKBH5,CM_751.213 [Congenital cataract],0.069,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.18,,,0.218,1
IL1B,GI_542.8 [Biliary cirrhosis],0.069,0,0.0,0.0,0.0,0.0,0.0,0.0,0.19,1.417,0.193,0.176,2.096,,2
TUBA1A,EM_209.4 [Diabetes insipidus],0.069,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.098,,0.021,0.285,1
SSBP3,BI_179.1 [Hypogammaglobulinemia NOS],0.069,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.953,2.582,,,0.203,2
GGNBP2,CM_750.16 [Arnold-Chiari syndrome*],0.069,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.13,0.045,0.011,0.222,1
HK1,GI_540.11 [Autoimmune hepatitis],0.069,0,0.0,0.0,0.0,0.0,0.0,0.0,0.085,1.845,0.215,0.255,0.881,,2
TNF,CM_770.5 [Congenital osteodystrophies],0.069,0,0.0,0.0,0.0,0.0,0.297,0.0,0.152,,0.2,0.197,0.036,0.988,3
BRCA1,SO_365.3 [Exophthalmos [Proptosis]],0.069,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.141,2.593,0.923,0.391,0.992,2
EBP,CM_770.5 [Congenital osteodystrophies],0.069,0,0.0,0.0,0.0,0.0,0.0,0.905,0.044,,0.282,0.117,0.04,0.328,3
VWF,MS_704.3 [Thrombotic microangiopathy],0.069,1,4.0,0.0,0.0,0.0,0.0,0.0,0.108,2.515,2.684,0.527,0.111,,2
JAG1,CV_441 [Arteriovenous malformation],0.069,0,0.0,0.0,0.0,0.0,0.0,0.0,0.043,2.328,3.394,0.354,0.279,0.995,3
RPS26,GE_972.2 [Hereditary ataxia],0.069,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.226,0.087,0.028,,0.315,2
TSC1,CM_770.5 [Congenital osteodystrophies],0.069,0,0.0,0.0,0.0,0.0,0.329,0.0,0.012,1.974,4.297,0.165,0.161,0.889,4
YPEL5,CM_750.16 [Arnold-Chiari syndrome*],0.069,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.079,0.018,,,0.176,2
FOXO3,GI_542.8 [Biliary cirrhosis],0.069,0,0.0,0.0,0.0,0.0,0.0,0.0,0.202,1.763,2.667,0.821,0.161,,2
HLA-DQA1,EM_209.4 [Diabetes insipidus],0.069,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,3.284,0.091,0.038,0.965,2
DRD1,GE_973.5 [Huntington's disease],0.069,0,0.0,0.0,0.0,0.0,0.0,0.0,0.736,2.547,0.156,0.045,0.044,,2
TMEM67,SO_386.6 [Night blindness],0.069,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.926,1.205,0.493,0.228,0.967,2
DRD3,"MB_280.4 [Sedative, hypnotic, or anxiolytic related disorders]",0.069,1,4.0,0.0,0.0,0.0,0.0,0.0,0.11,1.814,0.191,0.161,1.621,,2
PEX1,NS_341.1 [Cerebral palsy],0.069,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.858,3.085,0.295,0.444,0.992,2
HTR2A,MB_293.1 [Anorexia nervosa],0.069,1,4.0,0.0,0.0,0.0,0.0,0.0,0.081,3.181,2.827,0.127,0.117,,2
SRC,"MB_280.4 [Sedative, hypnotic, or anxiolytic related disorders]",0.069,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,1.983,0.091,0.089,0.126,,2
ATL1,NS_341.1 [Cerebral palsy],0.069,0,0.0,0.0,0.894,0.0,0.0,0.434,0.061,,3.013,0.045,0.089,1.0,4
RPL36,CM_770.5 [Congenital osteodystrophies],0.069,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.215,0.032,,0.218,1
MSTO1,GE_972.2 [Hereditary ataxia],0.069,0,0.0,0.0,0.854,0.0,0.0,0.0,0.17,,2.985,0.646,0.155,0.756,4
DCLK1,GI_540.11 [Autoimmune hepatitis],0.069,0,0.0,0.0,0.0,0.0,0.0,0.0,0.041,2.191,0.309,0.167,0.158,,2
CALM3,GU_580.1 [Acute nephritic syndrome],0.069,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.386,0.071,,,0.179,2
SIAH1,GE_972.9 [Muscular dystrophy],0.069,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,3.323,,,0.302,2
PRKCE,GE_973.5 [Huntington's disease],0.069,0,0.0,0.0,0.0,0.0,0.0,0.0,0.221,3.905,2.819,2.76,0.04,,2
CACNA1A,GE_972.1 [Hereditary neuropathy],0.069,1,3.0,0.0,0.0,0.0,0.261,0.0,0.041,4.137,2.504,0.153,0.131,,3
FBXW7,MS_727.5 [Cyst of bone],0.069,0,0.0,0.0,0.0,0.0,0.0,0.0,0.529,2.267,2.153,0.147,0.141,,2
MT-ND5,CV_414.1 [Hypertrophic cardiomyopathy],0.069,0,0.0,0.0,0.0,0.0,0.0,0.362,0.092,,,,,,2
KEAP1,CM_770.5 [Congenital osteodystrophies],0.069,0,0.0,0.0,0.0,0.0,0.0,0.0,0.101,,1.822,0.102,0.123,0.755,3
GPAA1,GE_972.2 [Hereditary ataxia],0.069,0,0.0,0.0,0.684,0.0,0.0,0.0,0.076,1.412,2.875,0.464,0.256,0.566,4
RPS3A,EM_208.1 [Hypoparathyroidism],0.069,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.69,0.324,,0.02,0.296,2
MBNL1,NS_328.13 [Frontotemporal dementia [FTD]],0.069,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,1.994,0.228,0.092,0.131,,2
GNGT2,SO_386.6 [Night blindness],0.069,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.781,0.038,,0.075,0.97,2
GABRA2,MB_306 [Conduct disorders],0.069,1,2.0,0.0,0.0,0.0,0.0,0.0,0.101,3.201,2.885,,0.072,,2
HSPB1,NS_341.1 [Cerebral palsy],0.069,0,0.0,0.0,0.547,0.0,0.0,0.0,0.012,,3.161,0.229,0.088,0.868,4
SUMO2,SO_386.5 [Color vision deficiencies],0.069,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.049,,,0.325,1
KEAP1,GE_978.3 [Osteochondrodysplasias],0.069,0,0.0,0.0,0.0,0.0,0.0,0.0,0.17,,2.091,0.094,0.112,,2
PYCR2,NS_341.1 [Cerebral palsy],0.069,0,0.0,0.0,0.547,0.0,0.0,0.0,0.012,1.373,0.231,0.14,0.118,0.868,4
PARP1,NS_344.2 [Benign intracranial hypertension],0.069,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.988,1.577,0.41,0.18,0.984,2
BCL2,CM_770.5 [Congenital osteodystrophies],0.069,0,0.0,0.0,0.0,0.0,0.0,0.0,0.085,1.949,0.109,0.036,0.071,0.973,3
NF1,GE_978.3 [Osteochondrodysplasias],0.069,0,0.0,0.0,0.0,0.0,0.378,0.0,0.072,2.236,2.734,0.283,0.287,,3
HIF1A,GE_976.5 [Polycystic kidney disease],0.069,0,0.0,0.0,0.0,0.0,0.0,0.0,0.107,1.943,1.879,0.359,0.211,,2
RPGRIP1L,SO_369.62 [Keratoconus],0.069,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,3.41,0.91,0.333,0.983,2
KDR,GE_975.2 [Hereditary hemorrhagic telangiectasia],0.069,1,2.0,0.0,0.0,0.0,0.0,0.0,0.102,2.768,3.421,1.222,0.173,,2
BANF1,CM_763.31 [Ventricular septal defect],0.069,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.572,0.079,,,0.329,2
NR3C1,RE_477.2 [Hypersensitivity pneumonitis],0.069,1,4.0,0.0,0.0,0.0,0.0,0.0,0.024,2.878,2.273,0.189,0.154,,2
PTEN,CM_763.31 [Ventricular septal defect],0.069,0,0.0,0.0,0.547,0.0,0.0,0.0,0.0,1.731,2.818,,2.095,0.978,3
KCNQ2,NS_328.13 [Frontotemporal dementia [FTD]],0.069,0,0.0,0.012,0.0,0.0,0.0,0.0,0.036,2.078,3.668,2.924,0.16,,3
HNRNPC,CV_441 [Arteriovenous malformation],0.069,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.102,,,0.169,1
TP53,GE_963.1 [Lipid storage disorders],0.069,0,0.0,0.0,0.0,0.0,0.299,0.0,0.048,1.964,0.109,0.08,0.093,0.95,4
SCN4A,GE_964.3 [Glycogen storage disease],0.069,1,1.0,0.0,0.0,0.0,0.423,0.0,0.03,,2.669,0.326,0.316,,3
TNF,MS_700.42 [Dermatomyositis],0.069,1,2.0,0.0,0.0,0.0,0.0,0.0,0.518,,0.709,0.143,0.037,,1
AR,SO_369.62 [Keratoconus],0.069,0,0.0,0.0,0.0,0.0,0.0,0.0,0.064,1.992,3.45,,0.014,0.598,3
HNF1A,GE_964.3 [Glycogen storage disease],0.069,0,0.0,0.0,0.0,0.0,0.386,0.0,0.044,,2.111,0.291,0.137,,3
ALKBH5,NS_344.2 [Benign intracranial hypertension],0.069,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.153,,,0.2,1
MSTN,NS_340.3 [Inflammatory and immune myopathies],0.069,1,2.0,0.0,0.0,0.0,0.551,0.0,0.152,,0.191,0.218,0.04,,2
BBS9,SO_369.62 [Keratoconus],0.069,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.426,3.023,0.588,0.301,0.985,2
APP,NS_344.13 [(Idiopathic) normal pressure hydrocephalus],0.069,0,0.0,0.0,0.0,0.0,0.0,0.0,0.113,2.446,0.229,0.456,0.188,,2
DCDC2,MB_303.1 [Dyslexia and alexia],0.069,0,0.0,0.0,0.0,0.0,0.0,0.495,0.188,1.945,0.084,0.116,0.093,,3
UBE2N,GE_963.1 [Lipid storage disorders],0.069,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,1.353,0.061,,,0.288,3
RPS23,EM_208.1 [Hypoparathyroidism],0.069,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.954,0.098,,,0.33,2
GUCY2D,SO_369.62 [Keratoconus],0.069,0,0.0,0.0,0.0,0.0,0.0,0.0,0.015,,2.178,0.231,0.392,1.0,3
OLFM1,NS_333.4 [Circadian rhythm sleep disorder],0.069,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,1.797,0.093,0.088,0.105,0.31,3
PLA2R1,GU_580.52 [Diffuse membranous glomerulonephritis],0.069,0,0.0,0.0,0.0,0.724,0.0,0.0,0.471,1.93,3.519,0.651,0.213,,2
SPTB,GE_963.1 [Lipid storage disorders],0.069,0,0.0,0.0,0.0,0.0,0.282,0.0,0.024,1.684,3.298,0.294,0.21,0.233,4
ROM1,SO_369.62 [Keratoconus],0.069,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,1.969,0.372,0.141,0.997,2
DNAJB2,NS_323.3 [Motor neuron disease],0.069,0,0.0,0.0,0.547,0.0,0.0,0.704,0.026,,3.048,2.033,0.17,0.465,4
MYO9A,GU_580.1 [Acute nephritic syndrome],0.069,0,0.0,0.0,0.701,0.0,0.0,0.0,0.018,,2.891,0.427,0.177,0.185,4
IL6ST,MS_700.3 [Systemic sclerosis],0.069,0,0.0,0.0,0.0,0.0,0.0,0.0,0.231,2.041,2.536,0.401,0.163,,2
RPS26,GE_961.1 [Phakomatoses],0.069,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.077,0.037,,0.123,1
UBE2D3,SO_369.62 [Keratoconus],0.069,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.069,,,0.163,1
GRM1,GE_973.5 [Huntington's disease],0.069,0,0.0,0.0,0.0,0.0,0.0,0.0,0.221,1.997,1.903,0.135,0.078,,2
RPL17,CV_441 [Arteriovenous malformation],0.069,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.179,,,0.276,1
PPARD,CV_433.3 [Cerebrovascular insufficiency],0.068,0,0.0,0.0,0.304,0.0,0.0,0.0,0.105,,1.976,0.101,1.611,0.765,4
SOX6,CM_770.5 [Congenital osteodystrophies],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,3.152,2.115,0.736,0.197,0.92,3
PRDX2,GE_970.2 [Thalassemia],0.068,0,0.0,0.0,0.0,0.0,0.372,0.0,0.041,,1.012,0.169,0.251,,2
UBE2E3,GU_580.1 [Acute nephritic syndrome],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.977,0.075,,,0.141,2
MAK,SO_369.62 [Keratoconus],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,1.923,0.182,0.238,0.992,2
DRD1,MB_305.1 [Tics and tic disorders],0.068,1,4.0,0.0,0.0,0.0,0.0,0.0,0.22,1.646,1.635,0.084,0.065,,2
MTOR,MS_700.43 [Polymyositis],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.061,2.5,1.664,0.194,0.147,,2
PTPRC,CM_770.5 [Congenital osteodystrophies],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.101,2.765,2.872,0.118,0.075,0.846,3
MEIS2,GE_964.3 [Glycogen storage disease],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.061,2.891,0.405,0.096,0.111,,2
ITCH,GE_977.6 [Congenital cutaneous mastocytosis*],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.052,1.983,0.164,0.041,0.068,,2
BCL2L2-PABPN1,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.063,,0.022,0.308,1
BACE1,GE_978.22 [Ehler's Danlos syndrome],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.462,,0.242,0.123,0.093,,1
MARK2,GU_580.1 [Acute nephritic syndrome],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.021,1.796,0.47,0.116,1.757,0.224,3
RRAGB,GE_963.1 [Lipid storage disorders],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.752,0.078,,1.977,0.046,2
TOPORS,SO_369.62 [Keratoconus],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.621,2.979,0.127,0.163,0.988,2
CFH,GE_972.1 [Hereditary neuropathy],0.068,0,0.0,0.0,0.0,0.0,0.29,0.0,0.185,2.517,2.679,0.055,0.103,,3
BRSK1,GU_580.52 [Diffuse membranous glomerulonephritis],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.091,3.309,2.073,0.067,0.114,,2
SERPINF1,CM_770.5 [Congenital osteodystrophies],0.068,0,0.0,0.0,0.0,0.0,0.0,0.733,0.32,,2.92,0.31,0.127,0.701,4
SRGAP3,GE_972.2 [Hereditary ataxia],0.068,0,0.0,0.125,0.0,0.0,0.0,0.0,0.018,1.907,2.707,0.541,0.254,0.429,4
NDUFS2,GE_972.2 [Hereditary ataxia],0.068,1,4.0,0.0,0.0,0.0,0.0,0.0,0.03,,2.62,0.241,0.17,0.992,3
YPEL5,GE_963.1 [Lipid storage disorders],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.115,0.034,,,0.16,2
TNFSF11,GE_970.2 [Thalassemia],0.068,0,0.0,0.0,0.0,0.0,0.287,0.0,0.058,2.782,1.407,0.142,0.154,,3
HIF1A,NS_341.1 [Cerebral palsy],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.191,2.622,1.267,1.052,1.893,0.942,3
RTN2,NS_341.1 [Cerebral palsy],0.068,0,0.0,0.0,0.0,0.0,0.0,0.693,0.061,,3.477,0.185,0.139,0.997,4
TEAD1,GE_972.9 [Muscular dystrophy],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.044,2.546,0.243,0.073,0.087,0.475,3
F9,BI_168.12 [Hemorrhagic disorder due to intrinsic circulating anticoagulants],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.067,1.949,3.183,,2.555,,2
FOXH1,CM_763.31 [Ventricular septal defect],0.068,0,0.0,0.0,0.684,0.0,0.0,0.0,0.185,,0.164,0.15,0.115,0.702,3
MSH2,BI_179.7 [Common variable immunodeficiency [CVID]],0.068,0,0.0,0.0,0.0,0.0,0.419,0.0,0.078,,2.06,1.517,0.097,,3
TUBB2A,CV_413.41 [Pulmonary valve stenosis],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.004,0.029,,,0.292,2
TNFRSF1A,GI_542.8 [Biliary cirrhosis],0.068,0,0.0,0.0,0.0,0.484,0.0,0.0,0.065,1.888,2.183,0.092,0.048,,2
B3GALNT2,GE_972.9 [Muscular dystrophy],0.068,0,0.0,0.0,0.836,0.0,0.0,0.0,0.064,1.774,3.343,0.28,0.14,0.974,4
TUBA1B,CM_751.213 [Congenital cataract],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.195,,,0.269,1
DNMT3A,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.574,3.137,3.343,3.126,0.905,2
ARPC4,CM_763.13 [Patent ductus arteriosus],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.017,,,0.306,1
PDZD7,SO_369.62 [Keratoconus],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.21,0.472,0.717,0.962,2
IFT74,SO_369.62 [Keratoconus],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.757,2.689,0.263,0.211,0.902,2
FST,GE_964.3 [Glycogen storage disease],0.068,1,0.5,0.0,0.0,0.0,0.0,0.0,0.056,2.998,1.802,0.087,0.081,,2
DRD1,"MB_280.4 [Sedative, hypnotic, or anxiolytic related disorders]",0.068,1,2.0,0.0,0.0,0.0,0.0,0.0,0.067,2.263,0.329,0.127,0.09,,2
YWHAE,GE_977.1 [Congenital ichthyosis],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.064,,0.007,0.291,1
ALB,GI_540.4 [Alcoholic hepatitis],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.313,,2.34,0.2,0.156,,2
INSR,GU_580.1 [Acute nephritic syndrome],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.13,3.111,3.215,0.197,0.136,0.913,3
GABRA2,MS_704.9 [Allergic purpura [Henoch-Schoenlein purpura]],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.505,0.106,,0.119,,1
DEPDC5,GI_540.11 [Autoimmune hepatitis],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.203,,2.864,0.425,0.238,,2
REL,MS_727.5 [Cyst of bone],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.639,,3.121,0.212,0.197,,2
FANCM,CV_441 [Arteriovenous malformation],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,3.078,1.504,0.108,0.991,2
DNM1,CV_414.1 [Hypertrophic cardiomyopathy],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.103,,3.324,1.32,0.593,0.143,3
BCL2,GI_542.8 [Biliary cirrhosis],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.297,2.642,0.155,0.035,0.082,,2
KRT18,GE_964.3 [Glycogen storage disease],0.068,0,0.0,0.0,0.0,0.0,0.271,0.0,0.092,,2.192,0.102,0.049,,3
NPHS2,GU_580.51 [Focal and segmental glomerular lesions*],0.068,0,0.0,0.0,0.0,0.0,0.599,0.509,0.481,,1.798,0.317,0.087,,4
PTPRC,BI_179.1 [Hypogammaglobulinemia NOS],0.068,0,0.0,0.0,0.304,0.0,0.0,0.0,0.018,1.998,3.5,0.079,0.096,0.993,4
RPS10,RE_484.1 [Spontaneous pneumothorax],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.04,,,0.268,1
TMPO,CV_414.1 [Hypertrophic cardiomyopathy],0.068,0,0.0,0.0,0.732,0.0,0.0,0.088,0.015,3.411,2.516,1.761,0.208,0.856,4
DYNC2H1,GE_978.3 [Osteochondrodysplasias],0.068,0,0.0,0.0,0.0,0.0,0.0,0.901,0.054,3.374,4.388,1.97,0.337,,3
AAK1,NS_323.3 [Motor neuron disease],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.033,,2.293,0.696,0.46,0.116,3
PTGS2,GE_970.1 [Sickle-cell disorders],0.068,1,4.0,0.0,0.0,0.0,0.0,0.0,0.018,2.275,0.064,0.036,0.071,,2
CUX1,MS_700.3 [Systemic sclerosis],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.637,2.797,3.351,0.539,0.132,,2
NR3C1,GU_580.51 [Focal and segmental glomerular lesions*],0.068,1,3.0,0.0,0.0,0.0,0.0,0.0,0.021,2.821,0.282,0.102,0.078,,2
INS,GI_516.1 [Pyloric stenosis],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.113,,0.084,0.973,1
GSK3B,MB_302.1 [Speech and language developmental delay],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.434,0.156,,0.088,0.993,2
CD40LG,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.097,3.079,0.178,,0.075,0.799,3
MYPN,CV_414.1 [Hypertrophic cardiomyopathy],0.068,0,0.0,0.0,0.866,0.0,0.698,0.472,0.11,1.433,3.03,0.412,0.008,0.935,5
POLR2H,RE_484.1 [Spontaneous pneumothorax],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.568,0.076,,0.111,0.13,2
NDUFA10,CM_763.31 [Ventricular septal defect],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.838,2.895,0.288,0.144,0.955,2
EDNRB,GE_973.5 [Huntington's disease],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.189,2.509,0.223,0.05,0.053,,2
PSMC4,RE_488.8 [Obesity hypoventilation syndrome [OHS]],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.69,0.08,,0.121,,1
GATA2,GE_973.5 [Huntington's disease],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.07,2.065,0.12,0.093,0.052,,2
HTR2C,GE_973.5 [Huntington's disease],0.068,1,3.0,0.0,0.0,0.0,0.0,0.0,0.125,3.443,0.137,,0.044,,2
FNIP1,RE_484.1 [Spontaneous pneumothorax],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.736,2.534,,0.09,0.188,2
CSNK2A1,NS_323.3 [Motor neuron disease],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,1.814,0.203,0.134,0.123,0.194,3
ETS1,GU_580.1 [Acute nephritic syndrome],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.043,2.235,2.245,0.077,0.109,0.902,3
TUBB2A,RE_484.1 [Spontaneous pneumothorax],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.757,0.066,,,0.08,2
DNMT3B,BI_179.1 [Hypogammaglobulinemia NOS],0.068,0,0.0,0.0,0.684,0.0,0.0,0.0,0.12,1.88,3.194,0.167,0.164,0.705,4
MDH2,CV_414.1 [Hypertrophic cardiomyopathy],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,1.938,0.152,0.219,0.988,2
SOD2,CV_414.1 [Hypertrophic cardiomyopathy],0.068,0,0.0,0.0,0.0,0.0,0.503,0.0,0.065,,1.987,0.949,1.727,0.999,4
OXT,MB_301.2 [Asperger's syndrome*],0.068,0,0.0,0.0,0.0,0.0,0.365,0.0,0.103,,0.106,0.074,0.091,,2
GSK3A,NS_323.3 [Motor neuron disease],0.068,1,2.0,0.0,0.0,0.0,0.0,0.0,0.024,,0.385,0.049,0.169,0.299,2
RPL23,BI_179.1 [Hypogammaglobulinemia NOS],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.196,,0.025,0.287,1
AVPR2,GU_580.1 [Acute nephritic syndrome],0.068,1,4.0,0.0,0.0,0.0,0.0,0.0,0.039,1.448,4.375,0.04,0.05,0.13,3
NLRP3,NS_343.3 [Complex regional pain syndrome],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.102,2.128,2.28,0.156,0.184,,2
IL7R,GI_542.8 [Biliary cirrhosis],0.068,0,0.0,0.0,0.0,0.596,0.0,0.0,0.088,2.354,1.481,0.684,0.145,,2
WDR26,CM_763.13 [Patent ductus arteriosus],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.78,,0.022,0.314,1
UBE2L3,CM_750.16 [Arnold-Chiari syndrome*],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.645,0.039,,,0.129,2
PIK3R5,GE_961.1 [Phakomatoses],0.068,1,1.0,0.0,0.0,0.0,0.0,0.0,0.03,,0.907,0.357,0.2,0.237,2
HIF1A,CM_770.5 [Congenital osteodystrophies],0.068,0,0.0,0.0,0.0,0.0,0.0,0.403,0.088,2.662,3.934,1.304,0.136,0.98,4
STH,GE_973.5 [Huntington's disease],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.064,,3.251,0.013,0.022,,2
TUBB2A,SO_369.62 [Keratoconus],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.217,0.048,,,0.273,2
SIAH1,EM_208.1 [Hypoparathyroidism],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.171,0.06,,,0.142,2
GAP43,GE_972.1 [Hereditary neuropathy],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.107,2.594,1.857,0.331,0.12,,2
USH2A,GE_972.2 [Hereditary ataxia],0.068,0,0.0,0.0,0.0,0.0,0.0,0.45,0.0,2.816,3.718,0.471,0.719,0.969,3
HLA-DQA1,GI_542.8 [Biliary cirrhosis],0.068,0,0.0,0.0,0.0,0.071,0.0,0.0,0.201,11.332,2.885,0.17,0.071,,2
STAT4,DE_669.2 [Behcet's syndrome],0.068,0,0.0,0.0,0.0,0.602,0.0,0.0,0.158,2.096,0.559,0.194,0.085,,2
PDE6H,SO_386.5 [Color vision deficiencies],0.068,0,0.0,0.0,0.745,0.0,0.0,0.695,0.063,1.415,0.051,0.091,0.05,0.995,4
SCN4A,GE_972.1 [Hereditary neuropathy],0.068,1,4.0,0.0,0.0,0.0,0.356,0.0,0.027,,2.943,0.746,1.251,,3
FN1,CV_433.3 [Cerebrovascular insufficiency],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.062,1.959,2.758,1.04,0.435,0.987,3
DCLK1,GE_961.1 [Phakomatoses],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.072,2.05,2.702,0.188,0.133,0.37,3
RPL32,SO_380.3 [Optic atrophy],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.159,,,0.326,1
SOD1,GE_972.2 [Hereditary ataxia],0.068,0,0.0,0.0,0.547,0.0,0.276,0.0,0.081,,2.808,2.634,0.098,0.99,5
B4GAT1,GE_972.9 [Muscular dystrophy],0.068,0,0.0,0.0,0.779,0.0,0.264,0.0,0.044,,0.192,0.062,0.075,,3
ISY1-RAB43,CM_770.5 [Congenital osteodystrophies],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.036,,,0.236,1
MT-CO2,SO_380.3 [Optic atrophy],0.068,0,0.0,0.0,0.0,0.0,0.0,0.121,0.012,,,,,,2
FURIN,EM_249.1 [Cerebral amyloid angiopathy*],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.049,2.432,2.112,0.129,0.135,,2
TJP1,EM_249.1 [Cerebral amyloid angiopathy*],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.08,1.887,3.593,0.202,0.677,,2
FN1,SO_369.62 [Keratoconus],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.168,1.579,2.757,0.675,0.615,0.617,3
FAM111A,GE_978.3 [Osteochondrodysplasias],0.068,0,0.0,0.0,0.0,0.0,0.0,0.772,0.067,,2.555,0.69,0.096,,3
FLVCR1,GE_972.2 [Hereditary ataxia],0.068,0,0.0,0.0,0.0,0.0,0.0,0.828,0.051,2.227,1.048,0.24,2.114,0.342,4
F2,GE_970.1 [Sickle-cell disorders],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.119,3.248,1.585,0.044,0.07,,2
RPS3A,CM_750.16 [Arnold-Chiari syndrome*],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.326,0.116,,0.011,0.297,2
ARFGEF2,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.027,1.984,3.242,0.87,0.357,0.089,3
ANGPT1,GU_580.1 [Acute nephritic syndrome],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.091,2.312,2.313,0.124,0.158,0.772,3
FGG,CV_433.3 [Cerebrovascular insufficiency],0.068,1,3.0,0.0,0.0,0.508,0.0,0.0,0.012,,2.612,0.394,0.112,0.435,3
COL27A1,MB_305.1 [Tics and tic disorders],0.068,0,0.0,0.0,0.0,0.482,0.0,0.0,0.109,2.068,4.339,0.034,0.066,,2
GRIA1,GE_973.5 [Huntington's disease],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.338,2.16,2.744,0.129,2.331,,2
GUCY2D,SO_386.6 [Night blindness],0.068,0,0.0,0.0,0.836,0.0,0.0,0.37,0.024,,3.06,0.528,0.218,1.0,4
NUTF2,CM_763.31 [Ventricular septal defect],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.119,,0.019,0.311,1
NAMPT,MS_704.9 [Allergic purpura [Henoch-Schoenlein purpura]],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.122,1.988,2.276,0.068,0.079,,2
SPIN1,RE_484.1 [Spontaneous pneumothorax],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.472,0.088,0.048,,0.14,2
KCNH2,CV_416.8 [Pre-excitation syndrome [Anomalous atrioventricular excitation]],0.068,1,4.0,0.0,0.0,0.0,0.414,0.151,0.0,,3.405,1.736,0.164,0.49,4
KPNB1,RE_484.1 [Spontaneous pneumothorax],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.677,,,0.226,2
FLT4,CV_441 [Arteriovenous malformation],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.021,1.948,2.526,0.039,0.085,0.988,3
PON2,NS_323.3 [Motor neuron disease],0.068,0,0.0,0.0,0.701,0.0,0.0,0.402,0.033,2.667,1.897,0.158,0.224,0.859,4
CCR5,GU_580.1 [Acute nephritic syndrome],0.068,1,1.0,0.0,0.304,0.0,0.0,0.0,0.08,,2.755,0.233,0.09,0.963,4
RPS12,NS_333.4 [Circadian rhythm sleep disorder],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.147,,0.025,0.321,1
FFAR4,GE_964.3 [Glycogen storage disease],0.068,0,0.0,0.0,0.0,0.0,0.413,0.0,0.061,3.615,3.295,2.913,0.097,,3
PDE6D,SO_369.62 [Keratoconus],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.608,0.524,,0.124,0.99,2
HMGA1,CM_751.213 [Congenital cataract],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.852,0.044,,,0.276,2
FANCA,CV_441 [Arteriovenous malformation],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.622,3.379,0.805,0.055,0.993,2
SNRPD2,CM_750.16 [Arnold-Chiari syndrome*],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.042,,,0.27,1
CFL1,EM_209.4 [Diabetes insipidus],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.046,,,0.272,1
ARPC4,CV_433.3 [Cerebrovascular insufficiency],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.045,,,0.274,1
PYGM,GE_972.9 [Muscular dystrophy],0.068,0,0.0,0.0,0.816,0.0,0.308,0.0,0.046,,0.633,0.226,2.357,0.847,5
AGTR1,EM_209.4 [Diabetes insipidus],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.937,3.629,0.358,1.678,0.913,2
DOT1L,DE_663.1 [Pemphigus],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.152,,3.517,2.968,1.927,,2
PPARD,GE_972.9 [Muscular dystrophy],0.068,1,1.0,0.0,0.0,0.0,0.0,0.0,0.132,,0.152,0.088,2.003,0.478,3
CRYBB3,CM_751.213 [Congenital cataract],0.068,0,0.0,0.0,0.426,0.0,0.0,0.826,0.048,1.345,2.413,0.923,0.103,0.99,4
SGMS1,CM_763.31 [Ventricular septal defect],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.658,2.806,,0.032,0.207,2
NDUFS1,GE_963.1 [Lipid storage disorders],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.033,2.631,0.56,0.312,0.165,0.997,3
LAMP1,NS_328.13 [Frontotemporal dementia [FTD]],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.208,,2.562,0.164,0.122,,2
SYVN1,GE_972.9 [Muscular dystrophy],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.122,,0.149,0.214,0.133,0.545,2
ESR2,"EM_209.11 [Tall stature, acromegaly and gigantism]",0.068,0,0.0,0.0,0.0,0.0,0.36,0.0,0.094,1.946,2.86,0.649,0.119,,3
USP24,NS_333.4 [Circadian rhythm sleep disorder],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.723,3.507,,0.074,0.184,2
GNAS,CV_433.3 [Cerebrovascular insufficiency],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.061,2.341,0.222,0.082,0.086,0.84,3
KCNK9,CV_433.3 [Cerebrovascular insufficiency],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.036,2.654,0.085,0.033,0.056,0.17,3
YPEL5,CM_763.13 [Patent ductus arteriosus],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.02,,,0.231,1
ZFR,GE_972.2 [Hereditary ataxia],0.068,0,0.0,0.0,0.0,0.0,0.0,0.129,0.046,2.209,1.599,0.181,0.168,0.388,4
HSPB1,GE_972.1 [Hereditary neuropathy],0.068,0,0.0,0.0,0.0,0.0,0.0,0.824,0.108,,1.978,0.412,0.143,,3
KAT5,GE_973.5 [Huntington's disease],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.618,,0.048,0.029,0.061,,1
SKP1,SO_369.62 [Keratoconus],0.068,0,0.0,0.0,0.0,0.0,0.0,0.121,0.061,2.475,0.135,0.138,0.012,0.262,4
FGFR2,GE_977.6 [Congenital cutaneous mastocytosis*],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.065,2.869,0.389,0.093,2.275,,2
ZC3H13,GE_961.1 [Phakomatoses],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.271,3.563,0.271,0.401,0.19,3
S1PR1,GE_972.1 [Hereditary neuropathy],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.052,2.984,1.857,0.087,0.098,,2
KRAS,CV_414.1 [Hypertrophic cardiomyopathy],0.068,0,0.0,0.0,0.426,0.0,0.654,0.121,0.0,2.239,3.444,,2.397,0.961,4
HECTD1,CV_433.3 [Cerebrovascular insufficiency],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.127,2.4,2.123,0.093,0.071,0.09,3
DRD1,CV_433.3 [Cerebrovascular insufficiency],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.024,2.23,3.353,3.116,0.086,0.253,3
RREB1,GU_580.1 [Acute nephritic syndrome],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,1.954,3.58,0.679,0.284,0.213,3
IL22,BI_179.1 [Hypogammaglobulinemia NOS],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,1.427,0.034,0.048,0.964,2
ANKRD1,CV_414.1 [Hypertrophic cardiomyopathy],0.068,0,0.0,0.0,0.84,0.0,0.0,0.174,0.2,1.701,2.084,0.404,0.24,0.918,4
SPTBN2,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.068,0,0.0,0.0,0.0,0.0,0.291,0.0,0.015,,2.832,0.699,0.972,0.169,4
RASA1,GE_961.1 [Phakomatoses],0.068,0,0.0,0.0,0.0,0.0,0.0,0.869,0.039,2.465,3.685,1.44,0.184,0.783,4
CCL5,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.068,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,3.38,0.061,0.055,0.985,2
UBE2L3,SO_365.3 [Exophthalmos [Proptosis]],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.805,0.097,,,0.331,2
IL12B,MS_705.2 [Juvenile rheumatoid arthritis [JRA/JIA]],0.067,1,3.0,0.0,0.0,0.43,0.0,0.0,0.584,1.473,2.135,0.05,0.051,,2
SNRPE,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.33,0.061,,,0.197,2
SH3TC2,GE_972.1 [Hereditary neuropathy],0.067,0,0.0,0.0,0.0,0.0,0.286,0.347,0.093,1.643,3.233,0.608,0.333,,4
CD226,GI_542.8 [Biliary cirrhosis],0.067,0,0.0,0.0,0.0,0.657,0.0,0.0,0.641,1.924,1.904,,0.108,,2
HLA-DRA,NS_328.13 [Frontotemporal dementia [FTD]],0.067,0,0.0,0.0,0.0,0.279,0.0,0.0,0.071,,0.383,0.066,0.059,,2
CFL1,GE_963.1 [Lipid storage disorders],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.04,,,0.242,1
GRID1,GE_972.2 [Hereditary ataxia],0.067,0,0.0,0.0,0.0,0.0,0.277,0.0,0.03,2.941,2.638,0.364,0.224,0.959,4
DRD2,CV_433.3 [Cerebrovascular insufficiency],0.067,1,2.0,0.0,0.0,0.0,0.0,0.0,0.104,1.89,0.595,0.304,0.097,0.39,3
CCND1,CV_433.3 [Cerebrovascular insufficiency],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.073,2.806,0.104,0.035,0.066,0.964,3
KMT2C,CV_414.1 [Hypertrophic cardiomyopathy],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.131,4.467,3.719,2.344,2.214,0.499,3
IDH2,CM_770.5 [Congenital osteodystrophies],0.067,0,0.0,0.0,0.0,0.0,0.275,0.442,0.106,,0.141,0.095,0.164,0.853,4
AGFG1,CM_770.5 [Congenital osteodystrophies],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,1.99,1.886,0.137,0.104,0.12,3
RPS10-NUDT3,BI_179.1 [Hypogammaglobulinemia NOS],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.148,0.018,0.024,0.282,1
EGFR,NS_333.4 [Circadian rhythm sleep disorder],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.069,3.202,3.058,2.74,0.228,0.992,3
HEXB,GE_963.1 [Lipid storage disorders],0.067,1,2.0,0.0,0.0,0.0,0.26,0.909,0.076,3.328,3.229,0.075,0.06,0.698,5
PATL1,GI_540.11 [Autoimmune hepatitis],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,2.059,5.975,5.283,0.154,,2
MFN2,GE_972.2 [Hereditary ataxia],0.067,0,0.0,0.0,0.426,0.0,0.0,0.29,0.065,2.216,2.786,0.48,0.165,0.981,4
OGA,GE_976.5 [Polycystic kidney disease],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,2.007,1.573,0.1,0.168,,2
XRCC5,CV_414.1 [Hypertrophic cardiomyopathy],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.122,2.201,2.115,0.266,0.192,0.859,3
CP,DE_663.2 [Pemphigoid],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.191,,2.555,0.17,0.097,,2
UBE2R2,CM_763.13 [Patent ductus arteriosus],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.04,0.031,0.012,0.284,1
JAZF1,MS_705.2 [Juvenile rheumatoid arthritis [JRA/JIA]],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.103,2.052,0.233,0.037,0.051,,2
SLC1A2,"MB_280.4 [Sedative, hypnotic, or anxiolytic related disorders]",0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.182,1.909,2.04,0.177,0.1,,2
PAX8,GU_580.51 [Focal and segmental glomerular lesions*],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.069,2.706,0.158,0.129,0.118,,2
ARID1B,GE_978.3 [Osteochondrodysplasias],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.195,3.906,3.642,0.315,0.57,,2
EYS,SO_386.6 [Night blindness],0.067,0,0.0,0.0,0.654,0.0,0.0,0.0,0.042,2.881,3.8,0.41,0.606,1.0,4
FOXO1,GE_976.5 [Polycystic kidney disease],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.015,4.246,2.274,0.047,0.161,,2
ADM,EM_211.1 [Adrenal hyperfunction],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.106,2.273,1.752,0.048,0.063,,2
AR,"MB_280.4 [Sedative, hypnotic, or anxiolytic related disorders]",0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.091,3.153,1.731,,0.016,,2
TNF,GE_970.2 [Thalassemia],0.067,0,0.0,0.0,0.0,0.0,0.341,0.0,0.082,,1.708,0.178,0.07,,3
ISY1-RAB43,SO_369.62 [Keratoconus],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.055,,,0.157,1
ADRB1,DE_663.2 [Pemphigoid],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.109,,3.749,0.048,0.06,,2
HIF1A,NS_333.4 [Circadian rhythm sleep disorder],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.058,1.91,1.826,0.23,0.125,0.986,3
SEMA4D,GE_973.5 [Huntington's disease],0.067,1,2.0,0.0,0.0,0.0,0.0,0.0,0.502,1.98,3.544,3.074,0.058,,2
KDR,MS_705.2 [Juvenile rheumatoid arthritis [JRA/JIA]],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.238,3.819,1.952,0.3,0.135,,2
COL4A1,SO_380.3 [Optic atrophy],0.067,0,0.0,0.0,0.0,0.0,0.0,0.416,0.018,2.311,2.722,1.066,0.525,0.797,4
TBX5,BI_162.1 [Constitutional (hereditary) aplastic anemia],0.067,0,0.0,0.0,0.0,0.0,0.365,0.0,0.033,1.936,0.208,0.066,0.063,,3
MTOR,GE_976.5 [Polycystic kidney disease],0.067,1,0.5,0.0,0.0,0.0,0.0,0.0,0.306,2.357,2.345,0.525,0.202,,2
VCAN,CM_770.5 [Congenital osteodystrophies],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.027,2.133,3.973,0.507,0.259,0.865,3
F9,GE_961.1 [Phakomatoses],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.924,1.07,,0.062,0.108,3
CD86,GI_542.8 [Biliary cirrhosis],0.067,1,4.0,0.0,0.0,0.0,0.0,0.0,0.314,1.47,1.402,0.119,2.101,,2
GRN,MB_302.1 [Speech and language developmental delay],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.024,,2.468,0.22,0.169,0.936,3
PITPNM3,CV_441 [Arteriovenous malformation],0.067,0,0.0,0.0,0.0,0.0,0.0,0.37,0.012,,2.293,1.361,0.238,0.045,4
IRF5,GI_542.8 [Biliary cirrhosis],0.067,0,0.0,0.0,0.0,0.32,0.0,0.0,0.088,4.656,0.922,0.173,0.194,,2
DSTYK,NS_323.3 [Motor neuron disease],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,2.148,2.471,0.207,0.254,0.018,3
PRDM1,GE_972.1 [Hereditary neuropathy],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,2.84,2.007,0.143,0.216,,2
PRKCE,GE_972.2 [Hereditary ataxia],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.079,1.787,0.374,0.119,0.133,0.949,3
NR3C1,GE_973.5 [Huntington's disease],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.15,1.678,0.167,0.075,1.768,,2
CFL1,GE_977.1 [Congenital ichthyosis],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.033,,,0.247,1
ADRB1,NS_328.13 [Frontotemporal dementia [FTD]],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.091,2.303,2.411,0.049,0.059,,2
LRPPRC,GE_972.2 [Hereditary ataxia],0.067,0,0.0,0.015,0.0,0.0,0.0,0.0,0.0,2.594,3.36,0.387,0.38,0.964,3
CD14,BI_179.1 [Hypogammaglobulinemia NOS],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.374,1.672,0.114,0.074,0.953,2
NDUFB5,GE_963.1 [Lipid storage disorders],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.372,0.054,0.06,0.939,2
NEFH,NS_341.1 [Cerebral palsy],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.912,3.679,0.093,0.102,0.969,2
KCND2,GE_972.2 [Hereditary ataxia],0.067,1,2.0,0.125,0.0,0.0,0.0,0.0,0.0,3.433,2.183,0.035,0.138,0.958,3
FAT1,GE_972.2 [Hereditary ataxia],0.067,0,0.0,0.0,0.789,0.0,0.0,0.182,0.049,3.218,3.624,0.239,0.272,0.855,4
GLP1R,MB_293.2 [Bulimia nervosa],0.067,1,4.0,0.0,0.0,0.0,0.0,0.0,0.111,1.661,3.868,0.229,0.16,,2
GRIN1,"MB_280.4 [Sedative, hypnotic, or anxiolytic related disorders]",0.067,1,4.0,0.0,0.0,0.0,0.0,0.0,0.012,,0.137,0.058,0.12,,1
SOX6,GE_972.2 [Hereditary ataxia],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,2.876,2.352,0.611,0.265,0.428,3
GRN,GE_963.1 [Lipid storage disorders],0.067,0,0.0,0.0,0.0,0.0,0.0,0.798,0.142,4.229,2.268,0.117,0.099,0.425,4
ADRA2C,MB_302.1 [Speech and language developmental delay],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.413,2.652,,0.033,0.237,2
RPL18A,NS_333.4 [Circadian rhythm sleep disorder],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.198,,,0.259,1
ROCK1,MS_727.5 [Cyst of bone],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.091,1.604,2.646,0.362,0.256,,2
PRPF31,SO_380.3 [Optic atrophy],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.441,1.858,0.173,0.158,0.992,2
FLNA,CV_438.41 [Aortic dissection],0.067,0,0.0,0.0,0.547,0.0,0.0,0.0,0.012,,3.691,0.154,0.284,0.888,4
VCP,NS_323.3 [Motor neuron disease],0.067,0,0.0,0.0,0.886,0.0,0.337,0.785,0.081,,0.242,,0.134,0.999,4
FNDC3A,SO_369.62 [Keratoconus],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,2.404,2.822,0.347,0.187,0.083,3
VCAN,CV_438.41 [Aortic dissection],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.021,3.153,2.641,1.047,1.061,0.966,3
RPGRIP1,NS_341.1 [Cerebral palsy],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,1.76,0.34,0.231,0.984,2
CPM,RE_477.2 [Hypersensitivity pneumonitis],0.067,0,0.0,0.0,0.0,0.309,0.0,0.0,0.07,1.816,0.158,0.28,0.191,,2
AR,MS_704.1 [Polyarteritis nodosa and related conditions],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.082,1.87,3.869,,0.019,,2
CXCL12,NS_341.1 [Cerebral palsy],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.846,0.201,0.042,0.079,0.948,2
ROCK2,GU_580.52 [Diffuse membranous glomerulonephritis],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.426,1.82,2.727,0.227,0.106,,2
VEGFC,SO_386.5 [Color vision deficiencies],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.653,3.264,,0.019,0.219,2
ATM,CV_441 [Arteriovenous malformation],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.778,3.168,0.905,0.146,0.996,2
SPANXN3,SO_369.62 [Keratoconus],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.291,4.423,,0.022,0.125,2
TUBB4B,SO_386.5 [Color vision deficiencies],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,4.059,,0.021,0.226,2
FOXP3,MS_705.2 [Juvenile rheumatoid arthritis [JRA/JIA]],0.067,0,0.0,0.024,0.0,0.0,0.406,0.0,0.129,,3.765,0.048,0.035,,4
VEGFA,RE_484.1 [Spontaneous pneumothorax],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.126,1.829,2.927,2.997,0.15,0.87,3
HIF1A,MS_700.43 [Polymyositis],0.067,0,0.0,0.027,0.0,0.0,0.0,0.0,0.102,1.714,3.711,0.142,0.086,,3
ACLY,GE_963.1 [Lipid storage disorders],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.109,,2.763,0.295,0.116,0.484,3
TANC2,MB_302.1 [Speech and language developmental delay],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,3.108,2.805,1.857,0.232,0.267,3
TG,CM_772.2 [Congenital hypothyroidism],0.067,0,0.0,0.0,0.0,0.0,0.0,0.657,0.208,2.488,4.606,1.036,0.177,,3
BDNF,MS_712.51 [Hypermobility syndrome],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.689,2.388,1.278,1.243,0.161,,2
LGALS1,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.217,0.293,0.087,0.913,1
PCBP1,EM_209.4 [Diabetes insipidus],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.828,3.523,,,0.25,2
SMARCA4,GE_961.1 [Phakomatoses],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.027,1.715,3.015,0.197,0.207,0.96,3
SLC4A2,CM_770.5 [Congenital osteodystrophies],0.067,0,0.0,0.0,0.684,0.0,0.0,0.0,0.131,,3.794,1.647,0.2,0.795,4
MTA2,SO_386.5 [Color vision deficiencies],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.317,,1.107,0.082,0.12,0.256,2
ADAMTS13,MS_704.2 [Wegener's granulomatosis],0.067,0,0.0,0.0,0.0,0.0,0.0,0.925,0.153,,3.509,0.107,0.127,,3
ATF7IP,GE_973.5 [Huntington's disease],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.04,2.488,1.613,0.096,0.088,,2
PTPRC,GE_978.3 [Osteochondrodysplasias],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.116,2.243,2.963,0.082,0.068,,2
SHANK3,SO_386.5 [Color vision deficiencies],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,4.043,,0.015,0.238,2
GLUL,GE_972.2 [Hereditary ataxia],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,3.794,0.125,0.04,0.089,0.89,3
EZH2,CM_750.16 [Arnold-Chiari syndrome*],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.042,3.172,0.048,2.442,0.991,2
COL8A2,SO_369.62 [Keratoconus],0.067,0,0.0,0.0,0.0,0.0,0.553,0.0,0.103,1.432,3.597,0.333,0.196,0.415,4
DNMT3B,GE_972.9 [Muscular dystrophy],0.067,0,0.0,0.0,0.684,0.0,0.0,0.402,0.121,,2.4,0.12,0.14,0.662,4
PPME1,RE_484.1 [Spontaneous pneumothorax],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.153,0.106,,0.121,0.11,2
MARK2,DE_663.2 [Pemphigoid],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,1.986,0.44,0.106,0.139,,2
ANLN,GU_580.52 [Diffuse membranous glomerulonephritis],0.067,0,0.0,0.0,0.0,0.0,0.0,0.655,0.17,2.546,2.949,0.389,0.161,,3
NOVA1,GE_963.1 [Lipid storage disorders],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.152,2.871,0.138,0.038,0.058,0.081,3
FGFR1,DE_663.1 [Pemphigus],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.015,2.576,0.134,0.155,0.1,,2
EZH2,GE_972.9 [Muscular dystrophy],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.113,2.288,1.758,0.045,0.066,0.762,3
TLR8,SO_380.3 [Optic atrophy],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,3.918,,0.088,0.09,2
APC,GE_961.1 [Phakomatoses],0.067,0,0.0,0.0,0.0,0.0,0.444,0.0,0.027,,2.4,0.63,0.431,0.598,4
SLC1A2,NS_341.1 [Cerebral palsy],0.067,0,0.0,0.0,0.304,0.0,0.0,0.0,0.146,1.994,3.146,0.148,0.103,0.92,4
TAC1,MS_700.3 [Systemic sclerosis],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.118,3.022,0.189,0.152,0.137,,2
LMNA,GU_580.1 [Acute nephritic syndrome],0.067,0,0.0,0.0,0.772,0.0,0.0,0.0,0.015,1.428,2.738,0.185,0.134,0.828,4
SMAD6,CV_433.3 [Cerebrovascular insufficiency],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.887,2.925,0.217,0.297,0.914,2
WNT16,MS_727.3 [Osteitis deformans [Paget's disease of bone]],0.067,0,0.0,0.0,0.0,0.496,0.0,0.0,0.024,2.389,1.31,0.378,0.236,,2
GSK3B,GI_540.11 [Autoimmune hepatitis],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.15,2.384,0.198,,0.124,,2
ITGB1,MS_700.3 [Systemic sclerosis],0.067,1,2.0,0.0,0.0,0.0,0.0,0.0,0.076,1.544,2.082,0.096,0.193,,2
MAP3K5,GE_972.1 [Hereditary neuropathy],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.105,1.971,3.994,0.875,1.641,,2
EDNRB,MS_704.2 [Wegener's granulomatosis],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.091,1.977,0.176,0.083,0.099,,2
CYLC1,CM_751.213 [Congenital cataract],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.158,4.069,,0.03,0.083,2
PHGDH,NS_341.1 [Cerebral palsy],0.067,0,0.0,0.0,0.684,0.0,0.0,0.0,0.0,2.343,0.497,0.677,0.166,0.93,3
TCF4,NS_333.4 [Circadian rhythm sleep disorder],0.067,0,0.0,0.0,0.0,0.46,0.0,0.0,0.04,3.13,0.386,0.134,1.737,0.79,3
SUPT6H,CV_414.1 [Hypertrophic cardiomyopathy],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,,2.34,0.951,0.344,0.137,3
PITX2,NS_323.3 [Motor neuron disease],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.024,2.634,2.274,0.203,0.145,0.072,3
YME1L1,GE_978.22 [Ehler's Danlos syndrome],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.091,,0.139,0.097,0.1,,1
COX6A1,GE_972.2 [Hereditary ataxia],0.067,0,0.0,0.0,0.0,0.0,0.327,0.0,0.0,,2.525,0.179,0.054,0.966,3
NFATC1,CM_763.31 [Ventricular septal defect],0.067,0,0.0,0.0,0.0,0.0,0.333,0.0,0.187,3.523,2.942,0.8,0.174,0.825,4
MAPK8IP3,CV_414.1 [Hypertrophic cardiomyopathy],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.036,1.33,2.906,0.917,0.453,0.099,3
CACNA2D4,GE_972.2 [Hereditary ataxia],0.067,1,4.0,0.0,0.0,0.0,0.0,0.0,0.0,2.771,3.266,0.548,1.15,0.902,2
SP4,MS_700.43 [Polymyositis],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.248,3.021,1.805,0.053,0.078,,2
TTC21B,GU_580.51 [Focal and segmental glomerular lesions*],0.067,0,0.0,0.0,0.0,0.0,0.0,0.402,0.102,1.321,3.103,0.536,0.189,,3
LHX5,GE_972.2 [Hereditary ataxia],0.067,0,0.0,0.132,0.0,0.0,0.0,0.0,0.036,2.597,0.139,0.087,0.08,0.833,4
POLG,GE_972.9 [Muscular dystrophy],0.067,0,0.0,0.0,0.732,0.0,0.0,0.0,0.03,1.86,2.512,0.262,0.655,0.528,4
CPEB4,MB_302.1 [Speech and language developmental delay],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.402,2.86,0.162,0.128,0.248,3
BMPR2,MS_700.3 [Systemic sclerosis],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.657,1.468,1.913,1.157,0.202,,2
NFATC2,NS_333.7 [Narcolepsy],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.047,1.963,3.699,3.059,0.136,,2
PPARG,GU_580.52 [Diffuse membranous glomerulonephritis],0.067,1,1.0,0.0,0.0,0.0,0.0,0.0,0.023,2.559,0.071,0.083,0.087,,2
DAG1,GU_580.52 [Diffuse membranous glomerulonephritis],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.098,1.942,2.808,0.297,0.13,,2
DYNLL2,SO_386.6 [Night blindness],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.406,0.095,,,0.202,2
MYH9,CV_433.3 [Cerebrovascular insufficiency],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.255,2.508,2.006,1.848,0.265,0.836,3
OFD1,SO_369.62 [Keratoconus],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,3.173,2.402,1.489,0.984,2
EPC1,GE_964.3 [Glycogen storage disease],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.071,2.524,1.046,0.21,0.166,,2
BRCA1,NS_341.1 [Cerebral palsy],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,3.89,1.288,0.235,0.985,2
TUBB2A,GE_972.1 [Hereditary neuropathy],0.067,1,4.0,0.0,0.0,0.0,0.0,0.0,0.086,2.082,0.063,,,,2
SLC40A1,CV_414.1 [Hypertrophic cardiomyopathy],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,1.905,2.436,1.931,0.219,0.137,3
AMPD2,GE_972.2 [Hereditary ataxia],0.067,0,0.0,0.0,0.426,0.0,0.0,0.621,0.044,,2.443,0.312,0.27,0.62,4
DCLK1,GE_972.2 [Hereditary ataxia],0.067,0,0.0,0.113,0.0,0.0,0.0,0.0,0.098,1.905,2.927,1.32,0.149,0.591,4
NUBPL,GE_972.2 [Hereditary ataxia],0.067,0,0.0,0.0,0.547,0.0,0.0,0.0,0.038,1.91,2.826,0.485,0.149,0.964,4
KCNJ13,SO_369.62 [Keratoconus],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.187,0.292,0.113,0.976,1
FN1,GE_972.9 [Muscular dystrophy],0.067,0,0.0,0.026,0.0,0.0,0.0,0.0,0.071,2.485,2.807,0.699,0.346,0.955,4
CTF1,NS_323.3 [Motor neuron disease],0.067,1,0.5,0.0,0.0,0.0,0.384,0.0,0.079,,1.74,0.182,0.132,0.032,4
AHR,GE_966.2 [Disorders of porphyrin metabolism],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.082,2.835,0.303,0.062,0.062,,2
NFASC,GE_961.1 [Phakomatoses],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.042,1.704,3.111,0.724,0.278,0.135,3
CP,MS_712.51 [Hypermobility syndrome],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.186,1.456,2.939,0.183,0.143,,2
ST14,GE_977.1 [Congenital ichthyosis],0.067,0,0.0,0.0,0.0,0.0,0.457,0.775,0.071,2.412,1.99,0.012,0.048,0.995,5
EBF1,CM_770.5 [Congenital osteodystrophies],0.067,0,0.0,0.0,0.0,0.0,0.296,0.0,0.012,2.253,0.173,0.105,0.091,0.501,4
GRIN2B,NS_328.13 [Frontotemporal dementia [FTD]],0.067,1,4.0,0.0,0.0,0.0,0.0,0.0,0.012,2.848,1.134,,,,2
FLT4,CV_414.1 [Hypertrophic cardiomyopathy],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.033,2.875,2.81,0.055,0.089,0.343,3
CACNA1E,CM_770.5 [Congenital osteodystrophies],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.24,2.52,3.832,0.105,0.184,0.245,3
PLD3,GE_972.2 [Hereditary ataxia],0.067,0,0.0,0.0,0.547,0.0,0.0,0.522,0.033,,1.635,0.242,0.19,0.639,4
RPL30,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.104,0.028,0.022,0.24,1
DICER1,GU_580.1 [Acute nephritic syndrome],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.033,2.215,2.45,0.142,0.89,0.784,3
MYCN,CV_433.3 [Cerebrovascular insufficiency],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.116,2.309,1.991,0.163,0.064,0.924,3
HDAC5,GE_976.5 [Polycystic kidney disease],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.167,1.498,2.678,0.144,0.235,,2
NAMPT,GE_964.3 [Glycogen storage disease],0.067,0,0.0,0.0,0.0,0.0,0.353,0.0,0.041,2.331,1.106,0.06,0.063,,3
CDH11,MS_700.3 [Systemic sclerosis],0.067,1,2.0,0.0,0.0,0.0,0.0,0.0,0.277,2.884,2.874,0.709,0.24,,2
PRKCE,CV_433.3 [Cerebrovascular insufficiency],0.067,1,0.5,0.0,0.0,0.0,0.0,0.0,0.152,4.18,1.022,0.077,0.104,0.673,3
KLHL24,CV_414.1 [Hypertrophic cardiomyopathy],0.067,0,0.0,0.0,0.745,0.0,0.0,0.233,0.134,3.26,2.61,1.264,0.452,0.053,4
SNRNP70,MS_700.3 [Systemic sclerosis],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.228,,2.745,0.099,0.123,,2
RRAGB,EM_209.4 [Diabetes insipidus],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.628,4.308,,0.063,0.167,2
HIF1A,CV_416.8 [Pre-excitation syndrome [Anomalous atrioventricular excitation]],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.761,1.82,0.279,0.163,0.969,2
DNMT1,GI_540.11 [Autoimmune hepatitis],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.103,1.835,2.9,0.238,0.22,,2
COL11A1,GE_963.1 [Lipid storage disorders],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,2.01,2.86,0.8,0.209,0.125,3
GABRB3,"MB_280.4 [Sedative, hypnotic, or anxiolytic related disorders]",0.067,1,4.0,0.0,0.0,0.0,0.0,0.0,0.036,1.985,0.129,0.039,0.064,,2
FLT1,CV_433.3 [Cerebrovascular insufficiency],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.048,2.435,2.199,0.382,0.226,0.941,3
ATM,BI_179.1 [Hypogammaglobulinemia NOS],0.067,0,0.0,0.0,0.522,0.0,0.0,0.0,0.048,,2.927,0.75,0.812,0.995,4
SOS1,NS_344.11 [Communicating hydrocephalus],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.036,2.789,0.313,0.097,0.109,,2
LYN,GU_580.1 [Acute nephritic syndrome],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.033,1.971,0.965,0.029,0.081,0.961,3
TMEM38B,CM_770.5 [Congenital osteodystrophies],0.067,0,0.0,0.0,0.0,0.0,0.0,0.693,0.198,2.838,2.703,0.14,0.11,0.46,4
PMPCA,SO_380.3 [Optic atrophy],0.067,0,0.0,0.0,0.779,0.0,0.0,0.452,0.061,,2.19,0.294,0.183,0.771,4
OR4M2,GE_970.2 [Thalassemia],0.067,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.084,,0.195,,0
COL9A3,CM_770.5 [Congenital osteodystrophies],0.067,0,0.0,0.0,0.865,0.0,0.0,0.495,0.06,,3.201,0.104,0.964,0.672,4
JPH3,NS_323.3 [Motor neuron disease],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.445,2.317,0.799,0.309,0.121,3
SMOC2,CM_770.5 [Congenital osteodystrophies],0.066,0,0.0,0.0,0.547,0.0,0.0,0.0,0.029,3.098,2.609,0.21,0.148,0.477,4
MERTK,SO_369.62 [Keratoconus],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.581,3.294,0.189,0.13,1.0,2
PKHD1,GU_580.1 [Acute nephritic syndrome],0.066,0,0.0,0.0,0.848,0.0,0.571,0.485,0.058,3.064,3.185,0.665,0.395,0.333,5
LRP8,GE_972.2 [Hereditary ataxia],0.066,0,0.0,0.119,0.0,0.0,0.267,0.0,0.108,2.172,4.049,1.785,0.114,0.778,5
DROSHA,GE_975.2 [Hereditary hemorrhagic telangiectasia],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.187,2.194,2.637,0.458,0.161,,2
CRB2,GU_580.52 [Diffuse membranous glomerulonephritis],0.066,0,0.0,0.0,0.0,0.0,0.0,0.802,0.314,4.723,3.358,0.542,0.165,,3
PDE6A,SO_386.5 [Color vision deficiencies],0.066,0,0.0,0.0,0.0,0.0,0.411,0.0,0.037,1.948,2.225,0.126,0.147,0.999,4
WNT5A,CM_770.5 [Congenital osteodystrophies],0.066,0,0.0,0.0,0.0,0.0,0.296,0.0,0.061,1.941,0.092,0.104,0.097,0.912,4
MT-CO1,NS_341.1 [Cerebral palsy],0.066,0,0.0,0.0,0.0,0.0,0.0,0.37,0.018,,,,,,2
VEGFA,EM_209.13 [Hyperprolactinemia*],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.15,2.112,1.981,0.169,0.117,,2
KIF5B,NS_323.3 [Motor neuron disease],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.017,1.78,2.529,0.247,0.28,0.384,3
CHD7,MS_700.3 [Systemic sclerosis],0.066,0,0.0,0.0,0.0,0.457,0.0,0.0,0.024,1.896,2.264,0.464,0.332,,2
DDI2,CM_750.16 [Arnold-Chiari syndrome*],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.176,,,0.197,1
EBF2,GE_972.1 [Hereditary neuropathy],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.033,2.527,0.497,0.145,0.164,,2
FN1,MS_712.51 [Hypermobility syndrome],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.196,2.588,3.687,0.692,1.417,,2
SPIN1,GU_580.1 [Acute nephritic syndrome],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.13,0.069,0.038,,0.086,2
MYOD1,EM_208.1 [Hypoparathyroidism],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.46,0.569,0.343,0.197,0.941,2
PHC3,GE_961.1 [Phakomatoses],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,2.242,2.581,0.234,0.23,0.089,3
COL6A3,GE_972.1 [Hereditary neuropathy],0.066,0,0.0,0.0,0.0,0.0,0.394,0.0,0.03,3.093,2.822,0.801,0.144,,3
NBN,BI_179.1 [Hypogammaglobulinemia NOS],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.353,0.471,0.15,0.961,2
CDK8,GE_972.2 [Hereditary ataxia],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.443,0.106,0.091,0.099,0.436,3
SMAD3,GI_540.11 [Autoimmune hepatitis],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.051,1.991,0.072,0.06,0.08,,2
FBN2,GE_978.21 [Marfan syndrome],0.066,0,0.0,0.0,0.0,0.0,0.0,0.336,0.143,2.604,3.505,0.491,0.664,,3
BECN1,CV_433.3 [Cerebrovascular insufficiency],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.197,,1.471,0.236,0.129,0.741,3
HNRNPC,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.251,0.093,,,0.156,2
RAD51B,GI_542.8 [Biliary cirrhosis],0.066,0,0.0,0.0,0.0,0.576,0.0,0.0,0.015,1.939,2.158,0.301,0.179,,2
KIF1C,GE_972.2 [Hereditary ataxia],0.066,0,0.0,0.0,0.868,0.0,0.0,0.339,0.1,2.476,3.195,0.128,0.152,0.687,4
EYA1,GU_580.52 [Diffuse membranous glomerulonephritis],0.066,0,0.0,0.0,0.0,0.0,0.0,0.281,0.03,2.093,1.439,0.159,0.12,,3
H6PD,NS_323.3 [Motor neuron disease],0.066,0,0.0,0.0,0.0,0.0,0.317,0.0,0.015,4.313,2.526,0.423,0.361,0.002,4
NR3C1,MB_293.1 [Anorexia nervosa],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.153,2.901,3.294,0.198,0.129,,2
BBS12,SO_380.3 [Optic atrophy],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,3.376,1.762,0.13,0.967,2
ABCB1,NS_323.3 [Motor neuron disease],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.118,,2.766,0.191,0.436,0.178,3
CDK5,GE_972.2 [Hereditary ataxia],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.036,,0.123,0.095,0.107,0.92,2
PITX2,CV_416.8 [Pre-excitation syndrome [Anomalous atrioventricular excitation]],0.066,0,0.0,0.0,0.426,0.0,0.467,0.121,0.0,3.158,1.377,0.152,0.113,0.267,4
SMARCA2,GE_972.2 [Hereditary ataxia],0.066,0,0.0,0.03,0.0,0.0,0.0,0.0,0.024,2.865,2.434,0.41,0.474,0.825,4
DYNC2I1,GE_978.3 [Osteochondrodysplasias],0.066,0,0.0,0.0,0.0,0.0,0.0,0.766,0.074,2.975,3.186,0.385,0.156,,3
CBLL1,GE_961.1 [Phakomatoses],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.615,2.24,0.111,0.125,0.068,3
MT-CO1,GU_580.51 [Focal and segmental glomerular lesions*],0.066,0,0.0,0.0,0.0,0.0,0.0,0.362,0.018,,,,,,2
MT-CO1,GU_580.52 [Diffuse membranous glomerulonephritis],0.066,0,0.0,0.0,0.0,0.0,0.0,0.362,0.018,,,,,,2
SUV39H2,MS_704.9 [Allergic purpura [Henoch-Schoenlein purpura]],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,3.702,0.102,,0.086,,2
GNAS,"MB_280.4 [Sedative, hypnotic, or anxiolytic related disorders]",0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.061,2.415,0.125,0.097,0.071,,2
CD40LG,MS_704.2 [Wegener's granulomatosis],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.071,1.979,2.41,,0.029,,2
RPS23,SO_386.5 [Color vision deficiencies],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.23,0.05,,,0.162,2
SND1,GU_580.1 [Acute nephritic syndrome],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.134,1.964,1.763,0.258,0.204,0.239,3
LASP1,GI_540.11 [Autoimmune hepatitis],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.091,2.05,0.229,0.077,0.07,,2
ABCA1,GU_580.51 [Focal and segmental glomerular lesions*],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.133,2.801,4.095,0.789,0.775,,2
RPS10,SO_380.3 [Optic atrophy],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.031,,,0.279,1
CRYGD,CM_751.213 [Congenital cataract],0.066,0,0.0,0.0,0.825,0.0,0.901,0.453,0.065,,2.076,1.159,0.097,0.993,5
IL1B,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.159,2.098,0.124,0.123,0.053,0.968,3
RYK,NS_323.3 [Motor neuron disease],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.064,3.22,2.903,,0.086,0.087,3
WNT5A,CM_751.213 [Congenital cataract],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.036,3.482,0.108,0.103,0.12,0.561,3
MSH3,NS_344.2 [Benign intracranial hypertension],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.022,2.366,0.348,0.585,0.975,2
TLL1,CV_414.1 [Hypertrophic cardiomyopathy],0.066,0,0.0,0.0,0.0,0.0,0.466,0.0,0.0,4.028,1.868,,0.14,0.153,3
GSK3B,DE_663.2 [Pemphigoid],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.118,2.29,0.168,,0.097,,2
BCORL1,CV_441 [Arteriovenous malformation],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.377,3.845,,0.069,0.126,2
CNTN1,GU_580.1 [Acute nephritic syndrome],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,3.054,1.461,0.319,0.221,0.179,3
AIDA,NS_344.2 [Benign intracranial hypertension],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.115,0.104,,0.098,0.065,2
NOS1,GE_972.9 [Muscular dystrophy],0.066,0,0.0,0.042,0.0,0.0,0.0,0.0,0.086,4.262,2.151,0.31,0.953,0.82,4
LYN,BI_179.1 [Hypogammaglobulinemia NOS],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,1.917,2.707,0.035,0.085,0.957,3
SEC61A1,CV_414.1 [Hypertrophic cardiomyopathy],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.049,1.356,0.195,0.065,1.566,0.084,3
NT5C2,GE_972.2 [Hereditary ataxia],0.066,0,0.0,0.0,0.0,0.0,0.0,0.751,0.079,,2.753,0.068,0.207,0.562,4
B3GALT6,CM_770.5 [Congenital osteodystrophies],0.066,0,0.0,0.0,0.547,0.0,0.0,0.29,0.044,,2.455,0.116,0.061,0.554,4
GSDMB,GI_542.8 [Biliary cirrhosis],0.066,0,0.0,0.0,0.0,0.27,0.0,0.0,0.088,4.948,2.574,0.25,0.1,,2
GRM1,NS_323.3 [Motor neuron disease],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.082,2.526,0.731,0.544,0.289,0.17,3
RXRA,CV_414.1 [Hypertrophic cardiomyopathy],0.066,0,0.0,0.0,0.0,0.0,0.584,0.0,0.093,3.036,3.056,1.828,0.128,0.63,4
TCF12,GE_977.6 [Congenital cutaneous mastocytosis*],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.067,2.843,0.089,0.152,0.091,,2
MITF,CM_770.5 [Congenital osteodystrophies],0.066,0,0.0,0.0,0.732,0.0,0.309,0.0,0.08,1.636,2.99,0.274,0.139,0.93,5
XIRP1,GE_972.9 [Muscular dystrophy],0.066,0,0.0,0.0,0.0,0.0,0.394,0.0,0.017,,2.646,0.952,0.164,0.325,4
SNAI2,GE_972.9 [Muscular dystrophy],0.066,0,0.0,0.062,0.0,0.0,0.0,0.0,0.03,1.658,0.074,,0.049,0.268,4
ILF3,NS_339.2 [Myotonic disorders],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.024,2.337,0.327,0.097,0.091,,2
SYNE1,NS_339.2 [Myotonic disorders],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.164,3.118,3.849,0.681,1.793,,2
ATP6V1H,MS_727.3 [Osteitis deformans [Paget's disease of bone]],0.066,0,0.0,0.0,0.0,0.0,0.419,0.0,0.024,,0.298,0.199,0.244,,2
JAG1,GE_978.3 [Osteochondrodysplasias],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.099,2.576,1.876,0.185,1.664,,2
TFAP2A,CM_751.213 [Congenital cataract],0.066,0,0.0,0.0,0.0,0.0,0.287,0.0,0.036,3.325,0.1,0.076,0.111,0.759,4
PALB2,BI_162.1 [Constitutional (hereditary) aplastic anemia],0.066,0,0.0,0.0,0.0,0.0,0.0,0.704,0.202,,1.951,0.093,0.126,,3
LGI1,GE_973.5 [Huntington's disease],0.066,0,0.0,0.0,0.0,0.0,0.252,0.0,0.061,1.947,0.072,0.055,0.06,,3
KIT,CV_414.1 [Hypertrophic cardiomyopathy],0.066,1,0.5,0.0,0.0,0.0,0.0,0.0,0.618,1.829,1.462,0.353,0.547,0.807,3
FGFR1,DE_663.2 [Pemphigoid],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.177,2.534,2.213,0.915,1.382,,2
NOVA1,CV_433.3 [Cerebrovascular insufficiency],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.146,2.168,0.104,0.065,0.096,0.168,3
RNF220,GE_963.1 [Lipid storage disorders],0.066,0,0.0,0.0,0.684,0.0,0.0,0.402,0.334,2.59,0.268,0.106,0.09,0.119,4
AHI1,GE_972.2 [Hereditary ataxia],0.066,0,0.0,0.107,0.0,0.0,0.0,0.0,0.036,2.603,4.074,0.437,0.306,0.995,4
MT-CO3,GE_972.2 [Hereditary ataxia],0.066,0,0.0,0.0,0.0,0.0,0.0,0.129,0.021,,,,,,2
SDF2,GE_972.9 [Muscular dystrophy],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.214,0.134,0.084,1.0,1
FOXG1,GE_977.1 [Congenital ichthyosis],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.427,0.118,,,0.185,2
ESR1,EM_209.13 [Hyperprolactinemia*],0.066,1,4.0,0.0,0.0,0.0,0.511,0.0,0.031,2.329,0.893,0.598,0.117,,3
CSNK1A1,CV_441 [Arteriovenous malformation],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.205,,,0.29,1
RPL26,GE_963.1 [Lipid storage disorders],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.03,,,0.325,1
HIF1A,MS_712.51 [Hypermobility syndrome],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.109,2.33,1.972,0.338,0.255,,2
PML,GI_542.8 [Biliary cirrhosis],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.794,1.861,1.413,0.085,0.128,,2
ACVR1B,DE_663.1 [Pemphigus],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.061,2.272,0.056,0.038,0.06,,2
VAV1,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,,3.29,2.667,1.566,0.95,3
ATP2B4,GE_961.1 [Phakomatoses],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,1.585,2.875,0.206,0.16,0.207,3
CRTC1,GE_972.2 [Hereditary ataxia],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.144,1.889,0.566,0.187,0.117,0.549,3
CBL,BI_179.1 [Hypogammaglobulinemia NOS],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.081,0.206,0.184,0.98,2
GCLC,GE_961.1 [Phakomatoses],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.164,1.791,2.967,0.174,0.146,0.428,3
SYK,MS_700.3 [Systemic sclerosis],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.042,2.791,1.747,0.247,0.156,,2
RPS10,GE_961.1 [Phakomatoses],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.027,,,0.277,1
CD19,MS_700.3 [Systemic sclerosis],0.066,1,3.0,0.0,0.0,0.0,0.0,0.0,0.463,,2.372,0.231,0.118,,2
IGF2BP2,MS_705.2 [Juvenile rheumatoid arthritis [JRA/JIA]],0.066,0,0.0,0.08,0.0,0.0,0.0,0.0,0.03,1.908,0.086,0.077,0.089,,3
ROCK2,MS_700.3 [Systemic sclerosis],0.066,1,2.0,0.0,0.0,0.0,0.0,0.0,0.029,2.516,2.114,0.135,0.207,,2
PPIP5K2,SO_369.62 [Keratoconus],0.066,0,0.0,0.0,0.532,0.0,0.0,0.0,0.084,1.309,3.356,0.832,0.217,0.122,4
HIF1A,GI_540.11 [Autoimmune hepatitis],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.111,2.794,2.439,0.35,0.181,,2
GAS1,NS_341.1 [Cerebral palsy],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.571,0.676,0.023,0.041,0.456,3
IL1B,DE_663.2 [Pemphigoid],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.31,,0.124,0.119,0.066,,1
GABRA3,GE_983.2 [Hemoglobin C trait [Sickle-cell trait]],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.7,1.576,,0.174,,1
SLC2A3,GE_972.9 [Muscular dystrophy],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.097,2.068,3.157,2.428,0.101,0.268,3
LBR,GI_542.8 [Biliary cirrhosis],0.066,0,0.0,0.0,0.654,0.0,0.0,0.0,0.216,1.467,2.388,0.449,0.227,,3
CLINT1,CV_433.3 [Cerebrovascular insufficiency],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.014,0.375,0.13,0.149,0.127,3
ATXN1,CM_770.5 [Congenital osteodystrophies],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.14,2.484,2.111,0.312,0.135,0.33,3
TEK,GE_978.3 [Osteochondrodysplasias],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.015,2.263,1.708,0.168,0.152,,2
LDHA,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.066,0,0.0,0.0,0.0,0.0,0.306,0.0,0.066,,2.637,0.085,0.117,0.918,4
WDFY3,MS_704.1 [Polyarteritis nodosa and related conditions],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.091,3.517,3.913,2.045,0.219,,2
PNKP,GE_972.2 [Hereditary ataxia],0.066,0,0.0,0.0,0.877,0.0,0.0,0.702,0.122,,2.086,1.784,0.228,0.916,4
EIF5A,BI_179.1 [Hypogammaglobulinemia NOS],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.081,,0.014,0.286,1
SCN8A,GE_961.1 [Phakomatoses],0.066,1,2.0,0.0,0.0,0.0,0.0,0.0,0.04,3.024,2.464,0.195,2.159,0.233,3
SSBP3,CM_750.16 [Arnold-Chiari syndrome*],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.949,0.171,,,0.207,2
PTGS2,GE_978.21 [Marfan syndrome],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.047,1.912,0.074,0.062,0.072,,2
GLP1R,CV_433.3 [Cerebrovascular insufficiency],0.066,1,2.0,0.0,0.0,0.0,0.0,0.0,0.275,1.4,2.548,0.167,0.134,0.196,3
MAP4K4,CM_770.5 [Congenital osteodystrophies],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.11,1.79,1.627,0.256,0.209,0.416,3
MSTN,GE_973.5 [Huntington's disease],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.381,,0.21,0.24,0.043,,1
ZFPM2,CV_414.1 [Hypertrophic cardiomyopathy],0.066,0,0.0,0.0,0.0,0.0,0.588,0.0,0.018,2.284,2.68,0.414,0.21,0.342,4
CALM1,GE_972.2 [Hereditary ataxia],0.066,0,0.0,0.022,0.0,0.0,0.0,0.0,0.0,2.637,0.082,,,0.319,3
NCOA3,SO_386.5 [Color vision deficiencies],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.068,1.334,3.501,0.474,0.171,0.246,3
RPSA,EM_209.4 [Diabetes insipidus],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,3.209,,,0.252,2
GJA10,SO_386.5 [Color vision deficiencies],0.066,0,0.0,0.0,0.0,0.0,0.428,0.0,0.0,,0.61,0.423,0.111,0.916,2
HIF1A,CV_441 [Arteriovenous malformation],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.061,1.896,1.987,0.354,0.217,0.966,3
TET1,CV_414.1 [Hypertrophic cardiomyopathy],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.213,1.433,2.693,0.202,0.237,0.118,3
CFL1,CV_416.8 [Pre-excitation syndrome [Anomalous atrioventricular excitation]],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.07,,,0.335,1
RPS10,NS_333.4 [Circadian rhythm sleep disorder],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.021,,,0.271,1
IKBKG,GE_961.1 [Phakomatoses],0.066,0,0.0,0.0,0.0,0.0,0.0,0.901,0.346,,2.814,0.412,0.088,0.411,4
PPP2R2C,CV_433.3 [Cerebrovascular insufficiency],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.265,0.12,,0.106,0.139,2
RPS10-NUDT3,NS_341.1 [Cerebral palsy],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.105,0.025,0.028,0.319,1
ATM,NS_341.1 [Cerebral palsy],0.066,0,0.0,0.0,0.684,0.0,0.0,0.0,0.068,2.201,3.954,0.748,0.412,0.97,4
RTN4IP1,GE_972.2 [Hereditary ataxia],0.066,0,0.0,0.0,0.547,0.0,0.0,0.0,0.086,,1.852,0.323,0.167,0.498,4
CACNA1S,GE_972.9 [Muscular dystrophy],0.066,0,0.0,0.0,0.745,0.0,0.299,0.525,0.041,1.587,3.51,0.528,0.255,0.902,5
FTH1,RE_484.1 [Spontaneous pneumothorax],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.061,2.06,0.513,0.041,0.058,0.322,3
SSBP3,GI_516.1 [Pyloric stenosis],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.031,0.287,,,0.259,2
PODXL,GE_963.1 [Lipid storage disorders],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.099,3.228,3.109,2.926,0.062,0.091,3
RUNX1,CV_433.3 [Cerebrovascular insufficiency],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.986,3.135,0.356,1.853,0.973,2
DRD1,NS_323.3 [Motor neuron disease],0.066,1,2.0,0.0,0.0,0.0,0.0,0.0,0.03,2.726,1.75,0.205,0.136,0.441,3
INS,CV_414.1 [Hypertrophic cardiomyopathy],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,1.441,,0.085,0.981,2
CHUK,GE_973.5 [Huntington's disease],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.101,,0.189,0.071,0.06,,1
BLNK,BI_179.1 [Hypogammaglobulinemia NOS],0.066,0,0.0,0.0,0.836,0.0,0.0,0.503,0.113,1.726,3.548,1.495,0.095,0.983,4
BBS1,SO_369.62 [Keratoconus],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.194,0.096,0.147,0.996,2
INF2,GU_580.52 [Diffuse membranous glomerulonephritis],0.066,0,0.0,0.0,0.0,0.0,0.0,0.877,0.196,2.223,2.419,0.305,0.094,,3
SRSF4,EM_211.1 [Adrenal hyperfunction],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.164,1.699,2.627,0.119,0.11,,2
NAB2,GE_961.1 [Phakomatoses],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.12,,0.177,0.073,1.669,0.195,3
SNRPD2,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.063,,,0.156,1
HMGCR,CV_433.3 [Cerebrovascular insufficiency],0.066,1,4.0,0.0,0.0,0.0,0.0,0.0,0.047,1.405,0.87,0.334,0.177,0.632,3
TRAPPC2,GE_970.1 [Sickle-cell disorders],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.039,,0.272,,0
TUBB4B,GE_963.1 [Lipid storage disorders],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.061,,0.013,0.307,1
SMARCA2,MB_306 [Conduct disorders],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,2.677,1.633,0.202,0.157,,2
MKLN1,DE_663.3 [Dermatitis herpetiformis],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.077,2.048,0.084,0.047,0.083,,2
BMP4,SO_369.62 [Keratoconus],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.122,3.715,2.324,0.304,0.126,0.441,3
YPEL5,EM_209.4 [Diabetes insipidus],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.033,,,0.167,1
GLI2,MS_700.3 [Systemic sclerosis],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.375,2.243,2.895,0.336,0.341,,2
SLC39A13,MS_712.51 [Hypermobility syndrome],0.066,0,0.0,0.0,0.0,0.0,0.271,0.2,0.354,1.766,0.233,0.05,0.21,,4
CDKN1A,NS_344.2 [Benign intracranial hypertension],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.353,0.923,0.884,2.436,0.965,2
EP300,MB_302.1 [Speech and language developmental delay],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.346,1.556,0.345,1.6,0.895,3
AGTR1,GE_976.5 [Polycystic kidney disease],0.066,1,4.0,0.0,0.0,0.0,0.264,0.0,0.32,1.981,2.653,0.351,0.206,,3
RPL7A,GE_963.1 [Lipid storage disorders],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,1.926,0.03,0.024,0.298,2
GJA1,CV_414.1 [Hypertrophic cardiomyopathy],0.066,0,0.0,0.0,0.0,0.0,0.738,0.0,0.191,3.373,0.395,0.066,1.786,0.892,4
PIM1,CV_438.41 [Aortic dissection],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.628,0.171,,,0.219,2
SLC6A3,GE_978.3 [Osteochondrodysplasias],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.208,2.611,3.452,0.146,1.631,,2
FOXO3,GE_970.2 [Thalassemia],0.066,0,0.0,0.0,0.0,0.0,0.32,0.0,0.059,2.241,1.194,0.505,1.152,,3
MT-CO3,CV_414.1 [Hypertrophic cardiomyopathy],0.066,0,0.0,0.0,0.0,0.0,0.0,0.452,0.018,,,,,,2
QRSL1,EM_208.1 [Hypoparathyroidism],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.017,2.145,2.862,2.319,0.269,0.143,3
KDR,DE_663.2 [Pemphigoid],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.108,2.871,2.638,0.589,0.22,,2
FOS,GE_972.9 [Muscular dystrophy],0.066,0,0.0,0.023,0.0,0.0,0.0,0.0,0.033,2.36,0.451,0.078,0.099,0.913,4
USP11,GE_970.2 [Thalassemia],0.066,0,0.0,0.0,0.0,0.0,0.456,0.0,0.0,,2.021,,0.171,,2
FOXO1,SO_365.3 [Exophthalmos [Proptosis]],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.061,2.92,1.661,0.045,0.197,0.908,3
RPL26,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.869,0.06,,,0.129,2
MFRP,SO_369.62 [Keratoconus],0.066,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.46,0.422,0.172,0.948,2
MON1B,GE_970.2 [Thalassemia],0.066,0,0.0,0.0,0.0,0.0,0.378,0.0,0.012,2.888,0.45,0.363,0.172,,3
RCC1,GE_961.1 [Phakomatoses],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,1.778,0.124,0.197,0.114,0.191,3
EGFR,NS_341.1 [Cerebral palsy],0.065,0,0.0,0.0,0.0,0.0,0.0,0.129,0.015,3.286,3.068,1.497,0.253,0.993,4
SLC16A1,CV_433.3 [Cerebrovascular insufficiency],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.257,3.004,3.214,3.759,0.119,0.35,3
RP9,SO_369.62 [Keratoconus],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.601,3.175,0.072,0.093,0.997,2
AKTIP,GE_972.9 [Muscular dystrophy],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,,0.059,0.09,2.257,0.268,3
LTBP3,CM_770.5 [Congenital osteodystrophies],0.065,0,0.0,0.0,0.0,0.0,0.289,0.402,0.022,1.346,2.562,0.345,0.646,0.507,5
MT-CO3,GE_972.1 [Hereditary neuropathy],0.065,0,0.0,0.0,0.0,0.0,0.0,0.362,0.012,,,,,,2
TNFAIP3,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.061,2.723,2.661,0.32,1.544,0.956,3
PTGS1,GU_580.1 [Acute nephritic syndrome],0.065,1,3.0,0.0,0.0,0.0,0.0,0.0,0.024,,2.426,0.411,0.172,0.911,3
UBN1,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.024,,2.399,0.461,0.58,0.226,3
GABRA2,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.955,0.104,,0.099,0.136,2
PODXL,GU_580.1 [Acute nephritic syndrome],0.065,0,0.0,0.0,0.828,0.0,0.0,0.0,0.223,3.373,2.622,0.977,0.099,0.815,4
PGR,GE_964.3 [Glycogen storage disease],0.065,0,0.0,0.0,0.0,0.0,0.266,0.0,0.074,2.445,2.269,0.185,0.106,,3
HDGF,EM_208.1 [Hypoparathyroidism],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,1.795,,0.025,0.288,2
CAV3,NS_338.1 [Myasthenia gravis],0.065,0,0.0,0.0,0.0,0.0,0.366,0.0,0.13,1.682,3.042,0.165,0.103,,3
WFS1,SO_386.5 [Color vision deficiencies],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.693,4.273,1.664,0.162,0.941,2
LAMA4,CV_414.1 [Hypertrophic cardiomyopathy],0.065,0,0.0,0.0,0.745,0.0,0.451,0.151,0.04,2.867,4.161,1.296,0.281,0.669,5
PPT1,GE_963.1 [Lipid storage disorders],0.065,1,2.0,0.0,0.0,0.0,0.344,0.871,0.067,1.542,2.529,0.205,0.057,0.289,5
FAM167A,MS_700.3 [Systemic sclerosis],0.065,0,0.0,0.0,0.0,0.241,0.0,0.0,0.199,3.286,3.501,1.186,0.191,,2
SLITRK1,CM_770.5 [Congenital osteodystrophies],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.164,3.224,0.323,0.109,0.074,0.527,3
SYNE1,CM_751.213 [Congenital cataract],0.065,0,0.0,0.0,0.547,0.0,0.0,0.0,0.0,2.521,3.731,0.638,0.785,0.92,3
CAMKK2,NS_339.2 [Myotonic disorders],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.243,1.713,4.337,0.187,0.09,,2
STMN1,SO_386.5 [Color vision deficiencies],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.143,0.046,0.032,0.304,1
NOTCH2,CM_770.5 [Congenital osteodystrophies],0.065,0,0.0,0.0,0.0,0.0,0.39,0.852,0.084,,3.193,,0.081,0.813,5
MAF,GU_580.1 [Acute nephritic syndrome],0.065,0,0.0,0.0,0.547,0.0,0.294,0.0,0.0,2.96,1.801,0.069,0.084,0.959,4
HDAC9,NS_323.3 [Motor neuron disease],0.065,1,3.0,0.0,0.0,0.0,0.0,0.0,0.051,2.571,2.711,0.66,0.32,0.148,3
RPL17,RE_484.1 [Spontaneous pneumothorax],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.462,0.182,,,0.222,2
CRYGS,CM_751.213 [Congenital cataract],0.065,0,0.0,0.0,0.813,0.0,0.707,0.755,0.017,,0.169,0.093,0.038,0.994,4
PER3,NS_333.4 [Circadian rhythm sleep disorder],0.065,0,0.0,0.0,0.0,0.0,0.396,0.622,0.078,2.383,3.366,0.652,0.211,0.517,5
COL5A2,NS_348.1 [Syringomyelia and syringobulbia],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.061,2.25,5.456,2.543,0.147,,2
NHLRC1,GE_972.2 [Hereditary ataxia],0.065,0,0.0,0.0,0.745,0.0,0.269,0.0,0.024,1.969,2.241,0.254,0.123,0.827,5
ILK,CV_414.1 [Hypertrophic cardiomyopathy],0.065,0,0.0,0.0,0.732,0.0,0.0,0.211,0.043,,2.285,0.4,0.286,0.829,4
LRBA,BI_179.1 [Hypogammaglobulinemia NOS],0.065,0,0.0,0.0,0.887,0.0,0.0,0.0,0.031,2.508,3.25,0.393,0.905,0.977,4
IL10,DE_669.2 [Behcet's syndrome],0.065,0,0.0,0.0,0.0,0.446,0.0,0.0,0.771,,1.094,0.045,0.026,,2
TRPC1,MS_700.3 [Systemic sclerosis],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.274,1.341,2.305,0.201,0.572,,2
AGFG1,GE_961.1 [Phakomatoses],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.44,2.333,0.175,0.122,0.153,3
GFER,CM_751.213 [Congenital cataract],0.065,0,0.0,0.0,0.547,0.0,0.0,0.0,0.012,,3.242,0.303,0.101,0.216,4
AMELX,DE_663.1 [Pemphigus],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.109,2.969,2.095,0.044,0.034,,2
GFRA1,"EM_209.11 [Tall stature, acromegaly and gigantism]",0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.033,1.957,0.182,0.102,0.119,,2
LDLR,CV_433.3 [Cerebrovascular insufficiency],0.065,0,0.0,0.0,0.745,0.0,0.0,0.0,0.112,,1.878,0.164,0.175,0.763,4
ADRA2C,NS_344.2 [Benign intracranial hypertension],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.091,3.001,,0.015,0.13,2
AGAP2,CV_414.1 [Hypertrophic cardiomyopathy],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,,2.404,0.418,0.285,0.121,3
CRB2,GU_580.51 [Focal and segmental glomerular lesions*],0.065,0,0.0,0.0,0.0,0.0,0.0,0.802,0.314,2.832,3.707,0.466,0.152,,3
MARCKS,MB_306 [Conduct disorders],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,2.666,2.506,0.018,0.019,,2
IQCB1,SO_369.62 [Keratoconus],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.93,3.793,1.562,0.21,0.998,2
NF1,NS_341.1 [Cerebral palsy],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,2.042,2.169,0.753,1.358,0.898,3
MET,MS_700.3 [Systemic sclerosis],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.295,2.659,3.208,1.643,0.343,,2
GGNBP2,CV_413.41 [Pulmonary valve stenosis],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.126,0.038,0.011,0.203,1
DRD2,"MB_280.4 [Sedative, hypnotic, or anxiolytic related disorders]",0.065,1,4.0,0.0,0.0,0.0,0.0,0.0,0.143,1.74,2.943,0.511,0.093,,2
JAM3,CM_751.213 [Congenital cataract],0.065,0,0.0,0.0,0.547,0.0,0.0,0.0,0.126,2.372,2.4,0.19,0.103,0.399,4
TLE3,EM_249.1 [Cerebral amyloid angiopathy*],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.122,3.627,0.574,0.632,1.929,,2
CYP7A1,GI_542.8 [Biliary cirrhosis],0.065,0,0.0,0.0,0.304,0.0,0.0,0.0,0.123,2.267,1.606,0.226,0.239,,3
BICC1,GE_976.5 [Polycystic kidney disease],0.065,0,0.0,0.0,0.0,0.0,0.384,0.0,0.088,4.114,3.226,0.29,0.283,,3
FOXO1,CM_763.31 [Ventricular septal defect],0.065,0,0.0,0.0,0.547,0.0,0.0,0.0,0.055,2.545,1.522,0.035,0.083,0.948,4
LRRC3B,EM_209.12 [Syndrome of inappropriate secretion of antidiuretic hormone],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.732,0.139,,0.131,,1
MEF2A,CV_414.1 [Hypertrophic cardiomyopathy],0.065,0,0.0,0.0,0.0,0.0,0.541,0.0,0.407,2.377,2.77,0.396,0.475,0.374,4
VAMP2,BI_179.1 [Hypogammaglobulinemia NOS],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.203,,0.019,0.305,1
INPP5D,GE_961.1 [Phakomatoses],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,2.147,0.6,0.228,0.2,0.267,3
KRT17,GE_977.1 [Congenital ichthyosis],0.065,0,0.0,0.0,0.0,0.0,0.44,0.0,0.0,,0.306,0.142,0.082,0.977,2
VEGFC,GE_963.1 [Lipid storage disorders],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.033,2.061,3.447,,2.065,0.313,3
ISY1-RAB43,NS_341.1 [Cerebral palsy],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.04,,,0.264,1
RELA,MS_727.5 [Cyst of bone],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.429,,3.242,0.106,0.151,,2
TERF2,SO_386.5 [Color vision deficiencies],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.125,,0.023,0.328,1
HIF1A,GE_973.5 [Huntington's disease],0.065,1,0.5,0.0,0.0,0.0,0.0,0.0,0.177,2.337,0.47,0.098,0.058,,2
RPS29,GE_963.1 [Lipid storage disorders],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.512,0.031,,,0.258,2
PTGS2,GE_978.3 [Osteochondrodysplasias],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.046,1.871,0.091,0.079,0.095,,2
MMP9,CM_770.5 [Congenital osteodystrophies],0.065,0,0.0,0.0,0.796,0.0,0.358,0.0,0.059,,4.163,0.88,0.173,0.982,5
SUCNR1,GE_961.1 [Phakomatoses],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,1.88,1.877,0.037,0.122,0.077,3
EIF5A,NS_333.4 [Circadian rhythm sleep disorder],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.09,,0.024,0.298,1
DRD1,NS_333.7 [Narcolepsy],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.073,2.509,1.799,0.089,0.065,,2
HDAC2,DE_663.2 [Pemphigoid],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.238,1.716,2.14,0.132,0.08,,2
FOSL2,MS_727.3 [Osteitis deformans [Paget's disease of bone]],0.065,0,0.0,0.0,0.0,0.0,0.367,0.0,0.021,3.686,2.257,0.129,0.094,,3
DDHD1,GE_972.2 [Hereditary ataxia],0.065,0,0.0,0.0,0.0,0.0,0.0,0.746,0.064,2.162,2.55,0.634,0.616,0.916,4
FBN2,GE_978.22 [Ehler's Danlos syndrome],0.065,0,0.0,0.0,0.0,0.0,0.0,0.249,0.012,2.762,2.099,0.549,0.263,,3
RPS26,MB_302.1 [Speech and language developmental delay],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.356,0.078,0.044,,0.12,2
KLHL7,GE_972.9 [Muscular dystrophy],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.015,,0.059,0.094,1.975,0.065,3
RPL9,GE_961.1 [Phakomatoses],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.148,0.027,,0.325,1
PPARG,GE_976.5 [Polycystic kidney disease],0.065,1,3.0,0.0,0.0,0.0,0.0,0.0,0.092,3.113,2.463,0.177,1.236,,2
AIPL1,SO_380.3 [Optic atrophy],0.065,0,0.0,0.0,0.0,0.0,0.406,0.0,0.0,2.04,1.98,0.512,0.128,0.99,3
STK39,NS_344.11 [Communicating hydrocephalus],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.081,3.519,0.209,0.074,0.062,,2
KDR,NS_344.2 [Benign intracranial hypertension],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.283,3.895,0.971,0.169,0.979,2
ITGAM,GE_970.2 [Thalassemia],0.065,0,0.0,0.0,0.0,0.0,0.464,0.0,0.03,,2.629,0.246,0.218,,3
CHN1,SO_381.5 [Vertical strabismus],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.077,2.178,0.117,0.093,2.021,,2
RNF216,GE_963.1 [Lipid storage disorders],0.065,0,0.0,0.0,0.547,0.0,0.0,0.281,0.044,1.947,0.32,0.248,0.147,0.445,4
LCA5,SO_386.5 [Color vision deficiencies],0.065,0,0.0,0.0,0.0,0.0,0.26,0.0,0.0,1.437,2.153,0.222,0.107,0.998,3
MAGEE1,CM_763.13 [Patent ductus arteriosus],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.118,3.587,,0.022,0.249,2
DPF2,NS_344.2 [Benign intracranial hypertension],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.381,,0.021,0.264,1
GATA2,GI_540.11 [Autoimmune hepatitis],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.139,1.974,2.596,0.265,0.148,,2
SMAD3,GE_961.1 [Phakomatoses],0.065,0,0.0,0.0,0.0,0.0,0.287,0.0,0.037,3.006,0.086,0.043,0.09,0.965,4
CREBBP,GE_973.5 [Huntington's disease],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.287,2.679,2.39,0.144,1.737,,2
TNFRSF18,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,1.801,0.304,0.102,0.946,2
CREBBP,CM_750.16 [Arnold-Chiari syndrome*],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.085,1.927,2.56,0.264,0.146,0.991,3
ISY1-RAB43,CV_413.41 [Pulmonary valve stenosis],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.029,,,0.169,1
ARPC4,GE_972.9 [Muscular dystrophy],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.026,,,0.169,1
ADM,MS_704.1 [Polyarteritis nodosa and related conditions],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.252,2.973,0.112,0.03,0.051,,2
NSRP1,NS_341.1 [Cerebral palsy],0.065,0,0.0,0.0,0.745,0.0,0.0,0.493,0.097,,3.655,0.132,0.116,0.451,4
EED,NS_323.3 [Motor neuron disease],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.715,1.253,,0.106,0.104,2
APP,MB_302.1 [Speech and language developmental delay],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.043,3.318,2.602,0.55,0.235,0.995,3
COL5A2,CV_438.41 [Aortic dissection],0.065,0,0.0,0.0,0.701,0.0,0.0,0.0,0.012,2.235,3.29,0.983,0.342,0.904,4
IFT27,SO_380.3 [Optic atrophy],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.805,2.614,2.591,0.103,0.956,2
FBN2,MS_700.3 [Systemic sclerosis],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.135,1.643,3.323,0.164,0.505,,2
TGFB2,GE_978.21 [Marfan syndrome],0.065,0,0.0,0.0,0.0,0.0,0.273,0.29,0.135,2.201,2.247,0.153,0.063,,4
TGFBR1,GE_977.6 [Congenital cutaneous mastocytosis*],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.14,,4.002,3.315,2.687,,2
PDGFRB,GU_580.51 [Focal and segmental glomerular lesions*],0.065,0,0.0,0.0,0.0,0.0,0.527,0.0,0.085,1.486,4.024,0.324,0.124,,3
PIK3R1,GE_977.6 [Congenital cutaneous mastocytosis*],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.068,4.294,0.088,0.05,0.067,,2
DOCK4,MB_303.1 [Dyslexia and alexia],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.283,2.666,3.444,0.364,0.169,,2
DES,CV_416.8 [Pre-excitation syndrome [Anomalous atrioventricular excitation]],0.065,0,0.0,0.0,0.0,0.0,0.475,0.0,0.0,,1.618,0.715,0.197,0.97,3
DNAJC13,GE_972.9 [Muscular dystrophy],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,1.813,2.326,0.192,0.211,0.197,3
NLGN1,MB_301.2 [Asperger's syndrome*],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.033,3.753,0.193,0.12,0.121,,2
BRD4,GE_976.5 [Polycystic kidney disease],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.179,1.722,2.312,1.151,0.245,,2
NR3C2,GE_972.9 [Muscular dystrophy],0.065,1,4.0,0.0,0.0,0.0,0.0,0.0,0.154,2.718,2.305,,0.029,0.521,3
RPL5,GE_972.9 [Muscular dystrophy],0.065,1,4.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.644,,0.026,0.264,1
RBFOX1,MB_302.1 [Speech and language developmental delay],0.065,0,0.0,0.0,0.0,0.0,0.0,0.515,0.07,3.902,2.665,1.251,0.197,0.912,4
MORF4L1,NS_339.2 [Myotonic disorders],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.193,1.99,0.06,0.033,0.044,,2
SDHB,GE_963.1 [Lipid storage disorders],0.065,0,0.0,0.0,0.547,0.0,0.0,0.0,0.104,,3.548,3.258,0.067,0.988,4
COL3A1,GE_972.9 [Muscular dystrophy],0.065,0,0.0,0.042,0.0,0.0,0.0,0.0,0.052,1.901,1.919,0.621,0.129,0.92,4
THBS1,GE_961.1 [Phakomatoses],0.065,0,0.0,0.0,0.0,0.0,0.252,0.0,0.084,2.808,1.966,,0.079,0.923,4
PACS1,GE_973.5 [Huntington's disease],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.139,1.392,1.071,0.05,2.461,,2
ZHX3,GU_580.52 [Diffuse membranous glomerulonephritis],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.021,2.344,4.025,2.557,1.673,,2
IL18,DE_663.1 [Pemphigus],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.086,,2.802,0.016,0.033,,2
SLC6A4,CM_770.5 [Congenital osteodystrophies],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.081,2.041,0.917,0.123,0.13,0.588,3
TJP1,SO_373.2 [Choroidal degenerations],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.182,2.182,2.695,1.572,0.234,,2
P4HB,GE_978.3 [Osteochondrodysplasias],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.101,1.389,2.287,0.209,0.11,,2
NDEL1,CM_750.16 [Arnold-Chiari syndrome*],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.158,0.034,0.032,0.248,1
DENND1B,GI_542.8 [Biliary cirrhosis],0.065,0,0.0,0.0,0.0,0.437,0.0,0.0,0.036,1.411,2.278,0.412,0.223,,2
CD151,GU_580.1 [Acute nephritic syndrome],0.065,0,0.0,0.0,0.684,0.0,0.391,0.0,0.018,3.136,0.26,0.147,0.09,0.325,5
CACNA1B,CV_433.3 [Cerebrovascular insufficiency],0.065,1,2.0,0.0,0.0,0.0,0.0,0.0,0.012,2.114,2.983,1.915,0.219,0.158,3
DNMT3B,CM_763.31 [Ventricular septal defect],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,,4.038,0.166,0.161,0.916,3
CNTN1,GE_972.9 [Muscular dystrophy],0.065,0,0.0,0.0,0.0,0.0,0.0,0.533,0.125,2.3,2.613,0.361,0.151,0.16,4
SLC1A2,NS_339.2 [Myotonic disorders],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.229,2.0,1.014,0.089,0.077,,2
SIK1,GU_580.1 [Acute nephritic syndrome],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.015,2.17,0.048,,0.029,0.293,3
FOS,MS_700.3 [Systemic sclerosis],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.303,1.813,5.589,0.497,0.126,,2
CD22,BI_179.7 [Common variable immunodeficiency [CVID]],0.065,0,0.0,0.0,0.0,0.0,0.69,0.0,0.103,,2.819,0.054,0.05,,3
GRN,MS_700.42 [Dermatomyositis],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.675,1.34,2.842,0.12,0.1,,2
COL11A2,MS_704.1 [Polyarteritis nodosa and related conditions],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.137,,3.915,3.34,0.127,,2
RHOG,MB_302.1 [Speech and language developmental delay],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.128,,0.012,0.273,1
C16orf82,GE_973.5 [Huntington's disease],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.063,1.981,2.394,0.037,0.03,,2
CP,NS_344.11 [Communicating hydrocephalus],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.102,2.276,1.584,0.059,0.061,,2
FKBP5,MB_296.4 [Borderline personality disorder],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.141,2.845,2.635,0.125,0.131,,2
MTPAP,GE_972.2 [Hereditary ataxia],0.065,0,0.0,0.0,0.796,0.0,0.0,0.555,0.048,2.461,1.362,0.151,0.172,0.448,4
HMGCR,GE_972.9 [Muscular dystrophy],0.065,0,0.0,0.0,0.848,0.0,0.0,0.42,0.141,,1.979,0.271,1.798,0.717,4
HK1,GE_964.3 [Glycogen storage disease],0.065,0,0.0,0.0,0.0,0.0,0.401,0.0,0.029,1.749,2.683,0.194,0.176,,3
TUBA1A,NS_341.1 [Cerebral palsy],0.065,0,0.0,0.0,0.796,0.0,0.0,0.4,0.052,,0.109,,3.344,0.882,4
AXL,GU_580.1 [Acute nephritic syndrome],0.065,1,1.0,0.0,0.0,0.0,0.0,0.0,0.103,2.548,2.756,0.234,0.95,0.78,3
DNM2,NS_323.3 [Motor neuron disease],0.065,0,0.0,0.0,0.426,0.0,0.412,0.0,0.02,,2.788,0.834,0.294,0.514,5
HEATR3,BI_162.1 [Constitutional (hereditary) aplastic anemia],0.065,0,0.0,0.0,0.801,0.0,0.0,0.585,0.093,1.941,0.723,0.21,0.111,,3
SNRPD2,CM_770.5 [Congenital osteodystrophies],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.611,0.051,,,0.337,2
UBE2L3,CM_763.31 [Ventricular septal defect],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.065,,,0.335,1
TMEM158,GE_978.3 [Osteochondrodysplasias],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,1.614,2.794,0.038,0.042,,2
PTGS2,GU_617.1 [Incompetence of cervix uteri],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,2.378,0.054,0.042,0.074,,2
SNAP25,MB_306 [Conduct disorders],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.104,2.423,0.109,0.016,0.08,,2
NR3C1,MS_700.43 [Polymyositis],0.065,1,4.0,0.0,0.0,0.0,0.0,0.0,0.018,2.45,0.224,0.104,0.079,,2
KITLG,GE_964.3 [Glycogen storage disease],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.023,2.81,0.115,0.106,0.09,,2
ADARB1,NS_323.3 [Motor neuron disease],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.047,1.988,2.038,0.251,1.349,0.067,3
USP14,GE_972.2 [Hereditary ataxia],0.065,0,0.0,0.0,0.0,0.0,0.316,0.0,0.095,2.024,2.513,0.164,0.139,0.641,4
COQ6,GU_580.1 [Acute nephritic syndrome],0.065,0,0.0,0.0,0.874,0.0,0.0,0.0,0.025,,2.505,0.267,0.183,0.232,4
CD9,GE_972.9 [Muscular dystrophy],0.065,0,0.0,0.03,0.0,0.0,0.0,0.0,0.061,3.863,0.192,0.108,0.085,0.327,4
TNFSF10,GI_540.11 [Autoimmune hepatitis],0.065,0,0.0,0.0,0.0,0.0,0.254,0.0,0.328,2.826,0.168,0.137,0.113,,3
ADNP,NS_323.3 [Motor neuron disease],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.036,1.895,2.532,1.779,0.229,0.15,3
USP15,DE_663.2 [Pemphigoid],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.073,1.959,0.11,0.144,0.161,,2
GABRA3,CV_430.3 [Nontraumatic subdural hemorrhage],0.065,1,4.0,0.0,0.0,0.0,0.0,0.0,0.0,2.514,0.955,,0.177,,1
PEPD,SO_369.62 [Keratoconus],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.237,1.348,3.813,1.445,0.218,0.105,3
FLT1,CV_441 [Arteriovenous malformation],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.031,1.966,2.689,0.997,0.235,0.951,3
OPTN,MS_727.3 [Osteitis deformans [Paget's disease of bone]],0.065,0,0.0,0.0,0.0,0.656,0.0,0.0,0.068,3.491,2.15,0.304,0.243,,2
KEAP1,GE_972.1 [Hereditary neuropathy],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.167,,1.681,0.141,0.227,,2
PAXIP1,GE_972.9 [Muscular dystrophy],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.083,2.034,0.037,0.026,0.28,2
PPARG,MB_302.1 [Speech and language developmental delay],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.966,0.099,0.144,0.108,0.952,3
MYD88,GI_540.11 [Autoimmune hepatitis],0.065,0,0.0,0.0,0.0,0.0,0.269,0.0,0.096,2.997,0.171,0.152,0.089,,3
SIRT6,CM_763.31 [Ventricular septal defect],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.535,0.181,0.131,0.953,2
DRD1,CM_770.5 [Congenital osteodystrophies],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.146,2.489,2.59,0.101,0.095,0.508,3
SSB,MS_700.42 [Dermatomyositis],0.065,0,0.0,0.071,0.0,0.0,0.0,0.0,0.088,1.9,0.15,0.062,0.089,,3
BFSP2,CM_751.213 [Congenital cataract],0.065,0,0.0,0.0,0.758,0.0,0.618,0.77,0.021,1.327,3.562,0.178,0.096,0.993,5
ABCD1,NS_341.1 [Cerebral palsy],0.065,0,0.0,0.0,0.872,0.0,0.0,0.645,0.061,,2.491,0.707,0.1,0.98,4
MTOR,BI_179.1 [Hypogammaglobulinemia NOS],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,1.318,3.24,0.296,0.225,0.99,3
ZFYVE9,MS_700.3 [Systemic sclerosis],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.359,,3.34,1.457,0.346,,2
P2RY10,CV_433.3 [Cerebrovascular insufficiency],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.234,3.799,,0.063,0.077,2
RASGRF1,CV_433.3 [Cerebrovascular insufficiency],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.085,1.847,1.12,0.235,2.052,0.12,3
TCF3,BI_179.1 [Hypogammaglobulinemia NOS],0.065,0,0.0,0.0,0.851,0.0,0.0,0.0,0.04,2.934,3.243,0.182,0.989,0.945,4
FLT3,GE_978.3 [Osteochondrodysplasias],0.065,0,0.0,0.0,0.0,0.0,0.299,0.0,0.154,2.249,2.495,0.129,0.14,,3
CTNNB1,EM_208.1 [Hypoparathyroidism],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.731,3.141,2.666,1.585,0.989,2
SPIN1,SO_369.62 [Keratoconus],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.995,0.074,0.041,,0.099,2
BRD4,MS_700.3 [Systemic sclerosis],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.199,2.296,3.548,0.93,0.214,,2
RPSA,CM_751.213 [Congenital cataract],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.127,,,0.172,1
ATP1A2,GE_961.1 [Phakomatoses],0.065,1,1.0,0.0,0.0,0.0,0.0,0.0,0.03,2.382,0.74,0.145,0.82,0.174,3
PPP2R2C,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.951,0.108,,0.081,0.213,2
PTK2,EM_249.1 [Cerebral amyloid angiopathy*],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.091,1.868,2.977,0.257,0.147,,2
ZMIZ1,CV_441 [Arteriovenous malformation],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.809,2.774,0.32,0.185,0.254,3
LRRK2,NS_341.1 [Cerebral palsy],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,1.876,2.653,0.446,0.324,0.99,3
SS18L1,NS_323.3 [Motor neuron disease],0.065,0,0.0,0.0,0.813,0.0,0.0,0.435,0.143,1.433,0.47,0.191,0.184,0.425,4
RRAGB,CV_414.1 [Hypertrophic cardiomyopathy],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.024,,2.545,,0.152,0.047,3
BMP4,CV_414.1 [Hypertrophic cardiomyopathy],0.065,0,0.0,0.0,0.0,0.0,0.459,0.0,0.012,3.07,2.858,1.128,0.979,0.391,4
THBD,GE_971.11 [Hereditary factor VIII deficiency [Hemophilia A]],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.061,2.314,3.091,0.051,0.048,,2
KLF2,SO_386.6 [Night blindness],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.099,2.654,,0.022,0.082,2
COL3A1,MS_712.51 [Hypermobility syndrome],0.065,0,0.0,0.0,0.0,0.0,0.0,0.428,0.093,1.58,3.639,0.377,1.996,,3
PDE4A,GE_978.22 [Ehler's Danlos syndrome],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.183,,2.474,0.215,0.111,,2
CD81,BI_179.1 [Hypogammaglobulinemia NOS],0.065,0,0.0,0.0,0.654,0.0,0.0,0.0,0.086,,0.179,0.108,0.07,0.974,3
HDAC7,GI_540.11 [Autoimmune hepatitis],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.055,1.938,3.244,3.61,0.146,,2
RELA,GI_540.11 [Autoimmune hepatitis],0.065,0,0.0,0.0,0.0,0.0,0.0,0.0,0.113,,1.655,0.069,0.126,,2
MSTN,CM_770.5 [Congenital osteodystrophies],0.064,0,0.0,0.0,0.0,0.0,0.339,0.0,0.12,,0.478,0.55,0.096,0.814,3
BPNT2,CM_770.5 [Congenital osteodystrophies],0.064,0,0.0,0.0,0.0,0.0,0.336,0.0,0.015,2.572,1.941,0.082,0.121,,3
CBL,CV_414.1 [Hypertrophic cardiomyopathy],0.064,0,0.0,0.0,0.547,0.0,0.511,0.0,0.018,,2.099,0.509,0.942,0.621,5
SNRPD2,CV_413.41 [Pulmonary valve stenosis],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.161,0.032,,,0.252,2
CDK6,MS_727.3 [Osteitis deformans [Paget's disease of bone]],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.099,3.196,0.487,,0.078,,2
PLXNC1,MS_704.1 [Polyarteritis nodosa and related conditions],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.14,2.399,2.53,0.172,0.154,,2
TSPO,NS_343.6 [Multi-system degeneration of the autonomic nervous system*],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.114,,3.043,0.039,0.043,,2
MTOR,DE_663.2 [Pemphigoid],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.23,1.785,2.485,1.143,0.244,,2
DSE,GE_978.22 [Ehler's Danlos syndrome],0.064,0,0.0,0.0,0.0,0.0,0.0,0.198,0.16,,3.395,0.133,0.108,,3
CPEB1,EM_209.4 [Diabetes insipidus],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.121,0.036,,0.331,1
KIT,NS_344.2 [Benign intracranial hypertension],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.88,1.336,0.149,0.126,0.983,2
MYL12B,DE_663.2 [Pemphigoid],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.088,2.282,0.047,0.035,0.058,,2
TFAP2A,GE_972.2 [Hereditary ataxia],0.064,0,0.0,0.084,0.0,0.0,0.0,0.0,0.137,2.352,3.549,0.099,0.109,0.875,4
PAX3,GE_972.1 [Hereditary neuropathy],0.064,0,0.0,0.0,0.0,0.0,0.296,0.0,0.012,3.149,3.667,2.644,0.977,,3
HIF1A,MS_704.3 [Thrombotic microangiopathy],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.065,1.712,0.863,0.086,1.769,,2
C6orf118,SO_365.3 [Exophthalmos [Proptosis]],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.652,2.215,0.222,0.129,0.925,2
RLBP1,SO_380.3 [Optic atrophy],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,1.778,0.318,0.129,0.979,2
TUBA1A,CM_750.16 [Arnold-Chiari syndrome*],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.387,0.079,,0.015,0.298,2
RYR1,NS_338.1 [Myasthenia gravis],0.064,0,0.0,0.0,0.0,0.0,0.379,0.145,0.025,1.942,3.317,0.727,1.659,,4
CDK4,MS_700.3 [Systemic sclerosis],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.17,,2.776,0.145,0.1,,2
SPIN1,SO_386.6 [Night blindness],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.976,0.073,0.042,,0.101,2
DRD1,MS_712.51 [Hypermobility syndrome],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.152,1.968,3.235,0.176,1.497,,2
ESR2,GE_972.2 [Hereditary ataxia],0.064,0,0.0,0.0,0.0,0.0,0.265,0.29,0.018,1.919,2.671,0.326,0.213,0.875,5
SCN5A,GE_963.1 [Lipid storage disorders],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.16,1.553,2.948,0.278,0.223,0.094,3
NR5A1,EM_211.1 [Adrenal hyperfunction],0.064,1,0.5,0.0,0.0,0.0,0.398,0.0,0.018,1.977,1.813,0.2,0.119,,3
ABCA2,GE_972.2 [Hereditary ataxia],0.064,0,0.0,0.0,0.547,0.0,0.329,0.0,0.137,,2.866,0.053,0.127,0.73,5
CA1,GU_580.1 [Acute nephritic syndrome],0.064,1,4.0,0.0,0.0,0.0,0.0,0.0,0.012,1.867,3.281,1.777,0.118,0.176,3
PIK3C2A,CV_433.3 [Cerebrovascular insufficiency],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,2.427,2.943,0.536,0.435,0.242,3
KY,GE_972.2 [Hereditary ataxia],0.064,0,0.0,0.0,0.0,0.0,0.3,0.362,0.024,,3.396,0.258,0.185,0.28,5
RPL9,CM_751.213 [Congenital cataract],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.302,0.126,0.027,,0.331,2
POGLUT1,GE_972.9 [Muscular dystrophy],0.064,0,0.0,0.0,0.853,0.0,0.0,0.71,0.062,1.532,0.609,0.167,0.101,0.51,4
WNT3,SO_369.62 [Keratoconus],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,1.364,0.082,0.071,0.116,0.165,3
ABL1,GU_580.1 [Acute nephritic syndrome],0.064,1,1.0,0.0,0.0,0.0,0.0,0.0,0.018,3.595,2.976,0.864,1.243,0.982,3
JAZF1,MS_700.3 [Systemic sclerosis],0.064,0,0.0,0.0,0.0,0.51,0.0,0.0,0.045,1.629,2.027,0.063,0.096,,2
FLT1,GE_975.2 [Hereditary hemorrhagic telangiectasia],0.064,1,2.0,0.0,0.0,0.0,0.0,0.0,0.012,2.154,3.772,2.698,1.196,,2
RARS2,GE_972.2 [Hereditary ataxia],0.064,0,0.0,0.0,0.808,0.0,0.0,0.0,0.018,,2.691,0.622,0.22,0.978,4
MYOF,GE_972.9 [Muscular dystrophy],0.064,0,0.0,0.048,0.547,0.0,0.288,0.0,0.104,3.419,3.295,0.83,1.346,0.718,6
HMGCR,NS_323.3 [Motor neuron disease],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.023,,2.635,0.63,0.295,0.334,3
RUNX2,NS_323.3 [Motor neuron disease],0.064,0,0.0,0.021,0.0,0.0,0.0,0.0,0.067,2.194,3.343,0.643,0.605,0.249,4
DYRK1A,CV_414.1 [Hypertrophic cardiomyopathy],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,1.356,2.55,0.249,0.3,0.273,3
BRD4,MS_727.5 [Cyst of bone],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.101,1.915,2.983,0.421,0.446,,2
PRMT5,CV_414.1 [Hypertrophic cardiomyopathy],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.099,2.852,2.597,0.258,0.221,0.67,3
FFAR3,GE_970.1 [Sickle-cell disorders],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.061,2.85,1.936,0.016,0.01,,2
NLRP3,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.491,1.493,1.981,0.13,0.167,0.968,3
CABP4,SO_386.6 [Night blindness],0.064,0,0.0,0.0,0.867,0.0,0.0,0.775,0.047,,1.36,0.424,0.128,1.0,4
ERCC1,SO_365.3 [Exophthalmos [Proptosis]],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.165,2.239,0.193,0.184,0.911,2
ETF1,CM_763.13 [Patent ductus arteriosus],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.069,,0.015,0.311,1
FOSL2,GE_978.3 [Osteochondrodysplasias],0.064,0,0.0,0.0,0.0,0.0,0.328,0.0,0.055,3.053,1.012,0.054,0.083,,3
NFE2L2,CV_433.3 [Cerebrovascular insufficiency],0.064,1,0.5,0.0,0.0,0.0,0.0,0.0,0.216,2.602,0.269,0.147,0.093,0.824,3
YPEL4,EM_211.1 [Adrenal hyperfunction],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.722,0.062,0.047,0.084,,2
ADRA2A,MB_306 [Conduct disorders],0.064,1,4.0,0.0,0.0,0.0,0.0,0.0,0.0,2.7,2.399,0.012,0.032,,1
SCN2A,SO_380.3 [Optic atrophy],0.064,0,0.0,0.0,0.547,0.0,0.0,0.0,0.0,3.063,1.999,0.435,0.217,0.969,3
GFRA1,NS_323.3 [Motor neuron disease],0.064,0,0.0,0.0,0.0,0.0,0.346,0.0,0.018,2.961,2.591,0.221,0.243,0.09,4
DLD,CV_414.1 [Hypertrophic cardiomyopathy],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.684,3.622,0.172,0.306,0.983,2
GABRA2,NS_352.2 [Parageusia*],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.926,0.096,,0.113,,1
CRY2,NS_333.4 [Circadian rhythm sleep disorder],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.039,,0.216,0.085,0.13,0.931,2
FOXP2,NS_328.13 [Frontotemporal dementia [FTD]],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.131,2.718,2.389,0.554,0.173,,2
PLG,GU_580.52 [Diffuse membranous glomerulonephritis],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.103,2.521,2.245,0.037,0.059,,2
PPARG,MS_727.3 [Osteitis deformans [Paget's disease of bone]],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.166,1.992,2.677,0.161,0.162,,2
DCLK1,BI_162.1 [Constitutional (hereditary) aplastic anemia],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,2.62,0.12,0.08,0.075,,2
TMEM63C,GU_580.52 [Diffuse membranous glomerulonephritis],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.202,1.944,2.867,0.119,0.108,,2
SON,BI_179.1 [Hypogammaglobulinemia NOS],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,,2.976,0.411,0.317,0.154,3
IFT88,GE_972.2 [Hereditary ataxia],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.734,2.896,0.718,0.243,0.978,2
HLA-DQA1,GU_580.52 [Diffuse membranous glomerulonephritis],0.064,0,0.0,0.0,0.0,0.314,0.0,0.0,0.066,17.245,1.721,0.071,0.037,,2
LGI1,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.067,1.394,2.749,0.158,0.137,0.157,3
SOX2,MS_700.3 [Systemic sclerosis],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.07,4.435,2.551,,0.066,,2
DRD3,GE_978.3 [Osteochondrodysplasias],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.145,2.148,0.145,0.129,0.108,,2
RPE65,SO_386.6 [Night blindness],0.064,0,0.0,0.0,0.848,0.0,0.268,0.37,0.066,1.384,0.514,0.373,0.162,1.0,5
CD79B,BI_179.1 [Hypogammaglobulinemia NOS],0.064,0,0.0,0.0,0.745,0.0,0.0,0.503,0.122,,2.052,0.038,0.073,0.99,4
KDR,MS_727.5 [Cyst of bone],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.04,2.054,3.273,2.452,0.381,,2
OGDH,NS_341.1 [Cerebral palsy],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.077,2.397,1.956,0.183,0.995,2
SLC2A10,CV_438.41 [Aortic dissection],0.064,0,0.0,0.0,0.426,0.0,0.0,0.0,0.012,2.544,2.695,0.406,1.056,0.866,4
RPL15,CV_441 [Arteriovenous malformation],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.769,,,0.31,2
RPL37,CM_763.13 [Patent ductus arteriosus],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.188,,0.017,0.308,1
WNT5A,NS_328.13 [Frontotemporal dementia [FTD]],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.061,2.56,0.11,0.137,0.125,,2
PPARGC1A,GU_580.51 [Focal and segmental glomerular lesions*],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.172,2.734,2.529,2.104,0.142,,2
NDUFAF5,SO_380.3 [Optic atrophy],0.064,0,0.0,0.0,0.684,0.0,0.0,0.352,0.0,1.698,3.745,3.367,0.1,0.915,3
DSP,DE_663.1 [Pemphigus],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.097,,3.385,0.171,0.21,,2
RPS10-NUDT3,CM_763.31 [Ventricular septal defect],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.154,0.034,0.022,0.171,1
MAOB,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.064,1,3.0,0.0,0.0,0.0,0.0,0.0,0.149,2.391,1.966,0.086,0.078,0.286,3
HSPG2,CM_770.5 [Congenital osteodystrophies],0.064,0,0.0,0.0,0.846,0.0,0.323,0.816,0.066,2.514,3.045,0.584,0.532,0.852,5
GLUL,EM_208.1 [Hypoparathyroidism],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.024,2.354,2.635,2.635,0.145,0.395,3
HRH2,GE_972.2 [Hereditary ataxia],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.32,0.245,,0.097,0.361,3
JAK3,BI_179.1 [Hypogammaglobulinemia NOS],0.064,0,0.0,0.0,0.728,0.0,0.0,0.0,0.041,,1.787,0.121,0.244,0.988,4
LBR,CM_770.5 [Congenital osteodystrophies],0.064,0,0.0,0.0,0.547,0.0,0.278,0.0,0.23,2.498,2.864,0.445,0.146,0.455,5
ANGPT1,SO_386.5 [Color vision deficiencies],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.046,2.834,2.936,2.789,0.069,0.18,3
ETF1,GE_977.1 [Congenital ichthyosis],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.091,,0.022,0.311,1
GPM6A,CM_763.13 [Patent ductus arteriosus],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.063,0.046,0.036,0.022,0.31,2
PCDH7,CM_770.5 [Congenital osteodystrophies],0.064,0,0.0,0.0,0.0,0.0,0.299,0.0,0.109,2.94,2.236,,0.019,0.306,4
SWAP70,BI_179.7 [Common variable immunodeficiency [CVID]],0.064,0,0.0,0.0,0.0,0.0,0.411,0.0,0.061,1.927,0.068,0.076,0.069,,3
PEPD,CV_438.43 [Coronary artery dissection],0.064,0,0.0,0.0,0.623,0.0,0.0,0.0,0.097,1.842,3.022,0.744,0.167,,3
SETD2,SO_365.3 [Exophthalmos [Proptosis]],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.061,1.97,3.433,0.413,0.286,0.924,3
RAPGEF1,GU_580.1 [Acute nephritic syndrome],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.024,1.861,3.125,0.948,0.209,0.195,3
KRAS,NS_338.1 [Myasthenia gravis],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.073,2.73,0.194,,0.064,,2
TUBB2A,BI_179.1 [Hypogammaglobulinemia NOS],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.16,0.041,,,0.151,2
HGF,MS_700.42 [Dermatomyositis],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.128,1.843,3.684,3.062,0.125,,2
SOX3,CM_772.1 [Congenital malformations of endocrine glands],0.064,0,0.0,0.0,0.0,0.0,0.0,0.201,0.062,3.046,2.978,0.051,0.019,,3
ISY1-RAB43,SO_365.3 [Exophthalmos [Proptosis]],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.59,0.082,,,0.138,2
GPHN,CV_433.3 [Cerebrovascular insufficiency],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,2.108,2.748,0.297,0.154,0.183,3
SLC16A2,CV_433.3 [Cerebrovascular insufficiency],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.103,1.887,1.848,,0.042,0.079,3
ADIPOR2,GE_970.2 [Thalassemia],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.989,0.076,,0.121,,1
SEC24B,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,1.419,2.831,0.469,0.194,0.134,3
SYNE2,GE_972.9 [Muscular dystrophy],0.064,0,0.0,0.0,0.801,0.0,0.0,0.63,0.044,2.794,3.428,0.379,0.126,0.948,4
SMARCA2,CV_438.41 [Aortic dissection],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.091,2.875,2.665,0.705,0.445,0.275,3
UBA52,MB_302.1 [Speech and language developmental delay],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.1,,,0.338,1
LMNA,GE_972.2 [Hereditary ataxia],0.064,0,0.0,0.0,0.0,0.0,0.278,0.0,0.03,1.344,3.255,0.212,0.172,0.899,4
TNF,NS_344.2 [Benign intracranial hypertension],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.252,,2.53,0.173,0.047,0.995,3
APEX1,NS_341.1 [Cerebral palsy],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.433,0.419,0.145,0.963,1
GRIA1,NS_328.13 [Frontotemporal dementia [FTD]],0.064,0,0.0,0.0,0.0,0.0,0.389,0.0,0.038,2.436,0.135,0.358,0.172,,3
AHR,GI_540.4 [Alcoholic hepatitis],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.082,3.28,2.436,0.159,0.17,,2
EIF2B4,GE_963.1 [Lipid storage disorders],0.064,0,0.0,0.0,0.0,0.0,0.32,0.783,0.018,,2.796,0.123,0.092,0.518,5
C1orf159,SO_380.3 [Optic atrophy],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,1.912,0.512,0.113,0.97,2
MAGOH,CM_750.16 [Arnold-Chiari syndrome*],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.097,,0.017,0.288,1
NLRP3,GE_972.1 [Hereditary neuropathy],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.121,2.739,2.799,0.187,0.198,,2
THRB,GE_978.3 [Osteochondrodysplasias],0.064,0,0.0,0.0,0.0,0.0,0.301,0.0,0.049,2.463,0.212,0.044,0.063,,3
AIPL1,SO_386.6 [Night blindness],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.95,2.508,1.808,0.131,1.0,2
ZMYND11,CV_413.41 [Pulmonary valve stenosis],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.282,0.088,0.043,0.015,0.262,2
ARF4,GI_540.11 [Autoimmune hepatitis],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.04,2.24,0.065,0.073,0.084,,2
ATL1,GE_964.3 [Glycogen storage disease],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.074,1.987,0.103,0.049,0.092,,2
PRKCD,GE_972.2 [Hereditary ataxia],0.064,0,0.0,0.0,0.0,0.0,0.258,0.0,0.021,2.644,0.971,0.134,1.284,0.837,4
SCN1A,MB_306 [Conduct disorders],0.064,1,4.0,0.0,0.0,0.0,0.0,0.008,0.012,,2.718,2.876,0.159,,3
VAMP2,GE_972.9 [Muscular dystrophy],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.148,,0.015,0.258,1
KIF3C,CM_763.31 [Ventricular septal defect],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.262,3.241,,0.022,0.294,2
RPL36,GE_972.9 [Muscular dystrophy],0.064,1,4.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.196,0.034,,0.141,1
MFN2,NS_341.1 [Cerebral palsy],0.064,0,0.0,0.0,0.684,0.0,0.0,0.29,0.021,2.131,3.119,0.257,0.135,0.989,4
SLC6A3,GE_963.1 [Lipid storage disorders],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.017,1.973,1.714,0.133,0.088,0.158,3
POLG,CV_414.1 [Hypertrophic cardiomyopathy],0.064,0,0.0,0.0,0.0,0.0,0.0,0.462,0.0,1.594,2.846,0.744,0.139,0.989,3
LDHA,GE_976.5 [Polycystic kidney disease],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.228,,2.006,0.195,0.116,,2
SRC,CV_441 [Arteriovenous malformation],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,1.859,0.135,0.099,0.198,0.825,3
FGFR1,MS_700.3 [Systemic sclerosis],0.064,1,4.0,0.0,0.0,0.0,0.0,0.0,0.033,4.743,5.693,1.076,0.221,,2
GABRA2,BI_179.1 [Hypogammaglobulinemia NOS],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.117,0.09,,0.091,0.064,2
GABRA1,BI_179.1 [Hypogammaglobulinemia NOS],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.945,0.064,,0.07,0.148,2
BRCA2,SO_365.3 [Exophthalmos [Proptosis]],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.608,2.682,0.114,0.45,0.988,2
NR3C1,GI_542.8 [Biliary cirrhosis],0.064,1,3.0,0.0,0.0,0.0,0.0,0.0,0.085,2.318,2.371,1.218,0.172,,2
NDUFA4,SO_380.3 [Optic atrophy],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.98,2.079,0.091,0.103,0.931,2
STAT1,NS_340.3 [Inflammatory and immune myopathies],0.064,0,0.0,0.274,0.0,0.157,0.0,0.0,0.093,,2.569,2.556,0.05,,3
CFHR1,GU_580.1 [Acute nephritic syndrome],0.064,0,0.0,0.0,0.426,0.062,0.0,0.008,0.036,,0.189,0.197,1.85,0.17,4
BCL2,NS_333.4 [Circadian rhythm sleep disorder],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.33,0.099,0.036,0.07,0.944,3
PDGFRA,CV_433.3 [Cerebrovascular insufficiency],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.046,2.408,2.357,0.108,0.072,0.972,3
KPNB1,CM_751.213 [Congenital cataract],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.207,,,0.284,1
SOX5,SO_381.5 [Vertical strabismus],0.064,0,0.0,0.0,0.0,0.0,0.0,0.29,0.033,3.35,1.574,0.166,1.762,,3
ALMS1,GU_580.1 [Acute nephritic syndrome],0.064,0,0.0,0.0,0.677,0.0,0.0,0.0,0.012,1.875,3.154,0.094,0.515,0.236,4
CA4,SO_386.6 [Night blindness],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.656,1.853,0.201,0.081,0.996,2
PIGR,GI_542.8 [Biliary cirrhosis],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.421,,2.88,0.286,1.495,,2
EZH2,CM_763.31 [Ventricular septal defect],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.024,1.942,1.834,0.05,0.098,0.978,3
ADD1,BI_162.1 [Constitutional (hereditary) aplastic anemia],0.064,0,0.0,0.0,0.0,0.0,0.437,0.0,0.03,,2.086,0.234,0.138,,3
PRKCA,MS_727.3 [Osteitis deformans [Paget's disease of bone]],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.015,2.254,2.015,0.146,0.161,,2
ENO2,NS_341.1 [Cerebral palsy],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.176,,2.311,0.179,1.602,0.946,3
NFKB2,GE_961.1 [Phakomatoses],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.122,,1.173,0.106,0.135,0.583,2
SLC7A1,NS_323.3 [Motor neuron disease],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.02,2.525,2.41,0.241,1.098,0.024,3
NDUFA11,GE_972.9 [Muscular dystrophy],0.064,1,3.0,0.0,0.0,0.0,0.0,0.0,0.0,2.511,3.019,0.031,0.034,0.109,2
MAGEA10,GI_516.1 [Pyloric stenosis],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.598,4.048,,0.071,0.069,2
ZDHHC15,NS_341.1 [Cerebral palsy],0.064,0,0.0,0.0,0.547,0.0,0.0,0.281,0.015,2.479,2.924,0.092,0.078,0.423,4
GRIA2,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,1.958,2.794,0.158,0.161,0.127,3
ARPC4,CV_413.41 [Pulmonary valve stenosis],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.021,,,0.251,1
ISY1-RAB43,CM_750.16 [Arnold-Chiari syndrome*],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.023,,,0.249,1
KIF3A,SO_369.62 [Keratoconus],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.097,3.226,1.566,0.152,0.986,2
TUBB4B,GE_961.1 [Phakomatoses],0.064,1,2.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.197,,0.023,0.283,2
AR,CM_763.31 [Ventricular septal defect],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.983,1.721,,0.013,0.979,2
TMEM164,CM_751.213 [Congenital cataract],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.035,4.209,,0.032,0.236,2
COPZ1,NS_323.3 [Motor neuron disease],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,1.715,0.151,0.187,0.14,0.019,3
SLC17A7,GE_972.2 [Hereditary ataxia],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.079,1.753,1.957,0.197,0.101,0.923,3
ACO2,GE_973.5 [Huntington's disease],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.683,,3.475,2.745,0.077,,2
KIF5C,CV_414.1 [Hypertrophic cardiomyopathy],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.109,2.433,1.453,0.25,0.032,3
FST,MS_700.42 [Dermatomyositis],0.064,0,0.0,0.06,0.0,0.0,0.0,0.0,0.14,3.001,0.269,0.049,0.052,,3
SLC8A1,GE_973.5 [Huntington's disease],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.061,1.978,3.946,3.511,0.078,,2
PKN2,CM_763.13 [Patent ductus arteriosus],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.115,0.064,0.016,0.026,0.243,2
FOXG1,BI_179.1 [Hypogammaglobulinemia NOS],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.239,1.948,,,0.276,2
NR3C1,MB_305.1 [Tics and tic disorders],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.036,3.191,0.274,0.109,0.086,,2
RHOA,SO_386.6 [Night blindness],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.219,,0.019,0.325,1
FANCA,BI_162.1 [Constitutional (hereditary) aplastic anemia],0.064,0,0.0,0.0,0.0,0.0,0.0,0.826,0.095,,2.399,0.321,0.161,,3
LCA5,SO_380.3 [Optic atrophy],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.567,1.202,0.187,0.988,2
ABL1,GI_540.11 [Autoimmune hepatitis],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.111,2.43,1.509,0.442,0.18,,2
CCND1,DE_663.2 [Pemphigoid],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.096,2.292,0.119,0.04,0.064,,2
MT-ATP8,GE_972.1 [Hereditary neuropathy],0.064,0,0.0,0.0,0.0,0.0,0.0,0.362,0.05,,,,,,2
CDK4,MS_727.3 [Osteitis deformans [Paget's disease of bone]],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.114,,2.489,0.192,0.107,,2
PTGS2,GE_975.2 [Hereditary hemorrhagic telangiectasia],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.109,1.614,0.106,0.077,0.094,,2
CALM1,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.496,0.087,,,0.314,2
IGF1R,GU_580.1 [Acute nephritic syndrome],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.035,3.19,3.011,0.332,0.539,0.928,3
PRKAA1,GI_540.11 [Autoimmune hepatitis],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.124,1.91,2.393,0.179,0.15,,2
ENAH,GI_540.11 [Autoimmune hepatitis],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.168,2.698,2.898,0.292,0.133,,2
IREB2,CM_770.5 [Congenital osteodystrophies],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,,2.493,0.324,0.165,0.285,3
APP,SO_386.5 [Color vision deficiencies],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.033,2.544,0.139,0.296,0.127,0.96,3
GOLGA2,CV_433.3 [Cerebrovascular insufficiency],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.122,,2.904,0.7,0.149,0.248,3
RPL17,SO_380.3 [Optic atrophy],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.859,2.371,,,0.222,2
HIPK2,GU_580.1 [Acute nephritic syndrome],0.064,0,0.0,0.0,0.0,0.0,0.358,0.0,0.03,2.604,2.384,,0.062,0.33,4
THBS1,CV_441 [Arteriovenous malformation],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.064,2.612,3.5,,0.111,0.896,3
MLH1,CV_441 [Arteriovenous malformation],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.568,2.54,0.361,0.27,0.975,2
LRP6,EM_249.1 [Cerebral amyloid angiopathy*],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.076,2.346,2.919,0.295,0.167,,2
COL3A1,MS_700.3 [Systemic sclerosis],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.279,1.854,3.177,0.866,0.228,,2
ETS2,CV_414.1 [Hypertrophic cardiomyopathy],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,2.256,2.835,0.177,0.135,0.231,3
TUBA1B,GE_961.1 [Phakomatoses],0.064,1,2.0,0.0,0.0,0.0,0.0,0.0,0.0,1.31,2.322,,,0.294,2
TBK1,MS_700.43 [Polymyositis],0.064,1,0.5,0.0,0.0,0.0,0.0,0.0,0.17,1.919,2.591,2.421,0.087,,2
ITGAL,DE_669.2 [Behcet's syndrome],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.185,,2.779,0.118,0.113,,2
IDH1,CM_770.5 [Congenital osteodystrophies],0.064,0,0.0,0.0,0.0,0.0,0.0,0.652,0.141,2.041,2.969,1.045,1.533,0.842,4
TEK,NS_344.11 [Communicating hydrocephalus],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.062,3.027,0.218,0.096,0.091,,2
ADAR,GE_972.2 [Hereditary ataxia],0.064,0,0.0,0.076,0.547,0.0,0.0,0.0,0.04,2.227,2.369,0.234,0.229,0.831,5
GAN,NS_323.3 [Motor neuron disease],0.064,0,0.0,0.0,0.0,0.0,0.372,0.0,0.03,3.245,2.578,0.105,0.135,0.048,4
HIPK2,NS_323.3 [Motor neuron disease],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.061,2.048,2.731,,0.076,0.345,3
CHM,SO_386.6 [Night blindness],0.064,0,0.0,0.0,0.0,0.0,0.0,0.29,0.024,2.617,2.406,0.118,1.615,0.99,4
RPE65,NS_341.1 [Cerebral palsy],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.15,2.132,0.822,0.182,0.98,2
FKBP10,CM_770.5 [Congenital osteodystrophies],0.064,0,0.0,0.0,0.0,0.0,0.0,0.718,0.227,,2.547,0.445,0.189,0.483,4
VARS2,NS_341.1 [Cerebral palsy],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.21,0.207,0.233,0.965,2
TCERG1,NS_323.3 [Motor neuron disease],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.035,2.803,2.59,0.812,0.254,0.101,3
GABRA1,NS_341.1 [Cerebral palsy],0.064,1,4.0,0.0,0.0,0.0,0.0,0.0,0.0,1.973,0.075,,0.06,0.977,2
SCRN1,SO_386.5 [Color vision deficiencies],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.185,1.947,0.181,0.094,0.063,0.136,3
NOS2,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.503,0.439,0.309,0.979,2
ARHGAP5,CV_433.3 [Cerebrovascular insufficiency],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,3.314,2.661,0.404,0.2,0.289,3
ITGB1,CV_414.1 [Hypertrophic cardiomyopathy],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.258,3.887,2.391,0.142,0.255,0.46,3
MYH9,GE_977.1 [Congenital ichthyosis],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.035,1.869,2.682,0.265,0.164,0.318,3
ADRA2C,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.064,1,4.0,0.0,0.0,0.0,0.0,0.0,0.0,2.237,2.64,,0.04,0.169,2
FN1,GI_542.8 [Biliary cirrhosis],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.123,2.44,4.54,0.782,0.177,,2
NTRK3,GU_580.52 [Diffuse membranous glomerulonephritis],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.164,1.878,2.814,1.133,1.829,,2
ADD2,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.064,0,0.0,0.0,0.0,0.0,0.309,0.0,0.088,,2.451,2.289,0.187,0.849,4
CRTC1,CV_414.1 [Hypertrophic cardiomyopathy],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.108,1.938,3.098,1.109,0.169,0.183,3
LPAR1,BI_162.1 [Constitutional (hereditary) aplastic anemia],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.061,3.609,0.062,0.041,0.07,,2
RTN2,GE_972.2 [Hereditary ataxia],0.064,0,0.0,0.0,0.0,0.0,0.0,0.741,0.075,,4.577,0.274,0.171,0.735,4
TNFAIP8L2,GI_542.8 [Biliary cirrhosis],0.064,0,0.0,0.0,0.0,0.0,0.265,0.0,0.252,,0.215,0.202,0.103,,2
PDE4A,CM_770.5 [Congenital osteodystrophies],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.046,,1.562,0.285,0.157,0.363,3
MYSM1,BI_162.1 [Constitutional (hereditary) aplastic anemia],0.064,0,0.0,0.0,0.426,0.0,0.254,0.0,0.012,1.609,0.084,0.173,0.108,,4
FN1,GE_977.6 [Congenital cutaneous mastocytosis*],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.255,3.584,4.062,1.824,0.178,,2
PPP2R2A,CV_416.8 [Pre-excitation syndrome [Anomalous atrioventricular excitation]],0.064,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.115,2.509,,0.025,0.265,2
PCBP2,GE_963.1 [Lipid storage disorders],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.048,,0.011,0.286,1
RPS10,GE_972.9 [Muscular dystrophy],0.063,1,4.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.018,,,0.157,1
RORA,CV_414.1 [Hypertrophic cardiomyopathy],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.888,2.485,,,0.229,2
NEDD8,CM_750.16 [Arnold-Chiari syndrome*],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.043,,0.01,0.312,1
GJB2,GE_977.1 [Congenital ichthyosis],0.063,0,0.0,0.0,0.547,0.0,0.0,0.0,0.085,3.538,4.315,0.461,0.095,0.939,4
SLC6A4,GE_973.5 [Huntington's disease],0.063,1,1.0,0.0,0.0,0.0,0.0,0.0,0.202,2.162,0.123,0.055,0.06,,2
COPS4,CV_413.41 [Pulmonary valve stenosis],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.044,0.011,0.025,0.268,1
FLNC,NS_328.13 [Frontotemporal dementia [FTD]],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.362,1.74,3.778,1.532,0.058,,2
JAG1,CM_763.31 [Ventricular septal defect],0.063,0,0.0,0.0,0.875,0.0,0.0,0.0,0.012,2.373,3.265,0.235,0.171,0.861,4
ETS1,NS_333.7 [Narcolepsy],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.131,3.019,0.979,0.078,0.068,,2
GABRB3,GE_972.9 [Muscular dystrophy],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.024,3.602,0.1,0.038,0.057,0.278,3
NFASC,MS_700.3 [Systemic sclerosis],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.07,1.701,2.461,0.614,0.322,,2
VCL,GE_972.9 [Muscular dystrophy],0.063,0,0.0,0.0,0.0,0.0,0.337,0.0,0.048,1.694,4.267,4.284,0.18,0.988,4
VEGFA,MS_700.3 [Systemic sclerosis],0.063,1,0.5,0.0,0.0,0.0,0.0,0.0,0.465,4.388,2.95,0.221,0.164,,2
HTR1A,MB_296.1 [Paranoid personality disorder],0.063,1,2.0,0.0,0.304,0.0,0.0,0.0,0.218,2.589,0.421,0.063,2.91,,3
HELZ2,GI_542.8 [Biliary cirrhosis],0.063,0,0.0,0.0,0.182,0.0,0.0,0.0,0.222,2.738,3.759,0.175,0.414,,3
ADAMTS13,MS_704.3 [Thrombotic microangiopathy],0.063,1,3.0,0.0,0.0,0.0,0.0,0.544,0.143,3.381,3.992,0.043,0.075,,3
RNASEH2B,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.063,0,0.0,0.0,0.0,0.0,0.0,0.908,0.105,1.889,3.365,1.105,0.115,0.807,4
SDHA,GE_972.2 [Hereditary ataxia],0.063,0,0.0,0.0,0.745,0.0,0.0,0.0,0.012,,1.384,1.188,0.111,0.988,4
ATRX,GE_970.2 [Thalassemia],0.063,0,0.0,0.0,0.0,0.0,0.0,0.868,0.114,3.005,2.707,1.593,0.198,,3
KCNV2,SO_380.3 [Optic atrophy],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.411,2.343,0.272,0.282,0.905,2
CACNA1C,NS_339.2 [Myotonic disorders],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.323,2.351,2.732,0.175,0.136,,2
PLXND1,MS_700.3 [Systemic sclerosis],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.61,1.961,2.889,1.922,0.254,,2
MCU,CV_433.3 [Cerebrovascular insufficiency],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.105,1.757,0.951,0.077,0.086,0.089,3
REV3L,BI_162.1 [Constitutional (hereditary) aplastic anemia],0.063,0,0.0,0.0,0.0,0.0,0.252,0.0,0.07,1.959,4.294,0.954,0.149,,3
SUCLG1,NS_341.1 [Cerebral palsy],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.19,2.848,0.082,1.491,0.968,2
FOXO1,MS_727.3 [Osteitis deformans [Paget's disease of bone]],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.033,2.355,0.316,0.054,0.176,,2
TNF,GU_580.52 [Diffuse membranous glomerulonephritis],0.063,1,2.0,0.0,0.0,0.0,0.0,0.0,0.468,,3.014,1.598,0.032,,2
SLC6A3,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.126,1.583,2.092,1.672,0.166,0.191,3
S1PR1,MS_727.5 [Cyst of bone],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,2.067,0.278,0.082,0.125,,2
PTK2,GI_540.11 [Autoimmune hepatitis],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.125,1.856,2.777,0.808,0.671,,2
NPAS2,MB_302.1 [Speech and language developmental delay],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.024,1.937,2.849,0.132,1.633,0.142,3
TP53,SO_380.3 [Optic atrophy],0.063,0,0.0,0.0,0.0,0.0,0.323,0.0,0.049,,1.937,0.128,0.13,0.996,4
HGF,CV_433.3 [Cerebrovascular insufficiency],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.197,2.915,2.725,0.283,0.19,0.982,3
PRKCD,CV_433.3 [Cerebrovascular insufficiency],0.063,1,2.0,0.0,0.0,0.0,0.0,0.0,0.202,,0.492,0.118,0.131,0.835,2
CD3G,BI_179.1 [Hypogammaglobulinemia NOS],0.063,0,0.0,0.0,0.547,0.0,0.0,0.0,0.0,1.947,2.436,0.181,0.071,0.945,3
PTPRC,EM_249.1 [Cerebral amyloid angiopathy*],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.076,2.934,2.131,0.052,0.08,,2
RBFOX2,GE_972.2 [Hereditary ataxia],0.063,0,0.0,0.055,0.0,0.0,0.0,0.0,0.055,2.313,0.582,0.264,0.17,0.817,4
RXRA,GE_963.1 [Lipid storage disorders],0.063,0,0.0,0.0,0.0,0.0,0.256,0.0,0.021,2.994,0.873,0.054,0.067,0.273,4
SPIB,MS_727.5 [Cyst of bone],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.654,2.088,0.241,0.074,0.111,,2
C3,MS_700.43 [Polymyositis],0.063,0,0.0,0.013,0.0,0.0,0.0,0.0,0.07,2.108,3.952,2.91,0.165,,3
STAT1,MS_705.2 [Juvenile rheumatoid arthritis [JRA/JIA]],0.063,0,0.0,0.0,0.0,0.128,0.254,0.0,0.094,,0.721,0.091,0.061,,3
AXDND1,GU_580.1 [Acute nephritic syndrome],0.063,0,0.0,0.0,0.0,0.0,0.0,0.008,0.033,2.275,2.372,0.167,1.021,0.062,4
DRD1,EM_209.13 [Hyperprolactinemia*],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,2.931,0.537,0.13,0.124,,2
CLU,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.063,0,0.0,0.0,0.547,0.0,0.0,0.0,0.024,2.07,2.469,0.132,1.765,0.952,4
ROCK1,MS_712.51 [Hypermobility syndrome],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.108,1.808,2.354,0.875,0.22,,2
PER2,NS_333.4 [Circadian rhythm sleep disorder],0.063,0,0.0,0.0,0.0,0.0,0.0,0.641,0.116,,3.324,0.309,0.186,0.839,4
CACNA1H,NS_323.3 [Motor neuron disease],0.063,0,0.0,0.0,0.86,0.0,0.0,0.0,0.058,3.013,3.427,0.744,0.724,0.02,4
RANGRF,CV_414.1 [Hypertrophic cardiomyopathy],0.063,0,0.0,0.0,0.0,0.0,0.494,0.0,0.046,,1.755,0.089,1.381,0.302,4
ITGB1,EM_209.4 [Diabetes insipidus],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,3.419,2.015,0.069,0.13,0.946,3
SRSF3,EM_208.1 [Hypoparathyroidism],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.065,,0.031,0.29,1
NRG2,GE_972.1 [Hereditary neuropathy],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.158,,4.796,1.313,0.197,,2
FLNA,GE_978.21 [Marfan syndrome],0.063,0,0.0,0.0,0.0,0.0,0.0,0.121,0.066,,1.812,0.064,2.025,,3
IL1B,MS_704.2 [Wegener's granulomatosis],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.077,3.662,0.115,0.095,0.047,,2
TRPV4,GE_972.1 [Hereditary neuropathy],0.063,0,0.0,0.0,0.0,0.0,0.0,0.833,0.207,1.618,2.328,0.798,0.362,,3
DPY30,GE_972.2 [Hereditary ataxia],0.063,0,0.0,0.0,0.0,0.0,0.0,0.462,0.097,1.963,0.069,,0.053,0.247,4
NFKB2,MS_727.5 [Cyst of bone],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.117,,2.557,0.171,0.189,,2
SH3TC2,GE_972.2 [Hereditary ataxia],0.063,0,0.0,0.0,0.684,0.0,0.404,0.281,0.045,1.826,3.874,0.696,0.273,0.644,5
SIGMAR1,NS_323.3 [Motor neuron disease],0.063,1,3.0,0.0,0.845,0.0,0.0,0.0,0.081,,0.959,0.56,0.162,0.988,3
ANK1,GE_972.2 [Hereditary ataxia],0.063,0,0.0,0.075,0.0,0.0,0.0,0.0,0.04,2.313,3.819,1.646,0.387,0.875,4
HTR2C,NS_323.3 [Motor neuron disease],0.063,1,3.0,0.0,0.0,0.0,0.0,0.0,0.012,2.399,0.495,,0.052,0.084,3
ADRB1,DE_663.1 [Pemphigus],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,1.974,4.512,0.044,0.03,,2
CHSY1,GE_961.1 [Phakomatoses],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,1.833,1.391,0.181,0.151,0.079,3
NDUFA6,GE_972.2 [Hereditary ataxia],0.063,1,4.0,0.0,0.0,0.0,0.0,0.0,0.0,1.592,1.783,0.202,0.066,0.939,2
CACNA1A,GE_964.3 [Glycogen storage disease],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.015,2.758,4.507,0.097,0.093,,2
SBF2,GE_972.9 [Muscular dystrophy],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,1.888,2.489,0.391,0.762,0.227,3
HEPH,GU_580.1 [Acute nephritic syndrome],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.811,5.379,2.525,0.2,0.103,3
MSC,GU_580.55 [Diffuse mesangiocapillary glomerulonephritis*],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.492,2.988,0.012,0.05,,1
GAS1,GE_971.14 [Von Willebrand's disease],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.498,3.127,0.013,0.038,,1
NRG1,CV_414.1 [Hypertrophic cardiomyopathy],0.063,0,0.0,0.0,0.0,0.0,0.482,0.0,0.043,3.176,2.703,0.696,0.299,0.343,4
DYNC1H1,NS_323.3 [Motor neuron disease],0.063,0,0.0,0.0,0.65,0.0,0.549,0.245,0.093,,2.923,0.332,0.054,0.872,5
SLC40A1,GE_970.2 [Thalassemia],0.063,1,2.0,0.0,0.0,0.0,0.484,0.0,0.048,1.634,1.171,0.074,0.595,,3
RORA,MS_727.3 [Osteitis deformans [Paget's disease of bone]],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.078,2.604,0.591,,,,2
C9orf72,GE_963.1 [Lipid storage disorders],0.063,0,0.0,0.0,0.0,0.0,0.324,0.0,0.037,2.575,0.129,0.123,0.098,0.037,4
ADCY1,GE_972.9 [Muscular dystrophy],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.065,1.696,0.856,0.049,1.934,0.117,3
KHSRP,NS_323.3 [Motor neuron disease],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.079,,2.701,,0.17,0.27,3
AR,EM_211.1 [Adrenal hyperfunction],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,1.943,4.172,,0.022,,2
RPL13A,SO_386.5 [Color vision deficiencies],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.146,,0.008,0.262,1
NXT2,GE_970.1 [Sickle-cell disorders],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.343,0.034,,0.176,,1
TLE1,GE_972.2 [Hereditary ataxia],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,3.128,1.638,0.085,0.825,0.455,3
CDK5,CV_433.3 [Cerebrovascular insufficiency],0.063,1,0.5,0.0,0.0,0.0,0.0,0.0,0.1,,0.124,0.078,0.091,0.564,2
THBS1,GE_963.1 [Lipid storage disorders],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.289,3.971,1.929,,0.049,0.327,3
BCL2,GE_972.1 [Hereditary neuropathy],0.063,1,3.0,0.0,0.0,0.0,0.264,0.0,0.044,2.082,1.349,0.066,0.083,,3
RELN,NS_341.1 [Cerebral palsy],0.063,0,0.0,0.0,0.532,0.0,0.0,0.0,0.0,2.354,3.664,1.216,0.416,0.951,3
KCNK9,EM_211.1 [Adrenal hyperfunction],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.039,2.623,0.111,0.035,0.087,,2
HMGA1,NS_323.3 [Motor neuron disease],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.071,,,0.152,1
AGFG1,NS_323.3 [Motor neuron disease],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.07,2.98,2.774,0.281,0.166,0.05,3
BTK,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.063,1,2.0,0.0,0.0,0.0,0.0,0.0,0.149,1.367,2.623,0.058,0.078,0.966,3
INPP5E,SO_386.6 [Night blindness],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.534,1.957,0.3,0.148,0.967,2
GRIK3,MB_296.2 [Schizoid personality disorder],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.061,3.46,0.1,0.102,0.072,,2
ACLY,GE_972.2 [Hereditary ataxia],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.302,,2.893,0.828,0.275,0.839,3
RAN,CM_751.213 [Congenital cataract],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.055,,,0.334,1
HIPK1,CV_414.1 [Hypertrophic cardiomyopathy],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.067,,3.124,0.367,0.413,0.151,3
MYO9B,NS_338.1 [Myasthenia gravis],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,2.129,4.426,2.95,0.143,,2
FXR1,GE_972.9 [Muscular dystrophy],0.063,0,0.0,0.0,0.0,0.0,0.0,0.438,0.198,2.107,0.215,0.336,0.121,0.607,4
CCL20,MS_700.3 [Systemic sclerosis],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.592,2.367,2.313,0.033,0.071,,2
C5,NS_323.3 [Motor neuron disease],0.063,1,3.0,0.0,0.0,0.0,0.0,0.0,0.104,1.871,2.709,0.608,0.397,0.168,3
ADAR,GE_963.1 [Lipid storage disorders],0.063,0,0.0,0.0,0.426,0.0,0.0,0.0,0.03,,3.708,3.392,0.132,0.913,4
NRP1,GE_961.1 [Phakomatoses],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.082,2.818,2.776,0.435,0.805,3
MRFAP1,CM_763.13 [Patent ductus arteriosus],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.648,0.088,,,0.204,2
FOXRED1,GE_972.2 [Hereditary ataxia],0.063,0,0.0,0.035,0.426,0.0,0.0,0.0,0.018,1.857,3.448,0.673,0.211,0.966,5
HLA-B,NS_338.1 [Myasthenia gravis],0.063,0,0.0,0.0,0.0,0.389,0.0,0.0,0.064,,3.169,1.612,0.144,,2
MT-CYB,CV_414.1 [Hypertrophic cardiomyopathy],0.063,0,0.0,0.0,0.0,0.0,0.0,0.362,0.211,,,,,,2
DNM2,CV_433.3 [Cerebrovascular insufficiency],0.063,0,0.0,0.0,0.0,0.187,0.0,0.0,0.073,1.987,1.483,0.261,0.173,0.611,3
TSC2,GE_963.1 [Lipid storage disorders],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.105,,2.637,0.19,0.27,0.19,3
FBN2,CM_763.31 [Ventricular septal defect],0.063,0,0.0,0.0,0.426,0.0,0.0,0.129,0.044,3.81,3.483,0.333,0.223,0.609,4
EZH2,CV_433.3 [Cerebrovascular insufficiency],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.079,1.817,0.356,0.051,0.124,0.969,3
IRF7,BI_179.1 [Hypogammaglobulinemia NOS],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,3.276,1.368,0.174,0.915,2
SARS1,NS_341.1 [Cerebral palsy],0.063,0,0.0,0.0,0.547,0.0,0.0,0.0,0.122,,1.69,1.591,0.125,,3
CDH2,"MB_280.4 [Sedative, hypnotic, or anxiolytic related disorders]",0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,3.07,1.591,0.149,0.158,,2
RBBP4,CM_751.213 [Congenital cataract],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.572,,0.02,0.325,2
GAS1,GE_963.1 [Lipid storage disorders],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.024,2.221,2.364,0.017,0.03,0.027,3
SORL1,NS_328.13 [Frontotemporal dementia [FTD]],0.063,0,0.0,0.0,0.0,0.0,0.261,0.0,0.2,2.599,3.724,1.366,0.97,,3
TNPO3,GI_542.8 [Biliary cirrhosis],0.063,0,0.0,0.0,0.0,0.384,0.0,0.0,0.093,1.754,1.563,0.26,0.278,,2
RXRA,GE_972.1 [Hereditary neuropathy],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.043,2.428,2.293,0.167,0.131,,2
CTDNEP1,CM_763.13 [Patent ductus arteriosus],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.082,0.047,0.023,0.261,1
ADD3,NS_341.1 [Cerebral palsy],0.063,0,0.0,0.0,0.547,0.0,0.0,0.673,0.039,2.866,3.391,1.009,0.163,0.337,4
C1orf226,GI_516.1 [Pyloric stenosis],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.15,2.306,,0.032,0.082,2
RUSC2,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.076,2.329,0.478,0.286,0.074,3
CD163,GI_540.11 [Autoimmune hepatitis],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.18,,1.597,0.195,0.903,,2
MTNR1A,CV_433.3 [Cerebrovascular insufficiency],0.063,1,4.0,0.0,0.0,0.0,0.0,0.0,0.036,2.186,3.068,1.144,0.12,0.298,3
UBQLN4,NS_323.3 [Motor neuron disease],0.063,0,0.0,0.0,0.547,0.0,0.0,0.0,0.019,,2.969,1.718,0.211,0.188,4
MED23,GE_972.2 [Hereditary ataxia],0.063,0,0.0,0.0,0.426,0.0,0.0,0.0,0.049,,1.633,0.269,0.331,0.322,4
KPNB1,MB_302.1 [Speech and language developmental delay],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.946,,,0.216,2
DNMT1,GE_973.5 [Huntington's disease],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.52,1.782,2.918,2.796,0.068,,2
SCN9A,GE_972.2 [Hereditary ataxia],0.063,1,2.0,0.125,0.701,0.0,0.0,0.0,0.03,2.676,3.06,0.569,0.392,0.966,5
NFKB1,MB_302.1 [Speech and language developmental delay],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.015,2.323,2.839,0.961,1.905,0.936,3
RRM1,NS_328.13 [Frontotemporal dementia [FTD]],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.088,2.697,3.112,2.97,0.103,,2
STAT5A,DE_663.2 [Pemphigoid],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.263,,3.418,0.276,0.135,,2
KCNH2,MS_712.51 [Hypermobility syndrome],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.201,,2.846,0.23,0.233,,2
PPP2R2B,GE_972.2 [Hereditary ataxia],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.053,3.266,1.812,0.217,1.69,0.988,3
RPL13,GE_972.9 [Muscular dystrophy],0.063,1,4.0,0.0,0.0,0.0,0.0,0.0,0.0,1.874,0.314,,,0.301,2
HMGCR,GE_972.1 [Hereditary neuropathy],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.169,,2.457,0.561,0.286,,2
FN1,GE_978.21 [Marfan syndrome],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.13,2.122,3.756,0.72,0.268,,2
BANF1,SO_386.6 [Night blindness],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.096,,,0.155,1
JAK3,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.063,0,0.0,0.0,0.0,0.0,0.256,0.0,0.0,2.102,3.013,0.113,0.529,0.976,3
TMEM38B,GE_978.3 [Osteochondrodysplasias],0.063,0,0.0,0.0,0.0,0.0,0.0,0.693,0.198,2.975,2.925,0.139,0.098,,3
STIM2,GE_973.5 [Huntington's disease],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.241,3.115,3.761,3.228,0.055,,2
MATR3,GE_972.9 [Muscular dystrophy],0.063,0,0.0,0.0,0.684,0.0,0.0,0.443,0.26,,0.173,0.115,1.894,0.915,4
RBM25,CV_414.1 [Hypertrophic cardiomyopathy],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,1.925,2.192,1.837,0.188,0.056,3
ALKBH5,CM_770.5 [Congenital osteodystrophies],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.569,0.194,,,0.278,2
ABCA1,GI_540.11 [Autoimmune hepatitis],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.503,2.744,2.449,0.38,0.172,,2
GNAS,"EM_209.11 [Tall stature, acromegaly and gigantism]",0.063,0,0.0,0.0,0.0,0.0,0.0,0.151,0.176,,0.324,0.087,0.049,,2
MAPK14,MS_712.51 [Hypermobility syndrome],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,3.554,0.129,0.054,0.122,,2
RFC1,GE_972.1 [Hereditary neuropathy],0.063,0,0.0,0.0,0.0,0.538,0.0,0.0,0.06,,2.702,1.105,0.356,,2
MTOR,NS_333.4 [Circadian rhythm sleep disorder],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,3.957,2.536,1.223,0.218,0.98,3
COL1A2,MS_727.3 [Osteitis deformans [Paget's disease of bone]],0.063,0,0.0,0.0,0.0,0.0,0.439,0.0,0.065,1.836,2.782,0.839,0.428,,3
AXIN2,CV_433.3 [Cerebrovascular insufficiency],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.082,2.429,2.554,0.245,0.145,0.824,3
CSNK1A1,SO_386.6 [Night blindness],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.728,0.69,,,0.192,2
SUCO,CM_770.5 [Congenital osteodystrophies],0.063,0,0.0,0.0,0.0,0.0,0.0,0.251,0.028,1.794,2.646,0.791,0.201,0.478,4
MEMO1,CV_416.8 [Pre-excitation syndrome [Anomalous atrioventricular excitation]],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.812,0.118,,0.074,0.182,2
NFE2L2,GE_970.2 [Thalassemia],0.063,1,0.5,0.0,0.0,0.0,0.27,0.0,0.055,3.276,0.735,0.095,0.148,,3
ESR1,NS_333.4 [Circadian rhythm sleep disorder],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.428,2.237,2.143,0.607,0.096,0.975,3
SLC6A4,CV_414.1 [Hypertrophic cardiomyopathy],0.063,0,0.0,0.0,0.0,0.0,0.259,0.0,0.103,,2.547,1.709,0.287,0.108,4
PKP2,GE_972.9 [Muscular dystrophy],0.063,0,0.0,0.0,0.0,0.0,0.0,0.129,0.015,4.167,1.271,0.274,0.137,0.886,4
KCND2,CV_414.1 [Hypertrophic cardiomyopathy],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.036,2.862,2.336,0.067,0.169,0.31,3
MMP9,GI_516.1 [Pyloric stenosis],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.567,1.679,0.325,0.952,2
ACSL4,GI_516.1 [Pyloric stenosis],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.419,2.244,0.277,0.137,0.981,2
VWF,MS_704.1 [Polyarteritis nodosa and related conditions],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.171,1.363,2.564,0.35,0.244,,2
HIF1A,NS_323.3 [Motor neuron disease],0.063,1,0.5,0.027,0.0,0.0,0.0,0.0,0.047,3.134,3.478,0.163,0.243,0.936,4
SNAI2,SO_386.6 [Night blindness],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.291,0.112,,0.099,0.121,2
ARPC4,CM_751.213 [Congenital cataract],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.027,,,0.265,1
ANKHD1-EIF4EBP3,GE_977.1 [Congenital ichthyosis],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.751,0.058,0.037,,0.08,2
CC2D2A,GE_972.2 [Hereditary ataxia],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.84,0.781,0.403,0.996,2
PHLDB1,GE_978.3 [Osteochondrodysplasias],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.097,,2.897,0.375,0.561,,2
NDUFA5,NS_341.1 [Cerebral palsy],0.063,1,2.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.166,0.066,0.033,0.962,1
WDR1,DE_663.2 [Pemphigoid],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.085,1.866,3.225,0.134,0.169,,2
GNAZ,CM_763.31 [Ventricular septal defect],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.13,,0.02,0.229,1
KIF2C,GE_961.1 [Phakomatoses],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,1.757,2.977,1.355,0.196,0.218,3
IKBKB,GE_973.5 [Huntington's disease],0.063,1,0.5,0.0,0.0,0.0,0.0,0.0,0.715,1.399,0.137,0.097,0.066,,2
MMP14,EM_249.1 [Cerebral amyloid angiopathy*],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.269,2.328,2.261,0.359,0.089,,2
PRKCE,MS_712.51 [Hypermobility syndrome],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,3.208,1.73,0.128,0.17,,2
NDUFS3,GE_963.1 [Lipid storage disorders],0.063,0,0.0,0.0,0.0,0.0,0.257,0.0,0.0,,2.166,2.003,0.081,0.998,3
ATRN,GE_963.1 [Lipid storage disorders],0.063,0,0.0,0.0,0.0,0.0,0.284,0.0,0.082,2.295,2.981,0.286,0.125,0.136,4
CYP19A1,EM_211.1 [Adrenal hyperfunction],0.063,1,4.0,0.0,0.0,0.0,0.318,0.0,0.04,1.993,2.049,0.241,1.058,,3
COQ2,GE_972.2 [Hereditary ataxia],0.063,0,0.0,0.0,0.566,0.0,0.0,0.0,0.036,1.463,1.846,0.235,1.586,0.743,4
NAMPT,CV_433.3 [Cerebrovascular insufficiency],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.125,1.962,1.63,0.074,0.068,0.71,3
FOXO1,MS_712.51 [Hypermobility syndrome],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.04,2.003,2.452,0.102,0.143,,2
PPP2R2C,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.958,0.134,,0.082,0.158,2
PLXND1,MS_700.43 [Polymyositis],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.161,1.963,3.565,0.103,0.158,,2
HIF1A,GE_977.6 [Congenital cutaneous mastocytosis*],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.087,1.927,0.519,0.103,0.072,,2
FKBP5,EM_211.1 [Adrenal hyperfunction],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.11,1.684,2.332,0.148,0.162,,2
DLAT,NS_341.1 [Cerebral palsy],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.121,0.22,0.16,0.956,2
REN,CV_414.1 [Hypertrophic cardiomyopathy],0.063,0,0.0,0.0,0.0,0.0,0.441,0.0,0.08,,2.655,0.4,0.194,0.331,4
CYC1,CV_414.1 [Hypertrophic cardiomyopathy],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,1.177,0.295,0.243,0.994,1
BCL2,GE_978.3 [Osteochondrodysplasias],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.078,2.6,0.087,0.035,0.059,,2
DPYSL2,CM_770.5 [Congenital osteodystrophies],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.043,3.517,2.32,0.092,0.125,0.397,3
COQ2,NS_343.6 [Multi-system degeneration of the autonomic nervous system*],0.063,0,0.0,0.0,0.0,0.0,0.0,0.541,0.54,1.601,1.885,0.095,2.612,,3
PTGS2,GU_580.51 [Focal and segmental glomerular lesions*],0.063,0,0.0,0.0,0.0,0.0,0.613,0.0,0.024,2.276,0.08,0.079,0.078,,3
ABCC9,GE_961.1 [Phakomatoses],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.307,1.39,1.509,0.207,0.281,0.19,3
LAMA1,GE_972.2 [Hereditary ataxia],0.063,0,0.0,0.0,0.895,0.0,0.0,0.0,0.015,2.712,3.14,0.163,0.63,0.752,4
PARP1,SO_365.3 [Exophthalmos [Proptosis]],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.167,2.188,2.921,0.523,0.347,0.97,3
GSK3B,MB_306 [Conduct disorders],0.063,1,3.0,0.0,0.0,0.0,0.0,0.0,0.058,2.961,0.111,,0.073,,2
NOTCH1,CV_433.3 [Cerebrovascular insufficiency],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.147,,2.998,0.197,0.326,0.995,3
CD163,GE_973.5 [Huntington's disease],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.106,1.385,1.473,0.08,0.085,,2
CDH3,SO_386.5 [Color vision deficiencies],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,3.247,0.274,0.125,0.975,2
SLC1A3,MB_305.1 [Tics and tic disorders],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.141,2.612,2.395,0.153,0.093,,2
CXCR4,GI_542.8 [Biliary cirrhosis],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.168,3.088,2.815,2.568,0.179,,2
DPF2,CM_750.16 [Arnold-Chiari syndrome*],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.278,,0.021,0.271,1
BRCA1,CV_441 [Arteriovenous malformation],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,3.176,0.581,0.399,0.993,2
HSP90B1,GE_973.5 [Huntington's disease],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,2.488,0.199,0.094,0.081,,2
KCNMB4,CM_763.13 [Patent ductus arteriosus],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.108,0.016,0.026,0.219,1
IER5,NS_341.1 [Cerebral palsy],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.458,1.494,,0.027,0.322,2
YAP1,CV_414.1 [Hypertrophic cardiomyopathy],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.194,2.422,2.613,0.326,0.224,0.503,3
NUP62,NS_344.2 [Benign intracranial hypertension],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,4.625,,0.009,0.308,2
SPARC,CM_770.5 [Congenital osteodystrophies],0.063,0,0.0,0.0,0.0,0.0,0.266,0.621,0.096,,0.299,0.364,0.089,0.947,4
ABCB7,MS_712.51 [Hypermobility syndrome],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.188,,1.91,0.202,1.71,,2
NDUFAF1,CV_414.1 [Hypertrophic cardiomyopathy],0.063,0,0.0,0.0,0.684,0.0,0.0,0.0,0.058,1.916,2.919,1.148,0.259,0.987,4
KIF5C,CM_770.5 [Congenital osteodystrophies],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,2.135,2.324,0.104,1.625,0.296,3
AUTS2,CV_414.1 [Hypertrophic cardiomyopathy],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,2.856,3.374,1.007,0.411,0.072,3
UBASH3B,DE_669.2 [Behcet's syndrome],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.259,1.91,0.45,0.103,0.129,,2
ARPC4,GE_972.2 [Hereditary ataxia],0.063,0,0.0,0.059,0.0,0.0,0.0,0.0,0.0,,0.043,,,0.273,2
SMC2,NS_323.3 [Motor neuron disease],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,1.944,2.932,0.421,0.307,0.041,3
IER5,CM_751.213 [Congenital cataract],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.833,1.496,,0.033,0.094,2
IPO9,NS_339.2 [Myotonic disorders],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.061,2.735,0.148,0.07,0.08,,2
IMMP2L,SO_369.62 [Keratoconus],0.063,0,0.0,0.0,0.532,0.0,0.0,0.0,0.012,2.366,2.472,0.225,0.11,0.197,4
MT-ND3,GE_972.1 [Hereditary neuropathy],0.063,0,0.0,0.0,0.0,0.0,0.0,0.362,0.061,,,,,,2
CD163,GE_964.3 [Glycogen storage disease],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.096,,1.588,0.177,0.154,,2
MAP3K7,CM_770.5 [Congenital osteodystrophies],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,3.194,0.355,0.111,0.124,0.904,3
HSD17B4,GE_972.2 [Hereditary ataxia],0.063,0,0.0,0.0,0.801,0.0,0.29,0.0,0.099,2.277,2.995,0.842,0.382,0.962,5
RPL18A,CM_770.5 [Congenital osteodystrophies],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.315,2.262,,,0.3,2
CLCN2,GE_972.2 [Hereditary ataxia],0.063,0,0.0,0.0,0.758,0.0,0.0,0.129,0.117,1.527,2.3,0.919,0.444,0.845,4
ALMS1,CV_414.1 [Hypertrophic cardiomyopathy],0.063,0,0.0,0.0,0.532,0.0,0.0,0.0,0.417,2.774,2.899,0.874,0.425,0.865,4
SLC4A4,GU_580.1 [Acute nephritic syndrome],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.021,1.804,3.292,0.522,0.207,0.234,3
CD4,GE_972.1 [Hereditary neuropathy],0.063,0,0.0,0.0,0.0,0.0,0.474,0.0,0.088,1.779,2.592,0.071,0.116,,3
SPTBN1,GI_542.8 [Biliary cirrhosis],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.117,2.183,2.782,0.485,0.457,,2
TLL1,CM_770.5 [Congenital osteodystrophies],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.071,2.823,2.842,,0.07,0.33,3
MYH11,GE_972.9 [Muscular dystrophy],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,1.987,4.022,0.402,0.247,0.86,3
CAMTA1,NS_323.3 [Motor neuron disease],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.07,2.34,3.51,1.346,0.436,0.153,3
BRPF1,MB_302.1 [Speech and language developmental delay],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,,1.672,0.255,0.52,0.214,3
BECN1,CV_414.1 [Hypertrophic cardiomyopathy],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.063,2.279,2.717,0.21,0.353,0.366,3
CPE,GE_963.1 [Lipid storage disorders],0.063,0,0.0,0.0,0.0,0.0,0.0,0.0,0.116,1.947,0.73,0.1,0.086,0.254,3
PRMT5,GE_972.2 [Hereditary ataxia],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.158,,2.568,0.179,0.173,0.802,3
IGF1R,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,3.193,3.293,0.345,0.263,0.905,3
PPM1A,CM_751.213 [Congenital cataract],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.376,0.075,,0.033,0.284,2
GRIN2B,MB_305.1 [Tics and tic disorders],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.061,2.967,0.2,,,,2
CNTNAP2,NS_323.3 [Motor neuron disease],0.062,0,0.0,0.0,0.0,0.0,0.289,0.0,0.018,2.9,2.609,0.589,0.582,0.19,4
NOTCH1,MB_302.1 [Speech and language developmental delay],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.128,3.375,2.292,0.226,0.938,3
KIF6,CV_438.41 [Aortic dissection],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.103,1.875,3.386,0.33,1.435,0.015,3
HSP90B1,DE_663.2 [Pemphigoid],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.158,1.473,1.971,0.211,0.141,,2
GABRB3,MB_301.2 [Asperger's syndrome*],0.062,0,0.0,0.0,0.0,0.0,0.327,0.0,0.085,3.003,0.1,0.028,0.053,,3
TNF,MB_293.1 [Anorexia nervosa],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.258,,3.12,2.624,0.028,,2
APC,GE_964.3 [Glycogen storage disease],0.062,0,0.0,0.0,0.0,0.0,0.393,0.0,0.018,1.361,3.718,1.386,0.353,,3
ATM,CV_413.41 [Pulmonary valve stenosis],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.488,2.516,0.228,0.766,0.973,2
MTOR,NS_344.2 [Benign intracranial hypertension],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.517,3.559,3.48,0.206,0.996,2
PPM1A,BI_179.1 [Hypogammaglobulinemia NOS],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.655,0.069,,0.029,0.2,2
BIK,CV_433.3 [Cerebrovascular insufficiency],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.066,2.612,1.744,0.043,0.037,0.225,3
GATA2,EM_209.4 [Diabetes insipidus],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,2.692,0.658,0.162,0.112,0.955,3
NDUFA6,NS_341.1 [Cerebral palsy],0.062,1,2.0,0.0,0.0,0.0,0.0,0.0,0.0,2.464,0.301,0.148,0.04,0.946,2
IFITM5,GE_978.3 [Osteochondrodysplasias],0.062,0,0.0,0.0,0.0,0.0,0.327,0.531,0.201,,0.143,0.149,0.05,,3
MORC2,GE_961.1 [Phakomatoses],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.152,2.664,3.062,1.906,0.192,0.169,3
GSK3B,NS_328.13 [Frontotemporal dementia [FTD]],0.062,1,2.0,0.0,0.0,0.0,0.0,0.0,0.05,3.001,0.176,,0.097,,2
IRF4,NS_338.1 [Myasthenia gravis],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.073,3.511,2.59,0.089,0.089,,2
FOXP1,MS_700.3 [Systemic sclerosis],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.071,1.851,0.061,,,,2
NTRK2,MS_712.51 [Hypermobility syndrome],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.14,2.929,1.833,0.126,0.232,,2
SREBF2,GE_973.5 [Huntington's disease],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.195,,1.704,0.14,0.09,,2
EIF3G,NS_333.7 [Narcolepsy],0.062,0,0.0,0.0,0.0,0.079,0.0,0.452,0.102,,0.336,0.071,0.053,,3
HNRNPA1,DE_663.2 [Pemphigoid],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.103,,0.141,0.107,0.067,,1
RUNX2,MS_727.5 [Cyst of bone],0.062,0,0.0,0.0,0.0,0.0,0.381,0.0,0.056,2.166,2.034,0.649,0.248,,3
CNP,GE_972.2 [Hereditary ataxia],0.062,0,0.0,0.0,0.0,0.0,0.318,0.0,0.015,,2.246,1.42,1.84,0.928,4
EZH2,GE_972.2 [Hereditary ataxia],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.158,1.4,2.041,0.06,0.127,0.905,3
KPNB1,GE_961.1 [Phakomatoses],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.217,,,0.217,1
RYR1,NS_341.1 [Cerebral palsy],0.062,1,4.0,0.0,0.0,0.0,0.0,0.0,0.03,1.938,4.739,0.405,0.207,0.896,3
UCHL1,CV_414.1 [Hypertrophic cardiomyopathy],0.062,0,0.0,0.0,0.547,0.0,0.0,0.0,0.061,1.87,0.824,0.121,0.104,0.169,4
FOXP2,NS_333.4 [Circadian rhythm sleep disorder],0.062,0,0.0,0.0,0.0,0.519,0.0,0.0,0.033,1.986,2.872,0.375,0.126,0.543,3
GAA,NS_323.3 [Motor neuron disease],0.062,0,0.0,0.0,0.0,0.0,0.382,0.0,0.014,3.142,2.731,0.978,0.447,0.289,4
NDUFA6,GE_963.1 [Lipid storage disorders],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.169,0.064,0.102,0.018,0.947,2
GATA3,DE_669.2 [Behcet's syndrome],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.693,3.083,0.187,0.201,0.057,,2
AP3B1,DE_663.1 [Pemphigus],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.091,2.249,2.126,0.162,0.118,,2
AXL,GE_977.6 [Congenital cutaneous mastocytosis*],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.217,1.875,2.8,0.075,0.088,,2
SIX3,GU_580.1 [Acute nephritic syndrome],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.282,2.255,,0.025,0.274,2
PTGS2,RE_477.2 [Hypersensitivity pneumonitis],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.206,,2.512,0.129,0.127,,2
ADAM17,CM_770.5 [Congenital osteodystrophies],0.062,0,0.0,0.0,0.0,0.0,0.265,0.0,0.082,,2.704,0.088,0.129,0.7,4
NF1,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.036,1.366,1.275,0.398,0.405,0.742,3
PRKCB,DE_663.2 [Pemphigoid],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.188,3.413,1.832,1.822,1.876,,2
BMPR2,CV_441 [Arteriovenous malformation],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.065,,2.98,0.296,0.222,0.948,3
TRPC5,GU_580.51 [Focal and segmental glomerular lesions*],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,3.095,0.128,0.108,0.077,,2
GLB1,GE_963.3 [Mucopolysaccharidoses],0.062,1,0.5,0.0,0.0,0.0,0.0,0.896,0.076,,0.162,0.123,0.087,,2
IFT81,CM_770.5 [Congenital osteodystrophies],0.062,0,0.0,0.0,0.0,0.0,0.0,0.724,0.04,,3.283,0.422,0.171,0.503,4
RPL27A,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.191,3.011,,,0.22,2
VPS13A,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.062,0,0.0,0.0,0.0,0.0,0.0,0.898,0.188,3.366,2.751,0.833,0.727,0.214,4
MEIS2,MS_700.3 [Systemic sclerosis],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,3.245,0.987,0.133,0.147,,2
PEX16,NS_341.1 [Cerebral palsy],0.062,0,0.0,0.0,0.426,0.0,0.0,0.0,0.043,1.992,0.255,0.129,0.164,0.986,4
LMO3,NS_344.2 [Benign intracranial hypertension],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.63,0.054,,3.657,0.128,2
PSMC4,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.344,0.127,,0.122,0.152,2
DCN,RE_484.1 [Spontaneous pneumothorax],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.701,0.926,0.387,0.625,0.958,2
VEGFA,MS_704.9 [Allergic purpura [Henoch-Schoenlein purpura]],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.126,2.501,2.835,0.212,0.116,,2
MESD,GE_978.3 [Osteochondrodysplasias],0.062,0,0.0,0.0,0.0,0.0,0.0,0.75,0.082,,0.183,0.131,0.097,,2
ACVR1B,NS_323.3 [Motor neuron disease],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,,2.662,2.513,1.337,0.038,3
BCORL1,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.712,3.943,,0.058,0.164,2
CDKL5,MB_302.1 [Speech and language developmental delay],0.062,0,0.0,0.0,0.0,0.0,0.263,0.37,0.017,1.627,0.173,0.164,0.114,0.978,5
VPS54,NS_323.3 [Motor neuron disease],0.062,0,0.0,0.0,0.532,0.0,0.258,0.0,0.033,,1.647,0.361,0.286,0.095,5
NR1H4,DE_663.2 [Pemphigoid],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.347,1.41,0.3,0.114,0.147,,2
KPNB1,GE_963.1 [Lipid storage disorders],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.196,,,0.184,1
SYNE2,GE_972.2 [Hereditary ataxia],0.062,0,0.0,0.0,0.654,0.0,0.0,0.29,0.0,2.531,3.337,0.459,0.958,0.93,3
HK1,EM_209.4 [Diabetes insipidus],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.061,2.243,2.527,0.199,0.144,0.164,3
TNF,NS_339.2 [Myotonic disorders],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.376,,0.912,0.123,0.024,,1
FGF7,MS_727.3 [Osteitis deformans [Paget's disease of bone]],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,,0.106,0.049,0.097,,1
DRD2,MB_296.2 [Schizoid personality disorder],0.062,1,4.0,0.0,0.0,0.0,0.0,0.0,0.132,1.955,0.257,0.133,0.053,,2
POMT2,SO_380.3 [Optic atrophy],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,1.498,0.436,0.712,0.986,2
HDAC4,NS_323.3 [Motor neuron disease],0.062,0,0.0,0.06,0.0,0.0,0.0,0.0,0.074,2.965,2.84,0.055,0.262,0.215,4
CD19,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.062,1,3.0,0.0,0.0,0.0,0.0,0.0,0.086,,3.129,0.182,0.11,0.988,3
GRIN2B,CM_751.213 [Congenital cataract],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.528,4.29,,,0.342,2
PIK3R1,GE_961.1 [Phakomatoses],0.062,1,1.0,0.0,0.0,0.0,0.0,0.0,0.03,2.985,2.613,0.123,1.743,0.913,3
IFT140,SO_386.6 [Night blindness],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,3.211,0.879,0.261,0.997,2
PIK3R5,GE_972.2 [Hereditary ataxia],0.062,0,0.0,0.0,0.654,0.0,0.0,0.521,0.061,1.813,1.258,0.388,0.192,0.56,4
FLNC,GE_972.2 [Hereditary ataxia],0.062,0,0.0,0.0,0.547,0.0,0.0,0.37,0.024,,3.322,0.827,0.574,0.769,4
FGFR2,SO_381.5 [Vertical strabismus],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.031,2.69,0.765,0.18,0.124,,2
FGFR2,CV_414.1 [Hypertrophic cardiomyopathy],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.119,2.509,3.397,0.388,0.301,0.605,3
PPARGC1A,CM_770.5 [Congenital osteodystrophies],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.043,2.693,1.043,0.275,0.178,0.92,3
NFKB1,GU_580.52 [Diffuse membranous glomerulonephritis],0.062,1,2.0,0.0,0.0,0.583,0.0,0.0,0.072,2.531,3.042,0.248,1.831,,2
TUBA1B,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.311,,,0.284,1
WDR45,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.062,0,0.0,0.0,0.0,0.0,0.292,0.493,0.123,,0.139,0.047,0.039,0.335,4
BDNF,MS_727.5 [Cyst of bone],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.103,2.024,2.366,0.618,0.149,,2
KRT2,GE_977.1 [Congenital ichthyosis],0.062,0,0.0,0.0,0.867,0.0,0.394,0.0,0.05,,2.495,0.054,0.05,0.994,5
TEAD1,GE_978.22 [Ehler's Danlos syndrome],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.146,2.72,2.359,0.059,0.073,,2
JAG1,CV_433.3 [Cerebrovascular insufficiency],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.033,4.409,3.246,0.229,0.165,0.981,3
NF1,DE_663.1 [Pemphigus],0.062,0,0.0,0.0,0.0,0.0,0.379,0.0,0.03,1.681,4.014,0.181,0.177,,3
ACTA1,CV_414.1 [Hypertrophic cardiomyopathy],0.062,0,0.0,0.0,0.779,0.0,0.0,0.402,0.1,,3.083,0.113,0.13,0.845,4
BCL2,MS_700.3 [Systemic sclerosis],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.146,2.797,1.558,0.04,0.08,,2
EPHA4,NS_323.3 [Motor neuron disease],0.062,1,0.5,0.0,0.801,0.0,0.412,0.0,0.071,2.27,2.729,0.426,0.317,0.669,5
TEK,CV_414.1 [Hypertrophic cardiomyopathy],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.024,2.263,2.71,0.386,1.126,0.427,3
PIK3CB,MS_704.1 [Polyarteritis nodosa and related conditions],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.152,1.345,2.075,0.209,1.939,,2
NPR1,CV_414.1 [Hypertrophic cardiomyopathy],0.062,0,0.0,0.0,0.426,0.0,0.591,0.0,0.043,,2.954,0.699,0.413,0.27,5
DHX9,GI_540.11 [Autoimmune hepatitis],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.094,,3.199,2.994,0.15,,2
IER5,CV_438.41 [Aortic dissection],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.221,1.931,,0.032,0.07,2
RUNX2,MS_715.5 [Ankylosing hyperostosis [Forestier]],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.073,2.397,0.199,0.122,0.093,,2
FMR1,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.21,1.866,3.659,0.264,0.122,0.123,3
TTC7B,MB_302.1 [Speech and language developmental delay],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.061,1.974,0.269,0.244,0.18,0.306,3
NLRP3,GI_542.8 [Biliary cirrhosis],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.282,1.86,2.567,0.174,0.226,,2
TCF20,GE_972.2 [Hereditary ataxia],0.062,0,0.0,0.038,0.0,0.0,0.0,0.0,0.043,1.585,4.376,0.375,0.436,0.334,4
SGCB,CV_414.1 [Hypertrophic cardiomyopathy],0.062,0,0.0,0.0,0.0,0.0,0.432,0.008,0.035,,0.67,0.36,0.205,0.321,4
LSAMP,MB_306 [Conduct disorders],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.036,2.372,0.079,0.059,0.049,,2
RIMS1,SO_386.5 [Color vision deficiencies],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.423,2.517,1.419,0.165,0.984,2
IL1B,GI_540.4 [Alcoholic hepatitis],0.062,1,2.0,0.0,0.0,0.0,0.0,0.0,0.163,,0.134,0.131,0.043,,1
INSR,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.055,2.017,2.543,0.226,0.161,0.918,3
PIK3C2A,GE_976.5 [Polycystic kidney disease],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.128,1.893,3.5,0.363,0.498,,2
NAA25,CV_433.3 [Cerebrovascular insufficiency],0.062,0,0.0,0.0,0.0,0.035,0.0,0.0,0.085,,2.25,0.142,0.152,0.335,3
TJP1,MS_704.1 [Polyarteritis nodosa and related conditions],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.263,2.102,2.8,1.003,0.241,,2
CD86,MS_700.3 [Systemic sclerosis],0.062,1,2.0,0.0,0.0,0.0,0.0,0.0,0.314,,2.607,0.084,0.089,,2
RUVBL2,GE_972.9 [Muscular dystrophy],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,1.972,,0.015,0.307,2
TNC,GE_972.9 [Muscular dystrophy],0.062,0,0.0,0.032,0.0,0.0,0.0,0.0,0.112,2.905,3.167,0.882,0.258,0.926,4
TTN,CV_433.3 [Cerebrovascular insufficiency],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.874,3.995,0.924,0.197,0.981,2
PPIA,SO_369.62 [Keratoconus],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.122,0.028,0.024,0.343,1
WDFY4,GI_542.8 [Biliary cirrhosis],0.062,0,0.0,0.0,0.0,0.489,0.0,0.0,0.018,1.46,4.143,0.863,0.442,,2
PLCE1,CV_438.41 [Aortic dissection],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,2.107,2.927,1.597,0.527,0.074,3
LEPR,MS_704.1 [Polyarteritis nodosa and related conditions],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.079,2.823,1.751,0.143,0.141,,2
PDGFRA,NS_323.3 [Motor neuron disease],0.062,1,3.0,0.0,0.0,0.0,0.0,0.0,0.012,2.885,2.717,0.195,0.099,0.294,3
OGDH,GI_542.8 [Biliary cirrhosis],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.167,,2.911,0.285,0.293,,2
CTNND2,CV_433.3 [Cerebrovascular insufficiency],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,2.663,3.856,0.293,0.204,0.229,3
PIK3R4,GE_972.9 [Muscular dystrophy],0.062,0,0.0,0.0,0.0,0.071,0.0,0.0,0.024,1.35,3.447,2.753,0.179,0.398,3
SRC,GE_972.9 [Muscular dystrophy],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.059,,0.089,0.05,0.125,0.897,2
CFTR,NS_341.1 [Cerebral palsy],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.564,3.378,0.856,1.243,0.96,2
SHROOM3,GU_580.1 [Acute nephritic syndrome],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.055,2.176,2.791,0.121,0.184,0.286,3
IL18,NS_328.13 [Frontotemporal dementia [FTD]],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.04,1.963,1.746,0.032,0.029,,2
ADRA2A,"MB_280.4 [Sedative, hypnotic, or anxiolytic related disorders]",0.062,1,4.0,0.0,0.0,0.0,0.0,0.0,0.018,2.566,0.361,0.036,0.062,,2
SLC52A3,NS_323.3 [Motor neuron disease],0.062,0,0.0,0.0,0.0,0.0,0.0,0.648,0.019,1.596,1.953,0.574,0.909,0.043,4
HMGB1,GU_580.1 [Acute nephritic syndrome],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.36,2.474,1.765,0.089,,0.929,3
SSBP3,CM_763.31 [Ventricular septal defect],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.873,1.462,,,0.25,2
VEGFA,GE_961.1 [Phakomatoses],0.062,1,2.0,0.0,0.0,0.0,0.0,0.0,0.074,2.565,2.031,0.185,1.552,0.975,3
RYR1,GE_972.2 [Hereditary ataxia],0.062,0,0.0,0.06,0.684,0.0,0.286,0.0,0.024,,3.568,1.268,0.279,0.954,6
FGG,MS_704.1 [Polyarteritis nodosa and related conditions],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.091,2.487,0.276,0.104,2.013,,2
PMM2,GE_972.9 [Muscular dystrophy],0.062,0,0.0,0.0,0.0,0.0,0.0,0.352,0.018,3.032,2.208,0.486,0.094,0.891,4
RUNX1,GE_970.2 [Thalassemia],0.062,0,0.0,0.0,0.0,0.0,0.407,0.0,0.036,3.877,1.931,0.74,0.373,,3
SNRPE,EM_209.4 [Diabetes insipidus],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.589,0.053,,,0.183,2
RAB35,RE_484.1 [Spontaneous pneumothorax],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.642,0.105,,0.074,0.101,2
RPL7,NS_333.4 [Circadian rhythm sleep disorder],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.096,1.062,,,0.15,2
SCN3A,NS_341.1 [Cerebral palsy],0.062,1,4.0,0.0,0.547,0.0,0.0,0.0,0.0,1.916,4.097,0.293,0.296,0.851,3
HDAC2,GE_972.9 [Muscular dystrophy],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.089,2.843,0.24,0.096,0.064,0.789,3
CD86,GI_540.11 [Autoimmune hepatitis],0.062,1,1.0,0.0,0.0,0.0,0.0,0.0,0.2,,1.197,0.084,0.087,,1
DYRK1A,NS_328.13 [Frontotemporal dementia [FTD]],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.087,1.672,2.564,0.122,0.182,,2
IGF1R,"EM_209.11 [Tall stature, acromegaly and gigantism]",0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.103,2.31,3.049,1.939,0.154,,2
PIGR,GI_540.11 [Autoimmune hepatitis],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.172,,2.096,1.431,0.161,,2
RPL11,SO_386.6 [Night blindness],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.159,,,0.17,1
ITGAL,CV_433.3 [Cerebrovascular insufficiency],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.097,,2.744,0.195,0.149,0.811,3
DRD2,GE_972.2 [Hereditary ataxia],0.062,0,0.0,0.0,0.0,0.0,0.313,0.0,0.025,,2.845,0.125,0.156,0.96,4
ANLN,GU_580.51 [Focal and segmental glomerular lesions*],0.062,0,0.0,0.0,0.0,0.0,0.0,0.655,0.17,2.996,3.745,0.64,0.148,,3
TWNK,GE_972.9 [Muscular dystrophy],0.062,0,0.0,0.0,0.547,0.0,0.0,0.0,0.046,,1.804,0.116,0.148,,3
KRT12,SO_369.62 [Keratoconus],0.062,0,0.0,0.0,0.426,0.0,0.44,0.0,0.061,2.666,1.096,0.73,1.266,0.316,5
DMP1,GE_978.3 [Osteochondrodysplasias],0.062,0,0.0,0.0,0.0,0.0,0.399,0.402,0.03,,1.999,0.206,0.104,,4
TMEM138,GE_972.2 [Hereditary ataxia],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.122,0.226,0.108,0.968,1
RAB18,GE_972.2 [Hereditary ataxia],0.062,0,0.0,0.021,0.0,0.0,0.302,0.0,0.015,2.522,0.151,,0.076,0.451,5
PTCH1,DE_663.2 [Pemphigoid],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.117,1.846,3.76,1.233,0.279,,2
UBE2L3,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.066,,,0.143,1
HCN2,CV_414.1 [Hypertrophic cardiomyopathy],0.062,0,0.0,0.0,0.0,0.0,0.279,0.0,0.03,2.328,2.96,0.367,1.806,0.102,4
BMP4,DE_663.2 [Pemphigoid],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.095,1.742,3.903,2.164,0.106,,2
HIF1A,MS_727.3 [Osteitis deformans [Paget's disease of bone]],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.085,2.474,0.877,0.344,0.27,,2
RS1,SO_386.6 [Night blindness],0.062,0,0.0,0.0,0.0,0.0,0.287,0.0,0.0,,4.026,3.127,0.071,0.99,3
GABRA4,NS_333.4 [Circadian rhythm sleep disorder],0.062,1,4.0,0.0,0.0,0.0,0.0,0.0,0.0,1.848,0.292,,0.085,0.204,2
SLC6A4,GE_978.3 [Osteochondrodysplasias],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.081,1.521,0.255,0.124,0.122,,2
SLC7A1,GE_972.9 [Muscular dystrophy],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.228,0.235,0.116,0.089,0.302,3
MAD1L1,MB_306 [Conduct disorders],0.062,0,0.0,0.0,0.0,0.267,0.0,0.0,0.027,2.83,2.29,0.109,0.162,,2
TRIM9,NS_338.1 [Myasthenia gravis],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.083,2.803,0.207,0.238,0.252,,2
NCOR1,MS_700.3 [Systemic sclerosis],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.578,,2.869,0.423,0.467,,2
AMD1,CV_441 [Arteriovenous malformation],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.704,1.154,,0.102,0.075,2
RAP2C,"EM_209.11 [Tall stature, acromegaly and gigantism]",0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.814,0.07,,5.088,,1
LSM12,SO_380.3 [Optic atrophy],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.856,,0.023,0.213,1
ATP8B1,GE_964.3 [Glycogen storage disease],0.062,0,0.0,0.0,0.0,0.0,0.477,0.0,0.035,2.649,3.984,0.371,0.242,,3
CCR2,BI_179.1 [Hypogammaglobulinemia NOS],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.977,0.334,0.095,0.943,2
FGFR1,MS_727.5 [Cyst of bone],0.062,0,0.0,0.0,0.0,0.0,0.485,0.0,0.048,2.766,2.89,0.673,0.25,,3
ERCC4,BI_162.1 [Constitutional (hereditary) aplastic anemia],0.062,0,0.0,0.0,0.0,0.0,0.0,0.771,0.165,2.915,2.243,0.571,0.13,,3
BMAL1,GE_964.3 [Glycogen storage disease],0.062,0,0.0,0.0,0.0,0.0,0.347,0.0,0.091,2.739,,,,,3
CANX,GE_972.2 [Hereditary ataxia],0.062,0,0.0,0.0,0.0,0.0,0.33,0.0,0.015,,2.875,0.234,0.139,0.939,4
MESD,CM_770.5 [Congenital osteodystrophies],0.062,0,0.0,0.0,0.0,0.0,0.0,0.75,0.082,,0.229,0.141,0.098,,2
PEX1,SO_386.6 [Night blindness],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.147,0.228,0.266,0.997,2
C9orf72,MS_704.1 [Polyarteritis nodosa and related conditions],0.062,0,0.0,0.0,0.0,0.0,0.364,0.0,0.134,2.314,3.633,2.309,0.119,,3
GFM1,NS_341.1 [Cerebral palsy],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.231,0.311,0.227,0.964,2
TJP1,GE_974.3 [Hereditary choroidal dystrophies],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.182,1.923,2.956,2.011,0.108,,2
APP,CM_763.31 [Ventricular septal defect],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.061,2.897,2.148,0.432,0.206,0.946,3
EPHA4,NS_341.1 [Cerebral palsy],0.062,0,0.0,0.0,0.547,0.0,0.0,0.0,0.012,2.956,2.942,0.231,0.182,0.809,4
CDH13,NS_323.3 [Motor neuron disease],0.062,0,0.0,0.0,0.532,0.0,0.0,0.0,0.024,2.691,4.777,,1.91,0.159,4
RPL11,CM_751.213 [Congenital cataract],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.095,0.183,,,0.214,2
ITGA4,GE_973.5 [Huntington's disease],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.097,3.399,1.531,0.129,0.079,,2
PMPCB,NS_341.1 [Cerebral palsy],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.87,0.382,0.192,0.965,2
SLC24A3,CV_433.3 [Cerebrovascular insufficiency],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.069,2.111,0.63,0.069,0.115,0.11,3
GLB1,NS_341.1 [Cerebral palsy],0.062,0,0.0,0.0,0.547,0.0,0.0,0.0,0.0,1.877,2.283,0.245,0.135,0.953,3
BRD2,NS_323.3 [Motor neuron disease],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.031,1.658,1.841,0.461,1.612,0.078,3
L2HGDH,GE_963.1 [Lipid storage disorders],0.062,0,0.0,0.0,0.547,0.0,0.266,0.0,0.024,,1.562,0.144,0.115,0.107,5
FARSA,NS_341.1 [Cerebral palsy],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,3.271,0.223,0.168,0.964,2
CFP,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.062,0,0.0,0.0,0.426,0.0,0.0,0.0,0.106,,1.124,0.106,0.09,0.91,3
RPL23,CV_433.3 [Cerebrovascular insufficiency],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.203,,0.02,0.226,1
GRM5,GE_972.2 [Hereditary ataxia],0.062,0,0.0,0.088,0.0,0.0,0.0,0.0,0.04,2.104,0.834,0.41,0.236,0.944,4
JUP,CV_414.1 [Hypertrophic cardiomyopathy],0.062,0,0.0,0.0,0.825,0.0,0.508,0.153,0.07,1.769,2.361,0.426,0.383,0.376,5
LPIN1,GE_972.9 [Muscular dystrophy],0.062,0,0.0,0.0,0.547,0.0,0.0,0.0,0.024,3.448,2.018,0.332,0.142,0.837,4
WNT5A,GU_580.1 [Acute nephritic syndrome],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.052,3.144,2.145,0.119,0.114,0.929,3
PATZ1,GE_972.2 [Hereditary ataxia],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,,0.213,0.133,0.164,0.305,2
FOXP3,GE_972.2 [Hereditary ataxia],0.062,0,0.0,0.0,0.0,0.0,0.274,0.0,0.123,,2.693,0.093,0.058,0.92,4
AR,MB_293.2 [Bulimia nervosa],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,2.437,3.341,,0.021,,2
DAG1,NS_323.3 [Motor neuron disease],0.062,0,0.0,0.0,0.0,0.0,0.343,0.0,0.012,,3.552,0.191,0.359,0.163,4
KCNQ2,NS_323.3 [Motor neuron disease],0.062,1,2.0,0.0,0.0,0.0,0.0,0.0,0.012,1.411,2.437,0.224,0.217,0.124,3
DHFR,NS_341.1 [Cerebral palsy],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.137,0.035,0.04,0.994,1
ATXN1,NS_323.3 [Motor neuron disease],0.062,0,0.0,0.066,0.532,0.0,0.0,0.0,0.104,2.8,3.045,0.564,0.643,0.69,5
RPH3A,EM_209.4 [Diabetes insipidus],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.114,2.248,2.804,0.414,0.143,0.173,3
BDNF,CV_414.1 [Hypertrophic cardiomyopathy],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.083,2.846,1.77,0.612,0.164,0.439,3
ITGAL,MS_700.3 [Systemic sclerosis],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.643,,2.915,0.233,0.264,,2
LGALS9,BI_179.7 [Common variable immunodeficiency [CVID]],0.062,0,0.0,0.0,0.0,0.0,0.388,0.0,0.195,1.906,0.299,0.105,0.054,,3
PDE1A,GE_976.5 [Polycystic kidney disease],0.062,0,0.0,0.0,0.0,0.0,0.447,0.0,0.074,2.077,0.378,0.242,0.255,,3
HIF1A,GE_966.2 [Disorders of porphyrin metabolism],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,2.529,2.785,0.119,0.078,,2
PPARG,CM_770.5 [Congenital osteodystrophies],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.04,,0.113,0.105,0.095,0.97,2
WNK1,GE_972.1 [Hereditary neuropathy],0.062,0,0.0,0.0,0.0,0.0,0.0,0.153,0.081,1.66,2.718,0.769,0.228,,3
FN1,CV_414.1 [Hypertrophic cardiomyopathy],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.386,2.605,2.921,0.467,0.146,0.482,3
PPP2R2C,GE_961.1 [Phakomatoses],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.336,0.152,,0.089,0.11,2
NRXN1,GE_978.3 [Osteochondrodysplasias],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.125,3.752,2.095,2.061,0.155,,2
RELN,MB_306 [Conduct disorders],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.132,1.617,2.859,0.27,0.288,,2
BRCA1,CM_763.31 [Ventricular septal defect],0.062,0,0.0,0.0,0.547,0.0,0.0,0.0,0.0,,2.762,0.819,0.215,0.971,3
REEP1,GE_972.1 [Hereditary neuropathy],0.062,0,0.0,0.0,0.0,0.0,0.262,0.146,0.026,1.966,2.335,0.037,0.123,,4
FOXO6,CV_413.41 [Pulmonary valve stenosis],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.33,0.211,,0.029,0.152,2
CD36,NS_341.1 [Cerebral palsy],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.222,3.755,0.905,0.265,0.932,2
F2,MS_700.3 [Systemic sclerosis],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.233,,3.651,0.16,0.126,,2
SLX4,BI_162.1 [Constitutional (hereditary) aplastic anemia],0.062,0,0.0,0.0,0.0,0.0,0.0,0.815,0.152,,3.701,1.11,0.132,,3
AICDA,GI_542.8 [Biliary cirrhosis],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.071,1.956,0.113,0.075,1.41,,2
ERCC4,GE_972.2 [Hereditary ataxia],0.062,0,0.0,0.0,0.834,0.0,0.0,0.462,0.254,2.161,1.913,0.414,0.275,0.876,4
MT-ND4,GE_972.1 [Hereditary neuropathy],0.062,0,0.0,0.0,0.0,0.0,0.0,0.362,0.03,,,,,,2
IL4R,MS_700.3 [Systemic sclerosis],0.062,1,2.0,0.0,0.0,0.0,0.0,0.0,0.103,1.634,2.396,0.077,0.112,,2
ESR1,GE_972.9 [Muscular dystrophy],0.062,1,3.0,0.0,0.0,0.0,0.0,0.162,0.015,1.693,1.926,0.787,0.065,0.958,4
HARS2,NS_341.1 [Cerebral palsy],0.062,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,3.574,1.49,2.496,0.975,2
CD22,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.024,1.916,2.256,0.151,0.151,0.955,3
ARF1,RE_484.1 [Spontaneous pneumothorax],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.158,,0.026,0.284,1
FOXO3,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.015,1.406,2.082,0.306,0.127,0.903,3
REL,SO_369.62 [Keratoconus],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,2.508,0.884,0.152,0.104,0.184,3
NUTF2,GE_963.1 [Lipid storage disorders],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.064,,0.018,0.292,1
SYP,NS_328.13 [Frontotemporal dementia [FTD]],0.061,0,0.0,0.03,0.0,0.0,0.0,0.0,0.064,,0.117,,1.895,,3
KCNA4,GE_972.1 [Hereditary neuropathy],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.061,2.647,2.416,,0.099,,2
IFIH1,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.061,0,0.0,0.0,0.0,0.0,0.0,0.803,0.144,2.754,3.212,0.766,0.506,0.882,4
SARS2,NS_341.1 [Cerebral palsy],0.061,0,0.0,0.0,0.684,0.0,0.0,0.0,0.024,,2.131,0.165,0.106,0.98,4
ATXN1,NS_341.1 [Cerebral palsy],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.266,2.471,0.867,0.135,0.895,3
SYK,GU_580.1 [Acute nephritic syndrome],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.087,2.292,3.249,2.284,0.119,0.95,3
COL4A1,DE_663.2 [Pemphigoid],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.326,3.101,2.548,0.068,0.298,,2
PPARG,GI_540.4 [Alcoholic hepatitis],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.061,3.014,0.102,0.115,0.105,,2
PFN1,MS_727.3 [Osteitis deformans [Paget's disease of bone]],0.061,0,0.0,0.0,0.0,0.0,0.0,0.201,0.073,,0.218,0.076,,,2
GSK3B,GE_977.1 [Congenital ichthyosis],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.021,2.069,0.099,,0.062,0.23,3
HMGB1,CV_414.1 [Hypertrophic cardiomyopathy],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.283,2.066,0.866,0.172,,0.319,3
LITAF,GE_972.1 [Hereditary neuropathy],0.061,0,0.0,0.0,0.0,0.0,0.325,0.575,0.048,1.992,0.803,0.21,0.073,,4
TTBK2,NS_328.13 [Frontotemporal dementia [FTD]],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.295,1.511,0.6,0.441,0.216,,2
PIP4K2B,CM_770.5 [Congenital osteodystrophies],0.061,0,0.0,0.0,0.0,0.0,0.306,0.0,0.0,2.149,2.828,,0.021,0.241,3
TGFBR1,CV_441 [Arteriovenous malformation],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.112,2.096,0.483,0.238,0.171,0.98,3
SDHAF2,GE_961.1 [Phakomatoses],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.023,,0.121,0.168,0.122,0.953,2
HPRT1,NS_341.1 [Cerebral palsy],0.061,0,0.0,0.0,0.547,0.0,0.0,0.0,0.025,,0.133,0.142,2.76,0.903,4
BBS2,SO_380.3 [Optic atrophy],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.962,2.558,0.36,0.106,0.974,2
IGF1R,GE_970.1 [Sickle-cell disorders],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.079,2.851,1.885,0.038,0.241,,2
PIK3R1,GI_540.11 [Autoimmune hepatitis],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.052,2.719,1.233,0.109,0.159,,2
NUP54,NS_328.13 [Frontotemporal dementia [FTD]],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.122,,0.446,0.155,0.119,,1
LYN,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.022,2.918,2.486,0.038,0.098,0.974,3
MARK2,CM_770.5 [Congenital osteodystrophies],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.017,3.12,2.689,0.086,0.139,0.558,3
BDNF,GE_978.3 [Osteochondrodysplasias],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,3.2,0.143,0.088,0.093,,2
BECN1,DE_663.2 [Pemphigoid],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.168,,0.355,0.263,0.154,,1
CD86,GU_580.1 [Acute nephritic syndrome],0.061,1,4.0,0.0,0.0,0.0,0.0,0.0,0.064,2.88,2.136,0.091,0.064,0.967,3
ZNF512B,NS_323.3 [Motor neuron disease],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.108,,2.706,1.011,0.273,0.239,3
OTX2,GE_972.2 [Hereditary ataxia],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.079,2.519,2.113,,0.072,0.982,3
ADRA2A,GE_978.22 [Ehler's Danlos syndrome],0.061,1,4.0,0.0,0.0,0.0,0.0,0.0,0.0,2.523,3.116,0.013,0.028,,1
BRD2,NS_333.4 [Circadian rhythm sleep disorder],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.09,,1.485,0.234,0.145,0.459,3
STAT3,CV_414.1 [Hypertrophic cardiomyopathy],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.434,,2.251,0.112,0.169,0.922,3
ELP3,NS_323.3 [Motor neuron disease],0.061,0,0.0,0.0,0.775,0.0,0.0,0.129,0.033,2.967,2.291,0.479,0.271,0.881,4
LRP6,CM_770.5 [Congenital osteodystrophies],0.061,0,0.0,0.0,0.0,0.0,0.284,0.0,0.019,1.721,2.986,0.364,0.204,0.863,4
GSK3B,GU_580.52 [Diffuse membranous glomerulonephritis],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.138,3.229,2.42,,0.079,,2
TMEM121B,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.736,2.885,0.018,0.051,,1
PPARGC1A,GE_961.1 [Phakomatoses],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.088,2.652,2.4,0.795,0.226,0.896,3
SUV39H1,NS_343.3 [Complex regional pain syndrome],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.102,,0.224,,0
FLYWCH2,GE_972.9 [Muscular dystrophy],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.704,3.436,,0.026,0.116,2
MEFV,DE_669.2 [Behcet's syndrome],0.061,0,0.0,0.0,0.0,0.0,0.0,0.493,0.561,2.927,3.963,0.093,0.096,,3
CP,MS_700.3 [Systemic sclerosis],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.093,,2.509,0.19,0.14,,2
CR1,GU_580.1 [Acute nephritic syndrome],0.061,0,0.0,0.0,0.58,0.0,0.0,0.0,0.07,1.324,2.827,0.433,0.16,0.76,4
ENOX2,DE_663.2 [Pemphigoid],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.219,1.932,2.809,0.16,0.167,,2
TBX20,CM_763.13 [Patent ductus arteriosus],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.093,2.416,0.098,0.093,0.059,0.831,3
PRDM16,NS_344.11 [Communicating hydrocephalus],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.146,2.772,2.239,0.147,0.06,,2
MBNL1,GE_972.9 [Muscular dystrophy],0.061,0,0.0,0.0,0.598,0.0,0.289,0.0,0.058,2.385,3.324,3.118,0.076,0.807,5
RHOQ,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.079,,0.112,0.161,1
PPARGC1A,NS_341.1 [Cerebral palsy],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.343,3.73,1.009,0.97,0.983,2
NTN1,GE_972.2 [Hereditary ataxia],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.073,2.616,1.851,0.194,0.186,0.669,3
ACLY,MS_705.2 [Juvenile rheumatoid arthritis [JRA/JIA]],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.145,,0.416,0.406,0.133,,1
TLE4,GE_961.1 [Phakomatoses],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,3.189,0.57,0.23,0.189,0.18,3
VEGFA,MS_727.3 [Osteitis deformans [Paget's disease of bone]],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.075,2.777,3.154,3.398,0.152,,2
PRLR,MS_712.51 [Hypermobility syndrome],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.239,2.099,2.523,0.989,0.902,,2
EPHA4,CM_770.5 [Congenital osteodystrophies],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.043,4.915,2.04,0.207,1.391,0.584,3
PTHLH,CV_414.1 [Hypertrophic cardiomyopathy],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.121,3.195,0.262,0.036,0.093,0.205,3
KLHL7,SO_380.3 [Optic atrophy],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,2.173,0.09,0.138,0.141,0.916,3
FIP1L1,GE_977.6 [Congenital cutaneous mastocytosis*],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.081,2.745,0.906,0.13,0.076,,2
RAB6B,SO_365.3 [Exophthalmos [Proptosis]],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.619,0.346,,0.119,0.185,2
TJP1,GI_540.11 [Autoimmune hepatitis],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,4.665,2.844,0.545,0.978,,2
HCN1,GE_961.1 [Phakomatoses],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,3.053,1.248,0.054,0.113,0.108,3
S1PR1,DE_663.1 [Pemphigus],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.243,2.513,0.099,0.029,0.049,,2
FURIN,MS_727.3 [Osteitis deformans [Paget's disease of bone]],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.303,2.815,2.849,0.218,,2
TNFAIP3,MS_727.5 [Cyst of bone],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.117,2.019,2.466,0.485,0.222,,2
NFASC,CM_770.5 [Congenital osteodystrophies],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.035,2.496,3.591,0.547,0.228,0.294,3
SLC17A7,DE_663.2 [Pemphigoid],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.115,1.332,2.473,0.162,0.091,,2
ALB,GE_978.3 [Osteochondrodysplasias],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.108,1.991,2.597,0.281,0.099,,2
GADD45A,DE_663.2 [Pemphigoid],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.094,2.721,0.121,0.054,2.084,,2
PPP1R12C,GE_973.5 [Huntington's disease],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.186,1.897,0.194,0.17,2.351,,2
BCL2,GI_516.1 [Pyloric stenosis],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.092,2.406,0.049,0.105,0.981,2
RAD51D,CV_441 [Arteriovenous malformation],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,3.17,1.775,0.236,0.954,2
PDE4A,GE_976.5 [Polycystic kidney disease],0.061,1,0.5,0.0,0.0,0.0,0.0,0.0,0.294,,2.553,0.934,0.278,,2
SEPTIN9,NS_335.3 [Neuralgic amyotrophy],0.061,0,0.0,0.0,0.0,0.0,0.0,0.6,0.086,2.147,0.349,0.175,0.068,,3
PEX7,SO_386.6 [Night blindness],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,1.969,0.393,0.115,0.987,2
TRIP12,MB_302.1 [Speech and language developmental delay],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,1.695,2.493,0.575,0.225,0.318,3
FN1,CM_763.13 [Patent ductus arteriosus],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,3.274,2.414,0.812,0.195,0.907,3
HGSNAT,GE_963.3 [Mucopolysaccharidoses],0.061,0,0.0,0.0,0.0,0.0,0.0,0.884,0.057,1.979,2.294,0.057,0.041,,3
JAG1,GU_580.51 [Focal and segmental glomerular lesions*],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.024,2.593,3.842,2.992,1.729,,2
SNRPD2,MB_302.1 [Speech and language developmental delay],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.074,,,0.345,1
CP,GI_542.8 [Biliary cirrhosis],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.187,2.531,3.583,0.224,0.158,,2
CCN2,CM_770.5 [Congenital osteodystrophies],0.061,0,0.0,0.0,0.0,0.0,0.318,0.0,0.07,2.521,1.245,0.097,0.133,,3
AVIL,GU_580.1 [Acute nephritic syndrome],0.061,0,0.0,0.0,0.796,0.0,0.0,0.0,0.012,,3.41,0.658,0.259,0.073,4
SYT1,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.025,0.517,0.038,0.024,0.258,2
GABRA1,CM_770.5 [Congenital osteodystrophies],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.735,0.063,,0.05,0.198,2
DROSHA,NS_323.3 [Motor neuron disease],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.084,1.679,2.301,1.12,0.323,0.604,3
THBD,BI_168.12 [Hemorrhagic disorder due to intrinsic circulating anticoagulants],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.245,2.449,1.96,0.043,0.053,,2
SMC5,BI_162.1 [Constitutional (hereditary) aplastic anemia],0.061,0,0.0,0.0,0.0,0.0,0.347,0.0,0.109,1.364,0.251,0.256,0.122,,3
PUM1,GE_972.2 [Hereditary ataxia],0.061,0,0.0,0.0,0.801,0.0,0.0,0.29,0.117,1.628,2.68,0.703,0.255,0.798,4
ENG,GU_580.1 [Acute nephritic syndrome],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.104,1.667,3.196,0.206,0.093,0.728,3
BMP6,CM_770.5 [Congenital osteodystrophies],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.14,3.342,0.402,0.375,0.124,0.914,3
GEMIN5,GE_972.2 [Hereditary ataxia],0.061,0,0.0,0.0,0.848,0.0,0.0,0.0,0.056,1.373,3.581,0.765,0.362,0.539,4
COL2A1,MS_727.5 [Cyst of bone],0.061,0,0.0,0.0,0.0,0.0,0.386,0.0,0.044,,2.369,0.905,0.396,,3
RPL7,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.321,2.767,,,0.204,2
CELF2,NS_323.3 [Motor neuron disease],0.061,0,0.0,0.044,0.0,0.0,0.0,0.0,0.021,3.941,2.84,0.043,0.131,0.335,4
PRKCE,DE_663.2 [Pemphigoid],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.061,2.768,2.236,0.094,0.108,,2
ATP13A2,NS_333.4 [Circadian rhythm sleep disorder],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.047,0.223,0.195,0.988,2
CNN3,MS_700.3 [Systemic sclerosis],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.535,1.711,1.83,0.058,0.108,,2
SPIN1,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.709,0.062,0.034,,0.068,2
VEGFA,MS_704.1 [Polyarteritis nodosa and related conditions],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.335,1.64,0.17,0.113,0.069,,2
ADRA2C,SO_365.3 [Exophthalmos [Proptosis]],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.692,2.595,,0.04,0.186,2
SGSH,GE_963.3 [Mucopolysaccharidoses],0.061,1,3.0,0.0,0.0,0.0,0.266,0.933,0.074,,3.468,3.032,0.097,,4
UBE2D3,EM_209.4 [Diabetes insipidus],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.324,0.042,,,0.146,2
NOS1,CV_433.3 [Cerebrovascular insufficiency],0.061,1,0.5,0.0,0.0,0.0,0.0,0.0,0.176,2.129,2.598,0.647,0.573,0.563,3
SLC40A1,GI_540.11 [Autoimmune hepatitis],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.295,,2.407,2.251,0.145,,2
ETV6,GE_961.1 [Phakomatoses],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.261,3.843,4.309,1.741,0.848,3
MTMR12,GE_972.9 [Muscular dystrophy],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.096,1.641,2.317,0.086,0.121,0.094,3
NAA30,CM_750.16 [Arnold-Chiari syndrome*],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.105,0.013,0.018,0.197,1
MYRF,CM_763.31 [Ventricular septal defect],0.061,0,0.0,0.0,0.547,0.0,0.0,0.0,0.012,1.375,3.67,1.446,0.19,0.318,4
RPL36,SO_380.3 [Optic atrophy],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.205,0.047,,0.191,1
CD79B,CM_763.13 [Patent ductus arteriosus],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.087,0.021,0.031,0.307,1
RET,GE_964.3 [Glycogen storage disease],0.061,0,0.0,0.0,0.0,0.0,0.503,0.0,0.032,1.743,3.675,0.47,0.217,,3
TLR4,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.21,3.076,2.995,0.329,1.338,0.992,3
MARK2,BI_162.1 [Constitutional (hereditary) aplastic anemia],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.015,2.025,0.965,0.079,0.096,,2
ANGPT1,NS_323.3 [Motor neuron disease],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.061,2.219,0.333,0.212,0.222,0.087,3
GJB4,CV_414.1 [Hypertrophic cardiomyopathy],0.061,0,0.0,0.0,0.426,0.0,0.0,0.0,0.182,1.327,2.743,1.247,0.72,0.047,4
GAD1,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.024,2.235,1.911,0.08,0.164,0.233,3
CDK4,MS_727.5 [Cyst of bone],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.171,,1.234,0.208,0.117,,1
USP48,EM_211.1 [Adrenal hyperfunction],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.024,1.677,1.993,0.195,0.173,,2
BCL6,GE_972.2 [Hereditary ataxia],0.061,0,0.0,0.061,0.0,0.0,0.0,0.0,0.067,2.711,2.915,0.25,0.153,0.886,4
RPS11,CM_750.16 [Arnold-Chiari syndrome*],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.366,,0.009,0.25,1
TUBB2A,CV_433.3 [Cerebrovascular insufficiency],0.061,1,4.0,0.0,0.0,0.0,0.0,0.0,0.0,2.183,2.665,,,0.229,2
GSK3B,GE_961.1 [Phakomatoses],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.057,2.082,2.188,,0.097,0.988,3
DICER1,"MB_280.4 [Sedative, hypnotic, or anxiolytic related disorders]",0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,1.958,1.697,0.106,0.17,,2
FOS,MS_727.3 [Osteitis deformans [Paget's disease of bone]],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.106,2.993,1.821,0.407,0.147,,2
NDUFB1,NS_341.1 [Cerebral palsy],0.061,1,2.0,0.0,0.0,0.0,0.0,0.0,0.0,1.782,2.146,0.037,0.057,0.921,2
UCHL1,NS_323.3 [Motor neuron disease],0.061,0,0.0,0.0,0.0,0.0,0.387,0.0,0.077,1.863,0.122,0.057,0.106,0.837,4
IGF2R,GE_963.1 [Lipid storage disorders],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.023,2.216,2.539,1.36,0.215,0.181,3
SORBS2,GE_972.9 [Muscular dystrophy],0.061,0,0.0,0.0,0.0,0.0,0.311,0.0,0.639,3.79,3.658,1.506,0.198,0.518,4
PRDM10,GU_580.1 [Acute nephritic syndrome],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,2.262,2.114,0.085,0.265,0.06,3
PRKCA,GE_972.9 [Muscular dystrophy],0.061,1,3.0,0.0,0.0,0.0,0.0,0.0,0.023,1.978,0.394,0.088,0.084,0.884,3
BANF1,GE_961.1 [Phakomatoses],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.454,0.102,,,0.142,2
SLC5A5,GE_964.3 [Glycogen storage disease],0.061,0,0.0,0.0,0.0,0.0,0.396,0.0,0.055,,0.561,0.287,0.14,,2
SCN8A,MB_302.1 [Speech and language developmental delay],0.061,1,4.0,0.0,0.0,0.0,0.0,0.0,0.012,3.081,2.27,0.205,0.179,0.812,3
HTR2C,MB_298 [Impulse disorders],0.061,1,4.0,0.0,0.0,0.0,0.0,0.0,0.012,2.141,2.479,,0.021,,2
TAAR1,NS_333.7 [Narcolepsy],0.061,1,4.0,0.0,0.0,0.0,0.0,0.0,0.104,,2.873,1.738,0.099,,2
ATXN2,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.118,,3.921,0.135,0.263,0.204,3
FLNA,GI_516.1 [Pyloric stenosis],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,1.855,0.333,0.311,0.98,2
SELE,GU_580.1 [Acute nephritic syndrome],0.061,1,1.0,0.0,0.182,0.0,0.0,0.0,0.071,,2.869,0.257,0.14,0.86,4
ANK3,MB_306 [Conduct disorders],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.115,2.737,3.397,1.156,0.683,,2
SRSF1,NS_323.3 [Motor neuron disease],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.095,1.935,0.078,,,0.67,3
TGFB1,CM_770.5 [Congenital osteodystrophies],0.061,1,1.0,0.0,0.0,0.0,0.276,0.813,0.139,2.071,0.23,0.033,0.029,0.989,5
AP4E1,CM_751.213 [Congenital cataract],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.024,2.087,3.609,0.353,0.938,0.315,3
CP,GE_961.1 [Phakomatoses],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.124,3.707,1.405,0.174,1.642,0.212,3
CFLAR,NS_323.3 [Motor neuron disease],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,2.203,2.156,0.058,0.124,0.197,3
CHAF1A,NS_344.2 [Benign intracranial hypertension],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.564,2.661,0.025,,0.236,2
C4A,GU_580.52 [Diffuse membranous glomerulonephritis],0.061,0,0.0,0.0,0.0,0.0,0.339,0.0,0.072,13.503,1.277,0.113,0.088,,3
SHANK2,GE_972.9 [Muscular dystrophy],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.191,2.705,0.074,0.161,0.106,3
BAP1,GE_961.1 [Phakomatoses],0.061,0,0.0,0.0,0.0,0.0,0.261,0.0,0.018,,2.172,0.108,0.162,0.972,4
ELOVL4,GE_972.2 [Hereditary ataxia],0.061,0,0.0,0.067,0.828,0.0,0.0,0.29,0.065,1.366,0.551,0.126,0.123,0.88,5
DCX,GE_972.2 [Hereditary ataxia],0.061,0,0.0,0.03,0.0,0.0,0.0,0.0,0.033,3.1,0.344,,0.014,0.938,4
TJP1,CM_770.5 [Congenital osteodystrophies],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.021,1.951,2.347,0.166,0.421,0.698,3
TAS2R1,GE_974.3 [Hereditary choroidal dystrophies],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.406,2.753,0.013,0.032,,1
UMOD,GE_976.5 [Polycystic kidney disease],0.061,0,0.0,0.0,0.0,0.0,0.475,0.0,0.12,1.842,2.97,0.455,0.224,,3
PRDM5,GE_978.22 [Ehler's Danlos syndrome],0.061,0,0.0,0.0,0.0,0.0,0.0,0.447,0.037,2.997,0.127,0.31,0.131,,3
ATRN,BI_179.7 [Common variable immunodeficiency [CVID]],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.158,2.731,0.323,0.175,0.076,,2
TGM6,NS_341.1 [Cerebral palsy],0.061,0,0.0,0.0,0.547,0.0,0.0,0.0,0.064,1.73,2.771,0.418,0.191,0.627,4
JAK2,MS_700.43 [Polymyositis],0.061,1,3.0,0.0,0.0,0.0,0.0,0.0,0.238,2.654,2.149,0.191,0.154,,2
RUNX1,CM_763.31 [Ventricular septal defect],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.847,0.286,0.342,0.118,0.993,2
LHX9,GE_963.1 [Lipid storage disorders],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.021,2.041,0.072,0.06,0.069,0.031,3
FMNL1,CM_770.5 [Congenital osteodystrophies],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.483,1.362,4.01,2.256,0.153,0.207,3
RAB1A,CM_750.16 [Arnold-Chiari syndrome*],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.067,,0.023,0.22,1
SLC44A1,NS_323.3 [Motor neuron disease],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.024,2.721,1.838,0.336,1.729,0.068,3
PTPRC,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.061,0,0.0,0.0,0.0,0.0,0.298,0.0,0.038,2.96,1.899,0.072,1.854,0.995,4
PITX2,CV_414.1 [Hypertrophic cardiomyopathy],0.061,0,0.0,0.0,0.0,0.0,0.656,0.0,0.012,2.479,1.469,0.202,0.158,0.264,4
KAT5,BI_162.1 [Constitutional (hereditary) aplastic anemia],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.119,,0.065,0.055,0.083,,1
IPO5,SO_369.62 [Keratoconus],0.061,0,0.0,0.0,0.426,0.0,0.0,0.0,0.012,2.171,1.81,0.398,0.18,0.432,4
RAB7A,SO_369.62 [Keratoconus],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.873,3.143,,,0.2,2
COL4A1,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,2.743,3.417,0.224,0.272,0.956,3
MT-ATP8,SO_380.3 [Optic atrophy],0.061,0,0.0,0.0,0.0,0.0,0.0,0.503,0.03,,,,,,2
CALR,GI_542.8 [Biliary cirrhosis],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.33,,3.419,0.27,0.124,,2
CD44,BI_179.1 [Hypogammaglobulinemia NOS],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.968,2.372,0.793,0.136,0.987,2
PCDH19,MB_302.1 [Speech and language developmental delay],0.061,0,0.0,0.0,0.0,0.0,0.0,0.366,0.091,2.428,0.228,0.096,0.165,0.798,4
HDAC9,MB_306 [Conduct disorders],0.061,1,3.0,0.0,0.0,0.0,0.0,0.0,0.063,2.806,1.442,0.193,0.125,,2
MAGEA10,GE_972.2 [Hereditary ataxia],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.312,3.612,,0.06,0.115,2
HDAC4,GE_972.2 [Hereditary ataxia],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.089,2.767,2.74,0.572,0.232,0.81,3
IL18,EM_211.1 [Adrenal hyperfunction],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.074,,2.722,0.025,0.04,,2
RBBP4,EM_209.4 [Diabetes insipidus],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.118,,0.015,0.252,1
ARPC4,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.037,,,0.157,1
PTGS2,EM_209.4 [Diabetes insipidus],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.067,2.064,3.193,0.09,0.098,0.969,3
RORB,GE_961.1 [Phakomatoses],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,2.287,2.785,0.056,0.065,0.194,3
FOXD3,CV_433.3 [Cerebrovascular insufficiency],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.138,2.176,1.56,0.055,0.056,0.463,3
BBS7,SO_369.62 [Keratoconus],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.465,1.384,0.159,0.977,2
ATIC,MS_705.2 [Juvenile rheumatoid arthritis [JRA/JIA]],0.061,1,4.0,0.101,0.0,0.0,0.0,0.0,0.076,1.905,0.131,0.328,0.142,,3
HMGB1,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.07,2.867,1.755,0.1,,0.976,3
PCK2,MB_302.1 [Speech and language developmental delay],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.172,3.875,0.864,0.655,0.196,3
COX6B1,CM_763.13 [Patent ductus arteriosus],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.097,,0.021,0.255,1
CRB2,GU_580.1 [Acute nephritic syndrome],0.061,0,0.0,0.0,0.878,0.0,0.0,0.0,0.05,2.21,3.249,0.142,0.207,0.134,4
GATM,CV_414.1 [Hypertrophic cardiomyopathy],0.061,0,0.0,0.0,0.0,0.0,0.267,0.0,0.073,,2.484,0.283,0.796,0.124,4
CUL1,GE_972.1 [Hereditary neuropathy],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.134,2.059,0.229,,0.078,,2
ISY1-RAB43,SO_386.5 [Color vision deficiencies],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.031,,,0.158,1
RAB1A,SO_386.5 [Color vision deficiencies],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.727,0.073,,0.029,0.259,2
MB,GE_964.3 [Glycogen storage disease],0.061,0,0.0,0.0,0.0,0.0,0.281,0.0,0.044,2.419,0.082,0.114,0.09,,3
ARID1B,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.023,3.387,3.196,1.29,0.444,0.225,3
MORF4L1,CV_413.41 [Pulmonary valve stenosis],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.982,0.062,0.024,0.03,0.324,2
CACNA1E,GE_972.1 [Hereditary neuropathy],0.061,1,3.0,0.0,0.0,0.0,0.0,0.0,0.015,3.559,2.965,0.131,0.32,,2
NRG1,CV_433.3 [Cerebrovascular insufficiency],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.086,2.579,1.287,0.618,0.149,0.695,3
LRP8,NS_323.3 [Motor neuron disease],0.061,0,0.0,0.0,0.0,0.0,0.353,0.0,0.012,3.138,2.749,0.41,0.148,0.084,4
THBS1,NS_344.13 [(Idiopathic) normal pressure hydrocephalus],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.091,3.415,2.346,,0.061,,2
IKZF1,GE_961.1 [Phakomatoses],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.729,0.118,0.187,0.125,0.741,3
SCN5A,GE_977.6 [Congenital cutaneous mastocytosis*],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.132,1.906,1.465,0.439,1.608,,2
NARS2,CV_416.8 [Pre-excitation syndrome [Anomalous atrioventricular excitation]],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.87,1.111,0.901,0.203,0.963,2
EBF2,DE_663.2 [Pemphigoid],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.046,2.576,0.211,0.106,0.113,,2
HMBS,GE_972.9 [Muscular dystrophy],0.061,0,0.0,0.0,0.0,0.0,0.303,0.0,0.157,,1.771,1.444,0.116,0.318,4
APP,GE_963.1 [Lipid storage disorders],0.061,1,0.5,0.0,0.0,0.0,0.0,0.0,0.053,1.598,0.26,0.399,0.134,0.976,3
SNRPD3,NS_323.3 [Motor neuron disease],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,1.722,3.271,,2.299,0.114,3
SDHB,GE_972.2 [Hereditary ataxia],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.431,2.737,0.219,0.157,0.987,3
TOP2A,DE_663.2 [Pemphigoid],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.074,,2.76,0.262,0.154,,2
ACHE,MB_306 [Conduct disorders],0.061,1,4.0,0.0,0.0,0.0,0.0,0.0,0.106,,3.017,0.249,0.131,,2
EED,GE_977.1 [Congenital ichthyosis],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.754,4.093,,0.025,0.147,2
DIP2B,GE_972.9 [Muscular dystrophy],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,,3.329,1.835,0.888,0.139,3
AGTR1,CV_433.3 [Cerebrovascular insufficiency],0.061,1,4.0,0.0,0.0,0.0,0.0,0.0,0.134,3.206,2.389,0.454,0.132,0.902,3
BCL2,GE_976.5 [Polycystic kidney disease],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.125,2.068,0.159,0.039,0.085,,2
PTPN1,CV_433.3 [Cerebrovascular insufficiency],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.091,2.41,1.232,0.039,0.095,0.602,3
ARF6,SO_386.6 [Night blindness],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.685,0.11,,0.022,0.309,2
CALM1,EM_209.4 [Diabetes insipidus],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.858,0.063,,,0.107,2
TYK2,MS_700.43 [Polymyositis],0.061,1,3.0,0.0,0.0,0.0,0.0,0.0,0.123,3.485,3.041,0.795,0.112,,2
GATA2,CV_414.1 [Hypertrophic cardiomyopathy],0.061,0,0.0,0.0,0.426,0.0,0.0,0.0,0.021,2.168,2.014,0.347,0.195,0.68,4
GABBR1,GE_972.2 [Hereditary ataxia],0.061,1,0.5,0.057,0.0,0.0,0.0,0.0,0.026,,1.916,1.386,0.163,0.971,4
ESR1,CV_433.3 [Cerebrovascular insufficiency],0.061,1,0.5,0.0,0.304,0.0,0.0,0.0,0.089,1.926,3.2,0.465,0.102,0.987,4
GABRA2,GE_972.2 [Hereditary ataxia],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.248,0.123,,1.715,0.871,2
ADRA2C,SO_380.3 [Optic atrophy],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.683,0.27,,0.034,0.184,2
FGFR2,DE_663.2 [Pemphigoid],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.094,2.649,3.399,1.57,0.143,,2
BDNF,NS_341.6 [Cauda equina syndrome],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.128,2.419,0.842,0.808,0.147,,2
DUSP4,GE_964.3 [Glycogen storage disease],0.061,0,0.0,0.0,0.0,0.0,0.264,0.0,0.064,3.419,1.832,0.087,0.11,,3
GNAZ,CV_413.41 [Pulmonary valve stenosis],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.081,,0.017,0.291,1
PTPN6,CV_414.1 [Hypertrophic cardiomyopathy],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.103,,2.73,0.398,0.202,0.255,3
HTR2A,MB_296.1 [Paranoid personality disorder],0.061,1,4.0,0.0,0.0,0.0,0.0,0.0,0.116,2.34,0.236,0.033,0.042,,2
CRPPA,GE_972.9 [Muscular dystrophy],0.061,0,0.0,0.0,0.89,0.0,0.0,0.714,0.189,1.961,3.31,0.12,0.07,,3
NTRK2,NS_323.3 [Motor neuron disease],0.061,1,0.5,0.0,0.0,0.0,0.0,0.0,0.08,1.991,2.45,2.051,0.226,0.904,3
WFS1,CM_751.213 [Congenital cataract],0.061,0,0.0,0.0,0.789,0.0,0.0,0.121,0.165,2.798,2.788,0.426,0.235,0.916,4
CAVIN1,GE_972.9 [Muscular dystrophy],0.061,0,0.0,0.0,0.547,0.0,0.0,0.0,0.066,,2.187,0.133,0.113,,3
GATA2,GE_964.3 [Glycogen storage disease],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.047,1.9,3.262,2.578,0.116,,2
HAND2,CV_414.1 [Hypertrophic cardiomyopathy],0.061,0,0.0,0.0,0.0,0.0,0.378,0.0,0.043,3.316,2.246,0.099,0.08,0.58,4
STXBP2,BI_179.1 [Hypogammaglobulinemia NOS],0.061,0,0.0,0.0,0.684,0.0,0.0,0.0,0.012,,1.089,0.153,0.143,0.922,3
PPARGC1B,GE_972.9 [Muscular dystrophy],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.032,1.747,2.975,0.574,0.127,0.198,3
VRK2,MB_293.1 [Anorexia nervosa],0.061,0,0.0,0.0,0.0,0.587,0.0,0.0,0.024,3.332,2.476,0.334,0.193,,2
HK1,CV_433.3 [Cerebrovascular insufficiency],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.021,,2.129,0.21,0.204,0.252,3
ST13,DE_663.2 [Pemphigoid],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.407,,2.127,0.217,0.124,,2
OSTM1,GE_978.3 [Osteochondrodysplasias],0.061,0,0.0,0.0,0.0,0.0,0.3,0.577,0.103,1.414,0.273,0.084,0.093,,4
ARPC4,CM_770.5 [Congenital osteodystrophies],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.646,0.028,,,0.276,2
ADCY1,NS_323.3 [Motor neuron disease],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,1.69,2.265,0.091,0.225,0.059,3
CRYZ,NS_323.3 [Motor neuron disease],0.061,0,0.0,0.0,0.0,0.326,0.0,0.0,0.061,2.313,3.144,0.27,0.895,0.13,3
AUTS2,MB_302.1 [Speech and language developmental delay],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.055,2.769,2.652,0.187,0.417,0.808,3
PLG,GE_972.9 [Muscular dystrophy],0.061,0,0.0,0.0,0.0,0.0,0.267,0.0,0.042,2.402,1.475,0.034,0.049,0.26,4
LIMK2,MS_712.51 [Hypermobility syndrome],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.225,,3.039,0.183,0.22,,2
SSBP3,GE_972.2 [Hereditary ataxia],0.061,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.309,3.097,,,0.304,2
APOE,GU_580.1 [Acute nephritic syndrome],0.061,0,0.0,0.0,0.874,0.0,0.0,0.0,0.244,,2.875,0.142,0.092,0.96,4
GRN,MS_704.1 [Polyarteritis nodosa and related conditions],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.095,,0.981,0.172,0.118,,1
VWF,GE_973.5 [Huntington's disease],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.325,1.687,1.829,0.134,0.121,,2
SLC1A2,NS_323.3 [Motor neuron disease],0.06,0,0.0,0.0,0.532,0.0,0.0,0.0,0.174,1.619,1.68,0.31,1.098,0.696,4
USH2A,NS_341.1 [Cerebral palsy],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.626,3.923,1.201,0.465,0.975,2
NF1,GE_972.9 [Muscular dystrophy],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.159,2.043,2.953,0.27,0.277,0.748,3
HDAC9,MS_727.5 [Cyst of bone],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.109,4.198,3.313,0.182,0.329,,2
MYH6,GE_972.9 [Muscular dystrophy],0.06,0,0.0,0.0,0.0,0.0,0.335,0.01,0.048,,3.729,3.004,0.11,0.976,5
ERBB4,MB_306 [Conduct disorders],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.069,5.826,1.046,0.229,0.185,,2
C3,GU_580.1 [Acute nephritic syndrome],0.06,0,0.0,0.0,0.844,0.0,0.0,0.176,0.077,2.392,3.446,0.363,0.267,0.87,4
NCOA1,EM_249.1 [Cerebral amyloid angiopathy*],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,2.288,4.405,0.19,0.17,,2
MTSS1,GE_972.2 [Hereditary ataxia],0.06,0,0.0,0.088,0.0,0.0,0.0,0.0,0.117,1.929,3.092,0.616,0.617,0.455,4
DPYSL5,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.182,1.796,2.395,0.136,0.118,0.147,3
GABRA2,NS_341.1 [Cerebral palsy],0.06,1,4.0,0.0,0.0,0.0,0.0,0.0,0.0,1.94,0.107,,2.127,0.651,2
PDE8B,GE_961.1 [Phakomatoses],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.021,1.763,2.857,0.103,0.188,0.023,3
SNAI2,"EM_209.11 [Tall stature, acromegaly and gigantism]",0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.068,2.635,0.093,,0.059,,2
BCORL1,GE_972.9 [Muscular dystrophy],0.06,0,0.0,0.0,0.426,0.0,0.0,0.0,0.0,2.832,2.803,,0.038,0.156,3
KCTD7,GE_963.1 [Lipid storage disorders],0.06,0,0.0,0.0,0.0,0.0,0.0,0.67,0.152,1.873,3.942,0.026,0.025,0.141,4
MSC,MB_296.2 [Schizoid personality disorder],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.742,2.285,0.012,0.034,,1
PPARGC1A,GI_540.11 [Autoimmune hepatitis],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.24,3.838,3.384,0.368,0.657,,2
PAX5,GE_972.9 [Muscular dystrophy],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,2.472,0.308,0.187,0.087,0.241,3
ACP5,GE_978.3 [Osteochondrodysplasias],0.06,0,0.0,0.0,0.0,0.0,0.352,0.0,0.136,2.264,2.831,0.156,0.088,,3
NR5A2,GU_580.52 [Diffuse membranous glomerulonephritis],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.254,2.245,2.409,0.08,0.073,,2
TSPAN5,SO_369.62 [Keratoconus],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.651,0.064,0.04,0.092,0.15,2
NLRP3,MS_719.2 [Muscle calcification and ossification],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.486,2.428,1.444,0.063,0.077,,2
APP,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,2.159,3.007,0.547,0.791,0.961,3
B4GALT5,BI_179.1 [Hypogammaglobulinemia NOS],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.052,0.12,,0.078,0.182,2
HOMEZ,CM_763.31 [Ventricular septal defect],0.06,0,0.0,0.0,0.684,0.0,0.0,0.0,0.102,,1.469,0.107,0.102,0.306,4
NXT2,GE_983.2 [Hemoglobin C trait [Sickle-cell trait]],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.051,,0.902,,0
KMT2B,GE_972.2 [Hereditary ataxia],0.06,0,0.0,0.0,0.547,0.0,0.0,0.0,0.015,1.559,2.949,0.276,0.279,0.762,4
MTOR,GE_964.3 [Glycogen storage disease],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.072,1.343,3.9,0.877,0.804,,2
INSR,GI_516.1 [Pyloric stenosis],0.06,0,0.0,0.0,0.0,0.0,0.0,0.121,0.0,3.687,2.826,0.277,1.851,0.941,3
SCN4A,NS_341.1 [Cerebral palsy],0.06,1,4.0,0.0,0.426,0.0,0.0,0.0,0.0,,3.017,0.755,0.331,0.936,3
RPS12,CV_433.3 [Cerebrovascular insufficiency],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.701,0.186,,0.027,0.223,2
RPL32,MB_302.1 [Speech and language developmental delay],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.324,0.135,,,0.165,2
SIM1,MB_298 [Impulse disorders],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.228,0.233,0.113,0.12,,2
KDR,GE_973.5 [Huntington's disease],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.085,2.096,2.239,0.185,0.085,,2
PSIP1,MS_704.1 [Polyarteritis nodosa and related conditions],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.103,3.481,3.878,0.209,0.102,,2
TUBB2B,RE_484.1 [Spontaneous pneumothorax],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.102,,,0.149,1
SBF1,GE_972.1 [Hereditary neuropathy],0.06,0,0.0,0.0,0.0,0.0,0.0,0.125,0.052,,2.952,,0.154,,3
UMOD,GU_580.52 [Diffuse membranous glomerulonephritis],0.06,0,0.0,0.0,0.0,0.0,0.636,0.0,0.162,1.363,2.965,0.212,0.104,,3
RBM15B,CM_763.13 [Patent ductus arteriosus],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,1.552,,0.022,0.269,2
DHX15,GE_972.9 [Muscular dystrophy],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.661,1.705,,0.023,0.29,2
GDF6,GE_961.1 [Phakomatoses],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.061,4.842,0.109,0.18,0.086,0.378,3
FANCB,BI_162.1 [Constitutional (hereditary) aplastic anemia],0.06,0,0.0,0.0,0.0,0.0,0.0,0.805,0.117,1.939,1.175,0.12,0.05,,3
BMP1,GE_978.3 [Osteochondrodysplasias],0.06,0,0.0,0.0,0.0,0.0,0.0,0.676,0.178,2.732,2.569,0.03,0.089,,3
S1PR1,MS_712.51 [Hypermobility syndrome],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,1.979,0.265,0.075,0.092,,2
MSX2,GE_978.3 [Osteochondrodysplasias],0.06,0,0.0,0.0,0.0,0.0,0.264,0.0,0.095,2.803,0.135,0.072,0.083,,3
GFPT1,NS_338.1 [Myasthenia gravis],0.06,0,0.0,0.0,0.0,0.0,0.0,0.834,0.072,1.904,3.224,0.132,1.073,,3
GRIN2A,GE_961.1 [Phakomatoses],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.347,2.733,3.084,0.344,0.221,0.53,3
FOXP3,SO_365.3 [Exophthalmos [Proptosis]],0.06,0,0.0,0.0,0.35,0.0,0.0,0.0,0.102,,2.05,0.138,0.102,0.89,4
RPSA,GI_516.1 [Pyloric stenosis],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.551,0.174,,,0.333,2
FMR1,GE_973.5 [Huntington's disease],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.117,3.363,0.067,0.092,0.053,,2
PEX1,GI_516.1 [Pyloric stenosis],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.904,2.47,0.711,0.703,0.991,2
TNC,CV_414.1 [Hypertrophic cardiomyopathy],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.188,2.87,2.657,0.359,0.924,0.202,3
COL1A1,GE_978.22 [Ehler's Danlos syndrome],0.06,0,0.0,0.0,0.0,0.0,0.353,0.705,0.119,1.967,3.428,0.048,0.054,,4
CSF1R,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.06,1,2.0,0.0,0.0,0.0,0.294,0.0,0.125,,3.298,1.27,0.146,0.92,4
GRID2,NS_341.1 [Cerebral palsy],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.064,2.754,3.422,0.33,3.354,0.945,3
RPL23A,GE_972.9 [Muscular dystrophy],0.06,1,4.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.184,,0.019,0.254,1
BMPR1B,GE_972.1 [Hereditary neuropathy],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.024,2.076,5.232,0.328,0.209,,2
MET,GU_580.1 [Acute nephritic syndrome],0.06,1,1.0,0.0,0.0,0.0,0.0,0.0,0.018,1.359,3.454,0.418,0.263,0.824,3
HLA-A,GI_542.8 [Biliary cirrhosis],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.245,1.332,5.906,1.51,0.168,,2
AXL,DE_663.2 [Pemphigoid],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.185,1.358,2.546,0.247,0.18,,2
COQ2,GU_580.51 [Focal and segmental glomerular lesions*],0.06,0,0.0,0.0,0.0,0.0,0.0,0.293,0.017,2.852,2.862,2.602,0.087,,3
PRRT2,GE_972.2 [Hereditary ataxia],0.06,0,0.0,0.0,0.547,0.0,0.279,0.0,0.073,1.553,1.763,0.065,0.083,0.983,5
HTT,GE_972.9 [Muscular dystrophy],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,2.375,3.543,3.361,0.273,0.754,3
USH1G,SO_369.62 [Keratoconus],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,3.53,0.039,0.085,0.97,2
BCL2,MS_727.5 [Cyst of bone],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.549,2.49,1.856,0.058,0.116,,2
KLHL2,GI_540.11 [Autoimmune hepatitis],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.266,,0.874,0.054,0.126,,1
ENG,CV_414.1 [Hypertrophic cardiomyopathy],0.06,0,0.0,0.0,0.0,0.0,0.446,0.0,0.037,2.592,2.946,0.351,0.178,0.069,4
MORC3,MS_700.42 [Dermatomyositis],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.393,,0.395,0.075,0.075,,1
RBM4,GU_580.1 [Acute nephritic syndrome],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.105,0.028,0.032,0.215,1
OPN1MW,GE_961.1 [Phakomatoses],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.033,2.041,0.075,,0.034,0.002,3
PTGS2,DE_663.2 [Pemphigoid],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.406,1.892,2.109,2.024,1.683,,2
UGCG,CM_763.13 [Patent ductus arteriosus],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.223,0.074,0.017,0.036,0.262,2
RPLP0,CM_751.213 [Congenital cataract],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.292,,0.019,0.276,2
SOBP,CV_414.1 [Hypertrophic cardiomyopathy],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,1.683,2.296,0.839,0.944,0.031,3
EP300,GE_972.2 [Hereditary ataxia],0.06,0,0.0,0.0,0.684,0.0,0.0,0.121,0.0,2.597,3.062,0.383,0.313,0.932,3
INSR,CM_770.5 [Congenital osteodystrophies],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.024,3.006,2.429,0.174,0.134,0.966,3
CAMK2D,NS_339.2 [Myotonic disorders],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.049,2.802,0.492,0.088,0.092,,2
SPPL3,SO_365.3 [Exophthalmos [Proptosis]],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.941,0.466,0.036,,0.254,2
IL21,CV_413.41 [Pulmonary valve stenosis],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.054,,0.014,0.248,1
RPS26,GE_972.9 [Muscular dystrophy],0.06,1,4.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.066,0.033,,0.079,1
SOX2,MS_727.5 [Cyst of bone],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.043,3.23,2.336,,0.085,,2
FGFR2,RE_477.2 [Hypersensitivity pneumonitis],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.055,3.664,1.959,0.246,0.164,,2
RHOA,SO_369.62 [Keratoconus],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.26,,0.024,0.327,1
UBXN7,CV_416.8 [Pre-excitation syndrome [Anomalous atrioventricular excitation]],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.736,0.786,,0.112,0.186,2
PSTPIP2,DE_663.2 [Pemphigoid],0.06,0,0.0,0.0,0.0,0.0,0.275,0.0,0.122,,2.311,0.318,0.095,,3
BPNT2,GE_978.3 [Osteochondrodysplasias],0.06,0,0.0,0.0,0.0,0.0,0.321,0.0,0.015,2.789,2.137,0.078,0.123,,3
GIT1,GE_973.5 [Huntington's disease],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.088,1.709,0.074,0.116,0.066,,2
ATF3,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.138,0.101,0.093,0.097,0.968,2
FOXG1,SO_381.5 [Vertical strabismus],0.06,0,0.0,0.0,0.0,0.0,0.0,0.362,0.284,3.274,2.58,,,,3
CAD,SO_386.5 [Color vision deficiencies],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,,3.959,0.308,0.805,0.248,3
ARF1,NS_344.2 [Benign intracranial hypertension],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.098,,0.021,0.227,1
CDH3,SO_386.6 [Night blindness],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.264,0.814,0.157,0.972,2
IL1B,MS_712.51 [Hypermobility syndrome],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.175,1.51,1.026,0.133,2.068,,2
NDUFAF6,SO_380.3 [Optic atrophy],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.415,0.357,0.105,0.941,2
RET,CV_441 [Arteriovenous malformation],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,1.775,3.186,0.26,0.329,0.964,3
C3orf38,GE_972.2 [Hereditary ataxia],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.038,3.42,0.537,0.117,0.987,2
YTHDF3,CM_770.5 [Congenital osteodystrophies],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.71,0.067,,0.027,0.243,2
CACNA1E,CV_433.3 [Cerebrovascular insufficiency],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,1.968,3.297,0.471,0.192,0.176,3
OPN1LW,SO_386.6 [Night blindness],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.447,,0.026,0.975,2
RPL32,CM_750.16 [Arnold-Chiari syndrome*],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.906,0.315,,,0.257,2
LDLR,GE_964.3 [Glycogen storage disease],0.06,0,0.0,0.0,0.0,0.0,0.394,0.0,0.043,,2.649,0.358,0.172,,3
FBXL4,SO_380.3 [Optic atrophy],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.704,2.856,0.381,0.163,0.948,2
CA2,NS_341.1 [Cerebral palsy],0.06,1,4.0,0.0,0.0,0.0,0.0,0.0,0.012,1.4,0.136,0.106,0.103,0.654,3
ADRA2C,EM_209.4 [Diabetes insipidus],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.989,3.189,,0.024,0.081,2
RPGRIP1L,SO_386.6 [Night blindness],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.676,1.224,0.262,0.991,2
PPARGC1A,SO_380.3 [Optic atrophy],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.027,3.157,1.645,0.331,0.24,0.97,3
CFL1,SO_386.6 [Night blindness],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.053,,,0.142,1
KIT,GU_580.51 [Focal and segmental glomerular lesions*],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.094,3.177,0.358,0.112,0.13,,2
YAP1,CM_763.31 [Ventricular septal defect],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.043,1.732,2.505,0.178,0.134,0.909,3
KIF3C,CM_763.13 [Patent ductus arteriosus],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.034,0.123,,0.014,0.268,2
F7,GE_971.14 [Von Willebrand's disease],0.06,0,0.0,0.0,0.0,0.0,0.419,0.0,0.048,3.137,2.073,0.245,0.113,,3
ANGPT1,GE_971.14 [Von Willebrand's disease],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.043,2.398,0.168,0.099,0.101,,2
PARP1,CM_750.16 [Arnold-Chiari syndrome*],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.042,1.52,0.251,0.133,0.979,2
SORT1,NS_344.2 [Benign intracranial hypertension],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.231,,2.82,0.176,0.119,0.414,3
KLHL12,GI_542.8 [Biliary cirrhosis],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.706,2.077,2.196,2.278,0.243,,2
IL2,CM_770.5 [Congenital osteodystrophies],0.06,0,0.0,0.0,0.0,0.0,0.268,0.0,0.062,2.419,0.074,,4.204,0.753,4
FOXN3,GU_580.1 [Acute nephritic syndrome],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,2.574,1.481,0.121,0.109,0.156,3
YWHAE,CV_441 [Arteriovenous malformation],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.67,0.143,,0.022,0.262,2
LTB4R,DE_663.2 [Pemphigoid],0.06,1,3.0,0.0,0.0,0.0,0.0,0.0,0.012,1.757,1.62,0.016,0.061,,2
ZEB1,NS_323.3 [Motor neuron disease],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.065,2.406,2.464,0.116,0.19,0.373,3
TONSL,GE_978.3 [Osteochondrodysplasias],0.06,0,0.0,0.0,0.0,0.0,0.0,0.851,0.018,1.598,3.46,0.18,0.624,,3
SLC1A2,GE_973.5 [Huntington's disease],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.355,1.727,0.128,0.078,0.054,,2
FN1,DE_663.2 [Pemphigoid],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.093,3.015,1.661,0.448,0.616,,2
WNT5A,NS_323.3 [Motor neuron disease],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.088,3.811,1.685,0.208,0.178,0.339,3
MT-ND3,SO_380.3 [Optic atrophy],0.06,0,0.0,0.0,0.0,0.0,0.0,0.493,0.031,,,,,,2
IFNG,EM_209.4 [Diabetes insipidus],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.763,0.801,1.009,0.052,0.971,2
CNTN1,NS_323.3 [Motor neuron disease],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,3.042,2.769,0.35,0.152,0.243,3
SCN8A,SO_380.3 [Optic atrophy],0.06,0,0.0,0.0,0.0,0.0,0.282,0.0,0.0,1.928,2.383,0.184,0.18,0.96,3
F2,GE_973.5 [Huntington's disease],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.386,,0.232,0.053,0.04,,1
VHL,GE_961.1 [Phakomatoses],0.06,0,0.0,0.0,0.0,0.0,0.0,0.951,0.074,,2.886,1.646,5.802,0.924,4
PPP3CB,SO_386.5 [Color vision deficiencies],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.042,0.026,0.034,0.304,1
TUBB4B,CM_750.16 [Arnold-Chiari syndrome*],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.044,,0.008,0.284,1
GABRA2,CM_751.213 [Congenital cataract],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.407,0.114,,0.111,0.119,2
MAP3K5,GE_977.6 [Congenital cutaneous mastocytosis*],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,2.784,0.107,0.108,0.093,,2
ETNK1,BI_179.1 [Hypogammaglobulinemia NOS],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.815,0.089,0.039,0.074,0.142,2
C5,CV_433.3 [Cerebrovascular insufficiency],0.06,1,0.5,0.0,0.304,0.0,0.0,0.0,0.07,1.791,2.574,0.319,0.257,0.469,4
ALDH3A1,SO_369.62 [Keratoconus],0.06,0,0.0,0.0,0.0,0.469,0.0,0.281,0.592,,0.675,0.532,0.204,0.207,4
SREK1,GE_973.5 [Huntington's disease],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.614,2.243,0.144,0.046,0.04,,2
TRAPPC2,GE_983.2 [Hemoglobin C trait [Sickle-cell trait]],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.085,,0.478,,0
RNASEH2A,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.06,0,0.0,0.0,0.0,0.0,0.0,0.865,0.099,,3.095,0.131,0.113,0.731,4
FAU,CM_770.5 [Congenital osteodystrophies],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.065,0.049,0.02,0.288,1
MMP13,CV_414.1 [Hypertrophic cardiomyopathy],0.06,0,0.0,0.0,0.0,0.0,0.438,0.0,0.023,,2.503,0.156,0.312,0.142,4
ARF6,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.726,0.114,,0.037,0.301,2
EIF2S2,SO_386.5 [Color vision deficiencies],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.376,0.149,0.028,0.032,0.222,2
RRAGD,GE_972.2 [Hereditary ataxia],0.06,0,0.0,0.024,0.0,0.0,0.0,0.0,0.03,2.699,0.412,0.054,0.101,0.2,4
SERPING1,GE_976.5 [Polycystic kidney disease],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.015,4.357,2.451,0.097,0.095,,2
CDH8,GE_961.1 [Phakomatoses],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,3.657,0.643,0.634,1.718,0.206,3
PDE6H,SO_369.62 [Keratoconus],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.962,0.091,0.136,0.092,0.927,2
FN1,CM_763.31 [Ventricular septal defect],0.06,0,0.0,0.0,0.532,0.0,0.0,0.0,0.1,2.188,3.078,0.675,0.081,0.939,4
CHRM1,CM_763.13 [Patent ductus arteriosus],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.063,0.014,0.026,0.269,1
CAPN3,NS_338.1 [Myasthenia gravis],0.06,0,0.0,0.0,0.0,0.0,0.392,0.0,0.018,3.172,2.328,0.356,0.166,,3
RAPH1,NS_323.3 [Motor neuron disease],0.06,0,0.0,0.052,0.0,0.0,0.0,0.0,0.012,1.851,2.316,0.297,0.318,0.049,4
FGFR3,NS_323.3 [Motor neuron disease],0.06,1,4.0,0.0,0.0,0.0,0.0,0.0,0.027,1.874,2.673,0.447,0.186,0.261,3
LAMB2,GU_580.51 [Focal and segmental glomerular lesions*],0.06,0,0.0,0.0,0.0,0.0,0.5,0.193,0.045,3.201,3.181,0.185,0.213,,4
BMP4,"EM_209.11 [Tall stature, acromegaly and gigantism]",0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.079,2.626,0.237,0.205,0.083,,2
FOXG1,CV_441 [Arteriovenous malformation],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.145,2.568,,,0.264,2
PIK3C2A,NS_323.3 [Motor neuron disease],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,2.102,2.87,0.723,0.386,0.073,3
VEGFA,NS_339.2 [Myotonic disorders],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.083,1.917,0.122,0.092,0.064,,2
HSPG2,MB_296.1 [Paranoid personality disorder],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.182,,3.733,0.511,0.11,,2
RAG1,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.06,0,0.0,0.0,0.779,0.0,0.0,0.0,0.061,,2.501,1.615,0.323,0.986,4
XPNPEP3,GU_580.1 [Acute nephritic syndrome],0.06,0,0.0,0.0,0.0,0.0,0.0,0.189,0.012,,1.198,0.31,0.181,0.027,3
PGR,GI_542.8 [Biliary cirrhosis],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.242,3.134,2.458,0.237,1.225,,2
KPNA4,NS_328.13 [Frontotemporal dementia [FTD]],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.196,0.265,0.093,0.097,,2
RPL23A,CM_770.5 [Congenital osteodystrophies],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.181,,0.027,0.308,1
AUTS2,NS_333.4 [Circadian rhythm sleep disorder],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.49,4.164,0.327,0.185,0.29,3
RPGR,SO_386.6 [Night blindness],0.06,0,0.0,0.0,0.547,0.0,0.359,0.281,0.059,2.408,0.173,0.118,0.058,1.0,5
DHH,GE_963.1 [Lipid storage disorders],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,1.33,0.07,0.089,2.174,0.142,3
NOTCH1,NS_341.1 [Cerebral palsy],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.036,1.478,3.916,0.268,0.3,0.996,3
DAG1,GU_580.51 [Focal and segmental glomerular lesions*],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.098,,0.414,0.29,0.136,,1
PRDM6,CM_763.13 [Patent ductus arteriosus],0.06,0,0.0,0.0,0.745,0.0,0.0,0.0,0.101,1.837,2.344,0.649,3.475,,3
HIF1A,DE_663.2 [Pemphigoid],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.101,2.108,1.91,0.261,1.611,,2
PMP22,NS_323.3 [Motor neuron disease],0.06,0,0.0,0.0,0.0,0.0,0.288,0.0,0.018,2.43,1.67,0.274,0.099,0.196,4
PIM1,NS_333.4 [Circadian rhythm sleep disorder],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.81,0.213,,,0.295,2
KIF5B,GE_978.3 [Osteochondrodysplasias],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.079,1.976,2.438,0.11,0.127,,2
BMP4,CM_751.213 [Congenital cataract],0.06,0,0.0,0.0,0.547,0.0,0.598,0.0,0.085,2.854,3.537,1.875,0.112,0.822,5
HEXB,GE_972.2 [Hereditary ataxia],0.06,0,0.0,0.063,0.0,0.0,0.313,0.0,0.111,3.137,2.935,0.161,0.121,0.816,5
CSF1,MS_700.3 [Systemic sclerosis],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.296,2.04,2.412,0.04,0.07,,2
ADAR,NS_340.3 [Inflammatory and immune myopathies],0.06,0,0.0,0.173,0.0,0.0,0.0,0.0,0.091,1.46,0.295,0.073,0.08,,3
GRIN1,GE_972.2 [Hereditary ataxia],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,,2.514,0.067,0.16,0.968,3
ACTN1,CV_414.1 [Hypertrophic cardiomyopathy],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.101,3.53,2.625,1.148,0.311,0.67,3
DNER,MS_727.5 [Cyst of bone],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.183,2.002,1.938,0.223,0.484,,2
LRP1B,EM_249.1 [Cerebral amyloid angiopathy*],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.237,2.771,3.573,0.612,0.207,,2
CCSER2,GE_961.1 [Phakomatoses],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.377,2.852,0.42,1.277,0.082,3
SMNDC1,SO_386.6 [Night blindness],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.369,0.069,,0.028,0.305,2
SOD1,GE_970.2 [Thalassemia],0.06,0,0.0,0.0,0.0,0.0,0.362,0.0,0.093,,0.307,0.05,0.151,,2
CDK2AP2,NS_341.1 [Cerebral palsy],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.706,0.056,0.029,0.031,0.176,2
NUP205,NS_323.3 [Motor neuron disease],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.055,3.904,2.273,0.348,0.49,0.141,3
TP73,NS_328.13 [Frontotemporal dementia [FTD]],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.093,,2.406,0.129,0.824,,2
TSN,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.689,0.053,,0.058,0.162,2
FERMT2,DE_663.2 [Pemphigoid],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.091,,0.878,0.296,0.151,,1
LMNA,GU_580.51 [Focal and segmental glomerular lesions*],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.076,1.915,0.428,0.125,3.585,,2
PPP2CA,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.087,,0.022,0.266,1
NR1D1,GE_972.9 [Muscular dystrophy],0.06,0,0.0,0.0,0.0,0.0,0.275,0.0,0.17,,2.49,1.069,0.086,0.485,4
RPL9,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.144,0.03,,0.159,1
RUVBL2,CV_413.41 [Pulmonary valve stenosis],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.179,,0.011,0.224,1
DGCR8,GU_580.1 [Acute nephritic syndrome],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,1.622,1.756,0.144,0.138,0.29,3
MAP2,CV_433.3 [Cerebrovascular insufficiency],0.06,1,0.5,0.0,0.0,0.0,0.0,0.0,0.212,2.372,3.873,1.702,0.265,0.633,3
COL5A2,MS_700.3 [Systemic sclerosis],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.257,2.712,3.298,0.347,0.312,,2
FAS,NS_323.3 [Motor neuron disease],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.236,2.28,1.852,,0.067,0.212,3
DRD4,MB_306 [Conduct disorders],0.06,1,4.0,0.0,0.0,0.0,0.0,0.0,0.181,,3.097,0.155,0.072,,2
PLEKHG4,GE_972.2 [Hereditary ataxia],0.06,0,0.0,0.0,0.547,0.0,0.0,0.0,0.042,,2.675,0.548,0.168,0.858,4
S1PR1,MS_700.3 [Systemic sclerosis],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.335,1.663,2.941,0.09,0.073,,2
DTNA,GE_972.9 [Muscular dystrophy],0.06,0,0.0,0.0,0.0,0.0,0.299,0.201,0.074,3.946,0.488,0.571,0.151,0.97,5
LPAR1,GE_978.21 [Marfan syndrome],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,2.068,0.074,0.048,0.076,,2
PPP5C,EM_209.4 [Diabetes insipidus],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.365,0.145,,0.094,0.081,2
PRPF8,SO_386.6 [Night blindness],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.038,,2.564,0.128,0.218,0.999,3
SEMA7A,GE_976.5 [Polycystic kidney disease],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.152,,2.806,0.264,0.232,,2
CREB3L1,CM_770.5 [Congenital osteodystrophies],0.06,0,0.0,0.0,0.0,0.0,0.289,0.557,0.443,1.445,3.848,0.116,0.073,0.443,5
CALR,MS_700.3 [Systemic sclerosis],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.427,,1.763,0.269,0.096,,2
PTGS2,NS_323.3 [Motor neuron disease],0.06,1,2.0,0.0,0.0,0.0,0.0,0.0,0.072,,0.177,0.198,0.178,0.839,2
GRIA2,MS_712.51 [Hypermobility syndrome],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.091,3.193,0.476,0.231,0.173,,2
PRKCD,GE_977.6 [Congenital cutaneous mastocytosis*],0.06,1,4.0,0.0,0.0,0.0,0.0,0.0,0.036,1.975,1.682,0.041,0.074,,2
RPL31,MB_302.1 [Speech and language developmental delay],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.758,0.964,,,0.19,2
ADORA1,MB_305.1 [Tics and tic disorders],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.122,,0.13,0.076,0.063,,1
RUNX2,GE_961.1 [Phakomatoses],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.049,3.791,0.808,0.221,0.175,0.899,3
VWF,MS_712.51 [Hypermobility syndrome],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.139,2.176,3.7,1.06,0.602,,2
ERBB4,RE_484.1 [Spontaneous pneumothorax],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.036,4.807,3.386,4.097,0.366,0.72,3
RAB33B,CM_770.5 [Congenital osteodystrophies],0.06,0,0.0,0.0,0.853,0.0,0.356,0.37,0.061,4.092,1.035,1.021,0.077,0.171,5
ERH,GE_972.2 [Hereditary ataxia],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.129,,0.023,0.265,1
ANP32B,CM_763.13 [Patent ductus arteriosus],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.117,,0.035,0.297,1
PCBP1,GU_580.1 [Acute nephritic syndrome],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.627,0.366,,,0.296,2
NR3C2,MB_296.4 [Borderline personality disorder],0.06,1,4.0,0.0,0.0,0.0,0.0,0.0,0.079,2.632,2.191,,0.05,,2
ARID1B,NS_344.11 [Communicating hydrocephalus],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.209,2.699,2.018,0.17,0.12,,2
ESR1,CM_763.31 [Ventricular septal defect],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.256,3.36,1.169,1.822,0.989,2
NAV2,GE_972.2 [Hereditary ataxia],0.06,0,0.0,0.033,0.0,0.0,0.0,0.0,0.029,2.919,2.667,0.148,0.385,0.495,4
HEXA,GE_963.1 [Lipid storage disorders],0.06,1,2.0,0.0,0.547,0.0,0.0,0.918,0.067,,2.393,2.157,0.118,0.253,4
SMAD3,CV_438.43 [Coronary artery dissection],0.06,0,0.0,0.0,0.547,0.0,0.0,0.0,0.021,1.88,0.063,0.06,0.063,,3
GLI2,GE_961.1 [Phakomatoses],0.06,0,0.0,0.0,0.0,0.0,0.26,0.0,0.036,4.268,3.613,0.875,0.284,0.944,4
STING1,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.114,1.358,2.759,0.179,0.105,,2
GUCA1A,SO_380.3 [Optic atrophy],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.758,2.949,0.214,0.075,0.953,2
GATA2,GE_977.6 [Congenital cutaneous mastocytosis*],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.12,1.852,0.137,0.079,0.064,,2
CCDC88C,GE_972.2 [Hereditary ataxia],0.06,0,0.0,0.0,0.85,0.0,0.0,0.362,0.055,3.691,2.994,0.045,0.195,0.771,4
SMAD7,CV_438.41 [Aortic dissection],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.418,2.489,1.668,0.151,0.974,3
BRSK1,GE_961.1 [Phakomatoses],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,1.898,3.549,0.1,0.169,0.16,3
STAT3,MS_727.5 [Cyst of bone],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.212,2.782,2.08,1.853,0.151,,2
POU2F1,DE_663.2 [Pemphigoid],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.109,2.678,2.298,0.831,0.083,,2
GRM1,MB_306 [Conduct disorders],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.092,1.8,1.294,0.223,0.11,,2
CORO1C,NS_323.3 [Motor neuron disease],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.026,2.57,2.007,1.46,0.17,0.028,3
SMAD3,MS_712.51 [Hypermobility syndrome],0.06,0,0.0,0.0,0.0,0.0,0.0,0.484,0.118,1.858,1.893,0.053,0.12,,3
SOCS6,NS_339.2 [Myotonic disorders],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.061,2.714,0.188,0.063,0.055,,2
MAP1B,NS_333.4 [Circadian rhythm sleep disorder],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.05,1.896,3.296,2.371,0.274,0.888,3
FGF19,GI_540.11 [Autoimmune hepatitis],0.06,0,0.0,0.0,0.0,0.0,0.0,0.0,0.31,2.0,1.388,0.024,0.071,,2
GATA2,GE_970.1 [Sickle-cell disorders],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.085,1.948,2.598,0.072,0.13,,2
VCAN,GE_978.21 [Marfan syndrome],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.348,1.377,3.608,0.611,0.184,,2
EP300,NS_323.3 [Motor neuron disease],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,1.891,2.698,0.553,0.42,0.38,3
GHR,"EM_209.11 [Tall stature, acromegaly and gigantism]",0.059,1,4.0,0.0,0.0,0.0,0.0,0.0,0.263,3.023,2.99,1.123,0.136,,2
GRIN2B,NS_333.7 [Narcolepsy],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,3.096,3.64,,,,2
ZEB1,CV_433.3 [Cerebrovascular insufficiency],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.045,2.026,2.026,0.613,0.114,0.926,3
CP,DE_669.2 [Behcet's syndrome],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.254,,1.969,0.087,0.061,,2
PRCD,SO_386.6 [Night blindness],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.772,0.187,,0.049,0.998,2
CD86,DE_663.2 [Pemphigoid],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.119,2.09,2.125,0.08,0.07,,2
REL,GI_540.11 [Autoimmune hepatitis],0.059,0,0.0,0.0,0.0,0.0,0.277,0.0,0.024,2.218,0.464,0.169,0.135,,3
CD86,MS_704.2 [Wegener's granulomatosis],0.059,1,3.0,0.0,0.0,0.0,0.0,0.0,0.075,2.596,2.267,0.077,0.079,,2
RPS12,CM_763.13 [Patent ductus arteriosus],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.63,0.071,,0.01,0.27,2
MAOB,MB_296.4 [Borderline personality disorder],0.059,1,4.0,0.0,0.0,0.0,0.0,0.0,0.068,1.437,0.72,0.078,1.701,,2
NFKB1,GE_976.5 [Polycystic kidney disease],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.104,2.012,2.265,0.629,0.19,,2
RPL37,GE_972.9 [Muscular dystrophy],0.059,1,4.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.353,,0.032,0.304,1
LRP4,NS_338.1 [Myasthenia gravis],0.059,1,0.5,0.0,0.0,0.0,0.0,0.727,0.132,,3.389,1.346,0.412,,3
RPL23A,CM_750.16 [Arnold-Chiari syndrome*],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.118,,0.011,0.224,1
RPS29,MB_302.1 [Speech and language developmental delay],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.47,0.057,,,0.135,2
GABRA2,SO_374.2 [Retinoschisis and retinal cysts],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.39,0.135,,0.143,,1
ANGPT1,CV_414.1 [Hypertrophic cardiomyopathy],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.074,2.183,2.191,0.279,0.193,0.153,3
UTRN,GE_972.9 [Muscular dystrophy],0.059,1,2.0,0.0,0.0,0.0,0.0,0.0,0.139,2.934,2.547,0.137,0.278,0.975,3
YME1L1,SO_380.3 [Optic atrophy],0.059,0,0.0,0.0,0.547,0.0,0.0,0.51,0.082,,2.263,2.033,0.145,0.928,4
SMAD3,GE_972.1 [Hereditary neuropathy],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.114,2.03,2.885,0.058,0.091,,2
ADCY1,MS_727.5 [Cyst of bone],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.059,2.661,2.308,0.091,0.785,,2
CD19,GI_540.11 [Autoimmune hepatitis],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.177,,3.25,0.211,0.123,,2
POU3F4,SO_373.2 [Choroidal degenerations],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.074,2.467,0.059,,,,2
NUMB,DE_663.1 [Pemphigus],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.243,,0.421,0.202,0.143,,1
EXT1,GE_977.6 [Congenital cutaneous mastocytosis*],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.027,2.24,0.1,0.087,0.065,,2
EPHA4,CV_433.3 [Cerebrovascular insufficiency],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.075,2.618,2.319,0.218,0.195,0.443,3
GLI3,CM_770.5 [Congenital osteodystrophies],0.059,0,0.0,0.0,0.0,0.0,0.378,0.0,0.059,2.429,3.208,0.304,0.206,0.89,4
ACADM,CV_414.1 [Hypertrophic cardiomyopathy],0.059,0,0.0,0.0,0.0,0.0,0.356,0.0,0.029,1.64,2.511,0.984,0.275,0.993,4
THRA,CM_772.2 [Congenital hypothyroidism],0.059,1,4.0,0.0,0.0,0.0,0.255,0.0,0.056,3.437,0.184,0.053,0.058,,3
PLG,DE_663.2 [Pemphigoid],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.144,2.711,1.869,0.044,0.073,,2
KIF5B,CM_770.5 [Congenital osteodystrophies],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.079,2.005,2.215,0.115,0.14,0.638,3
MRPS9,CV_416.8 [Pre-excitation syndrome [Anomalous atrioventricular excitation]],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.863,2.303,0.199,0.167,0.913,2
COL3A1,GE_972.2 [Hereditary ataxia],0.059,0,0.0,0.0,0.0,0.0,0.0,0.29,0.083,2.611,1.648,0.403,0.222,0.686,4
DRD3,GE_970.1 [Sickle-cell disorders],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.088,,1.506,0.047,0.366,,2
TSPAN5,SO_386.6 [Night blindness],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.74,0.058,0.032,0.098,0.15,2
SELENOI,NS_341.1 [Cerebral palsy],0.059,0,0.0,0.0,0.547,0.0,0.0,0.0,0.064,,1.289,0.152,0.101,,2
JPH1,GE_972.9 [Muscular dystrophy],0.059,0,0.0,0.0,0.0,0.0,0.275,0.0,0.087,2.142,0.308,0.154,0.094,0.533,4
HAPLN1,MS_705.2 [Juvenile rheumatoid arthritis [JRA/JIA]],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.386,3.363,3.319,2.251,0.086,,2
CCND2,SO_386.5 [Color vision deficiencies],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.079,3.868,0.15,0.025,0.038,0.302,3
IKBKB,BI_179.1 [Hypogammaglobulinemia NOS],0.059,0,0.0,0.0,0.426,0.0,0.0,0.0,0.027,,2.346,0.195,0.144,0.963,4
BLK,MS_704.1 [Polyarteritis nodosa and related conditions],0.059,0,0.0,0.0,0.0,0.649,0.0,0.402,0.79,,2.731,0.531,0.125,,3
RAD23B,NS_323.3 [Motor neuron disease],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.043,1.983,1.944,,0.127,0.252,3
RPS3A,BI_179.1 [Hypogammaglobulinemia NOS],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.245,1.004,,0.022,0.3,2
PTK2B,GE_973.5 [Huntington's disease],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.429,2.608,2.572,0.246,0.082,,2
RELN,CV_414.1 [Hypertrophic cardiomyopathy],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.157,2.417,3.36,0.604,0.211,0.166,3
GRIN3A,GE_973.5 [Huntington's disease],0.059,1,4.0,0.0,0.0,0.0,0.0,0.0,0.649,2.78,3.667,0.725,0.088,,2
EIF5A,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.079,,0.021,0.24,1
NCK2,"MB_280.4 [Sedative, hypnotic, or anxiolytic related disorders]",0.059,0,0.0,0.0,0.0,0.616,0.0,0.0,0.021,2.544,1.658,0.106,0.094,,2
PLXND1,MS_700.42 [Dermatomyositis],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.188,2.912,3.493,1.124,0.167,,2
HLA-DPB1,GI_542.8 [Biliary cirrhosis],0.059,0,0.0,0.0,0.0,0.259,0.0,0.0,0.296,6.135,2.523,0.191,0.114,,2
TP53,CV_441 [Arteriovenous malformation],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,,2.54,0.14,0.132,0.978,3
ANGPT2,CV_433.3 [Cerebrovascular insufficiency],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.115,,1.89,0.07,0.141,0.871,3
SNRPD2,NS_323.3 [Motor neuron disease],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.088,,,0.149,1
PSMB5,CM_750.16 [Arnold-Chiari syndrome*],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.063,0.036,0.032,0.24,1
BACE1,MS_700.3 [Systemic sclerosis],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.213,,2.487,0.25,0.175,,2
GNA11,GE_963.1 [Lipid storage disorders],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,2.101,0.055,0.016,0.04,0.087,3
ANXA11,GE_972.9 [Muscular dystrophy],0.059,0,0.0,0.0,0.547,0.0,0.0,0.37,0.024,1.688,3.253,1.014,0.145,0.187,4
VEGFA,CM_763.13 [Patent ductus arteriosus],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.14,2.477,0.085,0.074,0.059,0.917,3
PMS2,NS_344.2 [Benign intracranial hypertension],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.607,3.217,0.205,0.23,0.984,2
USP22,SO_386.6 [Night blindness],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.962,0.105,,0.09,0.2,2
CSNK2A1,GE_976.5 [Polycystic kidney disease],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.747,0.186,0.145,0.122,,2
GLI3,CM_763.31 [Ventricular septal defect],0.059,0,0.0,0.0,0.547,0.0,0.0,0.0,0.0,2.327,3.829,1.058,0.242,0.921,3
TUBB2A,CV_416.8 [Pre-excitation syndrome [Anomalous atrioventricular excitation]],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.589,0.046,,,0.123,2
DST,GE_972.1 [Hereditary neuropathy],0.059,0,0.0,0.0,0.0,0.0,0.345,0.312,0.035,2.035,2.986,0.207,0.295,,4
SERPINC1,CV_414.1 [Hypertrophic cardiomyopathy],0.059,0,0.0,0.0,0.0,0.0,0.283,0.0,0.018,1.793,2.192,0.387,0.126,0.161,4
DKK2,GE_978.22 [Ehler's Danlos syndrome],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.051,2.63,2.902,2.688,0.071,,2
TMED2,CV_413.41 [Pulmonary valve stenosis],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,3.843,,0.019,0.26,2
CHDH,CM_770.5 [Congenital osteodystrophies],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,2.274,3.598,0.508,1.088,0.298,3
CD83,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.072,1.598,0.12,0.076,0.964,2
TNFRSF11A,GE_978.3 [Osteochondrodysplasias],0.059,0,0.0,0.0,0.0,0.0,0.44,0.735,0.074,1.702,3.201,0.045,0.049,,4
RLIM,GI_516.1 [Pyloric stenosis],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,1.217,,2.591,0.969,2
GRIA1,MS_704.1 [Polyarteritis nodosa and related conditions],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.043,2.769,2.91,2.875,0.125,,2
TSPAN5,SO_380.3 [Optic atrophy],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.673,0.054,0.037,0.1,0.202,2
PARP1,CV_433.3 [Cerebrovascular insufficiency],0.059,1,2.0,0.0,0.0,0.0,0.0,0.0,0.107,1.71,2.554,0.096,0.212,0.931,3
INS,NS_341.1 [Cerebral palsy],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.08,,0.055,0.981,1
PSMA2,CV_413.41 [Pulmonary valve stenosis],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.063,,0.02,0.307,1
ADCY9,CV_414.1 [Hypertrophic cardiomyopathy],0.059,0,0.0,0.0,0.0,0.0,0.538,0.0,0.012,2.282,2.428,0.502,1.476,0.054,4
ARHGAP24,GU_580.51 [Focal and segmental glomerular lesions*],0.059,0,0.0,0.0,0.0,0.0,0.0,0.129,0.152,3.654,2.188,0.404,0.15,,3
SREBF2,CV_433.3 [Cerebrovascular insufficiency],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.085,,3.693,3.267,0.212,0.604,3
EFNB2,CV_441 [Arteriovenous malformation],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.035,2.343,2.576,2.393,0.082,0.947,3
VEGFA,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.062,2.821,2.639,0.18,0.113,0.974,3
BCORL1,RE_484.1 [Spontaneous pneumothorax],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.511,3.58,,0.08,0.129,2
RPL15,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.089,,,0.154,1
C4B,GI_542.8 [Biliary cirrhosis],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.082,,2.394,0.4,0.14,,2
ERAP1,DE_669.2 [Behcet's syndrome],0.059,0,0.0,0.0,0.0,0.52,0.0,0.0,0.421,,2.163,0.708,0.134,,2
KPNB1,SO_386.6 [Night blindness],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.999,,,0.189,2
IL21,CM_770.5 [Congenital osteodystrophies],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.642,3.057,,0.019,0.273,2
GSDMA,MS_700.3 [Systemic sclerosis],0.059,0,0.0,0.0,0.0,0.422,0.0,0.0,0.488,,2.341,0.319,0.165,,2
IL1B,CM_770.5 [Congenital osteodystrophies],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.133,,1.633,0.099,0.055,0.978,3
PPIA,EM_209.4 [Diabetes insipidus],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.086,0.016,0.02,0.348,1
TUBB4B,CM_751.213 [Congenital cataract],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.104,,0.02,0.23,1
DSP,NS_323.3 [Motor neuron disease],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.036,1.917,2.882,0.261,0.915,0.072,3
TNFRSF1A,SO_380.3 [Optic atrophy],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.023,1.38,2.137,0.062,2.97,0.231,3
HACD1,GE_972.9 [Muscular dystrophy],0.059,0,0.0,0.023,0.547,0.0,0.0,0.503,0.131,2.536,2.133,1.938,0.087,,4
INS,CM_770.5 [Congenital osteodystrophies],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.079,,0.057,0.982,1
CAD,NS_323.3 [Motor neuron disease],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,,3.169,0.265,0.636,0.074,3
RPSA,SO_386.5 [Color vision deficiencies],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.095,,,0.148,1
ZNF804A,MB_306 [Conduct disorders],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.088,2.169,2.31,0.088,0.072,,2
ITGB1,NS_341.1 [Cerebral palsy],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.875,2.006,0.087,0.133,0.979,2
TF,GE_970.1 [Sickle-cell disorders],0.059,0,0.0,0.0,0.0,0.0,0.282,0.0,0.16,2.105,2.042,0.293,0.092,,3
TP53,MS_727.5 [Cyst of bone],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.25,,2.336,1.86,0.174,,2
MYSM1,GE_961.1 [Phakomatoses],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.024,,2.524,0.355,0.841,0.127,3
HDAC9,MS_704.2 [Wegener's granulomatosis],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.109,2.143,2.565,1.558,0.15,,2
MEF2C,GE_976.5 [Polycystic kidney disease],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.717,0.079,,0.128,,1
BRD4,CV_433.3 [Cerebrovascular insufficiency],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.087,2.554,2.474,0.284,0.162,0.694,3
SNTA1,GE_972.9 [Muscular dystrophy],0.059,0,0.0,0.0,0.0,0.0,0.0,0.129,0.066,,2.702,0.142,0.096,0.965,4
VEGFA,EM_249.1 [Cerebral amyloid angiopathy*],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.244,2.563,3.908,0.116,0.105,,2
PRKCA,DE_663.2 [Pemphigoid],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.068,1.634,2.185,0.109,0.129,,2
NTN1,MS_700.3 [Systemic sclerosis],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.219,2.55,1.938,1.442,0.225,,2
GSK3B,NS_341.1 [Cerebral palsy],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.334,1.947,0.15,,0.085,0.944,3
CACNA1A,NS_323.3 [Motor neuron disease],0.059,0,0.0,0.0,0.426,0.0,0.254,0.129,0.039,3.474,3.866,0.166,1.361,0.487,5
TUBA1B,RE_484.1 [Spontaneous pneumothorax],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.274,,,0.257,1
TNPO3,MS_700.3 [Systemic sclerosis],0.059,0,0.0,0.0,0.0,0.418,0.0,0.0,0.067,3.396,1.667,0.239,0.257,,2
IFT172,CM_770.5 [Congenital osteodystrophies],0.059,0,0.0,0.0,0.0,0.0,0.288,0.452,0.012,,3.558,0.167,0.275,0.818,5
ZBTB16,CV_414.1 [Hypertrophic cardiomyopathy],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.043,2.592,2.389,0.562,0.201,0.105,3
NUDT11,GE_983.2 [Hemoglobin C trait [Sickle-cell trait]],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.601,0.033,,0.409,,1
HMGCR,MS_700.42 [Dermatomyositis],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.158,,0.226,0.204,0.118,,1
LTA,MS_704.1 [Polyarteritis nodosa and related conditions],0.059,0,0.0,0.0,0.0,0.301,0.0,0.0,0.049,,0.076,0.035,0.045,,2
PPME1,GU_580.1 [Acute nephritic syndrome],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.979,0.105,,0.084,0.091,2
TP53RK,GU_580.1 [Acute nephritic syndrome],0.059,0,0.0,0.0,0.836,0.0,0.0,0.0,0.018,,3.39,3.21,0.113,0.07,4
RHOQ,CV_438.2 [Aneurysm of iliac or artery of lower extremity],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.7,0.12,,0.142,,1
RBM4,GE_972.9 [Muscular dystrophy],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.014,0.143,0.017,0.023,0.212,2
AXIN2,MS_700.3 [Systemic sclerosis],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.117,2.967,3.931,0.314,0.205,,2
RPL9,EM_208.1 [Hypoparathyroidism],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.206,0.039,,0.185,1
KCNK9,CM_763.13 [Patent ductus arteriosus],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.655,0.043,0.019,0.028,0.237,2
GHR,NS_323.3 [Motor neuron disease],0.059,1,2.0,0.0,0.0,0.0,0.0,0.0,0.018,2.198,2.655,0.489,0.299,0.277,3
MAGEA10,CV_414.1 [Hypertrophic cardiomyopathy],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.575,3.332,,0.099,0.082,2
HDAC9,GE_964.3 [Glycogen storage disease],0.059,1,2.0,0.0,0.0,0.0,0.0,0.0,0.069,2.306,1.795,0.24,0.187,,2
HSPG2,MB_296.4 [Borderline personality disorder],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.182,2.359,3.623,0.503,0.303,,2
HNRNPDL,GE_972.9 [Muscular dystrophy],0.059,0,0.0,0.0,0.745,0.0,0.0,0.452,0.05,2.324,1.499,0.048,0.056,0.844,4
PURA,RE_484.1 [Spontaneous pneumothorax],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.41,,0.021,0.332,1
TENT5A,GE_978.3 [Osteochondrodysplasias],0.059,0,0.0,0.0,0.0,0.0,0.353,0.51,0.053,2.439,2.323,2.28,0.083,,4
RDH8,SO_386.5 [Color vision deficiencies],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.99,,0.036,0.976,1
FOXO1,DE_669.2 [Behcet's syndrome],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.091,2.232,0.138,0.031,0.078,,2
TNS1,GE_976.5 [Polycystic kidney disease],0.059,0,0.0,0.0,0.0,0.0,0.355,0.0,0.069,2.593,2.574,0.673,0.378,,3
DYNC1H1,MB_302.1 [Speech and language developmental delay],0.059,0,0.0,0.0,0.0,0.0,0.0,0.29,0.012,1.632,1.913,0.427,1.428,0.592,4
CCL20,GU_580.1 [Acute nephritic syndrome],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.017,1.355,2.764,0.029,0.052,0.897,3
CD163,GI_542.8 [Biliary cirrhosis],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.238,,2.948,0.24,0.22,,2
EBF2,MS_704.1 [Polyarteritis nodosa and related conditions],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.286,3.144,3.47,0.099,0.096,,2
RPS3A,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.756,0.7,,0.023,0.201,2
RPL19,CM_750.16 [Arnold-Chiari syndrome*],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.075,0.027,0.022,0.347,1
RAB5A,GE_963.1 [Lipid storage disorders],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.044,2.766,0.104,0.014,0.025,0.282,3
VEGFA,EM_211.1 [Adrenal hyperfunction],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.127,3.369,2.736,2.078,0.128,,2
VSX1,SO_369.62 [Keratoconus],0.059,0,0.0,0.0,0.872,0.0,0.0,0.576,0.75,,3.1,1.064,0.159,0.676,4
SP1,CV_414.1 [Hypertrophic cardiomyopathy],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.353,,1.595,0.139,0.165,0.93,3
FGF9,NS_333.4 [Circadian rhythm sleep disorder],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.724,0.165,0.034,0.024,0.25,2
DRD4,MB_293.1 [Anorexia nervosa],0.059,1,4.0,0.0,0.0,0.0,0.0,0.0,0.103,2.032,2.443,0.233,0.095,,2
BMP4,GE_970.1 [Sickle-cell disorders],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.061,2.2,1.893,0.207,0.125,,2
IL16,MS_700.3 [Systemic sclerosis],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.305,2.381,3.659,2.657,0.316,,2
FGFR1,CV_414.1 [Hypertrophic cardiomyopathy],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.128,2.857,2.52,0.534,0.27,0.681,3
MAX,"EM_209.11 [Tall stature, acromegaly and gigantism]",0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.015,2.188,0.088,0.039,0.068,,2
COL4A2,DE_663.2 [Pemphigoid],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.275,2.722,3.643,0.277,0.302,,2
PLOD1,SO_369.62 [Keratoconus],0.059,0,0.0,0.0,0.0,0.0,0.0,0.281,0.018,2.485,3.17,0.942,1.825,0.16,4
CALM1,EM_208.1 [Hypoparathyroidism],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.681,0.11,,,0.1,2
ASH2L,MS_704.1 [Polyarteritis nodosa and related conditions],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.167,,2.781,2.639,0.117,,2
GAA,GE_972.2 [Hereditary ataxia],0.059,0,0.0,0.0,0.0,0.0,0.372,0.0,0.056,,2.794,0.638,0.333,0.965,4
IGF1R,GI_540.11 [Autoimmune hepatitis],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.141,2.629,3.819,0.427,0.269,,2
HDAC3,MS_700.42 [Dermatomyositis],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.109,,0.08,0.086,1.99,,2
C9orf72,CM_770.5 [Congenital osteodystrophies],0.059,0,0.0,0.0,0.0,0.0,0.378,0.0,0.041,2.519,1.898,0.163,0.113,0.236,4
USP22,GU_580.1 [Acute nephritic syndrome],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.174,0.139,,0.096,0.119,2
CDK6,CV_414.1 [Hypertrophic cardiomyopathy],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.076,3.191,2.801,,0.101,0.679,3
RPL18A,SO_380.3 [Optic atrophy],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.557,,,0.234,1
CHRM4,CM_763.13 [Patent ductus arteriosus],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.089,,0.006,0.219,1
RAB33B,GE_978.3 [Osteochondrodysplasias],0.059,0,0.0,0.0,0.0,0.0,0.353,0.37,0.061,3.807,0.611,0.597,0.066,,4
SOS2,CV_413.41 [Pulmonary valve stenosis],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.091,1.616,2.026,0.102,0.104,0.789,3
LZTR1,CM_763.31 [Ventricular septal defect],0.059,0,0.0,0.0,0.547,0.0,0.0,0.0,0.012,1.858,3.688,0.504,0.278,0.715,4
VCP,NS_328.13 [Frontotemporal dementia [FTD]],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.228,2.173,3.126,,3.152,,2
YAP1,NS_323.3 [Motor neuron disease],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.315,2.292,0.28,0.199,0.432,3
ANGPT1,MS_705.2 [Juvenile rheumatoid arthritis [JRA/JIA]],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.073,2.29,0.14,0.078,0.084,,2
ZEB2,CV_433.3 [Cerebrovascular insufficiency],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.167,2.724,2.175,0.095,1.675,0.889,3
STMN1,GE_972.2 [Hereditary ataxia],0.059,0,0.0,0.058,0.0,0.0,0.271,0.0,0.173,,0.298,0.094,0.046,0.843,4
UBA52,GE_977.1 [Congenital ichthyosis],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.534,2.926,,,0.319,2
BCL2,MS_712.51 [Hypermobility syndrome],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.11,1.993,2.383,0.045,2.135,,2
NFATC2,GE_961.1 [Phakomatoses],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,2.378,3.458,2.539,0.205,0.567,3
DSP,MS_700.3 [Systemic sclerosis],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.134,2.09,2.947,0.321,0.612,,2
OPN1MW,SO_386.5 [Color vision deficiencies],0.059,0,0.0,0.0,0.825,0.0,0.638,0.726,0.099,,0.033,,0.021,0.762,4
HSPA4,DE_663.2 [Pemphigoid],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.033,1.989,0.948,0.405,0.175,,2
SLC2A3,NS_323.3 [Motor neuron disease],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,1.711,3.975,0.358,0.221,0.134,3
NLRP3,DE_669.2 [Behcet's syndrome],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.23,2.284,0.659,0.078,0.081,,2
IGF2R,GE_972.9 [Muscular dystrophy],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.174,2.432,2.25,0.287,0.239,0.429,3
DRD2,GE_963.1 [Lipid storage disorders],0.059,0,0.0,0.0,0.0,0.0,0.264,0.0,0.132,4.315,0.385,0.173,0.064,0.101,4
TP53,GE_973.5 [Huntington's disease],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.773,,0.066,0.051,0.045,,1
BCL2,GE_978.22 [Ehler's Danlos syndrome],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.11,1.783,0.063,0.019,0.057,,2
IL21,CM_750.16 [Arnold-Chiari syndrome*],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.651,0.049,,0.012,0.239,2
IL12RB2,MS_700.3 [Systemic sclerosis],0.059,0,0.0,0.0,0.0,0.673,0.0,0.0,0.195,1.67,2.568,0.82,0.223,,2
COX15,CV_414.1 [Hypertrophic cardiomyopathy],0.059,0,0.0,0.0,0.684,0.0,0.0,0.0,0.089,,0.475,0.424,0.278,1.0,3
CHRNB2,GE_972.2 [Hereditary ataxia],0.059,1,2.0,0.162,0.0,0.0,0.0,0.0,0.0,1.481,0.834,0.355,0.244,0.903,3
GLI3,GE_976.5 [Polycystic kidney disease],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.038,3.107,2.104,0.101,0.291,,2
UBE2H,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.819,0.076,,0.014,0.29,2
GABRQ,CV_433.3 [Cerebrovascular insufficiency],0.059,1,2.0,0.0,0.0,0.0,0.0,0.0,0.0,1.663,3.24,,0.07,0.11,2
ANGPT1,GE_973.5 [Huntington's disease],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.087,2.444,0.099,0.04,0.054,,2
MYH2,GE_972.9 [Muscular dystrophy],0.059,0,0.0,0.0,0.745,0.0,0.0,0.129,0.041,,3.432,2.459,1.61,0.91,4
TTN,CV_413.41 [Pulmonary valve stenosis],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,1.748,4.409,0.399,0.269,0.99,3
VSIR,DE_663.2 [Pemphigoid],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.234,,2.306,0.204,0.096,,2
DNM2,GE_970.61 [Hereditary spherocytosis],0.059,0,0.0,0.0,0.0,0.0,0.263,0.0,0.069,2.635,3.172,2.797,0.083,,3
ADAR,CM_763.31 [Ventricular septal defect],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.015,1.86,2.189,0.195,0.187,0.685,3
PPRC1,CV_414.1 [Hypertrophic cardiomyopathy],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,,2.815,0.593,0.399,0.126,3
APP,NS_328.13 [Frontotemporal dementia [FTD]],0.059,1,1.0,0.0,0.0,0.0,0.0,0.0,0.179,2.186,2.997,0.575,0.263,,2
TCF20,GE_972.9 [Muscular dystrophy],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.024,,2.367,0.16,0.23,0.128,3
BCL2,GE_972.9 [Muscular dystrophy],0.059,0,0.0,0.0,0.304,0.0,0.0,0.0,0.066,2.901,0.093,0.035,0.044,0.911,4
C11orf58,BI_179.1 [Hypogammaglobulinemia NOS],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.968,0.075,,0.035,0.269,2
OR10A2,CM_751.213 [Congenital cataract],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,3.343,2.865,0.054,0.909,2
DPYSL2,NS_323.3 [Motor neuron disease],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,3.481,1.608,0.172,0.214,0.544,3
P2RY10,GE_983.2 [Hemoglobin C trait [Sickle-cell trait]],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,3.869,,0.173,,1
RPL11,GE_963.1 [Lipid storage disorders],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.117,,,0.342,1
GNGT1,SO_386.6 [Night blindness],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.915,3.225,2.754,0.048,0.983,2
NF1,GE_963.1 [Lipid storage disorders],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.029,1.361,1.157,0.211,0.213,0.574,3
BRD2,GE_966.2 [Disorders of porphyrin metabolism],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.077,2.255,1.535,0.128,0.077,,2
RPS10-NUDT3,CM_763.13 [Patent ductus arteriosus],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.06,0.012,0.017,0.17,1
FASN,CM_770.5 [Congenital osteodystrophies],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.129,,3.034,0.085,0.439,0.889,3
REL,DE_669.2 [Behcet's syndrome],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.418,,0.447,0.074,0.085,,1
RUNX1,NS_344.2 [Benign intracranial hypertension],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.561,2.252,0.293,1.616,0.969,2
RPS26,GU_580.1 [Acute nephritic syndrome],0.059,1,1.0,0.0,0.0,0.0,0.0,0.0,0.012,1.727,0.08,0.029,,0.229,3
CD163,MS_700.42 [Dermatomyositis],0.059,0,0.0,0.045,0.0,0.0,0.0,0.0,0.49,2.027,3.006,0.089,0.115,,3
DNMT1,CV_414.1 [Hypertrophic cardiomyopathy],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.097,1.914,2.973,0.333,0.308,0.433,3
SNAP25,GE_963.1 [Lipid storage disorders],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.454,0.096,0.024,0.054,0.332,3
RYR2,MB_302.1 [Speech and language developmental delay],0.059,0,0.0,0.0,0.0,0.0,0.329,0.0,0.167,2.893,2.984,0.269,0.423,0.661,4
RPS14,GE_972.9 [Muscular dystrophy],0.059,1,4.0,0.0,0.0,0.0,0.0,0.0,0.0,2.851,0.073,0.017,0.038,0.24,2
SGMS2,MS_712.51 [Hypermobility syndrome],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.236,1.415,0.17,0.348,0.156,,2
FASLG,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.059,0,0.0,0.0,0.0,0.0,0.373,0.0,0.078,1.689,2.723,0.108,2.367,0.973,4
SCN9A,MB_302.1 [Speech and language developmental delay],0.059,1,4.0,0.0,0.0,0.0,0.0,0.53,0.018,2.341,2.985,0.673,0.236,0.476,4
PPARG,GE_978.21 [Marfan syndrome],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.067,3.928,0.059,0.086,0.063,,2
SREBF2,DE_663.1 [Pemphigus],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.328,,2.051,0.198,0.126,,2
SMOC1,MS_700.42 [Dermatomyositis],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.15,3.274,2.176,0.197,0.1,,2
AQP3,GE_976.5 [Polycystic kidney disease],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.148,2.857,1.617,0.135,0.142,,2
FOXG1,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.431,1.88,,,0.238,3
JAK2,GE_970.61 [Hereditary spherocytosis],0.059,0,0.0,0.0,0.0,0.0,0.318,0.0,0.061,3.532,1.037,0.174,0.133,,3
PSIP1,MS_700.42 [Dermatomyositis],0.059,0,0.0,0.018,0.0,0.0,0.0,0.0,0.093,1.907,0.181,0.155,0.08,,3
PRPF31,SO_386.6 [Night blindness],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.017,1.423,2.88,0.17,0.123,1.0,3
DYNC2I2,CM_770.5 [Congenital osteodystrophies],0.059,0,0.0,0.0,0.0,0.0,0.0,0.84,0.064,,2.777,0.292,0.18,,3
NUP62,SO_386.6 [Night blindness],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,3.001,,0.014,0.22,2
COQ8A,GE_972.2 [Hereditary ataxia],0.059,0,0.0,0.0,0.893,0.0,0.317,0.317,0.063,1.835,2.704,0.524,2.766,,4
MAPKAPK2,EM_209.4 [Diabetes insipidus],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.872,,0.021,0.313,2
GGCT,CV_433.3 [Cerebrovascular insufficiency],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.033,1.985,0.097,0.115,0.114,0.086,3
KCNA1,NS_341.1 [Cerebral palsy],0.059,1,3.0,0.0,0.547,0.0,0.0,0.0,0.0,2.64,3.0,0.067,0.076,0.95,3
BRD2,MB_293.1 [Anorexia nervosa],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.106,,1.761,0.272,1.414,,2
ABCB1,GI_540.11 [Autoimmune hepatitis],0.059,0,0.0,0.0,0.0,0.0,0.285,0.0,0.075,,2.957,0.124,0.316,,3
CBL,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.059,0,0.0,0.0,0.547,0.0,0.0,0.0,0.036,,1.705,0.314,0.242,0.879,4
GABRG2,GU_580.1 [Acute nephritic syndrome],0.059,1,4.0,0.0,0.0,0.0,0.0,0.0,0.0,3.129,0.095,0.04,0.067,0.118,2
LDLR,CV_438.41 [Aortic dissection],0.059,0,0.0,0.0,0.547,0.0,0.0,0.37,0.061,,2.565,0.368,0.623,0.569,4
NDUFB2,GE_972.2 [Hereditary ataxia],0.059,1,4.0,0.0,0.0,0.0,0.0,0.0,0.0,1.69,2.141,2.013,0.081,0.904,2
SPTLC1,GE_972.1 [Hereditary neuropathy],0.059,0,0.0,0.0,0.0,0.0,0.0,0.633,0.051,1.899,2.993,1.657,0.769,,3
RAP1A,NS_333.4 [Circadian rhythm sleep disorder],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.61,0.101,,0.035,0.215,2
MYH6,GE_964.3 [Glycogen storage disease],0.059,0,0.0,0.0,0.0,0.0,0.474,0.0,0.021,,2.805,0.169,0.125,,3
DRD1,GE_963.3 [Mucopolysaccharidoses],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.043,3.093,0.187,0.085,0.054,,2
S1PR1,GU_580.52 [Diffuse membranous glomerulonephritis],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.036,2.212,0.132,0.036,0.066,,2
SHANK1,SO_386.5 [Color vision deficiencies],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.745,2.958,,0.025,0.333,2
GRIN2B,NS_333.4 [Circadian rhythm sleep disorder],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,2.4,3.382,,,0.759,3
MYO18A,GE_961.1 [Phakomatoses],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,,2.928,0.641,1.299,0.18,3
LGI1,NS_323.3 [Motor neuron disease],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.021,1.463,4.253,0.237,0.203,0.137,3
DLX6,CV_433.3 [Cerebrovascular insufficiency],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.122,1.992,0.757,0.047,0.024,0.314,3
TNFSF11,"EM_209.11 [Tall stature, acromegaly and gigantism]",0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.225,,0.823,0.144,0.041,,1
IRF4,CV_433.3 [Cerebrovascular insufficiency],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.152,1.955,2.2,0.089,0.063,0.813,3
PIP4K2B,CV_413.41 [Pulmonary valve stenosis],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,3.745,,0.019,0.269,2
B4GALT5,MB_302.1 [Speech and language developmental delay],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.555,0.15,,0.086,0.161,2
FGFR2,MS_727.5 [Cyst of bone],0.059,0,0.0,0.0,0.0,0.0,0.307,0.0,0.018,1.903,0.819,0.396,0.237,,3
GTPBP4,GU_580.1 [Acute nephritic syndrome],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,1.986,2.791,1.868,0.151,0.138,3
ETS1,NS_340.3 [Inflammatory and immune myopathies],0.059,0,0.0,0.096,0.0,0.0,0.0,0.0,0.102,3.195,0.287,0.029,0.044,,3
ROM1,SO_380.3 [Optic atrophy],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,3.454,0.661,0.109,0.991,2
SYNPO,GU_580.52 [Diffuse membranous glomerulonephritis],0.059,0,0.0,0.0,0.0,0.0,0.0,0.129,0.158,,1.863,0.33,0.105,,3
VSNL1,NS_323.3 [Motor neuron disease],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.083,1.386,0.079,,0.077,0.076,3
MRPL3,CV_416.8 [Pre-excitation syndrome [Anomalous atrioventricular excitation]],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.556,1.863,0.259,0.148,0.937,2
LNPEP,CV_433.3 [Cerebrovascular insufficiency],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.207,,0.221,0.136,0.197,0.451,2
THBS1,DE_663.2 [Pemphigoid],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.066,2.51,1.904,,0.085,,2
DGKA,GE_961.1 [Phakomatoses],0.059,0,0.0,0.0,0.0,0.0,0.0,0.0,0.061,2.476,2.631,0.168,0.179,0.116,3
WNK2,CV_433.3 [Cerebrovascular insufficiency],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,1.83,4.372,0.545,0.341,0.162,3
F2,GE_976.5 [Polycystic kidney disease],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.091,3.249,2.334,0.161,1.747,,2
TCF3,CM_750.16 [Arnold-Chiari syndrome*],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.908,2.371,0.165,0.124,0.917,2
RPS10,BI_162.1 [Constitutional (hereditary) aplastic anemia],0.058,1,0.5,0.0,0.834,0.0,0.0,0.853,0.122,1.687,0.014,,,,3
VEGFD,RE_484.1 [Spontaneous pneumothorax],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.115,,3.202,2.929,0.119,,2
EPHA4,GE_978.3 [Osteochondrodysplasias],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.043,4.325,2.244,0.179,1.505,,2
GAS1,MS_717.1 [Cervicocranial syndrome],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.336,2.966,0.014,0.032,,1
TSC1,GU_580.1 [Acute nephritic syndrome],0.058,0,0.0,0.0,0.0,0.0,0.44,0.0,0.03,2.983,1.919,0.223,0.174,0.656,4
YTHDF3,GE_972.2 [Hereditary ataxia],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.798,3.491,,0.026,0.209,2
SULT2B1,GE_977.1 [Congenital ichthyosis],0.058,0,0.0,0.0,0.0,0.0,0.0,0.735,0.099,2.606,0.342,0.081,0.048,0.95,4
ADRA2A,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.058,1,4.0,0.0,0.0,0.0,0.0,0.0,0.0,2.854,2.749,0.038,0.05,0.436,2
LPAR1,MS_704.1 [Polyarteritis nodosa and related conditions],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.04,2.29,0.099,0.044,0.08,,2
MID1IP1,GE_972.9 [Muscular dystrophy],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.361,3.784,,0.026,0.243,2
ABCB11,GI_542.8 [Biliary cirrhosis],0.058,0,0.0,0.0,0.304,0.0,0.0,0.0,0.219,1.676,2.227,0.118,0.116,,3
NR3C2,CV_414.1 [Hypertrophic cardiomyopathy],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.05,3.034,3.223,,0.035,0.254,3
PTPN23,MB_302.1 [Speech and language developmental delay],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,,2.884,0.373,0.293,0.168,3
SMARCAL1,GU_580.1 [Acute nephritic syndrome],0.058,0,0.0,0.0,0.895,0.0,0.0,0.184,0.061,1.877,3.343,1.228,0.202,0.41,4
AR,MB_305.1 [Tics and tic disorders],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.015,2.722,3.066,,0.011,,2
FOXO6,CM_750.16 [Arnold-Chiari syndrome*],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.215,0.193,,0.019,0.157,2
TNFRSF11B,CM_770.5 [Congenital osteodystrophies],0.058,0,0.0,0.0,0.0,0.0,0.319,0.0,0.145,1.645,2.911,0.103,1.989,0.966,4
FOXP3,BI_179.7 [Common variable immunodeficiency [CVID]],0.058,0,0.0,0.0,0.0,0.0,0.591,0.0,0.239,,2.455,2.431,0.02,,3
RHOG,BI_179.1 [Hypogammaglobulinemia NOS],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.325,2.693,,0.015,0.193,2
ANK1,BI_162.1 [Constitutional (hereditary) aplastic anemia],0.058,0,0.0,0.0,0.0,0.0,0.571,0.0,0.03,2.684,1.581,0.794,0.163,,3
TRAF6,CV_414.1 [Hypertrophic cardiomyopathy],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.085,1.886,2.16,0.072,0.137,0.45,3
AR,MS_727.5 [Cyst of bone],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.024,2.383,2.584,,0.023,,2
SF3B2,GE_961.1 [Phakomatoses],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.024,,1.749,0.259,0.172,0.169,3
PPIA,GE_977.1 [Congenital ichthyosis],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.067,0.014,0.011,0.139,1
CYP19A1,GE_978.3 [Osteochondrodysplasias],0.058,1,2.0,0.0,0.0,0.0,0.361,0.0,0.055,1.663,0.184,0.159,0.119,,3
COL3A1,GE_978.21 [Marfan syndrome],0.058,0,0.0,0.0,0.0,0.0,0.0,0.121,0.041,1.884,2.603,0.409,0.106,,3
FASLG,DE_663.2 [Pemphigoid],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.149,,1.653,0.101,0.064,,2
HMGA1,CV_414.1 [Hypertrophic cardiomyopathy],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.401,0.077,,,0.129,2
GDF6,CM_750.16 [Arnold-Chiari syndrome*],0.058,0,0.0,0.0,0.547,0.0,0.0,0.0,0.012,2.097,0.091,0.094,0.068,0.464,4
YTHDC2,CM_770.5 [Congenital osteodystrophies],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,,0.348,0.213,0.17,0.301,2
CD163,DE_663.1 [Pemphigus],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.086,1.332,2.508,0.1,0.109,,2
EPHB4,CV_441 [Arteriovenous malformation],0.058,0,0.0,0.0,0.0,0.0,0.0,0.884,0.067,1.826,2.612,0.954,0.337,0.938,4
SLC4A2,GE_978.3 [Osteochondrodysplasias],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.181,,3.372,1.721,0.179,,2
MTOR,GE_974.3 [Hereditary choroidal dystrophies],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.049,2.501,1.799,0.121,0.09,,2
ABCB4,GI_540.11 [Autoimmune hepatitis],0.058,0,0.0,0.0,0.0,0.0,0.42,0.0,0.071,1.374,2.572,0.868,0.435,,3
RET,GU_580.52 [Diffuse membranous glomerulonephritis],0.058,0,0.0,0.0,0.0,0.0,0.443,0.0,0.018,,2.756,0.734,0.16,,3
PABPN1,NS_323.3 [Motor neuron disease],0.058,0,0.0,0.0,0.0,0.0,0.394,0.0,0.036,,2.722,0.311,0.121,0.363,4
SUMO2,GE_977.1 [Congenital ichthyosis],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.078,,,0.144,1
CNP,GE_961.1 [Phakomatoses],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.102,,0.498,0.199,0.104,0.429,2
WNT5A,SO_369.62 [Keratoconus],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.036,2.22,0.129,0.111,0.111,0.517,3
GAP43,GE_977.1 [Congenital ichthyosis],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.024,2.122,0.071,0.144,0.052,0.106,3
VSNL1,CV_433.3 [Cerebrovascular insufficiency],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,2.257,0.058,,0.059,0.18,3
APP,GE_977.6 [Congenital cutaneous mastocytosis*],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.085,4.0,0.091,0.193,0.098,,2
RAD23B,GE_961.1 [Phakomatoses],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.477,0.351,,0.089,0.166,3
HNRNPC,RE_484.1 [Spontaneous pneumothorax],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.461,2.924,,,0.246,2
DNMT1,NS_341.1 [Cerebral palsy],0.058,0,0.0,0.0,0.547,0.0,0.0,0.129,0.0,1.504,3.487,0.177,0.162,0.935,3
ERH,CM_751.213 [Congenital cataract],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.104,,0.025,0.284,1
SERPING1,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.058,1,1.0,0.0,0.0,0.0,0.0,0.0,0.05,2.833,2.011,0.065,0.074,0.865,3
HIF1A,EM_209.4 [Diabetes insipidus],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.079,2.299,3.519,0.197,0.114,0.98,3
SQSTM1,NS_333.4 [Circadian rhythm sleep disorder],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.365,3.482,0.215,0.127,0.949,2
ATL3,NS_341.1 [Cerebral palsy],0.058,0,0.0,0.0,0.547,0.0,0.0,0.0,0.021,1.634,0.586,0.164,0.15,0.952,4
GNPAT,NS_323.3 [Motor neuron disease],0.058,0,0.0,0.0,0.0,0.0,0.282,0.0,0.012,,2.459,1.941,0.269,0.068,4
JAG1,GE_972.1 [Hereditary neuropathy],0.058,0,0.0,0.0,0.0,0.0,0.312,0.0,0.037,2.947,2.425,0.357,0.242,,3
OTUD7A,NS_323.3 [Motor neuron disease],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,3.115,3.335,0.253,0.307,0.085,3
TUBA1B,NS_323.3 [Motor neuron disease],0.058,1,2.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.9,,,0.252,1
SIRPA,GE_961.1 [Phakomatoses],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.477,2.802,3.466,1.791,0.078,0.226,3
BACE1,MS_712.51 [Hypermobility syndrome],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.462,,2.775,2.523,0.193,,2
NOTCH1,GU_580.1 [Acute nephritic syndrome],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.04,2.021,3.208,0.292,0.358,0.901,3
PPARG,SO_365.3 [Exophthalmos [Proptosis]],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.093,1.856,3.058,0.169,0.173,0.947,3
SUV39H2,GE_961.1 [Phakomatoses],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.769,0.115,,0.067,0.105,2
ALAD,NS_339.2 [Myotonic disorders],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.073,3.601,2.364,0.099,0.071,,2
RUNX2,GE_977.1 [Congenital ichthyosis],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,3.21,0.212,0.123,0.111,0.067,3
RPS20,EM_208.1 [Hypoparathyroidism],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.586,0.079,,0.116,0.332,2
USP22,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.334,0.148,,0.112,0.12,2
HTT,NS_328.13 [Frontotemporal dementia [FTD]],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.088,,3.095,0.178,0.479,,2
ADRA2A,GU_617.1 [Incompetence of cervix uteri],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.195,2.511,0.013,0.032,,1
SRC,DE_663.2 [Pemphigoid],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.074,1.793,0.103,0.06,0.131,,2
NDUFB8,GE_963.1 [Lipid storage disorders],0.058,0,0.0,0.0,0.684,0.0,0.0,0.0,0.0,,0.162,0.112,0.058,0.991,2
PRDM1,MS_727.5 [Cyst of bone],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.5,3.845,3.213,1.14,0.487,,2
BRCA1,CM_763.13 [Patent ductus arteriosus],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.882,0.138,0.108,0.989,2
PTPRC,MS_704.2 [Wegener's granulomatosis],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.036,1.97,0.531,0.08,0.071,,2
GABRA4,EM_209.4 [Diabetes insipidus],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.098,0.31,,0.093,0.165,2
SHANK3,SO_369.62 [Keratoconus],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.6,3.299,,0.027,0.294,2
SNAP25,GE_972.2 [Hereditary ataxia],0.058,0,0.0,0.138,0.684,0.0,0.0,0.402,0.041,1.557,1.764,0.035,0.075,0.965,5
AGO2,NS_323.3 [Motor neuron disease],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.073,2.599,2.475,,0.152,0.722,3
OPN1MW,MS_704.9 [Allergic purpura [Henoch-Schoenlein purpura]],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.977,0.078,,3.263,,1
POU3F4,SO_396.3 [Mixed conductive and sensorineural hearing loss],0.058,0,0.0,0.0,0.701,0.0,0.599,0.838,0.056,1.942,1.548,,,,4
SLC8A1,GU_580.1 [Acute nephritic syndrome],0.058,1,0.5,0.0,0.0,0.0,0.0,0.0,0.012,3.465,1.982,0.367,0.198,0.327,3
HIVEP3,CM_770.5 [Congenital osteodystrophies],0.058,0,0.0,0.0,0.0,0.0,0.375,0.0,0.087,2.458,2.879,0.774,0.588,0.629,4
BCOR,CM_751.213 [Congenital cataract],0.058,0,0.0,0.0,0.745,0.0,0.0,0.466,0.026,2.334,2.863,0.064,0.054,0.896,4
KIF5C,NS_323.3 [Motor neuron disease],0.058,0,0.0,0.0,0.0,0.0,0.348,0.0,0.049,2.949,1.987,0.182,0.729,0.585,4
KHDRBS1,CM_770.5 [Congenital osteodystrophies],0.058,0,0.0,0.0,0.0,0.0,0.264,0.0,0.012,1.973,0.075,0.043,0.095,0.698,4
KDR,MS_727.3 [Osteitis deformans [Paget's disease of bone]],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.12,2.497,2.59,0.705,0.29,,2
FOXG1,CV_438.41 [Aortic dissection],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.57,1.603,,,0.305,2
DRD3,MB_287.2 [Schizoaffective disorder],0.058,1,4.0,0.0,0.0,0.0,0.0,0.0,0.108,,2.458,2.028,0.141,,2
CAV2,GE_972.9 [Muscular dystrophy],0.058,0,0.0,0.039,0.0,0.0,0.28,0.0,0.103,2.549,0.121,0.098,0.071,0.743,5
NLGN4X,SO_369.62 [Keratoconus],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.137,3.721,,0.045,0.171,2
IFT81,GE_978.3 [Osteochondrodysplasias],0.058,0,0.0,0.0,0.0,0.0,0.0,0.724,0.04,,3.031,0.383,0.161,,3
SOX17,GE_972.2 [Hereditary ataxia],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,2.028,2.609,0.241,0.115,0.983,3
RPS10,CV_433.3 [Cerebrovascular insufficiency],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.018,,,0.152,1
ATG16L1,MS_705.2 [Juvenile rheumatoid arthritis [JRA/JIA]],0.058,0,0.0,0.0,0.0,0.311,0.0,0.0,0.208,1.615,2.888,0.042,2.762,,2
UBE2D3,CV_414.1 [Hypertrophic cardiomyopathy],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.077,,,0.147,1
FGFR2,GE_964.3 [Glycogen storage disease],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.033,2.949,2.27,0.22,0.155,,2
USP22,CV_416.8 [Pre-excitation syndrome [Anomalous atrioventricular excitation]],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.406,0.135,,0.108,0.114,2
CHAF1A,NS_333.4 [Circadian rhythm sleep disorder],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.652,3.625,0.022,,0.298,2
TRPC6,GU_580.51 [Focal and segmental glomerular lesions*],0.058,0,0.0,0.0,0.0,0.0,0.0,0.864,0.676,2.227,0.402,0.287,0.165,,3
HSPA12A,CV_433.3 [Cerebrovascular insufficiency],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.073,,4.464,4.365,0.17,0.048,3
NRP1,MS_704.1 [Polyarteritis nodosa and related conditions],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.395,2.609,2.491,0.613,0.209,,2
C19orf12,GE_972.2 [Hereditary ataxia],0.058,0,0.0,0.029,0.779,0.0,0.0,0.547,0.045,2.734,0.204,0.054,0.016,0.819,5
EGR3,GE_972.2 [Hereditary ataxia],0.058,0,0.0,0.0,0.0,0.0,0.282,0.0,0.051,,0.161,,0.104,0.28,3
SMARCE1,MS_703.2 [Chondrocalcinosis],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.174,0.208,0.158,0.134,,2
RPL23,GE_977.1 [Congenital ichthyosis],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.116,,0.014,0.26,1
NR3C1,"MB_280.4 [Sedative, hypnotic, or anxiolytic related disorders]",0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.059,2.238,0.426,0.165,1.727,,2
RUNX1,CV_441 [Arteriovenous malformation],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.345,1.997,0.679,0.767,0.98,2
CSNK2A2,GE_977.1 [Congenital ichthyosis],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.762,0.13,,2.927,0.118,2
GLT8D1,NS_328.13 [Frontotemporal dementia [FTD]],0.058,0,0.0,0.0,0.0,0.0,0.0,0.281,0.012,,0.161,0.257,0.162,,2
NCDN,CM_763.13 [Patent ductus arteriosus],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.117,0.026,0.033,0.306,1
RAB3GAP1,NS_341.1 [Cerebral palsy],0.058,0,0.0,0.0,0.0,0.0,0.0,0.362,0.012,1.745,0.671,0.304,0.233,0.799,4
JPH3,GE_973.5 [Huntington's disease],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.273,1.424,3.193,2.123,2.288,,2
GAS1,GE_975.2 [Hereditary hemorrhagic telangiectasia],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.525,3.077,0.018,0.031,,1
DPYSL2,GE_978.3 [Osteochondrodysplasias],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.043,2.929,2.429,0.095,0.104,,2
GGNBP2,SO_386.5 [Color vision deficiencies],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.174,0.046,0.023,0.301,2
ERBB4,CV_413.41 [Pulmonary valve stenosis],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,2.758,0.456,0.206,1.662,0.914,3
CHD4,MB_302.1 [Speech and language developmental delay],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,2.281,1.904,0.189,0.208,0.642,3
TNFRSF11B,MS_703.2 [Chondrocalcinosis],0.058,0,0.0,0.0,0.547,0.0,0.0,0.0,0.109,2.09,2.106,0.208,0.179,,3
GSK3B,CV_433.3 [Cerebrovascular insufficiency],0.058,1,3.0,0.0,0.0,0.0,0.0,0.0,0.288,1.936,1.949,,0.087,0.956,3
VEGFA,MB_291.1 [Conversion disorder],0.058,1,4.0,0.0,0.0,0.0,0.0,0.0,0.042,2.412,3.577,2.53,0.094,,2
NUP205,GU_580.52 [Diffuse membranous glomerulonephritis],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.067,1.415,2.307,0.384,0.216,,2
NCOA1,MS_704.1 [Polyarteritis nodosa and related conditions],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.061,2.0,2.837,0.21,0.163,,2
NEGR1,GE_963.1 [Lipid storage disorders],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.125,2.365,0.57,0.04,0.052,0.169,3
MYH14,GI_540.11 [Autoimmune hepatitis],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.107,1.941,2.808,1.911,0.153,,2
ANGPT2,GE_978.22 [Ehler's Danlos syndrome],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.098,1.955,0.194,0.039,0.108,,2
BMPR1A,MS_727.3 [Osteitis deformans [Paget's disease of bone]],0.058,1,4.0,0.0,0.0,0.0,0.0,0.0,0.061,2.888,2.252,0.177,0.204,,2
COQ2,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.058,0,0.0,0.0,0.0,0.0,0.0,0.541,0.276,,1.836,0.175,0.138,0.031,4
RBFOX2,MB_302.1 [Speech and language developmental delay],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,2.98,1.674,0.235,0.16,0.445,3
HCRTR2,NS_333.7 [Narcolepsy],0.058,1,2.0,0.0,0.0,0.0,0.811,0.0,0.216,2.429,3.027,0.071,0.08,,3
ZDHHC17,GE_963.1 [Lipid storage disorders],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.015,2.423,0.149,0.055,0.078,0.02,3
MASP2,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.058,1,3.0,0.0,0.58,0.0,0.0,0.0,0.091,1.635,1.768,0.338,0.214,0.819,4
GRIN1,MB_306 [Conduct disorders],0.058,1,4.0,0.0,0.0,0.0,0.0,0.0,0.04,,0.081,0.04,0.084,,1
PDCD6IP,NS_344.11 [Communicating hydrocephalus],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.15,2.041,0.152,0.071,0.073,,2
FN1,CV_413.41 [Pulmonary valve stenosis],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.463,3.446,0.134,0.231,0.984,2
TP53,GE_976.5 [Polycystic kidney disease],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.125,,2.167,1.912,0.15,,2
ZAP70,GE_977.6 [Congenital cutaneous mastocytosis*],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.085,1.968,0.251,0.097,0.064,,2
RPS24,GE_977.1 [Congenital ichthyosis],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.623,0.095,0.034,0.008,0.278,2
CSF1R,CM_770.5 [Congenital osteodystrophies],0.058,0,0.0,0.0,0.547,0.0,0.296,0.0,0.067,2.698,2.621,0.618,0.121,0.958,5
AGPAT1,CM_763.13 [Patent ductus arteriosus],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.044,,0.021,0.265,1
ARPC4,SO_386.5 [Color vision deficiencies],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.034,,,0.15,1
WNT3,NS_343.6 [Multi-system degeneration of the autonomic nervous system*],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.158,1.994,0.039,0.031,0.048,,2
BSCL2,GE_972.2 [Hereditary ataxia],0.058,0,0.0,0.0,0.0,0.0,0.0,0.705,0.148,1.946,3.058,0.121,0.097,0.894,4
FANCG,CV_441 [Arteriovenous malformation],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,3.034,2.461,0.137,0.989,2
FOXP1,GE_961.1 [Phakomatoses],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.073,2.787,0.05,,,0.664,3
GLT8D1,NS_323.3 [Motor neuron disease],0.058,0,0.0,0.0,0.85,0.0,0.0,0.129,0.113,,3.063,1.609,0.242,0.028,4
GFRA1,GE_972.9 [Muscular dystrophy],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.324,0.768,0.113,0.106,0.174,3
IDH1,GE_961.1 [Phakomatoses],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.197,,2.801,0.411,0.193,0.991,3
RPS26,NS_333.4 [Circadian rhythm sleep disorder],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.519,0.079,0.042,,0.096,2
HMGB2,GE_963.1 [Lipid storage disorders],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.281,,0.015,0.224,1
VEGFA,GE_978.22 [Ehler's Danlos syndrome],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.78,1.896,1.862,0.112,0.062,,2
AFF2,MB_302.1 [Speech and language developmental delay],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.049,2.156,3.975,0.192,0.172,0.893,3
PITX2,CM_763.31 [Ventricular septal defect],0.058,0,0.0,0.0,0.547,0.0,0.0,0.0,0.049,2.607,0.263,0.13,0.092,0.886,4
CD19,MS_727.5 [Cyst of bone],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.106,,3.379,0.288,0.171,,2
NDUFV1,SO_380.3 [Optic atrophy],0.058,0,0.0,0.0,0.684,0.0,0.0,0.0,0.058,,3.006,3.049,0.227,0.982,4
RAP1A,CV_414.1 [Hypertrophic cardiomyopathy],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.691,0.202,,0.066,0.21,2
RAF1,GI_540.11 [Autoimmune hepatitis],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.106,,0.241,0.231,0.113,,1
AR,CM_770.5 [Congenital osteodystrophies],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.041,2.057,2.414,,0.013,0.966,3
RELN,MB_303.1 [Dyslexia and alexia],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.188,2.89,3.187,1.002,1.736,,2
FKRP,NS_341.1 [Cerebral palsy],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.888,3.511,0.203,1.621,0.929,2
CREBL2,CM_763.13 [Patent ductus arteriosus],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.026,0.024,0.016,0.187,1
IKZF1,MS_700.3 [Systemic sclerosis],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,2.387,0.506,0.185,0.141,,2
ATP7B,NS_333.4 [Circadian rhythm sleep disorder],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.133,4.054,1.836,0.406,0.91,2
DAGLA,GE_972.2 [Hereditary ataxia],0.058,0,0.0,0.0,0.0,0.0,0.0,0.575,0.029,1.374,3.089,0.305,0.215,0.81,4
OR4D10,NS_341.1 [Cerebral palsy],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.319,0.194,0.055,0.927,1
TP53,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.076,,0.375,0.106,0.112,0.997,2
STAT6,GU_580.1 [Acute nephritic syndrome],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.103,2.196,2.741,0.127,0.139,0.933,3
OR2W3,SO_369.62 [Keratoconus],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.313,1.904,0.148,0.143,0.929,2
IGF1,GE_972.1 [Hereditary neuropathy],0.058,0,0.0,0.0,0.0,0.0,0.286,0.0,0.101,1.86,0.807,0.161,0.083,,3
KCNMA1,GE_973.5 [Huntington's disease],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.035,2.251,0.191,0.096,0.06,,2
KMT2A,CM_770.5 [Congenital osteodystrophies],0.058,0,0.0,0.0,0.0,0.0,0.329,0.0,0.31,,3.06,0.269,0.262,0.731,4
CRYAB,GE_972.9 [Muscular dystrophy],0.058,0,0.0,0.0,0.779,0.0,0.338,0.402,0.072,,0.336,0.152,0.086,0.963,4
SIM1,GE_972.9 [Muscular dystrophy],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.046,1.747,0.162,0.114,0.044,3
WNT5A,GE_972.1 [Hereditary neuropathy],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,2.875,0.115,0.167,0.156,,2
ITCH,NS_323.3 [Motor neuron disease],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.024,,2.051,0.126,0.678,0.306,3
SNAP25,NS_323.3 [Motor neuron disease],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,2.029,0.193,0.049,0.131,0.678,3
CABP4,SO_386.5 [Color vision deficiencies],0.058,0,0.0,0.0,0.0,0.0,0.295,0.392,0.018,,0.156,0.29,0.085,0.971,4
DNM2,GE_964.3 [Glycogen storage disease],0.058,0,0.0,0.0,0.0,0.0,0.398,0.0,0.012,,1.038,0.244,0.174,,2
SIAH1,SO_386.5 [Color vision deficiencies],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.505,0.054,,,0.348,2
ARHGEF6,GI_516.1 [Pyloric stenosis],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,1.765,0.284,0.146,0.983,2
FOXO3,GI_540.11 [Autoimmune hepatitis],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.08,1.575,5.923,5.56,0.12,,2
SOS1,CM_770.5 [Congenital osteodystrophies],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,2.136,3.537,2.464,0.152,0.611,3
SETDB1,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,,1.434,0.276,0.208,0.163,3
CST3,EM_249.1 [Cerebral amyloid angiopathy*],0.058,0,0.0,0.0,0.0,0.0,0.0,0.569,0.066,,2.814,0.122,0.048,,3
LCA5,SO_386.6 [Night blindness],0.058,0,0.0,0.0,0.547,0.0,0.0,0.0,0.018,1.394,2.631,1.257,0.167,1.0,4
BMAL1,GI_540.11 [Autoimmune hepatitis],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.085,2.964,,,,,2
VEGFA,EM_208.1 [Hypoparathyroidism],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.097,2.875,1.991,0.285,0.194,0.96,3
GNAT1,SO_386.5 [Color vision deficiencies],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,,0.127,0.219,0.105,0.996,2
GAS1,GU_580.1 [Acute nephritic syndrome],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.136,2.663,0.031,0.043,0.241,2
POU5F1,EM_208.1 [Hypoparathyroidism],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.988,2.881,0.181,0.083,0.986,2
MS4A1,BI_179.7 [Common variable immunodeficiency [CVID]],0.058,0,0.0,0.0,0.0,0.0,0.514,0.654,0.073,,1.797,0.03,0.035,,4
BECN1,MS_704.1 [Polyarteritis nodosa and related conditions],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.418,,1.862,0.202,0.096,,2
LAMP1,GI_542.8 [Biliary cirrhosis],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.073,2.004,2.305,0.624,0.143,,2
ERCC2,BI_162.1 [Constitutional (hereditary) aplastic anemia],0.058,0,0.0,0.0,0.0,0.0,0.37,0.0,0.039,,0.163,0.41,0.134,,2
WT1,GE_976.5 [Polycystic kidney disease],0.058,0,0.0,0.0,0.0,0.0,0.279,0.0,0.158,2.507,2.083,,0.046,,3
MAPK8IP3,NS_323.3 [Motor neuron disease],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.04,,3.729,1.777,0.693,0.157,3
CD163,GE_978.22 [Ehler's Danlos syndrome],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.103,1.551,3.142,2.993,0.118,,2
MYO5A,GE_972.2 [Hereditary ataxia],0.058,0,0.0,0.0,0.0,0.0,0.445,0.0,0.018,3.223,3.135,0.827,0.172,0.875,4
INSR,NS_333.4 [Circadian rhythm sleep disorder],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.024,2.113,2.867,0.16,0.163,0.91,3
RPL18A,GU_580.1 [Acute nephritic syndrome],0.058,1,1.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.246,,,0.232,1
TBX18,CM_763.31 [Ventricular septal defect],0.058,0,0.0,0.0,0.732,0.0,0.0,0.0,0.137,2.959,2.842,0.961,0.162,0.605,4
CLEC16A,GI_542.8 [Biliary cirrhosis],0.058,0,0.0,0.0,0.0,0.437,0.0,0.0,0.061,7.057,2.585,0.322,0.219,,2
PREP,GE_973.5 [Huntington's disease],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.094,1.552,0.079,0.127,0.079,,2
HGF,MS_705.2 [Juvenile rheumatoid arthritis [JRA/JIA]],0.058,0,0.0,0.055,0.0,0.0,0.0,0.0,0.084,2.097,3.391,2.741,0.129,,3
FGFR1,MS_712.51 [Hypermobility syndrome],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.094,2.511,2.736,1.686,0.788,,2
TUBA1B,BI_162.1 [Constitutional (hereditary) aplastic anemia],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.061,2.885,0.153,,,,2
GRIN1,NS_323.3 [Motor neuron disease],0.058,1,3.0,0.0,0.0,0.0,0.278,0.0,0.033,,0.2,0.08,0.208,0.691,3
PPP1R12A,GE_976.5 [Polycystic kidney disease],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.097,3.763,2.343,0.413,0.564,,2
ESR1,GI_542.8 [Biliary cirrhosis],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.713,3.091,2.731,2.566,1.971,,2
NDUFS8,CV_414.1 [Hypertrophic cardiomyopathy],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,,2.309,1.017,0.239,0.995,3
NDUFAF1,NS_341.1 [Cerebral palsy],0.058,1,2.0,0.0,0.0,0.0,0.0,0.0,0.0,,3.299,1.94,1.684,0.958,2
PEA15,BI_179.1 [Hypogammaglobulinemia NOS],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.196,0.025,0.031,0.292,1
RPL31,CM_750.16 [Arnold-Chiari syndrome*],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.532,0.295,,,0.226,2
CUL1,MS_727.5 [Cyst of bone],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.085,0.12,,0.12,,1
DCTN1,NS_328.13 [Frontotemporal dementia [FTD]],0.058,0,0.0,0.0,0.0,0.0,0.0,0.281,0.08,,3.677,0.337,0.21,,3
ITSN1,CV_433.3 [Cerebrovascular insufficiency],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.862,3.287,1.282,0.29,0.326,3
CALM1,GE_961.1 [Phakomatoses],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,2.843,0.08,,,0.0,3
ADCY5,GE_973.5 [Huntington's disease],0.058,0,0.0,0.0,0.0,0.0,0.27,0.0,0.095,1.935,3.026,0.048,0.087,,3
GCH1,NS_341.1 [Cerebral palsy],0.058,0,0.0,0.0,0.841,0.0,0.0,0.56,0.053,,0.237,0.283,0.069,0.978,3
SLC38A2,CV_433.3 [Cerebrovascular insufficiency],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.0,2.924,0.351,0.128,0.136,3
CDH13,SO_369.62 [Keratoconus],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.043,2.812,2.852,,0.07,0.126,3
EBP,GE_978.3 [Osteochondrodysplasias],0.058,0,0.0,0.0,0.0,0.0,0.0,0.905,0.044,,0.269,0.106,0.039,,2
SNAI2,GU_580.52 [Diffuse membranous glomerulonephritis],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,3.04,0.071,,0.061,,2
HTR1A,MB_296.4 [Borderline personality disorder],0.058,1,4.0,0.0,0.0,0.0,0.0,0.0,0.211,1.941,2.55,0.183,1.577,,2
ADAMTS13,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.058,0,0.0,0.0,0.886,0.0,0.0,0.0,0.148,1.322,3.195,2.287,0.162,0.905,4
ERH,CM_750.16 [Arnold-Chiari syndrome*],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.06,,0.027,0.302,1
RPS23,NS_333.4 [Circadian rhythm sleep disorder],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.909,0.063,,,0.343,2
WNT1,GE_972.2 [Hereditary ataxia],0.058,0,0.0,0.041,0.0,0.0,0.391,0.0,0.061,,0.317,0.212,0.167,0.826,4
KLF9,CM_763.13 [Patent ductus arteriosus],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.067,0.179,0.025,0.02,0.304,2
HMGCR,CV_414.1 [Hypertrophic cardiomyopathy],0.058,1,3.0,0.0,0.0,0.0,0.0,0.0,0.07,1.715,3.092,0.978,0.348,0.615,3
NTRK2,GE_972.1 [Hereditary neuropathy],0.058,1,0.5,0.0,0.0,0.0,0.309,0.0,0.082,3.233,3.041,0.165,0.236,,3
KDR,GE_964.3 [Glycogen storage disease],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.096,1.773,2.332,0.516,0.191,,2
FN1,DE_669.2 [Behcet's syndrome],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.179,3.339,3.381,1.165,0.517,,2
COL11A1,DE_663.2 [Pemphigoid],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.07,2.735,3.536,0.18,0.241,,2
VEGFA,MS_712.51 [Hypermobility syndrome],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.78,2.339,1.41,0.236,0.141,,2
RPL7,SO_386.6 [Night blindness],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.911,3.623,,,0.122,2
PTGS2,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.058,0,0.0,0.0,0.0,0.0,0.257,0.0,0.03,1.532,0.139,0.114,0.121,0.991,4
SLC6A6,CV_414.1 [Hypertrophic cardiomyopathy],0.058,0,0.0,0.0,0.0,0.06,0.564,0.0,0.091,2.78,2.715,1.818,0.098,0.044,4
GAS1,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.5,2.294,0.027,0.034,0.244,2
GLI3,CM_772.1 [Congenital malformations of endocrine glands],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,6.568,3.949,0.182,0.215,,2
KITLG,GE_977.6 [Congenital cutaneous mastocytosis*],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.126,2.985,0.04,0.055,0.04,,2
DYSF,NS_340.3 [Inflammatory and immune myopathies],0.058,0,0.0,0.0,0.854,0.0,0.546,0.0,0.048,1.815,2.873,0.741,0.176,,4
RPL19,GE_963.1 [Lipid storage disorders],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.074,0.019,0.019,0.349,1
RUNX1,DE_663.2 [Pemphigoid],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.666,2.777,0.461,0.25,0.138,,2
BACE2,NS_340.3 [Inflammatory and immune myopathies],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.094,2.268,0.559,0.097,0.062,,2
IL1B,GU_580.1 [Acute nephritic syndrome],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.105,1.378,2.514,0.114,0.049,0.996,3
KIF1C,NS_341.1 [Cerebral palsy],0.058,0,0.0,0.0,0.84,0.0,0.0,0.0,0.018,,2.896,0.088,0.108,0.903,4
MAPRE2,CV_414.1 [Hypertrophic cardiomyopathy],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.014,0.215,,0.128,0.064,2
KITLG,GE_963.1 [Lipid storage disorders],0.058,0,0.0,0.018,0.0,0.0,0.0,0.0,0.039,1.796,0.064,0.066,0.04,0.104,4
SPTLC1,GE_973.5 [Huntington's disease],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.122,1.941,0.124,0.063,2.072,,2
CIAO3,CV_441 [Arteriovenous malformation],0.058,0,0.0,0.0,0.0,0.0,0.0,0.129,0.012,1.801,3.123,0.355,0.273,,3
GRIA2,NS_323.3 [Motor neuron disease],0.058,1,2.0,0.0,0.0,0.0,0.0,0.0,0.114,1.965,2.514,1.516,0.207,0.703,3
ABL1,GE_970.1 [Sickle-cell disorders],0.058,1,1.0,0.0,0.0,0.0,0.0,0.0,0.079,2.765,2.067,0.677,0.535,,2
FOXG1,GE_963.1 [Lipid storage disorders],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.024,2.227,0.914,,,0.219,3
TLR8,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.058,0,0.0,0.0,0.0,0.0,0.0,0.402,0.15,,0.215,,0.091,0.881,3
HAS2,GU_580.1 [Acute nephritic syndrome],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,2.871,0.155,,0.057,0.293,3
UBA52,EM_209.4 [Diabetes insipidus],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.082,,,0.147,1
FERMT2,CV_414.1 [Hypertrophic cardiomyopathy],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.17,,2.963,0.31,0.625,0.123,3
GNAS,GE_972.2 [Hereditary ataxia],0.058,0,0.0,0.054,0.0,0.0,0.0,0.37,0.061,1.858,1.494,0.093,2.055,0.813,5
UQCRC1,NS_341.1 [Cerebral palsy],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,1.059,0.927,0.179,0.973,1
TMEM126B,GE_972.2 [Hereditary ataxia],0.058,0,0.0,0.04,0.0,0.0,0.0,0.0,0.0,,2.185,0.412,0.095,0.923,3
KLF2,GE_972.2 [Hereditary ataxia],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.033,2.334,2.584,,0.027,0.439,3
YPEL5,RE_484.1 [Spontaneous pneumothorax],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.129,0.074,,,0.122,2
TNF,GI_542.8 [Biliary cirrhosis],0.058,0,0.0,0.0,0.304,0.0,0.0,0.0,0.162,,0.344,0.344,0.061,,2
PIK3R4,NS_323.3 [Motor neuron disease],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.061,1.598,2.0,0.46,0.206,0.035,3
PRKCB,MS_727.3 [Osteitis deformans [Paget's disease of bone]],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.091,2.459,2.284,0.147,1.574,,2
SLC24A3,CV_414.1 [Hypertrophic cardiomyopathy],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.036,2.972,2.035,0.078,0.228,0.041,3
ABL1,DE_663.2 [Pemphigoid],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.582,2.568,3.265,1.107,0.161,,2
PTPN22,MS_705.2 [Juvenile rheumatoid arthritis [JRA/JIA]],0.058,0,0.0,0.0,0.0,0.289,0.0,0.0,0.439,,2.552,0.763,0.107,,2
WWP2,CV_414.1 [Hypertrophic cardiomyopathy],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.024,1.711,3.465,0.697,0.427,0.1,3
MYH11,GE_978.22 [Ehler's Danlos syndrome],0.058,0,0.0,0.0,0.0,0.0,0.0,0.121,0.067,1.863,2.478,0.652,0.199,,3
FOXO1,NS_339.2 [Myotonic disorders],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.082,3.474,0.143,0.018,0.055,,2
SLC6A4,CV_433.3 [Cerebrovascular insufficiency],0.058,1,3.0,0.0,0.0,0.0,0.0,0.0,0.045,,0.287,0.151,0.142,0.592,2
HMGB1,CV_438.41 [Aortic dissection],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.112,2.688,1.699,0.101,,0.486,3
IGF2BP2,GI_540.11 [Autoimmune hepatitis],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,1.884,0.174,0.128,0.164,,2
EYA1,GU_580.1 [Acute nephritic syndrome],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.021,2.837,2.596,0.219,0.171,0.348,3
CACNA1E,GE_961.1 [Phakomatoses],0.058,1,2.0,0.0,0.0,0.0,0.0,0.0,0.036,2.996,3.059,1.917,0.22,0.129,3
SUB1,GE_963.1 [Lipid storage disorders],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.174,0.085,0.021,0.029,0.213,2
MAP3K5,GE_973.5 [Huntington's disease],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.247,,2.319,0.086,0.1,,2
CUL3,CV_433.3 [Cerebrovascular insufficiency],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.024,2.506,0.093,0.067,0.097,0.423,3
DOCK8,MB_302.1 [Speech and language developmental delay],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.024,2.407,3.182,0.613,0.391,0.172,3
GAS1,SO_365.3 [Exophthalmos [Proptosis]],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.905,2.8,0.026,0.056,0.611,2
CCND1,GI_540.11 [Autoimmune hepatitis],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.056,2.782,0.153,0.042,0.08,,2
PRKAA1,CV_416.8 [Pre-excitation syndrome [Anomalous atrioventricular excitation]],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.096,1.45,2.072,0.188,0.151,0.922,3
BCL2,NS_323.3 [Motor neuron disease],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.066,2.423,0.183,0.046,0.096,0.898,3
NR3C2,CV_438.41 [Aortic dissection],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.31,2.276,,0.023,0.246,2
GNAZ,CM_750.16 [Arnold-Chiari syndrome*],0.058,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.071,,0.013,0.221,1
GRN,GU_580.1 [Acute nephritic syndrome],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.108,,3.464,0.236,0.144,0.819,3
SYK,GE_961.1 [Phakomatoses],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.067,1.688,0.235,0.23,0.148,0.817,3
TYK2,GI_542.8 [Biliary cirrhosis],0.057,0,0.0,0.0,0.0,0.44,0.0,0.0,0.038,2.166,2.298,0.409,0.261,,2
HNF4A,SO_386.6 [Night blindness],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.518,1.962,0.186,1.869,0.983,2
EPHA4,"EM_209.11 [Tall stature, acromegaly and gigantism]",0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,2.881,0.211,0.187,0.136,,2
TLL1,GI_540.11 [Autoimmune hepatitis],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.151,3.077,2.631,,2.002,,2
PTPN22,MS_700.3 [Systemic sclerosis],0.057,0,0.0,0.0,0.0,0.397,0.0,0.0,0.339,2.958,2.458,0.709,0.225,,2
PEX7,SO_380.3 [Optic atrophy],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.347,3.709,0.134,0.128,0.978,2
OGDHL,NS_341.1 [Cerebral palsy],0.057,0,0.0,0.0,0.426,0.0,0.0,0.0,0.0,,2.75,1.204,0.492,0.946,3
RPL18A,SO_365.3 [Exophthalmos [Proptosis]],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.976,,,0.239,1
KLF2,NS_333.4 [Circadian rhythm sleep disorder],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.463,3.547,,0.018,0.353,2
TMEM63A,GE_963.1 [Lipid storage disorders],0.057,0,0.0,0.0,0.0,0.0,0.0,0.666,0.072,1.524,2.325,0.21,0.139,0.248,4
TK2,CV_414.1 [Hypertrophic cardiomyopathy],0.057,0,0.0,0.0,0.684,0.0,0.0,0.0,0.021,1.927,2.179,0.8,0.234,0.968,4
RPS6KB1,GE_976.5 [Polycystic kidney disease],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.114,,0.152,0.056,1.697,,2
VCX3A,GE_977.1 [Congenital ichthyosis],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.154,2.75,2.528,0.074,0.022,0.276,3
NDUFS1,GE_972.2 [Hereditary ataxia],0.057,1,4.0,0.0,0.0,0.0,0.0,0.0,0.012,1.573,2.82,0.697,0.303,0.993,3
TET2,GE_978.3 [Osteochondrodysplasias],0.057,0,0.0,0.0,0.0,0.0,0.497,0.0,0.055,3.232,2.58,0.092,0.185,,3
SNRPD2,CV_433.3 [Cerebrovascular insufficiency],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.052,,,0.14,1
GP9,GI_516.1 [Pyloric stenosis],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,3.356,,3.257,0.089,2
RPL37,CM_750.16 [Arnold-Chiari syndrome*],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.222,,0.023,0.221,1
CSF1R,GE_972.2 [Hereditary ataxia],0.057,0,0.0,0.0,0.547,0.0,0.313,0.0,0.05,1.667,2.727,0.514,0.187,0.897,5
FANCF,CV_441 [Arteriovenous malformation],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.603,2.433,0.364,0.138,0.988,2
GABRA1,CV_438.2 [Aneurysm of iliac or artery of lower extremity],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.642,0.113,,0.139,,1
GATA6,CV_414.1 [Hypertrophic cardiomyopathy],0.057,0,0.0,0.0,0.426,0.0,0.0,0.0,0.044,3.399,4.605,,0.108,0.641,4
LIMK1,CV_433.3 [Cerebrovascular insufficiency],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.061,2.717,1.952,0.258,0.136,0.83,3
THRA,GE_978.3 [Osteochondrodysplasias],0.057,0,0.0,0.0,0.0,0.0,0.323,0.402,0.019,1.775,1.847,0.067,2.204,,4
TIAL1,NS_344.2 [Benign intracranial hypertension],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.605,0.074,,0.037,0.208,2
GJB1,GE_972.2 [Hereditary ataxia],0.057,0,0.0,0.0,0.547,0.0,0.342,0.129,0.035,,2.912,,0.033,0.647,5
FMR1,NS_343.6 [Multi-system degeneration of the autonomic nervous system*],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.21,3.259,0.069,0.088,0.046,,2
ETV6,GE_977.6 [Congenital cutaneous mastocytosis*],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.16,1.935,0.19,0.093,0.046,,2
FAT4,GE_963.1 [Lipid storage disorders],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,3.482,4.314,3.395,0.083,0.109,3
KCNQ2,MB_306 [Conduct disorders],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.044,3.081,2.556,0.087,0.078,,2
POSTN,MS_727.5 [Cyst of bone],0.057,0,0.0,0.0,0.0,0.0,0.283,0.0,0.093,3.102,2.249,0.44,0.425,,3
LRRC3B,GI_516.1 [Pyloric stenosis],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.196,0.136,,0.094,0.16,2
CACNA1F,SO_380.3 [Optic atrophy],0.057,0,0.0,0.0,0.0,0.0,0.444,0.0,0.041,,2.569,0.116,0.217,0.98,4
PSMA5,CM_750.16 [Arnold-Chiari syndrome*],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.044,,0.014,0.234,1
HSPD1,CV_414.1 [Hypertrophic cardiomyopathy],0.057,0,0.0,0.0,0.426,0.0,0.0,0.0,0.064,,0.69,0.139,0.152,0.989,3
ELAVL2,GE_972.2 [Hereditary ataxia],0.057,0,0.0,0.187,0.0,0.0,0.0,0.0,0.018,2.915,0.105,0.064,1.603,0.511,4
PPARG,CM_763.31 [Ventricular septal defect],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.823,0.088,0.104,0.103,0.98,2
UBE2E3,SO_386.6 [Night blindness],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.956,0.065,,,0.115,2
PRKDC,GE_976.5 [Polycystic kidney disease],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.608,1.993,3.149,0.615,0.378,,2
ANKHD1-EIF4EBP3,NS_344.2 [Benign intracranial hypertension],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.079,0.036,,0.112,1
SHANK3,BI_179.1 [Hypogammaglobulinemia NOS],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.528,,0.021,0.237,2
MBP,NS_343.6 [Multi-system degeneration of the autonomic nervous system*],0.057,0,0.0,0.0,0.0,0.0,0.265,0.0,0.24,1.903,2.45,0.142,0.053,,3
TLR8,SO_386.5 [Color vision deficiencies],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.954,0.121,,0.084,0.085,2
SIAH1,GI_540.11 [Autoimmune hepatitis],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.073,1.926,0.046,,,,2
RNASEH2A,NS_341.1 [Cerebral palsy],0.057,0,0.0,0.0,0.654,0.0,0.0,0.0,0.0,,0.273,0.143,0.106,0.942,2
TTL,CV_414.1 [Hypertrophic cardiomyopathy],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.048,,0.728,0.135,0.16,0.057,2
KCNA5,GE_972.2 [Hereditary ataxia],0.057,1,2.0,0.0,0.0,0.0,0.0,0.0,0.024,2.397,2.519,0.169,0.154,0.971,3
AKR1B1,EM_209.4 [Diabetes insipidus],0.057,0,0.0,0.0,0.0,0.0,0.315,0.0,0.04,3.497,2.265,0.191,0.107,0.246,4
MSTN,GE_972.1 [Hereditary neuropathy],0.057,0,0.0,0.0,0.0,0.0,0.365,0.0,0.018,,2.726,0.858,0.145,,3
TSPAN5,NS_333.4 [Circadian rhythm sleep disorder],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.223,0.052,0.044,0.094,0.178,2
KCNMA1,GE_961.1 [Phakomatoses],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.858,2.964,2.292,0.195,0.228,3
HK1,GI_542.8 [Biliary cirrhosis],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.451,1.942,2.564,1.009,0.261,,2
ALDH3A2,NS_341.1 [Cerebral palsy],0.057,0,0.0,0.0,0.0,0.0,0.0,0.37,0.055,2.001,2.343,0.318,1.364,0.859,4
RPS19,CV_433.3 [Cerebrovascular insufficiency],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,3.914,,,0.277,2
NFKB1,MS_727.5 [Cyst of bone],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.556,1.483,4.697,0.348,0.198,,2
ADRA2A,BI_179.1 [Hypogammaglobulinemia NOS],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.535,3.116,0.033,0.062,0.177,2
LCAT,GU_580.1 [Acute nephritic syndrome],0.057,0,0.0,0.0,0.547,0.0,0.0,0.0,0.281,,2.607,0.063,0.032,0.435,4
PCBP1,CV_433.3 [Cerebrovascular insufficiency],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.073,,2.506,,,0.299,3
TF,GU_580.1 [Acute nephritic syndrome],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.115,1.802,2.801,0.186,0.194,0.893,3
TAF12,CM_751.213 [Congenital cataract],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.4,0.016,0.021,0.306,2
ACSL1,GE_961.1 [Phakomatoses],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,1.907,1.731,0.152,1.131,0.261,3
EDNRB,GI_542.8 [Biliary cirrhosis],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.608,1.805,2.096,0.166,0.163,,2
YWHAE,SO_369.62 [Keratoconus],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.048,2.477,,0.019,0.218,2
CRAT,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.057,0,0.0,0.0,0.0,0.0,0.0,0.37,0.02,,2.76,0.086,0.213,0.105,4
PDCD5,CV_433.3 [Cerebrovascular insufficiency],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.122,2.512,3.144,0.057,0.066,0.225,3
BCL2L2-PABPN1,GE_961.1 [Phakomatoses],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.061,,0.028,0.302,1
CASZ1,CM_763.31 [Ventricular septal defect],0.057,0,0.0,0.0,0.0,0.0,0.301,0.0,0.11,3.072,2.278,0.885,0.648,0.446,4
EFNB2,GE_964.3 [Glycogen storage disease],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.061,2.578,0.17,0.071,0.107,,2
OPRM1,"MB_280.4 [Sedative, hypnotic, or anxiolytic related disorders]",0.057,1,4.0,0.0,0.0,0.0,0.0,0.0,0.351,3.135,3.279,0.093,1.83,,2
HSPB8,GE_972.9 [Muscular dystrophy],0.057,0,0.0,0.0,0.745,0.0,0.298,0.475,0.127,1.858,1.646,0.088,0.046,0.892,5
KCNK5,EM_211.1 [Adrenal hyperfunction],0.057,0,0.0,0.0,0.632,0.0,0.0,0.0,0.084,1.928,2.815,0.137,0.08,,3
ADD3,CM_770.5 [Congenital osteodystrophies],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.587,2.46,0.763,0.168,0.21,3
LINGO1,CV_433.3 [Cerebrovascular insufficiency],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.198,2.015,1.838,0.136,1.905,0.049,3
RPL15,GE_961.1 [Phakomatoses],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.085,,,0.152,1
LASP1,CV_413.41 [Pulmonary valve stenosis],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.714,0.112,0.027,0.035,0.301,2
UQCRFS1,GE_972.2 [Hereditary ataxia],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.055,2.799,0.124,0.102,0.094,0.961,3
BICD2,GE_972.2 [Hereditary ataxia],0.057,0,0.0,0.0,0.426,0.0,0.283,0.156,0.192,2.133,3.114,0.426,0.223,0.602,5
NBPF1,MS_700.3 [Systemic sclerosis],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.213,1.854,1.948,0.808,0.09,,2
TPI1,MS_700.3 [Systemic sclerosis],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.11,,0.241,0.06,0.062,,1
ITGB1,MS_728.2 [Osteochondritis dissecans],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.271,0.133,0.046,0.117,,2
SGMS2,GE_978.22 [Ehler's Danlos syndrome],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.236,1.712,0.112,0.157,0.069,,2
RET,GU_580.51 [Focal and segmental glomerular lesions*],0.057,0,0.0,0.0,0.0,0.0,0.443,0.0,0.018,2.722,0.25,0.311,0.151,,3
AIFM1,GE_972.2 [Hereditary ataxia],0.057,0,0.0,0.0,0.796,0.0,0.0,0.758,0.029,,3.157,0.144,0.065,0.948,4
HNRNPC,CV_416.8 [Pre-excitation syndrome [Anomalous atrioventricular excitation]],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.493,0.083,,,0.136,2
HMGCR,MS_719.2 [Muscle calcification and ossification],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.101,,0.286,0.166,0.104,,1
GRIN3A,MS_704.1 [Polyarteritis nodosa and related conditions],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.615,2.387,3.472,0.189,0.161,,2
HBG2,NS_341.1 [Cerebral palsy],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.021,0.126,,3.075,0.232,2
SMAD3,MS_727.3 [Osteitis deformans [Paget's disease of bone]],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.033,2.753,0.259,0.051,0.096,,2
JADE1,GE_961.1 [Phakomatoses],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.023,2.094,0.17,0.062,0.162,,2
KDM5A,DE_663.2 [Pemphigoid],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.188,,1.864,0.296,0.195,,2
ZMAT2,CM_763.31 [Ventricular septal defect],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.064,,0.025,0.327,1
TLR7,MS_727.5 [Cyst of bone],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.096,,2.967,0.19,0.155,,2
STAT1,MS_712.51 [Hypermobility syndrome],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.055,2.062,2.421,0.195,0.131,,2
MYH14,CV_414.1 [Hypertrophic cardiomyopathy],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.622,,2.649,0.15,0.657,0.516,3
CAT,GI_516.1 [Pyloric stenosis],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.752,2.423,0.522,0.327,0.993,2
NDNF,CM_770.5 [Congenital osteodystrophies],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.362,1.678,2.646,2.629,0.117,0.186,3
AR,MB_301.2 [Asperger's syndrome*],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.861,2.62,,0.011,,2
PTK2,GE_977.6 [Congenital cutaneous mastocytosis*],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.046,1.958,0.109,0.144,0.093,,2
ETNK1,GU_580.1 [Acute nephritic syndrome],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.164,0.07,0.041,0.076,0.179,2
KIT,DE_663.1 [Pemphigus],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.078,2.448,3.663,3.29,0.098,,2
RGS9BP,SO_386.5 [Color vision deficiencies],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.375,1.821,0.061,0.93,2
RNF2,SO_386.5 [Color vision deficiencies],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.042,,0.024,0.309,1
MYH9,GE_970.2 [Thalassemia],0.057,0,0.0,0.0,0.0,0.0,0.432,0.0,0.018,1.362,2.514,0.548,0.262,,3
FAM76B,SO_369.62 [Keratoconus],0.057,0,0.0,0.0,0.0,0.093,0.0,0.0,0.012,1.598,0.126,0.121,1.963,0.154,3
SCN5A,GE_978.22 [Ehler's Danlos syndrome],0.057,1,4.0,0.0,0.0,0.0,0.0,0.0,0.018,2.061,4.403,0.242,0.483,,2
CACNA2D1,GE_972.1 [Hereditary neuropathy],0.057,1,4.0,0.0,0.0,0.0,0.0,0.0,0.024,4.366,2.083,0.142,0.695,,2
MSH3,GE_973.5 [Huntington's disease],0.057,1,0.5,0.0,0.0,0.2,0.0,0.0,0.507,1.881,2.211,0.377,0.116,,2
KRAS,GE_961.1 [Phakomatoses],0.057,0,0.0,0.0,0.0,0.0,0.327,0.733,0.012,2.113,0.503,,0.039,0.983,5
SLC44A1,NS_333.4 [Circadian rhythm sleep disorder],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,2.313,2.731,2.023,0.136,0.134,3
TSHR,CM_772.2 [Congenital hypothyroidism],0.057,0,0.0,0.0,0.0,0.0,0.281,0.517,0.205,1.725,3.871,2.294,0.086,,4
ATP6V0B,CV_416.8 [Pre-excitation syndrome [Anomalous atrioventricular excitation]],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.293,0.072,0.036,0.08,0.108,2
SUCO,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.043,1.898,1.971,0.515,0.232,0.069,3
KIF7,GE_972.2 [Hereditary ataxia],0.057,0,0.0,0.0,0.684,0.0,0.0,0.29,0.03,2.466,2.985,0.144,0.333,0.938,4
SRSF1,GE_961.1 [Phakomatoses],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.033,1.512,0.058,,,0.316,3
GSK3B,CV_416.8 [Pre-excitation syndrome [Anomalous atrioventricular excitation]],0.057,0,0.0,0.0,0.0,0.0,0.39,0.0,0.0,2.443,0.194,,1.804,0.667,3
KDR,CV_414.1 [Hypertrophic cardiomyopathy],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.194,2.266,2.639,0.334,0.097,0.493,3
P2RY10,MS_703.2 [Chondrocalcinosis],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.639,0.144,,0.12,,1
ADRA2A,CM_763.13 [Patent ductus arteriosus],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.772,2.6,0.012,0.031,0.257,2
TLR4,MS_704.1 [Polyarteritis nodosa and related conditions],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.186,2.522,1.391,0.143,1.765,,2
GABBR1,NS_333.7 [Narcolepsy],0.057,1,4.0,0.0,0.0,0.0,0.0,0.0,0.015,2.304,0.197,0.119,0.101,,2
VAMP2,NS_344.2 [Benign intracranial hypertension],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.16,,0.019,0.254,1
ITGA4,GE_972.9 [Muscular dystrophy],0.057,1,2.0,0.0,0.0,0.0,0.0,0.0,0.382,3.327,3.552,0.247,0.136,0.791,3
WDR48,GE_972.2 [Hereditary ataxia],0.057,0,0.0,0.0,0.0,0.0,0.0,0.129,0.032,1.606,3.128,0.102,0.168,0.19,4
PTGS2,MS_705.2 [Juvenile rheumatoid arthritis [JRA/JIA]],0.057,1,4.0,0.021,0.0,0.0,0.0,0.0,0.018,1.953,2.822,0.06,0.071,,3
PLG,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.057,0,0.0,0.0,0.842,0.0,0.0,0.0,0.127,2.094,3.015,0.051,0.084,0.946,4
NALCN,GE_961.1 [Phakomatoses],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,3.111,2.431,0.177,0.289,0.138,3
EPHB2,MS_700.3 [Systemic sclerosis],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.657,2.522,3.108,0.625,1.734,,2
WDR19,GE_972.2 [Hereditary ataxia],0.057,0,0.0,0.0,0.0,0.0,0.291,0.0,0.024,5.433,4.194,0.214,0.438,0.93,4
ANO1,GU_580.1 [Acute nephritic syndrome],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.015,2.786,2.023,2.099,0.229,0.256,3
ALAD,GE_973.5 [Huntington's disease],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.173,,0.084,0.067,0.057,,1
EFEMP1,NS_323.3 [Motor neuron disease],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,1.875,2.32,0.229,0.189,0.048,3
ATP2B4,NS_341.1 [Cerebral palsy],0.057,0,0.0,0.0,0.684,0.0,0.0,0.0,0.015,2.659,3.082,0.182,0.138,0.91,4
SLIT2,DE_663.2 [Pemphigoid],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.097,2.441,2.792,0.518,0.285,,2
PPIB,MS_727.3 [Osteitis deformans [Paget's disease of bone]],0.057,0,0.0,0.0,0.0,0.0,0.377,0.0,0.036,,0.15,0.26,0.174,,2
SERPINC1,CV_438.41 [Aortic dissection],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.04,2.475,2.565,0.38,0.097,0.228,3
AR,GE_972.9 [Muscular dystrophy],0.057,1,1.0,0.0,0.0,0.0,0.277,0.0,0.059,2.596,1.286,,0.012,0.837,4
LTBP2,GE_977.6 [Congenital cutaneous mastocytosis*],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.176,1.772,2.485,0.199,0.093,,2
RPL15,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.428,0.079,,,0.12,2
MB,GU_580.1 [Acute nephritic syndrome],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.041,2.228,0.094,0.138,0.12,0.366,3
APP,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.057,1,2.0,0.0,0.0,0.0,0.0,0.0,0.08,2.236,2.432,0.741,2.065,0.95,3
RBFOX1,GE_972.9 [Muscular dystrophy],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.206,3.923,3.095,1.102,0.141,0.662,3
HTRA1,GE_963.1 [Lipid storage disorders],0.057,0,0.0,0.0,0.426,0.0,0.0,0.0,0.024,1.995,0.124,0.156,0.095,0.294,4
TET2,GE_977.6 [Congenital cutaneous mastocytosis*],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.17,1.941,2.269,0.05,0.105,,2
BACE1,EM_249.1 [Cerebral amyloid angiopathy*],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.154,,0.345,0.138,0.131,,1
SHOC2,CV_414.1 [Hypertrophic cardiomyopathy],0.057,0,0.0,0.0,0.684,0.0,0.0,0.129,0.094,1.523,1.988,0.179,0.184,0.443,4
SLC6A4,MB_296.2 [Schizoid personality disorder],0.057,1,4.0,0.0,0.304,0.0,0.0,0.0,0.073,,3.397,3.1,0.057,,3
CRK,CM_763.13 [Patent ductus arteriosus],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.062,0.034,0.035,0.278,1
TFR2,GE_970.2 [Thalassemia],0.057,0,0.0,0.0,0.0,0.0,0.504,0.0,0.043,,1.707,0.13,0.115,,3
HTT,MB_302.1 [Speech and language developmental delay],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.657,3.406,0.615,0.094,0.985,2
KCNH2,GE_963.1 [Lipid storage disorders],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,2.946,2.918,2.653,0.084,0.124,3
EIF2S1,GE_963.1 [Lipid storage disorders],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.168,0.027,0.03,0.269,1
RASA1,CV_413.41 [Pulmonary valve stenosis],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,3.498,0.162,0.168,0.088,0.863,3
CACNA1C,GE_972.9 [Muscular dystrophy],0.057,0,0.0,0.0,0.0,0.0,0.257,0.0,0.081,2.617,2.688,1.994,0.182,0.857,4
EIF5A,CV_413.41 [Pulmonary valve stenosis],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.058,,0.013,0.269,1
CEP290,SO_373.2 [Choroidal degenerations],0.057,0,0.0,0.0,0.0,0.0,0.43,0.0,0.018,2.255,2.852,0.414,0.462,,3
RPS29,CM_751.213 [Congenital cataract],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.815,0.04,,,0.133,2
RPS10-NUDT3,CV_413.41 [Pulmonary valve stenosis],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.07,0.019,0.023,0.137,1
RNF41,CM_763.13 [Patent ductus arteriosus],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.1,0.028,0.031,0.271,1
AR,GE_963.1 [Lipid storage disorders],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,2.232,0.548,,0.013,0.424,3
DPYSL3,GE_961.1 [Phakomatoses],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.043,1.851,2.463,0.145,0.12,0.21,3
HSPG2,DE_663.2 [Pemphigoid],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.134,1.847,6.706,0.291,0.302,,2
SNRNP200,SO_386.6 [Night blindness],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,,2.12,1.725,0.209,0.997,3
RXYLT1,GE_972.9 [Muscular dystrophy],0.057,0,0.0,0.0,0.825,0.0,0.0,0.0,0.05,1.49,0.244,0.174,0.123,,3
GALNS,CV_414.1 [Hypertrophic cardiomyopathy],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,1.821,0.637,0.285,0.958,2
ACLY,DE_669.2 [Behcet's syndrome],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.131,,0.32,0.393,0.127,,1
DHTKD1,NS_341.1 [Cerebral palsy],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.948,1.792,0.558,0.505,0.996,2
CDK2AP2,CM_763.13 [Patent ductus arteriosus],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.028,0.017,0.019,0.167,1
NLK,BI_162.1 [Constitutional (hereditary) aplastic anemia],0.057,0,0.0,0.0,0.0,0.0,0.268,0.0,0.341,,2.437,0.075,0.062,,3
IFIH1,CM_772.1 [Congenital malformations of endocrine glands],0.057,0,0.0,0.0,0.0,0.0,0.265,0.0,0.172,2.341,5.669,2.931,0.599,,3
POLR2H,EM_208.1 [Hypoparathyroidism],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.512,0.085,,0.112,0.077,2
NR3C1,CV_438.41 [Aortic dissection],0.057,1,4.0,0.0,0.0,0.0,0.0,0.0,0.03,2.85,1.515,0.251,1.071,0.736,3
MFSD8,NS_323.3 [Motor neuron disease],0.057,0,0.0,0.0,0.654,0.0,0.0,0.0,0.043,1.318,2.507,0.423,0.284,0.012,4
TPR,GE_972.9 [Muscular dystrophy],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.166,1.825,1.234,1.285,0.151,0.272,3
AK1,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.057,0,0.0,0.0,0.547,0.0,0.0,0.0,0.036,,1.963,0.216,0.135,0.477,4
VEGFA,GI_540.11 [Autoimmune hepatitis],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.15,2.548,2.685,2.112,0.116,,2
COL11A1,GE_961.1 [Phakomatoses],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.193,2.669,0.366,0.402,0.782,3
BDNF,MS_727.3 [Osteitis deformans [Paget's disease of bone]],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.114,2.083,0.68,0.636,0.141,,2
PPARG,RE_464.2 [Chronic nasopharyngitis],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.021,1.952,0.078,0.079,0.087,,2
HPSE2,GU_580.1 [Acute nephritic syndrome],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,2.361,2.65,0.123,0.842,0.094,3
ABCB1,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,1.966,2.276,0.316,0.259,0.911,3
FAT1,GE_972.9 [Muscular dystrophy],0.057,0,0.0,0.071,0.0,0.0,0.0,0.0,0.388,2.901,4.091,0.825,0.411,0.599,4
CHRM4,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.202,,0.019,0.225,1
RDH8,SO_386.6 [Night blindness],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.698,,0.055,0.987,1
BMP1,MS_727.3 [Osteitis deformans [Paget's disease of bone]],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.194,3.502,3.48,0.046,0.148,,2
RAB35,GE_970.1 [Sickle-cell disorders],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.829,0.088,,0.136,,1
ABCA1,GE_978.3 [Osteochondrodysplasias],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.095,2.752,4.516,0.144,0.268,,2
CLN6,GE_972.2 [Hereditary ataxia],0.057,0,0.0,0.0,0.852,0.0,0.0,0.29,0.0,1.336,2.671,0.392,1.413,0.927,3
ACLY,DE_663.2 [Pemphigoid],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.091,2.714,1.849,0.648,0.726,,2
INSR,"EM_209.11 [Tall stature, acromegaly and gigantism]",0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.098,1.932,2.52,0.124,0.111,,2
SRSF1,NS_333.4 [Circadian rhythm sleep disorder],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.044,,,0.149,1
IL7,BI_179.1 [Hypogammaglobulinemia NOS],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.036,0.304,,0.042,0.973,2
B4GALT5,GE_961.1 [Phakomatoses],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.414,0.147,,0.1,0.079,2
HSF2,BI_162.1 [Constitutional (hereditary) aplastic anemia],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.04,2.046,0.125,0.05,0.07,,2
DNAAF4,MB_303.1 [Dyslexia and alexia],0.057,0,0.0,0.0,0.0,0.0,0.0,0.628,0.373,2.524,3.023,0.081,0.054,,3
ABCG1,GE_963.1 [Lipid storage disorders],0.057,0,0.0,0.0,0.0,0.0,0.297,0.0,0.034,2.36,1.303,0.85,0.11,0.248,4
HSPA9,GE_972.2 [Hereditary ataxia],0.057,0,0.0,0.035,0.0,0.0,0.0,0.0,0.139,,2.515,0.27,0.202,0.972,4
CSK,MS_700.3 [Systemic sclerosis],0.057,0,0.0,0.0,0.0,0.146,0.0,0.0,0.104,1.64,1.487,0.136,0.11,,2
SMAD4,GE_975.2 [Hereditary hemorrhagic telangiectasia],0.057,0,0.0,0.0,0.0,0.0,0.0,0.626,0.354,,3.04,2.949,0.031,,3
MC1R,GE_966.2 [Disorders of porphyrin metabolism],0.057,1,4.0,0.0,0.0,0.0,0.27,0.0,0.045,,3.255,0.055,0.025,,3
JAK2,GE_970.1 [Sickle-cell disorders],0.057,0,0.0,0.0,0.0,0.0,0.409,0.0,0.042,1.705,3.952,2.435,0.164,,3
CPEB4,GE_977.6 [Congenital cutaneous mastocytosis*],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.036,2.852,0.141,0.059,0.06,,2
TNNT2,CV_416.8 [Pre-excitation syndrome [Anomalous atrioventricular excitation]],0.057,0,0.0,0.0,0.0,0.0,0.469,0.36,0.0,2.147,1.934,1.146,1.553,0.884,4
BBS4,SO_380.3 [Optic atrophy],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.753,3.214,1.427,0.169,0.98,2
FURIN,GE_977.6 [Congenital cutaneous mastocytosis*],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.035,2.099,0.236,0.078,0.06,,2
NLRP3,GE_978.22 [Ehler's Danlos syndrome],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.165,1.71,0.478,0.086,0.111,,2
ADRB1,CV_414.1 [Hypertrophic cardiomyopathy],0.057,1,4.0,0.0,0.0,0.0,0.0,0.0,0.136,,0.984,0.063,1.757,0.278,3
HDAC6,GE_972.1 [Hereditary neuropathy],0.057,1,1.0,0.0,0.0,0.0,0.0,0.0,0.147,,2.685,0.162,0.2,,2
MET,MS_727.3 [Osteitis deformans [Paget's disease of bone]],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.132,,2.726,0.693,0.147,,2
LY86,GE_972.9 [Muscular dystrophy],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.033,4.335,0.124,0.106,2.605,0.041,3
FOXP1,GE_963.1 [Lipid storage disorders],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.063,0.022,,,0.14,2
FOS,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.881,1.732,1.704,0.132,0.981,2
BDNF,GU_580.1 [Acute nephritic syndrome],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.944,1.717,0.328,1.963,0.885,3
USP47,NS_323.3 [Motor neuron disease],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.061,1.893,2.827,1.888,0.297,0.048,3
TYW1,DE_663.2 [Pemphigoid],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.126,2.713,3.31,0.09,0.098,,2
MTOR,CM_750.16 [Arnold-Chiari syndrome*],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.938,2.651,0.18,0.135,0.983,2
GABRA2,CV_416.8 [Pre-excitation syndrome [Anomalous atrioventricular excitation]],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.244,0.175,,0.114,0.153,2
BBS4,SO_369.62 [Keratoconus],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.952,1.73,0.266,0.996,2
GABRA2,RE_477.2 [Hypersensitivity pneumonitis],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.472,0.116,,0.121,,1
FAS,SO_386.5 [Color vision deficiencies],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.963,0.325,,0.023,0.287,2
ING2,SO_380.3 [Optic atrophy],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.086,0.125,0.04,0.075,0.134,2
TRERF1,GU_580.51 [Focal and segmental glomerular lesions*],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,1.959,2.038,0.141,0.174,,2
SMAD3,CM_750.16 [Arnold-Chiari syndrome*],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.238,0.08,0.013,0.051,0.979,2
ANGPT1,CV_441 [Arteriovenous malformation],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,1.979,1.554,0.196,0.175,0.841,3
COL19A1,NS_323.3 [Motor neuron disease],0.057,0,0.0,0.0,0.426,0.0,0.0,0.0,0.035,2.973,2.674,0.235,0.248,0.014,4
DCAF7,CV_413.41 [Pulmonary valve stenosis],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.315,0.017,0.026,0.293,1
S100P,MS_704.1 [Polyarteritis nodosa and related conditions],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.015,1.85,1.729,0.029,0.036,,2
CALM3,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.668,0.04,,,0.179,2
ACLY,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.193,,2.693,0.613,0.231,0.716,3
LGI1,NS_339.2 [Myotonic disorders],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.165,1.332,0.091,0.076,0.065,,2
DRD2,NS_341.1 [Cerebral palsy],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,1.77,0.595,0.268,0.119,0.898,3
BCL2,NS_341.1 [Cerebral palsy],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.112,0.107,0.038,0.065,0.981,2
PDK3,GE_972.1 [Hereditary neuropathy],0.057,0,0.0,0.0,0.0,0.0,0.0,0.523,0.07,1.317,0.948,0.048,0.135,,3
TPH2,MB_306 [Conduct disorders],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.141,1.857,3.743,3.506,0.086,,2
TNF,DE_663.2 [Pemphigoid],0.057,0,0.0,0.0,0.0,0.0,0.258,0.0,0.355,,0.606,0.252,0.068,,2
CD247,MS_700.43 [Polymyositis],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.109,2.824,0.738,0.093,0.028,,2
THBS1,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.055,2.458,2.837,,0.082,0.937,3
OFD1,SO_386.6 [Night blindness],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,3.403,2.11,0.109,0.976,2
IGLL1,BI_179.1 [Hypogammaglobulinemia NOS],0.057,0,0.0,0.0,0.745,0.0,0.0,0.503,0.033,2.266,1.378,0.093,0.058,0.869,4
EGFR,GE_972.9 [Muscular dystrophy],0.057,0,0.0,0.0,0.0,0.0,0.283,0.0,0.1,2.707,0.214,0.308,0.2,0.987,4
MRAS,CV_414.1 [Hypertrophic cardiomyopathy],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.112,,2.581,2.546,0.1,0.316,3
DDX5,SO_369.62 [Keratoconus],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,3.799,,0.032,0.303,2
LPP,CM_772.1 [Congenital malformations of endocrine glands],0.057,0,0.0,0.0,0.0,0.0,0.285,0.0,0.068,2.554,2.658,0.368,0.162,,3
LSM14A,GI_542.8 [Biliary cirrhosis],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.059,1.743,2.382,0.094,0.17,,2
SYT4,GE_972.1 [Hereditary neuropathy],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.061,4.787,2.644,0.085,0.184,,2
RUNX2,GE_963.1 [Lipid storage disorders],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.084,2.643,2.785,0.147,0.095,0.16,3
DRD4,NS_323.3 [Motor neuron disease],0.057,1,3.0,0.0,0.0,0.0,0.0,0.0,0.012,1.326,3.709,1.237,0.133,0.131,3
GATA3,GU_580.1 [Acute nephritic syndrome],0.057,0,0.0,0.0,0.426,0.0,0.0,0.0,0.04,3.505,2.097,0.322,0.079,0.972,4
BCORL1,EM_208.1 [Hypoparathyroidism],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,3.751,,0.069,0.164,2
SENP6,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.057,0,0.0,0.015,0.0,0.0,0.0,0.0,0.03,1.519,1.982,0.515,0.214,0.117,4
ETFA,NS_341.1 [Cerebral palsy],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.316,2.648,0.231,0.145,0.939,2
RRM2,GE_972.2 [Hereditary ataxia],0.057,0,0.0,0.019,0.0,0.0,0.0,0.0,0.036,2.206,0.183,0.16,0.087,0.64,4
EPAS1,CV_433.3 [Cerebrovascular insufficiency],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.046,2.879,3.451,0.243,0.151,0.93,3
PROP1,EM_209.13 [Hyperprolactinemia*],0.057,0,0.0,0.0,0.0,0.0,0.291,0.0,0.116,1.871,1.083,0.797,0.105,,3
SEL1L,GU_580.1 [Acute nephritic syndrome],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,1.966,2.685,0.404,0.164,0.297,3
KDM1A,DE_663.1 [Pemphigus],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.061,1.846,0.13,0.047,0.119,,2
DYNLL2,NS_344.2 [Benign intracranial hypertension],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.902,0.071,,,0.192,2
CCL2,EM_209.4 [Diabetes insipidus],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.896,,0.038,0.984,1
LTBP2,DE_663.1 [Pemphigus],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.52,1.993,2.832,0.279,0.154,,2
RICTOR,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,2.323,2.308,0.122,0.615,0.452,3
IGF2BP2,GE_970.2 [Thalassemia],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,3.044,1.949,0.098,0.545,,2
ATP2B4,CV_414.1 [Hypertrophic cardiomyopathy],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.078,2.741,4.523,0.343,0.441,0.438,3
ZBTB7C,CV_433.3 [Cerebrovascular insufficiency],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.015,2.562,0.355,0.116,0.129,0.063,3
CDYL,GE_976.5 [Polycystic kidney disease],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.156,3.105,2.266,0.043,1.714,,2
GABRA1,EM_209.4 [Diabetes insipidus],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.673,0.066,,0.049,0.23,2
RTN4R,CM_763.13 [Patent ductus arteriosus],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.848,0.095,,0.012,0.225,2
ALKBH5,BI_179.1 [Hypogammaglobulinemia NOS],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.205,,,0.268,1
GLUL,NS_341.1 [Cerebral palsy],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.036,2.6,2.556,0.036,0.079,0.924,3
MAP3K5,NS_323.3 [Motor neuron disease],0.057,1,0.5,0.0,0.0,0.0,0.0,0.0,0.069,2.4,2.625,1.49,0.295,0.222,3
PTPRE,GE_973.5 [Huntington's disease],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.049,2.694,0.22,0.099,0.072,,2
UBE2E2,EM_208.1 [Hypoparathyroidism],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.54,0.149,,0.119,0.167,2
SMAD2,MS_700.3 [Systemic sclerosis],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.25,1.923,0.172,0.087,0.096,,2
CTNNB1,GE_972.2 [Hereditary ataxia],0.057,0,0.0,0.0,0.745,0.0,0.0,0.862,0.042,1.753,2.041,0.055,1.827,0.995,4
SMAD3,RE_484.1 [Spontaneous pneumothorax],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,2.364,2.817,0.061,0.119,0.977,3
POC1B,SO_369.62 [Keratoconus],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.543,2.914,0.329,0.174,0.964,2
TET2,CM_763.31 [Ventricular septal defect],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.952,3.519,0.099,0.225,0.934,2
TMEM163,GE_963.1 [Lipid storage disorders],0.057,0,0.0,0.0,0.0,0.0,0.0,0.201,0.29,2.173,0.083,0.059,0.058,0.054,4
TIMP2,GE_976.5 [Polycystic kidney disease],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.317,1.82,1.873,0.151,0.072,,2
PPARG,MB_293.1 [Anorexia nervosa],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,2.681,0.096,0.13,0.125,,2
ESR1,NS_341.1 [Cerebral palsy],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.997,1.822,0.299,0.115,0.983,2
NDUFB7,NS_341.1 [Cerebral palsy],0.057,1,2.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.164,0.3,0.08,0.923,2
HLA-A,DE_663.2 [Pemphigoid],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.146,1.743,4.665,1.941,0.124,,2
DPAGT1,NS_338.1 [Myasthenia gravis],0.057,0,0.0,0.0,0.0,0.0,0.0,0.868,0.116,,2.041,1.352,0.137,,3
KLHL41,GE_972.9 [Muscular dystrophy],0.057,0,0.0,0.0,0.0,0.0,0.294,0.472,0.109,1.468,2.548,1.106,0.129,0.586,5
SNRNP200,SO_369.62 [Keratoconus],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.692,2.97,1.809,0.211,0.995,2
NLGN4X,MB_305.1 [Tics and tic disorders],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.076,1.924,2.307,,0.025,,2
CTSB,GE_964.3 [Glycogen storage disease],0.057,0,0.0,0.0,0.0,0.0,0.357,0.0,0.075,,2.96,0.085,0.202,,3
NAMPT,MS_705.2 [Juvenile rheumatoid arthritis [JRA/JIA]],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.253,1.919,0.827,0.05,0.057,,2
NOS1,MS_712.51 [Hypermobility syndrome],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.401,1.966,3.011,0.32,0.241,,2
TAF15,NS_323.3 [Motor neuron disease],0.057,0,0.0,0.0,0.868,0.0,0.0,0.004,0.039,1.399,3.069,,0.108,0.992,4
ITSN1,RE_484.1 [Spontaneous pneumothorax],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.508,2.76,0.049,0.007,0.31,2
EXT1,GE_978.21 [Marfan syndrome],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,3.568,0.157,0.118,0.085,,2
PREX1,CM_750.16 [Arnold-Chiari syndrome*],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.664,3.475,,0.023,0.284,2
PSME4,GE_972.1 [Hereditary neuropathy],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.079,1.454,3.402,1.122,0.3,,2
IL10,GU_580.1 [Acute nephritic syndrome],0.057,0,0.0,0.0,0.304,0.0,0.0,0.0,0.128,,2.43,0.093,0.056,0.992,4
PDGFRA,GU_580.1 [Acute nephritic syndrome],0.057,1,1.0,0.0,0.0,0.0,0.0,0.0,0.018,2.021,2.54,0.11,0.071,0.945,3
NR5A1,CM_772.1 [Congenital malformations of endocrine glands],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.082,2.012,2.367,0.176,0.082,,2
DDI2,SO_365.3 [Exophthalmos [Proptosis]],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.213,,,0.262,1
HLA-A,GU_580.1 [Acute nephritic syndrome],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.037,,2.948,0.335,0.116,0.934,3
GABRB3,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.664,0.134,0.039,0.095,0.104,2
MTNR1A,NS_333.4 [Circadian rhythm sleep disorder],0.057,1,4.0,0.0,0.0,0.0,0.0,0.0,0.078,2.186,1.809,0.267,0.103,0.299,3
PRLR,GE_961.1 [Phakomatoses],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,2.475,2.974,0.32,0.164,0.31,3
FLNA,MS_712.51 [Hypermobility syndrome],0.057,0,0.0,0.0,0.0,0.0,0.0,0.125,0.125,1.728,2.935,0.731,0.386,,3
RBFOX1,NS_339.2 [Myotonic disorders],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.291,3.069,3.891,1.607,0.115,,2
DNAJC3,GE_972.2 [Hereditary ataxia],0.057,0,0.0,0.0,0.547,0.0,0.0,0.0,0.065,1.69,2.795,0.086,1.584,0.607,4
SLC6A4,NS_323.3 [Motor neuron disease],0.057,1,3.0,0.0,0.0,0.0,0.0,0.0,0.018,,2.511,0.271,0.252,0.38,3
ENG,GE_978.22 [Ehler's Danlos syndrome],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.231,1.986,2.204,0.13,0.054,,2
TIPARP,CV_441 [Arteriovenous malformation],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,1.997,2.373,1.635,0.123,0.164,3
ITGB1,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,1.359,1.746,0.081,0.141,0.877,3
DSTYK,GE_961.1 [Phakomatoses],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,2.463,2.464,0.281,0.183,0.073,3
PRAMEF17,NS_341.1 [Cerebral palsy],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,3.088,0.256,0.067,0.912,2
COL1A2,NS_344.11 [Communicating hydrocephalus],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.075,1.966,1.333,0.301,0.095,,2
MB,CV_414.1 [Hypertrophic cardiomyopathy],0.057,0,0.0,0.0,0.0,0.0,0.51,0.0,0.042,4.007,2.5,2.517,0.168,0.534,4
ANO5,CM_770.5 [Congenital osteodystrophies],0.057,0,0.0,0.0,0.0,0.0,0.371,0.402,0.049,2.401,0.418,0.267,0.206,0.444,5
BTG3,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.117,2.473,2.232,0.034,0.079,0.092,3
SGCE,GE_972.2 [Hereditary ataxia],0.057,0,0.0,0.0,0.0,0.0,0.382,0.0,0.015,2.414,1.94,0.472,0.916,0.553,4
SHC3,CV_433.3 [Cerebrovascular insufficiency],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.122,1.927,2.018,0.415,0.131,0.086,3
UBA52,CM_751.213 [Congenital cataract],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.759,,,0.3,2
C11orf58,NS_344.2 [Benign intracranial hypertension],0.057,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.091,,0.033,0.305,1
NCS1,CM_750.16 [Arnold-Chiari syndrome*],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.094,0.021,0.034,0.311,1
TSC2,GU_580.1 [Acute nephritic syndrome],0.056,0,0.0,0.0,0.0,0.0,0.415,0.008,0.098,1.491,3.387,0.579,0.115,0.519,5
BCL2,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.028,2.36,0.147,0.047,0.074,0.991,3
NF2,CM_770.5 [Congenital osteodystrophies],0.056,0,0.0,0.0,0.0,0.0,0.612,0.0,0.11,,2.962,0.151,0.105,0.433,4
SOX3,MB_302.1 [Speech and language developmental delay],0.056,0,0.0,0.0,0.0,0.0,0.0,0.129,0.021,2.374,2.461,0.047,0.022,,3
NRCAM,NS_341.1 [Cerebral palsy],0.056,0,0.0,0.0,0.857,0.0,0.0,0.0,0.012,1.757,2.617,0.392,0.278,0.771,4
DSE,MS_712.51 [Hypermobility syndrome],0.056,0,0.0,0.0,0.0,0.0,0.0,0.198,0.16,1.513,2.69,0.28,0.243,,3
BRAF,CV_414.1 [Hypertrophic cardiomyopathy],0.056,0,0.0,0.0,0.745,0.0,0.0,0.249,0.335,2.418,1.55,0.083,0.102,0.943,4
SNRPD2,EM_209.4 [Diabetes insipidus],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.401,0.059,,,0.094,2
TNF,GE_973.5 [Huntington's disease],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.523,,0.153,0.09,0.019,,1
MAP4K1,NS_323.3 [Motor neuron disease],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,,1.483,0.202,0.235,0.041,3
COX6A2,GE_972.2 [Hereditary ataxia],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.431,0.249,0.089,0.938,1
EPHX2,GU_580.1 [Acute nephritic syndrome],0.056,0,0.0,0.0,0.304,0.0,0.0,0.0,0.22,1.72,2.049,0.291,0.167,0.457,4
MALT1,GE_972.2 [Hereditary ataxia],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.336,2.121,2.669,0.327,0.148,0.3,3
EZH2,GU_580.1 [Acute nephritic syndrome],0.056,0,0.0,0.0,0.0,0.0,0.329,0.0,0.189,,2.111,0.067,0.107,0.924,4
TLN1,GE_972.2 [Hereditary ataxia],0.056,0,0.0,0.0,0.0,0.0,0.0,0.129,0.012,,3.899,1.128,0.343,0.452,4
FANCD2,SO_365.3 [Exophthalmos [Proptosis]],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,3.089,0.236,0.625,0.959,2
TLR4,BI_179.1 [Hypogammaglobulinemia NOS],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.794,3.277,0.311,0.134,0.978,2
CEP41,SO_386.6 [Night blindness],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.332,3.378,2.653,1.691,0.896,2
CLCN7,CV_433.3 [Cerebrovascular insufficiency],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.027,1.885,2.29,0.449,0.75,0.2,3
MET,SO_369.62 [Keratoconus],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.076,1.938,2.795,0.813,0.34,0.256,3
PPIA,CV_438.41 [Aortic dissection],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.041,,0.151,0.027,0.024,0.338,2
RPL11,CV_414.1 [Hypertrophic cardiomyopathy],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.205,,,0.252,1
CNTNAP2,MB_302.1 [Speech and language developmental delay],0.056,0,0.0,0.0,0.0,0.0,0.316,0.54,0.056,3.577,1.718,0.531,0.391,0.909,5
SERPINE1,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.179,,2.606,0.265,0.13,0.955,3
APOB,MS_712.51 [Hypermobility syndrome],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.671,1.726,5.158,0.495,0.243,,2
ZBTB1,CM_763.13 [Patent ductus arteriosus],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.08,0.03,0.031,0.188,1
CRYAB,NS_340.3 [Inflammatory and immune myopathies],0.056,0,0.0,0.0,0.84,0.0,0.426,0.0,0.108,,0.193,0.078,0.046,,3
ERBB2,CM_763.31 [Ventricular septal defect],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.122,,2.871,2.497,0.101,0.946,3
CLEC3B,SO_386.6 [Night blindness],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,1.351,0.132,0.109,0.106,0.029,3
IL2RB,MS_704.1 [Polyarteritis nodosa and related conditions],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.149,1.941,0.252,0.073,0.051,,2
IFT80,GE_978.3 [Osteochondrodysplasias],0.056,0,0.0,0.0,0.0,0.0,0.319,0.402,0.046,,2.631,0.113,0.073,,4
SEPHS1,CV_433.3 [Cerebrovascular insufficiency],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.796,0.293,,0.089,0.111,2
SH2B1,GE_972.2 [Hereditary ataxia],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.027,,2.932,0.2,0.153,0.3,3
DUSP6,CV_433.3 [Cerebrovascular insufficiency],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.286,2.556,0.366,0.398,0.119,0.634,3
WDPCP,GE_972.2 [Hereditary ataxia],0.056,0,0.0,0.0,0.426,0.0,0.0,0.0,0.03,,3.55,0.302,0.225,0.925,4
SYT1,EM_209.4 [Diabetes insipidus],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.388,0.116,0.047,0.025,0.305,2
ADCY1,MB_293.2 [Bulimia nervosa],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.061,2.317,0.853,0.066,0.117,,2
STK39,NS_323.3 [Motor neuron disease],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.061,2.482,0.365,0.129,2.347,0.057,3
PIK3CG,SO_369.62 [Keratoconus],0.056,0,0.0,0.0,0.426,0.0,0.0,0.121,0.012,3.374,2.73,0.412,0.195,0.285,4
ADD1,GE_976.5 [Polycystic kidney disease],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.097,2.402,3.396,2.358,0.295,,2
PDGFRB,GE_977.6 [Congenital cutaneous mastocytosis*],0.056,1,4.0,0.0,0.0,0.0,0.0,0.0,0.043,2.633,3.644,2.628,0.07,,2
IL1B,GU_580.51 [Focal and segmental glomerular lesions*],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.155,1.567,0.084,0.086,0.044,,2
TWNK,SO_380.3 [Optic atrophy],0.056,0,0.0,0.0,0.745,0.0,0.0,0.0,0.012,,2.318,0.142,1.17,,3
SETD2,GE_973.5 [Huntington's disease],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.127,2.059,3.005,2.793,0.077,,2
NLGN1,SO_386.5 [Color vision deficiencies],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.073,1.927,2.303,0.124,0.099,0.193,3
KDR,MS_712.51 [Hypermobility syndrome],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.104,3.404,2.121,0.737,1.709,,2
ACLY,GE_961.1 [Phakomatoses],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,1.415,2.072,0.261,0.243,0.781,3
ABCC4,MS_704.1 [Polyarteritis nodosa and related conditions],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.532,1.89,3.562,0.932,0.215,,2
RARA,GI_542.8 [Biliary cirrhosis],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.038,2.374,1.335,0.379,0.163,,2
SOD2,GI_542.8 [Biliary cirrhosis],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.175,,1.034,0.192,0.125,,1
TBP,CV_414.1 [Hypertrophic cardiomyopathy],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,,1.697,0.25,0.149,0.181,3
ITGB1,GE_977.6 [Congenital cutaneous mastocytosis*],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.04,2.919,0.213,0.04,0.064,,2
RPL17,MB_302.1 [Speech and language developmental delay],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.011,3.027,,,0.245,2
KIT,MS_700.3 [Systemic sclerosis],0.056,1,2.0,0.0,0.0,0.0,0.0,0.0,0.196,2.321,3.392,0.247,0.187,,2
ITGB1,GE_973.5 [Huntington's disease],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.102,2.326,0.918,0.03,0.077,,2
CDK6,CV_441 [Arteriovenous malformation],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.076,3.895,2.301,,0.091,0.769,3
PPP2R2C,CV_414.1 [Hypertrophic cardiomyopathy],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.095,0.214,,0.159,0.165,2
PEX1,GE_972.2 [Hereditary ataxia],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,3.303,0.421,0.215,0.987,2
DHTKD1,GE_972.1 [Hereditary neuropathy],0.056,0,0.0,0.0,0.0,0.0,0.263,0.558,0.032,2.18,2.268,0.526,0.086,,4
ZZZ3,GI_516.1 [Pyloric stenosis],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.685,2.502,,0.077,0.187,2
SPTB,GE_978.3 [Osteochondrodysplasias],0.056,0,0.0,0.0,0.0,0.0,0.418,0.0,0.018,,3.536,1.066,0.281,,3
SORD,CM_751.213 [Congenital cataract],0.056,0,0.0,0.0,0.0,0.0,0.591,0.0,0.074,3.626,2.587,0.23,0.125,0.819,4
TUBA1B,GE_977.1 [Congenital ichthyosis],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.379,,,0.322,1
SLC30A1,CM_763.13 [Patent ductus arteriosus],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.792,0.067,0.028,0.035,0.269,2
TSHZ1,EM_249.1 [Cerebral amyloid angiopathy*],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.036,1.914,3.634,3.906,0.124,,2
PPARG,GE_961.1 [Phakomatoses],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.041,3.632,0.099,0.129,1.685,0.882,3
VCAN,GE_978.3 [Osteochondrodysplasias],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.024,2.664,4.178,0.402,0.23,,2
ALB,NS_333.4 [Circadian rhythm sleep disorder],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.118,1.866,3.813,1.483,0.095,0.766,3
TET2,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.056,0,0.0,0.0,0.0,0.0,0.324,0.0,0.232,2.152,2.972,0.146,1.461,0.743,4
AGFG1,CV_414.1 [Hypertrophic cardiomyopathy],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,2.428,3.849,0.275,0.197,0.078,3
RUNX1,GU_580.1 [Acute nephritic syndrome],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.308,0.289,0.124,1.512,0.975,2
DNAJC30,SO_380.3 [Optic atrophy],0.056,0,0.0,0.0,0.801,0.0,0.0,0.495,0.05,,0.206,0.072,0.117,0.096,3
RBM22,CV_413.41 [Pulmonary valve stenosis],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.055,0.024,0.026,0.188,1
EEF2,MS_700.3 [Systemic sclerosis],0.056,1,0.5,0.0,0.0,0.0,0.0,0.0,0.018,1.316,1.415,0.139,0.716,,2
MGAT5,GI_542.8 [Biliary cirrhosis],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.079,2.917,2.931,0.163,0.189,,2
SYK,GE_964.3 [Glycogen storage disease],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.039,1.944,0.304,0.174,0.125,,2
HSP90AA1,SO_386.6 [Night blindness],0.056,0,0.0,0.0,0.0,0.0,0.323,0.0,0.012,2.775,2.433,0.038,0.079,0.166,4
SCN7A,NS_323.3 [Motor neuron disease],0.056,1,4.0,0.0,0.0,0.0,0.0,0.0,0.012,2.706,2.959,0.95,0.476,0.017,3
PABPC4,GI_540.11 [Autoimmune hepatitis],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.308,2.205,0.184,0.157,,2
SCN1A,GE_978.22 [Ehler's Danlos syndrome],0.056,1,4.0,0.0,0.0,0.0,0.0,0.0,0.108,,2.039,0.216,0.147,,2
SFMBT2,GE_961.1 [Phakomatoses],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.049,2.407,2.725,0.322,0.261,0.072,3
FAF1,MS_712.51 [Hypermobility syndrome],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.055,2.016,1.631,0.087,0.161,,2
ABCB1,GE_972.1 [Hereditary neuropathy],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.291,,2.634,0.367,0.104,,2
RAN,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.065,,,0.139,1
COL1A2,GE_978.22 [Ehler's Danlos syndrome],0.056,0,0.0,0.0,0.0,0.0,0.306,0.786,0.066,,2.998,1.099,1.722,,4
MYH7,NS_340.3 [Inflammatory and immune myopathies],0.056,0,0.0,0.0,0.884,0.0,0.0,0.0,0.05,1.31,2.435,0.064,0.047,,3
RAG2,BI_179.1 [Hypogammaglobulinemia NOS],0.056,0,0.0,0.0,0.732,0.0,0.0,0.0,0.015,1.921,3.02,0.564,0.129,0.988,4
PIK3R1,BI_179.7 [Common variable immunodeficiency [CVID]],0.056,0,0.0,0.0,0.0,0.0,0.542,0.0,0.155,2.682,0.075,0.031,0.046,,3
MARK2,CV_433.3 [Cerebrovascular insufficiency],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.017,1.816,4.079,0.137,0.146,0.203,3
AIDA,GU_617.1 [Incompetence of cervix uteri],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.07,,0.139,,0
IL1RN,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.257,0.159,0.102,0.934,1
SULF2,NS_344.11 [Communicating hydrocephalus],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.322,2.378,0.172,0.219,0.106,,2
ITIH3,MB_306 [Conduct disorders],0.056,0,0.0,0.0,0.0,0.067,0.0,0.0,0.112,,3.98,0.423,1.281,,2
RORA,GE_961.1 [Phakomatoses],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.716,2.372,,,0.425,3
TUBB4B,GE_977.1 [Congenital ichthyosis],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.056,,0.006,0.209,1
AIDA,GE_964.3 [Glycogen storage disease],0.056,0,0.0,0.0,0.0,0.0,0.287,0.0,0.0,,0.107,,0.13,,1
RPS29,SO_365.3 [Exophthalmos [Proptosis]],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.646,2.647,,,0.269,2
RELN,GE_977.1 [Congenital ichthyosis],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.031,2.459,3.034,0.112,0.29,0.022,3
EGR3,DE_663.2 [Pemphigoid],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.597,0.109,,0.171,,1
NDUFAF2,GE_963.1 [Lipid storage disorders],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.329,0.359,0.034,0.96,1
ENAH,GE_972.2 [Hereditary ataxia],0.056,0,0.0,0.024,0.0,0.0,0.0,0.0,0.024,,0.591,0.312,0.137,0.422,3
SYT1,BI_179.1 [Hypogammaglobulinemia NOS],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.938,1.724,0.042,0.033,0.297,2
DSCAML1,SO_386.6 [Night blindness],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.715,2.803,0.036,0.068,0.191,3
ARFGEF2,GE_973.5 [Huntington's disease],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.144,,1.606,0.179,0.113,,2
MYO9A,SO_386.5 [Color vision deficiencies],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.669,3.325,0.446,0.114,0.978,2
BGN,CV_438.41 [Aortic dissection],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.092,3.926,2.525,0.265,1.542,0.915,3
LEPR,GI_542.8 [Biliary cirrhosis],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.116,1.84,2.882,0.198,0.437,,2
GABRG2,NS_323.3 [Motor neuron disease],0.056,1,1.0,0.0,0.0,0.0,0.271,0.0,0.0,3.508,1.594,0.039,0.119,0.145,3
PIP4K2B,GE_972.9 [Muscular dystrophy],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.876,,0.02,0.218,1
SMAD3,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.166,0.076,0.046,0.062,0.915,3
MERTK,SO_380.3 [Optic atrophy],0.056,0,0.0,0.0,0.0,0.0,0.308,0.0,0.018,2.071,2.662,0.198,0.128,0.979,4
TRIM54,CV_414.1 [Hypertrophic cardiomyopathy],0.056,0,0.0,0.0,0.765,0.0,0.573,0.0,0.069,,2.223,1.247,0.278,0.351,5
ACTN4,GU_580.1 [Acute nephritic syndrome],0.056,0,0.0,0.0,0.885,0.0,0.0,0.162,0.017,,3.132,0.083,0.16,0.793,4
EIF4A2,GE_977.1 [Congenital ichthyosis],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.422,,0.025,0.271,1
COQ2,GU_580.52 [Diffuse membranous glomerulonephritis],0.056,0,0.0,0.0,0.0,0.0,0.0,0.293,0.017,1.817,0.208,0.131,0.101,,3
PLCL2,GI_542.8 [Biliary cirrhosis],0.056,0,0.0,0.0,0.0,0.572,0.0,0.0,0.027,1.996,3.202,0.09,0.952,,2
FOXO3,GE_973.5 [Huntington's disease],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.805,1.949,3.599,0.118,0.064,,2
RUNX2,DE_663.2 [Pemphigoid],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.07,1.758,3.086,0.216,0.164,,2
APP,GU_580.1 [Acute nephritic syndrome],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.562,2.156,1.05,0.215,0.917,3
DUX4,GE_972.9 [Muscular dystrophy],0.056,0,0.0,0.0,0.0,0.0,0.0,0.402,0.449,,,,,,2
GRM1,CV_433.3 [Cerebrovascular insufficiency],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.053,1.423,2.1,1.878,0.186,0.214,3
PTGS2,CV_414.1 [Hypertrophic cardiomyopathy],0.056,1,3.0,0.0,0.0,0.0,0.0,0.0,0.0,1.67,2.249,0.183,0.178,0.939,2
PPARG,SO_380.3 [Optic atrophy],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.188,2.841,2.595,1.837,0.912,3
PROM1,SO_386.6 [Night blindness],0.056,0,0.0,0.0,0.0,0.0,0.274,0.0,0.066,1.897,2.481,0.318,0.21,0.998,4
ATXN7,NS_323.3 [Motor neuron disease],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.073,,2.725,0.318,0.679,0.305,3
FLT3,GE_963.1 [Lipid storage disorders],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.055,1.924,4.021,3.47,0.114,0.17,3
SH2D1A,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.347,0.161,,2.499,0.9,2
P4HB,NS_323.3 [Motor neuron disease],0.056,0,0.0,0.0,0.656,0.0,0.0,0.0,0.114,2.201,2.053,0.422,0.575,0.316,4
ABCB1,NS_338.1 [Myasthenia gravis],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.107,3.112,2.029,0.232,0.369,,2
CDK5,MS_700.3 [Systemic sclerosis],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.301,,3.028,2.897,0.103,,2
ALB,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.071,,1.95,0.162,0.135,0.973,3
CDK1,CV_433.3 [Cerebrovascular insufficiency],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.056,2.446,0.222,0.052,0.062,0.966,3
DNAJC13,MB_305.1 [Tics and tic disorders],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.024,2.009,4.327,0.518,0.169,,2
RRAGB,NS_335.3 [Neuralgic amyotrophy],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.078,,2.085,,1
MAPK8,CV_414.1 [Hypertrophic cardiomyopathy],0.056,0,0.0,0.0,0.0,0.0,0.296,0.0,0.211,1.881,0.149,0.088,0.153,0.551,4
BIRC2,GE_972.2 [Hereditary ataxia],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.343,1.848,2.455,0.435,0.127,0.445,3
NRN1,CV_433.3 [Cerebrovascular insufficiency],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.067,2.989,0.112,,0.065,0.11,3
PRL,EM_209.13 [Hyperprolactinemia*],0.056,0,0.0,0.0,0.0,0.0,0.35,0.0,0.167,1.885,0.215,0.046,0.116,,3
EXT1,GE_972.1 [Hereditary neuropathy],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.124,5.031,3.168,2.253,0.175,,2
GATA3,GI_542.8 [Biliary cirrhosis],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.036,2.922,0.233,0.089,0.117,,2
TNF,MS_712.51 [Hypermobility syndrome],0.056,0,0.0,0.0,0.0,0.0,0.25,0.0,0.594,,1.961,0.307,0.047,,3
GABRA1,GE_983.2 [Hemoglobin C trait [Sickle-cell trait]],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.47,0.119,,0.141,,1
NPM1,GE_973.5 [Huntington's disease],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.396,1.333,0.097,0.099,0.015,,2
KITLG,GI_540.11 [Autoimmune hepatitis],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.061,2.797,0.121,0.13,0.085,,2
NEFL,NS_323.3 [Motor neuron disease],0.056,0,0.0,0.0,0.0,0.0,0.0,0.121,0.11,2.874,1.69,,0.103,,3
NID2,GE_963.1 [Lipid storage disorders],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.024,2.823,2.746,0.401,0.148,0.228,3
DSP,GE_977.1 [Congenital ichthyosis],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.109,2.588,3.138,0.198,0.222,0.771,3
PPP2R2C,DE_666.6 [Cholinergic urticaria],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.644,0.07,,2.516,,1
PLXND1,CV_433.3 [Cerebrovascular insufficiency],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,1.739,2.524,0.268,0.274,0.493,3
CHUK,CV_433.3 [Cerebrovascular insufficiency],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.104,,2.754,0.979,0.121,0.799,3
SUMF1,GE_963.1 [Lipid storage disorders],0.056,0,0.0,0.0,0.0,0.0,0.0,0.924,0.286,2.912,1.48,0.163,0.105,0.391,4
IKZF3,MS_700.3 [Systemic sclerosis],0.056,0,0.0,0.0,0.0,0.148,0.0,0.0,0.111,,0.736,0.339,0.944,,2
CTDSP2,SO_369.62 [Keratoconus],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.332,0.126,,0.094,0.135,2
BCL2,SO_373.2 [Choroidal degenerations],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.155,2.248,0.079,0.026,0.045,,2
UQCRQ,GE_963.1 [Lipid storage disorders],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.098,0.03,0.039,0.958,1
GRIA1,MB_287.2 [Schizoaffective disorder],0.056,1,2.0,0.0,0.0,0.0,0.0,0.0,0.135,3.704,2.025,0.333,0.178,,2
BCL2,MS_705.2 [Juvenile rheumatoid arthritis [JRA/JIA]],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.067,2.078,0.073,0.015,0.055,,2
SOX2,GE_972.2 [Hereditary ataxia],0.056,0,0.0,0.027,0.547,0.0,0.434,0.0,0.058,2.807,0.155,,0.057,0.97,6
CALM1,CM_763.31 [Ventricular septal defect],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.036,0.068,,,0.115,2
BMP4,CV_433.3 [Cerebrovascular insufficiency],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.062,2.52,1.904,1.08,0.107,0.986,3
CREBBP,NS_341.1 [Cerebral palsy],0.056,0,0.0,0.0,0.0,0.0,0.0,0.29,0.0,1.703,3.556,0.4,0.255,0.912,3
ADIPOQ,GU_580.52 [Diffuse membranous glomerulonephritis],0.056,0,0.0,0.0,0.0,0.0,0.491,0.0,0.142,2.636,2.271,0.063,0.092,,3
BCL2,CV_441 [Arteriovenous malformation],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.073,2.553,0.14,0.059,0.102,0.954,3
FOXP1,CM_751.213 [Congenital cataract],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.538,0.059,,,0.343,2
MEIS1,CV_414.1 [Hypertrophic cardiomyopathy],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,2.969,2.904,0.171,0.202,0.063,3
ABL1,CM_770.5 [Congenital osteodystrophies],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.05,4.539,3.393,0.314,0.147,0.912,3
RFC1,GE_972.2 [Hereditary ataxia],0.056,0,0.0,0.0,0.836,0.0,0.0,0.0,0.1,2.558,3.354,0.496,0.51,0.466,4
CNTN1,GE_978.22 [Ehler's Danlos syndrome],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.122,3.183,1.735,0.327,1.891,,2
PTPRC,CV_414.1 [Hypertrophic cardiomyopathy],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.09,2.073,3.098,0.103,0.146,0.357,3
NOL4,GE_964.3 [Glycogen storage disease],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,2.729,0.14,0.163,0.115,,2
USP11,NS_323.3 [Motor neuron disease],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,3.216,,0.141,0.052,2
MMP16,MS_725.1 [Spinal osteochondrosis],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.061,2.959,0.462,0.063,0.082,,2
TAF10,GE_977.1 [Congenital ichthyosis],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.297,0.036,0.033,0.223,1
DNMT1,GE_961.1 [Phakomatoses],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.249,2.063,3.013,0.225,0.198,0.851,3
RTN4R,CM_750.16 [Arnold-Chiari syndrome*],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.45,1.873,,0.011,0.3,2
RPS11,GU_580.1 [Acute nephritic syndrome],0.056,1,1.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.633,,0.026,0.212,1
RPL32,EM_208.1 [Hypoparathyroidism],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.817,0.22,,,0.191,2
RUNX2,SO_386.5 [Color vision deficiencies],0.056,0,0.0,0.0,0.0,0.0,0.0,0.362,0.061,1.965,1.605,0.137,0.097,0.715,4
YPEL2,CV_433.3 [Cerebrovascular insufficiency],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.802,0.068,,3.245,0.054,2
ZMAT1,GU_580.1 [Acute nephritic syndrome],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.872,3.064,,0.071,0.074,2
ULK1,GE_970.2 [Thalassemia],0.056,0,0.0,0.0,0.0,0.0,0.389,0.0,0.046,,3.289,0.295,0.729,,3
THRB,CM_772.2 [Congenital hypothyroidism],0.056,1,4.0,0.0,0.0,0.0,0.0,0.0,0.07,3.172,0.143,0.019,0.059,,2
ERBB4,CM_763.31 [Ventricular septal defect],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,2.717,2.678,0.315,0.2,0.873,3
KCNH2,GE_978.22 [Ehler's Danlos syndrome],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.201,,1.784,0.116,0.1,,2
LGALS3,MS_727.3 [Osteitis deformans [Paget's disease of bone]],0.056,0,0.0,0.0,0.0,0.0,0.392,0.0,0.09,1.47,2.355,0.162,0.163,,3
DRD1,MB_287.2 [Schizoaffective disorder],0.056,1,4.0,0.0,0.0,0.0,0.0,0.0,0.012,2.352,0.441,0.147,0.118,,2
DHTKD1,NS_323.3 [Motor neuron disease],0.056,0,0.0,0.0,0.801,0.0,0.258,0.0,0.037,,2.787,1.047,0.485,0.056,5
SLC32A1,GE_961.1 [Phakomatoses],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.088,2.822,2.178,0.058,0.086,0.088,3
IL16,SO_365.3 [Exophthalmos [Proptosis]],0.056,0,0.0,0.0,0.304,0.0,0.0,0.0,0.082,1.881,2.595,0.124,0.907,0.463,4
NDUFAF4,GE_972.2 [Hereditary ataxia],0.056,1,4.0,0.0,0.0,0.0,0.0,0.0,0.0,2.204,3.593,0.171,0.096,0.972,2
MRTFA,MS_700.3 [Systemic sclerosis],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.211,1.952,2.931,1.412,0.24,,2
NCOA6,GE_964.3 [Glycogen storage disease],0.056,0,0.0,0.0,0.0,0.0,0.367,0.0,0.061,,3.272,1.757,0.258,,3
FBXW7,GE_972.2 [Hereditary ataxia],0.056,0,0.0,0.1,0.0,0.0,0.0,0.0,0.012,2.362,2.228,0.1,0.088,0.87,4
MAT2A,BI_179.1 [Hypogammaglobulinemia NOS],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.081,,0.022,0.332,1
CCDC88A,SO_369.62 [Keratoconus],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.706,2.956,,0.094,0.111,2
BRCA1,CV_414.1 [Hypertrophic cardiomyopathy],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.867,2.748,1.568,2.316,0.987,2
MT-CO1,CV_414.1 [Hypertrophic cardiomyopathy],0.056,0,0.0,0.0,0.0,0.0,0.577,0.452,0.03,,,,,,3
BMP2,GE_977.1 [Congenital ichthyosis],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.004,0.113,0.125,0.091,0.129,3
NFATC3,GE_977.6 [Congenital cutaneous mastocytosis*],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.176,2.258,3.146,0.186,0.104,,2
LATS1,GE_972.9 [Muscular dystrophy],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.08,,2.496,0.342,0.137,0.29,3
GRIA1,SO_386.5 [Color vision deficiencies],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,3.467,0.164,0.215,0.092,0.312,3
ERBB2,MS_727.5 [Cyst of bone],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.277,,3.387,2.641,0.198,,2
C2,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.056,1,0.5,0.0,0.758,0.0,0.0,0.0,0.061,,3.779,0.357,1.648,0.757,4
ZNF362,GE_963.1 [Lipid storage disorders],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.885,0.246,,0.112,0.155,2
SLC6A3,MS_712.51 [Hypermobility syndrome],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.093,2.318,2.483,0.306,0.22,,2
ISCA2,NS_341.1 [Cerebral palsy],0.056,0,0.0,0.0,0.547,0.0,0.0,0.281,0.0,,2.179,0.11,0.061,0.903,3
VCAM1,GU_580.1 [Acute nephritic syndrome],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.136,2.074,2.273,0.098,0.139,0.928,3
GABRB2,CM_770.5 [Congenital osteodystrophies],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.055,3.243,1.23,0.082,0.064,0.264,3
MEN1,GE_964.3 [Glycogen storage disease],0.056,0,0.0,0.0,0.0,0.0,0.38,0.0,0.072,,1.623,0.132,0.116,,3
SOX2,NS_328.13 [Frontotemporal dementia [FTD]],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,2.718,0.133,,2.605,,2
GMPPB,GE_972.9 [Muscular dystrophy],0.056,0,0.0,0.0,0.892,0.0,0.0,0.462,0.074,,0.279,0.142,0.085,0.995,3
ANK2,GE_972.1 [Hereditary neuropathy],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.097,3.395,3.166,0.437,0.514,,2
ADAM10,CV_438.41 [Aortic dissection],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.061,3.049,2.493,0.17,0.109,0.192,3
SMAD3,GU_580.52 [Diffuse membranous glomerulonephritis],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.068,3.898,0.054,0.061,0.064,,2
WDR47,CM_763.31 [Ventricular septal defect],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.061,,0.293,0.478,0.176,0.238,2
RPL18A,BI_179.1 [Hypogammaglobulinemia NOS],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.232,,,0.263,1
GATAD1,CM_763.13 [Patent ductus arteriosus],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.413,3.191,0.021,0.041,0.295,2
UBE2Q1,CM_763.13 [Patent ductus arteriosus],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.321,0.038,0.02,0.278,2
STIM1,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.056,0,0.0,0.0,0.426,0.0,0.0,0.0,0.189,1.701,3.337,0.981,0.158,0.586,4
FOS,GE_978.3 [Osteochondrodysplasias],0.056,0,0.0,0.0,0.0,0.0,0.324,0.0,0.046,3.025,3.809,4.086,0.08,,3
SMAD7,GE_964.3 [Glycogen storage disease],0.056,0,0.0,0.0,0.0,0.0,0.311,0.0,0.015,2.411,0.173,0.2,0.107,,3
FTH1,CV_414.1 [Hypertrophic cardiomyopathy],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.024,2.171,1.026,0.046,0.069,0.34,3
RPL14,GE_963.1 [Lipid storage disorders],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.583,0.212,,0.018,0.298,2
CRIM1,NS_323.3 [Motor neuron disease],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.844,2.971,0.406,0.329,0.03,3
TNFAIP3,GI_540.11 [Autoimmune hepatitis],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.329,2.392,2.966,0.552,0.15,,2
CMAS,EM_249.1 [Cerebral amyloid angiopathy*],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,1.486,0.085,0.068,0.102,,2
RAB27B,GE_972.2 [Hereditary ataxia],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.055,2.729,0.097,0.197,0.13,0.267,3
WNT5A,MS_727.3 [Osteitis deformans [Paget's disease of bone]],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.025,3.024,1.623,0.145,0.145,,2
MMP14,SO_369.62 [Keratoconus],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.305,,2.72,0.509,0.156,0.555,3
FOXJ1,NS_344.11 [Communicating hydrocephalus],0.056,0,0.0,0.0,0.0,0.0,0.0,0.402,0.37,,0.079,0.046,0.046,,2
PIWIL1,GE_961.1 [Phakomatoses],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,2.314,2.312,0.372,0.926,0.202,3
TF,SO_369.62 [Keratoconus],0.056,0,0.0,0.0,0.635,0.0,0.0,0.0,0.071,1.761,1.179,0.423,0.242,0.332,4
ATP7B,GE_963.1 [Lipid storage disorders],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.047,1.992,3.323,0.359,0.427,0.335,3
NLRP3,GE_964.3 [Glycogen storage disease],0.056,0,0.0,0.0,0.0,0.0,0.266,0.0,0.052,2.999,2.72,0.114,0.17,,3
IL4R,BI_179.1 [Hypogammaglobulinemia NOS],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.7,3.354,0.047,0.087,0.98,2
USP1,GE_972.2 [Hereditary ataxia],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.122,,2.526,0.269,1.355,0.448,3
FBXO28,SO_365.3 [Exophthalmos [Proptosis]],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.681,1.506,,0.073,0.17,2
RPS23,EM_209.4 [Diabetes insipidus],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.57,0.063,,,0.104,2
P4HB,GE_973.5 [Huntington's disease],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.164,,2.823,0.085,0.064,,2
ALDH18A1,GE_972.2 [Hereditary ataxia],0.056,0,0.0,0.0,0.547,0.0,0.0,0.327,0.116,,2.685,0.518,1.697,0.701,4
RUNX1,GE_972.2 [Hereditary ataxia],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.063,2.739,2.467,0.46,0.161,0.974,3
SOS1,CM_763.31 [Ventricular septal defect],0.056,0,0.0,0.0,0.547,0.0,0.282,0.0,0.073,1.828,1.928,1.552,1.15,0.748,5
SERPING1,GI_542.8 [Biliary cirrhosis],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.075,1.9,2.705,0.07,0.095,,2
C5,GE_970.1 [Sickle-cell disorders],0.056,1,2.0,0.0,0.0,0.0,0.0,0.0,0.067,2.367,4.513,2.493,0.458,,2
SLC12A3,EM_211.1 [Adrenal hyperfunction],0.056,0,0.0,0.0,0.9,0.0,0.0,0.0,0.049,,2.927,0.853,0.449,,3
OR7D4,CM_770.5 [Congenital osteodystrophies],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,1.836,0.131,0.052,0.953,2
TPO,CM_772.2 [Congenital hypothyroidism],0.056,0,0.0,0.0,0.0,0.0,0.0,0.58,0.129,2.493,4.054,1.731,0.118,,3
MMP14,CV_433.3 [Cerebrovascular insufficiency],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.14,,3.078,0.422,0.144,0.892,3
FAM47A,GI_516.1 [Pyloric stenosis],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.59,2.057,0.041,0.045,0.998,2
VAMP1,GE_972.2 [Hereditary ataxia],0.056,0,0.0,0.0,0.654,0.0,0.0,0.745,0.018,1.323,3.143,2.98,0.081,0.791,4
SAMD9L,GE_972.2 [Hereditary ataxia],0.056,0,0.0,0.0,0.772,0.0,0.0,0.0,0.093,,2.731,0.427,1.729,0.375,4
NFS1,NS_341.1 [Cerebral palsy],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.72,0.168,1.563,0.979,2
CALM1,GE_976.5 [Polycystic kidney disease],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.064,2.928,0.098,,,,2
GM2A,GE_963.1 [Lipid storage disorders],0.056,0,0.0,0.0,0.0,0.0,0.0,0.741,0.05,1.947,0.136,0.074,0.041,0.373,4
TBXAS1,CM_770.5 [Congenital osteodystrophies],0.056,0,0.0,0.0,0.0,0.0,0.0,0.847,0.091,2.772,3.14,1.122,0.129,0.344,4
SYK,RE_477.2 [Hypersensitivity pneumonitis],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,2.232,1.576,0.202,0.15,,2
COX10,GE_972.2 [Hereditary ataxia],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.515,0.598,0.423,1.881,0.964,2
TUBA1B,GI_516.1 [Pyloric stenosis],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.239,,,0.252,1
CACNA1B,GE_961.1 [Phakomatoses],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,1.931,3.281,0.117,0.297,0.192,3
ULK4,CV_433.3 [Cerebrovascular insufficiency],0.056,0,0.0,0.0,0.0,0.441,0.0,0.0,0.061,2.981,3.102,0.753,0.166,0.119,3
ADRA2C,CM_750.16 [Arnold-Chiari syndrome*],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.512,0.278,,0.017,0.134,2
ATP8B1,DE_663.2 [Pemphigoid],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.524,2.614,1.927,0.367,0.481,,2
PBRM1,GE_961.1 [Phakomatoses],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.077,3.762,3.689,0.523,0.264,0.841,3
CHD7,GE_972.2 [Hereditary ataxia],0.056,0,0.0,0.0,0.0,0.0,0.331,0.0,0.012,2.774,3.613,0.41,0.252,0.894,4
CD19,NS_338.1 [Myasthenia gravis],0.056,1,3.0,0.0,0.0,0.0,0.0,0.0,0.09,,4.128,0.21,0.114,,2
SLC13A5,CM_770.5 [Congenital osteodystrophies],0.056,0,0.0,0.0,0.0,0.0,0.272,0.0,0.079,,0.159,0.24,0.139,0.112,3
KCNMA1,GU_580.1 [Acute nephritic syndrome],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.807,4.035,1.656,0.178,0.266,3
FCRL3,GI_542.8 [Biliary cirrhosis],0.056,0,0.0,0.0,0.0,0.433,0.0,0.0,0.052,2.153,2.512,0.18,0.178,,2
SUCO,CV_433.3 [Cerebrovascular insufficiency],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.061,2.516,0.657,0.526,0.235,0.09,3
NR4A2,NS_323.3 [Motor neuron disease],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.064,2.64,0.373,0.097,0.155,0.287,3
PSMB7,CV_433.3 [Cerebrovascular insufficiency],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,1.609,0.131,0.122,1.775,0.366,3
HDAC9,GE_970.1 [Sickle-cell disorders],0.056,1,1.0,0.0,0.0,0.0,0.0,0.0,0.023,2.627,1.582,0.107,0.169,,2
RPS9,GE_963.1 [Lipid storage disorders],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.056,0.028,0.025,0.177,1
STAT5A,GE_973.5 [Huntington's disease],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.17,,0.1,0.137,0.05,,1
APC,GI_540.11 [Autoimmune hepatitis],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.094,2.432,2.702,0.763,0.122,,2
PDE8B,GE_972.2 [Hereditary ataxia],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,1.406,2.307,0.117,0.199,0.28,3
KITLG,GE_972.9 [Muscular dystrophy],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.061,2.281,0.087,0.087,0.057,0.229,3
UCK2,CV_413.41 [Pulmonary valve stenosis],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.689,0.044,0.025,0.035,0.186,2
ITGB1,MB_302.1 [Speech and language developmental delay],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.843,0.256,0.092,1.299,0.985,2
IRF4,BI_179.1 [Hypogammaglobulinemia NOS],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.059,2.563,2.362,0.058,0.068,0.96,3
PTGS1,NS_341.1 [Cerebral palsy],0.056,1,3.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.317,0.65,0.178,0.956,2
RHOG,GI_516.1 [Pyloric stenosis],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.78,,0.024,0.33,1
NLRP3,MS_712.51 [Hypermobility syndrome],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.165,,2.495,0.189,0.231,,2
RUBCN,GI_540.11 [Autoimmune hepatitis],0.056,0,0.0,0.0,0.0,0.0,0.28,0.0,0.335,1.436,2.757,0.325,1.454,,3
PURA,BI_179.1 [Hypogammaglobulinemia NOS],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.635,0.858,,0.014,0.248,2
RBM4,NS_344.2 [Benign intracranial hypertension],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.072,0.029,0.032,0.193,1
FOXP1,CM_763.31 [Ventricular septal defect],0.056,0,0.0,0.0,0.547,0.0,0.295,0.362,0.0,3.092,0.054,,,0.912,4
DICER1,DE_663.2 [Pemphigoid],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.015,2.62,3.451,1.883,0.217,,2
FASLG,SO_369.62 [Keratoconus],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.201,2.298,1.789,0.102,0.055,0.219,3
RUNX1,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.056,0,0.0,0.0,0.0,0.0,0.287,0.0,0.0,3.173,4.21,0.76,0.149,0.977,3
TP53,GE_970.2 [Thalassemia],0.056,0,0.0,0.0,0.0,0.0,0.31,0.0,0.055,,2.788,0.112,0.182,,3
XIRP2,CV_414.1 [Hypertrophic cardiomyopathy],0.056,0,0.0,0.0,0.0,0.0,0.527,0.0,0.157,2.841,3.212,0.725,0.133,0.327,4
TNC,MS_704.1 [Polyarteritis nodosa and related conditions],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.289,1.846,3.482,1.023,0.291,,2
LHX9,NS_344.11 [Communicating hydrocephalus],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.173,1.752,0.057,0.06,0.049,,2
RCC1,NS_323.3 [Motor neuron disease],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,1.303,2.171,1.192,1.292,0.112,3
NKX2-5,GE_963.1 [Lipid storage disorders],0.056,0,0.0,0.0,0.0,0.0,0.252,0.0,0.0,,0.186,0.031,0.025,0.186,2
HNF4A,GE_970.2 [Thalassemia],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.024,3.114,1.681,0.149,0.158,,2
MAP3K8,CV_433.3 [Cerebrovascular insufficiency],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.116,1.986,2.368,0.044,0.087,0.786,3
PPFIA1,CV_414.1 [Hypertrophic cardiomyopathy],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.122,1.969,2.455,0.882,0.247,0.03,3
EFNB2,MS_704.1 [Polyarteritis nodosa and related conditions],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.213,2.406,1.839,0.065,0.054,,2
FASN,GE_972.2 [Hereditary ataxia],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,,2.757,0.795,0.851,0.931,3
MYH3,MB_302.1 [Speech and language developmental delay],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.049,3.524,2.362,0.092,0.172,0.128,3
MAPKAPK2,SO_386.5 [Color vision deficiencies],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.538,,0.019,0.326,1
STAT1,MS_700.42 [Dermatomyositis],0.056,0,0.0,0.163,0.0,0.0,0.0,0.0,0.127,1.972,3.212,0.104,0.053,,3
NDUFA4,GE_973.5 [Huntington's disease],0.056,1,3.0,0.0,0.0,0.0,0.0,0.0,0.039,2.516,0.063,0.033,0.032,,2
VIP,MB_302.1 [Speech and language developmental delay],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.304,0.193,0.158,0.104,0.905,2
ZAP70,BI_179.1 [Hypogammaglobulinemia NOS],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.315,0.21,0.128,0.995,1
FGFR1,GE_978.3 [Osteochondrodysplasias],0.056,1,2.0,0.0,0.0,0.0,0.376,0.0,0.045,1.655,3.489,2.125,1.669,,3
PSMD4,GE_961.1 [Phakomatoses],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,,0.082,0.089,0.105,0.274,2
TNFRSF1A,GE_963.1 [Lipid storage disorders],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.087,1.727,2.84,2.84,0.018,0.355,3
IL1B,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.083,2.036,0.137,0.13,0.068,0.996,3
LPAR1,GE_977.1 [Congenital ichthyosis],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.835,0.073,0.04,0.071,0.17,2
GPD1L,GE_972.2 [Hereditary ataxia],0.056,0,0.0,0.058,0.0,0.0,0.0,0.0,0.0,3.142,0.368,0.127,2.603,0.95,3
SHANK1,EM_209.4 [Diabetes insipidus],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.965,3.679,,0.028,0.228,2
LRRK2,MB_298 [Impulse disorders],0.056,0,0.0,0.0,0.0,0.0,0.392,0.0,0.012,4.591,3.073,0.448,1.03,,3
MID1IP1,GE_961.1 [Phakomatoses],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.171,2.844,,0.024,0.21,2
KCNJ5,CV_414.1 [Hypertrophic cardiomyopathy],0.056,0,0.0,0.0,0.0,0.0,0.65,0.131,0.027,2.384,2.77,1.325,0.265,0.336,5
ACVR2B,MS_700.3 [Systemic sclerosis],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.061,1.899,1.429,0.13,0.152,,2
TLE3,MB_302.1 [Speech and language developmental delay],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.906,2.666,0.265,0.203,0.342,3
MTOR,NS_323.3 [Motor neuron disease],0.056,1,1.0,0.0,0.0,0.0,0.0,0.0,0.074,1.807,3.938,1.486,0.123,0.957,3
OPTN,GE_972.2 [Hereditary ataxia],0.056,0,0.0,0.0,0.547,0.0,0.0,0.0,0.04,2.261,3.674,0.276,0.212,0.795,4
CHMP4B,GE_972.9 [Muscular dystrophy],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.288,0.074,0.04,0.024,0.217,2
NFE2L2,GU_580.51 [Focal and segmental glomerular lesions*],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.087,2.748,2.942,0.054,0.062,,2
PRKCE,GU_580.1 [Acute nephritic syndrome],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.321,0.508,0.111,0.109,0.767,3
NFAM1,GU_580.1 [Acute nephritic syndrome],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.904,1.777,,0.031,0.303,2
RBM39,GE_972.9 [Muscular dystrophy],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.222,0.047,0.03,0.328,1
ABR,NS_339.2 [Myotonic disorders],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.024,2.177,0.13,0.087,0.105,,2
YTHDF1,CV_414.1 [Hypertrophic cardiomyopathy],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,,3.843,2.57,0.643,0.096,3
NKX2-3,SO_369.62 [Keratoconus],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,3.027,0.894,0.078,0.088,0.153,3
NFAT5,GE_972.9 [Muscular dystrophy],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.248,3.323,3.449,0.238,0.147,0.241,3
NUP62,EM_209.4 [Diabetes insipidus],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,3.1,,0.023,0.24,2
RPS3A,NS_333.4 [Circadian rhythm sleep disorder],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.175,,0.03,0.31,1
S1PR1,GE_970.1 [Sickle-cell disorders],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.084,3.643,0.154,0.023,0.053,,2
RMND5A,EM_208.1 [Hypoparathyroidism],0.056,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.881,0.13,,0.113,0.12,2
OPHN1,GI_516.1 [Pyloric stenosis],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.746,2.661,1.18,0.196,0.987,2
TUBB4B,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.085,,0.032,0.313,1
GCDH,NS_341.1 [Cerebral palsy],0.055,0,0.0,0.0,0.654,0.0,0.0,0.0,0.0,,3.42,3.226,0.163,0.935,3
PPIA,GI_540.11 [Autoimmune hepatitis],0.055,1,4.0,0.0,0.0,0.0,0.29,0.0,0.231,,0.144,0.032,0.024,,2
ACTA1,GE_963.1 [Lipid storage disorders],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.038,1.93,0.075,0.042,0.049,0.337,3
EDNRA,MS_712.51 [Hypermobility syndrome],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.047,2.221,0.694,0.096,0.16,,2
GRIA1,SO_380.3 [Optic atrophy],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.091,2.71,2.971,0.397,0.165,0.752,3
DRD2,MB_296.4 [Borderline personality disorder],0.055,1,4.0,0.0,0.0,0.0,0.0,0.0,0.239,,2.87,1.623,4.321,,2
FGFR1,EM_209.4 [Diabetes insipidus],0.055,0,0.0,0.0,0.0,0.0,0.279,0.0,0.012,3.759,2.216,1.417,2.746,0.963,4
TLL1,GE_961.1 [Phakomatoses],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,3.585,2.163,,0.09,0.365,3
RTN1,CV_433.3 [Cerebrovascular insufficiency],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.106,4.233,2.635,0.358,0.128,0.188,3
NEDD8,CM_751.213 [Congenital cataract],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.07,,0.02,0.275,1
CD28,DE_663.1 [Pemphigus],0.055,0,0.0,0.0,0.0,0.0,0.471,0.0,0.129,2.171,0.174,0.064,0.034,,3
SRXN1,CM_772.2 [Congenital hypothyroidism],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.699,1.796,0.012,0.033,,1
WNK2,GE_972.9 [Muscular dystrophy],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.02,1.422,3.47,0.393,0.239,0.204,3
NTRK2,NS_341.1 [Cerebral palsy],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.091,3.517,0.53,0.084,1.72,0.898,3
AGK,CV_414.1 [Hypertrophic cardiomyopathy],0.055,0,0.0,0.0,0.878,0.0,0.0,0.0,0.076,2.183,2.882,0.461,0.249,0.426,4
GAS1,NS_333.4 [Circadian rhythm sleep disorder],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.963,2.792,0.019,0.07,0.128,2
TGFBR3,DE_669.2 [Behcet's syndrome],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.197,,3.641,0.346,0.112,,2
GRK2,MS_712.51 [Hypermobility syndrome],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.176,,2.689,0.26,0.215,,2
HPDL,GE_972.2 [Hereditary ataxia],0.055,0,0.0,0.0,0.0,0.0,0.0,0.523,0.015,,2.564,0.26,0.142,0.367,4
TRPM6,EM_208.1 [Hypoparathyroidism],0.055,0,0.0,0.0,0.893,0.0,0.0,0.0,0.015,2.31,2.944,0.634,0.497,0.635,4
EIF5A,EM_209.4 [Diabetes insipidus],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.523,0.072,,0.014,0.204,2
E2F1,GE_972.2 [Hereditary ataxia],0.055,0,0.0,0.026,0.0,0.0,0.0,0.0,0.0,1.373,1.26,0.037,0.087,0.992,3
UBE2I,SO_369.62 [Keratoconus],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.081,,0.031,0.288,1
PIK3R1,GE_964.3 [Glycogen storage disease],0.055,0,0.0,0.0,0.0,0.0,0.342,0.0,0.03,4.931,1.774,0.082,0.118,,3
SLC8A1,CV_414.1 [Hypertrophic cardiomyopathy],0.055,0,0.0,0.0,0.0,0.0,0.588,0.0,0.072,2.698,2.623,1.185,0.176,0.262,4
DKK1,DE_669.2 [Behcet's syndrome],0.055,0,0.0,0.0,0.0,0.452,0.0,0.0,0.061,1.988,4.317,0.062,0.051,,2
IL1R1,MS_704.1 [Polyarteritis nodosa and related conditions],0.055,1,3.0,0.0,0.0,0.0,0.0,0.0,0.227,,1.025,0.181,0.053,,1
TNC,DE_669.2 [Behcet's syndrome],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.274,3.537,3.366,0.401,0.231,,2
MTOR,GI_516.1 [Pyloric stenosis],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.422,2.754,0.775,0.388,0.989,2
SETD2,GE_961.1 [Phakomatoses],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.019,1.772,3.107,0.319,0.195,0.944,3
FBXW2,CV_413.41 [Pulmonary valve stenosis],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,3.803,,0.031,0.267,2
AHR,DE_663.2 [Pemphigoid],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.166,2.662,3.317,0.133,0.162,,2
RRAGB,DE_663.6 [Acantholytic Disorders*],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.5,0.062,,1.883,,1
BRCA2,CM_750.16 [Arnold-Chiari syndrome*],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.179,3.884,0.231,1.458,0.947,2
IL1B,GE_972.2 [Hereditary ataxia],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.11,,2.814,2.805,0.058,0.941,3
ROCK1,GE_973.5 [Huntington's disease],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.358,,0.393,0.096,0.072,,1
LIG3,GE_977.6 [Congenital cutaneous mastocytosis*],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.133,2.297,0.163,0.183,0.104,,2
SLC26A5,CM_770.5 [Congenital osteodystrophies],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.015,1.366,2.678,0.186,0.962,0.226,3
RPL7,GU_580.1 [Acute nephritic syndrome],0.055,1,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.449,2.88,,,0.164,2
HDAC7,MS_700.3 [Systemic sclerosis],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.152,3.808,2.054,0.327,0.18,,2
MAPK3,CM_770.5 [Congenital osteodystrophies],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.033,1.888,2.766,0.191,0.157,0.963,3
HSPA8,CV_414.1 [Hypertrophic cardiomyopathy],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.024,2.334,2.709,0.444,0.173,0.882,3
ADD3,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.061,2.233,2.729,0.28,0.231,0.124,3
HADHB,GE_972.1 [Hereditary neuropathy],0.055,0,0.0,0.0,0.0,0.0,0.0,0.121,0.101,2.372,2.911,1.295,0.581,,3
S1PR1,GE_961.1 [Phakomatoses],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.058,2.354,0.674,0.068,0.075,0.373,3
FAM167A,MS_719.2 [Muscle calcification and ossification],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.182,1.862,2.523,0.101,1.827,,2
TNFRSF1A,GE_972.9 [Muscular dystrophy],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.13,,0.165,0.064,0.03,0.31,2
LSAMP,MB_296.4 [Borderline personality disorder],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,3.513,0.106,0.085,0.073,,2
MORC3,NS_340.3 [Inflammatory and immune myopathies],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.187,3.131,0.233,0.045,0.048,,2
RAD21,GI_540.11 [Autoimmune hepatitis],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.383,,3.627,1.18,0.144,,2
DPP4,GU_580.1 [Acute nephritic syndrome],0.055,1,3.0,0.0,0.0,0.0,0.0,0.0,0.112,2.983,2.468,0.492,1.103,0.934,3
GRIN1,NS_341.1 [Cerebral palsy],0.055,1,4.0,0.0,0.0,0.0,0.0,0.0,0.0,,1.989,0.053,0.116,0.976,2
GABRB3,GU_580.1 [Acute nephritic syndrome],0.055,1,4.0,0.0,0.0,0.0,0.0,0.0,0.0,3.652,0.129,0.039,0.066,0.131,2
FGF10,GE_977.1 [Congenital ichthyosis],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.898,0.294,,0.023,0.267,2
TERF2,CV_413.41 [Pulmonary valve stenosis],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.205,,0.024,0.245,1
EGR1,MS_700.3 [Systemic sclerosis],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.553,,0.997,0.391,0.115,,1
BRD4,CM_751.213 [Congenital cataract],0.055,0,0.0,0.0,0.547,0.0,0.0,0.0,0.085,1.997,3.332,0.288,1.443,0.524,4
PDIA3,NS_323.3 [Motor neuron disease],0.055,0,0.0,0.0,0.644,0.0,0.0,0.0,0.07,2.555,2.957,0.265,0.206,0.562,4
GATA2,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,1.541,0.272,0.235,0.144,0.928,3
NCAM1,GE_963.1 [Lipid storage disorders],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.015,2.33,2.115,,0.03,0.304,3
RPL9,RE_484.1 [Spontaneous pneumothorax],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.174,0.041,,0.342,1
SNRPD2,GI_516.1 [Pyloric stenosis],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.26,0.078,,,0.121,2
SSBP3,CM_751.213 [Congenital cataract],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.36,2.262,,,0.255,2
ATRX,GI_516.1 [Pyloric stenosis],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.618,3.011,0.274,0.129,0.99,2
PHAF1,NS_339.2 [Myotonic disorders],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.158,,0.217,0.12,0.079,,1
MICU1,GE_972.9 [Muscular dystrophy],0.055,0,0.0,0.0,0.745,0.0,0.0,0.0,0.073,,0.43,0.188,0.106,0.406,3
SPIN1,GE_972.9 [Muscular dystrophy],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.043,1.726,0.046,0.035,,0.318,3
SPIN4,SO_396.3 [Mixed conductive and sensorineural hearing loss],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.495,0.079,,2.868,,1
STK39,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.061,2.478,2.346,0.104,0.105,0.149,3
EPOR,GE_970.2 [Thalassemia],0.055,1,2.0,0.0,0.0,0.0,0.597,0.0,0.024,,2.232,0.149,0.158,,3
CBX3,GE_972.9 [Muscular dystrophy],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.047,,0.098,0.076,0.042,0.343,2
KCNQ1,CV_416.8 [Pre-excitation syndrome [Anomalous atrioventricular excitation]],0.055,0,0.0,0.0,0.684,0.0,0.481,0.365,0.0,1.712,2.437,0.611,0.771,0.644,4
RNASEH2B,NS_341.1 [Cerebral palsy],0.055,0,0.0,0.0,0.547,0.0,0.0,0.362,0.097,2.145,2.344,2.046,0.105,0.966,4
GJB2,SO_396.3 [Mixed conductive and sensorineural hearing loss],0.055,0,0.0,0.0,0.0,0.0,0.0,0.599,0.024,2.623,2.39,0.741,0.2,,3
ACOX3,NS_341.1 [Cerebral palsy],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.542,2.693,1.005,0.811,0.956,2
ADRA2A,EM_211.1 [Adrenal hyperfunction],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.036,2.948,3.25,0.037,0.082,,2
PSIP1,GU_580.1 [Acute nephritic syndrome],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,3.357,1.588,0.265,1.72,0.172,3
ANGPT2,MS_704.1 [Polyarteritis nodosa and related conditions],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.207,2.736,0.364,0.322,0.132,,2
PCGF1,CV_413.41 [Pulmonary valve stenosis],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.575,0.026,0.031,0.293,1
NDUFV2,NS_341.1 [Cerebral palsy],0.055,1,2.0,0.0,0.0,0.0,0.0,0.0,0.0,1.465,2.331,1.384,0.121,0.991,2
ZBTB17,CV_414.1 [Hypertrophic cardiomyopathy],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,,2.74,0.519,0.253,0.101,3
VWF,NS_340.3 [Inflammatory and immune myopathies],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.166,,3.369,0.766,0.119,,2
NPC1L1,GI_540.11 [Autoimmune hepatitis],0.055,1,4.0,0.0,0.0,0.0,0.0,0.0,0.113,1.464,3.68,0.369,0.28,,2
SMARCA4,SO_381.5 [Vertical strabismus],0.055,0,0.0,0.0,0.0,0.0,0.0,0.008,0.012,2.194,1.53,0.143,0.134,,3
RPL31,CM_770.5 [Congenital osteodystrophies],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.793,0.443,,,0.273,2
CD9,GE_977.6 [Congenital cutaneous mastocytosis*],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.048,2.754,0.121,0.076,0.055,,2
TUBB4B,EM_209.4 [Diabetes insipidus],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.454,,0.012,0.231,2
AGR2,GE_972.2 [Hereditary ataxia],0.055,0,0.0,0.0,0.0,0.0,0.266,0.0,0.046,2.288,0.081,0.147,0.118,0.472,4
CACNA1B,MB_302.1 [Speech and language developmental delay],0.055,1,4.0,0.0,0.0,0.0,0.0,0.0,0.012,2.167,2.925,0.413,0.3,0.427,3
THBS1,MS_727.3 [Osteitis deformans [Paget's disease of bone]],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.061,2.434,2.951,,0.091,,2
KANK1,GE_972.2 [Hereditary ataxia],0.055,0,0.0,0.0,0.0,0.0,0.0,0.526,0.03,1.94,2.997,0.504,0.421,0.46,4
AGFG1,SO_373.2 [Choroidal degenerations],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.16,1.334,3.679,3.376,0.079,,2
RNF170,GE_972.2 [Hereditary ataxia],0.055,0,0.0,0.0,0.684,0.0,0.0,0.0,0.221,,0.2,0.115,0.083,0.655,3
BCL2L1,CV_433.3 [Cerebrovascular insufficiency],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.107,1.605,0.169,0.04,0.067,0.938,3
HDAC4,GE_978.22 [Ehler's Danlos syndrome],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.114,2.745,2.883,0.162,0.123,,2
QKI,GE_961.1 [Phakomatoses],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,2.922,1.991,0.064,0.072,0.338,3
FST,CM_770.5 [Congenital osteodystrophies],0.055,0,0.0,0.0,0.0,0.0,0.282,0.0,0.031,3.008,1.034,0.067,0.088,0.602,4
WNT5A,GE_963.1 [Lipid storage disorders],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,3.896,0.053,0.066,0.069,0.09,3
HTT,NS_344.11 [Communicating hydrocephalus],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.084,1.827,1.898,0.835,1.291,,2
TAF11,GE_972.9 [Muscular dystrophy],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,1.828,0.092,0.089,2.554,0.173,3
HDAC2,GE_970.1 [Sickle-cell disorders],0.055,1,2.0,0.0,0.0,0.0,0.0,0.0,0.079,2.564,0.107,0.035,0.046,,2
EP300,CV_433.3 [Cerebrovascular insufficiency],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.033,,2.308,0.315,0.251,0.968,3
LOX,CV_438.41 [Aortic dissection],0.055,0,0.0,0.0,0.0,0.0,0.0,0.54,0.041,,2.778,3.172,0.131,0.948,4
IL2RA,GI_540.11 [Autoimmune hepatitis],0.055,1,1.0,0.0,0.0,0.0,0.267,0.0,0.103,2.384,1.001,0.044,0.06,,3
MAP2K7,DE_663.2 [Pemphigoid],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.161,,3.458,3.586,0.097,,2
CHMP4B,CM_763.31 [Ventricular septal defect],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.384,0.121,0.047,0.031,0.292,2
DDX17,SO_369.62 [Keratoconus],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.241,,0.032,0.29,1
CELSR2,CV_441 [Arteriovenous malformation],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.022,3.641,,0.133,0.196,2
RPL38,MS_719.2 [Muscle calcification and ossification],0.055,0,0.0,0.0,0.0,0.0,0.371,0.0,0.0,2.915,0.076,,3.802,,2
BMP7,GU_580.1 [Acute nephritic syndrome],0.055,0,0.0,0.0,0.0,0.0,0.331,0.0,0.121,2.401,2.722,0.308,0.147,0.86,4
CSTB,GE_972.2 [Hereditary ataxia],0.055,0,0.0,0.0,0.547,0.0,0.371,0.0,0.108,2.659,0.551,0.34,0.068,0.818,5
TRAF3,CV_414.1 [Hypertrophic cardiomyopathy],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.036,2.638,3.106,0.762,0.15,0.262,3
GABRA2,GI_540.11 [Autoimmune hepatitis],0.055,1,1.0,0.0,0.0,0.0,0.0,0.0,0.0,2.617,0.176,,0.125,,1
KCNV1,CV_438.2 [Aneurysm of iliac or artery of lower extremity],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.623,0.111,,0.128,,1
EZH2,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.091,1.862,0.389,0.054,0.106,0.928,3
RPS6KA3,GE_973.5 [Huntington's disease],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.201,1.955,0.118,0.056,2.332,,2
CD40LG,MB_302.1 [Speech and language developmental delay],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.036,2.244,1.914,,0.036,0.739,3
LAMA2,CV_413.41 [Pulmonary valve stenosis],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.319,2.172,0.065,0.294,0.967,2
NPHP1,GU_580.1 [Acute nephritic syndrome],0.055,0,0.0,0.0,0.745,0.0,0.0,0.132,0.047,2.344,1.998,0.401,0.235,0.233,4
NAGLU,GE_963.3 [Mucopolysaccharidoses],0.055,1,0.5,0.0,0.0,0.0,0.0,0.934,0.067,,4.029,0.172,0.097,,3
RBBP5,GE_977.1 [Congenital ichthyosis],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.073,0.03,0.033,0.213,1
AR,MB_306 [Conduct disorders],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.088,1.966,3.044,,0.007,,2
CD58,GI_542.8 [Biliary cirrhosis],0.055,0,0.0,0.0,0.0,0.675,0.0,0.0,0.13,,2.435,,0.093,,2
CD36,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.055,0,0.0,0.0,0.779,0.0,0.0,0.0,0.012,3.289,3.188,0.751,0.237,0.966,4
ATP6AP2,EM_211.1 [Adrenal hyperfunction],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.086,1.883,2.306,0.089,0.062,,2
TBX1,CM_763.31 [Ventricular septal defect],0.055,0,0.0,0.0,0.854,0.0,0.0,0.0,0.08,1.313,0.776,0.071,0.071,0.941,4
ACTA2,GI_516.1 [Pyloric stenosis],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.684,0.107,,2.669,0.884,2
SATB1,MS_727.3 [Osteitis deformans [Paget's disease of bone]],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.061,2.888,2.147,0.112,0.166,,2
RPL36,BI_162.1 [Constitutional (hereditary) aplastic anemia],0.055,0,0.0,0.0,0.426,0.0,0.0,0.503,0.021,,0.066,0.022,,,2
PSMD4,GE_972.9 [Muscular dystrophy],0.055,1,1.0,0.0,0.0,0.0,0.0,0.0,0.03,,0.059,0.058,0.074,0.334,2
GPT2,NS_341.1 [Cerebral palsy],0.055,0,0.0,0.0,0.547,0.0,0.0,0.0,0.031,,2.423,1.213,0.136,0.918,4
SLC8A1,GE_972.2 [Hereditary ataxia],0.055,0,0.0,0.047,0.0,0.0,0.0,0.0,0.036,2.639,3.3,0.409,0.242,0.949,4
NDUFS5,GE_963.1 [Lipid storage disorders],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.341,0.095,0.059,0.045,0.973,2
CSNK2A2,CV_438.41 [Aortic dissection],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.927,3.749,,0.092,0.147,2
DCD,CV_438.7 [Aneurysm of heart],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.824,3.324,0.013,0.029,,1
NDUFB1,SO_380.3 [Optic atrophy],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.731,0.358,0.051,0.09,0.921,2
KCNH5,GI_542.8 [Biliary cirrhosis],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.207,3.625,2.793,0.436,0.47,,2
CDK8,CV_414.1 [Hypertrophic cardiomyopathy],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.091,1.492,0.145,0.129,0.151,0.27,3
DLX1,CV_416.8 [Pre-excitation syndrome [Anomalous atrioventricular excitation]],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.64,0.056,,0.075,0.19,2
TBX4,GE_978.3 [Osteochondrodysplasias],0.055,0,0.0,0.0,0.0,0.0,0.44,0.0,0.033,1.897,2.884,2.279,0.094,,3
MAPKAP1,MB_306 [Conduct disorders],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,1.955,0.095,0.084,0.1,,2
TNIK,MS_704.1 [Polyarteritis nodosa and related conditions],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.024,2.172,2.505,0.107,0.181,,2
PTH,CM_772.1 [Congenital malformations of endocrine glands],0.055,0,0.0,0.0,0.0,0.0,0.275,0.779,0.018,,0.113,0.037,0.044,,3
KHDRBS1,MB_296.4 [Borderline personality disorder],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,1.666,0.094,0.066,0.118,,2
ZNF362,SO_386.5 [Color vision deficiencies],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.907,1.807,,0.021,0.281,2
H4C13,GU_580.51 [Focal and segmental glomerular lesions*],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,2.162,3.701,0.039,0.011,,2
CASP1,MS_705.2 [Juvenile rheumatoid arthritis [JRA/JIA]],0.055,0,0.0,0.0,0.547,0.0,0.0,0.0,0.137,,3.143,0.073,0.103,,3
NCOR1,CM_750.16 [Arnold-Chiari syndrome*],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.622,3.65,0.357,1.052,0.949,2
GAGE12H,EM_249.1 [Cerebral amyloid angiopathy*],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.073,,2.8,,1
TEK,DE_663.2 [Pemphigoid],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.108,3.746,3.02,0.209,0.177,,2
RHO,SO_369.62 [Keratoconus],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,1.763,0.888,0.185,1.0,2
MRPL3,CV_414.1 [Hypertrophic cardiomyopathy],0.055,0,0.0,0.0,0.654,0.0,0.0,0.0,0.064,4.24,1.116,0.084,0.225,0.948,4
PDGFRB,NS_323.3 [Motor neuron disease],0.055,1,4.0,0.0,0.0,0.0,0.0,0.0,0.018,2.003,2.111,0.595,0.32,0.213,3
IER5,GU_580.1 [Acute nephritic syndrome],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.996,1.853,,0.034,0.143,2
FAR1,CM_751.213 [Congenital cataract],0.055,0,0.0,0.0,0.684,0.0,0.0,0.0,0.066,2.564,2.339,0.114,1.982,0.268,4
RUNX2,CV_414.1 [Hypertrophic cardiomyopathy],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,2.589,3.069,0.402,0.27,0.197,3
PTHLH,MS_727.5 [Cyst of bone],0.055,0,0.0,0.0,0.0,0.0,0.365,0.0,0.055,2.614,0.279,0.039,0.086,,3
SOS1,SO_381.5 [Vertical strabismus],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,1.962,1.122,0.175,0.124,,2
GRN,CV_433.3 [Cerebrovascular insufficiency],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.505,1.845,2.414,0.185,0.12,0.678,3
MTOR,EM_209.13 [Hyperprolactinemia*],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.091,2.318,3.332,0.315,0.244,,2
TGFBR3,CV_433.3 [Cerebrovascular insufficiency],0.055,0,0.0,0.0,0.0,0.403,0.0,0.0,0.0,2.454,2.874,0.092,0.219,0.959,2
CP,BI_162.1 [Constitutional (hereditary) aplastic anemia],0.055,0,0.0,0.0,0.0,0.0,0.437,0.0,0.036,,4.486,2.74,0.057,,3
MORF4L2,GE_961.1 [Phakomatoses],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.95,4.006,,0.029,0.069,2
MYBPC1,NS_323.3 [Motor neuron disease],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,1.995,2.061,1.325,0.239,0.054,3
RNASE1,BI_168.12 [Hemorrhagic disorder due to intrinsic circulating anticoagulants],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,1.53,3.525,0.022,0.031,,2
PREX1,CM_770.5 [Congenital osteodystrophies],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.036,3.387,3.375,,0.049,0.312,3
PTP4A2,CM_763.13 [Patent ductus arteriosus],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.366,0.037,0.037,0.021,0.189,2
HMGB1,NS_344.2 [Benign intracranial hypertension],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.122,2.729,0.695,0.082,,0.958,3
ASPA,GE_963.1 [Lipid storage disorders],0.055,0,0.0,0.0,0.895,0.0,0.328,0.0,0.027,1.375,0.204,0.296,0.077,0.743,5
HDAC5,MS_700.3 [Systemic sclerosis],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.172,,3.477,0.231,0.187,,2
EGR3,RE_484.1 [Spontaneous pneumothorax],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.557,0.17,,0.105,0.326,2
VCAN,MS_700.3 [Systemic sclerosis],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.63,2.945,3.212,1.367,0.256,,2
RHOG,CM_751.213 [Congenital cataract],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.123,,0.022,0.195,1
DLAT,CV_414.1 [Hypertrophic cardiomyopathy],0.055,0,0.0,0.0,0.426,0.0,0.0,0.0,0.0,,2.537,2.815,0.331,0.909,3
SOX10,GE_972.1 [Hereditary neuropathy],0.055,0,0.0,0.0,0.0,0.0,0.265,0.151,0.085,,2.802,0.086,0.132,,4
UNC13A,GE_972.2 [Hereditary ataxia],0.055,0,0.0,0.083,0.0,0.0,0.0,0.29,0.012,1.997,3.256,0.079,0.138,0.855,5
SMARCA4,CM_770.5 [Congenital osteodystrophies],0.055,0,0.0,0.0,0.0,0.0,0.409,0.0,0.03,1.464,1.357,0.171,0.156,0.927,4
HCN4,GE_961.1 [Phakomatoses],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.257,,2.945,0.154,0.096,0.066,3
VWF,GI_540.11 [Autoimmune hepatitis],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.223,2.401,2.983,0.909,0.14,,2
HLA-G,DE_663.1 [Pemphigus],0.055,0,0.0,0.0,0.0,0.383,0.553,0.0,0.135,1.628,0.258,0.135,0.048,,3
CSF1,NS_343.3 [Complex regional pain syndrome],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.043,3.024,1.177,0.053,0.071,,2
HSPG2,GE_977.6 [Congenital cutaneous mastocytosis*],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.222,2.604,3.381,1.022,0.112,,2
COL11A1,MS_700.3 [Systemic sclerosis],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.091,2.183,3.343,0.728,0.511,,2
KL,CV_433.3 [Cerebrovascular insufficiency],0.055,0,0.0,0.0,0.304,0.0,0.0,0.0,0.142,2.278,2.876,0.346,0.885,0.703,4
FBN3,GE_978.21 [Marfan syndrome],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.102,2.741,2.708,0.273,0.135,,2
HNRNPC,EM_209.4 [Diabetes insipidus],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.722,2.479,,,0.144,2
DNM1,MB_302.1 [Speech and language developmental delay],0.055,0,0.0,0.0,0.0,0.0,0.342,0.0,0.012,,3.292,3.329,1.65,0.894,4
SIRPA,GE_963.1 [Lipid storage disorders],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,1.981,3.816,2.629,0.053,0.053,3
ALDH1A2,GE_963.1 [Lipid storage disorders],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,2.547,0.283,0.076,0.105,0.166,3
ARL13B,SO_386.6 [Night blindness],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.325,1.665,0.237,0.148,0.984,2
ITGB5,MS_700.3 [Systemic sclerosis],0.055,1,2.0,0.0,0.0,0.0,0.0,0.0,0.259,1.738,2.827,0.31,0.263,,2
EDNRA,NS_344.11 [Communicating hydrocephalus],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.061,2.186,0.047,0.038,0.054,,2
ESR2,MB_293.1 [Anorexia nervosa],0.055,1,3.0,0.0,0.0,0.52,0.0,0.0,0.068,,2.607,0.894,0.967,,2
BEX5,EM_209.4 [Diabetes insipidus],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.067,,2.739,0.064,2
TEK,CV_441 [Arteriovenous malformation],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.042,2.988,3.499,0.315,0.277,0.933,3
ALDH7A1,NS_341.1 [Cerebral palsy],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,3.484,0.207,0.19,0.97,2
KIF1A,NS_323.3 [Motor neuron disease],0.055,0,0.0,0.0,0.834,0.0,0.0,0.0,0.043,2.443,3.155,2.839,0.08,0.532,4
NRF1,CV_413.42 [Pulmonary valve insufficiency*],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.898,0.125,,0.165,,1
INS,GE_972.2 [Hereditary ataxia],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.113,,0.058,0.989,1
RTN1,GU_580.1 [Acute nephritic syndrome],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.225,1.962,2.741,0.224,1.602,0.081,3
LRP6,GI_542.8 [Biliary cirrhosis],0.055,0,0.0,0.0,0.0,0.0,0.276,0.0,0.012,2.305,1.988,0.655,0.35,,3
CHAT,MB_305.1 [Tics and tic disorders],0.055,0,0.0,0.0,0.0,0.0,0.531,0.0,0.076,,1.145,0.275,0.131,,2
HTR2A,MB_306 [Conduct disorders],0.055,1,4.0,0.0,0.0,0.0,0.0,0.0,0.064,3.599,2.299,0.089,0.077,,2
AXIN1,CM_770.5 [Congenital osteodystrophies],0.055,0,0.0,0.0,0.0,0.0,0.32,0.0,0.061,,1.911,0.241,0.15,0.905,4
ARF1,SO_386.6 [Night blindness],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.103,,0.023,0.307,1
SQSTM1,MS_727.5 [Cyst of bone],0.055,0,0.0,0.0,0.0,0.0,0.417,0.0,0.018,,2.513,1.043,0.268,,3
RPS18,GE_972.9 [Muscular dystrophy],0.055,1,4.0,0.0,0.0,0.0,0.0,0.0,0.0,1.686,0.069,,0.032,0.348,2
RPS14,GE_963.1 [Lipid storage disorders],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.087,0.009,0.021,0.181,1
SLC31A1,GE_972.1 [Hereditary neuropathy],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,2.544,0.095,0.154,0.09,,2
TNFSF11,MS_727.5 [Cyst of bone],0.055,1,2.0,0.0,0.0,0.0,0.0,0.0,0.158,1.983,2.513,0.308,0.119,,2
PTPRC,GE_970.1 [Sickle-cell disorders],0.055,0,0.0,0.0,0.0,0.0,0.268,0.0,0.068,2.788,1.467,0.028,0.029,,3
TFPI,CV_414.1 [Hypertrophic cardiomyopathy],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,2.503,0.906,0.074,0.163,0.082,3
SUV39H1,RE_472.6 [Nodules of vocal cords*],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.078,,2.151,,1
SLC1A3,GE_973.5 [Huntington's disease],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.172,2.084,0.548,0.103,0.053,,2
UBE2D2,NS_344.2 [Benign intracranial hypertension],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.371,,0.01,0.229,2
BCL6,NS_338.1 [Myasthenia gravis],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.108,2.75,2.391,0.277,1.614,,2
KCNK3,CV_433.3 [Cerebrovascular insufficiency],0.055,0,0.0,0.0,0.0,0.422,0.0,0.0,0.101,1.917,0.462,,0.067,0.465,3
MYB,DE_663.2 [Pemphigoid],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.07,1.872,1.871,0.59,0.181,,2
CHD7,GE_971.14 [Von Willebrand's disease],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,2.335,3.494,3.408,0.21,,2
HSPH1,CV_433.3 [Cerebrovascular insufficiency],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.144,2.258,2.577,1.778,0.149,0.311,3
GABRA3,SO_369.62 [Keratoconus],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.852,1.949,,0.082,0.065,2
MSH2,NS_344.2 [Benign intracranial hypertension],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.54,2.712,0.651,0.846,0.992,2
LONP1,GE_972.2 [Hereditary ataxia],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.041,2.293,2.456,0.651,0.303,0.889,3
PAX7,GE_972.9 [Muscular dystrophy],0.055,0,0.0,0.0,0.0,0.0,0.291,0.0,0.287,1.661,3.148,1.207,0.126,0.921,4
CTSF,GE_963.1 [Lipid storage disorders],0.055,0,0.0,0.0,0.0,0.0,0.0,0.835,0.072,1.81,2.621,0.262,0.109,0.075,4
NFASC,DE_663.2 [Pemphigoid],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.213,3.052,3.522,1.198,0.248,,2
GRIN2B,NS_340.3 [Inflammatory and immune myopathies],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.036,2.79,0.104,,,,2
UBA52,CM_750.16 [Arnold-Chiari syndrome*],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.042,,,0.34,1
EYA1,GE_964.3 [Glycogen storage disease],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.76,0.346,0.202,0.194,,2
CHRM4,SO_380.3 [Optic atrophy],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,1.559,,0.014,0.262,2
TAS2R1,MB_296.7 [Dependent personality disorder],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.648,3.078,0.014,0.027,,1
PROM1,CV_414.1 [Hypertrophic cardiomyopathy],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,2.292,2.905,0.575,1.049,0.228,3
ALDH5A1,GE_972.2 [Hereditary ataxia],0.055,0,0.0,0.0,0.547,0.0,0.268,0.0,0.044,1.936,1.773,0.139,0.2,0.748,5
EIF4A1,CM_750.16 [Arnold-Chiari syndrome*],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.066,,0.026,0.32,1
KRAS,DE_663.2 [Pemphigoid],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.104,3.065,0.617,,0.055,,2
ADA2,BI_162.1 [Constitutional (hereditary) aplastic anemia],0.055,0,0.0,0.0,0.684,0.0,0.0,0.648,0.04,2.164,1.746,0.189,0.07,,3
PTGS2,GI_516.1 [Pyloric stenosis],0.055,1,4.0,0.0,0.0,0.0,0.0,0.0,0.0,1.342,2.491,0.144,0.178,0.962,2
MYH3,NS_340.3 [Inflammatory and immune myopathies],0.055,0,0.0,0.182,0.547,0.0,0.419,0.0,0.043,1.512,3.32,0.04,0.068,,5
GRIN2B,CV_416.8 [Pre-excitation syndrome [Anomalous atrioventricular excitation]],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.065,2.833,,,0.341,2
FLNA,GE_961.1 [Phakomatoses],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.103,,2.924,0.068,0.237,0.848,3
PPIB,GI_540.11 [Autoimmune hepatitis],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.101,,0.133,0.208,0.159,,1
NEDD8,CV_413.41 [Pulmonary valve stenosis],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.047,,0.015,0.339,1
NTRK2,GI_540.11 [Autoimmune hepatitis],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.133,3.334,0.595,0.116,0.168,,2
SCN1A,GE_961.1 [Phakomatoses],0.055,1,2.0,0.0,0.0,0.0,0.0,0.0,0.036,,2.793,0.38,0.26,0.191,3
RDH12,SO_386.6 [Night blindness],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,1.928,0.137,0.32,0.133,1.0,3
TNFSF11,DE_663.2 [Pemphigoid],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.445,2.914,1.689,0.195,0.048,,2
MAP3K1,DE_663.2 [Pemphigoid],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.055,2.847,3.509,2.418,0.209,,2
ADRA2A,SO_386.5 [Color vision deficiencies],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.385,2.679,0.031,0.044,0.084,2
NDUFA1,CV_414.1 [Hypertrophic cardiomyopathy],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.161,,0.032,0.993,1
BARD1,BI_162.1 [Constitutional (hereditary) aplastic anemia],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.106,2.517,4.076,2.797,0.095,,2
ARPC1A,CM_763.13 [Patent ductus arteriosus],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.326,0.094,0.033,0.027,0.237,2
LPAR1,CM_770.5 [Congenital osteodystrophies],0.055,0,0.0,0.0,0.0,0.0,0.253,0.0,0.066,2.764,0.098,0.067,0.094,0.602,4
CDC42EP3,MS_700.3 [Systemic sclerosis],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.073,3.105,2.519,0.139,0.137,,2
ESR1,DE_663.2 [Pemphigoid],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.703,3.216,2.871,0.334,0.109,,2
FMR1,GE_972.2 [Hereditary ataxia],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.082,4.102,3.057,0.304,0.146,0.983,3
PPP2R2A,CV_433.3 [Cerebrovascular insufficiency],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.016,0.114,,0.013,0.269,2
APOB,CV_433.3 [Cerebrovascular insufficiency],0.055,0,0.0,0.0,0.812,0.0,0.0,0.0,0.156,2.923,3.814,0.649,0.181,0.838,4
SMCHD1,MB_302.1 [Speech and language developmental delay],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,1.994,3.085,1.364,0.201,0.229,3
RUVBL2,MB_302.1 [Speech and language developmental delay],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.532,3.91,,0.018,0.283,2
GFAP,SO_386.6 [Night blindness],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.98,0.127,0.117,0.988,2
PLXNA4,NS_323.3 [Motor neuron disease],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.743,3.476,0.524,0.185,0.172,3
STK11,GI_540.11 [Autoimmune hepatitis],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.097,,0.507,0.09,0.091,,1
THRA,NS_323.3 [Motor neuron disease],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.061,1.449,0.603,0.094,0.156,0.06,3
RPS23,SO_365.3 [Exophthalmos [Proptosis]],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.302,0.104,,,0.149,2
PPP3CB,CM_750.16 [Arnold-Chiari syndrome*],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.039,0.017,0.034,0.31,1
RPS24,BI_162.1 [Constitutional (hereditary) aplastic anemia],0.055,0,0.0,0.0,0.861,0.0,0.0,0.857,0.111,3.583,0.108,0.038,0.009,,3
TSC2,CM_751.213 [Congenital cataract],0.055,0,0.0,0.0,0.547,0.0,0.0,0.0,0.0,1.866,3.418,0.336,0.972,0.822,3
CRY1,NS_333.4 [Circadian rhythm sleep disorder],0.055,0,0.0,0.0,0.0,0.0,0.0,0.575,0.031,1.992,0.463,0.177,0.148,0.433,4
TIAL1,CV_441 [Arteriovenous malformation],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.481,0.07,,0.086,0.152,2
MEF2C,CV_414.1 [Hypertrophic cardiomyopathy],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.128,2.115,2.638,,0.148,0.783,3
SLC6A3,GE_972.9 [Muscular dystrophy],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.727,0.804,0.144,0.102,0.273,3
HMGB1,GE_972.1 [Hereditary neuropathy],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.139,4.289,1.892,0.143,,,2
ACE2,SO_369.62 [Keratoconus],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.164,,2.398,0.156,1.017,0.114,3
GNAS,CV_414.1 [Hypertrophic cardiomyopathy],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.036,2.671,2.171,0.139,0.133,0.707,3
HLA-A,CV_433.3 [Cerebrovascular insufficiency],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,1.956,2.512,0.166,0.107,0.935,3
CAPRIN1,NS_323.3 [Motor neuron disease],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,1.468,4.253,0.282,0.221,0.567,3
COX5A,NS_341.1 [Cerebral palsy],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.906,2.619,0.066,0.996,2
NDUFB8,NS_341.1 [Cerebral palsy],0.055,1,2.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.039,0.154,0.073,0.994,2
AGPS,CV_433.3 [Cerebrovascular insufficiency],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,1.893,0.241,0.075,0.109,0.104,3
SLC1A3,DE_663.2 [Pemphigoid],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.094,2.612,1.949,0.245,0.134,,2
PLCB1,NS_323.3 [Motor neuron disease],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,2.976,1.763,0.319,0.288,0.386,3
ATAD5,GE_972.2 [Hereditary ataxia],0.055,0,0.0,0.024,0.0,0.0,0.0,0.0,0.012,1.614,3.315,2.389,0.189,0.438,4
RBP3,SO_386.5 [Color vision deficiencies],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,3.271,0.04,0.067,0.998,2
FLT1,GE_970.2 [Thalassemia],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.392,3.658,3.306,0.4,,2
PDE1B,GE_973.5 [Huntington's disease],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.092,1.969,0.594,0.081,0.05,,2
NF1,NS_344.11 [Communicating hydrocephalus],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.057,,3.987,3.254,1.685,,2
PCBP2,CM_751.213 [Congenital cataract],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.354,0.073,,0.022,0.234,2
CNOT2,CM_750.16 [Arnold-Chiari syndrome*],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.647,0.108,,0.031,0.296,2
C1QTNF5,SO_386.6 [Night blindness],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.677,0.153,0.036,0.984,2
SMAD3,CV_438.41 [Aortic dissection],0.055,0,0.0,0.0,0.654,0.0,0.0,0.37,0.052,3.764,1.973,0.057,3.294,0.986,4
IL3RA,GE_972.2 [Hereditary ataxia],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.087,,4.069,0.242,0.16,0.148,3
OTX2,SO_380.3 [Optic atrophy],0.055,0,0.0,0.0,0.0,0.0,0.373,0.0,0.0,3.432,2.45,,0.082,0.994,3
DYNC1I1,MB_296.2 [Schizoid personality disorder],0.055,0,0.0,0.0,0.547,0.0,0.0,0.0,0.043,2.307,0.093,0.13,0.071,,3
FOXO6,GE_961.1 [Phakomatoses],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.247,3.102,,0.041,0.188,2
NUP98,SO_386.5 [Color vision deficiencies],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.14,1.772,2.861,0.408,0.168,0.252,3
CLDN5,GU_580.51 [Focal and segmental glomerular lesions*],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.082,2.589,0.125,0.035,0.049,,2
ADM,MS_712.51 [Hypermobility syndrome],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.282,2.475,1.647,0.047,0.083,,2
NLGN4X,CM_770.5 [Congenital osteodystrophies],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.707,0.147,,0.039,0.223,3
APC,GE_963.1 [Lipid storage disorders],0.055,0,0.0,0.0,0.0,0.0,0.265,0.0,0.03,3.073,3.061,0.552,0.253,0.088,4
PCDH9,CV_433.3 [Cerebrovascular insufficiency],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,3.189,1.928,1.004,0.212,0.313,3
IGHMBP2,GE_972.1 [Hereditary neuropathy],0.055,0,0.0,0.0,0.0,0.0,0.338,0.519,0.069,2.081,4.715,1.127,0.305,,4
SETBP1,GE_961.1 [Phakomatoses],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.409,3.248,2.78,0.247,0.521,3
COPS4,CM_763.13 [Patent ductus arteriosus],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.048,0.016,0.03,0.241,1
APP,NS_339.2 [Myotonic disorders],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.089,3.719,2.826,0.258,0.132,,2
CAMTA1,GE_972.2 [Hereditary ataxia],0.055,0,0.0,0.106,0.745,0.0,0.269,0.81,0.067,2.52,3.034,0.676,1.856,0.664,6
DACH1,NS_333.4 [Circadian rhythm sleep disorder],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.663,3.409,,0.025,0.247,2
AIDA,SO_386.6 [Night blindness],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.114,,0.12,0.058,1
KEAP1,GE_972.2 [Hereditary ataxia],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.106,,0.973,0.126,0.183,0.734,2
IL1A,SO_369.62 [Keratoconus],0.055,0,0.0,0.0,0.532,0.0,0.0,0.0,0.342,,0.595,0.199,0.084,0.264,3
ARID2,GI_542.8 [Biliary cirrhosis],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.079,2.21,2.689,0.281,0.23,,2
HNRNPH3,CM_763.13 [Patent ductus arteriosus],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.047,0.031,0.035,0.224,1
CC2D2A,SO_369.62 [Keratoconus],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,5.136,0.586,0.145,0.991,2
PSEN1,GE_972.1 [Hereditary neuropathy],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.024,2.217,0.368,0.135,0.164,,2
ADAMTS2,GE_978.22 [Ehler's Danlos syndrome],0.055,0,0.0,0.0,0.0,0.0,0.0,0.209,0.015,2.416,3.632,0.257,0.138,,3
BCL2,MS_727.3 [Osteitis deformans [Paget's disease of bone]],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.015,2.475,0.138,0.042,0.096,,2
UBA52,CV_414.1 [Hypertrophic cardiomyopathy],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.124,,,0.152,1
HTR2A,MB_293.2 [Bulimia nervosa],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.073,2.547,2.863,0.144,0.147,,2
GRIA4,MS_704.1 [Polyarteritis nodosa and related conditions],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.043,1.945,1.371,0.131,0.146,,2
NF2,DE_663.2 [Pemphigoid],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.264,,1.776,0.151,0.148,,2
RPL31,GE_963.1 [Lipid storage disorders],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.873,0.281,,,0.193,2
EXT1,GE_961.1 [Phakomatoses],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.853,2.872,0.211,0.159,0.364,3
PJA1,GE_972.9 [Muscular dystrophy],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.141,2.074,,0.021,0.298,2
FN1,GE_964.3 [Glycogen storage disease],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.049,2.727,5.075,2.218,0.575,,2
SLC12A4,GE_970.2 [Thalassemia],0.055,0,0.0,0.0,0.0,0.0,0.427,0.0,0.018,,3.088,0.437,0.57,,3
DAPK1,GE_973.5 [Huntington's disease],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.318,2.581,3.246,0.142,0.089,,2
RNF2,CM_751.213 [Congenital cataract],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.095,0.075,,0.032,0.327,2
NCF1,GE_973.5 [Huntington's disease],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.298,2.989,1.765,0.102,0.033,,2
GLI2,EM_209.4 [Diabetes insipidus],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,1.96,2.984,0.934,0.228,0.968,3
SSB,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.024,,0.69,0.118,2.091,0.22,3
XPR1,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.055,0,0.0,0.0,0.0,0.0,0.0,0.402,0.206,2.551,2.465,1.43,0.136,0.829,4
OPN1LW,GU_580.55 [Diffuse mesangiocapillary glomerulonephritis*],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.076,,5.112,,1
GATA2,CM_770.5 [Congenital osteodystrophies],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.074,,2.066,0.174,1.824,0.86,3
GUCA1A,GE_974.3 [Hereditary choroidal dystrophies],0.055,0,0.0,0.0,0.0,0.0,0.421,0.402,0.094,1.995,0.17,0.071,0.023,,4
CPEB1,CV_413.41 [Pulmonary valve stenosis],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.279,0.034,,0.299,1
TGFBR2,GE_978.21 [Marfan syndrome],0.055,0,0.0,0.0,0.0,0.0,0.0,0.881,0.141,2.558,1.894,0.138,0.073,,3
RCC1,GU_580.52 [Diffuse membranous glomerulonephritis],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.085,1.408,0.119,0.115,0.076,,2
TAB1,GI_540.11 [Autoimmune hepatitis],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.112,,2.534,0.198,0.161,,2
SYK,GI_540.4 [Alcoholic hepatitis],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.026,2.694,1.91,0.236,0.145,,2
LCP1,CM_770.5 [Congenital osteodystrophies],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.067,,2.093,0.205,0.137,0.474,3
SLC40A1,GU_580.52 [Diffuse membranous glomerulonephritis],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,1.996,0.104,0.064,0.086,,2
BCORL1,EM_209.4 [Diabetes insipidus],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.64,3.566,,2.759,0.14,2
TICAM1,BI_179.4 [Selective deficiency of immunoglobulin A [IgA]],0.055,0,0.0,0.0,0.0,0.0,0.32,0.0,0.0,2.625,2.445,0.026,0.035,,2
CTH,NS_341.1 [Cerebral palsy],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.215,0.209,0.174,0.142,0.911,2
ASB7,NS_333.4 [Circadian rhythm sleep disorder],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.642,0.279,,0.077,0.188,2
GABRA1,GE_970.2 [Thalassemia],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.732,0.141,,0.155,,1
RBP4,MS_704.1 [Polyarteritis nodosa and related conditions],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.608,,3.621,1.905,0.06,,2
PIK3CD,SO_380.3 [Optic atrophy],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,2.303,3.141,1.874,0.185,0.268,3
UBE2D3,SO_386.6 [Night blindness],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.046,,,0.146,1
CELF2,GE_972.9 [Muscular dystrophy],0.055,0,0.0,0.04,0.0,0.0,0.0,0.0,0.012,2.784,1.425,0.017,2.617,0.24,4
TNFAIP3,NS_338.1 [Myasthenia gravis],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.093,2.868,2.835,0.454,0.18,,2
ADRA2A,SO_381.5 [Vertical strabismus],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.901,2.824,0.022,0.06,,1
RPL7,EM_208.1 [Hypoparathyroidism],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.974,2.72,,,0.337,2
NFKB1,NS_338.1 [Myasthenia gravis],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.08,2.457,1.829,0.377,0.175,,2
ZAN,GE_961.1 [Phakomatoses],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.128,1.407,4.334,1.691,1.68,0.137,3
NDUFS2,NS_341.1 [Cerebral palsy],0.055,1,2.0,0.0,0.0,0.0,0.0,0.0,0.0,,1.14,0.195,0.125,0.992,1
RORA,MS_704.1 [Polyarteritis nodosa and related conditions],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.091,2.441,0.491,,,,2
SHANK2,"MB_280.4 [Sedative, hypnotic, or anxiolytic related disorders]",0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,2.925,1.778,0.141,0.211,,2
FOXO6,GE_972.9 [Muscular dystrophy],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.942,2.724,,0.021,0.233,2
PTPN1,DE_663.2 [Pemphigoid],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,2.725,0.517,0.048,0.089,,2
AIFM1,GE_972.1 [Hereditary neuropathy],0.055,0,0.0,0.0,0.0,0.0,0.0,0.78,0.057,2.185,0.19,0.168,2.574,,3
SNAP25,SO_386.5 [Color vision deficiencies],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.826,0.073,0.024,0.074,0.745,3
DRD3,CM_770.5 [Congenital osteodystrophies],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.145,2.269,0.16,0.147,0.111,0.395,3
COL4A5,GE_976.5 [Polycystic kidney disease],0.055,0,0.0,0.0,0.0,0.0,0.265,0.0,0.101,3.483,2.144,0.529,0.272,,3
PDE4A,MS_712.51 [Hypermobility syndrome],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.183,,1.95,0.84,1.877,,2
FRAT1,NS_339.2 [Myotonic disorders],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.505,1.612,0.012,0.032,,1
CD40LG,CV_433.3 [Cerebrovascular insufficiency],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.056,1.963,2.593,,0.044,0.837,3
CTDSPL,CV_413.41 [Pulmonary valve stenosis],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.778,0.122,0.046,0.03,0.295,2
ADRA2C,SO_386.6 [Night blindness],0.055,1,4.0,0.0,0.0,0.0,0.0,0.0,0.0,2.174,2.427,,0.038,0.152,2
NPTX1,GU_580.1 [Acute nephritic syndrome],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.049,1.965,3.259,2.911,0.083,0.101,3
RPL13,MB_302.1 [Speech and language developmental delay],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.213,1.76,,,0.237,2
FGF23,MS_727.5 [Cyst of bone],0.055,1,2.0,0.0,0.0,0.0,0.284,0.0,0.158,,1.984,0.164,0.106,,3
DICER1,CM_763.31 [Ventricular septal defect],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.036,1.578,3.049,0.541,0.183,0.902,3
CNTNAP1,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.055,0,0.0,0.0,0.0,0.0,0.363,0.0,0.073,,3.004,1.999,0.236,0.466,4
IL10,GI_542.8 [Biliary cirrhosis],0.055,0,0.0,0.0,0.0,0.0,0.282,0.0,0.387,1.526,0.672,0.089,0.083,,3
THBS1,GE_972.2 [Hereditary ataxia],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,2.734,1.459,,0.099,0.869,3
NKX6-2,GE_963.1 [Lipid storage disorders],0.055,0,0.0,0.0,0.0,0.0,0.31,0.0,0.109,3.31,0.069,0.114,0.094,0.645,4
BRD7,CM_770.5 [Congenital osteodystrophies],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,2.408,1.433,0.198,0.118,0.461,3
MTOR,GE_978.22 [Ehler's Danlos syndrome],0.055,0,0.0,0.0,0.0,0.0,0.0,0.0,0.026,2.188,1.718,0.226,0.155,,2
LRP1,GE_972.2 [Hereditary ataxia],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.061,,5.633,1.049,0.502,0.907,3
MKKS,SO_380.3 [Optic atrophy],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.848,3.094,1.299,0.162,0.966,2
CBLB,BI_179.1 [Hypogammaglobulinemia NOS],0.054,0,0.0,0.0,0.654,0.0,0.0,0.0,0.0,3.432,2.281,0.274,0.208,0.862,3
CACNA1D,GE_972.1 [Hereditary neuropathy],0.054,1,3.0,0.0,0.0,0.0,0.268,0.0,0.018,1.89,2.795,0.795,0.405,,3
EIF2AK3,GE_973.5 [Huntington's disease],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.221,,0.387,0.178,0.091,,1
MDM2,GI_540.11 [Autoimmune hepatitis],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.114,1.91,0.256,0.272,0.081,,2
UQCRC2,GE_972.2 [Hereditary ataxia],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,1.919,0.17,0.194,0.174,0.968,3
TMEM108,MB_306 [Conduct disorders],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.153,3.475,2.046,0.137,0.05,,2
PIM1,SO_386.6 [Night blindness],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.186,0.075,,,0.107,2
MAP3K20,CV_414.1 [Hypertrophic cardiomyopathy],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,3.058,2.382,0.373,0.356,,2
ELOVL4,SO_386.6 [Night blindness],0.054,0,0.0,0.0,0.0,0.0,0.305,0.0,0.0,2.036,1.662,0.087,0.102,0.981,3
F9,CV_430.3 [Nontraumatic subdural hemorrhage],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.531,1.447,,0.138,,1
BMP2,GE_963.1 [Lipid storage disorders],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.05,2.586,0.205,0.101,0.085,0.162,3
BBS5,SO_386.6 [Night blindness],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,3.188,0.746,0.119,0.989,2
PTEN,SO_365.3 [Exophthalmos [Proptosis]],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.52,0.188,,0.111,0.99,2
IL13RA2,MS_700.3 [Systemic sclerosis],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.189,2.142,2.928,2.328,0.165,,2
GABRB3,BI_179.1 [Hypogammaglobulinemia NOS],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.399,0.122,0.034,0.072,0.136,2
SIX3,CV_433.3 [Cerebrovascular insufficiency],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.529,2.494,,0.019,0.212,2
HMGCR,GI_540.11 [Autoimmune hepatitis],0.054,1,4.0,0.0,0.0,0.0,0.0,0.0,0.026,1.6,2.081,0.433,0.267,,2
TUBA1B,GE_963.1 [Lipid storage disorders],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.362,,,0.189,1
RPS23,SO_380.3 [Optic atrophy],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.132,0.105,,,0.344,2
SIPA1L2,GE_972.1 [Hereditary neuropathy],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.05,2.393,4.682,2.057,0.42,,2
ARF1,GE_972.9 [Muscular dystrophy],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.086,,0.012,0.28,1
GRIA3,NS_323.3 [Motor neuron disease],0.054,1,2.0,0.0,0.0,0.0,0.0,0.0,0.061,2.792,1.689,0.083,0.037,0.365,3
SNAI2,GE_978.22 [Ehler's Danlos syndrome],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.061,2.186,0.07,,0.048,,2
OMA1,NS_323.3 [Motor neuron disease],0.054,0,0.0,0.0,0.426,0.0,0.0,0.0,0.018,1.836,2.213,0.424,0.232,0.038,4
CD86,MS_700.42 [Dermatomyositis],0.054,1,4.0,0.029,0.0,0.0,0.0,0.0,0.036,1.487,0.169,0.055,0.044,,3
TUBB2A,SO_386.5 [Color vision deficiencies],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.037,,,0.142,1
RBM22,GE_977.1 [Congenital ichthyosis],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.068,0.027,0.031,0.245,1
USP22,NS_341.1 [Cerebral palsy],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.952,0.113,,2.119,0.85,2
COL12A1,GE_972.9 [Muscular dystrophy],0.054,0,0.0,0.033,0.775,0.0,0.0,0.402,0.033,2.73,3.518,0.094,0.302,0.493,5
SLC4A4,CV_433.3 [Cerebrovascular insufficiency],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.024,3.075,3.225,0.547,0.166,0.163,3
DSCAM,NS_344.11 [Communicating hydrocephalus],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.089,3.105,1.668,0.266,0.11,,2
ROBO2,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.002,3.509,,0.124,0.2,2
PTHLH,EM_211.1 [Adrenal hyperfunction],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.04,3.124,0.192,0.036,0.074,,2
DDX17,CV_416.8 [Pre-excitation syndrome [Anomalous atrioventricular excitation]],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.221,3.319,,0.024,0.308,2
KIF4A,NS_344.11 [Communicating hydrocephalus],0.054,0,0.0,0.0,0.0,0.0,0.0,0.281,0.083,,3.141,0.09,0.052,,3
THBS1,MB_296.4 [Borderline personality disorder],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.195,3.208,3.062,,0.075,,2
ATG9A,GE_972.2 [Hereditary ataxia],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.165,1.798,2.201,0.969,0.194,0.364,3
ATXN2,NS_328.13 [Frontotemporal dementia [FTD]],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.252,,1.96,0.714,0.309,,2
SPP1,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.871,3.287,0.234,0.077,0.948,2
BMP2,MS_727.3 [Osteitis deformans [Paget's disease of bone]],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.062,4.207,0.512,0.161,0.176,,2
MAPK14,CV_433.3 [Cerebrovascular insufficiency],0.054,1,1.0,0.0,0.0,0.0,0.0,0.0,0.103,,0.91,0.06,0.075,0.987,2
PRKCH,CV_433.3 [Cerebrovascular insufficiency],0.054,0,0.0,0.0,0.304,0.0,0.0,0.129,0.03,2.225,3.377,0.949,1.557,0.212,4
NLGN4X,CM_772.2 [Congenital hypothyroidism],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.024,2.186,2.441,,0.035,,2
ARIH1,CM_763.13 [Patent ductus arteriosus],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.148,,0.016,0.219,1
ZEB2,GE_972.9 [Muscular dystrophy],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.036,1.955,0.169,0.072,1.838,0.249,3
RPS29,SO_369.62 [Keratoconus],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.959,0.043,,,0.12,2
COL4A1,SO_369.62 [Keratoconus],0.054,0,0.0,0.0,0.0,0.0,0.0,0.281,0.096,2.406,2.948,0.497,0.309,0.514,4
SIAH1,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.011,0.055,,,0.093,2
ANGPT2,GI_540.11 [Autoimmune hepatitis],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.103,1.632,1.986,0.155,0.192,,2
SMARCA4,DE_663.1 [Pemphigus],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.608,1.728,0.406,0.101,0.105,,2
ZNF687,MS_727.3 [Osteitis deformans [Paget's disease of bone]],0.054,0,0.0,0.0,0.0,0.0,0.0,0.697,0.101,,2.269,0.034,0.083,,3
KCNV1,CV_433.3 [Cerebrovascular insufficiency],0.054,1,3.0,0.0,0.0,0.0,0.0,0.0,0.0,1.833,0.074,,0.066,0.108,2
PSMC4,SO_386.5 [Color vision deficiencies],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.055,,0.092,0.134,1
PSMD14,GE_977.1 [Congenital ichthyosis],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.228,3.876,,0.023,0.19,2
EGR3,NS_335.3 [Neuralgic amyotrophy],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.601,0.077,,2.797,,1
CUL1,SO_369.62 [Keratoconus],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.737,0.184,,0.069,0.242,2
DNMT3A,NS_339.2 [Myotonic disorders],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.116,2.583,2.852,0.169,0.158,,2
ZMAT1,SO_380.3 [Optic atrophy],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.69,3.307,,0.06,0.103,2
KCNQ2,MB_302.1 [Speech and language developmental delay],0.054,0,0.0,0.0,0.0,0.0,0.403,0.0,0.054,,2.381,0.163,0.13,0.764,4
INSR,EM_209.4 [Diabetes insipidus],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.195,1.756,0.145,0.117,0.9,3
CACNA1A,MB_302.1 [Speech and language developmental delay],0.054,0,0.0,0.0,0.0,0.0,0.381,0.0,0.029,3.484,3.059,0.123,0.112,0.926,4
EYA2,SO_369.62 [Keratoconus],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,3.036,1.014,0.255,0.767,0.153,3
STAT5A,BI_179.1 [Hypogammaglobulinemia NOS],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.39,3.419,0.312,0.145,0.977,2
NOTCH1,GU_580.52 [Diffuse membranous glomerulonephritis],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.109,2.189,3.018,0.339,0.226,,2
GATA3,GE_977.6 [Congenital cutaneous mastocytosis*],0.054,0,0.0,0.0,0.0,0.0,0.25,0.0,0.121,1.951,0.103,0.114,0.044,,3
HBG1,GE_970.2 [Thalassemia],0.054,1,2.0,0.0,0.0,0.0,0.0,0.534,0.012,,2.436,2.436,0.147,,3
TP53,MS_700.3 [Systemic sclerosis],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.381,,2.938,2.338,0.116,,2
RPL18A,GE_963.1 [Lipid storage disorders],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.462,0.142,,,0.141,2
SMAD7,SO_369.62 [Keratoconus],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.076,3.761,1.082,0.237,0.118,0.258,3
PCDH15,GE_972.1 [Hereditary neuropathy],0.054,0,0.0,0.0,0.0,0.0,0.535,0.0,0.018,3.479,3.368,2.057,0.303,,3
VEGFA,GE_963.1 [Lipid storage disorders],0.054,0,0.0,0.0,0.0,0.0,0.255,0.0,0.151,2.126,1.948,0.103,0.079,0.423,4
DPM2,SO_380.3 [Optic atrophy],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,1.093,0.066,0.068,0.962,1
KCNK9,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.826,0.107,0.043,0.084,0.155,2
ATXN2,NS_343.6 [Multi-system degeneration of the autonomic nervous system*],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.213,,4.005,1.806,0.132,,2
CHRNA4,NS_323.3 [Motor neuron disease],0.054,0,0.0,0.0,0.785,0.0,0.0,0.132,0.07,2.321,3.262,0.722,0.27,0.21,4
LCT,MS_700.3 [Systemic sclerosis],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.101,1.4,2.808,0.28,1.738,,2
HMGB1,NS_323.3 [Motor neuron disease],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.108,2.186,2.022,0.129,,0.632,3
DHX15,MB_302.1 [Speech and language developmental delay],0.054,0,0.0,0.0,0.0,0.0,0.0,0.129,0.0,2.714,0.2,,0.029,0.239,3
BEX5,SO_381.5 [Vertical strabismus],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.053,,2.958,,1
TAC1,DE_663.2 [Pemphigoid],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.123,2.447,0.115,0.117,0.1,,2
HDAC4,NS_328.13 [Frontotemporal dementia [FTD]],0.054,0,0.0,0.0,0.0,0.0,0.329,0.0,0.025,2.524,2.671,0.301,0.225,,3
TGFB2,SO_365.3 [Exophthalmos [Proptosis]],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.321,2.689,0.395,0.158,0.907,3
IFNA2,BI_179.1 [Hypogammaglobulinemia NOS],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.091,0.046,0.02,0.964,1
ADRB1,MS_727.3 [Osteitis deformans [Paget's disease of bone]],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,3.176,3.985,0.05,0.075,,2
EFEMP1,GE_976.5 [Polycystic kidney disease],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.061,1.65,2.508,0.203,0.168,,2
TOMM70,GI_540.11 [Autoimmune hepatitis],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.021,3.87,0.212,0.179,0.163,,2
AZIN1,GI_540.11 [Autoimmune hepatitis],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.067,2.532,2.414,0.103,0.131,,2
VWF,MS_700.42 [Dermatomyositis],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.252,1.948,3.591,0.54,0.223,,2
DSP,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.036,2.081,3.511,0.407,1.656,0.241,3
UBE2N,SO_369.62 [Keratoconus],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.044,,,0.146,1
RAD51C,GE_972.2 [Hereditary ataxia],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.27,2.277,3.368,2.732,0.167,0.688,3
MAPK8IP1,CV_433.3 [Cerebrovascular insufficiency],0.054,1,1.0,0.0,0.0,0.0,0.0,0.0,0.142,1.432,3.015,0.135,0.135,0.108,3
KCNQ2,GE_961.1 [Phakomatoses],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.04,1.991,3.535,0.16,0.122,0.174,3
ENPP2,GI_540.11 [Autoimmune hepatitis],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.198,1.927,3.496,1.013,0.297,,2
HRAS,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,1.799,1.738,0.102,0.986,2
DNM1L,GE_973.5 [Huntington's disease],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.424,,0.128,0.107,0.065,,1
POSTN,RE_484.1 [Spontaneous pneumothorax],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.147,0.897,0.477,0.2,0.968,2
ADCY1,CM_770.5 [Congenital osteodystrophies],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.067,3.34,2.594,0.054,1.885,0.219,3
MDGA2,CM_770.5 [Congenital osteodystrophies],0.054,0,0.0,0.0,0.0,0.0,0.271,0.0,0.061,2.358,2.439,,0.042,0.253,4
DDR2,GU_580.1 [Acute nephritic syndrome],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.064,1.467,2.851,0.451,0.184,0.343,3
TUBA4A,NS_328.13 [Frontotemporal dementia [FTD]],0.054,0,0.0,0.011,0.0,0.0,0.0,0.0,0.11,,0.073,0.042,0.117,,2
THBS1,MS_704.1 [Polyarteritis nodosa and related conditions],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.122,4.919,1.936,,0.057,,2
RPS29,GE_961.1 [Phakomatoses],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.566,2.415,,,0.2,2
INS,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.1,,0.048,0.985,1
RPL7,RE_484.1 [Spontaneous pneumothorax],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.174,2.545,,,0.142,2
DHX15,CV_413.41 [Pulmonary valve stenosis],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.23,0.1,,0.022,0.289,2
CYP2B6,MS_727.5 [Cyst of bone],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.109,1.87,2.475,0.183,0.908,,2
HACE1,NS_341.1 [Cerebral palsy],0.054,0,0.0,0.0,0.862,0.0,0.0,0.525,0.035,3.121,3.216,0.161,0.194,0.479,4
SSBP3,EM_209.4 [Diabetes insipidus],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.42,1.847,,,0.247,2
CAMK4,GE_972.2 [Hereditary ataxia],0.054,0,0.0,0.0,0.0,0.0,0.311,0.503,0.014,1.923,2.322,1.238,0.171,0.713,5
RNASEH2B,GE_963.1 [Lipid storage disorders],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.148,1.862,0.197,0.157,0.907,2
IQCB1,SO_386.5 [Color vision deficiencies],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,1.31,0.168,0.089,0.111,0.992,3
PPIA,SO_386.5 [Color vision deficiencies],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.091,0.047,0.018,0.198,1
BMP4,GI_540.11 [Autoimmune hepatitis],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.088,2.485,2.744,0.314,0.112,,2
DLL1,CV_414.1 [Hypertrophic cardiomyopathy],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.024,1.562,2.487,1.074,0.22,0.082,3
HRAS,SO_365.3 [Exophthalmos [Proptosis]],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.193,0.241,0.144,0.969,1
MAX,SO_386.5 [Color vision deficiencies],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,1.51,0.077,0.031,0.073,0.276,3
CYP19A1,CM_770.5 [Congenital osteodystrophies],0.054,1,2.0,0.0,0.0,0.0,0.361,0.0,0.046,1.901,0.21,0.188,0.13,0.858,4
JAZF1,GE_970.1 [Sickle-cell disorders],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,1.979,0.106,0.019,0.094,,2
PDHA1,CV_414.1 [Hypertrophic cardiomyopathy],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,1.925,0.159,0.105,0.998,2
SNRPD2,RE_484.1 [Spontaneous pneumothorax],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.049,0.098,,,0.336,2
ALB,MS_712.51 [Hypermobility syndrome],0.054,0,0.0,0.0,0.0,0.0,0.0,0.362,0.232,,3.083,0.559,0.178,,3
PAX3,GE_972.2 [Hereditary ataxia],0.054,0,0.0,0.281,0.0,0.0,0.0,0.0,0.03,2.731,1.117,0.411,0.158,0.628,4
VDR,MS_727.3 [Osteitis deformans [Paget's disease of bone]],0.054,1,3.0,0.0,0.0,0.0,0.337,0.0,0.078,2.467,2.319,0.302,0.138,,3
CDKN1A,CV_413.41 [Pulmonary valve stenosis],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.403,4.132,0.069,0.04,0.952,2
JAK2,GE_971.14 [Von Willebrand's disease],0.054,0,0.0,0.0,0.0,0.0,0.448,0.0,0.023,2.065,2.68,1.467,0.197,,3
ADCY1,"EM_209.11 [Tall stature, acromegaly and gigantism]",0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.07,2.302,2.648,0.051,0.092,,2
PSMC4,GE_972.9 [Muscular dystrophy],0.054,1,1.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.063,,0.095,0.29,1
GHR,MS_705.2 [Juvenile rheumatoid arthritis [JRA/JIA]],0.054,1,3.0,0.0,0.0,0.0,0.0,0.0,0.164,1.703,2.622,0.389,0.112,,2
IFIH1,MS_727.5 [Cyst of bone],0.054,0,0.0,0.0,0.0,0.0,0.0,0.802,0.181,2.574,2.446,1.436,0.475,,3
EDNRB,RE_464.2 [Chronic nasopharyngitis],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.091,2.173,0.413,0.089,0.08,,2
ATP7B,GE_972.2 [Hereditary ataxia],0.054,0,0.0,0.0,0.772,0.0,0.261,0.37,0.0,1.365,4.168,2.15,0.542,0.657,4
HIF1A,CM_763.31 [Ventricular septal defect],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.069,2.058,0.227,1.648,0.975,2
SDHC,GE_961.1 [Phakomatoses],0.054,0,0.0,0.0,0.0,0.0,0.0,0.402,0.026,,0.124,0.186,0.077,0.992,3
NRXN1,GE_963.1 [Lipid storage disorders],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.024,2.844,2.629,0.551,0.13,0.064,3
PAXIP1,SO_386.5 [Color vision deficiencies],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.654,2.5,0.045,0.019,0.281,2
DOCK8,BI_179.1 [Hypogammaglobulinemia NOS],0.054,0,0.0,0.0,0.758,0.0,0.0,0.0,0.012,2.908,3.832,0.627,0.334,0.927,4
C3,GI_542.8 [Biliary cirrhosis],0.054,0,0.0,0.0,0.0,0.0,0.269,0.0,0.261,2.054,2.681,0.524,0.233,,3
HADH,CV_414.1 [Hypertrophic cardiomyopathy],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.442,1.944,0.524,0.241,0.951,2
ITGB8,CV_414.1 [Hypertrophic cardiomyopathy],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.067,,3.59,2.642,0.225,0.068,3
BEAN1,GE_972.2 [Hereditary ataxia],0.054,0,0.0,0.0,0.426,0.0,0.431,0.0,0.029,,2.129,1.719,0.098,,4
FAF1,NS_323.3 [Motor neuron disease],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.033,3.73,2.536,0.154,0.194,0.229,3
PPP2R2A,GE_977.1 [Congenital ichthyosis],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.685,0.064,,0.015,0.265,2
DNMT1,CV_433.3 [Cerebrovascular insufficiency],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.056,2.317,2.842,0.181,1.17,0.854,3
MYO1A,SO_369.62 [Keratoconus],0.054,0,0.0,0.0,0.0,0.0,0.359,0.0,0.03,,2.373,0.429,0.387,0.164,4
CD180,MS_700.3 [Systemic sclerosis],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.176,2.862,2.756,0.131,0.155,,2
TUBA1B,CV_433.3 [Cerebrovascular insufficiency],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.777,,,0.333,2
SBF1,CV_433.3 [Cerebrovascular insufficiency],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.883,3.99,,0.1,0.294,2
ABCA13,NS_328.13 [Frontotemporal dementia [FTD]],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.122,1.802,4.837,1.079,0.375,,2
ATG5,GE_972.2 [Hereditary ataxia],0.054,0,0.0,0.0,0.547,0.0,0.0,0.0,0.064,1.394,0.51,0.079,0.102,0.741,4
RAB24,SO_386.5 [Color vision deficiencies],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.328,0.065,,0.03,0.225,2
COX6A2,CV_416.8 [Pre-excitation syndrome [Anomalous atrioventricular excitation]],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.628,0.267,0.087,0.905,2
MSC,GE_972.9 [Muscular dystrophy],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.185,3.771,0.026,0.062,0.134,2
GRIN2B,SO_380.3 [Optic atrophy],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.082,2.788,,,0.956,2
PRLR,"EM_209.11 [Tall stature, acromegaly and gigantism]",0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.104,2.229,1.73,1.884,0.118,,2
HMGA1,SO_380.3 [Optic atrophy],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.049,,,0.341,1
EDNRA,GE_961.1 [Phakomatoses],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.176,,0.545,0.079,0.108,0.316,2
KPNB1,NS_333.4 [Circadian rhythm sleep disorder],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.183,,,0.338,1
DNAJB4,NS_323.3 [Motor neuron disease],0.054,0,0.0,0.0,0.0,0.0,0.508,0.0,0.023,2.035,0.811,0.14,0.116,0.097,4
WNT3A,MS_700.3 [Systemic sclerosis],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.109,1.4,2.353,0.064,0.176,,2
RFWD3,BI_162.1 [Constitutional (hereditary) aplastic anemia],0.054,0,0.0,0.0,0.0,0.0,0.0,0.402,0.105,2.073,0.456,0.099,0.13,,3
BARD1,NS_344.2 [Benign intracranial hypertension],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.724,2.132,0.279,0.139,0.913,2
YAP1,GE_972.2 [Hereditary ataxia],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.122,1.774,2.751,1.213,0.157,0.84,3
KCNMA1,RE_464.2 [Chronic nasopharyngitis],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.039,2.359,2.543,0.174,0.114,,2
SNRPE,BI_179.1 [Hypogammaglobulinemia NOS],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.761,0.068,,,0.207,2
UBE2D2,CM_750.16 [Arnold-Chiari syndrome*],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.048,,0.006,0.263,1
NFIA,MS_705.2 [Juvenile rheumatoid arthritis [JRA/JIA]],0.054,0,0.0,0.156,0.0,0.0,0.0,0.0,0.049,2.017,0.255,0.097,0.079,,3
CD14,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.665,1.092,0.134,2.295,0.922,2
MAGEB6,GI_516.1 [Pyloric stenosis],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.726,3.647,,0.042,0.084,2
VCAM1,SO_365.3 [Exophthalmos [Proptosis]],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.105,1.904,1.108,0.144,1.187,0.838,3
DACH1,BI_179.1 [Hypogammaglobulinemia NOS],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.348,1.73,,0.026,0.272,2
SLC40A1,GE_970.1 [Sickle-cell disorders],0.054,1,2.0,0.0,0.0,0.0,0.357,0.0,0.084,2.595,2.491,0.022,0.106,,3
NLRP3,NS_344.11 [Communicating hydrocephalus],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.653,1.994,0.641,0.05,0.078,,2
SOD2,GE_972.2 [Hereditary ataxia],0.054,0,0.0,0.0,0.0,0.0,0.3,0.0,0.102,,0.203,0.164,0.105,0.976,3
TGFBR2,NS_344.2 [Benign intracranial hypertension],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.955,2.759,0.236,0.113,0.977,2
STON2,SO_369.62 [Keratoconus],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.255,1.744,2.631,0.288,0.583,0.074,3
FLNA,GE_978.22 [Ehler's Danlos syndrome],0.054,0,0.0,0.0,0.0,0.0,0.0,0.125,0.125,,1.845,0.8,0.165,,3
NPEPPS,NS_323.3 [Motor neuron disease],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.061,,0.839,0.187,0.193,0.189,2
KCNV1,GU_580.1 [Acute nephritic syndrome],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.62,0.069,,0.077,0.071,2
RPS5,GE_972.9 [Muscular dystrophy],0.054,1,4.0,0.0,0.0,0.0,0.0,0.0,0.03,,0.17,0.059,0.04,0.312,2
PVALB,GE_972.2 [Hereditary ataxia],0.054,0,0.0,0.072,0.0,0.0,0.0,0.0,0.032,1.959,0.101,0.076,0.081,0.955,4
HLA-A,NS_344.2 [Benign intracranial hypertension],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,4.579,0.975,0.09,0.921,2
YARS1,GE_972.1 [Hereditary neuropathy],0.054,0,0.0,0.0,0.0,0.0,0.0,0.657,0.072,,2.679,0.246,0.272,,3
MEIS2,DE_663.2 [Pemphigoid],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.055,3.32,1.96,0.096,1.578,,2
EP300,CV_438.41 [Aortic dissection],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,2.777,2.577,1.167,0.233,0.869,3
PITX2,"MB_280.4 [Sedative, hypnotic, or anxiolytic related disorders]",0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.072,2.953,1.556,0.13,0.084,,2
NFE2L2,GE_972.9 [Muscular dystrophy],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.121,2.403,0.352,0.124,2.376,0.753,3
RAB35,MS_728.2 [Osteochondritis dissecans],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.836,0.073,,2.392,,1
NLRP3,MS_728.2 [Osteochondritis dissecans],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.085,1.926,1.29,0.109,0.137,,2
YTHDF3,CM_763.13 [Patent ductus arteriosus],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.388,0.04,,0.011,0.225,2
MEMO1,SO_380.3 [Optic atrophy],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.031,0.112,,0.074,0.146,2
SEZ6L,CV_433.3 [Cerebrovascular insufficiency],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,2.644,3.172,0.135,0.217,0.09,3
CSF1,MS_705.2 [Juvenile rheumatoid arthritis [JRA/JIA]],0.054,0,0.0,0.0,0.0,0.359,0.0,0.0,0.385,2.368,3.498,0.023,0.04,,2
VAMP2,CM_751.213 [Congenital cataract],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.191,,0.017,0.326,1
MUC2,DE_663.2 [Pemphigoid],0.054,0,0.0,0.0,0.0,0.0,0.275,0.0,0.2,1.585,2.918,0.117,0.153,,3
ADRB1,"MB_280.4 [Sedative, hypnotic, or anxiolytic related disorders]",0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,1.667,2.21,0.032,0.044,,2
TRIM8,GU_580.51 [Focal and segmental glomerular lesions*],0.054,0,0.0,0.0,0.0,0.0,0.0,0.43,0.217,,1.153,0.142,0.034,,2
PRPH2,GE_974.3 [Hereditary choroidal dystrophies],0.054,0,0.0,0.0,0.0,0.0,0.637,0.574,0.111,,0.135,0.023,0.025,,3
CALU,NS_339.2 [Myotonic disorders],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.036,2.277,0.076,0.095,0.056,,2
ADGRB2,NS_341.1 [Cerebral palsy],0.054,0,0.0,0.0,0.547,0.0,0.0,0.0,0.024,1.864,3.072,0.314,0.167,,3
COL4A2,NS_347.1 [Cerebral cysts],0.054,0,0.0,0.0,0.0,0.0,0.0,0.719,0.066,2.937,2.689,0.424,0.372,,3
NR2E1,CV_414.1 [Hypertrophic cardiomyopathy],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.864,0.319,,0.097,0.137,2
HK1,DE_669.2 [Behcet's syndrome],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.728,0.108,0.133,0.122,,2
KIF5C,GE_961.1 [Phakomatoses],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,1.561,3.266,2.643,0.163,0.184,3
CD74,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,1.905,0.064,0.099,0.978,2
ACHE,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.054,1,3.0,0.0,0.0,0.0,0.29,0.0,0.093,,3.336,1.227,0.166,0.588,4
KLHL2,CM_770.5 [Congenital osteodystrophies],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,1.903,1.768,0.05,0.095,0.13,3
SH3PXD2B,GE_978.3 [Osteochondrodysplasias],0.054,0,0.0,0.0,0.0,0.0,0.269,0.0,0.129,2.149,2.367,0.292,0.148,,3
BRINP3,NS_333.4 [Circadian rhythm sleep disorder],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,2.258,3.641,1.791,1.513,0.036,3
ARRB1,EM_209.4 [Diabetes insipidus],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.387,2.819,0.17,1.843,0.914,2
RELA,GE_972.9 [Muscular dystrophy],0.054,1,3.0,0.0,0.0,0.0,0.0,0.0,0.101,,2.747,0.05,0.067,0.581,3
FN1,MS_700.3 [Systemic sclerosis],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.191,3.022,3.002,0.348,0.126,,2
PTK2,CV_433.3 [Cerebrovascular insufficiency],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.034,2.121,0.248,0.313,1.113,0.826,3
TLR7,MS_704.2 [Wegener's granulomatosis],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.091,2.394,0.89,0.085,0.078,,2
ABL1,CV_438.41 [Aortic dissection],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.192,1.754,0.247,0.226,0.551,3
SCN1A,CV_416.8 [Pre-excitation syndrome [Anomalous atrioventricular excitation]],0.054,1,4.0,0.0,0.0,0.0,0.445,0.0,0.0,,2.357,0.361,0.583,0.371,3
ADAR,GE_961.1 [Phakomatoses],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,1.955,2.806,0.218,0.213,0.313,3
DKK2,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.122,2.537,2.056,0.196,0.1,0.118,3
FOXP2,GE_961.1 [Phakomatoses],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,2.706,2.447,0.435,0.169,0.405,3
SIRPA,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.073,1.905,1.663,0.285,0.091,0.874,3
TREM1,DE_663.1 [Pemphigus],0.054,0,0.0,0.0,0.0,0.0,0.429,0.0,0.064,3.534,0.189,0.065,0.063,,3
FBXL4,GE_972.2 [Hereditary ataxia],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.084,1.704,0.463,0.189,0.965,2
GLE1,NS_323.3 [Motor neuron disease],0.054,0,0.0,0.0,0.862,0.0,0.0,0.443,0.084,,2.118,0.712,0.38,0.399,4
CDH2,GI_540.11 [Autoimmune hepatitis],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.061,3.35,2.399,0.109,0.226,,2
TP53,SO_373.2 [Choroidal degenerations],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.114,2.032,3.462,0.085,0.068,,2
KLF2,SO_380.3 [Optic atrophy],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.028,0.259,,0.028,0.17,2
ERH,CM_770.5 [Congenital osteodystrophies],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.597,0.096,,0.021,0.212,2
DHX30,CV_414.1 [Hypertrophic cardiomyopathy],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.102,1.399,3.195,0.276,0.148,0.253,3
GAS1,SO_380.3 [Optic atrophy],0.054,0,0.0,0.0,0.0,0.0,0.265,0.0,0.0,2.943,1.927,0.03,0.045,0.205,3
TMEM158,CM_770.5 [Congenital osteodystrophies],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,,2.673,0.044,0.042,0.236,3
CCL2,BI_179.1 [Hypogammaglobulinemia NOS],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.272,,0.038,0.981,1
PRKAA1,NS_323.3 [Motor neuron disease],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.017,4.667,0.724,0.27,0.225,0.309,3
THBD,DE_669.2 [Behcet's syndrome],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.131,2.0,2.6,0.055,0.045,,2
PTPN6,DE_663.2 [Pemphigoid],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.179,,0.563,0.446,0.127,,1
SNAI2,SO_380.3 [Optic atrophy],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.336,0.127,,0.081,0.229,2
MAG,GE_972.1 [Hereditary neuropathy],0.054,0,0.0,0.0,0.0,0.0,0.306,0.0,0.244,2.137,2.356,0.615,0.202,,3
DNMT3B,GI_540.11 [Autoimmune hepatitis],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.061,1.631,1.683,0.201,1.08,,2
CARM1,NS_323.3 [Motor neuron disease],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.05,1.674,1.786,0.047,0.14,0.015,3
COL5A2,GE_978.22 [Ehler's Danlos syndrome],0.054,0,0.0,0.0,0.0,0.0,0.0,0.783,0.122,1.506,3.103,0.814,1.356,,3
CNR1,MB_293.1 [Anorexia nervosa],0.054,1,3.0,0.0,0.0,0.0,0.0,0.0,0.083,2.803,0.191,0.137,0.153,,2
VEGFC,CV_414.1 [Hypertrophic cardiomyopathy],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.059,3.35,1.393,,0.041,0.279,3
GPAT4,CV_413.42 [Pulmonary valve insufficiency*],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.545,0.411,,0.208,,1
SCN1A,SO_380.3 [Optic atrophy],0.054,0,0.0,0.0,0.0,0.0,0.257,0.0,0.036,2.046,3.283,0.34,0.73,0.983,4
MSI2,NS_323.3 [Motor neuron disease],0.054,0,0.0,0.032,0.0,0.0,0.0,0.0,0.035,2.46,2.392,0.18,0.159,0.159,4
NR3C1,DE_663.2 [Pemphigoid],0.054,1,4.0,0.0,0.0,0.0,0.0,0.0,0.062,1.682,2.821,0.19,0.125,,2
TOP2A,MS_700.3 [Systemic sclerosis],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.077,,2.736,0.341,0.211,,2
GAD1,GU_580.52 [Diffuse membranous glomerulonephritis],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.097,2.2,0.304,0.051,0.099,,2
GAD1,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.041,2.376,2.0,0.065,0.15,0.267,3
ELMO1,MS_700.3 [Systemic sclerosis],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,2.396,2.486,2.399,0.186,,2
TBX4,RE_484.1 [Spontaneous pneumothorax],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,2.142,3.73,2.206,0.18,0.245,3
GLI2,GE_972.2 [Hereditary ataxia],0.054,0,0.0,0.0,0.0,0.0,0.31,0.0,0.012,3.464,3.038,0.445,0.329,0.969,4
TOR1A,NS_323.3 [Motor neuron disease],0.054,0,0.0,0.0,0.0,0.0,0.265,0.0,0.032,2.808,2.268,0.785,1.077,0.103,4
GOLGB1,GE_978.3 [Osteochondrodysplasias],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.102,1.986,4.009,0.984,0.496,,2
FBN2,MS_712.51 [Hypermobility syndrome],0.054,0,0.0,0.0,0.0,0.0,0.0,0.369,0.012,2.151,2.939,0.714,0.233,,3
ADRB1,MS_705.2 [Juvenile rheumatoid arthritis [JRA/JIA]],0.054,0,0.0,0.037,0.0,0.0,0.0,0.0,0.012,1.904,1.923,0.035,0.029,,3
TP53BP2,GI_540.11 [Autoimmune hepatitis],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.231,1.656,2.957,0.112,1.923,,2
HBB,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.054,0,0.0,0.0,0.886,0.0,0.0,0.452,0.075,,2.127,1.922,0.051,0.997,4
PLXNB1,MS_700.3 [Systemic sclerosis],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.188,,3.191,0.639,0.622,,2
NDUFS8,NS_341.1 [Cerebral palsy],0.054,1,2.0,0.0,0.0,0.0,0.0,0.0,0.0,1.865,0.148,0.235,0.111,0.969,2
LOXL3,SO_369.62 [Keratoconus],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.021,1.993,2.506,0.373,0.299,0.195,3
FNIP1,CV_416.8 [Pre-excitation syndrome [Anomalous atrioventricular excitation]],0.054,0,0.0,0.0,0.426,0.0,0.0,0.151,0.018,,2.192,,0.08,0.51,4
IL23R,DE_669.2 [Behcet's syndrome],0.054,0,0.0,0.0,0.0,0.108,0.0,0.0,0.444,,4.465,0.628,0.071,,2
NRXN1,MB_305.1 [Tics and tic disorders],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.084,2.964,2.105,0.032,0.112,,2
DRD2,MB_302.1 [Speech and language developmental delay],0.054,1,3.0,0.0,0.0,0.0,0.0,0.0,0.04,,2.519,0.319,0.109,0.902,3
RAB24,RE_484.1 [Spontaneous pneumothorax],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.614,0.119,,0.081,0.095,2
EIF2B1,GE_963.1 [Lipid storage disorders],0.054,0,0.0,0.0,0.0,0.0,0.0,0.752,0.198,,0.147,0.121,0.08,0.739,3
PTK2,GE_976.5 [Polycystic kidney disease],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.128,2.081,4.075,0.149,1.903,,2
ACAA2,EM_208.1 [Hypoparathyroidism],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.782,3.967,2.456,0.578,0.93,2
COPS2,GE_977.1 [Congenital ichthyosis],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.601,0.043,,0.031,0.22,2
ABL1,NS_323.3 [Motor neuron disease],0.054,1,1.0,0.0,0.0,0.0,0.0,0.0,0.079,1.652,2.831,0.487,1.746,0.884,3
CSNK1A1,CV_416.8 [Pre-excitation syndrome [Anomalous atrioventricular excitation]],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.637,1.015,,,0.206,2
TNF,MB_293.2 [Bulimia nervosa],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.15,,2.543,2.543,0.057,,2
RPL36,NS_344.2 [Benign intracranial hypertension],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.261,0.04,,0.269,1
NDUFA10,CV_414.1 [Hypertrophic cardiomyopathy],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,2.42,3.265,0.458,0.306,0.998,3
ICAM1,SO_365.3 [Exophthalmos [Proptosis]],0.054,0,0.0,0.0,0.304,0.0,0.0,0.0,0.088,1.889,2.359,0.163,0.123,0.792,4
MAP3K5,GE_970.1 [Sickle-cell disorders],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.015,2.268,1.653,0.065,0.287,,2
NUP93,GE_972.2 [Hereditary ataxia],0.054,0,0.0,0.0,0.684,0.0,0.0,0.0,0.076,,2.71,0.383,0.224,0.458,4
CHAF1A,CM_751.213 [Congenital cataract],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.355,0.035,,0.31,2
RUNX1,GE_973.5 [Huntington's disease],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.198,2.171,2.708,0.153,0.063,,2
CNTNAP1,SO_380.3 [Optic atrophy],0.054,0,0.0,0.0,0.0,0.0,0.459,0.0,0.0,,3.523,0.971,0.724,0.76,3
DKK1,EM_208.1 [Hypoparathyroidism],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.747,0.972,1.042,1.827,0.909,2
TENM3,CM_751.213 [Congenital cataract],0.054,0,0.0,0.0,0.654,0.0,0.0,0.0,0.0,3.491,3.092,,0.103,0.214,3
FGF7,MS_712.51 [Hypermobility syndrome],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,2.111,0.089,0.045,0.099,,2
CHUK,GI_540.11 [Autoimmune hepatitis],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.334,,0.615,0.24,0.161,,1
VWF,MS_700.43 [Polymyositis],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.113,1.407,3.101,0.187,0.199,,2
PITX2,GE_972.9 [Muscular dystrophy],0.054,0,0.0,0.0,0.0,0.0,0.283,0.0,0.076,2.18,0.175,0.092,0.062,0.647,4
CRABP1,CM_770.5 [Congenital osteodystrophies],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.043,3.714,0.069,0.078,0.073,0.309,3
ADRA2A,MS_725.1 [Spinal osteochondrosis],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.387,2.909,0.021,0.043,,1
RRM2B,GE_964.3 [Glycogen storage disease],0.054,0,0.0,0.0,0.0,0.0,0.291,0.0,0.032,2.062,0.107,0.069,1.875,,3
NFKB1,CV_414.1 [Hypertrophic cardiomyopathy],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.132,1.613,1.555,0.209,0.21,0.872,3
TSN,EM_209.4 [Diabetes insipidus],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.827,0.068,,3.27,0.051,2
ITGA4,CV_414.1 [Hypertrophic cardiomyopathy],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.024,2.928,2.66,0.856,1.124,0.13,3
SPG7,SO_380.3 [Optic atrophy],0.054,0,0.0,0.0,0.841,0.0,0.0,0.434,0.049,1.805,4.066,0.612,0.218,0.929,4
STAT3,NS_323.3 [Motor neuron disease],0.054,1,0.5,0.0,0.0,0.0,0.0,0.0,0.083,,2.323,0.124,0.156,0.943,3
KIF26B,GE_972.2 [Hereditary ataxia],0.054,0,0.0,0.0,0.547,0.0,0.0,0.413,0.0,5.07,3.475,0.043,0.15,0.611,3
BECN1,GE_972.9 [Muscular dystrophy],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.047,2.918,2.397,0.2,1.843,0.779,3
KCNK9,DE_663.2 [Pemphigoid],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.024,3.354,0.122,0.035,0.076,,2
F3,GE_971.14 [Von Willebrand's disease],0.054,1,0.5,0.0,0.0,0.0,0.482,0.0,0.042,2.513,0.57,0.094,2.377,,3
BARD1,SO_365.3 [Exophthalmos [Proptosis]],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.75,2.328,0.552,0.308,0.914,2
TSPAN5,GU_580.1 [Acute nephritic syndrome],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.6,0.054,0.045,0.093,0.225,2
TIAL1,NS_333.4 [Circadian rhythm sleep disorder],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.508,0.045,,2.603,0.208,2
RAN,GU_580.1 [Acute nephritic syndrome],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,,0.071,,,0.193,2
CD69,GI_542.8 [Biliary cirrhosis],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.081,2.783,0.124,0.125,0.098,,2
PRKCA,GE_973.5 [Huntington's disease],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.079,4.469,0.201,0.045,0.049,,2
TNFSF10,MS_700.3 [Systemic sclerosis],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.224,2.151,2.849,0.172,0.125,,2
ZBTB16,GE_972.2 [Hereditary ataxia],0.054,0,0.0,0.058,0.0,0.0,0.418,0.0,0.018,3.357,2.265,0.249,0.145,0.361,5
RPS29,GI_516.1 [Pyloric stenosis],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.127,0.063,,,0.098,2
TMEM121B,GU_603.4 [Atrophy of testis],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.536,2.325,0.013,0.025,,1
NTRK2,MB_293.1 [Anorexia nervosa],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.07,3.196,1.889,0.123,1.561,,2
GNAZ,NS_333.4 [Circadian rhythm sleep disorder],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,1.575,,0.018,0.286,2
TET2,MS_704.1 [Polyarteritis nodosa and related conditions],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.231,2.497,3.657,0.083,0.939,,2
ATXN7,GU_580.1 [Acute nephritic syndrome],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.691,4.661,1.369,0.158,0.073,3
HMGCR,GE_978.22 [Ehler's Danlos syndrome],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.094,,0.766,0.707,0.119,,1
VWF,BI_168.12 [Hemorrhagic disorder due to intrinsic circulating anticoagulants],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.101,1.954,3.515,0.495,0.241,,2
PRG4,MS_725.1 [Spinal osteochondrosis],0.054,0,0.0,0.0,0.0,0.0,0.482,0.0,0.044,2.316,0.73,0.324,1.743,,3
CSNK2A2,GU_580.1 [Acute nephritic syndrome],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,2.144,0.674,,0.07,0.244,3
SLC6A4,NS_328.13 [Frontotemporal dementia [FTD]],0.054,1,4.0,0.0,0.0,0.0,0.0,0.0,0.046,,1.556,0.188,0.186,,2
IL1B,GE_978.3 [Osteochondrodysplasias],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.132,,1.856,0.097,0.048,,2
NLRP3,GI_540.11 [Autoimmune hepatitis],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.556,1.906,3.385,0.142,0.185,,2
LPAR1,NS_344.11 [Communicating hydrocephalus],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.041,2.832,0.048,0.023,0.048,,2
ADRA2A,SO_380.3 [Optic atrophy],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.205,2.992,0.034,0.052,0.3,2
REST,GE_972.2 [Hereditary ataxia],0.054,0,0.0,0.0,0.0,0.0,0.334,0.0,0.024,1.642,2.257,0.184,0.135,0.937,4
MYB,GE_964.3 [Glycogen storage disease],0.054,0,0.0,0.0,0.0,0.0,0.348,0.0,0.012,2.803,2.283,0.123,0.166,,3
HK1,BI_162.1 [Constitutional (hereditary) aplastic anemia],0.054,0,0.0,0.0,0.0,0.0,0.377,0.0,0.034,1.44,0.119,0.131,0.106,,3
TAAR1,"MB_280.4 [Sedative, hypnotic, or anxiolytic related disorders]",0.054,1,4.0,0.0,0.0,0.0,0.0,0.0,0.19,,2.309,0.223,0.099,,2
SCNN1A,EM_211.1 [Adrenal hyperfunction],0.054,1,4.0,0.012,0.732,0.0,0.0,0.0,0.061,1.344,2.408,1.708,0.215,,4
VPS4A,GE_972.2 [Hereditary ataxia],0.054,0,0.0,0.0,0.0,0.0,0.283,0.0,0.073,,1.905,0.081,0.141,0.443,4
YPEL2,MB_291.1 [Conversion disorder],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.97,0.078,,3.036,,1
NOS1,GE_972.2 [Hereditary ataxia],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.043,3.047,3.793,0.733,0.325,0.951,3
AMH,GE_972.2 [Hereditary ataxia],0.054,0,0.0,0.053,0.0,0.0,0.0,0.0,0.109,,2.799,0.218,0.151,0.28,4
SYNCRIP,NS_323.3 [Motor neuron disease],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.086,1.937,2.07,0.202,0.153,0.522,3
THBD,GE_978.22 [Ehler's Danlos syndrome],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.074,2.001,1.335,0.053,2.837,,2
BRD2,DE_663.2 [Pemphigoid],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.163,,2.337,0.311,0.164,,2
ZFP36L1,MS_705.2 [Juvenile rheumatoid arthritis [JRA/JIA]],0.054,0,0.0,0.0,0.0,0.4,0.0,0.0,0.038,2.114,0.11,,0.046,,2
ITGA8,GU_580.1 [Acute nephritic syndrome],0.054,0,0.0,0.0,0.532,0.0,0.0,0.0,0.065,2.628,0.658,0.12,0.442,0.443,4
CSNK1A1,NS_340.3 [Inflammatory and immune myopathies],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.094,1.935,0.307,,,,2
NLRP3,GE_973.5 [Huntington's disease],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.763,1.912,0.505,0.045,0.062,,2
TRPM6,MS_712.51 [Hypermobility syndrome],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.109,2.449,2.972,0.542,0.126,,2
KCNJ11,BI_179.1 [Hypogammaglobulinemia NOS],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.33,2.845,,0.036,0.314,2
LRRC3B,CV_430.3 [Nontraumatic subdural hemorrhage],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.925,0.166,,0.113,,1
PRMT8,CM_763.13 [Patent ductus arteriosus],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.517,0.073,0.013,0.037,0.288,2
RAD23B,RE_484.1 [Spontaneous pneumothorax],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.725,0.495,,0.131,0.189,2
SMARCA1,GE_961.1 [Phakomatoses],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.024,2.516,3.981,0.077,2.748,0.166,3
SDHAF2,NS_341.1 [Cerebral palsy],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.41,0.147,0.074,0.911,2
SLC6A4,NS_333.7 [Narcolepsy],0.054,1,4.0,0.0,0.0,0.0,0.0,0.0,0.018,2.897,0.222,0.111,0.117,,2
AR,GU_580.1 [Acute nephritic syndrome],0.054,1,1.0,0.0,0.0,0.0,0.0,0.0,0.018,3.611,1.883,,0.019,0.959,3
RPL17,EM_208.1 [Hypoparathyroidism],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.351,0.199,,,0.167,2
RPS11,GE_977.1 [Congenital ichthyosis],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.325,,0.013,0.337,1
PTCH1,CM_750.16 [Arnold-Chiari syndrome*],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.556,1.715,0.322,1.881,0.982,2
CORO2B,CM_770.5 [Congenital osteodystrophies],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.122,2.467,0.319,0.149,0.099,0.167,3
CDK5R1,NS_323.3 [Motor neuron disease],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.021,2.607,0.124,0.05,0.094,0.278,3
TP53,GE_978.22 [Ehler's Danlos syndrome],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.156,2.006,0.728,0.075,0.059,,2
MAU2,CV_414.1 [Hypertrophic cardiomyopathy],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.674,2.881,,0.102,0.165,2
ATP2B2,GE_977.1 [Congenital ichthyosis],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.073,2.328,1.664,0.133,0.124,0.206,3
CHST3,GE_978.3 [Osteochondrodysplasias],0.054,0,0.0,0.0,0.0,0.0,0.0,0.21,0.097,1.78,1.255,0.146,0.129,,3
NDUFA1,GI_540.11 [Autoimmune hepatitis],0.054,1,4.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.058,,3.143,,1
GAGE1,GU_617.1 [Incompetence of cervix uteri],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.058,,3.776,,1
ELK1,GE_973.5 [Huntington's disease],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.06,,4.185,,1
RBBP7,SO_381.5 [Vertical strabismus],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.059,,3.343,,1
RBBP7,NS_344.13 [(Idiopathic) normal pressure hydrocephalus],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.059,,3.102,,1
ARHGAP35,CV_433.3 [Cerebrovascular insufficiency],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,3.079,,0.024,0.227,2
ADM,GU_580.1 [Acute nephritic syndrome],0.054,0,0.0,0.0,0.0,0.0,0.331,0.0,0.084,4.195,2.526,0.046,0.069,0.642,4
SLC9A6,GE_972.2 [Hereditary ataxia],0.054,0,0.0,0.079,0.684,0.0,0.298,0.0,0.072,,3.007,2.95,0.122,0.882,6
MMP9,CV_413.41 [Pulmonary valve stenosis],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,3.586,1.116,0.113,0.965,2
POC1B,SO_380.3 [Optic atrophy],0.054,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.788,1.784,0.332,0.159,0.966,2
MSC,DE_666.4 [Dermatographic urticaria],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.74,3.528,0.015,0.049,,1
NR3C1,NS_323.3 [Motor neuron disease],0.053,1,2.0,0.0,0.0,0.0,0.0,0.0,0.041,2.003,1.803,0.298,1.026,0.646,3
TINF2,GE_972.2 [Hereditary ataxia],0.053,0,0.0,0.0,0.547,0.0,0.0,0.0,0.048,,1.859,0.079,0.117,0.574,4
SLC52A2,SO_380.3 [Optic atrophy],0.053,0,0.0,0.0,0.547,0.0,0.0,0.402,0.012,,2.767,0.333,0.14,0.282,4
COL6A3,GE_963.1 [Lipid storage disorders],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,2.85,2.708,0.101,0.251,0.201,3
ITSN1,MS_704.1 [Polyarteritis nodosa and related conditions],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.061,2.066,4.028,0.475,0.248,,2
AHI1,SO_381.5 [Vertical strabismus],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.199,2.411,3.877,0.606,0.174,,2
NBPF1,CV_441 [Arteriovenous malformation],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.091,1.87,2.658,1.05,0.089,,2
HDAC6,CV_433.3 [Cerebrovascular insufficiency],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.107,,3.907,0.126,0.113,0.617,3
PPP2R2A,CV_413.41 [Pulmonary valve stenosis],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.496,2.987,,0.011,0.31,2
KITLG,CM_770.5 [Congenital osteodystrophies],0.053,0,0.0,0.0,0.0,0.0,0.257,0.0,0.055,1.969,0.089,0.096,0.075,0.806,4
MAP1B,GI_516.1 [Pyloric stenosis],0.053,0,0.0,0.0,0.547,0.0,0.0,0.362,0.0,2.94,3.064,0.13,0.426,0.892,3
NAMPT,GE_978.3 [Osteochondrodysplasias],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.059,1.873,0.114,0.043,0.099,,2
PJA1,GE_973.5 [Huntington's disease],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.065,2.94,0.281,,0.012,,2
SRSF1,SO_386.6 [Night blindness],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.049,,,0.341,1
GH1,"EM_209.11 [Tall stature, acromegaly and gigantism]",0.053,0,0.0,0.0,0.0,0.0,0.438,0.0,0.285,1.448,1.433,0.129,0.044,,3
PDGFRB,GU_580.1 [Acute nephritic syndrome],0.053,1,2.0,0.0,0.0,0.0,0.0,0.0,0.13,1.902,3.281,1.138,1.383,0.883,3
EIF2AK3,CM_770.5 [Congenital osteodystrophies],0.053,0,0.0,0.0,0.894,0.0,0.0,0.0,0.062,,1.683,0.391,1.02,0.705,4
PRKCE,GE_977.6 [Congenital cutaneous mastocytosis*],0.053,1,4.0,0.0,0.0,0.0,0.0,0.0,0.036,1.994,1.661,0.055,0.057,,2
HDAC9,GI_540.11 [Autoimmune hepatitis],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.075,2.307,4.053,0.32,0.223,,2
CACNA2D2,NS_323.3 [Motor neuron disease],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,,1.983,0.467,0.294,0.029,3
CTDSP2,GU_580.1 [Acute nephritic syndrome],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.141,,0.117,0.082,1
RBBP4,GE_972.9 [Muscular dystrophy],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.464,,0.014,0.19,2
FGD5,GU_580.1 [Acute nephritic syndrome],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.061,2.921,3.328,0.33,1.027,0.085,3
AP2B1,RE_484.1 [Spontaneous pneumothorax],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.955,0.23,,0.085,0.202,2
SPCS2,CM_763.13 [Patent ductus arteriosus],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.038,0.039,0.028,0.287,1
PAX9,GE_978.3 [Osteochondrodysplasias],0.053,0,0.0,0.0,0.0,0.0,0.336,0.0,0.061,2.296,2.436,0.106,0.087,,3
UBE2E3,SO_369.62 [Keratoconus],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.021,0.082,,,0.134,2
CLDN5,GE_972.9 [Muscular dystrophy],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.036,2.112,0.163,0.028,0.05,0.469,3
AGPS,NS_323.3 [Motor neuron disease],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,1.427,3.552,0.146,0.211,0.099,3
NR3C1,MS_700.42 [Dermatomyositis],0.053,1,4.0,0.0,0.0,0.0,0.0,0.0,0.018,2.739,3.263,3.051,0.087,,2
ANGPT1,NS_339.2 [Myotonic disorders],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.061,3.209,0.128,0.102,0.063,,2
VPS29,CV_413.41 [Pulmonary valve stenosis],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.046,0.024,0.035,0.245,1
NOS3,GE_963.1 [Lipid storage disorders],0.053,0,0.0,0.0,0.182,0.0,0.276,0.0,0.21,,3.157,0.435,0.178,0.223,5
DLG4,CV_438.41 [Aortic dissection],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.278,,0.024,0.222,1
TFAP2A,MS_700.3 [Systemic sclerosis],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.064,1.767,0.151,0.092,0.128,,2
CHEK1,SO_365.3 [Exophthalmos [Proptosis]],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.072,0.4,1.085,0.963,2
RPL14,RE_484.1 [Spontaneous pneumothorax],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.026,2.235,,0.029,0.28,2
IL1R1,MS_700.3 [Systemic sclerosis],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.173,1.886,0.58,0.414,0.093,,2
DPYSL2,GE_961.1 [Phakomatoses],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.081,,1.556,0.114,0.153,0.394,3
FLNC,NS_323.3 [Motor neuron disease],0.053,0,0.0,0.0,0.426,0.0,0.406,0.0,0.0,,3.517,1.305,1.699,0.331,4
SHOX,GU_580.55 [Diffuse mesangiocapillary glomerulonephritis*],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.064,,3.58,,1
RRM2,NS_323.3 [Motor neuron disease],0.053,1,2.0,0.0,0.0,0.0,0.0,0.0,0.064,1.934,1.833,0.173,0.092,0.428,3
RAB8A,GE_963.1 [Lipid storage disorders],0.053,0,0.0,0.0,0.0,0.0,0.391,0.0,0.061,2.333,0.081,0.038,0.042,0.03,4
USP24,EM_209.4 [Diabetes insipidus],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.452,2.63,,0.087,0.124,2
NIPBL,GE_961.1 [Phakomatoses],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.108,1.847,1.92,0.253,0.217,0.538,3
GAS1,GE_978.3 [Osteochondrodysplasias],0.053,0,0.0,0.0,0.0,0.0,0.287,0.0,0.0,3.147,1.336,0.017,0.048,,2
NR5A2,BI_162.1 [Constitutional (hereditary) aplastic anemia],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.044,2.368,0.155,0.066,0.062,,2
ZMAT2,CM_763.13 [Patent ductus arteriosus],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.022,,0.013,0.23,1
ATG9A,CV_433.3 [Cerebrovascular insufficiency],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.128,3.117,2.301,0.449,1.363,0.115,3
KCNN3,MB_293.1 [Anorexia nervosa],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.07,2.991,0.579,0.061,0.08,,2
PTGS2,MS_700.42 [Dermatomyositis],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.158,1.394,0.081,0.071,0.083,,2
LRP1,GE_971.11 [Hereditary factor VIII deficiency [Hemophilia A]],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.135,,4.034,0.613,0.722,,2
TBC1D20,GE_972.2 [Hereditary ataxia],0.053,0,0.0,0.0,0.547,0.0,0.371,0.0,0.012,,2.897,0.142,0.168,0.293,5
CACNA1A,CV_433.3 [Cerebrovascular insufficiency],0.053,0,0.0,0.0,0.745,0.0,0.0,0.0,0.018,4.426,2.557,0.087,0.094,0.409,4
TSPAN5,CM_763.31 [Ventricular septal defect],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.736,0.038,0.045,0.093,0.152,2
UCHL1,GE_972.1 [Hereditary neuropathy],0.053,0,0.0,0.0,0.0,0.0,0.333,0.0,0.094,1.476,0.282,0.064,0.093,,3
SCN5A,GE_964.3 [Glycogen storage disease],0.053,1,1.0,0.0,0.0,0.0,0.436,0.0,0.042,2.113,3.005,0.554,0.371,,3
FGF19,GE_970.1 [Sickle-cell disorders],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.597,4.863,0.008,0.033,,1
CP,GE_966.2 [Disorders of porphyrin metabolism],0.053,0,0.0,0.0,0.0,0.0,0.291,0.0,0.049,2.612,0.365,0.073,0.047,,3
FHL2,CV_414.1 [Hypertrophic cardiomyopathy],0.053,0,0.0,0.0,0.732,0.0,0.0,0.129,0.626,2.055,3.547,2.164,0.176,0.439,4
NUP62,GU_580.1 [Acute nephritic syndrome],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.513,,0.02,0.217,2
KHDRBS1,NS_323.3 [Motor neuron disease],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.079,1.951,2.016,0.077,0.127,0.518,3
CHM,SO_369.62 [Keratoconus],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.694,1.505,0.184,0.127,0.99,2
PAX8,GU_580.1 [Acute nephritic syndrome],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.017,1.961,0.719,0.209,0.149,0.71,3
FGF10,CM_751.213 [Congenital cataract],0.053,0,0.0,0.0,0.0,0.0,0.417,0.0,0.0,2.884,0.55,,0.034,0.307,3
MEMO1,RE_484.1 [Spontaneous pneumothorax],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.788,0.16,,0.075,0.083,2
YPEL5,SO_369.62 [Keratoconus],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.458,0.04,,,0.124,2
DROSHA,NS_328.13 [Frontotemporal dementia [FTD]],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.097,2.452,3.58,0.471,0.236,,2
HMGB1,RE_477.2 [Hypersensitivity pneumonitis],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.07,2.797,1.713,0.107,,,2
RORA,NS_323.3 [Motor neuron disease],0.053,0,0.0,0.022,0.0,0.0,0.59,0.0,0.0,2.951,2.744,,,0.162,4
ERVW-1,NS_338.1 [Myasthenia gravis],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.073,2.415,,,,,2
RHOG,CM_750.16 [Arnold-Chiari syndrome*],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.264,,0.01,0.243,1
BMP1,CM_770.5 [Congenital osteodystrophies],0.053,0,0.0,0.0,0.0,0.0,0.0,0.676,0.178,2.24,2.424,0.029,0.091,0.866,4
LBR,GE_978.3 [Osteochondrodysplasias],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.23,3.027,2.795,0.394,0.131,,2
ADCY1,EM_211.1 [Adrenal hyperfunction],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.064,1.886,2.055,0.052,0.148,,2
WNT3,NS_328.13 [Frontotemporal dementia [FTD]],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,1.71,0.102,0.076,0.138,,2
SLC4A1,NS_323.3 [Motor neuron disease],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,1.547,3.204,0.809,0.289,0.055,3
ZNF362,CM_763.13 [Patent ductus arteriosus],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.768,0.332,,0.008,0.203,2
RPL13,GE_963.1 [Lipid storage disorders],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,3.911,,,0.321,2
STRAP,NS_323.3 [Motor neuron disease],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.024,2.175,2.736,0.104,0.146,0.098,3
RPS5,CM_750.16 [Arnold-Chiari syndrome*],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.464,0.129,0.044,0.032,0.217,2
SSBP3,SO_365.3 [Exophthalmos [Proptosis]],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.334,1.844,,,0.257,2
TNFRSF1B,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.053,0,0.0,0.0,0.426,0.0,0.0,0.0,0.015,2.957,2.034,0.037,0.071,0.928,4
KDM1A,GI_540.11 [Autoimmune hepatitis],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.602,1.52,2.175,0.143,0.171,,2
SCN1A,MS_712.51 [Hypermobility syndrome],0.053,1,4.0,0.0,0.0,0.0,0.0,0.0,0.108,,2.543,0.458,0.326,,2
BMP4,MS_700.3 [Systemic sclerosis],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.041,3.192,1.86,0.396,0.166,,2
HSP90B1,GE_972.2 [Hereditary ataxia],0.053,0,0.0,0.059,0.0,0.0,0.0,0.0,0.03,3.132,1.035,0.237,0.226,0.827,4
PPARGC1A,GE_966.2 [Disorders of porphyrin metabolism],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.089,1.979,2.149,0.056,0.086,,2
ANO5,MS_727.3 [Osteitis deformans [Paget's disease of bone]],0.053,0,0.0,0.0,0.0,0.0,0.374,0.0,0.033,2.87,2.9,0.355,0.364,,3
PNMA2,GE_963.1 [Lipid storage disorders],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.888,4.299,,0.025,0.094,2
VAMP2,SO_369.62 [Keratoconus],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.241,,0.02,0.212,1
CSNK1E,"MB_280.4 [Sedative, hypnotic, or anxiolytic related disorders]",0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,1.871,0.137,0.039,0.15,,2
SLC14A1,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.045,2.389,0.154,0.318,0.968,0.244,3
AUTS2,GE_972.2 [Hereditary ataxia],0.053,0,0.0,0.131,0.0,0.0,0.0,0.0,0.018,2.564,2.575,0.457,0.298,0.552,4
MAPK8IP1,SO_380.3 [Optic atrophy],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.024,,2.113,1.861,0.182,0.223,3
AP5Z1,NS_341.1 [Cerebral palsy],0.053,0,0.0,0.0,0.872,0.0,0.0,0.121,0.13,2.44,3.65,0.648,0.182,,3
ZFPM2,CV_413.41 [Pulmonary valve stenosis],0.053,0,0.0,0.0,0.547,0.0,0.295,0.0,0.021,2.714,2.208,0.356,0.102,0.857,5
GAS1,GE_961.1 [Phakomatoses],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.886,2.692,0.036,0.04,0.728,2
MYT1L,NS_323.3 [Motor neuron disease],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,4.069,2.954,0.309,0.823,0.06,3
MCU,CV_414.1 [Hypertrophic cardiomyopathy],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.061,,2.246,0.143,0.144,0.087,3
ITGB1,CM_770.5 [Congenital osteodystrophies],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,2.347,0.647,0.074,1.818,0.933,3
FGFR2,DE_663.1 [Pemphigus],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,2.868,0.512,0.127,0.094,,2
IFT172,GE_978.3 [Osteochondrodysplasias],0.053,0,0.0,0.0,0.0,0.0,0.287,0.452,0.012,,3.717,0.11,0.257,,4
RPL18A,GI_516.1 [Pyloric stenosis],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.549,,,0.18,2
CCR3,DE_669.2 [Behcet's syndrome],0.053,0,0.0,0.0,0.0,0.449,0.0,0.0,0.065,2.838,3.133,1.133,0.064,,2
NACC1,GU_580.1 [Acute nephritic syndrome],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.767,3.078,,0.087,0.093,2
KCNH7,MB_306 [Conduct disorders],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.103,4.631,2.181,0.318,0.114,,2
PKD1,GU_580.1 [Acute nephritic syndrome],0.053,0,0.0,0.0,0.0,0.0,0.617,0.628,0.052,3.809,4.142,0.45,0.043,0.462,5
NLGN4X,GE_961.1 [Phakomatoses],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.533,0.168,,0.048,0.234,3
GABRA1,MB_302.1 [Speech and language developmental delay],0.053,1,2.0,0.0,0.0,0.0,0.397,0.0,0.0,2.512,0.077,,0.086,0.763,3
UBE2L3,SO_386.5 [Color vision deficiencies],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.007,0.047,,,0.121,2
GLUL,SO_380.3 [Optic atrophy],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.015,2.237,0.133,0.05,0.086,0.691,3
RARA,NS_344.11 [Communicating hydrocephalus],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.249,,0.127,0.134,0.057,,1
CALR,MS_700.43 [Polymyositis],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.255,,2.343,0.089,0.071,,2
ADRA1D,EM_209.4 [Diabetes insipidus],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.079,2.212,3.942,2.391,1.809,,2
NDUFB5,GE_972.2 [Hereditary ataxia],0.053,1,4.0,0.0,0.0,0.0,0.0,0.0,0.0,1.706,0.137,0.076,0.125,0.872,2
PPARGC1A,MS_700.3 [Systemic sclerosis],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.137,3.005,1.858,0.667,0.42,,2
GABRA2,CM_763.31 [Ventricular septal defect],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.093,0.09,,0.099,0.283,2
SP4,MB_306 [Conduct disorders],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.059,2.032,2.284,0.064,0.089,,2
CACNA1C,NS_341.1 [Cerebral palsy],0.053,0,0.0,0.0,0.0,0.0,0.0,0.29,0.0,3.236,3.118,0.277,0.223,0.972,3
COL12A1,CM_770.5 [Congenital osteodystrophies],0.053,0,0.0,0.0,0.0,0.0,0.297,0.0,0.03,1.572,3.992,0.727,0.265,0.678,4
DYNLL2,CV_413.41 [Pulmonary valve stenosis],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.06,,,0.179,1
HDLBP,GE_977.1 [Congenital ichthyosis],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,3.818,,0.032,0.247,2
PTEN,CV_441 [Arteriovenous malformation],0.053,0,0.0,0.0,0.816,0.0,0.0,0.0,0.075,1.965,0.215,,0.113,0.994,4
GNE,GU_580.1 [Acute nephritic syndrome],0.053,0,0.0,0.0,0.0,0.0,0.313,0.0,0.036,2.288,0.909,0.313,0.209,0.091,4
GRN,MS_700.43 [Polymyositis],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.36,,3.246,0.14,0.089,,2
EPHA6,GU_580.51 [Focal and segmental glomerular lesions*],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.049,3.281,3.893,2.911,0.061,,2
SIX3,NS_344.2 [Benign intracranial hypertension],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.977,2.244,,0.018,0.285,2
MOB4,CM_763.31 [Ventricular septal defect],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.104,0.022,0.033,0.247,1
CRIM1,GU_580.1 [Acute nephritic syndrome],0.053,0,0.0,0.0,0.0,0.0,0.323,0.0,0.068,2.28,2.369,0.78,0.197,0.164,4
SLC37A4,GE_964.3 [Glycogen storage disease],0.053,0,0.0,0.0,0.0,0.0,0.289,0.856,0.055,,3.212,0.168,0.059,,4
AMMECR1L,CM_763.13 [Patent ductus arteriosus],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.153,0.024,0.03,0.191,1
RAP1A,SO_386.5 [Color vision deficiencies],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.158,0.089,,0.024,0.292,2
RPL35A,GE_972.9 [Muscular dystrophy],0.053,1,4.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.724,0.03,0.03,0.221,1
C4A,GI_540.11 [Autoimmune hepatitis],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.21,,2.763,0.142,0.12,,2
HMGCS2,NS_341.1 [Cerebral palsy],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.346,2.439,0.354,0.161,0.904,2
EGFR,GE_976.5 [Polycystic kidney disease],0.053,1,2.0,0.0,0.0,0.0,0.0,0.0,0.243,1.952,1.582,0.149,0.407,,2
RPS7,SO_386.5 [Color vision deficiencies],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.133,0.019,0.031,0.256,1
VWF,DE_663.2 [Pemphigoid],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.184,1.765,2.936,0.438,0.333,,2
XRCC2,CV_441 [Arteriovenous malformation],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.161,3.129,0.464,0.151,0.965,2
RREB1,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.852,3.397,0.261,0.319,0.21,3
APP,NS_341.1 [Cerebral palsy],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.027,4.061,2.995,0.971,0.205,0.997,3
UBE2N,CM_750.16 [Arnold-Chiari syndrome*],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.023,,,0.334,1
AIDA,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.111,,0.12,0.075,1
KIT,MB_296.4 [Borderline personality disorder],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.981,1.592,0.203,0.166,,2
RUVBL2,NS_333.4 [Circadian rhythm sleep disorder],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,3.62,,0.018,0.31,2
COL5A1,GE_977.1 [Congenital ichthyosis],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.061,3.236,,0.021,0.235,2
SSB,MS_704.1 [Polyarteritis nodosa and related conditions],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.24,,2.2,0.095,0.075,,2
RPS23,BI_179.1 [Hypogammaglobulinemia NOS],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.118,0.054,,,0.346,2
ICAM1,BI_179.1 [Hypogammaglobulinemia NOS],0.053,0,0.0,0.0,0.502,0.0,0.0,0.0,0.0,,2.933,0.108,2.548,0.967,3
PDE4C,CV_433.3 [Cerebrovascular insufficiency],0.053,1,4.0,0.0,0.0,0.0,0.0,0.0,0.0,4.872,,,,0.149,2
HNRNPC,CV_414.1 [Hypertrophic cardiomyopathy],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,1.92,0.116,,,0.098,3
ACAN,MS_725.1 [Spinal osteochondrosis],0.053,0,0.0,0.0,0.813,0.0,0.344,0.0,0.12,1.81,2.936,0.037,0.044,,4
HSPB1,GE_972.9 [Muscular dystrophy],0.053,0,0.0,0.0,0.547,0.0,0.0,0.0,0.045,,2.9,2.572,2.473,0.839,4
RPL18,GE_972.9 [Muscular dystrophy],0.053,1,4.0,0.0,0.0,0.0,0.0,0.0,0.0,,1.597,0.047,0.028,0.327,2
CXCL12,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.749,0.232,0.047,0.075,0.954,2
NFKB1,MS_712.51 [Hypermobility syndrome],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.083,2.057,1.887,0.551,0.17,,2
SLC1A6,GE_973.5 [Huntington's disease],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.04,2.186,2.854,2.774,0.068,,2
RPL11,CV_433.3 [Cerebrovascular insufficiency],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.822,0.18,,,0.314,2
NTN1,GI_540.11 [Autoimmune hepatitis],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.398,2.331,3.404,1.32,0.184,,2
PITX2,SO_380.3 [Optic atrophy],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.033,2.855,0.526,0.138,0.091,0.494,3
COA5,CV_414.1 [Hypertrophic cardiomyopathy],0.053,0,0.0,0.0,0.547,0.0,0.0,0.0,0.044,,0.361,0.066,0.081,0.988,3
CELF5,GI_516.1 [Pyloric stenosis],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.686,0.358,,0.118,0.11,2
PSMD1,GE_961.1 [Phakomatoses],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,2.442,3.013,0.092,0.149,0.172,3
COL4A1,MB_302.1 [Speech and language developmental delay],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,2.87,2.646,0.157,0.397,0.46,3
NR2E1,CV_416.8 [Pre-excitation syndrome [Anomalous atrioventricular excitation]],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.731,3.128,,0.072,0.107,2
MAP3K1,GI_542.8 [Biliary cirrhosis],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.061,2.923,3.488,3.11,0.292,,2
MTA1,CV_441 [Arteriovenous malformation],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.261,,2.773,0.206,0.161,0.268,3
ZMAT1,CM_751.213 [Congenital cataract],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.359,3.052,,0.069,0.102,2
CDH2,MS_727.3 [Osteitis deformans [Paget's disease of bone]],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.046,2.253,2.531,0.097,0.474,,2
ESPL1,CV_414.1 [Hypertrophic cardiomyopathy],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.043,,2.796,0.21,0.317,0.275,3
IL12A,MS_700.3 [Systemic sclerosis],0.053,0,0.0,0.0,0.0,0.434,0.0,0.0,0.04,1.563,0.845,,0.098,,2
TP53,CM_751.213 [Congenital cataract],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.094,,3.633,0.11,0.101,0.987,3
C9orf72,NS_328.13 [Frontotemporal dementia [FTD]],0.053,1,2.0,0.018,0.0,0.044,0.0,0.0,0.305,2.245,1.912,0.217,1.119,,3
DDX1,GE_972.2 [Hereditary ataxia],0.053,0,0.0,0.041,0.0,0.0,0.0,0.0,0.091,,1.6,0.333,0.201,0.55,4
ZNF800,CM_770.5 [Congenital osteodystrophies],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.292,,0.024,0.258,2
ADGRV1,MS_728.2 [Osteochondritis dissecans],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.109,1.556,3.567,0.847,0.475,,2
SPDYE3,GE_972.2 [Hereditary ataxia],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,3.395,1.915,0.068,1.0,2
CDH2,NS_344.13 [(Idiopathic) normal pressure hydrocephalus],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.353,3.04,2.947,1.043,2.298,,2
SUMO2,SO_386.6 [Night blindness],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.046,,,0.341,1
PCDHGC4,CM_750.16 [Arnold-Chiari syndrome*],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,1.908,,0.026,0.311,2
MKI67,GI_516.1 [Pyloric stenosis],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.808,3.003,0.179,0.354,0.976,2
UBE2E2,CV_414.1 [Hypertrophic cardiomyopathy],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.448,0.155,,0.11,0.169,2
HNRNPUL1,NS_323.3 [Motor neuron disease],0.053,0,0.0,0.0,0.426,0.0,0.0,0.0,0.087,,2.826,1.369,0.224,0.177,4
HRH2,NS_333.4 [Circadian rhythm sleep disorder],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.939,0.194,,0.076,0.143,2
PSIP1,MS_700.3 [Systemic sclerosis],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.07,2.053,1.88,0.447,0.141,,2
NEDD8,GE_972.9 [Muscular dystrophy],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.056,,0.017,0.283,1
MDGA2,CM_763.13 [Patent ductus arteriosus],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.023,3.668,,0.03,0.248,2
SLC6A2,GE_961.1 [Phakomatoses],0.053,1,4.0,0.0,0.0,0.0,0.0,0.0,0.018,1.414,2.898,0.333,0.163,0.108,3
CRB1,SO_369.62 [Keratoconus],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.165,1.647,3.45,0.274,0.159,1.0,3
SLC33A1,NS_341.1 [Cerebral palsy],0.053,0,0.0,0.0,0.772,0.0,0.0,0.451,0.031,1.718,2.981,0.893,1.743,0.964,4
SETDB1,GE_973.5 [Huntington's disease],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.218,,0.593,0.09,0.067,,1
VEGFA,MS_705.2 [Juvenile rheumatoid arthritis [JRA/JIA]],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.23,2.062,2.756,0.105,0.055,,2
MARK2,MB_302.1 [Speech and language developmental delay],0.053,0,0.0,0.0,0.0,0.0,0.0,0.129,0.012,1.966,3.279,0.117,0.143,0.619,4
ALB,MS_700.3 [Systemic sclerosis],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.101,,1.701,0.455,0.155,,2
KIT,GE_972.9 [Muscular dystrophy],0.053,1,0.5,0.0,0.0,0.0,0.0,0.0,0.012,2.835,2.454,0.128,0.126,0.902,3
NFKB1,GE_978.3 [Osteochondrodysplasias],0.053,0,0.0,0.0,0.0,0.0,0.261,0.0,0.122,1.923,0.768,0.285,0.107,,3
KLF7,SO_386.5 [Color vision deficiencies],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.12,0.075,0.017,0.033,0.196,2
GSTM1,MS_704.9 [Allergic purpura [Henoch-Schoenlein purpura]],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,3.173,0.175,0.057,0.034,,2
KCNK9,CM_770.5 [Congenital osteodystrophies],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.659,0.077,0.03,0.066,0.147,2
SALL4,GE_961.1 [Phakomatoses],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.061,3.156,2.344,0.214,0.156,0.753,3
RPS10,EM_209.4 [Diabetes insipidus],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.018,,,0.137,1
FURIN,"EM_209.11 [Tall stature, acromegaly and gigantism]",0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.079,,2.902,2.688,0.15,,2
DICER1,GE_963.1 [Lipid storage disorders],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.049,2.653,2.106,0.319,0.14,0.643,3
FOXM1,GU_580.1 [Acute nephritic syndrome],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.114,,2.883,0.558,0.16,0.773,3
ELN,RE_484.1 [Spontaneous pneumothorax],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.017,1.354,2.64,0.222,1.674,0.958,3
C3,GE_973.5 [Huntington's disease],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.238,1.392,2.648,0.134,0.104,,2
PRRC2A,MS_704.1 [Polyarteritis nodosa and related conditions],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.073,,2.09,0.154,0.267,,2
RIMKLB,BI_179.1 [Hypogammaglobulinemia NOS],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.651,0.195,,3.454,0.132,2
PDGFC,GI_540.11 [Autoimmune hepatitis],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,2.861,0.904,0.126,0.094,,2
TP53,GE_970.1 [Sickle-cell disorders],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.064,1.961,1.665,0.069,0.137,,2
SCN1A,GE_964.3 [Glycogen storage disease],0.053,1,1.0,0.0,0.0,0.0,0.302,0.0,0.012,,1.077,0.294,0.219,,2
PITRM1,GE_972.2 [Hereditary ataxia],0.053,0,0.0,0.0,0.0,0.0,0.28,0.503,0.018,2.685,4.523,0.293,0.263,0.782,5
BRD2,GE_978.22 [Ehler's Danlos syndrome],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.187,1.696,1.953,1.544,0.099,,2
RNF40,CM_770.5 [Congenital osteodystrophies],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,1.778,2.778,0.391,0.173,0.386,3
UBE2E3,NS_323.3 [Motor neuron disease],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,3.601,0.116,,,0.12,3
KCNT1,GE_972.2 [Hereditary ataxia],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.335,2.754,0.13,0.18,0.978,2
SRC,GE_978.22 [Ehler's Danlos syndrome],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,1.568,0.083,0.047,0.119,,2
OGA,GU_580.1 [Acute nephritic syndrome],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.121,,2.559,0.087,0.118,,2
GAD2,MB_287.2 [Schizoaffective disorder],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.143,2.928,1.777,0.317,0.118,,2
AFF3,GE_978.3 [Osteochondrodysplasias],0.053,0,0.0,0.0,0.0,0.0,0.325,0.0,0.012,2.086,2.806,0.088,0.133,,3
DRD4,MB_293.2 [Bulimia nervosa],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.085,1.388,3.63,0.295,0.131,,2
IL6ST,GE_973.5 [Huntington's disease],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.087,2.492,1.933,0.093,0.06,,2
RDH12,NS_341.1 [Cerebral palsy],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.939,1.476,0.129,0.98,2
MC1R,CV_433.3 [Cerebrovascular insufficiency],0.053,1,2.0,0.0,0.0,0.0,0.0,0.0,0.012,,2.915,0.041,0.07,0.305,3
VCAN,GE_972.2 [Hereditary ataxia],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,2.124,4.9,1.494,0.322,0.65,3
CASR,DE_663.2 [Pemphigoid],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.217,,0.132,0.156,0.183,,1
KDR,BI_162.1 [Constitutional (hereditary) aplastic anemia],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.073,3.282,2.562,0.265,0.121,,2
SIRPA,GI_542.8 [Biliary cirrhosis],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.347,3.123,2.192,0.85,0.105,,2
BSN,NS_343.6 [Multi-system degeneration of the autonomic nervous system*],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.287,,3.022,0.332,1.167,,2
SLC1A2,CV_433.3 [Cerebrovascular insufficiency],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.181,,3.306,0.164,0.131,0.196,3
KCNQ4,GE_972.1 [Hereditary neuropathy],0.053,0,0.0,0.0,0.0,0.0,0.549,0.0,0.049,,2.583,0.153,0.56,,3
TRPV4,CM_770.5 [Congenital osteodystrophies],0.053,0,0.0,0.0,0.86,0.0,0.0,0.643,0.09,,2.23,0.516,2.031,0.62,4
PDE6D,SO_386.6 [Night blindness],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.134,1.093,,0.068,0.998,2
KDR,GE_977.6 [Congenital cutaneous mastocytosis*],0.053,1,4.0,0.0,0.0,0.0,0.0,0.0,0.023,1.979,4.522,0.197,0.09,,2
UBE2L3,CV_414.1 [Hypertrophic cardiomyopathy],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.486,0.123,,,0.135,2
HK1,GE_961.1 [Phakomatoses],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.785,3.969,4.202,0.197,0.5,3
PDCD6IP,GE_963.1 [Lipid storage disorders],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.043,2.343,2.338,0.084,0.092,0.151,3
KRT18,DE_663.2 [Pemphigoid],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.132,,0.164,0.097,0.055,,1
PGAM1,NS_341.1 [Cerebral palsy],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.964,0.273,0.072,0.947,1
GATA3,MS_700.3 [Systemic sclerosis],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.591,3.171,2.491,0.345,0.1,,2
GPAT4,GI_550.4 [Cholesterolosis of gallbladder],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.746,0.449,,0.206,,1
NIN,DE_663.2 [Pemphigoid],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.122,1.34,2.834,0.667,0.239,,2
USP5,MS_704.1 [Polyarteritis nodosa and related conditions],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.158,,0.138,0.283,0.132,,1
HMGB1,NS_338.1 [Myasthenia gravis],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.079,3.144,0.389,0.094,,,2
SEMA3A,CM_770.5 [Congenital osteodystrophies],0.053,0,0.0,0.0,0.0,0.0,0.0,0.402,0.017,2.042,1.697,0.402,0.116,0.763,4
SIRT1,CV_433.3 [Cerebrovascular insufficiency],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.223,1.997,3.044,0.232,0.112,0.955,3
SLC5A3,EM_208.1 [Hypoparathyroidism],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.818,2.141,,0.087,0.134,2
ATL1,GE_972.1 [Hereditary neuropathy],0.053,0,0.0,0.0,0.0,0.0,0.0,0.44,0.074,,2.238,0.073,0.148,,3
RPH3A,CV_433.3 [Cerebrovascular insufficiency],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.155,2.484,2.177,0.116,0.157,0.027,3
SERPINE2,CV_433.3 [Cerebrovascular insufficiency],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.176,3.069,1.768,0.188,0.102,0.684,3
NIPA1,NS_323.3 [Motor neuron disease],0.053,0,0.0,0.0,0.765,0.0,0.0,0.209,0.044,1.325,2.136,0.05,0.048,0.802,4
RPRD1A,CM_763.13 [Patent ductus arteriosus],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.978,0.041,0.015,0.035,0.235,2
CDK4,GU_580.1 [Acute nephritic syndrome],0.053,1,1.0,0.0,0.0,0.0,0.0,0.0,0.207,,0.218,0.15,0.077,0.821,2
SUV39H1,"MB_280.4 [Sedative, hypnotic, or anxiolytic related disorders]",0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.067,,2.265,,1
PAX8,CM_763.31 [Ventricular septal defect],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.055,2.278,2.879,0.164,0.147,0.757,3
COX5B,GE_963.1 [Lipid storage disorders],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.174,0.152,0.065,0.977,1
RELN,GI_516.1 [Pyloric stenosis],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.971,2.888,0.849,0.167,0.976,2
MEF2D,CV_433.3 [Cerebrovascular insufficiency],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.111,,1.785,0.129,0.112,0.623,3
SURF1,GE_972.2 [Hereditary ataxia],0.053,0,0.0,0.0,0.0,0.0,0.0,0.442,0.065,4.38,1.915,0.18,0.191,0.981,4
TPX2,GE_961.1 [Phakomatoses],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.005,2.956,1.43,0.15,0.284,3
SDR9C7,GE_977.1 [Congenital ichthyosis],0.053,0,0.0,0.0,0.547,0.0,0.308,0.727,0.03,2.585,1.761,1.438,0.062,0.993,5
MMACHC,NS_341.1 [Cerebral palsy],0.053,0,0.0,0.0,0.547,0.0,0.0,0.0,0.03,,2.833,0.264,0.132,0.804,4
CABP4,SO_380.3 [Optic atrophy],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,1.85,0.717,0.131,0.954,2
ADRA2A,MB_305.1 [Tics and tic disorders],0.053,1,4.0,0.0,0.0,0.0,0.0,0.0,0.075,2.418,0.254,0.025,0.039,,2
IRF4,MS_704.1 [Polyarteritis nodosa and related conditions],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.191,2.935,0.599,0.056,0.061,,2
SMU1,CM_763.13 [Patent ductus arteriosus],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.078,,0.025,0.274,1
SLC5A7,NS_338.1 [Myasthenia gravis],0.053,0,0.0,0.0,0.0,0.0,0.0,0.729,0.095,1.95,2.487,0.146,0.142,,3
SNAP25,MB_296.1 [Paranoid personality disorder],0.053,1,2.0,0.0,0.0,0.0,0.0,0.0,0.049,2.822,0.052,0.019,0.033,,2
ZIC2,NS_347.1 [Cerebral cysts],0.053,0,0.0,0.0,0.547,0.0,0.0,0.0,0.14,1.462,2.97,0.103,0.099,,3
TUBA1B,GU_580.1 [Acute nephritic syndrome],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,1.325,,,0.203,2
CCL20,GE_971.11 [Hereditary factor VIII deficiency [Hemophilia A]],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.497,2.136,0.014,0.03,,1
FST,MS_700.43 [Polymyositis],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.152,3.053,0.631,0.06,0.052,,2
ATP5MC3,NS_341.1 [Cerebral palsy],0.053,0,0.0,0.0,0.547,0.0,0.0,0.0,0.061,2.738,0.325,0.069,0.064,,3
YTHDF3,CM_763.31 [Ventricular septal defect],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.751,0.073,,0.019,0.238,2
PRKCA,CV_413.13 [Mitral valve stenosis],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.399,1.427,0.171,0.166,,2
NFKB2,MS_712.51 [Hypermobility syndrome],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.036,1.692,1.864,0.154,0.163,,2
PLA2G6,NS_341.1 [Cerebral palsy],0.053,0,0.0,0.0,0.856,0.0,0.0,0.0,0.021,1.344,0.745,0.534,0.799,0.99,4
GABRQ,NS_323.3 [Motor neuron disease],0.053,1,1.0,0.0,0.0,0.0,0.0,0.0,0.018,,1.38,,0.136,0.014,3
RAB24,NS_344.2 [Benign intracranial hypertension],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.713,0.059,,0.024,0.157,2
KIF3C,CM_750.16 [Arnold-Chiari syndrome*],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.349,0.162,,0.024,0.258,2
PPARA,CV_433.3 [Cerebrovascular insufficiency],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.086,1.641,2.506,0.169,0.148,0.929,3
ETNK1,MB_302.1 [Speech and language developmental delay],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.176,0.295,0.047,0.088,0.192,2
DIP2B,GE_972.2 [Hereditary ataxia],0.053,0,0.0,0.081,0.0,0.0,0.0,0.0,0.018,,2.191,0.435,1.056,0.435,4
KIF5A,NS_344.2 [Benign intracranial hypertension],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,,0.638,0.161,0.146,0.184,2
BCL2,RE_477.2 [Hypersensitivity pneumonitis],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.058,2.706,0.121,0.033,0.124,,2
CSNK2A2,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.974,0.238,,0.083,0.205,2
PIK3CA,GE_963.1 [Lipid storage disorders],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,2.639,0.078,0.027,0.065,0.23,3
SLC1A3,GE_978.3 [Osteochondrodysplasias],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.144,1.964,2.477,0.187,0.109,,2
RPL35,NS_333.4 [Circadian rhythm sleep disorder],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,1.118,0.03,0.028,0.329,1
MAGOH,CV_433.3 [Cerebrovascular insufficiency],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.912,,0.025,0.218,2
HGF,SO_365.3 [Exophthalmos [Proptosis]],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.109,1.876,2.597,1.449,1.489,0.933,3
ADCY5,DE_663.2 [Pemphigoid],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.055,3.18,2.73,0.123,1.016,,2
NR3C2,CM_751.213 [Congenital cataract],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.745,1.76,,0.026,0.31,2
SNRNP70,MS_712.51 [Hypermobility syndrome],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,2.7,2.596,0.096,0.166,,2
PCDH12,GE_972.2 [Hereditary ataxia],0.053,0,0.0,0.0,0.547,0.0,0.0,0.29,0.024,,3.471,1.303,0.271,0.348,4
MYH4,GE_972.9 [Muscular dystrophy],0.053,0,0.0,0.0,0.0,0.0,0.433,0.0,0.073,,3.696,0.949,0.143,0.728,4
PTPRC,MS_700.42 [Dermatomyositis],0.053,0,0.0,0.041,0.0,0.0,0.0,0.0,0.046,1.903,2.256,0.04,0.06,,3
PEX11A,GE_972.2 [Hereditary ataxia],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.37,0.342,0.119,0.927,1
HDGF,CV_441 [Arteriovenous malformation],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.204,1.871,,0.031,0.289,2
EXOSC3,NS_341.1 [Cerebral palsy],0.053,0,0.0,0.0,0.547,0.0,0.0,0.0,0.012,,3.043,0.323,0.106,0.919,4
SRXN1,RE_472.6 [Nodules of vocal cords*],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.504,2.283,0.018,0.056,,1
MECP2,SO_380.3 [Optic atrophy],0.053,0,0.0,0.0,0.684,0.0,0.33,0.0,0.0,,3.374,0.173,1.069,0.944,4
MBNL1,NS_323.3 [Motor neuron disease],0.053,0,0.0,0.017,0.0,0.0,0.272,0.0,0.012,1.949,0.323,0.154,0.992,0.54,5
FAF2,NS_323.3 [Motor neuron disease],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,,0.225,0.198,0.157,0.092,2
CADM1,MS_712.51 [Hypermobility syndrome],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.033,2.085,1.893,0.146,0.134,,2
WDR47,DE_663.2 [Pemphigoid],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.084,,3.403,0.233,0.199,,2
DRD3,MB_303.1 [Dyslexia and alexia],0.053,1,4.0,0.0,0.0,0.0,0.0,0.0,0.021,2.683,0.108,0.108,0.077,,2
KDM6A,GE_973.5 [Huntington's disease],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.099,2.351,0.125,0.105,0.067,,2
YAP1,GI_542.8 [Biliary cirrhosis],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.112,1.708,1.862,1.269,0.18,,2
SUCLA2,GE_972.2 [Hereditary ataxia],0.053,0,0.0,0.02,0.547,0.0,0.0,0.0,0.03,1.958,2.211,1.154,0.893,0.981,5
PTK2,GE_972.9 [Muscular dystrophy],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.042,2.824,1.723,0.2,0.142,0.632,3
PPARGC1A,DE_663.2 [Pemphigoid],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.119,2.324,3.364,0.322,0.252,,2
MET,NS_323.3 [Motor neuron disease],0.053,0,0.0,0.0,0.0,0.0,0.277,0.0,0.138,2.027,2.895,0.367,0.12,0.399,4
NFKB1,GU_580.1 [Acute nephritic syndrome],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.204,1.628,3.182,0.402,0.124,0.989,3
KCNA4,DE_663.2 [Pemphigoid],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.079,2.051,1.658,,0.07,,2
ADAM17,GE_978.3 [Osteochondrodysplasias],0.053,0,0.0,0.0,0.0,0.0,0.254,0.0,0.128,1.931,2.762,0.047,0.118,,3
RNASE3,GE_974.3 [Hereditary choroidal dystrophies],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.085,2.97,1.731,0.042,0.028,,2
TSPAN5,EM_209.4 [Diabetes insipidus],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.74,0.04,0.037,0.108,0.1,2
MAOA,GE_972.9 [Muscular dystrophy],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.274,2.756,2.352,0.067,0.039,0.322,3
ZBTB20,CV_433.3 [Cerebrovascular insufficiency],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,2.429,2.435,0.897,0.11,0.19,3
KANK1,NS_341.1 [Cerebral palsy],0.053,0,0.0,0.0,0.58,0.0,0.0,0.526,0.043,2.064,3.467,1.034,0.323,0.661,4
CDK2AP2,CV_413.41 [Pulmonary valve stenosis],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.031,0.025,0.015,0.122,1
ANGPTL2,MS_700.42 [Dermatomyositis],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.156,,0.223,0.268,0.118,,1
GRIK2,CV_433.3 [Cerebrovascular insufficiency],0.053,1,2.0,0.0,0.0,0.0,0.0,0.0,0.201,3.044,2.773,0.241,0.173,0.066,3
GABRA3,NS_341.1 [Cerebral palsy],0.053,1,4.0,0.0,0.0,0.0,0.0,0.0,0.0,2.062,3.459,,0.076,0.777,2
SUCO,GE_978.3 [Osteochondrodysplasias],0.053,0,0.0,0.0,0.0,0.0,0.0,0.251,0.028,1.424,2.858,1.081,0.182,,3
TLR8,GE_972.1 [Hereditary neuropathy],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.612,3.361,,0.128,,1
C5,NS_338.1 [Myasthenia gravis],0.053,1,4.0,0.0,0.0,0.0,0.0,0.0,0.149,1.316,3.355,1.102,0.354,,2
FST,GE_978.3 [Osteochondrodysplasias],0.053,0,0.0,0.0,0.0,0.0,0.262,0.0,0.031,2.936,0.932,0.067,0.063,,3
GALK1,CM_751.213 [Congenital cataract],0.053,0,0.0,0.0,0.772,0.0,0.0,0.0,0.096,,3.442,0.172,0.103,0.917,4
SH2D4B,BI_179.1 [Hypogammaglobulinemia NOS],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.279,3.749,0.304,0.13,0.975,2
PTPRC,RE_484.1 [Spontaneous pneumothorax],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.082,2.688,0.111,0.15,0.804,3
TET2,GI_516.1 [Pyloric stenosis],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.413,3.144,2.607,0.423,0.924,2
ARL6,SO_386.6 [Night blindness],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.4,2.55,0.113,0.096,0.983,2
SERPINE2,MS_700.3 [Systemic sclerosis],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.181,2.298,1.105,0.915,0.152,,2
PPEF1,CM_763.13 [Patent ductus arteriosus],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.711,4.106,,0.023,0.085,2
RPL5,BI_162.1 [Constitutional (hereditary) aplastic anemia],0.053,0,0.0,0.0,0.895,0.0,0.322,0.875,0.177,,0.404,,0.026,,3
RTN4R,CV_416.8 [Pre-excitation syndrome [Anomalous atrioventricular excitation]],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.99,3.114,,0.029,0.293,2
ANP32A,GE_970.2 [Thalassemia],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.323,0.077,,0.182,,1
SNRNP70,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.049,1.877,3.31,0.084,0.096,0.197,3
PREP,NS_343.6 [Multi-system degeneration of the autonomic nervous system*],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.14,1.461,0.102,0.131,0.074,,2
IL1B,CV_433.3 [Cerebrovascular insufficiency],0.053,1,3.0,0.0,0.0,0.0,0.0,0.0,0.145,2.045,0.136,0.113,0.041,0.984,3
ARF6,SO_386.5 [Color vision deficiencies],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.85,0.077,,0.025,0.204,2
SLC8A1,GE_972.9 [Muscular dystrophy],0.053,0,0.0,0.0,0.0,0.0,0.261,0.0,0.057,2.134,0.508,0.246,0.158,0.766,4
MARK2,NS_323.3 [Motor neuron disease],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.043,1.389,3.013,0.17,0.249,0.3,3
TRERF1,GE_961.1 [Phakomatoses],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.073,3.106,3.631,0.965,0.253,0.116,3
RPL11,EM_208.1 [Hypoparathyroidism],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,3.188,,,0.231,2
HMGB1,MB_302.1 [Speech and language developmental delay],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,1.938,2.413,0.11,,0.917,3
C9orf72,GE_964.3 [Glycogen storage disease],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.113,2.516,0.198,0.171,0.145,,2
BCL2L1,DE_663.2 [Pemphigoid],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.07,1.916,0.188,0.038,0.053,,2
CYLC1,GE_972.2 [Hereditary ataxia],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.471,2.979,,0.029,0.301,2
HIRA,GE_970.2 [Thalassemia],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.022,1.983,2.42,0.194,0.433,,2
RBM4,CM_770.5 [Congenital osteodystrophies],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.081,0.02,0.035,0.21,1
BCL2,MS_704.1 [Polyarteritis nodosa and related conditions],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.088,1.994,0.098,0.02,0.049,,2
NRP1,CV_441 [Arteriovenous malformation],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.055,3.077,2.462,2.04,0.352,0.961,3
USP24,GU_580.1 [Acute nephritic syndrome],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.881,3.756,,0.104,0.174,2
RPS3A,GU_580.1 [Acute nephritic syndrome],0.053,1,1.0,0.0,0.0,0.0,0.0,0.0,0.0,2.192,0.225,,0.023,0.267,2
RPS11,SO_369.62 [Keratoconus],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.149,,0.021,0.193,1
FOXP3,GE_973.5 [Huntington's disease],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.212,,0.093,0.036,3.887,,2
RTN4R,CM_770.5 [Congenital osteodystrophies],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.46,2.924,,0.02,0.26,2
GAP43,GE_972.2 [Hereditary ataxia],0.053,0,0.0,0.166,0.0,0.0,0.0,0.0,0.018,2.866,1.814,0.297,0.129,0.878,4
LAMB2,GU_580.1 [Acute nephritic syndrome],0.053,0,0.0,0.0,0.897,0.0,0.0,0.356,0.049,,2.304,0.425,0.338,0.665,4
EEF2,CV_414.1 [Hypertrophic cardiomyopathy],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,,2.246,0.172,0.257,0.329,3
LRP5,GE_976.5 [Polycystic kidney disease],0.053,0,0.0,0.0,0.0,0.0,0.0,0.121,0.112,2.457,2.519,0.112,0.146,,3
NDUFA13,CM_763.31 [Ventricular septal defect],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.109,0.226,0.116,0.903,1
CACNA1C,CM_763.31 [Ventricular septal defect],0.053,0,0.0,0.0,0.732,0.0,0.273,0.0,0.033,3.152,3.406,0.284,0.221,0.777,5
RPL23A,SO_380.3 [Optic atrophy],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,3.552,,0.029,0.275,2
GAN,GE_972.1 [Hereditary neuropathy],0.053,0,0.0,0.0,0.0,0.0,0.251,0.177,0.027,2.09,2.423,2.261,0.154,,4
ADRB1,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.053,1,4.0,0.0,0.0,0.0,0.0,0.0,0.015,3.067,3.007,2.908,0.05,0.545,3
SH3BP2,GE_978.3 [Osteochondrodysplasias],0.053,0,0.0,0.0,0.0,0.0,0.38,0.0,0.055,2.01,1.748,0.804,1.571,,3
DNMT3B,GE_970.2 [Thalassemia],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.015,,2.508,0.418,0.345,,2
RPL35,CM_751.213 [Congenital cataract],0.053,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.421,0.042,0.031,0.307,1
FOXO6,CM_763.31 [Ventricular septal defect],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.944,1.586,,0.028,0.212,2
PRKCQ,MS_705.2 [Juvenile rheumatoid arthritis [JRA/JIA]],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.068,2.808,0.178,0.178,0.119,,2
KCND3,CV_433.3 [Cerebrovascular insufficiency],0.052,1,3.0,0.0,0.0,0.0,0.0,0.0,0.012,1.818,1.693,0.096,0.087,0.213,3
AARS1,GE_972.1 [Hereditary neuropathy],0.052,0,0.0,0.0,0.0,0.0,0.0,0.796,0.062,,2.893,0.344,1.693,,3
VWF,MS_704.2 [Wegener's granulomatosis],0.052,1,4.0,0.0,0.0,0.0,0.0,0.0,0.098,2.64,2.937,0.801,0.281,,2
FGFR1,MS_728.2 [Osteochondritis dissecans],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.044,3.443,2.716,0.263,0.137,,2
FANCC,CV_441 [Arteriovenous malformation],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.729,2.605,0.743,0.275,0.993,2
HOXA5,CV_433.3 [Cerebrovascular insufficiency],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.061,2.16,0.114,0.151,0.119,0.574,3
MYH14,GE_972.1 [Hereditary neuropathy],0.052,0,0.0,0.0,0.0,0.0,0.0,0.129,0.026,3.096,4.113,0.156,0.199,,3
ADIPOR1,NS_339.2 [Myotonic disorders],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,,0.075,0.019,0.054,,1
ZFHX3,GE_972.2 [Hereditary ataxia],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.033,3.102,2.388,0.305,0.928,0.63,3
PTPRC,GE_970.2 [Thalassemia],0.052,0,0.0,0.0,0.0,0.0,0.343,0.0,0.012,2.58,2.212,0.055,0.185,,3
AHR,NS_323.3 [Motor neuron disease],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.024,2.291,2.938,0.235,0.229,0.296,3
CRTC1,CV_433.3 [Cerebrovascular insufficiency],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.094,,0.213,0.16,0.096,0.327,2
DNER,GE_963.1 [Lipid storage disorders],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.116,1.929,3.789,1.149,0.104,0.041,3
HDAC4,RE_477.2 [Hypersensitivity pneumonitis],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.059,2.81,2.05,1.903,0.211,,2
EEF1G,CV_413.41 [Pulmonary valve stenosis],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.105,0.043,0.034,0.336,1
LSM12,CM_763.13 [Patent ductus arteriosus],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.081,,0.016,0.285,1
GRIK3,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,2.483,4.926,1.98,0.179,0.043,3
GATM,GE_976.5 [Polycystic kidney disease],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.374,,1.444,0.255,0.179,,2
NRN1,NS_323.3 [Motor neuron disease],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.061,1.993,0.193,,0.112,0.108,3
KDSR,GE_972.9 [Muscular dystrophy],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.061,2.212,0.136,0.149,0.113,0.227,3
KPNB1,CV_414.1 [Hypertrophic cardiomyopathy],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.004,,,0.192,2
RPL37,CV_413.41 [Pulmonary valve stenosis],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.623,0.245,,0.026,0.283,2
TLR8,CV_438.41 [Aortic dissection],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.685,2.208,,0.087,0.094,2
CD81,MS_700.3 [Systemic sclerosis],0.052,0,0.0,0.0,0.0,0.091,0.0,0.0,0.087,,1.927,0.111,0.11,,2
KCNMA1,GE_978.3 [Osteochondrodysplasias],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,3.268,1.789,0.202,0.138,,2
KIT,RE_484.1 [Spontaneous pneumothorax],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.485,2.558,0.301,0.238,0.844,3
PLOD1,MS_712.51 [Hypermobility syndrome],0.052,0,0.0,0.0,0.0,0.0,0.0,0.85,0.128,,2.596,0.96,0.293,,3
HRH2,GE_970.2 [Thalassemia],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.739,0.384,,0.14,,1
KCNK9,CM_750.16 [Arnold-Chiari syndrome*],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.425,0.056,0.015,0.037,0.207,2
STRN4,GE_972.9 [Muscular dystrophy],0.052,0,0.0,0.0,0.0,0.0,0.0,0.37,0.024,,3.018,0.273,0.113,0.069,4
FBN2,SO_381.5 [Vertical strabismus],0.052,0,0.0,0.0,0.0,0.0,0.0,0.129,0.03,2.117,3.446,0.633,0.285,,3
ZC3H12A,GI_540.11 [Autoimmune hepatitis],0.052,0,0.0,0.0,0.0,0.0,0.281,0.0,0.027,2.725,2.805,0.262,0.173,,3
RAB1A,GE_963.1 [Lipid storage disorders],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.801,2.257,,0.027,0.268,2
EPHB4,GE_975.2 [Hereditary hemorrhagic telangiectasia],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.127,,3.176,2.648,2.093,,2
MAGEH1,GU_580.1 [Acute nephritic syndrome],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.036,2.594,0.103,,0.024,0.088,3
COL1A2,GE_973.5 [Huntington's disease],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.132,3.052,2.196,0.251,0.091,,2
MAP3K5,GI_540.4 [Alcoholic hepatitis],0.052,1,2.0,0.0,0.0,0.0,0.0,0.0,0.015,1.678,3.366,0.187,0.198,,2
PDE6A,SO_380.3 [Optic atrophy],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.848,2.086,0.467,0.225,0.98,2
IL21,CM_763.13 [Patent ductus arteriosus],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.04,,0.011,0.215,1
OGDH,CM_770.5 [Congenital osteodystrophies],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,1.767,0.43,0.182,0.204,0.641,3
TIMP4,CV_414.1 [Hypertrophic cardiomyopathy],0.052,0,0.0,0.0,0.0,0.0,0.454,0.0,0.068,,1.698,0.329,0.227,0.038,4
MMP14,GU_580.1 [Acute nephritic syndrome],0.052,0,0.0,0.0,0.35,0.0,0.0,0.0,0.064,1.766,1.908,0.442,0.123,0.849,4
SLC4A1,GE_970.2 [Thalassemia],0.052,0,0.0,0.0,0.0,0.0,0.579,0.0,0.038,,2.607,0.681,0.45,,3
RPS9,CM_750.16 [Arnold-Chiari syndrome*],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.03,0.02,0.032,0.273,1
KHDRBS1,GE_978.3 [Osteochondrodysplasias],0.052,0,0.0,0.0,0.0,0.0,0.264,0.0,0.012,1.332,0.079,0.04,0.092,,3
SUB1,CV_413.41 [Pulmonary valve stenosis],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.634,0.041,0.02,0.257,2
DDI2,RE_484.1 [Spontaneous pneumothorax],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.472,,,0.296,1
F11,CV_433.3 [Cerebrovascular insufficiency],0.052,1,2.0,0.0,0.0,0.525,0.0,0.0,0.023,1.802,3.448,0.115,0.163,0.217,3
HK1,GE_977.6 [Congenital cutaneous mastocytosis*],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.203,0.09,0.098,0.084,,2
DAB2IP,DE_663.2 [Pemphigoid],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.632,3.803,2.517,1.581,,2
FGF9,SO_386.6 [Night blindness],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.154,0.111,0.04,0.034,0.209,2
SEPTIN9,RE_464.2 [Chronic nasopharyngitis],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.255,1.996,1.848,0.216,0.078,,2
CFLAR,GE_961.1 [Phakomatoses],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,2.608,0.12,0.045,0.077,0.492,3
BRD2,MB_305.1 [Tics and tic disorders],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.195,,1.112,0.195,0.098,,1
WWP1,GE_972.9 [Muscular dystrophy],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.104,2.047,1.803,0.318,0.133,0.272,3
RPS6KB1,GE_961.1 [Phakomatoses],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.108,1.304,0.352,0.035,0.091,0.913,3
UBE2N,GE_977.1 [Congenital ichthyosis],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.034,,,0.141,1
UBE2N,SO_386.5 [Color vision deficiencies],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.038,,,0.143,1
RAN,RE_484.1 [Spontaneous pneumothorax],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.085,,,0.146,1
RHOG,SO_380.3 [Optic atrophy],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.719,0.528,,0.025,0.167,2
COL1A1,CV_414.1 [Hypertrophic cardiomyopathy],0.052,0,0.0,0.0,0.0,0.0,0.455,0.129,0.101,1.41,2.727,0.153,0.082,0.691,5
SSTR3,"EM_209.11 [Tall stature, acromegaly and gigantism]",0.052,1,4.0,0.0,0.0,0.0,0.0,0.0,0.015,,3.21,0.079,2.694,,2
PRPF6,SO_386.6 [Night blindness],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.564,3.288,1.008,0.144,0.99,2
NFKB1,GE_972.9 [Muscular dystrophy],0.052,1,3.0,0.0,0.0,0.0,0.0,0.0,0.102,1.922,3.922,0.268,0.095,0.792,3
THRA,CM_770.5 [Congenital osteodystrophies],0.052,0,0.0,0.0,0.0,0.0,0.313,0.402,0.019,3.086,1.554,0.067,2.167,0.577,5
SLC5A3,RE_484.1 [Spontaneous pneumothorax],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.789,0.211,,0.097,0.072,2
RAB5A,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.155,2.325,0.172,0.031,0.046,0.396,3
YPEL2,CM_763.13 [Patent ductus arteriosus],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.116,0.036,,0.014,0.219,2
SLC5A3,CV_414.1 [Hypertrophic cardiomyopathy],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.813,2.436,,0.099,0.1,2
BBS2,SO_369.62 [Keratoconus],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.921,3.036,1.515,0.145,0.991,2
GRIN1,GE_977.6 [Congenital cutaneous mastocytosis*],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.099,,0.052,0.023,0.054,,1
PPP2R2C,RE_472.2 [Polyp of vocal cord and larynx],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.81,0.183,,0.12,,1
ATXN2,GI_542.8 [Biliary cirrhosis],0.052,0,0.0,0.0,0.0,0.257,0.0,0.0,0.018,,3.932,1.472,1.101,,2
ULK1,GE_973.5 [Huntington's disease],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,,2.372,0.21,0.083,,2
PTK2B,GU_580.1 [Acute nephritic syndrome],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,2.53,3.599,1.216,1.008,0.764,3
CLDN5,CM_763.31 [Ventricular septal defect],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.061,2.721,0.194,0.038,0.074,0.348,3
DNA2,GE_972.9 [Muscular dystrophy],0.052,0,0.0,0.0,0.0,0.0,0.0,0.129,0.021,1.589,2.539,2.239,0.172,0.132,4
BAX,MB_302.1 [Speech and language developmental delay],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.684,2.484,0.103,0.949,2
MFF,GE_973.5 [Huntington's disease],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.205,1.859,0.127,0.183,0.07,,2
CDH13,CV_414.1 [Hypertrophic cardiomyopathy],0.052,0,0.0,0.0,0.0,0.0,0.371,0.0,0.0,2.61,3.0,,0.099,0.083,3
MEF2C,NS_323.3 [Motor neuron disease],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,3.633,0.099,,0.125,0.499,3
PCBP1,GI_540.11 [Autoimmune hepatitis],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.073,1.955,0.447,,,,2
UBE2T,BI_162.1 [Constitutional (hereditary) aplastic anemia],0.052,0,0.0,0.0,0.0,0.0,0.0,0.708,0.101,,0.181,0.245,0.051,,2
SOX9,CV_414.1 [Hypertrophic cardiomyopathy],0.052,0,0.0,0.0,0.0,0.0,0.396,0.0,0.03,2.908,2.886,0.122,0.134,0.314,4
TRIM55,CV_414.1 [Hypertrophic cardiomyopathy],0.052,0,0.0,0.0,0.802,0.0,0.55,0.0,0.061,,2.086,0.625,0.283,0.76,5
RPS19,SO_365.3 [Exophthalmos [Proptosis]],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.285,,,0.301,2
CFTR,GI_516.1 [Pyloric stenosis],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.841,3.275,1.286,0.552,0.932,2
STXBP5,GE_971.14 [Von Willebrand's disease],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.073,2.331,2.53,0.624,0.177,,2
HSF2,GE_972.9 [Muscular dystrophy],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.798,0.121,0.044,0.095,0.219,2
BRSK2,CV_414.1 [Hypertrophic cardiomyopathy],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,1.749,2.144,0.823,0.115,0.113,3
OR8D1,GE_983.2 [Hemoglobin C trait [Sickle-cell trait]],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.894,,0.316,,0
TET2,CM_750.16 [Arnold-Chiari syndrome*],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.219,0.445,0.093,0.125,0.924,2
C3,BI_179.4 [Selective deficiency of immunoglobulin A [IgA]],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.11,1.357,1.163,0.184,0.118,,2
PDE4A,MS_700.3 [Systemic sclerosis],0.052,1,2.0,0.0,0.0,0.0,0.0,0.0,0.086,,2.354,0.644,0.238,,2
NBEAL2,DE_663.2 [Pemphigoid],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.091,1.438,3.857,1.265,0.28,,2
ELMO1,MS_727.3 [Osteitis deformans [Paget's disease of bone]],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.024,2.021,2.618,0.209,0.955,,2
MKI67,SO_386.5 [Color vision deficiencies],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.117,2.029,3.936,0.821,1.696,0.916,3
SBF1,CV_416.8 [Pre-excitation syndrome [Anomalous atrioventricular excitation]],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.681,2.517,,0.135,0.284,2
TBX20,CV_414.1 [Hypertrophic cardiomyopathy],0.052,0,0.0,0.0,0.0,0.0,0.617,0.0,0.059,1.721,1.743,0.457,0.626,0.79,4
HNF4A,GE_964.3 [Glycogen storage disease],0.052,0,0.0,0.0,0.0,0.0,0.398,0.0,0.012,2.008,0.288,0.154,0.101,,3
JAG1,GE_972.9 [Muscular dystrophy],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.207,2.699,3.311,0.189,0.141,0.684,3
GABRA2,CV_433.3 [Cerebrovascular insufficiency],0.052,1,4.0,0.0,0.0,0.0,0.0,0.0,0.0,1.617,3.56,,0.11,0.065,2
AKAP8L,GE_973.5 [Huntington's disease],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.125,,2.33,0.093,0.056,,2
C4A,GU_580.51 [Focal and segmental glomerular lesions*],0.052,0,0.0,0.0,0.0,0.0,0.339,0.0,0.083,,0.164,0.093,0.077,,2
MTOR,NS_344.11 [Communicating hydrocephalus],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.066,1.931,2.72,0.151,0.113,,2
NDUFB11,NS_341.1 [Cerebral palsy],0.052,1,2.0,0.0,0.0,0.0,0.0,0.0,0.0,,1.567,0.038,0.04,0.981,2
FCGRT,NS_338.1 [Myasthenia gravis],0.052,1,4.0,0.0,0.0,0.0,0.0,0.0,0.122,1.357,2.771,0.079,0.107,,2
ROCK2,SO_386.5 [Color vision deficiencies],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.041,1.891,2.725,0.218,1.697,0.306,3
FN1,GU_580.51 [Focal and segmental glomerular lesions*],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.23,3.296,3.101,0.782,0.345,,2
KLHL3,GE_972.9 [Muscular dystrophy],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.061,1.514,0.135,0.102,0.1,0.295,3
CDH23,SO_386.6 [Night blindness],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.407,3.484,0.557,0.341,0.997,2
KITLG,EM_249.1 [Cerebral amyloid angiopathy*],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.043,3.483,0.114,0.083,0.054,,2
TRAF4,MS_704.1 [Polyarteritis nodosa and related conditions],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.176,,0.164,0.13,0.08,,1
SLC11A2,GE_970.2 [Thalassemia],0.052,1,0.5,0.0,0.0,0.0,0.483,0.0,0.012,1.861,2.438,0.111,0.397,,3
ARIH1,CV_414.1 [Hypertrophic cardiomyopathy],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.788,1.709,,0.097,0.164,2
IRF7,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.556,2.53,0.195,0.941,2
BCOR,DE_663.2 [Pemphigoid],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.061,3.452,2.996,2.997,0.06,,2
EZH2,GE_966.2 [Disorders of porphyrin metabolism],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.578,2.347,0.336,0.028,0.044,,2
ITGAL,GE_973.5 [Huntington's disease],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.044,,0.102,0.08,0.077,,1
ATAD3A,GE_972.2 [Hereditary ataxia],0.052,0,0.0,0.0,0.732,0.0,0.0,0.0,0.074,,4.297,3.95,0.562,0.772,4
HSPB1,NS_323.3 [Motor neuron disease],0.052,0,0.0,0.0,0.84,0.0,0.0,0.0,0.062,,1.925,0.402,0.139,0.896,4
FRZB,NS_323.3 [Motor neuron disease],0.052,0,0.0,0.031,0.0,0.0,0.414,0.0,0.012,,2.406,0.809,0.208,0.008,5
CST3,GE_970.1 [Sickle-cell disorders],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.102,,1.323,0.044,0.131,,2
TMEM132E,NS_333.4 [Circadian rhythm sleep disorder],0.052,0,0.0,0.0,0.0,0.386,0.0,0.0,0.012,2.145,3.66,0.945,0.176,0.032,3
LEF1,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.743,3.167,0.339,0.127,0.979,2
BCL2,MS_704.9 [Allergic purpura [Henoch-Schoenlein purpura]],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.047,2.597,0.132,0.033,0.076,,2
EIF4A1,GE_963.1 [Lipid storage disorders],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.067,,0.033,0.245,1
ITGAV,GE_978.22 [Ehler's Danlos syndrome],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.104,2.561,1.763,0.236,0.148,,2
TLR8,NS_323.3 [Motor neuron disease],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.978,2.967,,0.106,0.162,2
PRKCA,EM_209.4 [Diabetes insipidus],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.061,2.232,0.451,0.11,0.097,0.933,3
VAMP2,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,1.943,,0.024,0.228,2
GLUL,DE_663.2 [Pemphigoid],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.198,0.128,0.04,0.083,,2
OPA1,DE_663.3 [Dermatitis herpetiformis],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.399,1.741,3.903,1.266,0.125,,2
IKZF1,GI_540.11 [Autoimmune hepatitis],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.272,1.947,0.174,0.138,,2
C4A,NS_328.13 [Frontotemporal dementia [FTD]],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.233,,2.565,0.164,0.157,,2
DDX20,NS_323.3 [Motor neuron disease],0.052,0,0.0,0.0,0.0,0.0,0.0,0.129,0.023,,2.427,0.413,0.315,0.094,4
HTT,DE_663.2 [Pemphigoid],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,2.015,4.152,0.487,0.422,,2
PTPRC,SO_380.3 [Optic atrophy],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,2.461,1.772,0.076,0.102,0.491,3
SMCHD1,NS_339.2 [Myotonic disorders],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.079,3.735,3.105,1.759,,2
HIF1A,RE_464.2 [Chronic nasopharyngitis],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.152,1.475,2.283,0.19,0.108,,2
DSP,GE_964.3 [Glycogen storage disease],0.052,0,0.0,0.0,0.0,0.0,0.264,0.0,0.035,2.305,2.675,0.129,0.215,,3
RPS3A,SO_386.6 [Night blindness],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,3.161,,0.019,0.227,2
INS,NS_344.2 [Benign intracranial hypertension],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.082,,0.041,0.978,1
MEMO1,MB_302.1 [Speech and language developmental delay],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.426,0.098,,2.529,0.265,2
NEUROD6,"MB_280.4 [Sedative, hypnotic, or anxiolytic related disorders]",0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,3.138,0.08,0.099,0.077,,2
TENM3,GE_972.1 [Hereditary neuropathy],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,4.876,2.967,,0.119,,2
RPSA,RE_484.1 [Spontaneous pneumothorax],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.972,0.169,,,0.346,2
KDM4A,CV_433.3 [Cerebrovascular insufficiency],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.061,,1.546,0.443,0.164,0.215,3
PRF1,BI_179.1 [Hypogammaglobulinemia NOS],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.503,1.556,0.074,0.154,0.963,2
SLC6A6,GE_972.9 [Muscular dystrophy],0.052,0,0.0,0.0,0.0,0.0,0.326,0.0,0.032,1.904,0.765,0.029,0.055,0.145,4
E2F3,GU_580.52 [Diffuse membranous glomerulonephritis],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.036,2.016,0.26,0.041,0.075,,2
DSG4,DE_663.1 [Pemphigus],0.052,0,0.0,0.0,0.0,0.0,0.336,0.0,0.177,1.659,0.561,0.156,0.086,,3
GSTM1,GE_961.1 [Phakomatoses],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.266,1.997,2.308,0.082,0.031,0.462,3
WDR62,NS_341.1 [Cerebral palsy],0.052,0,0.0,0.0,0.684,0.0,0.0,0.0,0.03,,3.803,0.884,0.264,0.873,4
SMURF2,NS_323.3 [Motor neuron disease],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.061,2.035,2.97,2.583,0.36,0.123,3
PPARG,NS_333.4 [Circadian rhythm sleep disorder],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.82,0.125,0.114,0.079,0.959,3
HEPACAM,GE_972.2 [Hereditary ataxia],0.052,0,0.0,0.0,0.547,0.0,0.0,0.0,0.012,,2.539,0.193,0.111,0.555,4
TIMP2,EM_249.1 [Cerebral amyloid angiopathy*],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.172,2.405,2.814,0.098,0.032,,2
PCBP1,NS_333.4 [Circadian rhythm sleep disorder],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.986,0.288,,,0.261,2
ABL1,GE_970.2 [Thalassemia],0.052,0,0.0,0.0,0.0,0.0,0.266,0.0,0.018,2.151,2.954,0.723,0.616,,3
LAMA3,GE_972.9 [Muscular dystrophy],0.052,0,0.0,0.0,0.547,0.0,0.0,0.0,0.0,,4.127,0.24,0.16,0.931,3
SLC6A4,MB_302.1 [Speech and language developmental delay],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,,0.336,0.134,0.192,0.859,2
CD40LG,GE_972.1 [Hereditary neuropathy],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.122,1.886,1.446,,0.051,,2
CTDSP2,CV_416.8 [Pre-excitation syndrome [Anomalous atrioventricular excitation]],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.139,,0.107,0.08,1
TET2,GE_973.5 [Huntington's disease],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.036,2.691,3.729,0.052,0.118,,2
SPIN1,GE_961.1 [Phakomatoses],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.065,0.051,,0.181,1
EBF1,MS_727.5 [Cyst of bone],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,2.719,2.735,0.207,0.162,,2
IL18,NS_323.3 [Motor neuron disease],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.021,,2.82,0.038,0.044,0.459,3
BANF1,SO_369.62 [Keratoconus],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.08,,,0.132,1
CUX1,GE_976.5 [Polycystic kidney disease],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.149,3.073,2.734,0.688,0.111,,2
ALPP,GE_972.9 [Muscular dystrophy],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.324,2.675,1.111,0.151,1.13,0.065,3
ADM,CV_414.1 [Hypertrophic cardiomyopathy],0.052,0,0.0,0.0,0.0,0.0,0.257,0.0,0.167,1.987,0.706,0.057,0.096,0.164,4
TFRC,BI_179.7 [Common variable immunodeficiency [CVID]],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.059,2.69,3.284,2.997,0.071,,2
PTPRD,GI_540.11 [Autoimmune hepatitis],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.099,3.231,3.199,0.625,0.44,,2
GABRA2,GI_509.3 [Hypertrophy of tongue papillae],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.187,0.114,,0.117,,1
NPEPPS,NS_328.13 [Frontotemporal dementia [FTD]],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,2.408,0.992,0.054,0.139,,2
CACNA1A,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.052,0,0.0,0.0,0.0,0.0,0.427,0.129,0.038,1.789,3.22,2.461,0.078,0.412,5
PTK2B,CV_433.3 [Cerebrovascular insufficiency],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.19,1.949,3.774,0.149,0.2,0.732,3
REPS1,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.052,0,0.0,0.0,0.0,0.0,0.0,0.502,0.039,,2.417,0.421,0.175,0.294,4
LPGAT1,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.524,0.117,0.034,0.09,0.167,2
FGFR2,EM_249.1 [Cerebral amyloid angiopathy*],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,2.42,0.721,0.182,0.117,,2
GSK3B,GU_580.1 [Acute nephritic syndrome],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.039,2.276,1.696,,0.118,0.941,3
ZBTB18,GE_972.2 [Hereditary ataxia],0.052,0,0.0,0.0,0.547,0.0,0.0,0.0,0.0,2.59,0.202,,0.098,0.234,3
CTDP1,DE_669.2 [Behcet's syndrome],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.143,2.889,0.226,0.302,0.124,,2
RHOG,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.519,,0.014,0.201,1
EBF1,GE_977.6 [Congenital cutaneous mastocytosis*],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.207,2.2,1.823,0.056,0.053,,2
RGS7BP,GE_972.1 [Hereditary neuropathy],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,2.11,0.104,0.062,0.14,,2
SOCS6,CM_763.13 [Patent ductus arteriosus],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.372,0.128,0.048,0.029,0.308,2
ALB,GE_978.22 [Ehler's Danlos syndrome],0.052,0,0.0,0.0,0.0,0.0,0.0,0.362,0.232,1.896,1.564,0.244,0.08,,3
KCNA4,GE_972.2 [Hereditary ataxia],0.052,1,2.0,0.0,0.0,0.0,0.0,0.0,0.012,2.708,3.107,,0.087,0.885,3
SDHA,GE_963.1 [Lipid storage disorders],0.052,0,0.0,0.0,0.547,0.0,0.0,0.0,0.086,2.382,3.148,0.193,0.052,0.991,4
WT1,CV_414.1 [Hypertrophic cardiomyopathy],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.096,2.399,2.711,,0.057,0.562,3
RPL19,BI_162.1 [Constitutional (hereditary) aplastic anemia],0.052,0,0.0,0.0,0.654,0.0,0.0,0.013,0.026,2.475,0.042,0.022,0.026,,3
NOS1,GE_970.1 [Sickle-cell disorders],0.052,1,3.0,0.0,0.0,0.0,0.0,0.0,0.012,2.318,0.502,0.164,0.529,,2
SETX,GE_972.1 [Hereditary neuropathy],0.052,0,0.0,0.0,0.0,0.0,0.0,0.156,0.073,2.083,3.258,0.558,0.737,,3
FN1,GE_970.2 [Thalassemia],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.137,3.145,3.674,0.456,0.935,,2
NOX4,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.052,0,0.0,0.0,0.0,0.151,0.0,0.0,0.108,2.508,3.932,1.56,0.27,0.756,3
MSI2,NS_339.2 [Myotonic disorders],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.62,2.778,3.15,0.067,0.065,,2
CP,CV_414.1 [Hypertrophic cardiomyopathy],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.119,,2.537,0.223,0.207,0.07,3
ASTN2,MB_306 [Conduct disorders],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.065,2.763,5.989,3.935,0.187,,2
SNX9,GU_580.52 [Diffuse membranous glomerulonephritis],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.106,2.383,0.134,0.129,0.128,,2
GNA12,GE_964.3 [Glycogen storage disease],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.789,0.107,0.107,0.082,,2
PNPT1,NS_341.1 [Cerebral palsy],0.052,0,0.0,0.0,0.532,0.0,0.0,0.0,0.0,,0.692,0.431,0.2,0.957,2
TSPAN5,MB_302.1 [Speech and language developmental delay],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.165,0.059,0.042,0.103,0.266,2
JAK2,MS_700.42 [Dermatomyositis],0.052,1,3.0,0.0,0.0,0.0,0.0,0.0,0.238,3.352,1.784,0.225,0.166,,2
RPL14,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.626,3.149,,0.031,0.262,2
PSMD1,CV_414.1 [Hypertrophic cardiomyopathy],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.033,,2.464,0.128,0.579,0.167,3
LDHA,GE_964.3 [Glycogen storage disease],0.052,0,0.0,0.0,0.0,0.0,0.346,0.547,0.024,2.552,0.495,0.378,0.074,,4
GDAP2,GE_972.2 [Hereditary ataxia],0.052,0,0.0,0.0,0.816,0.0,0.0,0.0,0.015,,2.788,0.469,0.239,0.235,4
HRH2,CV_416.8 [Pre-excitation syndrome [Anomalous atrioventricular excitation]],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.642,0.231,,0.086,0.217,2
REL,NS_338.1 [Myasthenia gravis],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.385,1.75,0.163,0.146,,2
JAG1,SO_386.5 [Color vision deficiencies],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,2.318,2.725,0.163,0.124,0.96,3
FLNA,CM_763.13 [Patent ductus arteriosus],0.052,0,0.0,0.0,0.0,0.0,0.0,0.442,0.024,,3.96,0.419,0.097,0.918,4
KCNV1,SO_365.3 [Exophthalmos [Proptosis]],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.092,0.117,,0.106,0.133,2
F2,DE_669.2 [Behcet's syndrome],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.228,2.112,2.694,0.079,0.065,,2
TFAP2B,GE_978.22 [Ehler's Danlos syndrome],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.112,2.031,1.972,0.12,0.063,,2
GABRA2,GE_972.9 [Muscular dystrophy],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.208,0.09,,0.086,0.195,2
NFE2L2,GE_978.22 [Ehler's Danlos syndrome],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.087,1.984,2.284,0.105,0.068,,2
LRP4,NS_323.3 [Motor neuron disease],0.052,1,0.5,0.0,0.0,0.0,0.0,0.0,0.108,,3.586,0.499,0.407,0.114,3
PTPA,CV_433.3 [Cerebrovascular insufficiency],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.322,1.412,0.816,0.119,1.749,,2
CISD2,CM_763.13 [Patent ductus arteriosus],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.03,0.027,0.018,0.167,1
PPP2R2C,MS_703.2 [Chondrocalcinosis],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.672,0.238,,0.185,,1
NDUFS1,SO_380.3 [Optic atrophy],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,1.686,0.102,0.231,0.974,2
CHGB,NS_323.3 [Motor neuron disease],0.052,0,0.0,0.0,0.566,0.0,0.0,0.0,0.088,2.595,2.649,0.504,0.199,0.107,4
CNTN1,MS_712.51 [Hypermobility syndrome],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.122,3.454,2.472,0.259,1.51,,2
ARPC4,CV_438.41 [Aortic dissection],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.882,0.053,,,0.082,2
SOX17,NS_341.1 [Cerebral palsy],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.28,3.156,0.165,0.093,0.977,2
SLC12A2,GE_972.1 [Hereditary neuropathy],0.052,0,0.0,0.0,0.0,0.0,0.502,0.0,0.023,2.971,2.22,0.56,0.942,,3
ACLY,GI_542.8 [Biliary cirrhosis],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.131,,3.235,0.303,0.334,,2
EZH2,GE_961.1 [Phakomatoses],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.022,1.747,2.069,0.056,0.113,0.932,3
MEX3B,CV_413.41 [Pulmonary valve stenosis],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.054,1.806,0.035,0.065,0.164,2
GRN,MB_306 [Conduct disorders],0.052,0,0.0,0.0,0.0,0.272,0.0,0.0,0.062,,2.579,0.127,0.098,,2
UBE2D2,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.467,0.068,,0.022,0.311,2
NLRP3,GE_976.5 [Polycystic kidney disease],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.134,2.859,2.408,0.19,0.238,,2
ABL1,CV_414.1 [Hypertrophic cardiomyopathy],0.052,1,0.5,0.0,0.0,0.0,0.452,0.0,0.0,3.014,2.841,1.14,0.359,0.911,3
PTGS2,GI_540.4 [Alcoholic hepatitis],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.036,2.073,2.114,0.111,0.13,,2
AIDA,CV_438.3 [Aneurysm of carotid artery],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.117,,0.134,,0
NRG1,NS_323.3 [Motor neuron disease],0.052,0,0.0,0.0,0.0,0.0,0.297,0.0,0.095,3.301,3.105,0.255,0.249,0.614,4
WTAP,CV_433.3 [Cerebrovascular insufficiency],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.024,1.853,1.73,,0.075,0.233,3
MLH1,NS_323.3 [Motor neuron disease],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,,4.17,0.643,0.262,0.049,3
INSR,NS_339.2 [Myotonic disorders],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.26,1.831,1.056,0.11,0.102,,2
NAMPT,MB_306 [Conduct disorders],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.061,1.984,0.609,0.037,0.059,,2
CD55,GU_580.52 [Diffuse membranous glomerulonephritis],0.052,0,0.0,0.0,0.0,0.0,0.437,0.0,0.433,2.866,0.139,0.075,0.07,,3
SPI1,GE_961.1 [Phakomatoses],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.608,,0.267,0.235,0.067,0.556,2
APP,MB_306 [Conduct disorders],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.091,2.01,2.409,0.989,0.146,,2
NLRP3,MS_700.43 [Polymyositis],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.419,1.836,0.754,0.072,0.089,,2
BMAL1,NS_333.4 [Circadian rhythm sleep disorder],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.068,2.012,,,,,2
RPS29,CV_414.1 [Hypertrophic cardiomyopathy],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.062,,,0.127,1
LORICRIN,MB_302.1 [Speech and language developmental delay],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.043,2.081,2.085,0.05,0.05,,2
DRD2,GE_978.22 [Ehler's Danlos syndrome],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.231,1.363,3.562,1.288,0.1,,2
PTPRF,SO_369.62 [Keratoconus],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.191,1.787,3.39,0.1,0.116,0.118,3
SORT1,MS_705.2 [Juvenile rheumatoid arthritis [JRA/JIA]],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.146,,2.18,0.144,0.091,,2
VWF,EM_211.1 [Adrenal hyperfunction],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.098,2.677,3.154,0.911,0.125,,2
CD163,DE_669.4 [Febrile neutrophilic dermatosis [Sweet's syndrome]*],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.046,2.04,0.165,0.054,0.061,,2
AGPAT1,GE_977.1 [Congenital ichthyosis],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.064,,0.023,0.347,1
CASP3,NS_344.2 [Benign intracranial hypertension],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.355,1.938,0.163,0.089,0.973,2
ANGPT1,CV_438.43 [Coronary artery dissection],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.624,0.2,0.1,0.113,,2
CDH1,CV_433.3 [Cerebrovascular insufficiency],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.015,,2.343,0.313,0.19,0.982,3
EHD3,MS_704.3 [Thrombotic microangiopathy],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.079,1.424,0.078,0.051,0.056,,2
PPP1CB,EM_209.4 [Diabetes insipidus],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.325,0.097,0.026,0.027,0.258,2
KIF21A,GE_972.9 [Muscular dystrophy],0.052,0,0.0,0.023,0.0,0.0,0.0,0.0,0.091,,3.001,0.089,0.219,0.142,4
KCNV1,GE_972.9 [Muscular dystrophy],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.869,0.052,,2.954,0.09,2
RUVBL2,SO_386.5 [Color vision deficiencies],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.685,,0.017,0.279,2
RPL35A,SO_380.3 [Optic atrophy],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.148,0.028,0.033,0.311,1
CDKN1C,GU_580.51 [Focal and segmental glomerular lesions*],0.052,0,0.0,0.0,0.0,0.0,0.47,0.0,0.091,1.404,2.14,,2.659,,3
DYNLL2,CM_763.13 [Patent ductus arteriosus],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.45,0.047,,,0.24,2
PLAG1,MS_704.2 [Wegener's granulomatosis],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.091,1.349,0.18,0.145,0.069,,2
MUC2,CV_414.1 [Hypertrophic cardiomyopathy],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.102,2.638,2.775,0.179,0.251,0.065,3
NFKB2,BI_179.7 [Common variable immunodeficiency [CVID]],0.052,0,0.0,0.0,0.0,0.0,0.687,0.561,0.17,,0.868,0.045,0.042,,3
GRIA4,NS_341.1 [Cerebral palsy],0.052,1,4.0,0.0,0.0,0.0,0.0,0.0,0.0,1.729,2.45,0.168,1.035,0.907,2
BRD2,CV_414.1 [Hypertrophic cardiomyopathy],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.082,,3.192,1.91,0.418,0.13,3
FSTL1,CV_438.43 [Coronary artery dissection],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.103,2.702,3.457,3.202,1.825,,2
GNAS,EM_209.12 [Syndrome of inappropriate secretion of antidiuretic hormone],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.983,0.231,0.15,0.118,,2
KCNV1,RE_484.1 [Spontaneous pneumothorax],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.601,0.103,,0.124,0.068,2
SNRNP200,SO_386.5 [Color vision deficiencies],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.463,3.339,0.156,0.153,0.986,2
MKI67,BI_179.1 [Hypogammaglobulinemia NOS],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.638,3.856,0.167,0.215,0.982,2
SMAD3,GE_976.5 [Polycystic kidney disease],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.08,2.707,2.608,0.072,0.111,,2
MED13,GE_961.1 [Phakomatoses],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.061,3.255,2.702,0.722,0.301,0.09,3
SLC4A1,GE_970.1 [Sickle-cell disorders],0.052,0,0.0,0.0,0.0,0.0,0.423,0.0,0.045,,1.422,0.735,0.098,,3
ACTN2,GE_973.5 [Huntington's disease],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.035,2.195,1.288,0.169,0.088,,2
ARHGEF3,GI_540.11 [Autoimmune hepatitis],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.109,2.098,1.983,0.432,0.143,,2
SOCS3,GI_542.8 [Biliary cirrhosis],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.202,3.195,0.258,,2.419,,2
TARDBP,CV_416.8 [Pre-excitation syndrome [Anomalous atrioventricular excitation]],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.257,0.032,0.026,0.275,1
SMAD5,CV_416.8 [Pre-excitation syndrome [Anomalous atrioventricular excitation]],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.617,0.193,,0.032,0.279,2
HDAC2,GE_972.2 [Hereditary ataxia],0.052,0,0.0,0.068,0.0,0.0,0.0,0.0,0.036,1.913,0.237,0.167,0.101,0.904,4
RUNX1,SO_365.3 [Exophthalmos [Proptosis]],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.822,0.145,0.088,0.229,0.97,2
TSPAN5,NS_344.2 [Benign intracranial hypertension],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.004,0.035,0.037,0.095,0.145,2
ADA,BI_179.1 [Hypogammaglobulinemia NOS],0.052,0,0.0,0.0,0.895,0.0,0.0,0.0,0.049,,3.194,0.638,0.131,0.98,4
PRKCA,GE_972.2 [Hereditary ataxia],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.04,3.159,1.869,0.147,0.132,0.836,3
GNA14,NS_324.2 [Degenerative diseases of the basal ganglia (excluding parkinsonism)],0.052,0,0.0,0.0,0.0,0.0,0.0,0.362,0.018,2.241,0.458,0.278,1.553,0.318,4
CD86,MS_705.2 [Juvenile rheumatoid arthritis [JRA/JIA]],0.052,1,4.0,0.259,0.0,0.0,0.0,0.0,0.063,1.65,0.726,0.056,0.06,,3
MTOR,CV_413.41 [Pulmonary valve stenosis],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.288,3.205,0.178,0.151,0.984,2
PSMA2,CM_763.31 [Ventricular septal defect],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.099,,0.033,0.286,1
PTK2B,SO_369.62 [Keratoconus],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.023,2.338,2.551,0.756,0.231,0.062,3
CD70,BI_179.1 [Hypogammaglobulinemia NOS],0.052,0,0.0,0.0,0.547,0.0,0.0,0.0,0.046,1.709,0.222,0.059,2.251,0.894,4
BCORL1,NS_333.4 [Circadian rhythm sleep disorder],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.669,3.408,,2.069,0.077,2
ITPR1,CV_413.13 [Mitral valve stenosis],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,5.18,4.026,0.576,0.744,,2
TFRC,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.142,2.552,2.513,1.362,0.186,0.995,3
PSAP,NS_344.13 [(Idiopathic) normal pressure hydrocephalus],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.091,,2.672,0.26,0.115,,2
ASF1A,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.984,0.083,,3.155,0.111,2
DRD4,MB_287.2 [Schizoaffective disorder],0.052,1,4.0,0.0,0.0,0.0,0.0,0.0,0.096,,2.194,0.273,0.118,,2
ACTA2,CV_438.41 [Aortic dissection],0.052,0,0.0,0.0,0.853,0.0,0.0,0.37,0.077,2.027,3.403,,0.048,0.978,4
GAP43,CV_433.3 [Cerebrovascular insufficiency],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.223,2.464,2.155,0.217,0.101,0.624,3
SERPINC1,CV_433.3 [Cerebrovascular insufficiency],0.052,1,4.0,0.0,0.0,0.0,0.0,0.0,0.104,,0.665,0.109,0.068,0.647,2
CCL1,GE_972.2 [Hereditary ataxia],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,2.072,3.255,0.065,0.034,0.219,3
PDGFRA,DE_663.2 [Pemphigoid],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.157,2.156,2.691,0.131,0.055,,2
RELN,NS_344.11 [Communicating hydrocephalus],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.081,2.435,2.316,0.927,0.186,,2
RASGRF1,SO_369.62 [Keratoconus],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.036,2.89,3.409,0.248,0.685,0.166,3
PLXND1,MS_719.2 [Muscle calcification and ossification],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.134,2.648,2.692,1.302,0.125,,2
RPL19,GU_580.1 [Acute nephritic syndrome],0.052,1,1.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.106,0.045,0.035,0.242,1
ABAT,GE_972.2 [Hereditary ataxia],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.015,2.915,0.225,0.188,0.223,0.961,3
ZNF704,NS_323.3 [Motor neuron disease],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.377,2.287,1.134,0.203,0.009,3
PPP1R12A,DE_663.2 [Pemphigoid],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.073,1.754,1.119,0.371,0.157,,2
VDR,GU_580.1 [Acute nephritic syndrome],0.052,1,4.0,0.0,0.0,0.0,0.0,0.0,0.364,1.765,2.935,0.181,0.083,0.923,3
BRCA1,GE_972.2 [Hereditary ataxia],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.115,1.933,2.766,0.338,0.283,0.961,3
IGF1R,MS_700.3 [Systemic sclerosis],0.052,1,1.0,0.0,0.0,0.0,0.0,0.0,0.212,3.208,3.166,0.439,0.299,,2
KCNV1,NS_338.1 [Myasthenia gravis],0.052,1,4.0,0.0,0.0,0.0,0.0,0.0,0.0,2.262,0.071,,0.114,,1
GALC,NS_341.1 [Cerebral palsy],0.052,0,0.0,0.0,0.684,0.0,0.0,0.0,0.027,3.375,2.737,0.586,0.187,0.941,4
TGM2,CM_770.5 [Congenital osteodystrophies],0.052,0,0.0,0.0,0.0,0.0,0.383,0.0,0.088,2.412,2.517,0.726,0.18,0.85,4
DUSP4,MS_700.3 [Systemic sclerosis],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.103,1.902,0.237,0.117,0.146,,2
EDN1,CM_763.31 [Ventricular septal defect],0.052,0,0.0,0.0,0.532,0.0,0.0,0.0,0.118,2.104,0.304,0.096,0.074,0.688,4
FLNA,BI_161.2 [Extrinsic (acquired) hemolytic anemias],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.16,,3.601,0.861,0.267,0.678,3
CLN3,GE_963.1 [Lipid storage disorders],0.052,1,2.0,0.0,0.0,0.0,0.0,0.912,0.084,,2.784,1.965,0.13,0.077,4
CASK,GI_516.1 [Pyloric stenosis],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.272,2.321,0.248,0.231,0.968,2
IL21R,MS_700.3 [Systemic sclerosis],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.293,2.5,2.233,0.297,0.105,,2
PDC,SO_386.5 [Color vision deficiencies],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.956,0.094,0.164,0.071,0.908,2
APC,MB_306 [Conduct disorders],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.046,2.328,3.936,1.876,0.24,,2
TENM3,GE_961.1 [Phakomatoses],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.363,3.312,,0.095,0.163,2
CELF5,SO_386.6 [Night blindness],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.788,0.241,,0.091,0.21,2
CD9,MS_728.2 [Osteochondritis dissecans],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.182,2.146,2.799,1.924,0.091,,2
DRD4,MB_296.4 [Borderline personality disorder],0.052,1,4.0,0.0,0.0,0.0,0.0,0.0,0.036,,2.613,0.303,0.119,,2
SPAST,NS_323.3 [Motor neuron disease],0.052,0,0.0,0.0,0.829,0.0,0.0,0.0,0.055,1.939,2.23,0.075,1.199,0.826,4
CDC7,BI_162.1 [Constitutional (hereditary) aplastic anemia],0.052,0,0.0,0.0,0.0,0.0,0.362,0.0,0.03,2.457,0.178,0.08,0.118,,3
NFASC,SO_380.3 [Optic atrophy],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,2.091,2.105,0.193,0.251,0.412,3
RPL35,GE_977.1 [Congenital ichthyosis],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.683,0.25,0.035,0.019,0.323,2
DROSHA,CV_433.3 [Cerebrovascular insufficiency],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.012,1.621,2.084,0.186,0.211,0.505,3
TPP1,NS_341.1 [Cerebral palsy],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,,1.921,0.083,0.156,0.962,3
HMGB1,GE_972.2 [Hereditary ataxia],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.098,2.256,1.11,0.096,,0.821,3
SLC7A5,GE_961.1 [Phakomatoses],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.119,2.694,2.334,0.21,0.191,0.63,3
NFKB1,GE_972.1 [Hereditary neuropathy],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.09,3.449,2.836,0.938,0.183,,2
RHOG,EM_208.1 [Hypoparathyroidism],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.422,0.192,,0.021,0.208,2
FOXP2,GE_973.5 [Huntington's disease],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.542,3.048,0.103,0.154,0.068,,2
HIF1A,NS_338.1 [Myasthenia gravis],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.076,3.405,1.805,0.406,0.199,,2
DICER1,NS_323.3 [Motor neuron disease],0.052,1,0.5,0.032,0.0,0.0,0.0,0.0,0.023,1.903,2.661,0.45,0.326,0.788,4
FXYD6-FXYD2,GE_972.2 [Hereditary ataxia],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.328,0.057,,,0.284,2
VEGFA,BI_162.1 [Constitutional (hereditary) aplastic anemia],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.071,2.435,0.14,0.103,0.065,,2
MOV10,GI_540.11 [Autoimmune hepatitis],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.065,,4.62,0.101,0.183,,2
IGF1R,CV_438.41 [Aortic dissection],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.015,3.569,1.923,0.483,1.312,0.748,3
HP,GU_580.52 [Diffuse membranous glomerulonephritis],0.052,0,0.0,0.0,0.0,0.0,0.379,0.0,0.047,3.134,1.891,1.289,0.092,,3
CD19,GE_972.2 [Hereditary ataxia],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.094,,2.692,0.234,0.121,0.542,3
NR3C2,NS_323.3 [Motor neuron disease],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.03,3.136,2.653,,0.038,0.128,3
CYC1,NS_341.1 [Cerebral palsy],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,1.832,0.156,0.119,0.985,2
ATXN2L,NS_333.4 [Circadian rhythm sleep disorder],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.018,1.816,2.83,1.481,0.19,0.061,3
TGFB3,CV_438.41 [Aortic dissection],0.052,0,0.0,0.0,0.426,0.0,0.0,0.0,0.0,,0.19,0.268,1.334,0.972,3
DYNC2H1,CM_770.5 [Congenital osteodystrophies],0.052,0,0.0,0.0,0.0,0.0,0.0,0.901,0.054,3.162,4.244,1.853,0.198,0.516,4
NFKB1,NS_323.3 [Motor neuron disease],0.052,1,0.5,0.0,0.0,0.0,0.0,0.0,0.065,1.558,2.526,0.313,1.049,0.931,3
HGF,SO_369.62 [Keratoconus],0.052,0,0.0,0.0,0.635,0.0,0.0,0.0,0.204,1.85,0.477,0.318,0.233,0.524,4
IL1RAPL1,GE_972.9 [Muscular dystrophy],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.126,3.583,0.224,0.054,0.057,0.28,3
GABRG2,NS_344.2 [Benign intracranial hypertension],0.052,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.003,0.078,0.02,0.068,0.152,2
